file_name	file_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.submitter_id	cases.0.samples.0.portions.0.analytes.0.submitter_id	cases.0.samples.0.portions.0.slides.0.submitter_id	cases.0.samples.0.portions.0.slides.1.submitter_id	cases.0.samples.0.portions.0.submitter_id	cases.0.samples.0.submitter_id	cases.0.submitter_id	cases.0.case_id	cases.0.disease_type	cases.0.primary_site	cases.0.project.project_id	cases.0.samples.0.days_to_collection	cases.0.samples.0.initial_weight	cases.0.samples.0.is_ffpe	cases.0.samples.0.oct_embedded	cases.0.samples.0.pathology_report_uuid	cases.0.samples.0.portions.0.analytes.0.a260_a280_ratio	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_id	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_quantity	cases.0.samples.0.portions.0.analytes.0.aliquots.0.aliquot_volume	cases.0.samples.0.portions.0.analytes.0.aliquots.0.concentration	cases.0.samples.0.portions.0.analytes.0.aliquots.0.source_center	cases.0.samples.0.portions.0.analytes.0.aliquots.0.state	cases.0.samples.0.portions.0.analytes.0.analyte_id	cases.0.samples.0.portions.0.analytes.0.analyte_type	cases.0.samples.0.portions.0.analytes.0.analyte_type_id	cases.0.samples.0.portions.0.analytes.0.concentration	cases.0.samples.0.portions.0.analytes.0.spectrophotometer_method	cases.0.samples.0.portions.0.analytes.0.state	cases.0.samples.0.portions.0.is_ffpe	cases.0.samples.0.portions.0.portion_id	cases.0.samples.0.portions.0.portion_number	cases.0.samples.0.portions.0.slides.0.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.0.percent_necrosis	cases.0.samples.0.portions.0.slides.0.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.0.percent_normal_cells	cases.0.samples.0.portions.0.slides.0.percent_stromal_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_cells	cases.0.samples.0.portions.0.slides.0.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.0.section_location	cases.0.samples.0.portions.0.slides.0.slide_id	cases.0.samples.0.portions.0.slides.0.state	cases.0.samples.0.portions.0.slides.1.percent_lymphocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_monocyte_infiltration	cases.0.samples.0.portions.0.slides.1.percent_necrosis	cases.0.samples.0.portions.0.slides.1.percent_neutrophil_infiltration	cases.0.samples.0.portions.0.slides.1.percent_normal_cells	cases.0.samples.0.portions.0.slides.1.percent_stromal_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_cells	cases.0.samples.0.portions.0.slides.1.percent_tumor_nuclei	cases.0.samples.0.portions.0.slides.1.section_location	cases.0.samples.0.portions.0.slides.1.slide_id	cases.0.samples.0.portions.0.slides.1.state	cases.0.samples.0.portions.0.state	cases.0.samples.0.portions.0.weight	cases.0.samples.0.sample_id	cases.0.samples.0.sample_type	cases.0.samples.0.sample_type_id	cases.0.samples.0.state	cases.0.samples.0.tissue_type	cases.0.state	cases.0.demographic.submitter_id	cases.0.demographic.age_at_index	cases.0.demographic.days_to_birth	cases.0.demographic.days_to_death	cases.0.demographic.demographic_id	cases.0.demographic.ethnicity	cases.0.demographic.gender	cases.0.demographic.race	cases.0.demographic.state	cases.0.demographic.vital_status	cases.0.demographic.year_of_birth	cases.0.demographic.year_of_death	cases.0.exposures.0.submitter_id	cases.0.exposures.0.alcohol_history	cases.0.exposures.0.bmi	cases.0.exposures.0.cigarettes_per_day	cases.0.exposures.0.exposure_id	cases.0.exposures.0.height	cases.0.exposures.0.pack_years_smoked	cases.0.exposures.0.state	cases.0.exposures.0.weight	cases.0.diagnoses.0.submitter_id	cases.0.diagnoses.0.age_at_diagnosis	cases.0.diagnoses.0.ajcc_clinical_t	cases.0.diagnoses.0.ajcc_pathologic_m	cases.0.diagnoses.0.ajcc_pathologic_n	cases.0.diagnoses.0.ajcc_pathologic_stage	cases.0.diagnoses.0.ajcc_pathologic_t	cases.0.diagnoses.0.ajcc_staging_system_edition	cases.0.diagnoses.0.classification_of_tumor	cases.0.diagnoses.0.days_to_diagnosis	cases.0.diagnoses.0.days_to_last_follow_up	cases.0.diagnoses.0.diagnosis_id	cases.0.diagnoses.0.icd_10_code	cases.0.diagnoses.0.last_known_disease_status	cases.0.diagnoses.0.morphology	cases.0.diagnoses.0.primary_diagnosis	cases.0.diagnoses.0.prior_malignancy	cases.0.diagnoses.0.prior_treatment	cases.0.diagnoses.0.progression_or_recurrence	cases.0.diagnoses.0.site_of_resection_or_biopsy	cases.0.diagnoses.0.state	cases.0.diagnoses.0.synchronous_malignancy	cases.0.diagnoses.0.tissue_or_organ_of_origin	cases.0.diagnoses.0.tumor_grade	cases.0.diagnoses.0.tumor_stage	cases.0.diagnoses.0.year_of_diagnosis	cases.0.diagnoses.0.treatments.0.submitter_id	cases.0.diagnoses.0.treatments.1.submitter_id	cases.0.diagnoses.0.treatments.0.state	cases.0.diagnoses.0.treatments.0.treatment_id	cases.0.diagnoses.0.treatments.0.treatment_or_therapy	cases.0.diagnoses.0.treatments.0.treatment_type	cases.0.diagnoses.0.treatments.1.state	cases.0.diagnoses.0.treatments.1.treatment_id	cases.0.diagnoses.0.treatments.1.treatment_or_therapy	cases.0.diagnoses.0.treatments.1.treatment_type	id
fc996542-68f3-4b12-9eb5-dd8680f461fa.htseq.counts.gz	c2effc49-d09c-453d-b533-29611a24355d	TCGA-5N-A9KI-01A-31R-A42T-07	TCGA-5N-A9KI-01A-31R	TCGA-5N-A9KI-01A-03-TS3		TCGA-5N-A9KI-01A-31	TCGA-5N-A9KI-01A	TCGA-5N-A9KI	4fece3d0-649c-4771-b9c4-a3397cea0feb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	903	162.0	False	false	9F2417E9-F7F7-480E-86C8-A5CD1D54CD73	1.94	8b3cfbe2-bb77-4fe0-af7c-569f83701beb			0.17	23	released	b3a8046e-b593-4b20-aa97-008b7dd0935e	RNA	R	0.17	UV Spec	released	False	ee3609f6-a102-4212-a75e-b0d99da08489	31	2.0	1.0	1.0	5.0	0.0	19.0	80.0	80.0	TOP	ab279ef9-6784-4167-b004-6cf911313591	released												released	30.0	d45fa399-718f-48e4-9b59-c58293d47829	Primary Tumor	01	released	Not Reported	released	TCGA-5N-A9KI_demographic	76	-27777	76	288eb045-6a07-5ea4-a3ac-0727e53aca9b	not hispanic or latino	female	white	released	Dead	1935	2011	TCGA-5N-A9KI_exposure	Not Reported	22.405876951331496	3.287671232876712	d74b8ae7-d915-51a5-a3b7-1bba889e5266	165.0	60.0	released	61.0	TCGA-5N-A9KI_diagnosis	27777	T4a	MX	NX	Stage III	T4	7th	not reported	0		cbd16a62-2e04-5466-b4c5-7671070a1593	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-5N-A9KI_treatment_1	TCGA-5N-A9KI_treatment	released	650be4a0-ba80-5722-899a-32149522f2db	no	Pharmaceutical Therapy, NOS	released	09067b36-b2f4-5f27-a81c-2f79e9928d23	no	Radiation Therapy, NOS	c2effc49-d09c-453d-b533-29611a24355d
e7b8a025-567a-4fb4-ab87-2820dfc62382.htseq.counts.gz	5040fe4e-f284-42e8-a153-c67d7f4b4d60	TCGA-GD-A2C5-01A-12R-A180-07	TCGA-GD-A2C5-01A-12R	TCGA-GD-A2C5-01A-01-TS1		TCGA-GD-A2C5-01A-12	TCGA-GD-A2C5-01A	TCGA-GD-A2C5	5d54c742-5a8e-4c40-8d62-95e75e210ab8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	76	260.0	False	false	1522A38C-0867-4275-AB24-FF21B8E988B5	1.79	b8ecfb28-27d0-4ad4-b73c-cc21be41af31			0.17	23	released	4c62383b-e0a3-40f3-bfda-bf1e6ef413e2	RNA	R	0.17	UV Spec	released	False	a8d4a857-3df6-4d13-8b5e-e47c1d03818e	12	1.0	0.0	5.0	0.0	0.0	45.0	50.0	85.0	TOP	743d7349-5493-4db9-9309-cee9c5b1fbea	released												released	30.0	2cd62676-762c-461d-b111-1f81e7cd5877	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A2C5_demographic	53	-19498		208a3f03-443c-58b9-b020-5d02d8865a7e	not hispanic or latino	female	white	released	Alive	1958		TCGA-GD-A2C5_exposure	Not Reported	24.32322868339264	1.6986301369863013	38f332cf-2700-5a71-8167-dd809d32398b	149.0	31.0	released	54.0	TCGA-GD-A2C5_diagnosis	19498		MX	N2	Stage IV	T3a	7th	not reported	0	812	870f150b-96ab-535d-943c-923968f71a41	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A2C5_treatment_1	TCGA-GD-A2C5_treatment	released	a07c757d-75fc-5f75-b4b7-6d259dafcc33	yes	Pharmaceutical Therapy, NOS	released	51cdd7a1-2def-5ae5-a12c-dfce613d8d60	yes	Radiation Therapy, NOS	5040fe4e-f284-42e8-a153-c67d7f4b4d60
9997a399-7d9c-4a88-beb6-5643cdc32ef6.htseq.counts.gz	79083fb2-8b27-4a78-9efa-9db246ab16c8	TCGA-ZF-AA52-01A-12R-A39I-07	TCGA-ZF-AA52-01A-12R	TCGA-ZF-AA52-01A-01-TSA		TCGA-ZF-AA52-01A-12	TCGA-ZF-AA52-01A	TCGA-ZF-AA52	6c5f09f0-2019-4440-8554-e8912bce5e98	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1543	130.0	False	true	85DADBA7-A561-4282-B405-9906A8D3678E	1.86	f18b7d09-aace-4a7e-839a-6f6eeb189f63			0.16	23	released	307b8ffa-58b9-4d84-92de-f3d636b9c5b1	RNA	R	0.16	UV Spec	released	False	7f8113d1-bbb8-4e48-bb37-266b537fc176	12	0.0	0.0	10.0	0.0	0.0	20.0	70.0	80.0	TOP	040b1a37-56b6-4d9f-bdc1-d9402b306d0c	released												released	30.0	1b16d49d-4db7-472c-86be-4be3a1c68624	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA52_demographic	70	-25579	1077	5565dfa5-8a17-5b51-b112-0530960c4446	not hispanic or latino	male	white	released	Dead	1939	2011	TCGA-ZF-AA52_exposure	Not Reported	23.503556057507403	0.1095890410958904	560ad1a3-fa9c-5a1e-8bba-2c7c5b5d4750	181.0	2.0	released	77.0	TCGA-ZF-AA52_diagnosis	25579	T2	MX	NX	Stage III	T3a	6th	not reported	0		cda5d6f6-4b0b-5023-be3b-0f83a33ad120	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2009	TCGA-ZF-AA52_treatment	TCGA-ZF-AA52_treatment_1	released	6d3c57fd-c09c-53d7-90f9-e769209531ad	no	Radiation Therapy, NOS	released	9eb6a287-45ed-5126-9ca4-c1a56521e376	no	Pharmaceutical Therapy, NOS	79083fb2-8b27-4a78-9efa-9db246ab16c8
02bace7d-6f61-4eba-8f3c-205a11c68a67.htseq.counts.gz	4a596189-ccc6-4c82-9be6-3f27bf1e72b7	TCGA-DK-AA74-01A-11R-A39I-07	TCGA-DK-AA74-01A-11R	TCGA-DK-AA74-01A-01-TSA		TCGA-DK-AA74-01A-11	TCGA-DK-AA74-01A	TCGA-DK-AA74	0198d8e5-a14b-44ee-b1c4-d248994845ad	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1258	620.0	False	true	4734B88D-F4C1-433E-A13F-BE4994766B90	1.86	ab176170-0468-4170-91cd-1e8f0b425b0b			0.16	23	released	f5a1163e-b753-4231-b0e3-bc6e2772d566	RNA	R	0.16	UV Spec	released	False	6b925d9a-6c66-4446-a1f4-3a904a65180b	11	3.0	2.0	0.0	7.0	0.0	30.0	70.0	70.0	TOP	9d351ec2-451a-42d1-9e5a-dbd54efb56ab	released												released	30.0	3c6f20b8-63a3-4992-a53f-c56d76153c5b	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA74_demographic	75	-27730		4a290c4a-cf8a-5622-9c67-5c3464d432df	not hispanic or latino	male	white	released	Alive	1935		TCGA-DK-AA74_exposure	Not Reported	31.37798916633637	1.8630136986301369	9792eb61-713f-576c-b19e-1aa34ca655f4	174.0	34.0	released	95.0	TCGA-DK-AA74_diagnosis	27730		M0	N0	Stage III	T3	7th	not reported	0	1708	d9fb4ea3-3c56-5220-bd97-56ef855db28e	C67.1	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Dome of bladder	released	Not Reported	Dome of bladder	not reported	stage iii	2010	TCGA-DK-AA74_treatment	TCGA-DK-AA74_treatment_1	released	5c79b1fb-046f-53b3-bddb-0cc137cce544	no	Radiation Therapy, NOS	released	3d412a5d-4118-5475-ad85-f4a619adca94	no	Pharmaceutical Therapy, NOS	4a596189-ccc6-4c82-9be6-3f27bf1e72b7
d692a80c-d2ae-4827-85a4-c7372a46bcf5.htseq.counts.gz	36f76a45-5941-4c38-8315-6271e24a1164	TCGA-MV-A51V-01A-11R-A26T-07	TCGA-MV-A51V-01A-11R	TCGA-MV-A51V-01A-01-TSA		TCGA-MV-A51V-01A-11	TCGA-MV-A51V-01A	TCGA-MV-A51V	d2f329b3-5b44-414b-bccd-7b2d1345d21e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	171	230.0	False	true	E6737FA1-2DEE-4CF3-AE45-6866FF1F7FF4	1.89	4c8aa0aa-c1ae-4aff-96f2-4636bb1d5c47			0.18	23	released	af05acd4-241d-428a-b09e-078d598cb621	RNA	R	0.18	UV Spec	released	False	7eed3283-3281-4caf-9032-314acf58e925	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	ffb5bc23-ac44-4023-aa72-532b229a7898	released												released	30.0	c0da46cf-81eb-4f1f-8f95-07bccee9f7de	Primary Tumor	01	released	Not Reported	released	TCGA-MV-A51V_demographic	75	-27430		bba17237-2a18-50cb-9d6b-2104ddc96bd2	not hispanic or latino	male	white	released	Alive	1937		TCGA-MV-A51V_exposure	Not Reported			6a37d95a-4864-5aa0-8291-4bfc0ea4f7d5			released	120.0	TCGA-MV-A51V_diagnosis	27430		M0	N0	Stage III	T3a	7th	not reported	0	410	23a16e81-e83d-57e1-be22-9bc7b1e5297b	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-MV-A51V_treatment	TCGA-MV-A51V_treatment_1	released	c20f10bc-c164-5d9c-a114-9a8eb1754512	no	Radiation Therapy, NOS	released	276b228d-5c06-5d01-a549-1f3b66973b88	no	Pharmaceutical Therapy, NOS	36f76a45-5941-4c38-8315-6271e24a1164
2d4ca934-6973-49c9-842f-0325d8d7f4e3.htseq.counts.gz	6b9d4ce3-ed0e-4b7c-b335-ce56ae44cc0c	TCGA-E7-A6MD-01A-41R-A352-07	TCGA-E7-A6MD-01A-41R	TCGA-E7-A6MD-01A-04-TSD		TCGA-E7-A6MD-01A-41	TCGA-E7-A6MD-01A	TCGA-E7-A6MD	92d27fec-30c2-4496-965d-df509d869eaa	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	221	890.0	False	true	9BDC33BB-1DF1-4B0E-A39C-1A173AC0C2CF	1.79	bf6f4d8e-7aa4-42ae-961d-4686984fc871			0.17	23	released	d90b2ca4-f67b-4b6e-a84e-753984cc15d3	RNA	R	0.17	UV Spec	released	False	d2aab72c-216c-4370-a7e2-9a8b0182ae67	41	0.0	0.0	0.0	0.0	0.0	40.0	60.0	70.0	TOP	4a710903-3ebf-4e09-a75b-db53df35caed	released												released	30.0	a42eb242-f16d-4195-b5cf-7b274acfdea1	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A6MD_demographic	66	-24180		118699eb-25a8-5246-b4f9-3bc1212985bc	not hispanic or latino	male	white	released	Alive	1946		TCGA-E7-A6MD_exposure	Not Reported			3ba4ddf9-88e2-5fe6-a892-ec15beea59db			released		TCGA-E7-A6MD_diagnosis	24180	T2	M0	N1	Stage IV	T4a	7th	not reported	0	129	0797ba25-6ae6-5a72-b051-11589373e4af	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iv	2012	TCGA-E7-A6MD_treatment	TCGA-E7-A6MD_treatment_1	released	2a59841e-7584-5733-87cb-f0d3f270dfd5	not reported	Radiation Therapy, NOS	released	45ec9771-2093-58c4-abc0-59cdfe5a4544	not reported	Pharmaceutical Therapy, NOS	6b9d4ce3-ed0e-4b7c-b335-ce56ae44cc0c
ded3d643-44c9-4c09-b26c-58ff45e39e59.htseq.counts.gz	3d36a1e9-cef6-4f52-88ff-38d513594365	TCGA-K4-A3WU-01B-11R-A23N-07	TCGA-K4-A3WU-01B-11R	TCGA-K4-A3WU-01B-01-TS1		TCGA-K4-A3WU-01B-11	TCGA-K4-A3WU-01B	TCGA-K4-A3WU	9aa6522a-120a-4691-993e-3f8534f644b5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	112	270.0	False	false	57551F09-2ACE-481D-99A0-53A0E7814F70	1.8	6c392517-fe3d-4d86-8397-c08734fe20cc			0.18	23	released	a6cb6c2b-353f-4575-bead-618ec666b506	RNA	R	0.18	UV Spec	released	False	b7a60235-12be-44e0-b1ff-e44d328309f9	11	5.0	1.0	20.0	0.0	15.0	0.0	65.0	75.0	TOP	9c0aeb9c-6265-41c9-a761-df75aaf4a9be	released												released	30.0	f91a5f96-cd62-4bdb-b4aa-15c24bee80de	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A3WU_demographic	87	-32134		4d944686-8bdf-52f6-91de-c31451c97041	not hispanic or latino	male	white	released	Alive	1925		TCGA-K4-A3WU_exposure	Not Reported	23.183673469387756		a4fb0f63-f85a-5cf7-aed2-75d6ca3946d1	175.0		released	71.0	TCGA-K4-A3WU_diagnosis	32134	TX	MX	N0	Stage III	T4a	7th	not reported	0	105	926a6122-6d5c-58c2-ac94-835a49f389b5	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-K4-A3WU_treatment	TCGA-K4-A3WU_treatment_1	released	8ace4042-6279-595e-a351-efa109dd6d01	no	Radiation Therapy, NOS	released	556abe13-7af9-5e94-85e5-153adf005e21	no	Pharmaceutical Therapy, NOS	3d36a1e9-cef6-4f52-88ff-38d513594365
7b0bb368-7e9c-4638-9ecc-d1a00ca64ae7.htseq.counts.gz	f3e97d7c-6f7c-41ab-8983-01fb9ba3195a	TCGA-K4-A54R-11A-11R-A26T-07	TCGA-K4-A54R-11A-11R	TCGA-K4-A54R-11A-01-TS1		TCGA-K4-A54R-11A-11	TCGA-K4-A54R-11A	TCGA-K4-A54R	52fddd92-fa5e-4fac-8e44-e64c98c84f86	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	224	50.0	False	true		1.86	fea0469f-786a-4203-95c9-60d0f76c9045			0.18	23	released	6c57dc2a-aaa7-48cc-8b0c-a17acf6dfad2	RNA	R	0.18	UV Spec	released	False	c564b22f-3d87-41b9-a922-8d10f6ef07f3	11	3.0	1.0	0.0	1.0	25.0	75.0	0.0	0.0	TOP	f2d0c146-361d-42c8-95f6-513ddb5cc635	released												released	30.0	f65c2e6d-8ae0-4413-bba1-44146bec7bac	Solid Tissue Normal	11	released	Not Reported	released	TCGA-K4-A54R_demographic	59	-21601		7b9988aa-478f-5845-aaca-049569893e03	not hispanic or latino	male	white	released	Alive	1953		TCGA-K4-A54R_exposure	Not Reported			1c0a981b-5db4-57fd-b2d3-78ab3bcfb7d1			released		TCGA-K4-A54R_diagnosis	21601		MX	N0	Stage II	T2b	7th	not reported	0	842	f5941d8f-afdb-53ac-9f94-f6e29471d54d	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage ii	2012	TCGA-K4-A54R_treatment_1	TCGA-K4-A54R_treatment	released	0d158d59-d3ac-52df-b618-2f23884e8b55	no	Pharmaceutical Therapy, NOS	released	40167fe7-9131-5a02-b2ea-30eecbbd5a50	no	Radiation Therapy, NOS	f3e97d7c-6f7c-41ab-8983-01fb9ba3195a
b2bb6d5c-9e6e-4b0c-bcd2-737295294661.htseq.counts.gz	2b126008-9c5e-4eaf-b8c3-2f1b1b12a4e9	TCGA-DK-A3IK-01A-32R-A21D-07	TCGA-DK-A3IK-01A-32R	TCGA-DK-A3IK-01A-03-TSC		TCGA-DK-A3IK-01A-32	TCGA-DK-A3IK-01A	TCGA-DK-A3IK	3f0a0748-9acc-4d0b-ba18-7c08bd183f86	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	124	720.0	False	true	4BB6EAAF-643A-43F8-A54C-0103A45AD684	1.83	42db28fc-4d5f-4b0f-aa86-7d27197c7649			0.17	23	released	51e9cc74-064e-43d7-a9a3-055e31133552	RNA	R	0.17	UV Spec	released	False	af1c8ce3-ae7f-42a1-bd1c-acaa6c503131	32	2.0	0.0	0.0	0.0	10.0	10.0	80.0	75.0	TOP	b04f78fd-0597-46fa-ad6a-9ae56bec0d8d	released												released	30.0	4ff20c48-29ee-4101-b409-c4573e38cf92	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IK_demographic	87	-32076	146	c3ddc56f-a243-5eeb-b723-71ce84734d47	not hispanic or latino	male	white	released	Dead	1924		TCGA-DK-A3IK_exposure	Not Reported	26.647187728268808		e5c83648-1292-5df9-87a5-deba7e398d16	185.0		released	91.2	TCGA-DK-A3IK_diagnosis	32076		M0	N2	Stage IV	T3	6th	not reported	0	67	cb628374-ca8a-5a78-b5c5-ed7e7199d663	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2011	TCGA-DK-A3IK_treatment_1	TCGA-DK-A3IK_treatment	released	31ef9cf4-9486-510d-b7cb-c0c8760c7b5a	not reported	Pharmaceutical Therapy, NOS	released	9c8b2662-5787-5b6f-9122-706e67862589	not reported	Radiation Therapy, NOS	2b126008-9c5e-4eaf-b8c3-2f1b1b12a4e9
a8b4c5de-a026-4f9a-a9d5-e9d6748ade5e.htseq.counts.gz	598d4823-3260-4f9c-b44e-aad9314fbe5f	TCGA-XF-A9SJ-01A-11R-A39I-07	TCGA-XF-A9SJ-01A-11R	TCGA-XF-A9SJ-01A-01-TSA		TCGA-XF-A9SJ-01A-11	TCGA-XF-A9SJ-01A	TCGA-XF-A9SJ	b319798a-3f35-4902-8ecf-5be529d99312	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3298	510.0	False	true	0093D096-4A35-4543-9FDB-838AE59F0833	1.9	bdf3914e-37f0-4dc2-a246-b22c6ee15f81			0.16	23	released	a7dc1193-3b06-46c4-9d8c-a586598c0136	RNA	R	0.16	UV Spec	released	False	bb36f5b3-1b76-4356-af22-a202062685be	11	3.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	36fd27c4-66c1-4123-adb5-948c5dfe6d5a	released												released	30.0	fd042907-f6ca-4c8b-8e6d-aa24678f444a	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SJ_demographic	83	-30362	98	b0cd2400-d696-59d2-80bc-b80e0672a29e	not hispanic or latino	male	white	released	Dead	1921	2004	TCGA-XF-A9SJ_exposure	Not Reported	27.757487216946675	3.0136986301369864	544c6ed1-24ae-5d6e-a417-c653f3fdea7b	185.0	55.0	released	95.0	TCGA-XF-A9SJ_diagnosis	30362		MX	N2	Stage IV	T3b	6th	not reported	0		77c02230-8a64-5810-b17a-024b09888c4e	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2004	TCGA-XF-A9SJ_treatment	TCGA-XF-A9SJ_treatment_1	released	4349e9d8-8e05-5431-94e9-f4ebf1653ca7	no	Radiation Therapy, NOS	released	66507ef4-cbfc-55fc-990d-792cbaa4fadb	no	Pharmaceutical Therapy, NOS	598d4823-3260-4f9c-b44e-aad9314fbe5f
2e87cee4-718c-4112-aeb7-aad11ccaf13b.htseq.counts.gz	a4db3852-c2e9-4710-b03a-419d59f4e459	TCGA-DK-A1AB-01A-11R-A13Y-07	TCGA-DK-A1AB-01A-11R	TCGA-DK-A1AB-01A-01-TSA		TCGA-DK-A1AB-01A-11	TCGA-DK-A1AB-01A	TCGA-DK-A1AB	f027d254-ec01-4882-a8a7-964ae90b7d49	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	162	310.0	False	true	5FCDE7D1-8263-465D-B0A6-C660B152D86F	1.81	fd79008e-fae5-4276-bc25-eae14eb7b7e4			0.15	23	released	e57baa38-ecdb-463c-9a30-839bb045886d	RNA	R	0.15	UV Spec	released	False	ae929c9e-772e-471f-81fb-0bc8fe41995e	11	2.0	1.0	3.0	1.0	0.0	22.0	75.0	75.0	TOP	d6b87ece-cee6-4565-84d9-3eab55716665	released												released	30.0	253f84ab-fce2-4e2d-955b-0b8d13a9e4f0	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AB_demographic	74	-27126	508	ba01cd71-a7b2-58f5-9769-72b43acbf4da	not hispanic or latino	female	white	released	Dead	1936		TCGA-DK-A1AB_exposure	Not Reported	33.91251333638165		c3d91cfa-dfa3-50c3-b61c-275479d399fe	162.0		released	89.0	TCGA-DK-A1AB_diagnosis	27126		M0	N2	Stage IV	T4a	6th	not reported	0	271	ebc1476a-db5d-5dcd-bde8-e28beefeaef0	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A1AB_treatment_1	TCGA-DK-A1AB_treatment	released	503aeb01-9dcf-59dc-872f-35466347bda7	yes	Pharmaceutical Therapy, NOS	released	1f384c41-8e6c-554d-8d0d-675d1b4f9590	no	Radiation Therapy, NOS	a4db3852-c2e9-4710-b03a-419d59f4e459
8760f18d-3f6d-494a-9ff0-0f22df5a1344.htseq.counts.gz	1af82ec8-d092-4245-a36f-8b992c996a7e	TCGA-GU-A42R-01A-11R-A23N-07	TCGA-GU-A42R-01A-11R	TCGA-GU-A42R-01A-01-TSA		TCGA-GU-A42R-01A-11	TCGA-GU-A42R-01A	TCGA-GU-A42R	0691b8c5-6244-407c-8601-fa1bda01ff2a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	16	160.0	False	true	A916842B-DCE7-42FE-82BC-277D09DFC698	1.8	50dd2bb1-e069-42f8-89f4-1e3055adafee			0.15	23	released	351dcb77-7ad6-4043-a4b8-f46c361e509f	RNA	R	0.15	UV Spec	released	False	97420cbf-568f-4b9c-98d9-e4a752342249	11	0.0	0.0	10.0	0.0	0.0	20.0	70.0	80.0	TOP	23ae363b-d19a-4ca9-8219-ca22eae68071	released												released	30.0	979c176f-5c5c-45ad-a430-beb929d47035	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A42R_demographic	68	-25134	577	7b2555ee-88d5-54d4-8de7-49a0da64381a	not hispanic or latino	male	white	released	Dead	1944		TCGA-GU-A42R_exposure	Not Reported	31.48148148148148	1.095890410958904	3ce695c3-204c-5187-adc4-e60d0cd80e6e	180.0	20.0	released	102.0	TCGA-GU-A42R_diagnosis	25134	T2b	MX	N2	Stage IV	T4a	7th	not reported	0	344	29f6ef3b-4a41-504d-a20c-6c0a47a10fdc	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-GU-A42R_treatment_1	TCGA-GU-A42R_treatment	released	858848be-9762-52b3-bb3d-a74131c93e1e	yes	Pharmaceutical Therapy, NOS	released	a7886568-eddf-5858-bb2b-ed1ee58422bb	no	Radiation Therapy, NOS	1af82ec8-d092-4245-a36f-8b992c996a7e
32841ed1-16e3-4a88-8f5c-7aaf24c84e70.htseq.counts.gz	48566693-0845-44b2-8612-4f713fee1bd7	TCGA-BL-A13J-11A-13R-A10U-07	TCGA-BL-A13J-11A-13R	TCGA-BL-A13J-11A-01-TS1		TCGA-BL-A13J-11A-13	TCGA-BL-A13J-11A	TCGA-BL-A13J	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	246		False	false		1.84	c808f209-8527-4105-819b-610508d9d3b3			0.13	23	released	a4338e9e-9d1e-4b97-8911-049681bf6d54	RNA	R	0.13	UV Spec	released	False	f2202050-aa9a-41b1-8b18-06a0e0fb7600	13	1.0	0.0	0.0	0.0	70.0	30.0	0.0	0.0	TOP	02e153ec-4497-4d52-a6b1-6b80e50a426d	released												released	30.0	2a834a44-9490-4c60-b587-ebe890c3fb0a	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BL-A13J_demographic	65	-23927	81	3a19ccff-885d-524c-85e5-a2606dace97c	not hispanic or latino	male	white	released	Dead	1945	2010	TCGA-BL-A13J_exposure	Not Reported	22.98539751216874	1.3150684931506849	bbd00b5a-a20a-5205-b773-ac6250abbc20	172.0	24.0	released	68.0	TCGA-BL-A13J_diagnosis	23927		M0	N2	Stage IV	T4		not reported	0		48d48f46-0677-517c-b11e-8c7e100a85b2	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2010	TCGA-BL-A13J_treatment	TCGA-BL-A13J_treatment_1	released	691d6cde-1889-5398-be89-5d0b9c88851b	no	Radiation Therapy, NOS	released	04e5320c-e9af-52f4-af45-77a50901166e	no	Pharmaceutical Therapy, NOS	48566693-0845-44b2-8612-4f713fee1bd7
151f8dc5-cfe9-468b-8a85-516ad4a0d29c.htseq.counts.gz	d1d558fb-a666-4ba5-be9b-c5d2c38345d3	TCGA-XF-A9T4-01A-11R-A39I-07	TCGA-XF-A9T4-01A-11R	TCGA-XF-A9T4-01A-01-TSA		TCGA-XF-A9T4-01A-11	TCGA-XF-A9T4-01A	TCGA-XF-A9T4	f9a03eaa-a228-429c-99c5-8e877379db0f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2146	740.0	False	true	82129FB4-5062-4878-931D-C09C336EAE4A	1.88	3a644871-42e4-44b0-901e-512596a018b1			0.16	23	released	d2843808-d56b-48fa-bbce-76f8013941e0	RNA	R	0.16	UV Spec	released	False	49467885-a046-4651-b760-eebb142eb6f9	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	c7d7692a-8a5a-43a1-899a-605484158fda	released												released	30.0	d87953c9-fb82-4c22-9d64-71d1d40071ce	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T4_demographic	48	-17728	495	ccd8c87c-9595-50b6-a114-c3216e5eb3e8	not hispanic or latino	male	white	released	Dead	1960	2009	TCGA-XF-A9T4_exposure	Not Reported	24.691358024691358		b1be1164-3369-56c3-aaa8-9f7c9513a391	180.0		released	80.0	TCGA-XF-A9T4_diagnosis	17728		MX	N1	Stage IV	T2b	6th	not reported	0		01998c14-240c-502d-b802-2ce75f56ba25	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2008	TCGA-XF-A9T4_treatment	TCGA-XF-A9T4_treatment_1	released	6ef306ad-aeb4-5091-9b09-7ff07b1dc06d	no	Radiation Therapy, NOS	released	5b6bcfee-b737-57aa-aa6b-47a36fa3823d	yes	Pharmaceutical Therapy, NOS	d1d558fb-a666-4ba5-be9b-c5d2c38345d3
1e9b3641-f9a3-4e6b-bd2b-4f5eadb44a95.htseq.counts.gz	36cb789c-d361-43ba-b7d6-89659a645406	TCGA-GV-A3JW-01A-11R-A20F-07	TCGA-GV-A3JW-01A-11R	TCGA-GV-A3JW-01A-01-TSA		TCGA-GV-A3JW-01A-11	TCGA-GV-A3JW-01A	TCGA-GV-A3JW	3d644eaf-82fc-4bc7-93b7-3e600e8c6511	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	168	260.0	False	true	AC922A7D-2261-4322-99B5-BA845CC77C85	1.79	57eda6ed-26b0-4bf6-98ad-80f4872b9832			0.17	23	released	7bbea2c4-b284-4c06-bd34-27f71c4da0eb	RNA	R	0.17	UV Spec	released	False	93266f9b-4100-4c42-80f7-5dc5f8062e9f	11	3.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	44f30a37-da81-4eb3-ac7b-089d1ef8296a	released												released	30.0	b02c03b6-24aa-42d3-9310-741de1ef0d30	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3JW_demographic	74	-27091		4da11258-f734-52de-9cda-d3ce26e487a8	not hispanic or latino	male	white	released	Alive	1937		TCGA-GV-A3JW_exposure	Not Reported	29.402920244578837		31c496cd-84ac-58b9-aed0-2bc7cc1e6332	173.0		released	88.0	TCGA-GV-A3JW_diagnosis	27091	T2	MX	NX	Stage II	T2	7th	not reported	0	649	f42346cc-3ce2-5820-9527-770cdc9a28cb	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-GV-A3JW_treatment	TCGA-GV-A3JW_treatment_1	released	4991972c-d15c-559f-bce5-12d18b75ea03	yes	Radiation Therapy, NOS	released	a9dedcfe-4ae9-5bca-8ede-2dab98dd81f9	yes	Pharmaceutical Therapy, NOS	36cb789c-d361-43ba-b7d6-89659a645406
b544edf5-c496-4a5a-91c2-ac3801b97642.htseq.counts.gz	73346681-fd50-476e-ba9d-6b9afa675f74	TCGA-ZF-A9RM-01A-11R-A38B-07	TCGA-ZF-A9RM-01A-11R	TCGA-ZF-A9RM-01A-01-TSA		TCGA-ZF-A9RM-01A-11	TCGA-ZF-A9RM-01A	TCGA-ZF-A9RM	7d71945a-b81a-405c-bb17-cec9b1d7592c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1133	230.0	False	true	F5403E2C-C4B0-4F82-A4E8-E210017FC34B	1.86	bd7c10f2-12d7-4405-a3bc-0809237dcb85			0.18	23	released	09fe20eb-be7a-4b46-9056-66d919bbc60e	RNA	R	0.18	UV Spec	released	False	fa01d031-94d7-4ec9-b80a-6110fa347f37	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	95.0	TOP	9ff9c8fc-42f4-44d6-9803-d6dd8acbbc31	released												released	30.0	6167b47f-c0ed-4aaf-af10-271eef31b663	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RM_demographic	70	-25642		498d28f9-588e-52a4-81bb-74461c60a127	not hispanic or latino	male	white	released	Alive	1940		TCGA-ZF-A9RM_exposure	Not Reported	29.06879615089044	0.4383561643835616	fa18da15-81b5-5c60-8ddc-9242a5bde46f	173.0	8.0	released	87.0	TCGA-ZF-A9RM_diagnosis	25642	T2	MX	N0	Stage II	T0	7th	not reported	0	1455	dd8e3e6c-0adf-5e27-a91c-8df9a90d6622	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2010	TCGA-ZF-A9RM_treatment_1	TCGA-ZF-A9RM_treatment	released	172b8f16-70f8-5a60-8e13-36588d85721b	no	Pharmaceutical Therapy, NOS	released	3293ddcb-fcf4-554f-8b00-ac90c3b96c87	no	Radiation Therapy, NOS	73346681-fd50-476e-ba9d-6b9afa675f74
bafde7f6-9776-4008-be46-38f25b288097.htseq.counts.gz	7dfde740-cfa5-4d3c-8e49-58ecba6d68da	TCGA-KQ-A41P-01A-12R-A33J-07	TCGA-KQ-A41P-01A-12R	TCGA-KQ-A41P-01A-01-TSA		TCGA-KQ-A41P-01A-12	TCGA-KQ-A41P-01A	TCGA-KQ-A41P	d7af7e2c-f742-46ed-814b-1967d7e8c2d2	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	554	290.0	False	true	454B14C5-DD25-4249-85A6-71638DD756F7	1.82	4c23170b-a5e0-41c8-8309-a5bfb2823491			0.16	23	released	4af1131f-cb31-4375-9296-5396f2c1c0b2	RNA	R	0.16	UV Spec	released	False	028f3f6e-d2be-4301-8917-c3e093e4c550	12	5.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	3000ad53-2134-40c4-ab7f-758610e04643	released												released	30.0	4e500021-3c23-46a8-b60b-9952e5c91434	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41P_demographic	76	-27816		635808a2-68f7-5d74-be37-c620ff3cfc54	not hispanic or latino	male	white	released	Alive	1935		TCGA-KQ-A41P_exposure	Not Reported	24.08822311716662		1298252c-2e45-5357-882a-cdf08592c576	163.0		released	64.0	TCGA-KQ-A41P_diagnosis	27816		M1	N3	Stage IV	T3b	7th	not reported	0	1094	33d3abee-d2a4-5594-9817-1d0235c162d2	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2011	TCGA-KQ-A41P_treatment	TCGA-KQ-A41P_treatment_1	released	9a7ca91b-038c-5a5e-a7f5-e03ac7ee1127	no	Radiation Therapy, NOS	released	9f160417-4f6e-5d96-9436-65b8a2fe9891	yes	Pharmaceutical Therapy, NOS	7dfde740-cfa5-4d3c-8e49-58ecba6d68da
58b361c3-fbd2-48d2-a1ae-7e0ef506bbd0.htseq.counts.gz	7a240ed5-f965-45aa-a49f-96c8e576655b	TCGA-XF-A8HE-01A-11R-A36F-07	TCGA-XF-A8HE-01A-11R	TCGA-XF-A8HE-01A-01-TS1		TCGA-XF-A8HE-01A-11	TCGA-XF-A8HE-01A	TCGA-XF-A8HE	841b4582-a268-4a55-a9a2-47c7e5c3b69f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3457	810.0	False	true	AC201676-ED94-488A-BCC3-A9302FDF1D48	1.94	06c37fa7-a8d3-4727-ba1d-69b584b8f585			0.17	23	released	df5e6579-54e8-4690-a09d-b51f7ce0466f	RNA	R	0.17	UV Spec	released	False	45f2ca7b-72a2-41e7-b57b-bcf819dc7a93	11	2.0	0.0	4.0	4.0	0.0	0.0	96.0	80.0	TOP	73d75749-4cb3-432b-bc27-9dfa0241a604	released												released	30.0	fc7aeb8e-4258-47d0-b53b-aa4c358252ad	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HE_demographic	47	-17212		e24eb088-a2b0-5b34-bff6-5fb350968bb4	not hispanic or latino	male	white	released	Alive	1957		TCGA-XF-A8HE_exposure	Not Reported	25.24933720489837		b7a59dcf-e641-50d9-bd17-22e9b092bcd3	178.0		released	80.0	TCGA-XF-A8HE_diagnosis	17212		MX	N0	Stage III	T3b	6th	not reported	0	3817	4c5acf31-43c8-580a-9963-aa18da2d1944	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2004	TCGA-XF-A8HE_treatment	TCGA-XF-A8HE_treatment_1	released	7ec79a1c-39c3-50fa-855f-b4f73c67448a	no	Radiation Therapy, NOS	released	20b3a9f9-1ef1-5385-a32b-a78d81468a85	no	Pharmaceutical Therapy, NOS	7a240ed5-f965-45aa-a49f-96c8e576655b
dd1dfaeb-20a4-4237-ad46-6cc609af2c53.htseq.counts.gz	97a833e1-c2e0-48ad-874e-af222fa5d183	TCGA-4Z-AA7N-01A-11R-A39I-07	TCGA-4Z-AA7N-01A-11R	TCGA-4Z-AA7N-01A-01-TS1		TCGA-4Z-AA7N-01A-11	TCGA-4Z-AA7N-01A	TCGA-4Z-AA7N	7934bd8c-0822-44a3-88a4-a3135a448f2b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1347	70.0	False	true	2CC89A9F-1F30-4232-B960-D8F54E7C57D4	1.91	45517ca1-d687-4f8a-90e4-0b3937221a00			0.18	23	released	ba5897f3-51ab-48cc-9ad4-30d0f385b6de	RNA	R	0.18	UV Spec	released	False	64d83fd4-b052-4bd7-897d-209aebaa12e4	11	12.0	1.0	1.0	5.0	0.0	39.0	60.0	60.0	TOP	3698b2a4-fba5-4d93-9056-59a63f6e33d1	released												released	30.0	8d9b8713-9cd7-484b-9e71-6f381d00c5c3	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7N_demographic	65	-24090	1367	66295a6c-ac6f-5b19-b85e-2a98a9e852d7	not reported	male	white	released	Dead	1945		TCGA-4Z-AA7N_exposure	Not Reported	30.421849648458625		8fd2c806-4525-5c6c-a106-892dba1c8f0f	172.0		released	90.0	TCGA-4Z-AA7N_diagnosis	24090	T2	M0	N0	Stage III	T3a	7th	not reported	0	655	f305c394-67ba-56aa-8a4c-d882051b4ada	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2010	TCGA-4Z-AA7N_treatment	TCGA-4Z-AA7N_treatment_1	released	95cf3cca-0268-5fe2-bd58-6688b701b6ef	yes	Radiation Therapy, NOS	released	3714e097-47dd-5210-916a-bfecc294ca1f	no	Pharmaceutical Therapy, NOS	97a833e1-c2e0-48ad-874e-af222fa5d183
7fdb1ca4-9bcd-418a-8bb6-681fdfd98288.htseq.counts.gz	7d556fd6-5e63-4986-a243-b88a35fcd251	TCGA-KQ-A41Q-01A-11R-A33J-07	TCGA-KQ-A41Q-01A-11R	TCGA-KQ-A41Q-01A-01-TSA		TCGA-KQ-A41Q-01A-11	TCGA-KQ-A41Q-01A	TCGA-KQ-A41Q	a21bdd7e-f3cf-4826-9967-7eaffc0d035a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1294	480.0	False	true	5047D01C-1425-4EE5-BB6F-5DD484C9E030	1.81	c130027b-a3f5-49be-b26d-a0416b7904b5			0.17	23	released	2eccb400-545f-421f-9b73-f0bb8042c988	RNA	R	0.17	UV Spec	released	False	895b8d91-98fc-44ee-bad1-5c2701ddeae3	11	2.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	TOP	71977a32-e534-4f75-8f5d-b4dbe22f184c	released												released	30.0	a52db352-836e-4ba4-8f84-4760e4bf0e39	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41Q_demographic	89	-32511		0bd274d9-9db0-5b42-9d82-e915c79aa82b	not hispanic or latino	male	white	released	Alive	1920		TCGA-KQ-A41Q_exposure	Not Reported	24.09297052154195		88b86090-e745-5703-89a4-e643f919ec5a	168.0		released	68.0	TCGA-KQ-A41Q_diagnosis	32511		MX	N0	Stage III	T3b	7th	not reported	0	361	9cb7ded4-5df6-5cc7-995a-2633168df35b	C67.3	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Anterior wall of bladder	released	Not Reported	Anterior wall of bladder	not reported	stage iii	2009	TCGA-KQ-A41Q_treatment_1	TCGA-KQ-A41Q_treatment	released	d954d05f-fd68-5ccb-80e6-39e00e97191a	yes	Pharmaceutical Therapy, NOS	released	85ee9f61-704f-52d8-9e9b-07052d761a42	no	Radiation Therapy, NOS	7d556fd6-5e63-4986-a243-b88a35fcd251
58169377-7606-4c1e-9af9-a03f23a8df64.htseq.counts.gz	e112cfc8-dcc3-4338-9e9b-459f41fb171c	TCGA-2F-A9KQ-01A-11R-A38B-07	TCGA-2F-A9KQ-01A-11R	TCGA-2F-A9KQ-01A-01-TSA		TCGA-2F-A9KQ-01A-11	TCGA-2F-A9KQ-01A	TCGA-2F-A9KQ	25eaf3f9-c364-423c-aaae-925e7b393afc	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2470	160.0	False	false	F35113C2-F4CC-43EC-8C52-B71B357DDA46	1.92	aa3e32f5-11ad-462a-aa5b-f477cfab3f4f			0.16	23	released	21e5f2bb-318b-49f5-a882-36105fd4febd	RNA	R	0.16	UV Spec	released	False	cdb57afd-c1b8-47cd-8480-b8f546b842ec	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	2b19ac4b-1ff9-4867-a9ee-b39e265ef330	released												released	30.0	32d94d14-818a-4ae5-b290-73170fa2a3ef	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KQ_demographic	69	-25259		ec00db64-3fbd-584d-a298-5654e202d09f	not hispanic or latino	male	white	released	Alive	1938		TCGA-2F-A9KQ_exposure	Not Reported	25.510204081632654		65e7c4aa-383b-5375-920c-886b2edd67b6	168.0		released	72.0	TCGA-2F-A9KQ_diagnosis	25259	TX	M0	N0	Stage III	T3a	6th	not reported	0	2886	314fc1b4-26d6-5fbf-86d9-3337c46c4ab3	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2007	TCGA-2F-A9KQ_treatment_1	TCGA-2F-A9KQ_treatment	released	41cbe0f6-21ea-5687-bd47-5deb7e5b461d	no	Pharmaceutical Therapy, NOS	released	7eda994a-7ac9-5689-9b4c-a1f4060770f6	no	Radiation Therapy, NOS	e112cfc8-dcc3-4338-9e9b-459f41fb171c
eeb06eaa-4116-40dc-ab8c-555fe6806ec1.htseq.counts.gz	440e3ea8-2cf9-4e7b-8120-ac177cfddd65	TCGA-PQ-A6FI-01A-11R-A31N-07	TCGA-PQ-A6FI-01A-11R	TCGA-PQ-A6FI-01A-01-TS1		TCGA-PQ-A6FI-01A-11	TCGA-PQ-A6FI-01A	TCGA-PQ-A6FI	04b9090a-e8ef-4f52-bc52-af90caa84168	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	721	130.0	False	true	9B3FA7CE-F924-4DD5-9E2E-13F889A2B3AA	1.86	74cbc344-560b-439b-bd14-1542ce579967			0.18	23	released	60745c7b-3e05-4549-9535-c352f12a0c0d	RNA	R	0.18	UV Spec	released	False	ec00e780-fb79-4ae7-a699-6acb46a65b00	11	2.0	0.0	10.0	0.0	0.0	0.0	90.0	75.0	TOP	0edd0af7-ab76-44bb-88e6-d8a39fe2d8b2	released												released	30.0	760ad8fe-5f5b-4eed-9147-67780330e08c	Primary Tumor	01	released	Not Reported	released	TCGA-PQ-A6FI_demographic	70	-25672		f08bcd99-5419-5044-bb8c-741f7858040e	not hispanic or latino	male	white	released	Alive	1941		TCGA-PQ-A6FI_exposure	Not Reported	30.103806228373703	3.1780821917808217	df67b103-7ded-548a-ad00-6a9050d00228	170.0	58.0	released	87.0	TCGA-PQ-A6FI_diagnosis	25672		MX	N0	Stage II	T2a	7th	not reported	0	372	be949c12-6df5-534d-b69f-932db993097a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-PQ-A6FI_treatment	TCGA-PQ-A6FI_treatment_1	released	f852797f-6af8-54b0-9f42-a1e119793de1	no	Radiation Therapy, NOS	released	528fb6dc-1bd3-52eb-a9e6-b220632aed9e	no	Pharmaceutical Therapy, NOS	440e3ea8-2cf9-4e7b-8120-ac177cfddd65
d08385ff-4816-4ead-a582-01656b74935e.htseq.counts.gz	8aa058c7-1ef1-462c-8265-bdff7a90bb86	TCGA-DK-A2I2-01A-11R-A180-07	TCGA-DK-A2I2-01A-11R	TCGA-DK-A2I2-01A-01-TS1		TCGA-DK-A2I2-01A-11	TCGA-DK-A2I2-01A	TCGA-DK-A2I2	234086dd-5a74-4ff1-94ab-bad43ee69d5c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	217	530.0	False	true	40F557A8-987A-422A-B28B-A11F2119EE3F	1.93	325c6503-12a1-4985-99a0-b968850f9d92			0.16	23	released	de71d273-2909-4a89-a0f4-41bdc3bbbac0	RNA	R	0.16	UV Spec	released	False	2113db9b-0e38-4fc1-a952-31603be24dcb	11	5.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	7f324f83-57bf-4dc6-a16d-e20a6b428a11	released												released	30.0	45f8e4b6-5d36-47d7-a77d-e5e4c15848b3	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A2I2_demographic	63	-23116	237	c139c815-b9ba-5a8c-bdec-8bf95c190e68	not hispanic or latino	female	white	released	Dead	1947	2010	TCGA-DK-A2I2_exposure	Not Reported	29.666548000474663		972b94cb-9c5c-56e5-a654-55d3fed2bb1d	159.0		released	75.0	TCGA-DK-A2I2_diagnosis	23116		M0	N3	Stage IV	T3	6th	not reported	0		ffae1c0c-94b4-5261-9088-7ac326c06b87	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A2I2_treatment	TCGA-DK-A2I2_treatment_1	released	9b9d8e38-5e39-5fdc-b718-5cdec534ae2a	no	Radiation Therapy, NOS	released	66018105-fd47-5b7d-96ff-c45a66731561	no	Pharmaceutical Therapy, NOS	8aa058c7-1ef1-462c-8265-bdff7a90bb86
8266eaa8-ef8c-4e0a-b167-c4d301598b0e.htseq.counts.gz	21d3f5c1-62c0-4fe4-9922-4f63453c87ad	TCGA-DK-A1AF-01A-11R-A13Y-07	TCGA-DK-A1AF-01A-11R	TCGA-DK-A1AF-01A-01-TSA		TCGA-DK-A1AF-01A-11	TCGA-DK-A1AF-01A	TCGA-DK-A1AF	f3104468-bf17-434b-8a7e-bc3b253121ea	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	129	200.0	False	true	587A4629-6ADF-46A3-9F02-A167120286D2	1.86	3add40ce-6d64-4ded-9ab6-2f076c420dc4			0.17	23	released	42c7fb43-340b-4833-8a29-7e4b47622cb7	RNA	R	0.17	UV Spec	released	False	8c1feaee-5f7c-4f33-984a-0497df79a72c	11	6.0	2.0	0.0	1.0	0.0	30.0	70.0	70.0	TOP	df3dc54c-2f67-46a4-8e10-6d4d7c510a69	released												released	30.0	7f6ea115-7795-4552-bb1c-33bfd5f9fe8a	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AF_demographic	84	-30914		4062eb95-e04e-548a-8b8b-a489271449ec	not hispanic or latino	female	white	released	Alive	1926		TCGA-DK-A1AF_exposure	Not Reported	28.263504155124654		4e4a3ff4-f972-5bea-93cb-83dca359cbea	152.0		released	65.3	TCGA-DK-A1AF_diagnosis	30914		M0	N2	Stage IV	T3	6th	not reported	0	536	abdcdf80-9825-5987-b019-2fb07ec96c1b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A1AF_treatment	TCGA-DK-A1AF_treatment_1	released	1375506c-6653-52e9-bc22-ce8c59ddc833	no	Radiation Therapy, NOS	released	c697a15b-1789-59b5-84c1-904250693e0e	yes	Pharmaceutical Therapy, NOS	21d3f5c1-62c0-4fe4-9922-4f63453c87ad
c02741cf-f103-411b-8bac-32138b8f26e5.htseq.counts.gz	72e9f462-4f6e-4e0d-b154-cd0e0cee5686	TCGA-KQ-A41R-01A-21R-A352-07	TCGA-KQ-A41R-01A-21R	TCGA-KQ-A41R-01A-02-TSB		TCGA-KQ-A41R-01A-21	TCGA-KQ-A41R-01A	TCGA-KQ-A41R	e492d5a9-7ec5-454b-ae89-077c90f67489	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	294	240.0	False	true	D54B3725-D134-4F18-9FFC-8074F8942BC6	1.8	9c9b4aa6-08b2-43f3-b68b-995df66c0494			0.15	23	released	150095df-b1a6-47bf-b39c-037fb8223924	RNA	R	0.15	UV Spec	released	False	89cfcbfb-0542-44dd-b03f-948230a4c339	21	2.0	0.0	5.0	0.0	0.0	20.0	75.0	80.0	TOP	f0d171df-67af-427b-8eef-c33eda93536c	released												released	30.0	d25c4cba-553c-459a-9249-433726b84c3a	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41R_demographic	80	-29351		c4bc83bb-8713-5115-9a6d-3c2203ce9521	not hispanic or latino	female	white	released	Alive	1931		TCGA-KQ-A41R_exposure	Not Reported		1.095890410958904	d932e6fc-5005-5738-a3a0-270e2da7edc8		20.0	released		TCGA-KQ-A41R_diagnosis	29351		MX	N0	Stage II	T2	7th	not reported	0	1350	2256719d-ca57-5db0-8334-8382f7cffa1a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-KQ-A41R_treatment	TCGA-KQ-A41R_treatment_1	released	b8cc3b96-a1e8-5fc8-8757-d9f9991c7810	no	Radiation Therapy, NOS	released	252864c0-8cb3-5a46-a7f1-aa3f324ff376	no	Pharmaceutical Therapy, NOS	72e9f462-4f6e-4e0d-b154-cd0e0cee5686
384809f6-af50-4fcb-b269-c72c1a0e77a4.htseq.counts.gz	190d9a20-21b9-412b-8f2b-b43371f459b1	TCGA-GC-A3OO-01A-11R-A22U-07	TCGA-GC-A3OO-01A-11R	TCGA-GC-A3OO-01A-01-TS1		TCGA-GC-A3OO-01A-11	TCGA-GC-A3OO-01A	TCGA-GC-A3OO	1ff60fd9-3ca3-43be-92a8-8dba2cd4d4df	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	111	10	False	false	F4DFFC0E-5A8F-4BC0-8CF2-011F13468ABD	1.8	ad2ee4b7-ec51-4076-bc5b-6601b5abeecb	2.21	13	0.17	23	released	0ad7e305-55fc-4232-a4f3-8023c39b6fc9	RNA	R	0.17	UV Spec	released	False	99cb1634-291c-4b81-9aeb-f7a25a99d08b	11	0	0	0	0	0	20	80	60	TOP	95dff291-07a6-4740-be5f-78e7a1ad40e2	released												released	10	91e7f41c-17b3-4724-96ef-d3c207b964e1	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3OO_demographic	79	-29065		d5311ddc-aef9-5139-b102-e30910ae5129	not hispanic or latino	male	white	released	Alive	1932		TCGA-GC-A3OO_exposure	Not Reported	38.81871659350831		b086615d-4445-5e07-b820-f08ce43f3b7b	183.0		released	130.0	TCGA-GC-A3OO_diagnosis	29065	T2b	M0	N0	Stage II	T2b	7th	not reported	0	481	4d51b5fd-9656-5d5d-9b90-83b9f56ad6bd	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-GC-A3OO_treatment_1	TCGA-GC-A3OO_treatment	released	5d467917-146c-5646-8f5a-4ec8f978ae4e	no	Pharmaceutical Therapy, NOS	released	29c3b136-54e4-5cb9-860c-3c47cb68e6e0	no	Radiation Therapy, NOS	190d9a20-21b9-412b-8f2b-b43371f459b1
95622ade-3084-4ddb-93a1-e6baac7769f7.htseq.counts.gz	8780ee07-863f-4da1-afcc-85ec1769ee57	TCGA-DK-A3WX-01A-22R-A22U-07	TCGA-DK-A3WX-01A-22R	TCGA-DK-A3WX-01A-02-TSB		TCGA-DK-A3WX-01A-22	TCGA-DK-A3WX-01A	TCGA-DK-A3WX	d63c186d-add6-492e-8250-e83f46d39d00	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	223	280	False	true	9E6A2855-20DB-4EFD-ADFF-8B82CD356533	1.79	024bc00e-0419-4dc6-8df4-ad3af476314d	2.21	13	0.17	23	released	75a32307-a1ee-40d8-b4ac-e39de3b001cd	RNA	R	0.17	UV Spec	released	False	9a6871b8-1f87-438f-a9f2-5ad509a73ffc	22	5	2	20	8	0	60	20	60	TOP	f36c40c2-0e6c-4c24-ac4e-6cdde929e460	released												released	30	fed73c89-75f1-45c9-b14b-7840c52c305f	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3WX_demographic	67	-24553	321	327ecda5-b5b2-510f-9047-a64c588d06d2	not hispanic or latino	female	white	released	Dead	1944	2011	TCGA-DK-A3WX_exposure	Not Reported	28.04037814452812	1.643835616438356	a7da5918-d7ba-5a9c-b597-6687d86c0996	158.0	30.0	released	70.0	TCGA-DK-A3WX_diagnosis	24553	T2	M0	N0	Stage III	T3	6th	not reported	0		75da8c11-004f-52d1-9efd-4603456a038b	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2011	TCGA-DK-A3WX_treatment_1	TCGA-DK-A3WX_treatment	released	82f99123-9b17-5ea3-a27b-f5113231e3c7	yes	Pharmaceutical Therapy, NOS	released	1cbe837a-4f51-572c-88de-0a6351892297	yes	Radiation Therapy, NOS	8780ee07-863f-4da1-afcc-85ec1769ee57
7a2815fa-4e07-4d3c-ab0a-6ab62e4b3216.htseq.counts.gz	5af04f7a-b307-4cf3-9bd8-7ce2c8698cc0	TCGA-GD-A3OP-11A-11R-A220-07	TCGA-GD-A3OP-11A-11R	TCGA-GD-A3OP-11A-01-TS1		TCGA-GD-A3OP-11A-11	TCGA-GD-A3OP-11A	TCGA-GD-A3OP	31da07bb-6752-49a3-a7ea-5427c04a9458	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	120	False	false		1.85	4ebf0418-8dc9-45d3-a525-d5e2ddef1fb5	1.95	13	0.15	23	released	cf6e514e-cc32-4dc0-9096-f6f6bd9176c4	RNA	R	0.15	UV Spec	released	False	4ec10ea4-8d9a-4a07-ba91-898ddfe6ebf6	11	0	0	0	0	10	90	0	0	TOP	1565c919-dac3-4771-b6a0-45d09a2568e7	released												released	30	22340b82-9219-49c6-b511-fda79f24f36e	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GD-A3OP_demographic	84	-30956		5f4725ee-f7e9-5c1f-92a7-cadf8407ab33	not hispanic or latino	female	white	released	Alive	1927		TCGA-GD-A3OP_exposure	Not Reported			897e56dc-1f09-5203-a594-c79340889c62			released		TCGA-GD-A3OP_diagnosis	30956		MX	N2	Stage IV	T4a	7th	not reported	0	64	eb33f4c4-5a01-5da3-a735-b6fa9b706657	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A3OP_treatment_1	TCGA-GD-A3OP_treatment	released	79638d7c-f35b-5da5-87b8-4a4edd409862	not reported	Pharmaceutical Therapy, NOS	released	a51e720f-9ca8-59cb-bccd-c68fe848f424	not reported	Radiation Therapy, NOS	5af04f7a-b307-4cf3-9bd8-7ce2c8698cc0
8f6adb29-73cc-4152-8c4e-0a1231ce9c15.htseq.counts.gz	5de06604-d6d4-49e3-a163-5808783c5649	TCGA-CU-A0YN-01A-21R-A10U-07	TCGA-CU-A0YN-01A-21R	TCGA-CU-A0YN-01A-02-BSB	TCGA-CU-A0YN-01A-02-TSB	TCGA-CU-A0YN-01A-21	TCGA-CU-A0YN-01A	TCGA-CU-A0YN	679a6869-2ce9-4472-8db1-8869e2c1a440	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1827	60.0	False	false	B3A36579-3E87-408D-AC04-19A8136E1E7A	1.88	3d1b5ffe-38d6-4073-9020-c6897727341c			0.17	23	released	fa3b7970-3ae9-4476-aadc-d1c4c5c837f0	RNA	R	0.17	UV Spec	released	False	5edc1aad-263a-4bc8-b822-1ecbf637480b	21	0.0	0.0	10.0	0.0	0.0	2.0	88.0	88.0	BOTTOM	3f747a70-289c-4dfb-a0f5-4547cdc26eda	released	1.0	0.0	22.0	0.0	0.0	3.0	75.0	75.0	TOP	bdc4ba09-b77f-44a3-9d46-16c0ac07fda1	released	released	30.0	dbcc2fcb-a103-46da-9893-6ec689d2f98e	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A0YN_demographic	60	-21927	393	52bcca0e-66d3-563b-9d5e-32f95fe87cfa	not hispanic or latino	male	white	released	Dead	1945	2006	TCGA-CU-A0YN_exposure	Not Reported	21.27256659512688	2.191780821917808	40d5a527-56f9-514b-b498-b9d592828e1a	178.0	40.0	released	67.4	TCGA-CU-A0YN_diagnosis	21927		M0	N0	Stage III	T3a	6th	not reported	0		9710f220-c2ba-54af-905e-26226f53c6c3	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2005	TCGA-CU-A0YN_treatment	TCGA-CU-A0YN_treatment_1	released	f5b72aca-780b-52b7-8cd9-32caafee920a	no	Radiation Therapy, NOS	released	2d1d5195-975d-5c26-80ba-cb48fdfe2d7f	no	Pharmaceutical Therapy, NOS	5de06604-d6d4-49e3-a163-5808783c5649
03872f69-93f5-4d6c-aeb3-dadbc2762682.htseq.counts.gz	f222e2c0-b9fe-4041-bcce-3b7af3970c8e	TCGA-4Z-AA7W-01A-11R-A39I-07	TCGA-4Z-AA7W-01A-11R	TCGA-4Z-AA7W-01A-01-TS1		TCGA-4Z-AA7W-01A-11	TCGA-4Z-AA7W-01A	TCGA-4Z-AA7W	821b99bc-7e14-45b9-898d-6e8e149bc8a7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	518	140.0	False	true	07E6E6FB-7E6B-4439-937A-9D479EFC7515	1.87	20c1d8e8-3bb4-4d6b-ae70-659cf0ea07de			0.17	23	released	8a33dec8-b6f0-44bd-89a5-120b8b06bdbb	RNA	R	0.17	UV Spec	released	False	b991600a-760c-41e1-b17e-26b2e532a794	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	10285360-a42d-4cb5-82cf-6f4f3aef4231	released												released	30.0	b6ff3630-077b-4878-b4fc-731600c6368d	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7W_demographic	55	-20424		495041a8-748f-5743-bac9-e83bc8016039	not reported	male	white	released	Alive	1957		TCGA-4Z-AA7W_exposure	Not Reported	24.314123965742485		9b37c515-607e-56b1-9e02-9c40c074a272	166.0		released	67.0	TCGA-4Z-AA7W_diagnosis	20424	T2a	M0	N0	Stage II	T2a	7th	not reported	0	840	c1c6d85a-82b4-5d20-bbce-0394f9ed9576	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2012	TCGA-4Z-AA7W_treatment	TCGA-4Z-AA7W_treatment_1	released	37fa6ea0-add8-50f8-8207-36f41abe5306	no	Radiation Therapy, NOS	released	cde4559d-0b86-541a-9dee-6e205e65d4b3	no	Pharmaceutical Therapy, NOS	f222e2c0-b9fe-4041-bcce-3b7af3970c8e
babb9b78-6b24-4621-8adb-ec81cb149170.htseq.counts.gz	e6d3be5a-53c9-40e8-b962-e8d17f89ae82	TCGA-CF-A9FL-01A-11R-A38B-07	TCGA-CF-A9FL-01A-11R	TCGA-CF-A9FL-01A-01-TSA		TCGA-CF-A9FL-01A-11	TCGA-CF-A9FL-01A	TCGA-CF-A9FL	96292f0e-5d09-4c44-8dfc-73ebde6bf137	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	294	350.0	False	true	1B45E29B-BFF5-4A16-A378-3ECD312DFE2F	1.89	718250e5-65a4-4365-8e2e-3dd4966c4fc6			0.18	23	released	22f0e772-6d1c-4c6d-b423-209adfa521ac	RNA	R	0.18	UV Spec	released	False	9f9d6869-ebce-42e2-81b1-1c943962a929	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	3735fa9c-c590-4983-bff5-c1ffc979352d	released												released	30.0	fa832ba6-9d24-40ba-a7e9-0b426b8b402a	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A9FL_demographic	85	-31099	565	5faf8cbf-bf1e-5e7c-9122-10c7a680b6c0	not hispanic or latino	male	asian	released	Dead	1928		TCGA-CF-A9FL_exposure	Not Reported	16.52892561983471		10ef6e81-69e9-5805-9294-05257cf4c6f4	165.0		released	45.0	TCGA-CF-A9FL_diagnosis	31099		M0	N0	Stage III	T3b	6th	not reported	0	84	e9b7ef14-c4b1-5f77-b267-64d6ea51c4e2	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2013	TCGA-CF-A9FL_treatment	TCGA-CF-A9FL_treatment_1	released	8e15272f-cec5-5f04-8a48-8d3a319a4227	no	Radiation Therapy, NOS	released	8a020d0f-6fee-58dd-ad9e-1a4b20c846a5	no	Pharmaceutical Therapy, NOS	e6d3be5a-53c9-40e8-b962-e8d17f89ae82
c0313f07-c432-46fc-88f4-1b248678b4d3.htseq.counts.gz	d520ca64-7990-4538-8553-c94268782a8a	TCGA-E7-A7PW-01A-11R-A352-07	TCGA-E7-A7PW-01A-11R	TCGA-E7-A7PW-01A-01-TSA		TCGA-E7-A7PW-01A-11	TCGA-E7-A7PW-01A	TCGA-E7-A7PW	045fe498-6a07-41ff-9956-dc0fb0483e7f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	117	1780.0	False	true	7C70BB37-3B12-4980-A232-20E47478BE78	1.84	73afa387-c132-48d6-82da-26517c161f13			0.18	23	released	1c0d9e10-b3e3-41ed-bd49-5c1afa9dcea4	RNA	R	0.18	UV Spec	released	False	6a43994d-71da-438e-a51e-c40f911130da	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	a1a3346b-b696-4a4b-8c8f-229764031e85	released												released	30.0	06dfea18-68e6-460d-a03f-02a92d49c171	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A7PW_demographic	63	-23057		06683865-369c-5a9e-a48f-9a8a6a629182	not hispanic or latino	male	asian	released	Alive	1950		TCGA-E7-A7PW_exposure	Not Reported	19.03114186851211	0.273972602739726	817a97c9-ab3d-53ff-b8ab-e38b7b877d46	170.0	5.0	released	55.0	TCGA-E7-A7PW_diagnosis	23057		M0	NX	Stage III	T3a	7th	not reported	0	416	b652e71d-e8b8-5e94-bd02-3945dcd58e42	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-E7-A7PW_treatment_1	TCGA-E7-A7PW_treatment	released	2daae445-7590-5411-90c1-67ecb6f5953f	no	Pharmaceutical Therapy, NOS	released	bee5ad4a-28db-595d-b819-4823bd4a3d02	yes	Radiation Therapy, NOS	d520ca64-7990-4538-8553-c94268782a8a
99497cc1-b2cf-476b-9b39-b5fbc152c2ea.htseq.counts.gz	d40881e9-17c3-439f-8e3e-4d139e04146c	TCGA-FD-A6TA-01A-12R-A33J-07	TCGA-FD-A6TA-01A-12R	TCGA-FD-A6TA-01A-01-TS1		TCGA-FD-A6TA-01A-12	TCGA-FD-A6TA-01A	TCGA-FD-A6TA	fcda9873-3a93-40b2-913d-4df1e6a27efb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1620	320.0	False	true	876F967E-2CC2-4AFA-9BE7-23D77F6531E3	1.92	6321d37f-3658-447d-96a4-099e8072217a			0.17	23	released	44a1caa2-4329-45db-a6ea-18ab577121e1	RNA	R	0.17	UV Spec	released	False	0db482dd-339b-4c67-a572-6ddd2bf4ac10	12	8.0	2.0	5.0	2.0	0.0	35.0	60.0	82.0	TOP	fc485db2-c186-43cf-89b5-68b4fb6c941b	released												released	30.0	5840fc62-5ac2-4794-8ce9-cdd7bce8019b	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TA_demographic	58	-21196		ac678d9f-c599-5b34-8ede-be2de3dfdf6f	not hispanic or latino	male	white	released	Alive	1951		TCGA-FD-A6TA_exposure	Not Reported	27.143037495265748		b59db251-f40d-55d2-ac5a-eb71a26cfc63	178.0		released	86.0	TCGA-FD-A6TA_diagnosis	21196		MX	N2	Stage IV	T3b	7th	not reported	0	1912	e022fa2c-2a15-5c85-8572-ce0adb5dd1c7	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2009	TCGA-FD-A6TA_treatment_1	TCGA-FD-A6TA_treatment	released	50fe17f7-cb20-555c-8026-9dc3ef2e902b	yes	Pharmaceutical Therapy, NOS	released	1672805b-1926-5662-ae46-d860e7322ef9	no	Radiation Therapy, NOS	d40881e9-17c3-439f-8e3e-4d139e04146c
17a1bd88-a4c7-446f-8097-3a5142d0f5b9.htseq.counts.gz	daba1079-76e1-4b2d-b572-13c0efd5c5cc	TCGA-FD-A43S-01A-21R-A23W-07	TCGA-FD-A43S-01A-21R	TCGA-FD-A43S-01A-02-TSB		TCGA-FD-A43S-01A-21	TCGA-FD-A43S-01A	TCGA-FD-A43S	77236911-d9e0-4b85-829a-a98f1e4b92d2	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	127	1040.0	False	true	E9828A9C-1DD0-45ED-A033-32140DB0C2A2	1.8	a36865ec-a5fa-4277-a887-325373acadb1			0.16	23	released	fccfc5fd-2b88-492e-8462-377590bae28f	RNA	R	0.16	UV Spec	released	False	928f766c-7303-4a0a-ba45-d7461d7cbc36	21	3.0	0.0	0.0	0.0	60.0	0.0	40.0	60.0	TOP	27e872d5-e56c-429d-94ee-ee03531978dd	released												released	30.0	6eb06b71-55d3-4356-8198-bb2643c29e45	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43S_demographic	71	-25993		da3ed7d7-35ab-5cff-8c7c-f1aef3d76692	not hispanic or latino	female	white	released	Alive	1941		TCGA-FD-A43S_exposure	Not Reported	24.747454257779218	8.219178082191782	8dbf987a-2bcb-5260-aed0-2a6a1e6408dd	157.0	150.0	released	61.0	TCGA-FD-A43S_diagnosis	25993	T2	MX	N0	Stage III	T3b	7th	not reported	0	455	3d333a17-123c-531a-9683-3130e277e67e	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-FD-A43S_treatment	TCGA-FD-A43S_treatment_1	released	bd87a0ad-0aa6-524a-a363-06f0b61c5c49	no	Radiation Therapy, NOS	released	d1e2ed7a-9e7d-5d91-86c3-f25a052f7812	yes	Pharmaceutical Therapy, NOS	daba1079-76e1-4b2d-b572-13c0efd5c5cc
9c2fda9c-7daa-40f8-8158-b5fe369d055a.htseq.counts.gz	347163a2-ab90-4f1c-84eb-0041f1464043	TCGA-K4-A4AC-01A-21R-A26T-07	TCGA-K4-A4AC-01A-21R	TCGA-K4-A4AC-01A-02-TSB		TCGA-K4-A4AC-01A-21	TCGA-K4-A4AC-01A	TCGA-K4-A4AC	2088ac24-a8b4-49af-a954-2b78b88a6f66	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	81	600.0	False	true	6925099A-6C31-478E-A7A2-78472DC0BD46	1.87	90c55ddf-3ac3-4599-80f6-e29e486d2070			0.17	23	released	471a625e-468d-4cdf-8871-88d491592b11	RNA	R	0.17	UV Spec	released	False	d49de3cc-d9b4-4c93-8370-a6f79d8aa8cf	21	3.0	2.0	3.0	0.0	0.0	15.0	82.0	85.0	TOP	0c7f4f61-8f2a-4304-92ed-cae7ea02e9bc	released												released	30.0	15ee18e3-8da7-4eea-83f7-7e49d15914c1	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A4AC_demographic	83	-30655	278	280243bb-2818-58b6-afef-f705998931bd	not hispanic or latino	male	white	released	Dead	1929		TCGA-K4-A4AC_exposure	Not Reported			0eb06d06-d3c8-5e8d-bb6f-e8c6568b811e			released		TCGA-K4-A4AC_diagnosis	30655		MX	N0	Stage II	T2b	7th	not reported	0	197	6dca2b4c-4665-563d-af5f-397cdeaab47f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-K4-A4AC_treatment_1	TCGA-K4-A4AC_treatment	released	cede8cb1-fe66-5c7a-81f6-c775b4e04953	no	Pharmaceutical Therapy, NOS	released	c5f7a435-8a5f-55d3-add9-5264b5c7de01	yes	Radiation Therapy, NOS	347163a2-ab90-4f1c-84eb-0041f1464043
34dbf011-cc93-4188-97c5-e5ade331435c.htseq.counts.gz	a9d5bfd0-4125-4493-a3e0-1df6ee5c05ef	TCGA-BT-A2LD-01A-12R-A20F-07	TCGA-BT-A2LD-01A-12R	TCGA-BT-A2LD-01A-01-TSA		TCGA-BT-A2LD-01A-12	TCGA-BT-A2LD-01A	TCGA-BT-A2LD	9dd97821-7afd-4982-8b1d-f14f845b79f7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	49	200.0	False	true	69B3EA67-CD1F-4B86-989C-DEE4FEFA7906	1.85	6f3cb879-cf6d-4347-8aae-b6a6ee7a4274			0.15	23	released	8dd9081d-e435-450c-a547-2dd8cc90a2ff	RNA	R	0.15	UV Spec	released	False	a1de48a2-e657-4221-9c8b-640690447e45	12	0.0	0.0	0.0	0.0	0.0	15.0	85.0	90.0	TOP	df426041-2578-49b6-8fee-4b90fb578503	released												released	30.0	aeb379d5-b157-4bce-82c5-0cd0077db01f	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A2LD_demographic	78	-28673	623	3d01840a-b8cc-5d1b-9b02-34002d3cf627	not hispanic or latino	female	white	released	Dead	1933		TCGA-BT-A2LD_exposure	Not Reported	38.57875853555032		e2ca20d0-57d5-55cd-8ff4-b9fb0523a719	161.0		released	100.0	TCGA-BT-A2LD_diagnosis	28673	T3a	M0	N1	Stage IV	T3a	7th	not reported	0	111	3ba185d1-3035-5306-8a83-1607b6e86620	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iv	2011	TCGA-BT-A2LD_treatment_1	TCGA-BT-A2LD_treatment	released	9584ed90-4281-5340-a355-818b81e61daa	yes	Pharmaceutical Therapy, NOS	released	9ffca01b-7a1e-5a72-b746-79ae83e6a687	yes	Radiation Therapy, NOS	a9d5bfd0-4125-4493-a3e0-1df6ee5c05ef
30d33e0d-c983-4ee2-9ef7-aba934b8c2e9.htseq.counts.gz	9fa04f0c-3d8f-43ad-9e6c-38d451899313	TCGA-DK-A6B2-01A-11R-A30C-07	TCGA-DK-A6B2-01A-11R	TCGA-DK-A6B2-01A-01-TSA		TCGA-DK-A6B2-01A-11	TCGA-DK-A6B2-01A	TCGA-DK-A6B2	10c825d7-4e21-43e7-ac95-dda75fbdaf74	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	472	590.0	False	true	B8914E0E-6446-4467-9BB3-08593BFBEFCD	1.9	f1e23b9a-a79f-439c-a4b9-58fbe9899e98			0.17	23	released	20dbee52-2d07-426f-bbbe-034787e043d7	RNA	R	0.17	UV Spec	released	False	8fba0aa5-d31b-4f1c-b81b-0a4d64dbbf1e	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	ffc2b0b8-2166-4aba-a57a-a63acff7b693	released												released	30.0	639277ed-3037-489b-a219-f1edba494cd0	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6B2_demographic	70	-25625		0c89880b-a9a0-5752-876e-725662999de4	not hispanic or latino	male	white	released	Alive	1942		TCGA-DK-A6B2_exposure	Not Reported	34.15365954866098	3.1232876712328768	2c5bc03b-fd5d-5b1c-ad99-a51e5fa9ba6f	177.0	57.0	released	107.0	TCGA-DK-A6B2_diagnosis	25625		M0	N1	Stage IV	T3	6th	not reported	0	477	bd71cb46-0359-5087-9b0a-b70159111068	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2012	TCGA-DK-A6B2_treatment_1	TCGA-DK-A6B2_treatment	released	c8ca7ea3-dd30-5b33-9016-0df7d606f1fa	yes	Pharmaceutical Therapy, NOS	released	d2e821e0-9fab-5b23-8129-44d426118e1b	no	Radiation Therapy, NOS	9fa04f0c-3d8f-43ad-9e6c-38d451899313
02eef730-a48f-444d-a755-a83bc31845da.htseq.counts.gz	3610c594-a6fe-4678-8d0c-90458b5a9e77	TCGA-DK-A3IM-01A-11R-A20F-07	TCGA-DK-A3IM-01A-11R	TCGA-DK-A3IM-01A-01-TSA		TCGA-DK-A3IM-01A-11	TCGA-DK-A3IM-01A	TCGA-DK-A3IM	41b59716-116f-4942-8b63-409870a87e26	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	254	480.0	False	true	860A2391-F5B1-4E5B-AEDB-FD318817F1F1	1.82	a09bfd63-c31c-461a-b5a4-60670f421233			0.17	23	released	4f5e35a8-28b3-47cc-892a-f327b21d17bf	RNA	R	0.17	UV Spec	released	False	ab41fd32-f6e6-427b-8adb-3f17472e3d16	11	1.0	1.0	20.0	2.0	5.0	0.0	75.0	85.0	TOP	ca555396-3388-42ed-8de1-595a75cc7bf7	released												released	30.0	7a37ae7c-6b46-410d-ae2b-12fd868c25b3	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IM_demographic	76	-28106	248	21523e21-2ec8-546b-bf85-7a8e97264b3a	not hispanic or latino	male	white	released	Dead	1935		TCGA-DK-A3IM_exposure	Not Reported	30.21142090118602	0.4383561643835616	74652f30-fe7b-5069-94d7-e2296ad2a323	174.6	8.0	released	92.1	TCGA-DK-A3IM_diagnosis	28106		M0	N0	Stage III	T3	6th	not reported	0	238	4f167eca-aeef-5c7b-b0af-22772ab5efb9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-DK-A3IM_treatment_1	TCGA-DK-A3IM_treatment	released	28ad0755-f571-54f1-95b8-dcdb82836bc9	not reported	Pharmaceutical Therapy, NOS	released	bca95f13-51df-5c08-ae0f-86579e6662b7	not reported	Radiation Therapy, NOS	3610c594-a6fe-4678-8d0c-90458b5a9e77
cd31d6ac-5218-4b91-b025-e7d2b12bfe0a.htseq.counts.gz	053a47cc-28a0-4f25-b633-d3e0c0931d77	TCGA-GU-A766-01A-11R-A32O-07	TCGA-GU-A766-01A-11R	TCGA-GU-A766-01A-01-TSA		TCGA-GU-A766-01A-11	TCGA-GU-A766-01A	TCGA-GU-A766	e7680a8e-1c0e-426b-abd8-d0d8e7d0e5aa	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	99	380.0	False	true	295B55E8-4220-4342-96E3-C4A8065B3D58	1.89	d6280a13-a376-4ede-8aab-7a7633cb3b9e			0.17	23	released	cb71b8d1-316f-4dc1-8718-5581835d0216	RNA	R	0.17	UV Spec	released	False	8be8fa59-bd97-4f33-96ef-eed4d710239d	11	0.0	0.0	0.0	0.0	0.0	50.0	50.0	65.0	TOP	4d7a851d-63b0-4e53-b6d3-f31881425e6a	released												released	30.0	15255077-f06b-45df-84c0-cab7850a729c	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A766_demographic	62	-22774		180d36a7-9b8f-53bf-bcc7-a733a206490a	not hispanic or latino	male	white	released	Alive	1951		TCGA-GU-A766_exposure	Not Reported	33.30612244897959		c923087e-61d7-56ee-8331-021baceb17eb	175.0		released	102.0	TCGA-GU-A766_diagnosis	22774		MX	N0	Stage II	T2a	7th	not reported	0	480	def0c4d2-8808-5844-afda-1cfe778ea1cf	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-GU-A766_treatment_1	TCGA-GU-A766_treatment	released	425965b0-1172-50c8-81f9-b07f6ddfa641	yes	Pharmaceutical Therapy, NOS	released	fdf7eeed-bc66-5821-9fef-c24c01bbfa59	no	Radiation Therapy, NOS	053a47cc-28a0-4f25-b633-d3e0c0931d77
fa28a918-4bd4-46cc-b702-1374665157f6.htseq.counts.gz	b56fc47f-0573-4cb6-9208-033cd9b34088	TCGA-LT-A5Z6-01A-11R-A28M-07	TCGA-LT-A5Z6-01A-11R	TCGA-LT-A5Z6-01A-01-TSA		TCGA-LT-A5Z6-01A-11	TCGA-LT-A5Z6-01A	TCGA-LT-A5Z6	ec7fc492-53cc-4b71-a66a-1cef1adeba33	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	14	350.0	False	true	1249D02D-48D2-477E-AAAE-51B1D625C8F7	1.85	1002d9de-3bd1-4d22-8f2a-64b3114264e0			0.16	23	released	fed0a054-9d24-4998-b2a8-854c44ac5026	RNA	R	0.16	UV Spec	released	False	2753d25e-699e-49ff-865d-edb7886d2a9d	11	9.0	2.0	2.0	5.0	0.0	33.0	65.0	65.0	TOP	9a33c75b-48e8-4b5c-a41c-59d9ccd9506f	released												released	30.0	60701f6c-48e8-4576-a0a5-c9748d192085	Primary Tumor	01	released	Not Reported	released	TCGA-LT-A5Z6_demographic	56	-20746		3cf8c25b-f0a9-58d5-bf88-8bd7b37621f6	not hispanic or latino	male	white	released	Alive	1957		TCGA-LT-A5Z6_exposure	Not Reported	25.68007405416704		c82fc363-1bf4-5d6b-b1cc-f0ae73bd9d94	183.0		released	86.0	TCGA-LT-A5Z6_diagnosis	20746	T2	MX	NX	Stage II		7th	not reported	0	474	de2ca3a5-c008-5a29-974a-beb6c45098be	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-LT-A5Z6_treatment	TCGA-LT-A5Z6_treatment_1	released	5b3fcd9e-17cd-5967-9fb9-028c8adb95de	no	Radiation Therapy, NOS	released	1b6633bb-7e6d-5bef-adf7-4746fc1a3adc	yes	Pharmaceutical Therapy, NOS	b56fc47f-0573-4cb6-9208-033cd9b34088
6eb5b143-1f76-4434-a9df-3d602ac0ba72.htseq.counts.gz	46c1de22-9e01-4ce1-88fc-aee293424302	TCGA-BL-A0C8-01B-04R-A277-07	TCGA-BL-A0C8-01B-04R	TCGA-BL-A0C8-01B-04-BS4	TCGA-BL-A0C8-01B-03-BS3	TCGA-BL-A0C8-01B-04	TCGA-BL-A0C8-01B	TCGA-BL-A0C8	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	806		True	false	5077D8C6-57D2-4C6A-9316-71BE40224195	1.84	0c879828-5cfa-4b58-805e-0a1f78fc8fe7			0.16	23	released	8071dda9-1407-4448-920a-6c24f80666d9	RNA	R	0.16	UV Spec	released	True	6bfa3f4b-3d5c-4ec7-acb4-f4aa16734db8	04	0.0	0.0	0.0	0.0	0.0	20.0	80.0	95.0	BOTTOM	8ab97d27-3fb1-41c1-aad9-ab244adb4bce	released	0.0	0.0	0.0	0.0	0.0	20.0	80.0	95.0	TOP	27a09548-1d6c-4b2d-bf7d-ce688ba085ae	released	released	400.0	5365eef9-56ca-4e3f-a187-3316158c4a32	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A0C8_demographic	73	-26819		55a888fc-b0f7-5238-a6b7-c823d70676f4	not hispanic or latino	male	white	released	Alive	1936		TCGA-BL-A0C8_exposure	Not Reported	42.41888650422926	0.547945205479452	d9d9da95-b150-5f9e-a211-b3122e64f138	178.0	10.0	released	134.4	TCGA-BL-A0C8_diagnosis	26819		M0	NX	Stage I	T1		not reported	0	1219	325c1514-52f8-5ea4-8e87-78d1911d3cf9	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage i	2009	TCGA-BL-A0C8_treatment_1	TCGA-BL-A0C8_treatment	released	04001d39-fe03-51fc-bbd4-85e050d41997	yes	Pharmaceutical Therapy, NOS	released	d93cde56-03c3-5823-850d-bab213286b6a	no	Radiation Therapy, NOS	46c1de22-9e01-4ce1-88fc-aee293424302
d5260819-be16-42eb-9b6f-15191b87b2f7.htseq.counts.gz	fde53928-d99b-4558-adeb-c505636ac5d1	TCGA-FT-A3EE-01A-11R-A206-07	TCGA-FT-A3EE-01A-11R	TCGA-FT-A3EE-01A-01-TS1		TCGA-FT-A3EE-01A-11	TCGA-FT-A3EE-01A	TCGA-FT-A3EE	cce62116-3dcd-400d-ada0-9839ca02466e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	251	50	False	true	5F7AEE5D-7F5F-495F-B497-31BDDCF1D338	1.78	1b08c8c9-5739-409d-9cbc-3b06ad1f60e6	2.34	13	0.18	23	released	86cb823f-5946-450e-a254-28dbb315790f	RNA	R	0.18	UV Spec	released	False	37ca7488-da4d-48c2-b38a-251d30b74d84	11	1	0	0	0	0	0	100	90	TOP	dbfd6283-7138-44b2-b4a0-b36c5b6e386d	released												released	30	2356f78c-0653-468f-83db-6cf6107bd259	Primary Tumor	01	released	Not Reported	released	TCGA-FT-A3EE_demographic	80	-29293	99	65cb0b06-b28e-5fd5-99bd-83b69f3c3917	not hispanic or latino	female	white	released	Dead	1931	2011	TCGA-FT-A3EE_exposure	Not Reported	29.340039628105473		8b0d977c-56c9-5c90-8f7f-4fee1cb51035	162.0		released	77.0	TCGA-FT-A3EE_diagnosis	29293		MX	N0	Stage III	T4a	7th	not reported	0		c1f5e919-2af5-5802-b503-494da19b380b	C67.5	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder neck	released	No	Bladder neck	not reported	stage iii	2011	TCGA-FT-A3EE_treatment	TCGA-FT-A3EE_treatment_1	released	cad03a7f-7075-5c79-bdf9-7117e76e191b	not reported	Radiation Therapy, NOS	released	484ce690-02e4-53d1-bf1b-8d05d9467fb6	not reported	Pharmaceutical Therapy, NOS	fde53928-d99b-4558-adeb-c505636ac5d1
41568597-5081-414b-998b-d86b47556727.htseq.counts.gz	b076cff3-d21b-4450-8e4a-13358cec5b45	TCGA-G2-AA3C-01A-21R-A39I-07	TCGA-G2-AA3C-01A-21R	TCGA-G2-AA3C-01A-02-TSB		TCGA-G2-AA3C-01A-21	TCGA-G2-AA3C-01A	TCGA-G2-AA3C	c04cc413-95b0-4b56-af55-9596a5ead4a6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1740	430.0	False	true	B1E681AE-43AC-4E17-B334-3ACC476DC289	1.81	9192d03e-87ee-424a-90fa-7e66c3b6abe3			0.16	23	released	2655280a-eb98-4be8-8873-c178427d09af	RNA	R	0.16	UV Spec	released	False	19cb27fc-f4da-4d86-998b-ed4917b4c47e	21	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	948d4322-cfb8-4717-8c65-3b3a42e0bdbf	released												released	30.0	83d4e9e9-7910-4686-9ed4-17c7d85127eb	Primary Tumor	01	released	Not Reported	released	TCGA-G2-AA3C_demographic	66	-24267	211	cf798d40-060d-543f-b923-07591d9784f6	not hispanic or latino	male	white	released	Dead	1943	2009	TCGA-G2-AA3C_exposure	Not Reported	26.583175803402646	0.2191780821917808	3fde8b05-f763-5c7f-9776-0c5d94eefe91	184.0	4.0	released	90.0	TCGA-G2-AA3C_diagnosis	24267	T3	M0	N1	Stage IV	T3b	6th	not reported	0		a4754bd3-61cc-5605-b231-cb40afc62690	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2009	TCGA-G2-AA3C_treatment_1	TCGA-G2-AA3C_treatment	released	018d260d-f0ac-52ca-b64b-5f92c3ad12da	yes	Pharmaceutical Therapy, NOS	released	8bbeca03-3717-55c5-8a43-2236eed50852	no	Radiation Therapy, NOS	b076cff3-d21b-4450-8e4a-13358cec5b45
97f5cca1-355a-43fa-94de-df83f165bc4f.htseq.counts.gz	4f1bc11c-8ddb-4b31-b663-7d01c1487cf6	TCGA-KQ-A41S-01A-12R-A33J-07	TCGA-KQ-A41S-01A-12R	TCGA-KQ-A41S-01A-01-TSA		TCGA-KQ-A41S-01A-12	TCGA-KQ-A41S-01A	TCGA-KQ-A41S	cc8602bb-78e2-4732-9784-83c3388b999e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	321	450.0	False	true	75B6EA6C-3EC8-4283-883C-25DD6A6A6E59	1.77	ed8b8326-fa77-4e72-b146-49c0543a5792			0.16	23	released	d2441d27-b3ac-4330-95bf-66de4c796433	RNA	R	0.16	UV Spec	released	False	c96fdc82-44cc-4c8f-91d7-e78e80a7242d	12	5.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	59e02fbc-02ea-4c32-a7b5-b0acdd76f914	released												released	30.0	546e9ec3-7745-4a94-bb1d-b5f40203669a	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41S_demographic	87	-32041		3603b78d-46fb-5375-8bc0-71c16680ef73	not reported	female	white	released	Alive	1924		TCGA-KQ-A41S_exposure	Not Reported			5c4d8606-a9f3-5291-b5df-e467a68513d2			released		TCGA-KQ-A41S_diagnosis	32041		MX	NX	Stage III	T4a	7th	not reported	0	35	06013a3b-7395-59a6-967b-b25ea08c9a66	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2011	TCGA-KQ-A41S_treatment	TCGA-KQ-A41S_treatment_1	released	a4e418a6-0e3f-5978-8cc1-cf625b261731	no	Radiation Therapy, NOS	released	8a0a60b9-54c0-541f-9c7e-29058de899ba	no	Pharmaceutical Therapy, NOS	4f1bc11c-8ddb-4b31-b663-7d01c1487cf6
b991af62-5624-4ad2-87d1-303e994a7001.htseq.counts.gz	6889b9f9-0a98-42b1-b8c3-c5596afea2c3	TCGA-BT-A3PJ-01A-21R-A220-07	TCGA-BT-A3PJ-01A-21R	TCGA-BT-A3PJ-01A-02-TSB		TCGA-BT-A3PJ-01A-21	TCGA-BT-A3PJ-01A	TCGA-BT-A3PJ	cb664eef-be6f-44ef-aa90-6f6da0e6440a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	98	160	False	true	D2E98BC0-ED05-4653-9515-259D0361F2C4	1.85	5968c8d3-5f1a-4eb8-8d9b-8bd3fd3fd9f1	2.21	13	0.17	23	released	c592e5b0-76b3-4665-9bbe-c239d171d8ab	RNA	R	0.17	UV Spec	released	False	1826d77e-3d1c-4406-bd4c-6b630dad7a5c	21	0	0	2	0	5	8	85	90	TOP	1125a68a-3409-435a-b357-359ccabebf2d	released												released	30	29d79b83-fa80-490e-a8a1-c51c9ad061fe	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A3PJ_demographic	76	-27821		ab2cd3cc-eb3f-5b48-a27f-85e65b6c3f32	not hispanic or latino	male	white	released	Alive	1935		TCGA-BT-A3PJ_exposure	Not Reported			144b183e-3d3f-5825-9a07-876436a267ed			released		TCGA-BT-A3PJ_diagnosis	27821		M0	N0	Stage III	T3b	7th	not reported	0	789	5f62ad0c-4315-513a-a6ff-88083384f9be	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2011	TCGA-BT-A3PJ_treatment	TCGA-BT-A3PJ_treatment_1	released	94e6c866-44c4-5d3f-97c9-461405431823	no	Radiation Therapy, NOS	released	b56d4934-143d-5729-a397-e466d146c165	yes	Pharmaceutical Therapy, NOS	6889b9f9-0a98-42b1-b8c3-c5596afea2c3
ee17781c-26cc-43e4-9fc3-41e4d83df04d.htseq.counts.gz	a54f7595-4a84-4bdd-9201-43228af5fbd3	TCGA-ZF-A9R1-01A-11R-A39I-07	TCGA-ZF-A9R1-01A-11R	TCGA-ZF-A9R1-01A-01-TS1		TCGA-ZF-A9R1-01A-11	TCGA-ZF-A9R1-01A	TCGA-ZF-A9R1	f1bd8305-5c3f-4c82-9e68-ba9cf4ecdf7b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	317	150.0	False	true	D0951273-E0D2-4B6F-8033-4745A2AAD74E	1.83	c720ac3f-9cb8-4a5c-aa7a-0fb852e11360			0.17	23	released	36c9e37e-5973-40c7-b2aa-22064c195114	RNA	R	0.17	UV Spec	released	False	4875903d-009e-4aab-ad03-9fbb4a911ff9	11	2.0	1.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	5ae49e2a-0d3a-4120-baee-df60c939bf4d	released												released	30.0	58a00e33-adbc-499f-bb0d-5c8463ae7a5d	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R1_demographic	81	-29610		851b8786-ae44-51cf-ab3d-fd8902afaba2	not hispanic or latino	male	white	released	Alive	1932		TCGA-ZF-A9R1_exposure	Not Reported	30.486685032139576		6a8a6b2e-02d8-5b3c-b7c4-8a00c948615c	165.0		released	83.0	TCGA-ZF-A9R1_diagnosis	29610	T1	M0	N1	Stage IV	T3b	7th	not reported	0	773	1c3202ea-63b0-5326-b926-3f257998993b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-ZF-A9R1_treatment	TCGA-ZF-A9R1_treatment_1	released	37e13b4c-398d-59a5-9067-32e750b61408	no	Radiation Therapy, NOS	released	28b88b22-7046-52a2-b801-816884f9fe77	yes	Pharmaceutical Therapy, NOS	a54f7595-4a84-4bdd-9201-43228af5fbd3
1e87b17f-db23-400f-96f0-608bc7d98009.htseq.counts.gz	8a8fee5e-64f3-4033-ac21-3b06e80fe100	TCGA-ZF-AA4T-01A-11R-A38B-07	TCGA-ZF-AA4T-01A-11R	TCGA-ZF-AA4T-01A-01-TS1		TCGA-ZF-AA4T-01A-11	TCGA-ZF-AA4T-01A	TCGA-ZF-AA4T	1859a4c5-78bc-4b1a-a26e-3d2b4cb221c2	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1834	160.0	False	true	9BB5D705-F2CF-4BD3-8E55-7F8BCB2A0DE5	1.76	7897b96a-99f9-4db8-abda-04caa8059896			0.18	23	released	17cd7916-8e43-4dd9-ae0a-83f5ba4c8e23	RNA	R	0.18	UV Spec	released	False	c151f653-d305-498a-b761-7cad0d4b394f	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	0bacd5f5-7fe6-4253-883e-a61798065910	released												released	30.0	8a3c17f4-bfbc-43ef-b28c-a340d67e84cf	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4T_demographic	65	-23974	599	bd6be006-b75b-5f4c-88d3-1c2ea97ffbfd	not hispanic or latino	male	white	released	Dead	1943	2009	TCGA-ZF-AA4T_exposure	Not Reported	28.731746890210925		a77adbda-df58-5d2b-8355-1f9b8b5b2d7d	172.0		released	85.0	TCGA-ZF-AA4T_diagnosis	23974	T2	MX	N2	Stage IV	T4	6th	not reported	0		3ba0a28f-1095-56b0-a2e9-5c15206d3789	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-ZF-AA4T_treatment_1	TCGA-ZF-AA4T_treatment	released	5ac009fd-c07d-598b-b6ae-2154c7a9ef7a	not reported	Pharmaceutical Therapy, NOS	released	fe6d6c1b-1e21-52ae-a902-e6bad84190d0	not reported	Radiation Therapy, NOS	8a8fee5e-64f3-4033-ac21-3b06e80fe100
6f7b59ee-05b7-417b-bc61-474b38be240b.htseq.counts.gz	a5a0ea3c-c4e1-44d9-9660-6b270fed9978	TCGA-FD-A5BV-01A-11R-A26T-07	TCGA-FD-A5BV-01A-11R	TCGA-FD-A5BV-01A-01-TSA		TCGA-FD-A5BV-01A-11	TCGA-FD-A5BV-01A	TCGA-FD-A5BV	4fa31971-15e2-4c9b-b49a-b3b7096262e4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	156	660.0	False	true	9CD8EA72-6DF6-4DD6-9F32-610AB97C9E0D	1.87	72ea067a-e5ae-43f3-97b8-2283b35df8d6			0.15	23	released	53b45582-ea3f-4450-92d9-d310eae6b660	RNA	R	0.15	UV Spec	released	False	fb50d251-3e54-4d24-8a26-a2b4c771f598	11	4.0	2.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	802a91fa-3ba7-47ee-b4da-c32eb19679a3	released												released	30.0	ea8a6b07-16b1-4879-ae7d-082e2c5f1c34	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BV_demographic	47	-17501	163	95fe92d1-b1c2-55a4-8f4d-953f7dacbf57	not hispanic or latino	female	white	released	Dead	1965	2012	TCGA-FD-A5BV_exposure	Not Reported	17.908855357415028	1.5342465753424657	7f30cf9a-4d3e-5327-a944-2a6ae65a3581	162.0	28.0	released	47.0	TCGA-FD-A5BV_diagnosis	17501		MX	N0	Stage III	T3b	7th	not reported	0		b8ae52cf-8af1-5e6f-b1e4-1b1d50209e5e	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2012	TCGA-FD-A5BV_treatment	TCGA-FD-A5BV_treatment_1	released	6f8c21f0-9152-5b09-81e1-12f36ac60ae5	no	Radiation Therapy, NOS	released	ddc18a8a-02d4-5725-97a9-d318604ad907	no	Pharmaceutical Therapy, NOS	a5a0ea3c-c4e1-44d9-9660-6b270fed9978
cfe77bce-236e-4927-a318-404d15f30504.htseq.counts.gz	c212878d-0f2d-4de4-8389-2a3ceab39490	TCGA-YF-AA3L-01A-11R-A38B-07	TCGA-YF-AA3L-01A-11R	TCGA-YF-AA3L-01A-01-TS1		TCGA-YF-AA3L-01A-11	TCGA-YF-AA3L-01A	TCGA-YF-AA3L	661967e5-94b3-4f98-9402-6ab137893c16	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	88	80.0	False	false	B30B0CE0-2C49-4970-A67A-1F777A4E00BB	1.83	b4f88ea9-de76-4d5b-a535-5a1a010903e4			0.17	23	released	9e5b3a21-de93-4e21-a833-3d4c6dc5b3b9	RNA	R	0.17	UV Spec	released	False	b1d3849d-6639-4e6b-95d9-dec49aaf7d1c	11	2.0	1.0	0.0	3.0	0.0	20.0	80.0	80.0	TOP	097b8f5c-bce9-40c2-b394-86bf66cf857a	released												released	30.0	40849937-c37d-4625-a7d7-38286046621f	Primary Tumor	01	released	Not Reported	released	TCGA-YF-AA3L_demographic	47	-17268		dfbd2eb1-266f-57a1-afab-96f1ba20ef8f	hispanic or latino	female	not reported	released	Alive	1966		TCGA-YF-AA3L_exposure	Not Reported	33.4438173728687	3.287671232876712	a07b24bc-4d4c-5e40-aff3-6e5ada5dd2bf	183.0	60.0	released	112.0	TCGA-YF-AA3L_diagnosis	17268		MX	N0	Stage II	T2b	7th	not reported	0	364	dda3a76b-3134-5c49-aa48-f26b006f9bce	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-YF-AA3L_treatment_1	TCGA-YF-AA3L_treatment	released	8dcc4d5c-cced-593a-ab1c-c0dd06ee044d	yes	Pharmaceutical Therapy, NOS	released	c3e0c12c-3bd8-5d6d-aad1-70f162bf4736	no	Radiation Therapy, NOS	c212878d-0f2d-4de4-8389-2a3ceab39490
8ac283d9-5595-4378-8f4d-55c1d01ff9c0.htseq.counts.gz	49bc68ea-a3f5-4f8f-bee4-3829da0a8281	TCGA-FJ-A871-01A-11R-A352-07	TCGA-FJ-A871-01A-11R	TCGA-FJ-A871-01A-01-TS1		TCGA-FJ-A871-01A-11	TCGA-FJ-A871-01A	TCGA-FJ-A871	bb38805e-2ccc-4169-ba01-34b98adf5bd0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	43	60.0	False	true	6F7FA0D6-7A3A-48D2-A45A-326F730E6926	1.79	c19f7f59-5df6-4a57-91b0-635817d4fafd			0.17	23	released	b6fe7f15-e3ea-4e75-9850-045ae272df49	RNA	R	0.17	UV Spec	released	False	703ef8f4-f831-4acd-96ee-da16bfbd83a9	11	3.0	0.0	8.0	0.0	0.0	0.0	92.0	75.0	TOP	b7d48e3f-f2f0-4afe-84fa-7891b5e5dbde	released												released	30.0	3b4729fc-02a4-4e6a-b24c-34bc68943300	Primary Tumor	01	released	Not Reported	released	TCGA-FJ-A871_demographic	49	-18051	272	e7b1c239-d607-5eb7-8453-88dc551973fc	not hispanic or latino	male	white	released	Dead	1964	2013	TCGA-FJ-A871_exposure	Not Reported	24.897060231734173	0.00821917808219178	a381c445-b6de-50d9-8e96-5a37f372805d	177.0	0.15	released	78.0	TCGA-FJ-A871_diagnosis	18051	T2	MX	NX	Stage III	T3b	7th	not reported	0		b2da66b0-dabe-5b0a-9c3b-332808c74370	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2013	TCGA-FJ-A871_treatment	TCGA-FJ-A871_treatment_1	released	4868f977-f23b-542a-8607-1198db08c221	no	Radiation Therapy, NOS	released	df5c6a6b-e623-5635-93e3-8862f1980461	yes	Pharmaceutical Therapy, NOS	49bc68ea-a3f5-4f8f-bee4-3829da0a8281
ff624a77-3815-481d-b351-0e810648dfd4.htseq.counts.gz	7bd9452b-8341-43e4-9740-b80d97e78cd1	TCGA-FD-A6TF-01A-52R-A32O-07	TCGA-FD-A6TF-01A-52R	TCGA-FD-A6TF-01A-05-TSE		TCGA-FD-A6TF-01A-52	TCGA-FD-A6TF-01A	TCGA-FD-A6TF	6134f549-6876-4c07-8e58-49ec87eaf4c0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	80	670.0	False	true	BDE506A5-17A5-459C-87DD-6FFBF0D713F6	1.88	fe6853dd-864f-4257-869f-a425aab32346			0.16	23	released	15a86bc1-a563-4238-a186-ae2af1eec240	RNA	R	0.16	UV Spec	released	False	f5169ff7-b6c3-426b-aa8d-e8b312e11104	52	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	18728f93-f489-437a-9d2a-235d535b99d5	released												released	30.0	7f933632-2dc4-44f6-835e-1a9865f26349	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TF_demographic	80	-29317	69	49cca15e-3fcf-5b4b-8d60-a91375e0e8a1	not hispanic or latino	female	white	released	Dead	1933		TCGA-FD-A6TF_exposure	Not Reported	35.05886426592798		1ccf0fbf-f159-5941-a033-46a2e3dd3fc8	152.0		released	81.0	TCGA-FD-A6TF_diagnosis	29317	T2	M1	N2	Stage IV	T3b	7th	not reported	0	63	19a0a64e-bd77-5630-93a2-d966b65fc894	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2013	TCGA-FD-A6TF_treatment_1	TCGA-FD-A6TF_treatment	released	8d4c89ee-3cc0-5e00-9419-af63c6f26b31	no	Pharmaceutical Therapy, NOS	released	9f9e0593-5960-5702-ac4b-3dd26d3c0ac2	no	Radiation Therapy, NOS	7bd9452b-8341-43e4-9740-b80d97e78cd1
930336aa-630f-4d00-8aef-ce6df316428c.htseq.counts.gz	853f828a-8e60-4330-aeba-6e140a0892dd	TCGA-ZF-A9RN-01A-11R-A42T-07	TCGA-ZF-A9RN-01A-11R	TCGA-ZF-A9RN-01A-01-TSA		TCGA-ZF-A9RN-01A-11	TCGA-ZF-A9RN-01A	TCGA-ZF-A9RN	73db40ce-2ba7-4a56-aef2-b78d2c744be1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1184	260.0	False	true	BA6EAB50-FDB2-4E63-AD3E-E60236ABA7F7	1.9	debf57c3-f5e0-418a-ad1c-40a8ccc93692			0.17	23	released	7c565fc8-22e7-4d94-a444-dcf21890e248	RNA	R	0.17	UV Spec	released	False	ac9eae9c-e3e6-4b7e-a22a-fadcb8cae192	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	90.0	TOP	88b189c9-b20b-48a8-8737-fc266cc5c433	released												released	30.0	34a093d9-85bd-4e22-814c-60e74b97998b	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RN_demographic	67	-24795	615	c9804787-981f-5bfb-a89d-e36f9b4b37cd	not hispanic or latino	female	white	released	Dead	1943	2011	TCGA-ZF-A9RN_exposure	Not Reported	29.046570270356536		045b28c2-baea-5677-b523-96886715f08b	177.0		released	91.0	TCGA-ZF-A9RN_diagnosis	24795	T3b	M0	NX	Stage III	T3b	7th	not reported	0		7b132f8b-e13d-5568-afda-ae1a598cc6e1	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2010	TCGA-ZF-A9RN_treatment_1	TCGA-ZF-A9RN_treatment	released	3db8813e-f38f-5a47-b389-cbc46402ff06	yes	Pharmaceutical Therapy, NOS	released	f5055d28-b051-595c-adfb-75254467b5da	no	Radiation Therapy, NOS	853f828a-8e60-4330-aeba-6e140a0892dd
72179348-aeaf-4e7b-9e8e-dd7aa116e39e.htseq.counts.gz	6e484aed-2439-48a2-a3ee-c3c96ab69949	TCGA-GV-A3QF-01A-31R-A22U-07	TCGA-GV-A3QF-01A-31R	TCGA-GV-A3QF-01A-03-TS3		TCGA-GV-A3QF-01A-31	TCGA-GV-A3QF-01A	TCGA-GV-A3QF	47990d5e-a0e1-4752-86f5-4f5b84e219df	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	149	250	False	true	DE5B5338-18C3-44AA-AB8E-ADFC18EA5C87	1.86	f732f86b-5190-4827-8471-656a43b47681	2.34	13	0.18	23	released	7400a0e2-5dcf-4dc6-9b6e-a1a044cf262e	RNA	R	0.18	UV Spec	released	False	61d077de-ee2a-412e-b999-3fc28e695051	31	2	0	0	0	0	0	100	90	TOP	d6afe7b7-f819-4e48-963c-391bbd1a67e3	released												released	20	6647c98e-7aa1-49e4-a067-d53aebacff9c	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3QF_demographic	79	-28890	617	6c4f8522-4f99-50f6-865d-b40cbcc3d666	not hispanic or latino	male	white	released	Dead	1932		TCGA-GV-A3QF_exposure	Not Reported	23.620287912158062	3.287671232876712	ccf07cc8-f629-5942-8763-7688d2df2e48	177.0	60.0	released	74.0	TCGA-GV-A3QF_diagnosis	28890		MX	N2	Stage IV	T3b	7th	not reported	0	232	425dd7e0-ab2b-59db-91dd-3051d98ddee2	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iv	2011	TCGA-GV-A3QF_treatment_1	TCGA-GV-A3QF_treatment	released	4b56baab-6e47-5f3e-a5b7-9cfeb51d893f	yes	Pharmaceutical Therapy, NOS	released	3227c45b-f0b2-549f-b661-29c8e041bf8b	no	Radiation Therapy, NOS	6e484aed-2439-48a2-a3ee-c3c96ab69949
b4ebfcd6-9b4e-4c61-96de-7bc4335c519d.htseq.counts.gz	fc5b26f8-c523-4632-8daa-9f1072dca754	TCGA-FD-A3N5-01A-11R-A21D-07	TCGA-FD-A3N5-01A-11R	TCGA-FD-A3N5-01A-01-TSA		TCGA-FD-A3N5-01A-11	TCGA-FD-A3N5-01A	TCGA-FD-A3N5	a658becf-3934-49f2-9e74-291dca61d4bb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	260	330.0	False	true	9E5D7033-E1B3-47A8-9526-D45B3113A54C	1.8	e7925508-8b2f-4c39-bd7a-033e78b1f875			0.16	23	released	cb79bce6-5501-4af6-9408-5d66dfd0cf41	RNA	R	0.16	UV Spec	released	False	a6255467-ff99-4d50-9f9c-b758c6f91ce7	11	2.0	1.0	7.0	1.0	0.0	13.0	80.0	80.0	TOP	8cc5bfd1-817f-47d9-9d95-0d1e5a6b01f9	released												released	30.0	66559b5f-ab2f-406b-9edb-0f5085eec7c5	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3N5_demographic	69	-25342	685	fd6b537a-1c45-56ba-9dee-f54ba137ca99	not hispanic or latino	male	black or african american	released	Dead	1942		TCGA-FD-A3N5_exposure	Not Reported		2.191780821917808	7cfb7b3b-8e14-5931-856f-7c95c6affbc2		40.0	released		TCGA-FD-A3N5_diagnosis	25342		MX	N0	Stage II	T2b	7th	not reported	0	363	db8d7a27-5179-5ac6-ab5e-50e6b52652b8	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2011	TCGA-FD-A3N5_treatment_1	TCGA-FD-A3N5_treatment	released	51c365eb-37e5-5a87-94cd-ff4d1e8deed5	no	Pharmaceutical Therapy, NOS	released	446e8441-ef54-587e-84fe-74d8b71fe73c	no	Radiation Therapy, NOS	fc5b26f8-c523-4632-8daa-9f1072dca754
40e23210-e626-4818-88f8-053adcbb75a2.htseq.counts.gz	6bb625af-8989-4517-80e9-318fda1d90b0	TCGA-XF-A8HG-01A-11R-A36F-07	TCGA-XF-A8HG-01A-11R	TCGA-XF-A8HG-01A-01-TSA		TCGA-XF-A8HG-01A-11	TCGA-XF-A8HG-01A	TCGA-XF-A8HG	b9b61cf9-8711-4c3a-8511-659070cfe36b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2900	550.0	False	true	BBBBC7D7-4994-4B78-9C65-22B4E8C61261	1.85	79b6d16e-cc87-416d-8440-2aa9ad3ed3d3			0.18	23	released	5e6dd011-fc57-4a0e-95aa-6b6591508f2b	RNA	R	0.18	UV Spec	released	False	fb8d9556-167c-4581-b8e4-3d9b060654e9	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	b4de7beb-227e-4cce-8692-e50c085cac2f	released												released	30.0	f9eb39b8-2c51-4c13-b434-d11944ed3ccc	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HG_demographic	69	-25421	467	32d1db26-b70b-531d-b036-5d4ff021b63c	not hispanic or latino	male	white	released	Dead	1936	2006	TCGA-XF-A8HG_exposure	Not Reported	28.695929429269846	0.4383561643835616	f0713dda-20ab-551a-8c71-c326d347a2c4	194.0	8.0	released	108.0	TCGA-XF-A8HG_diagnosis	25421	T2	MX	N0	Stage III	T3b	6th	not reported	0		4160af98-da31-5b9e-b4c2-3a8003d1d5d7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2005	TCGA-XF-A8HG_treatment	TCGA-XF-A8HG_treatment_1	released	49673cb8-be58-5128-af35-138b3b12cb1a	no	Radiation Therapy, NOS	released	14b20fa5-a0bd-5a5e-aafc-57011a1d6071	yes	Pharmaceutical Therapy, NOS	6bb625af-8989-4517-80e9-318fda1d90b0
0e5ed072-6e3c-4708-b05d-482439b01b6a.htseq.counts.gz	e4ba3306-3fea-449a-9336-c7f107a22573	TCGA-XF-A9SM-01A-11R-A42T-07	TCGA-XF-A9SM-01A-11R	TCGA-XF-A9SM-01A-01-TSA		TCGA-XF-A9SM-01A-11	TCGA-XF-A9SM-01A	TCGA-XF-A9SM	b027f4e2-f260-4d60-a1f4-444bc49c4a0b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3364	710.0	False	true	77D2B628-13A0-486E-866E-C10DDF141B2B	1.89	2ffd7576-f25e-44f1-ba9f-7db6030aa0c6			0.17	23	released	ec03ff47-df50-4fdb-80a9-685608ddd13a	RNA	R	0.17	UV Spec	released	False	f56955a7-4aa7-4654-bdd9-7e94dd395e16	11	4.0	1.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	511b1891-0727-4624-b6f5-09c53ef38bb8	released												released	30.0	072bd7a0-264f-4239-84d1-d8a85497e06f	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SM_demographic	76	-27826		c51b6d83-90e8-5950-aef2-8133020e2b85	not hispanic or latino	male	white	released	Alive	1928		TCGA-XF-A9SM_exposure	Not Reported	38.51405763103533	0.6575342465753424	a3e13a85-9d57-5c20-a90c-b48cfb4b819a	169.0	12.0	released	110.0	TCGA-XF-A9SM_diagnosis	27826		MX	N0	Stage III	T3b	6th	not reported	0	1048	753d9704-6208-548f-a42f-ee1352b172a8	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2004	TCGA-XF-A9SM_treatment	TCGA-XF-A9SM_treatment_1	released	3cee6436-6e7d-565f-80c3-f93d141d4033	no	Radiation Therapy, NOS	released	a6a6eb58-8ffe-52d1-b0d8-f4fde824e7eb	no	Pharmaceutical Therapy, NOS	e4ba3306-3fea-449a-9336-c7f107a22573
61e4e0fd-6eaa-418e-9579-5aa967110708.htseq.counts.gz	7369279c-64f2-4d03-ab35-04f57b52edd0	TCGA-XF-AAME-01A-12R-A42T-07	TCGA-XF-AAME-01A-12R	TCGA-XF-AAME-01A-01-TSA		TCGA-XF-AAME-01A-12	TCGA-XF-AAME-01A	TCGA-XF-AAME	c8388ac0-975d-4f1e-8324-8cabdc75738d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2877	250.0	False	true	F59EB865-9B98-4A22-9237-513CADD28F65	2.0	8c50bd9a-1849-4466-aab6-da20488610f9			0.18	23	released	5cd5cf8b-2d5d-4d6a-a848-a6a6cac0656d	RNA	R	0.18	UV Spec	released	False	4a402184-20ba-4717-b5a6-58b372df1087	12	10.0	0.0	0.0	0.0	0.0	35.0	65.0	65.0	TOP	b66a7cc1-80c8-4a32-9202-45540e293fb1	released												released	20.0	2447a5c6-3afc-428b-9162-c76024631af1	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAME_demographic	64	-23448	2828	2961e289-a686-51a0-bad8-0c85ca58820d	not hispanic or latino	female	white	released	Dead	1942	2013	TCGA-XF-AAME_exposure	Not Reported	26.171875		6427cc9c-e3a4-5d63-8afb-aa538f337031	160.0		released	67.0	TCGA-XF-AAME_diagnosis	23448		MX	N0	Stage II	T2b	6th	not reported	0		ec47a9f9-5a5c-5d4d-ab6f-094f8ed7bb11	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2006	TCGA-XF-AAME_treatment_1	TCGA-XF-AAME_treatment	released	4336f7be-7e2b-5a87-8fbf-bf3a21395f87	yes	Pharmaceutical Therapy, NOS	released	5a2920ed-ace2-557c-bd60-a45f202f4269	yes	Radiation Therapy, NOS	7369279c-64f2-4d03-ab35-04f57b52edd0
9a16b3c9-6b30-4d88-a7bc-e1f2619d88ac.htseq.counts.gz	1d93ad0b-66e0-401b-aa34-401e4b0781af	TCGA-GC-A3YS-01A-11R-A23N-07	TCGA-GC-A3YS-01A-11R	TCGA-GC-A3YS-01A-01-TSA		TCGA-GC-A3YS-01A-11	TCGA-GC-A3YS-01A	TCGA-GC-A3YS	4d323b18-ce5a-4516-862d-7ed1fdf1f008	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	90	200.0	False	false	702DCFCC-C28D-4122-B12F-DED2154826BE	1.81	10e3d6b9-8f72-4902-94ca-f89811b98e35			0.15	23	released	d897f2d2-c06c-4c3c-af89-b5799d9dab4b	RNA	R	0.15	UV Spec	released	False	054882c2-2e98-4640-a741-9c4d272abb38	11	4.0	2.0	0.0	2.0	0.0	20.0	80.0	80.0	TOP	ce6abc91-edf8-4193-87e9-ecf767d7f78f	released												released	30.0	9606581b-1e91-4a91-865d-878b08631782	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3YS_demographic	61	-22515		c326b088-d437-556f-8c4c-2ae79102bc62	not hispanic or latino	male	white	released	Alive	1951		TCGA-GC-A3YS_exposure	Not Reported	23.66691015339664	3.1780821917808217	0ae57489-fa9f-5a7c-ab89-69c2f1d55359	185.0	58.0	released	81.0	TCGA-GC-A3YS_diagnosis	22515		MX	N1	Stage IV	T3a	7th	not reported	0	758	6ada1e41-4e02-5272-99d5-644fd0c14fb5	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-GC-A3YS_treatment_1	TCGA-GC-A3YS_treatment	released	1780417c-9fc3-5e0a-9bea-a115518b1362	yes	Pharmaceutical Therapy, NOS	released	0dde2795-f7a9-5056-9862-27142100084f	no	Radiation Therapy, NOS	1d93ad0b-66e0-401b-aa34-401e4b0781af
15941f8a-9656-4fb5-95fa-70697a849f31.htseq.counts.gz	60dcbfe0-4c86-4d27-93fc-e5bbeb95a20e	TCGA-FD-A62O-01A-11R-A30C-07	TCGA-FD-A62O-01A-11R	TCGA-FD-A62O-01A-01-TSA		TCGA-FD-A62O-01A-11	TCGA-FD-A62O-01A	TCGA-FD-A62O	472502eb-ad99-4a1a-8445-1a11dc02a6d9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	141	490.0	False	true	41E61CCB-5006-491B-94B7-BE81FB559D0E	1.88	50fdf7c3-0e77-4013-ae2b-0e7c70b8d3e3			0.17	23	released	3a4c2655-b944-4e44-ba75-792d9cff0254	RNA	R	0.17	UV Spec	released	False	e2250c81-bf50-4711-b4c5-60d1bdae06e7	11	3.0	1.0	0.0	3.0	0.0	15.0	85.0	85.0	TOP	370c7019-c245-4e56-88d1-42e82a3a1b90	released												released	30.0	ab5607a4-8851-4797-abdd-df58facbe33b	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A62O_demographic	74	-27310	216	a27d77e0-128a-5118-9c99-820ac06f6726	not hispanic or latino	male	white	released	Dead	1938		TCGA-FD-A62O_exposure	Not Reported	19.409358296754156		71da6c89-0e90-5dab-9aeb-1c46a8434df1	183.0		released	65.0	TCGA-FD-A62O_diagnosis	27310		MX	N2	Stage IV	T3a	7th	not reported	0	147	c849a9a8-048f-5517-ac79-2d0f25ad153e	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2012	TCGA-FD-A62O_treatment	TCGA-FD-A62O_treatment_1	released	c7d119ff-4fe1-586b-b3d3-abc9b14f6ea1	no	Radiation Therapy, NOS	released	612703fe-7b37-5adf-b560-df6929229891	yes	Pharmaceutical Therapy, NOS	60dcbfe0-4c86-4d27-93fc-e5bbeb95a20e
6b1f2e6a-f8f2-4f08-8ca5-76874cb5cc4d.htseq.counts.gz	2296f6ff-93b8-491d-8279-02a0e4170188	TCGA-DK-A3IL-01A-11R-A20F-07	TCGA-DK-A3IL-01A-11R	TCGA-DK-A3IL-01A-01-TSA		TCGA-DK-A3IL-01A-11	TCGA-DK-A3IL-01A	TCGA-DK-A3IL	178b28cd-99c3-48dc-8d09-1ef71b4cee80	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	149	240.0	False	true	FE31B934-2AE5-4CA6-981D-DF7C0F9E1677	1.77	f154cc00-e118-4d4c-b9d2-2f1f71e0a964			0.16	23	released	1eaaf9ea-ce53-4853-9a04-99b321851ea4	RNA	R	0.16	UV Spec	released	False	584ab831-2540-49e7-ae2d-ffe450693f8e	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	119277b8-9772-4878-89a8-019c9da151da	released												released	30.0	59d6683f-5eb7-493d-8e8e-78b88be2cd70	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IL_demographic	79	-29047	413	25fdc0de-f282-5a30-a682-e0a38b03da61	not hispanic or latino	female	white	released	Dead	1932		TCGA-DK-A3IL_exposure	Not Reported	28.515625	5.917808219178082	e3a7df5a-73cd-5af0-84fe-f1ce8cbe5bb5	160.0	108.0	released	73.0	TCGA-DK-A3IL_diagnosis	29047		M0	N2	Stage IV	T3	6th	not reported	0	121	e90a388f-3338-5f6b-951e-b862615f1980	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2011	TCGA-DK-A3IL_treatment	TCGA-DK-A3IL_treatment_1	released	00e94e2c-d7ad-59ba-87cc-59c97dd7b245	not reported	Radiation Therapy, NOS	released	279fe2e9-3e23-5e25-9d80-95bfb30d9fb8	not reported	Pharmaceutical Therapy, NOS	2296f6ff-93b8-491d-8279-02a0e4170188
daec2c2a-9f58-43bc-a799-958929e549f5.htseq.counts.gz	98133f98-99b8-4155-b915-d69ae26c8bcd	TCGA-XF-AAN0-01A-11R-A42T-07	TCGA-XF-AAN0-01A-11R	TCGA-XF-AAN0-01A-01-TSA		TCGA-XF-AAN0-01A-11	TCGA-XF-AAN0-01A	TCGA-XF-AAN0	e7e95597-ef88-4442-8c01-8d633822e7b5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2551	690.0	False	true	0F0F3285-4798-4D8F-95D3-20AB4F0ED269	1.86	ec11833d-476a-442e-82c6-f924bea495c1			0.16	23	released	f8725872-b501-4a6d-b587-5646913466b5	RNA	R	0.16	UV Spec	released	False	4461881b-8c1b-4b2b-91fe-990b993130d0	11	2.0	1.0	0.0	4.0	0.0	15.0	85.0	85.0	TOP	1a8caee2-efb6-4da3-b6dd-f0c70aad8cab	released												released	30.0	bb4fde10-e87d-405f-92a4-282f1595e4d7	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN0_demographic	68	-24877	1718	1905e44b-c66f-5214-9491-6365223084a6	not hispanic or latino	male	white	released	Dead	1939	2011	TCGA-XF-AAN0_exposure	Not Reported	25.35154137371552	3.0684931506849313	eb4d8da0-afa0-5260-afb3-5d5b770c798a	172.0	56.0	released	75.0	TCGA-XF-AAN0_diagnosis	24877		M0	N2	Stage IV	T4a	6th	not reported	0		aa36a53d-a903-5607-a66d-16b857a252f9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2007	TCGA-XF-AAN0_treatment_1	TCGA-XF-AAN0_treatment	released	8b6b5a5f-4944-54cd-9fe0-736fda003df5	yes	Pharmaceutical Therapy, NOS	released	02918174-bde4-568f-b5bd-8c6c7256b831	no	Radiation Therapy, NOS	98133f98-99b8-4155-b915-d69ae26c8bcd
09960f41-c1aa-4f75-8431-4df396f1a099.htseq.counts.gz	2113e2c0-1de3-4016-9eff-52358f7260b3	TCGA-FD-A62N-01A-11R-A30C-07	TCGA-FD-A62N-01A-11R	TCGA-FD-A62N-01A-01-TSA		TCGA-FD-A62N-01A-11	TCGA-FD-A62N-01A	TCGA-FD-A62N	b7439edc-b7ab-407e-810a-c60864a915bf	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	188	1090.0	False	true	16D179ED-9A97-4CB8-BC78-0D4D20AE6B8E	1.87	d68e2da7-7bd4-4510-8751-02e9f16ad4e6			0.17	23	released	fca67467-4a00-44cf-b1ec-7551b0147dce	RNA	R	0.17	UV Spec	released	False	8db27a1d-fd70-4300-b4ad-0fc73df60e9b	11	8.0	2.0	0.0	4.0	0.0	35.0	65.0	65.0	TOP	c8a34f00-8505-4b63-b209-537689ce001e	released												released	30.0	08a5e125-28b4-41cd-9a7a-60fe8377cc1e	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A62N_demographic	69	-25297		14faed11-f489-5fc3-b1a8-33d257852909	not hispanic or latino	male	asian	released	Alive	1943		TCGA-FD-A62N_exposure	Not Reported	25.359256128486894	0.547945205479452	28c70dd6-bd00-533c-bdf0-9ba100ed0eda	182.0	10.0	released	84.0	TCGA-FD-A62N_diagnosis	25297		MX	N0	Stage III	T3b	7th	not reported	0	82	6935f9c2-f4aa-500a-b567-ab4d54bf265d	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2012	TCGA-FD-A62N_treatment	TCGA-FD-A62N_treatment_1	released	540ee94c-1bc4-5fe3-87fa-5093fc2bc545	not reported	Radiation Therapy, NOS	released	e292fc93-ba72-54aa-9c86-cdf9e8d36540	not reported	Pharmaceutical Therapy, NOS	2113e2c0-1de3-4016-9eff-52358f7260b3
f360f886-9780-4578-b2bf-9fd791c02d9e.htseq.counts.gz	1449ae86-7da5-426e-9b84-51b58616d4e7	TCGA-GV-A3QI-01A-11R-A220-07	TCGA-GV-A3QI-01A-11R	TCGA-GV-A3QI-01A-01-TSA		TCGA-GV-A3QI-01A-11	TCGA-GV-A3QI-01A	TCGA-GV-A3QI	06f936e9-5a90-40d3-b91a-713f2b4e6e11	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	105	410.0	False	true	3792A65B-C233-4DDF-88F8-8829B73616FE	1.88	ea9d4bd8-1f4e-4ad5-81f7-803b078f2603			0.18	23	released	ffc59e86-1afb-4cdb-8651-191b21ee7876	RNA	R	0.18	UV Spec	released	False	1d4435fe-3a24-426d-9b49-d800551fc4a0	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	88217dc9-06a0-4839-8269-85ce0798ef89	released												released	30.0	45f1a50a-8d05-48c5-8f82-ba4955117d1b	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3QI_demographic	47	-17383		cb67b71b-b161-56e4-8351-7f3a57eeb27d	not hispanic or latino	male	white	released	Alive	1964		TCGA-GV-A3QI_exposure	Not Reported	26.643598615916954	1.917808219178082	7d0c7aa3-0f9d-553b-8e05-95663e14cdc9	170.0	35.0	released	77.0	TCGA-GV-A3QI_diagnosis	17383		MX	N0	Stage III	T3b	7th	not reported	0	1110	a9e3548e-d221-5808-a9be-e82e157a5853	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2011	TCGA-GV-A3QI_treatment_1	TCGA-GV-A3QI_treatment	released	9cc604d4-1d82-50b0-9f6a-d21b6d4c134a	yes	Pharmaceutical Therapy, NOS	released	43c77ca8-9aa4-58ab-bed3-ed541bdcec67	no	Radiation Therapy, NOS	1449ae86-7da5-426e-9b84-51b58616d4e7
5f7906a7-ef21-45e5-b974-3f506dfa7467.htseq.counts.gz	ac062287-91bb-44b5-b347-6bc94f5e1ebe	TCGA-UY-A9PE-01A-11R-A38B-07	TCGA-UY-A9PE-01A-11R	TCGA-UY-A9PE-01A-01-TS1		TCGA-UY-A9PE-01A-11	TCGA-UY-A9PE-01A	TCGA-UY-A9PE	fed69898-a229-4b81-bbd9-cdcb164dae7b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		80.0	False	true	4B7A7988-B259-4630-86A6-522EAFAFF078	1.87	394c0fda-d609-4a29-a758-c3b984e50d1d			0.15	23	released	defad41b-0d13-4b67-8871-4c63b255acdc	RNA	R	0.15	UV Spec	released	False	26635462-9073-478d-891e-a5b2aeed563d	11	2.0	1.0	2.0	5.0	0.0	23.0	75.0	75.0	TOP	499c8025-6b90-4110-b1bf-d1073a3a805e	released												released	30.0	287baaa7-3a6b-44e0-865d-f268cf414c5a	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PE_demographic	86	-31755		4df5b890-cd1f-5ef5-a15d-77274c416cc6	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PE_exposure	Not Reported	29.761904761904763	2.4657534246575343	1b305815-8c92-5b76-b316-5b426ba0dc67	168.0	45.0	released	84.0	TCGA-UY-A9PE_diagnosis	31755		MX	N2	Stage IV	T2b	7th	not reported	0	189	f33ca6de-84b1-5cc3-a76b-da036109740e	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A9PE_treatment	TCGA-UY-A9PE_treatment_1	released	6d37c9bd-4427-5fc6-a14f-cfbb590ce941	no	Radiation Therapy, NOS	released	dde9a48b-7dd9-513d-ad6e-ad37824d554b	not reported	Pharmaceutical Therapy, NOS	ac062287-91bb-44b5-b347-6bc94f5e1ebe
9909de98-8f6a-4b76-b9ef-b5274300d2f3.htseq.counts.gz	0fcb7066-e65a-4201-8716-dea88d579b6c	TCGA-UY-A9PF-01A-11R-A38B-07	TCGA-UY-A9PF-01A-11R	TCGA-UY-A9PF-01A-01-TS1		TCGA-UY-A9PF-01A-11	TCGA-UY-A9PF-01A	TCGA-UY-A9PF	3bd918a8-3b92-4042-b4a1-f9dfcd6fe405	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		90.0	False	true	9521187B-B7A8-48F8-860A-57A28664BD26	1.88	6f82f237-061e-47ae-a3fa-d03b6aeb1c1b			0.17	23	released	4c0bc720-df5b-4b44-883b-e6381f9217cd	RNA	R	0.17	UV Spec	released	False	24c28c88-8737-41f9-bdc1-8589ec72eb86	11	2.0	1.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	f3458fb1-7f2e-48d5-bdf2-c16987547a47	released												released	30.0	0b4b4931-c6d5-484d-9951-979636275b55	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PF_demographic	77	-28470		1ef0b966-2cac-5566-bd8f-437d33466787	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PF_exposure	Not Reported	31.84806428049671	0.273972602739726	862a8c57-d4a5-52aa-b5e0-76b6cabd0dae	185.0	5.0	released	109.0	TCGA-UY-A9PF_diagnosis	28470		MX	N2	Stage IV	T3a	7th	not reported	0	117	802d8019-c4b5-5649-b94c-47d9ef9bded0	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv		TCGA-UY-A9PF_treatment_1	TCGA-UY-A9PF_treatment	released	f8865a1f-abcd-586b-9f7f-5eefd7018012	not reported	Pharmaceutical Therapy, NOS	released	4776d316-d752-53ba-ac0d-09086e9c8757	no	Radiation Therapy, NOS	0fcb7066-e65a-4201-8716-dea88d579b6c
4c48686f-e84f-458d-bdd6-058dcedb0c86.htseq.counts.gz	eb99bde8-7e6d-4194-aec7-85cd2f1aab68	TCGA-CF-A47S-01A-11R-A23W-07	TCGA-CF-A47S-01A-11R	TCGA-CF-A47S-01A-01-TSA		TCGA-CF-A47S-01A-11	TCGA-CF-A47S-01A	TCGA-CF-A47S	d2df20d4-6704-41e6-b33d-616225bd737c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	283	530.0	False	true	2B7A84EA-F94C-411A-95BD-220615D821CE	1.82	5eb594ca-ba46-45d2-8532-0fabac564e34			0.18	23	released	6ceb177b-48f0-4eaf-9011-85c44a7eff14	RNA	R	0.18	UV Spec	released	False	d4e69681-19bd-480b-9213-3d0a2c3748b3	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	7377793c-8d66-4251-9a78-861512ffad68	released												released	30.0	33b36c09-79eb-48d4-bb56-36a2e502cd05	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47S_demographic	41	-15225		a843f9fa-25d5-5054-9c06-ee75c60b3f15	not hispanic or latino	male	asian	released	Alive	1970		TCGA-CF-A47S_exposure	Not Reported	21.295294753921038		d9410de1-8085-5ee5-86ad-910b73e2528e	172.0		released	63.0	TCGA-CF-A47S_diagnosis	15225	T2	M0	N0	Stage II	T2	7th	not reported	0	333	46a3d795-349c-5abf-92a5-fed6a012bf44	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-CF-A47S_treatment_1	TCGA-CF-A47S_treatment	released	5c60679f-4b87-5003-8d61-1ed1dacc70b5	yes	Pharmaceutical Therapy, NOS	released	3c3f3500-d114-5d09-a642-899e0869d0b1	yes	Radiation Therapy, NOS	eb99bde8-7e6d-4194-aec7-85cd2f1aab68
2eb23517-6e3b-4d88-a99e-04fd54502fa8.htseq.counts.gz	66c68caa-ddb1-485e-bebb-e1cc9586eb74	TCGA-4Z-AA89-01A-11R-A39I-07	TCGA-4Z-AA89-01A-11R	TCGA-4Z-AA89-01A-01-TS1		TCGA-4Z-AA89-01A-11	TCGA-4Z-AA89-01A	TCGA-4Z-AA89	604c0d60-6ba9-4d2f-98db-e310c58bc8ca	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	763	340.0	False	true	5D5A2A97-F2B3-4EBE-BD57-C035D1710874	1.89	88cb8b2c-9d76-4b91-bbca-5e62e251e3d6			0.17	23	released	8b2afba1-2e3c-4b30-8820-8dc0124e934b	RNA	R	0.17	UV Spec	released	False	9a093277-3b3f-4393-9445-d3d04662ab81	11	10.0	0.0	17.0	0.0	0.0	10.0	73.0	87.0	TOP	201c5f35-21b6-4c4a-aec7-39ee32a42406	released												released	30.0	692a6349-8712-4b9a-82fe-5d08e9cf5ccf	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA89_demographic	60	-22271		a4adc0ca-d6e9-59c6-8fa4-8d841a823126	not reported	male	white	released	Alive	1951		TCGA-4Z-AA89_exposure	Not Reported	31.435911303407245	2.191780821917808	0488b1bf-1874-5fcf-96c4-515d484fa717	172.0	40.0	released	93.0	TCGA-4Z-AA89_diagnosis	22271	TX	M0	N0	Stage IV	T4b	7th	not reported	0	1029	c9c1169c-c203-5ee9-8341-8fddabe40e64	C67.0	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iv	2011	TCGA-4Z-AA89_treatment	TCGA-4Z-AA89_treatment_1	released	b3b3ee90-5506-5148-86b0-80f866d084b3	yes	Radiation Therapy, NOS	released	499c3a3f-6aa9-5cbc-8976-efbf7e8fba55	yes	Pharmaceutical Therapy, NOS	66c68caa-ddb1-485e-bebb-e1cc9586eb74
ab93cdd7-6d27-4321-a8f8-f111e7784532.htseq.counts.gz	c30d3ae3-3e83-482d-9793-f06e79f6279f	TCGA-UY-A78M-01A-21R-A352-07	TCGA-UY-A78M-01A-21R	TCGA-UY-A78M-01A-02-TSB		TCGA-UY-A78M-01A-21	TCGA-UY-A78M-01A	TCGA-UY-A78M	069b6e47-012c-483e-bee4-36a2a21a3486	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		220.0	False	true	04F6BAED-CAA0-4396-9332-3EB8BA902895	1.81	49951b76-0020-4c3c-a279-8175c82c3bc6			0.17	23	released	3d6a8ddf-bc42-4a5e-bc2c-8d051e38746d	RNA	R	0.17	UV Spec	released	False	820f8841-0c18-4360-9bad-98efba46c738	21	3.0	1.0	0.0	4.0	0.0	30.0	70.0	70.0	TOP	962c0b74-6ae3-4567-b2ac-9799f79962ad	released												released	30.0	eadbc728-7f25-474e-82f4-e863d79c8dd6	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78M_demographic	81	-29706	690	2a8efaf3-e8db-54ca-b80f-7ef7dedf5739	not hispanic or latino	female	asian	released	Dead			TCGA-UY-A78M_exposure	Not Reported	23.49523687470631		5e19180a-3d8a-5b9f-ba1f-7edbf73196b4	153.0		released	55.0	TCGA-UY-A78M_diagnosis	29706		MX	N2	Stage IV	T2	6th	not reported	0		e4e0f67d-af94-5e69-aee2-41d7b8f06ec6	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A78M_treatment_1	TCGA-UY-A78M_treatment	released	64db6360-29c5-5889-baf3-6870ced37720	not reported	Pharmaceutical Therapy, NOS	released	2df2d229-6c3c-5a30-9aa4-d3653c116fcb	not reported	Radiation Therapy, NOS	c30d3ae3-3e83-482d-9793-f06e79f6279f
134fc543-032e-4ee2-8a00-de791e68e037.htseq.counts.gz	37e7ba4d-7133-4450-b98b-c08b24f5e1cc	TCGA-DK-AA77-01A-11R-A39I-07	TCGA-DK-AA77-01A-11R	TCGA-DK-AA77-01A-01-TSA		TCGA-DK-AA77-01A-11	TCGA-DK-AA77-01A	TCGA-DK-AA77	eb4f8c76-08d9-4ba4-846e-969fded63a87	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	168	950.0	False	true	382A39E0-F94D-4828-8B30-22A4080724BB	1.86	94b917da-6579-4d30-b81b-eba739bbae5c			0.16	23	released	3cc3c66a-c50d-4a92-887d-ed2fc489ade1	RNA	R	0.16	UV Spec	released	False	cc15173e-ebfc-437f-aa68-07ffd8a9e2ec	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	26caf5cb-cc4f-4522-bd2b-343fb70205fe	released												released	30.0	d9b66125-cf32-4928-9488-8efb146684f9	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA77_demographic	61	-22365		08fd0b40-9f77-5e9b-958a-8dea89b2c032	not hispanic or latino	male	white	released	Alive	1952		TCGA-DK-AA77_exposure	Not Reported	27.379664683612763		817f29e9-9b06-5f89-a536-a40fe14f7f55	172.0		released	81.0	TCGA-DK-AA77_diagnosis	22365		M0	N0	Stage II	T2a	7th	not reported	0	618	dd7c43cb-31a4-51a4-beec-c663cf4d7781	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2013	TCGA-DK-AA77_treatment	TCGA-DK-AA77_treatment_1	released	6ed3a2d0-1373-5af6-a9a5-c09e5864ff79	no	Radiation Therapy, NOS	released	05014f89-9893-5a46-80b0-d5aa0df56518	yes	Pharmaceutical Therapy, NOS	37e7ba4d-7133-4450-b98b-c08b24f5e1cc
e924ce65-d4fc-46aa-9182-f19bfaa17fc7.htseq.counts.gz	5f82dfcd-8537-48e1-945c-87f5823d3c7f	TCGA-FD-A6TD-01A-51R-A33J-07	TCGA-FD-A6TD-01A-51R	TCGA-FD-A6TD-01A-05-TSE		TCGA-FD-A6TD-01A-51	TCGA-FD-A6TD-01A	TCGA-FD-A6TD	c80e71b3-7c6c-4e16-8446-6dfda780bc18	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	224	1230.0	False	true	11A1BF15-67A7-4D7F-B4F2-67EE00685E82	1.88	f6660fcd-6277-4eb7-8135-5aea56fedd7c			0.17	23	released	a0fa69d7-df63-47f9-9011-fb4a045af722	RNA	R	0.17	UV Spec	released	False	34fa334b-5bcb-41bb-964f-93f4d566d902	51	4.0	0.0	0.0	0.0	5.0	0.0	95.0	75.0	TOP	948753ab-57a6-4017-8153-52d1d3d43e57	released												released	30.0	cb958d50-5538-4f82-987d-3fb103cd75c7	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TD_demographic	77	-28328	386	451cbae1-4f01-5fac-8f5c-53d933efe33f	not hispanic or latino	male	white	released	Dead	1935		TCGA-FD-A6TD_exposure	Not Reported	39.73261027141668		97aeae8c-93a0-51fb-a5f5-d43addf9fe77	193.0		released	148.0	TCGA-FD-A6TD_diagnosis	28328	T1	MX	N0	Stage III	T3a	7th	not reported	0	204	3cbf4d2f-6956-5a6b-b950-78935ae4c7f0	C67.3	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Anterior wall of bladder	released	Not Reported	Anterior wall of bladder	not reported	stage iii	2012	TCGA-FD-A6TD_treatment	TCGA-FD-A6TD_treatment_1	released	cf422fc9-adbc-500d-9d17-02a44f2a6032	no	Radiation Therapy, NOS	released	2d46355e-ae87-51e9-8854-ace36e1a8b04	no	Pharmaceutical Therapy, NOS	5f82dfcd-8537-48e1-945c-87f5823d3c7f
32648f93-4bfc-4c39-a35c-33fc90be175e.htseq.counts.gz	983efa5c-27c4-45f7-a0fd-0230931d9da8	TCGA-DK-AA6U-01A-11R-A39I-07	TCGA-DK-AA6U-01A-11R	TCGA-DK-AA6U-01A-01-TS1		TCGA-DK-AA6U-01A-11	TCGA-DK-AA6U-01A	TCGA-DK-AA6U	104c8e20-1b29-4d77-9633-359a35be48fb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	172	30.0	False	true	BC479C80-74F1-417F-BEE4-6C69975C0BF6	1.9	81741a67-7bfd-46c5-8784-a4c87eb71c5e			0.17	23	released	a0097695-cd22-4738-b026-6618971f8639	RNA	R	0.17	UV Spec	released	False	4285ff8a-9440-4a8f-91df-c2055eee7c1d	11	3.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	17c982e2-e810-4f04-853c-582dc30742da	released												released	30.0	ccfee146-e91d-413a-8466-33efb4502990	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6U_demographic	64	-23611		a99383f6-20ba-5ac4-b4f8-0a19c9eef0a1	not hispanic or latino	male	white	released	Alive	1949		TCGA-DK-AA6U_exposure	Not Reported	29.33741144159046	0.821917808219178	14f312a5-2edb-5f0a-a352-ffb8e57f9c09	179.0	15.0	released	94.0	TCGA-DK-AA6U_diagnosis	23611	T2	M0	N0	Stage II		7th	not reported	0	578	cc4d4253-bc86-55ad-9f8e-70d5c673d460	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-DK-AA6U_treatment_1	TCGA-DK-AA6U_treatment	released	816b28c2-cabc-586a-a951-98c1200c90a9	yes	Pharmaceutical Therapy, NOS	released	51cda8aa-8fa7-5e55-933b-c57e0aa601ce	no	Radiation Therapy, NOS	983efa5c-27c4-45f7-a0fd-0230931d9da8
a4249cc5-3d27-4662-b528-5878bb89380b.htseq.counts.gz	8dd582f6-86e5-4ca1-a688-98c9d8db30f4	TCGA-GU-A767-01A-11R-A32O-07	TCGA-GU-A767-01A-11R	TCGA-GU-A767-01A-01-TS1		TCGA-GU-A767-01A-11	TCGA-GU-A767-01A	TCGA-GU-A767	bfaba069-0914-46b4-927d-b5ea3a4a341f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	365	80.0	False	true	4D04BC45-D78F-41DB-8E3B-70763300611A	1.88	3833acbb-2ea2-4442-90af-6b009ae2543b			0.16	23	released	7d13aa01-c067-4906-a937-adc65e761cbd	RNA	R	0.16	UV Spec	released	False	02a576bd-cca0-4a54-ad0e-c82403fb6e4e	11	0.0	0.0	0.0	0.0	0.0	50.0	50.0	60.0	TOP	86b4c5a4-3b14-45c6-b42b-f661276052f1	released												released	30.0	95c5614a-96ad-4252-bb62-dc2abfd6786b	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A767_demographic	81	-29739	144	2074f406-4fef-5017-b5e2-543075a3dc24	not hispanic or latino	male	white	released	Dead	1931	2012	TCGA-GU-A767_exposure	Not Reported	22.79035792549306		1548e17d-90e0-5113-9f8e-4223d23eb1f7	185.0		released	78.0	TCGA-GU-A767_diagnosis	29739		MX	N2	Stage IV	T3b	7th	not reported	0		df6c8cd5-0dd2-51a1-aaa3-8f0a5fdae6bb	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-GU-A767_treatment	TCGA-GU-A767_treatment_1	released	a616a511-6a50-5ee6-8fc4-23115292e483	no	Radiation Therapy, NOS	released	8aa0c96d-fa3b-56b7-80e4-60c2cf9fce68	no	Pharmaceutical Therapy, NOS	8dd582f6-86e5-4ca1-a688-98c9d8db30f4
844c1614-007b-41eb-89ac-e81667c98743.htseq.counts.gz	f635485b-1982-46ea-a298-bd6be696db40	TCGA-DK-A1AE-01A-11R-A13Y-07	TCGA-DK-A1AE-01A-11R	TCGA-DK-A1AE-01A-01-TSA		TCGA-DK-A1AE-01A-11	TCGA-DK-A1AE-01A	TCGA-DK-A1AE	493a4ff2-37a5-4b79-928d-83dbfe534556	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	107	600	False	true	C248FA15-7190-448F-9298-CBEA48C155CB	1.8	b9f76fc8-ca33-46c5-89a0-ae16d42f987f	4.27	26.7	0.16	23	released	8287e7e0-e55f-400a-8819-739a565f7916	RNA	R	0.16	UV Spec	released	False	f79b3b68-fe60-4131-9475-6c6c7c10acfd	11	2	1	0	1	0	20	80	80	TOP	2055a8d3-ac6f-4d9f-a0a4-42de261c514a	released												released	30	67865453-d515-4d63-84e8-cfb2686a211d	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AE_demographic	84	-30707		fa8ffe25-1e1d-5bf7-8d7f-5f330882d20f	not hispanic or latino	male	white	released	Alive	1926		TCGA-DK-A1AE_exposure	Not Reported	20.882755855524742	0.547945205479452	d28ac128-5b85-5708-a637-f6119fb43126	173.0	10.0	released	62.5	TCGA-DK-A1AE_diagnosis	30707		M0	N0	Stage III	T3	6th	not reported	0	491	1ad98a08-4a06-5dc4-ac0a-35654d2242e4	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-DK-A1AE_treatment	TCGA-DK-A1AE_treatment_1	released	096604e2-cce8-5964-8dc1-d36c12dce248	yes	Radiation Therapy, NOS	released	6fe7bde0-e2c3-5c2c-88f3-a6d5011463a6	no	Pharmaceutical Therapy, NOS	f635485b-1982-46ea-a298-bd6be696db40
ff437bad-1e61-4cb5-996e-95ab07eecfa0.htseq.counts.gz	9cf66f84-1eee-4855-8741-50b050144158	TCGA-E7-A8O7-01A-11R-A36F-07	TCGA-E7-A8O7-01A-11R	TCGA-E7-A8O7-01A-01-TSA		TCGA-E7-A8O7-01A-11	TCGA-E7-A8O7-01A	TCGA-E7-A8O7	1e15cb17-cf22-4f06-a3d9-e528e77d1876	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	97	1100.0	False	true	6EF2834F-F28C-4E95-AC82-568590C9444D	1.94	0379335d-61be-4142-9ba3-2676dd0945d8			0.18	23	released	bf7b7737-d077-462b-a588-8dc6e0a90f5a	RNA	R	0.18	UV Spec	released	False	628616e0-e847-4377-b107-fbeb1fa961f7	11	8.0	1.0	3.0	3.0	0.0	15.0	82.0	90.0	TOP	a803f220-b487-44c0-832d-9d0b53f9cc79	released												released	30.0	627cfa74-c61b-4401-8242-7c74d65f9c9f	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A8O7_demographic	52	-19063		108699b2-a5af-528e-bf4e-3a1b796328d0	not hispanic or latino	male	asian	released	Alive	1961		TCGA-E7-A8O7_exposure	Not Reported	20.549886621315192		383be4e4-ac0b-5063-b404-b616020ed593	168.0		released	58.0	TCGA-E7-A8O7_diagnosis	19063	T3	M0	N0	Stage II	T2	7th	not reported	0	466	0d080aa9-39b9-53ff-9c69-af76f7d9e4bb	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-E7-A8O7_treatment_1	TCGA-E7-A8O7_treatment	released	b1300f10-1467-5fdd-b221-88b4338ecc61	not reported	Pharmaceutical Therapy, NOS	released	e7c3dc78-3643-58c9-b09e-8a64ab19c437	no	Radiation Therapy, NOS	9cf66f84-1eee-4855-8741-50b050144158
7cbea792-5e47-424c-94d6-084fb49247d1.htseq.counts.gz	a5809a58-c89a-423d-9c19-97d6ece25c62	TCGA-CF-A47T-01A-11R-A23W-07	TCGA-CF-A47T-01A-11R	TCGA-CF-A47T-01A-01-TSA		TCGA-CF-A47T-01A-11	TCGA-CF-A47T-01A	TCGA-CF-A47T	0db0f02f-94f5-492f-8840-5254792f6879	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	276	520.0	False	true	BAAF2D41-6A16-48A3-B758-DC5CDF369C94	1.84	fc2ec949-9292-4709-b0ea-37368add311d			0.16	23	released	39615463-1be4-47c7-91e6-dae13e71051f	RNA	R	0.16	UV Spec	released	False	acfaea56-44a0-4931-9efb-d2e8a953b180	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	99.0	TOP	30a8886a-5b14-4ac1-9908-0b2c9694d789	released												released	30.0	6365aa9b-ccdd-40af-aa59-0396905dcb3e	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47T_demographic	58	-21347	385	0ce80b44-d206-508d-af82-039514172ded	not hispanic or latino	female	asian	released	Dead	1953		TCGA-CF-A47T_exposure	Not Reported	22.476586888657646		742f72c0-0c38-5f1e-acf8-e4c2d8701cee	155.0		released	54.0	TCGA-CF-A47T_diagnosis	21347	T2	M0	N0	Stage II	T2	7th	not reported	0	205	75fedaa1-7479-5e4e-8bb9-01452ed95ab9	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-CF-A47T_treatment_1	TCGA-CF-A47T_treatment	released	9761f567-89a0-5368-8751-c1eb5ccbde02	yes	Pharmaceutical Therapy, NOS	released	4d38c118-6274-5719-84d8-dc495c15be3d	yes	Radiation Therapy, NOS	a5809a58-c89a-423d-9c19-97d6ece25c62
bdb254d4-48fe-42d1-b907-0c81cf4c50c0.htseq.counts.gz	d4ce3f7a-633a-4d24-95b5-953b2bfd1e9f	TCGA-BL-A13I-01B-04R-A277-07	TCGA-BL-A13I-01B-04R	TCGA-BL-A13I-01B-03-BS3	TCGA-BL-A13I-01B-04-BS4	TCGA-BL-A13I-01B-04	TCGA-BL-A13I-01B	TCGA-BL-A13I	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	503		True	false	976FBDBF-55C5-4957-986B-D2DE85FF7540	1.88	d42e2e38-07f6-474e-8ced-ad87b671db7c			0.16	23	released	5bad4f1e-11d1-46b3-8b98-53d435645e40	RNA	R	0.16	UV Spec	released	True	15afe153-70ba-415a-843c-3ae6a3eecd49	04	0.0	0.0	5.0	0.0	0.0	10.0	85.0	90.0	TOP	4ab561ee-b671-4fd3-ab97-d6659fedf6fb	released	0.0	0.0	5.0	0.0	0.0	10.0	85.0	90.0	BOTTOM	0d55c909-15b8-464c-a663-6cb80d28c82c	released	released	400.0	5bd2e340-f1a9-4fd9-9620-5b202a88fbe9	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13I_demographic	57	-20885	223	ba9fff81-0ad3-56b5-a9a5-a7f1ad7cd96d	not hispanic or latino	female	white	released	Dead	1953	2010	TCGA-BL-A13I_exposure	Not Reported	20.690494543389182	0.821917808219178	ec9dc6f1-7f95-5ead-a277-4f172b7f118c	157.0	15.0	released	51.0	TCGA-BL-A13I_diagnosis	20885		M0	N0	Stage III	T3	7th	not reported	0		d9b084dc-a65f-5913-923c-5e7ec4067300	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-BL-A13I_treatment_1	TCGA-BL-A13I_treatment	released	91bd2aa1-fe84-59d5-9733-6d6fb91a2e81	no	Pharmaceutical Therapy, NOS	released	dbe66ff2-4969-5523-8044-ad4730dc163f	no	Radiation Therapy, NOS	d4ce3f7a-633a-4d24-95b5-953b2bfd1e9f
66569cc4-a8ef-4686-871f-497c95bbe8e8.htseq.counts.gz	e14ca8b4-a230-4bc6-8ec6-19689bf889f2	TCGA-E7-A6MF-01A-12R-A32O-07	TCGA-E7-A6MF-01A-12R	TCGA-E7-A6MF-01A-01-TSA		TCGA-E7-A6MF-01A-12	TCGA-E7-A6MF-01A	TCGA-E7-A6MF	faf3c230-c661-4d6e-9b73-2b679bc6deff	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	114	490.0	False	true	3431AE0E-2696-4DE7-BBA8-E3CD0185632B	1.94	791bcd93-c949-49b3-aaa4-4c8af82f5ec1			0.18	23	released	92e27873-5383-4f5f-a52a-ab815e7f8475	RNA	R	0.18	UV Spec	released	False	dd95e6a5-80bd-4bd1-9723-6b9b8bd5437d	12	2.0	2.0	0.0	0.0	5.0	5.0	90.0	90.0	TOP	8536180e-3ae6-432a-b753-5c60856c4f19	released												released	30.0	938c0423-dc2c-4321-861a-56b474358624	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A6MF_demographic	37	-13867		588db1c4-939a-5945-8b78-968dad3cab25	not hispanic or latino	male	asian	released	Alive	1976		TCGA-E7-A6MF_exposure	Not Reported	22.675736961451246	0.136986301369863	721f2641-624f-54b7-bae6-77ed6720f81f	168.0	2.5	released	64.0	TCGA-E7-A6MF_diagnosis	13867	T2a	M0	NX	Stage II	T2a	7th	not reported	0	750	5f81b417-8618-547e-81f4-8b2abef8f93f	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-E7-A6MF_treatment_1	TCGA-E7-A6MF_treatment	released	4dab948b-792b-552b-8aad-d0ccfb321be3	no	Pharmaceutical Therapy, NOS	released	e7c04577-2ce9-5f65-8aae-0f96f85cd992	no	Radiation Therapy, NOS	e14ca8b4-a230-4bc6-8ec6-19689bf889f2
bd7e6aec-e9b1-40da-88a9-b13d8256c793.htseq.counts.gz	c70a3c45-9fab-4ce0-a6c5-971e596a391c	TCGA-CU-A0YO-01A-11R-A10U-07	TCGA-CU-A0YO-01A-11R	TCGA-CU-A0YO-01A-01-BS1	TCGA-CU-A0YO-01A-01-TS1	TCGA-CU-A0YO-01A-11	TCGA-CU-A0YO-01A	TCGA-CU-A0YO	4a9ef220-922c-49cf-bbed-d173b214ed31	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	482	90	False	false	2216705A-2F61-47ED-9E0B-619AE7515C0B	1.75	2fdb2cad-53e5-44e4-8b80-ee5801964b20	4.27	26.7	0.16	23	released	ecc0ecf4-f1b5-4f6d-b951-97a6b4390187	RNA	R	0.16	UV Spec	released	False	c76e811a-774b-4a42-b73e-54e1b02f7700	11	2	0	0	0	8	32	60	60	BOTTOM	741a8272-fc06-484a-85e3-3dad89add7b0	released	3	1	0	1	0	45	55	55	TOP	6c571ef8-3f4a-48b7-abff-61a0985739a7	released	released	30	9e190462-39fc-41b2-b1d6-2da150412fcf	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A0YO_demographic	84	-30817	149	b8a46743-3043-5616-816f-83fe7cb53b6e	not hispanic or latino	male	white	released	Dead	1925	2009	TCGA-CU-A0YO_exposure	Not Reported			c2f4d525-e76e-53ff-831d-5480a2506b97			released		TCGA-CU-A0YO_diagnosis	30817		MX	N2	Stage IV	T3a	6th	not reported	0		cd1ce0d1-907e-501e-8ad6-3e3c92170c9d	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2009	TCGA-CU-A0YO_treatment	TCGA-CU-A0YO_treatment_1	released	686e9411-2342-5798-9616-3fd5038b4764	no	Radiation Therapy, NOS	released	fcf9f760-53c5-5129-a572-0381ac20d0b0	no	Pharmaceutical Therapy, NOS	c70a3c45-9fab-4ce0-a6c5-971e596a391c
a08161a3-c3ee-44c5-bf83-1f9bc65e5519.htseq.counts.gz	8576fdc1-9646-4ec2-8918-f781ece90fc2	TCGA-S5-A6DX-01A-11R-A31N-07	TCGA-S5-A6DX-01A-11R	TCGA-S5-A6DX-01A-01-TSA		TCGA-S5-A6DX-01A-11	TCGA-S5-A6DX-01A	TCGA-S5-A6DX	76400a3d-45c4-47f8-bd81-0a345a949a1f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	113	340.0	False	true	8CDBA39E-6DF0-4EDA-BEF9-0864B0AE5B42	1.84	10efe18b-413b-4e57-b6e2-ce5cd2dbb839			0.16	23	released	a1b6bfab-21d0-4ce8-957c-a772f7d1c843	RNA	R	0.16	UV Spec	released	False	7931a354-b083-4126-a87d-8cbc12650887	11	4.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	c974e7bf-a396-4e11-a1b5-99096dd76add	released												released	30.0	bfe6a8b9-7c89-471d-b728-e9b34fabf4db	Primary Tumor	01	released	Not Reported	released	TCGA-S5-A6DX_demographic	83	-30594	56	726bdf17-e547-5087-8320-cd6cbc281165	not hispanic or latino	male	white	released	Dead	1930	2013	TCGA-S5-A6DX_exposure	Not Reported	30.040816326530614	3.835616438356164	5aa82e3b-9abd-55b2-a96c-b8aff7a41add	175.0	70.0	released	92.0	TCGA-S5-A6DX_diagnosis	30594	T4a	MX	N2	Stage IV	T4a	7th	not reported	0		1b50121c-ad96-52b2-b90d-c107a135123f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-S5-A6DX_treatment_1	TCGA-S5-A6DX_treatment	released	ff18f3bd-7ce4-5c7e-9605-6a44e9cc5cc7	no	Pharmaceutical Therapy, NOS	released	61beb81f-4a84-5d1c-87b7-9c6e1c954226	no	Radiation Therapy, NOS	8576fdc1-9646-4ec2-8918-f781ece90fc2
0eb54f4b-5484-4757-96df-9da9ed25668e.htseq.counts.gz	3a4fb1ee-19cb-47c4-a7f4-3b434386b4b2	TCGA-G2-A2EF-01A-12R-A18C-07	TCGA-G2-A2EF-01A-12R	TCGA-G2-A2EF-01A-01-TSA		TCGA-G2-A2EF-01A-12	TCGA-G2-A2EF-01A	TCGA-G2-A2EF	2a142731-119c-495d-ad30-eb0b48bacb46	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1485	120.0	False	true	6C7C3694-0D25-476F-BCAF-83BCC10C7C3B	1.85	4000adba-115e-40bf-afbb-35ad20c4e416			0.17	23	released	9d014516-69cf-4f4b-bb8f-8c23920db101	RNA	R	0.17	UV Spec	released	False	927e674f-6836-4635-9c71-71e4f26f22d7	12	4.0	3.0	15.0	0.0	0.0	25.0	60.0	75.0	TOP	cbed6127-8f54-4242-b39b-89e558e6cca0	released												released	30.0	981f581e-32af-486b-9b60-0c8f1047c879	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EF_demographic	50	-18467		ca8fe5f2-99a5-5965-976e-15d1c0dbd670	not hispanic or latino	male	white	released	Alive	1957		TCGA-G2-A2EF_exposure	Not Reported	24.475872657063853	1.917808219178082	023c6279-cfb4-5ec8-977f-467ad5ab11d8	172.7	35.0	released	73.0	TCGA-G2-A2EF_diagnosis	18467	T2a	M0	N0	Stage II		6th	not reported	0	1884	dd92c267-39d0-5fa5-a221-cce0a5f755e7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2007	TCGA-G2-A2EF_treatment	TCGA-G2-A2EF_treatment_1	released	6e679563-bdd3-5622-a969-4ce4f8141216	no	Radiation Therapy, NOS	released	e7355349-02f2-54e5-835b-96265f2786fa	yes	Pharmaceutical Therapy, NOS	3a4fb1ee-19cb-47c4-a7f4-3b434386b4b2
6b7b957f-e68d-49c9-b71d-ec09b5414f33.htseq.counts.gz	fe81753b-1f4d-4b55-bd97-8d7f46b2c137	TCGA-XF-A9T5-01A-11R-A42T-07	TCGA-XF-A9T5-01A-11R	TCGA-XF-A9T5-01A-01-TSA		TCGA-XF-A9T5-01A-11	TCGA-XF-A9T5-01A	TCGA-XF-A9T5	f9a7ab94-70df-4194-8102-66021d01dadd	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2105	1050.0	False	true	23A2FC99-03F3-4A72-8F33-14ED56125E65	1.85	a126ebd8-a7e3-4ea6-92a4-cf8a3a99b19b			0.17	23	released	fa6fd8e9-eea4-4bd8-b92c-63ffd80e1e9b	RNA	R	0.17	UV Spec	released	False	c5de42cf-fd79-44bb-856b-3b7aa586a66b	11	3.0	0.0	0.0	0.0	10.0	0.0	90.0	75.0	TOP	7a0d47fd-7e5c-45a0-a3ea-7c4615bb6e86	released												released	30.0	cb05500b-f83d-4d3a-8da1-eedafb7d02ac	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T5_demographic	78	-28578		9a6b5960-82f0-5ddc-9680-76103b2db3b0	not hispanic or latino	female	white	released	Alive	1930		TCGA-XF-A9T5_exposure	Not Reported	27.88518738845925		d84b42dd-b81c-5adc-8573-debc71c9fb70	164.0		released	75.0	TCGA-XF-A9T5_diagnosis	28578		MX	N1	Stage IV	T3a	6th	not reported	0	2027	b0a6df66-547f-5f92-8da0-22f7854745d9	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-XF-A9T5_treatment	TCGA-XF-A9T5_treatment_1	released	83bcdf85-101c-5afe-98ee-1017bb4a75be	yes	Radiation Therapy, NOS	released	fcc4c15b-455f-5d4b-9a28-20578ad61bf3	yes	Pharmaceutical Therapy, NOS	fe81753b-1f4d-4b55-bd97-8d7f46b2c137
e8fd8597-6516-4f80-89e2-1dd1a3d50f56.htseq.counts.gz	b227f25c-fd4f-4cdc-ba35-e5951c57ff0b	TCGA-BT-A20R-01A-12R-A16R-07	TCGA-BT-A20R-01A-12R	TCGA-BT-A20R-01A-01-TSA		TCGA-BT-A20R-01A-12	TCGA-BT-A20R-01A	TCGA-BT-A20R	f8780a4b-7f55-41d1-bf92-8513955d150e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1794	220.0	False	true	F974D857-0AA3-4BAA-9C65-A71F27A72877	2.04	d785b32a-686a-43d6-9e0b-0b63cfd63772			0.18	23	released	2d864a7b-3663-46fc-b998-aa9a2a028ac9	RNA	R	0.18	UV Spec	released	False	dd225247-1657-4507-aace-94673133c835	12	0.0	0.0	0.0	0.0	5.0	10.0	85.0	65.0	TOP	8a75162f-2b5d-4fec-bbfc-ed8ca7f2413d	released												released	30.0	20231b7f-cb6a-4cd0-9c46-10d4e959d483	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20R_demographic	79	-28987	154	22bf7106-accf-514f-a1e8-c9ca34ee2367	not hispanic or latino	female	white	released	Dead	1927	2006	TCGA-BT-A20R_exposure	Not Reported			f983c151-07e0-5519-99f9-9c8f04ad8465			released		TCGA-BT-A20R_diagnosis	28987	T3b	M0	N1	Stage IV	T3b	6th	not reported	0		fe910470-54ec-5a10-acba-f1aa4b14186c	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2006	TCGA-BT-A20R_treatment	TCGA-BT-A20R_treatment_1	released	e8ef11c4-39ad-589b-83db-caad8cc5e42f	no	Radiation Therapy, NOS	released	3f6bb63a-0c1e-5f26-9650-a69cc299f3b9	no	Pharmaceutical Therapy, NOS	b227f25c-fd4f-4cdc-ba35-e5951c57ff0b
eea29b1e-88c6-45f5-8153-2ea542b6682b.htseq.counts.gz	a1c167c8-442d-4b6f-a430-2a49c270101a	TCGA-G2-A2EL-01A-12R-A18C-07	TCGA-G2-A2EL-01A-12R	TCGA-G2-A2EL-01A-01-TSA		TCGA-G2-A2EL-01A-12	TCGA-G2-A2EL-01A	TCGA-G2-A2EL	30c7445e-d0c4-4a0f-96a4-27e4259ee10b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	698	120.0	False	true	E021F112-7358-4CD0-870A-A29D0115CAE3	1.79	3458d1fe-d159-4522-a627-70c5cc180daa			0.16	23	released	9ff575c7-ff09-40ea-8515-ce842829d400	RNA	R	0.16	UV Spec	released	False	abca59f3-bb97-4acc-a597-73cc2034e620	12	3.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	948c548f-7f64-4454-813a-df03188c3d58	released												released	10.0	90f1d206-3e97-4c88-922c-fe4773c37caa	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EL_demographic	77	-28370	819	79eba6a2-66da-57a8-9d6a-88c6c4a21e89	not hispanic or latino	male	white	released	Dead	1932	2011	TCGA-G2-A2EL_exposure	Not Reported	27.776910832995224	2.191780821917808	a76b3d17-abae-5ffe-9eba-b944066037fb	179.0	40.0	released	89.0	TCGA-G2-A2EL_diagnosis	28370	T2a	M0	N0	Stage II		6th	not reported	0		e6a68b67-2324-5bb3-a3e4-254eecb27afe	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2009	TCGA-G2-A2EL_treatment	TCGA-G2-A2EL_treatment_1	released	28c50dc7-75af-5efd-be1f-41ef09d4172d	no	Radiation Therapy, NOS	released	7341a904-5563-53a6-924b-42b963bfda46	yes	Pharmaceutical Therapy, NOS	a1c167c8-442d-4b6f-a430-2a49c270101a
b233209a-04e9-4f58-9e54-46f58c762d3b.htseq.counts.gz	fe55f3d2-6578-4a2e-9ade-37f6603d5d21	TCGA-GU-A763-01A-11R-A32O-07	TCGA-GU-A763-01A-11R	TCGA-GU-A763-01A-01-TS1		TCGA-GU-A763-01A-11	TCGA-GU-A763-01A	TCGA-GU-A763	f632bc31-3aa0-4783-b10b-818ecb26d40b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	447	90.0	False	true	91819D13-8938-4216-966F-930D9E0BF4E7	1.87	459468e0-79bc-4544-b168-27a85342d4c1			0.17	23	released	39b583a9-63f3-406b-8cc1-dd2c64b19478	RNA	R	0.17	UV Spec	released	False	12b98bd0-3463-4989-bd95-f3e026cbea0c	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	80.0	TOP	a18471ae-af38-4a9f-b08b-4e6ec70c0970	released												released	30.0	248b4e29-74de-40b8-b006-69c6bdac640e	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A763_demographic	72	-26527		3a794864-8fec-5814-b491-d94ab1e2f172	not hispanic or latino	male	white	released	Alive	1940		TCGA-GU-A763_exposure	Not Reported	24.67550027041644	2.4657534246575343	607fc1bd-72c2-542a-b9d3-fd72d84a914c	172.0	45.0	released	73.0	TCGA-GU-A763_diagnosis	26527		M0	N0	Stage III	T4	7th	not reported	0	997	18044ef1-3498-50b1-8fb7-59f484ccb517	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2012	TCGA-GU-A763_treatment_1	TCGA-GU-A763_treatment	released	37a213a4-76c7-5d6e-a8a6-ea4eba09276e	yes	Pharmaceutical Therapy, NOS	released	ddd02c15-2cab-56bd-ae21-0b64971be40c	no	Radiation Therapy, NOS	fe55f3d2-6578-4a2e-9ade-37f6603d5d21
15a0c1b3-fe5c-47d4-9675-7bf8ec838e3a.htseq.counts.gz	a084dc66-5669-423d-865a-3fe123466ba5	TCGA-FD-A6TB-01A-12R-A33J-07	TCGA-FD-A6TB-01A-12R	TCGA-FD-A6TB-01A-01-TSA		TCGA-FD-A6TB-01A-12	TCGA-FD-A6TB-01A	TCGA-FD-A6TB	389d1e21-5b97-4231-a3d7-71fecb918beb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	273	750.0	False	true	D324203B-97F7-4EDF-B1D2-217F63ACAF92	1.92	8038ffb4-38d5-437a-9457-4943c0202a8a			0.17	23	released	7446f36e-4837-45fd-9c5a-2b62a00618e9	RNA	R	0.17	UV Spec	released	False	0969612e-9369-492a-8029-864016e63bdf	12	28.0	2.0	1.0	2.0	0.0	39.0	60.0	65.0	TOP	4e755537-0b4d-459a-b1e7-cb29b04d2316	released												released	30.0	133a4be0-26a6-4f42-9ebf-52d3e48d35a9	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TB_demographic	82	-30185		70e013f1-fbee-562b-ba46-3bce59b70e12	not hispanic or latino	male	white	released	Alive	1930		TCGA-FD-A6TB_exposure	Not Reported	21.453287197231834	1.643835616438356	32984fdb-427f-5540-8f1a-0bd9bfd6ae16	170.0	30.0	released	62.0	TCGA-FD-A6TB_diagnosis	30185	T1	MX	N0	Stage III	T3a	7th	not reported	0	572	b0c19479-dba8-50b7-b551-d23c83a6c272	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2012	TCGA-FD-A6TB_treatment_1	TCGA-FD-A6TB_treatment	released	2bdd0366-39c1-581e-bded-32a5f0a11119	no	Pharmaceutical Therapy, NOS	released	ddec3b87-1814-544b-82a7-2e068564a9da	no	Radiation Therapy, NOS	a084dc66-5669-423d-865a-3fe123466ba5
c80c2250-6668-43d3-bb2a-882e039fb2c6.htseq.counts.gz	11b24a28-b528-41b3-a36b-1579483d0349	TCGA-CF-A9FF-01A-11R-A38B-07	TCGA-CF-A9FF-01A-11R	TCGA-CF-A9FF-01A-01-TSA		TCGA-CF-A9FF-01A-11	TCGA-CF-A9FF-01A	TCGA-CF-A9FF	736e8cdf-e2d7-4141-86a9-45c34178a1c8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	106	320.0	False	true	6B1308E3-4C23-43B7-9608-1EA6D435525D	1.9	1a65f0c1-c6e4-470b-8be1-1744332a1470			0.17	23	released	38dae6cb-e7e2-43fb-991d-cb5be834e2d6	RNA	R	0.17	UV Spec	released	False	cf5704d5-c4e2-4018-bca7-4c51f1d0471c	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	faf0c1a6-c70a-49bc-a7b9-42264ff3bce4	released												released	30.0	286d1a8d-f384-4a49-a612-8511c5e9a8af	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A9FF_demographic	52	-19195		b16c3af6-2aa6-5e02-91cf-53a6992ac618	not hispanic or latino	male	asian	released	Alive	1961		TCGA-CF-A9FF_exposure	Not Reported	19.362472659471475		3eda14aa-5a12-565d-a151-353c216ca278	167.0		released	54.0	TCGA-CF-A9FF_diagnosis	19195		M0	N0	Stage II	T2	6th	not reported	0	361	3b5334a5-3156-5a17-9095-d6a798b9eccd	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-CF-A9FF_treatment	TCGA-CF-A9FF_treatment_1	released	74540392-de0a-5fc3-87e2-20f40c4bcc87	no	Radiation Therapy, NOS	released	bcc7e3a1-4ba9-5f28-a70a-2b7d85ae7145	no	Pharmaceutical Therapy, NOS	11b24a28-b528-41b3-a36b-1579483d0349
74c80c62-8411-4f72-92c4-c7a847c89e67.htseq.counts.gz	dc7fba5b-9bbb-4185-a706-f3bbf3c2d05e	TCGA-FD-A5BS-01A-21R-A26T-07	TCGA-FD-A5BS-01A-21R	TCGA-FD-A5BS-01A-02-TSB		TCGA-FD-A5BS-01A-21	TCGA-FD-A5BS-01A	TCGA-FD-A5BS	b581e799-93d1-4f1c-bcb7-7e7ae86a869e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1107	650.0	False	true	09B55176-4149-4D38-B5D9-F3F98DDA02C3	1.83	18bb3804-de1e-4988-abbf-89c36d07cc01			0.17	23	released	a4d5668f-d00a-4018-a127-9c3e55d1a959	RNA	R	0.17	UV Spec	released	False	8aa5dc5c-94e4-4454-a9e6-96bf13bfe37d	21	6.0	3.0	4.0	5.0	0.0	26.0	70.0	70.0	TOP	21a9159b-7dd1-4f26-951e-c99c004c1956	released												released	30.0	083eb339-613b-44ad-8937-a457b158ef4c	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BS_demographic	68	-24963		53d33156-b490-5365-a383-71f4ace67de7	not hispanic or latino	male	white	released	Alive	1941		TCGA-FD-A5BS_exposure	Not Reported			1f5022dc-e91d-5fc6-9bd0-f302ea299af5			released		TCGA-FD-A5BS_diagnosis	24963		MX	N0	Stage III	T3b	7th	not reported	0	1639	1a1903ec-744d-5423-a85b-80b5ad22d7a4	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2009	TCGA-FD-A5BS_treatment_1	TCGA-FD-A5BS_treatment	released	ba423676-f9fa-5480-adb2-836e66435fc5	yes	Pharmaceutical Therapy, NOS	released	a2e62a67-b48a-580a-84b6-ec2386cfd1bd	no	Radiation Therapy, NOS	dc7fba5b-9bbb-4185-a706-f3bbf3c2d05e
fcd7dc6c-37b2-4550-901b-71a35ce4ca60.htseq.counts.gz	55bb90d8-21d7-4a80-92dd-4211e82bc352	TCGA-E7-A97P-01A-11R-A38B-07	TCGA-E7-A97P-01A-11R	TCGA-E7-A97P-01A-01-TSA		TCGA-E7-A97P-01A-11	TCGA-E7-A97P-01A	TCGA-E7-A97P	18e6bdb0-b62d-4367-86e9-befbbf5e458c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	90	750.0	False	true	F93869FD-9F81-4BB1-B0A4-489E5293C31F	1.96	f2282782-43ba-47a5-abba-1f412a2fc535			0.17	23	released	592021fc-51e3-495e-ac1d-0a3d2d334357	RNA	R	0.17	UV Spec	released	False	344cb5ec-3298-4e65-aec2-8308e4566cd6	11	0.0	0.0	15.0	0.0	0.0	15.0	70.0	85.0	TOP	13e14a90-7de2-4895-838a-02969bbd7b14	released												released	30.0	8f094241-95a3-4940-bb07-9c096d27818f	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A97P_demographic	73	-26956	437	b5fe78c1-4568-5621-b7d1-5bd2ddcec418	not hispanic or latino	male	asian	released	Dead	1940		TCGA-E7-A97P_exposure	Not Reported	17.578125		9a5f1c2b-6aed-5247-bcd5-65f0fc951205	160.0		released	45.0	TCGA-E7-A97P_diagnosis	26956	T3	M0	NX	Stage II	T2	7th	not reported	0	13	107a309f-0555-5754-9b09-1be9c03e55b9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-E7-A97P_treatment_1	TCGA-E7-A97P_treatment	released	b4025d2c-e1b4-55a8-b95b-4ce2470f54f8	no	Pharmaceutical Therapy, NOS	released	4ab66a9a-b4fb-5244-b0a1-daa3f6070e68	no	Radiation Therapy, NOS	55bb90d8-21d7-4a80-92dd-4211e82bc352
ebe1d575-e448-45d6-a30d-8f8c8710d1cc.htseq.counts.gz	a77b56af-fba1-4601-9b2b-a4b7f214219d	TCGA-G2-AA3D-01A-11R-A39I-07	TCGA-G2-AA3D-01A-11R	TCGA-G2-AA3D-01A-01-TS1		TCGA-G2-AA3D-01A-11	TCGA-G2-AA3D-01A	TCGA-G2-AA3D	e1540865-69c2-4b60-a78e-97d0ce2957dc	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1726	50.0	False	true	F4A8627A-5551-4E1D-A49E-370FD0F39D02	1.86	0c23ff84-4469-485b-b3fd-2298cd6c8e42			0.16	23	released	b8159f32-f195-43b5-9a37-bc22c2a53287	RNA	R	0.16	UV Spec	released	False	c0fc8999-450a-4b04-84bf-c3d1c0d3d85d	11	3.0	0.0	0.0	0.0	40.0	0.0	60.0	65.0	TOP	a131605c-9a58-40ee-802e-12b84a341151	released												released	30.0	678f654e-8792-4041-8cfb-09fe2c3ba7f4	Primary Tumor	01	released	Not Reported	released	TCGA-G2-AA3D_demographic	60	-22205		6745176c-efca-5a9b-a27d-4cf3fe41cd0d	not hispanic or latino	male	white	released	Alive	1949		TCGA-G2-AA3D_exposure	Not Reported	36.59245579836531	1.36986301369863	e2afb5a9-95e7-597f-a78e-52a576275e52	171.0	25.0	released	107.0	TCGA-G2-AA3D_diagnosis	22205	T2	M0	N2	Stage IV	T3	6th	not reported	0	2139	6d2d817d-0334-5ba5-a750-b96ef60bdc94	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2009	TCGA-G2-AA3D_treatment_1	TCGA-G2-AA3D_treatment	released	a73bf44c-52cf-576d-9ccf-6bba96221c97	yes	Pharmaceutical Therapy, NOS	released	886e1747-3fac-5966-b7da-dd8c1e656cc1	no	Radiation Therapy, NOS	a77b56af-fba1-4601-9b2b-a4b7f214219d
d8586777-f71e-433a-bdbb-2245fd5e2864.htseq.counts.gz	101db3ac-e5c6-45d0-8a98-aebba37c79d1	TCGA-BL-A3JM-01A-12R-A21D-07	TCGA-BL-A3JM-01A-12R	TCGA-BL-A3JM-01A-01-TSA		TCGA-BL-A3JM-01A-12	TCGA-BL-A3JM-01A	TCGA-BL-A3JM	0f4fb205-b13c-4a85-97b3-779429e6ccdd	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	513	240.0	False	false	D6831C2D-C567-4649-9C51-75E1B202D8F9	1.79	9a7e2ecf-3470-427e-93cd-8461a3a3a5b8			0.17	23	released	992add52-dad7-4aa2-9190-252cb7818b3f	RNA	R	0.17	UV Spec	released	False	257b1b4d-34c2-4257-9391-b5e11dfae13b	12	0.0	0.0	0.0	0.0	0.0	35.0	65.0	80.0	TOP	678d0707-aa11-496b-ab25-9d92de589064	released												released	20.0	110acee1-915f-43a2-b382-5d0af1fc167f	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A3JM_demographic	62	-23000	205	f35e22ed-c84a-5bc9-b532-e56367e24fa5	not hispanic or latino	male	white	released	Dead	1948	2010	TCGA-BL-A3JM_exposure	Not Reported	22.576870925372813	2.684931506849315	38659325-24dd-5d94-a15c-6ffd3f0fe788	195.58	49.0	released	86.36	TCGA-BL-A3JM_diagnosis	23000		M0	N0	Stage III	T3	7th	not reported	0		4c92143b-3c3d-5a1e-a9cc-ce44052a9442	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-BL-A3JM_treatment_1	TCGA-BL-A3JM_treatment	released	0e639ab6-3051-5000-902c-52b403e7fc23	no	Pharmaceutical Therapy, NOS	released	9d92c72f-40fe-50de-87bb-9ee56ffda78b	yes	Radiation Therapy, NOS	101db3ac-e5c6-45d0-8a98-aebba37c79d1
ca99abb4-2dae-47b1-992d-6c4c5e555aae.htseq.counts.gz	36177248-7ecb-4566-ad8b-7c5c0568d0b1	TCGA-GV-A3JZ-01A-11R-A21D-07	TCGA-GV-A3JZ-01A-11R	TCGA-GV-A3JZ-01A-01-TSA		TCGA-GV-A3JZ-01A-11	TCGA-GV-A3JZ-01A	TCGA-GV-A3JZ	9cc92795-7a24-4875-87f0-3efccbfcc970	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	132	170.0	False	true	A1CF42EF-92A6-4214-BB25-7C71F665EFDC	1.75	f3872d71-1889-4756-bdb4-d5ae383758a8			0.17	23	released	c4c3d827-3b2f-48c8-bab6-d2832cfe92be	RNA	R	0.17	UV Spec	released	False	3e7fb7f1-b942-4c8f-8a98-4f95d28d3a6c	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	d45b67e7-ea07-4213-94b7-8acc22dd1112	released												released	30.0	449e18fb-cbc0-4365-aeec-edc6a6b276bd	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3JZ_demographic	55	-20420		fc446ba6-4b5e-5ee7-9d53-8bc5561fc4fc	not hispanic or latino	male	white	released	Alive	1956		TCGA-GV-A3JZ_exposure	Not Reported	25.082863029651527	0.821917808219178	1b622a0e-6481-5aa7-946e-cf20db7c1cf3	183.0	15.0	released	84.0	TCGA-GV-A3JZ_diagnosis	20420		MX	N3	Stage IV	T4a	7th	not reported	0	603	5002ce18-3c71-5703-ad89-0dae9fa7f7b1	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2011	TCGA-GV-A3JZ_treatment	TCGA-GV-A3JZ_treatment_1	released	85a4d910-32f6-5e77-a441-6b5301f85fa6	no	Radiation Therapy, NOS	released	d5b4b775-f626-57cd-9053-cfe030c19a8d	yes	Pharmaceutical Therapy, NOS	36177248-7ecb-4566-ad8b-7c5c0568d0b1
7cd11fe2-c1bc-480d-a0a3-3e05e9c8faae.htseq.counts.gz	0df53933-e2dc-426a-8e76-0e856817aaff	TCGA-ZF-A9R5-01A-12R-A42T-07	TCGA-ZF-A9R5-01A-12R	TCGA-ZF-A9R5-01A-01-TS1		TCGA-ZF-A9R5-01A-12	TCGA-ZF-A9R5-01A	TCGA-ZF-A9R5	aaa55de1-8f53-4b56-ba0a-67cff909cf81	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	743	60.0	False	true	5871BCC6-E728-4DFD-B2F2-C5C1C2E43B4C	1.73	9e99dced-8649-4a7e-bba9-ccde95cc4045			0.15	23	released	14978504-405f-4ec9-8714-fa0b9195867b	RNA	R	0.15	UV Spec	released	False	24f2f872-0423-4082-a1eb-84fe56b3d73d	12	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	20cada4f-67f0-47cf-9218-57110a2bc570	released												released	20.0	1ad5ffd6-8cc7-4638-9915-0d1a69311c9e	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R5_demographic	59	-21811		de23fe5e-6367-5e40-a0ca-20a3d95568f0	not hispanic or latino	male	white	released	Alive	1952		TCGA-ZF-A9R5_exposure	Not Reported	22.386314277122523	3.780821917808219	940d777b-ed54-570b-ad17-2dfce807c53c	173.0	69.0	released	67.0	TCGA-ZF-A9R5_diagnosis	21811		M0	N0	Stage III	T3	7th	not reported	0	1090	adfc54ee-48e9-54a4-8d80-241786b77805	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-ZF-A9R5_treatment_1	TCGA-ZF-A9R5_treatment	released	a38116fa-747e-55f0-a3c3-f818d54c155a	no	Pharmaceutical Therapy, NOS	released	e2cd1009-8fba-5524-b214-dc376cfd4336	no	Radiation Therapy, NOS	0df53933-e2dc-426a-8e76-0e856817aaff
eb9a898e-1153-44e8-bc91-73d923169672.htseq.counts.gz	543473e8-dc1d-4f01-92ee-0d2abeb76a5c	TCGA-UY-A9PH-01A-11R-A38B-07	TCGA-UY-A9PH-01A-11R	TCGA-UY-A9PH-01A-01-TS1		TCGA-UY-A9PH-01A-11	TCGA-UY-A9PH-01A	TCGA-UY-A9PH	cd10dc46-356a-420b-b3f5-9e4ed4e7ecab	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		70.0	False	true	0F1A84D7-7EB5-4FDD-BB99-FC4DBB712814	1.93	2a3b1b1a-9364-4bb2-beca-6933f88204c5			0.18	23	released	5345c98b-fc3c-4cba-b273-385f9e1dec5a	RNA	R	0.18	UV Spec	released	False	59d5fe51-1109-4931-b3b7-d318aede22c5	11	2.0	1.0	0.0	5.0	0.0	20.0	80.0	80.0	TOP	80488228-2124-40da-b59f-f8219b2bd7ea	released												released	30.0	89f7f38a-8228-40ec-9043-e2eca1d1d44d	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PH_demographic	73	-26654		88d6f7cf-e966-5c1a-b974-ee10eae16386	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PH_exposure	Not Reported	23.634033007530846		462aa7a9-adf7-534d-a53d-4cf100b5461b	158.0		released	59.0	TCGA-UY-A9PH_diagnosis	26654		MX	N0	Stage II	T2b	7th	not reported	0	1561	09b7278a-5506-5709-a6d0-7313ad841245	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii		TCGA-UY-A9PH_treatment	TCGA-UY-A9PH_treatment_1	released	edb1f50d-30f6-5a7e-ad10-f3e6c5d9d2c1	no	Radiation Therapy, NOS	released	49f5bd00-3d7e-5f54-8b0f-c1c8d386cd8e	no	Pharmaceutical Therapy, NOS	543473e8-dc1d-4f01-92ee-0d2abeb76a5c
a49b739f-b106-498c-9453-c6240ffe338a.htseq.counts.gz	1cf6bc60-295a-47b1-8853-2a5bea04a6fe	TCGA-E7-A7XN-01A-11R-A352-07	TCGA-E7-A7XN-01A-11R	TCGA-E7-A7XN-01A-01-TSA		TCGA-E7-A7XN-01A-11	TCGA-E7-A7XN-01A	TCGA-E7-A7XN	286cf147-b7f7-4a05-8e41-7fbd3717ad71	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	90	780.0	False	true	FB206F17-A9B7-4EDE-8DA3-62A7C99BBEB2	1.79	a931a672-1565-4de6-9c64-d5a74f4cac1f			0.17	23	released	7abecd7b-2493-4303-87eb-e8512bf2407d	RNA	R	0.17	UV Spec	released	False	f8e7e683-073a-4888-ae68-5d202c29f75b	11	4.0	1.0	12.0	1.0	0.0	30.0	58.0	90.0	TOP	b3c50c7c-c178-4489-b947-13ffa54bde6e	released												released	30.0	63eec89c-e81f-420e-a7b5-d63a241415f5	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A7XN_demographic	66	-24466		13ee26cd-4860-59dd-ba39-0a2bdf202b54	not hispanic or latino	male	asian	released	Alive	1947		TCGA-E7-A7XN_exposure	Not Reported	17.63085399449036	0.547945205479452	25a205ce-82c0-599a-8af0-7aa42982fe48	165.0	10.0	released	48.0	TCGA-E7-A7XN_diagnosis	24466		M0	N0	Stage III	T3	7th	not reported	0	428	cbfb3564-2e33-56bd-9e9e-790c0c0eb9a7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-E7-A7XN_treatment_1	TCGA-E7-A7XN_treatment	released	4e47bdcd-b40c-5cb6-abac-b4b3aa7e7017	no	Pharmaceutical Therapy, NOS	released	e0e8a17f-38a6-5019-9380-6136db11fa6b	no	Radiation Therapy, NOS	1cf6bc60-295a-47b1-8853-2a5bea04a6fe
fc751614-a3cf-49bd-8c0d-413211dadc61.htseq.counts.gz	e2d7a062-bc83-4b23-a015-85117eb2640c	TCGA-XF-A9T8-01A-11R-A39I-07	TCGA-XF-A9T8-01A-11R	TCGA-XF-A9T8-01A-01-TSA		TCGA-XF-A9T8-01A-11	TCGA-XF-A9T8-01A	TCGA-XF-A9T8	317e1db6-df93-4793-a4df-2fa234d8a81a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1972	1140.0	False	true	7F4BAF33-CF00-4B19-914A-5AA8CFB3D797	1.89	949b3248-f078-43cc-b6d8-39e9eabf88f1			0.15	23	released	46020003-3903-4a54-ace9-d877bab12fa9	RNA	R	0.15	UV Spec	released	False	4867d74f-3662-4fdb-9618-7fa6532786d5	11	0.0	0.0	0.0	0.0	20.0	20.0	60.0	70.0	TOP	0b124594-c948-4013-92d9-f4596e352f36	released												released	30.0	74caea53-239b-453b-a4e6-c8be49fc9bc2	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T8_demographic	64	-23403	418	17f9b68a-b578-5111-9aad-018bee2b7d4b	not hispanic or latino	male	white	released	Dead	1944	2009	TCGA-XF-A9T8_exposure	Not Reported	24.615210502489813	0.821917808219178	513ab8bc-c133-5e62-87c6-c3779869dbb9	188.0	15.0	released	87.0	TCGA-XF-A9T8_diagnosis	23403		MX	N0	Stage III	T3b	4th	not reported	0		aa19bec6-d4c6-5712-ace9-a454086dffbc	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2008	TCGA-XF-A9T8_treatment_1	TCGA-XF-A9T8_treatment	released	4ef8281f-79b7-5a05-80d3-6c0134468402	not reported	Pharmaceutical Therapy, NOS	released	f043d6e8-1c6c-5b13-be55-8528ea186b37	not reported	Radiation Therapy, NOS	e2d7a062-bc83-4b23-a015-85117eb2640c
583cf94b-9519-42ee-a66b-5290850d3775.htseq.counts.gz	938da948-cf9b-40e1-a8cf-85004e2f19b0	TCGA-DK-A3X1-01A-12R-A22U-07	TCGA-DK-A3X1-01A-12R	TCGA-DK-A3X1-01A-01-TSA		TCGA-DK-A3X1-01A-12	TCGA-DK-A3X1-01A	TCGA-DK-A3X1	6bddafde-7004-49b6-80cf-8081cd4b7d44	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1157	480	False	true	45B099D5-2E5F-4B70-9B17-D37BC5CA0D40	1.86	d74030bf-dfa1-4f65-9596-fd505733139e	2.34	13	0.18	23	released	cf007394-d7ad-4636-82a1-7e2ca9d350ed	RNA	R	0.18	UV Spec	released	False	87f8950f-bdaa-4a8e-98da-07a6df095883	12	6	1	3	1	0	47	50	70	TOP	2c017f7d-37f9-4ea5-a0a1-2a03bd09fc26	released												released	30	3d440a83-214e-432f-89d2-b523bfe7c6ef	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3X1_demographic	78	-28757		6d3329a5-79ca-5792-86b4-c07aa0a0b617	not hispanic or latino	female	white	released	Alive	1931		TCGA-DK-A3X1_exposure	Not Reported		1.095890410958904	5c7669b4-d357-527b-80ec-32e42f36b5a9		20.0	released		TCGA-DK-A3X1_diagnosis	28757		M0	N0	Stage III	T3	6th	not reported	0	2009	e0f85963-d687-5b3c-8e05-a506208dfb7d	C67.1	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Dome of bladder	released	Not Reported	Dome of bladder	not reported	stage iii	2009	TCGA-DK-A3X1_treatment	TCGA-DK-A3X1_treatment_1	released	2457ebe6-5bc0-5301-a6e3-4eaa6958f68b	no	Radiation Therapy, NOS	released	afc46aee-8b13-58e6-9c7f-3dd602274246	no	Pharmaceutical Therapy, NOS	938da948-cf9b-40e1-a8cf-85004e2f19b0
8c011753-33b3-4e29-880f-456994ab8349.htseq.counts.gz	74a400d3-fe62-412c-ba4d-747ee47a18be	TCGA-E5-A4TZ-01A-11R-A31N-07	TCGA-E5-A4TZ-01A-11R	TCGA-E5-A4TZ-01A-01-TS1		TCGA-E5-A4TZ-01A-11	TCGA-E5-A4TZ-01A	TCGA-E5-A4TZ	ca6403dd-3bd5-4023-8ea1-9957ec44dba5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1003	80.0	False	false	07FC68D0-114F-4840-836C-53B2A8A18CEC	1.87	b7290db7-112b-494e-80f7-bb05860f6c7e			0.17	23	released	56abdd49-7367-4c3c-8aad-611844efd79b	RNA	R	0.17	UV Spec	released	False	9b6df740-f90c-4744-8cd8-c01682a744f1	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	80.0	TOP	933291ea-2ff3-4638-b985-e1af6154c044	released												released	30.0	38ca6485-9a8e-40ba-8172-25dfe79aaabb	Primary Tumor	01	released	Not Reported	released	TCGA-E5-A4TZ_demographic	64	-23566	467	2804fb02-1f7a-55d9-b509-712e6e04470c	not hispanic or latino	male	white	released	Dead	1946	2011	TCGA-E5-A4TZ_exposure	Not Reported	27.764650283553873	4.657534246575342	81da0d44-c63a-5969-8f7f-8e51c4bb589c	184.0	85.0	released	94.0	TCGA-E5-A4TZ_diagnosis	23566		MX	N2	Stage IV	T4b	7th	not reported	0		7b5e59e5-0bf8-5959-9739-b36aeaa0187f	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2010	TCGA-E5-A4TZ_treatment_1	TCGA-E5-A4TZ_treatment	released	1ab8d19c-cc73-55b6-a3d2-cd12bb938d04	yes	Pharmaceutical Therapy, NOS	released	82b49c3d-cdd8-5e4c-9e88-e330238b68c5	yes	Radiation Therapy, NOS	74a400d3-fe62-412c-ba4d-747ee47a18be
3833f138-a4b7-40b9-bbc4-7f28973305e4.htseq.counts.gz	6718364f-1db7-4e87-a3d5-9df807646c09	TCGA-XF-AAN3-01A-11R-A42T-07	TCGA-XF-AAN3-01A-11R	TCGA-XF-AAN3-01A-01-TSA		TCGA-XF-AAN3-01A-11	TCGA-XF-AAN3-01A	TCGA-XF-AAN3	24ad2168-b25a-4de8-a021-dfe1c74fcc6e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2445	590.0	False	true	A0641D3F-1AB4-446B-B5AB-BB5882E82730	1.83	ed035849-50d7-4ce5-93fd-88a7735a8c92			0.17	23	released	4c1c0847-4e9e-4a8c-998d-93e21dbf5c96	RNA	R	0.17	UV Spec	released	False	ed9035ec-602f-40e5-b0df-b067dd0c6f4d	11	2.0	1.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	5bdf0479-2557-4def-aba5-f791e74948b0	released												released	30.0	633b412a-5681-47ce-bd5e-3d0a37f76bd2	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN3_demographic	76	-27909		9d65c683-a108-5633-9304-16549085bd9e	not hispanic or latino	male	white	released	Alive	1931		TCGA-XF-AAN3_exposure	Not Reported	19.841269841269842		163eccf9-6a8c-51e5-bf09-30103a96a1c8	168.0		released	56.0	TCGA-XF-AAN3_diagnosis	27909		MX	N2	Stage IV	T3b	6th	not reported	0	2625	2412d52a-fa7e-54d0-bd9e-57d3ace784cb	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2007	TCGA-XF-AAN3_treatment	TCGA-XF-AAN3_treatment_1	released	6ab31e39-7e60-52e0-8ab9-25e1cd6ce618	no	Radiation Therapy, NOS	released	2dac90fc-29d9-5012-8a25-7088ceb45b8c	yes	Pharmaceutical Therapy, NOS	6718364f-1db7-4e87-a3d5-9df807646c09
05472ddf-411c-40e1-9fca-525fc14ec490.htseq.counts.gz	9be8909b-9009-4d42-beb7-410bc9f5721b	TCGA-E7-A7DV-01A-11R-A33J-07	TCGA-E7-A7DV-01A-11R	TCGA-E7-A7DV-01A-01-TSA		TCGA-E7-A7DV-01A-11	TCGA-E7-A7DV-01A	TCGA-E7-A7DV	3effd691-570c-478a-8903-3771a1b43f2e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	164	1610.0	False	true	7226D91A-DF25-4FAE-B300-5E33F29C0E61	1.9	c8fd7f63-e309-4a7e-876d-7ca2cf954abe			0.17	23	released	65a7399e-7564-47d3-b727-99faae027abe	RNA	R	0.17	UV Spec	released	False	cfe27aa6-8a49-48a5-b292-a5affee8ae6d	11	5.0	0.0	20.0	0.0	0.0	20.0	60.0	92.0	TOP	789b2bc4-8af0-4df3-955e-b4cdc074de2c	released												released	30.0	d8f4c926-cc18-4d72-9e3d-ae7f58d846cf	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A7DV_demographic	44	-16145		0a8b6bd2-6c50-565c-b91c-56d8fe78fb4e	not hispanic or latino	male	white	released	Alive	1969		TCGA-E7-A7DV_exposure	Not Reported	23.738662131519273		268aeac3-2b91-50f1-8e4d-8f4a93fe73ff	168.0		released	67.0	TCGA-E7-A7DV_diagnosis	16145		MX	N3	Stage IV	T4	7th	not reported	0	37	66142eb2-5b21-566c-9cc6-720efddf7292	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2013	TCGA-E7-A7DV_treatment_1	TCGA-E7-A7DV_treatment	released	67866f15-3576-5214-95be-518239a15d47	not reported	Pharmaceutical Therapy, NOS	released	b4a17b63-a6f2-50dc-a9da-479fe813bd1d	no	Radiation Therapy, NOS	9be8909b-9009-4d42-beb7-410bc9f5721b
58e60ae5-3245-46f5-8e76-bfe09910002a.htseq.counts.gz	7d977500-bbdd-4a01-a6d6-b57941a8b1d3	TCGA-BT-A20O-01A-21R-A14Y-07	TCGA-BT-A20O-01A-21R	TCGA-BT-A20O-01A-02-TSB		TCGA-BT-A20O-01A-21	TCGA-BT-A20O-01A	TCGA-BT-A20O	c0e7fbe7-b9cb-4e65-941b-cd7d581c54ec	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2702	330.0	False	true	B2E8ABBC-33FF-4B89-AE29-34097296CB39	1.83	cfb10485-b097-4470-bd7e-5ed2abd2e8ac			0.16	23	released	fddca802-b6e2-4d6c-af9f-68e5a064c0b7	RNA	R	0.16	UV Spec	released	False	9fc91eff-2970-488e-b839-07aa81597fef	21	5.0	0.0	5.0	0.0	0.0	25.0	70.0	75.0	TOP	0fdbe64a-2e3e-42ed-868e-39660ee58b2b	released												released	30.0	5ecd84ad-44fd-4599-bf3d-ab725e0404ec	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20O_demographic	75	-27534	370	49394189-d42e-563a-99a8-a6ce5f4a384b	not hispanic or latino	male	white	released	Dead	1928	2004	TCGA-BT-A20O_exposure	Not Reported			26bdf767-4816-5a7c-a45c-759f2602bd43			released		TCGA-BT-A20O_diagnosis	27534	T3a	MX	N0	Stage III	T3a	6th	not reported	0		5535ed45-eba5-535e-988b-d6fce1e33008	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2003	TCGA-BT-A20O_treatment_1	TCGA-BT-A20O_treatment	released	47be0a9b-1e4c-5a65-a50b-0105f30ecc2e	no	Pharmaceutical Therapy, NOS	released	ccdec459-61df-5af2-8ac5-4a3111a00e74	yes	Radiation Therapy, NOS	7d977500-bbdd-4a01-a6d6-b57941a8b1d3
7731c385-2324-4f4f-907a-509ff3117edd.htseq.counts.gz	be4d591c-6119-45c8-bd09-ee95a4c056aa	TCGA-XF-AAMY-01A-11R-A42T-07	TCGA-XF-AAMY-01A-11R	TCGA-XF-AAMY-01A-01-TSA		TCGA-XF-AAMY-01A-11	TCGA-XF-AAMY-01A	TCGA-XF-AAMY	9d2b19eb-bd61-490e-982b-fadf2c4aadf7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2758	1090.0	False	true	AEF3C925-7B93-42F8-921B-9A2D3912DE99	1.86	97d81888-4ec1-438c-bbc3-1d10216e7606			0.16	23	released	2ea91e23-353f-4db4-98a8-b2db53b2878d	RNA	R	0.16	UV Spec	released	False	12fb23e9-504a-4f7c-8e2e-b8e3fb8605e5	11	4.0	1.0	0.0	3.0	0.0	25.0	75.0	75.0	TOP	2d614d82-01ac-4823-ab77-bb77b82b13df	released												released	30.0	288048a5-f521-4bc9-8c3a-dac39bf946b7	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMY_demographic	78	-28509		2109bc5d-2a66-5aea-95ec-56b3d39c031d	not hispanic or latino	male	white	released	Alive	1928		TCGA-XF-AAMY_exposure	Not Reported	37.558389092286326		6ef330c9-1ab8-5ead-9171-96c71efd00ac	178.0		released	119.0	TCGA-XF-AAMY_diagnosis	28509		MX	N0	Stage III	T3b	5th	not reported	0	3011	3acdf163-d452-5ccf-b25c-ccd886ee6493	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-AAMY_treatment_1	TCGA-XF-AAMY_treatment	released	2b260fa5-511a-5f30-82de-a84e5d4f2fb9	yes	Pharmaceutical Therapy, NOS	released	04db0b7e-0f32-51d4-8ce4-47d2196dd368	no	Radiation Therapy, NOS	be4d591c-6119-45c8-bd09-ee95a4c056aa
a69188da-1c3b-4d14-b50c-86e3a7ff0a5e.htseq.counts.gz	dd327132-83c3-4a1c-93fa-5837148fcb69	TCGA-BT-A20V-01A-11R-A14Y-07	TCGA-BT-A20V-01A-11R	TCGA-BT-A20V-01A-01-TSA		TCGA-BT-A20V-01A-11	TCGA-BT-A20V-01A	TCGA-BT-A20V	24f21425-b001-4986-aedf-5b4dd851c6ad	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1072	360.0	False	true	9D40A90D-AD9C-4754-A65C-799C23183534	1.86	80cdd385-2a6a-4d59-81c7-f36786637323			0.17	23	released	d4f74344-394a-4328-bc2f-06d7415494f6	RNA	R	0.17	UV Spec	released	False	a7121f92-09a6-4a5d-9bd9-8e7e7713e498	11	0.0	0.0	5.0	0.0	0.0	35.0	60.0	60.0	TOP	69b8b994-469c-483e-8027-108444183c32	released												released	30.0	967443e3-35c3-4f41-9bb5-dc899d290806	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20V_demographic	59	-21551	154	b15ec8ee-1d36-5b87-86f1-bf85076c3b4b	not hispanic or latino	female	black or african american	released	Dead	1949	2008	TCGA-BT-A20V_exposure	Not Reported			b27073ab-5fc8-56fb-91a6-5b300a9fe974			released		TCGA-BT-A20V_diagnosis	21551	T4a	M0	N2	Stage IV	T4a	6th	not reported	0		4e6ae2f0-eea3-53af-98a9-909433919e3a	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2008	TCGA-BT-A20V_treatment_1	TCGA-BT-A20V_treatment	released	6e506d79-a0bf-5a3e-a2eb-909d322f4acb	no	Pharmaceutical Therapy, NOS	released	75120752-a2bf-55b0-a8a0-fb414bef9b97	no	Radiation Therapy, NOS	dd327132-83c3-4a1c-93fa-5837148fcb69
e3adee45-923c-4adb-8181-7534b6653d75.htseq.counts.gz	6a2e6ba5-2d47-4386-b3b7-a7b889dd0db6	TCGA-GC-A3BM-01A-11R-A22U-07	TCGA-GC-A3BM-01A-11R	TCGA-GC-A3BM-01A-01-MS1		TCGA-GC-A3BM-01A-11	TCGA-GC-A3BM-01A	TCGA-GC-A3BM	7840aea9-40c4-473e-be33-8fa0b9f332c9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	276	120	False	false	F3408556-9259-4700-B9A0-F41E516B420C	1.78	8f7b5e84-55c2-4f98-a6a2-56b862161a98	1.95	13	0.15	23	released	97bfea9e-2cf1-4fab-8b87-457dab6e66be	RNA	R	0.15	UV Spec	released	False	93fdf14e-fc27-4b37-b190-a8d3f4096dfd	11	3	0	1	0	0	10	89	97	TOP	621fbcdb-b195-404c-8968-f58fb4e501a7	released												released	30	5c631ce8-f96a-4c35-a459-556fc4ab21e1	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3BM_demographic	70	-25609	651	d856cf7f-3e38-5370-b2d3-716dc3652816	not hispanic or latino	male	white	released	Dead	1940		TCGA-GC-A3BM_exposure	Not Reported	28.081632653061224	1.643835616438356	778627ac-4b18-5ae3-8a94-6eb04c691278	175.0	30.0	released	86.0	TCGA-GC-A3BM_diagnosis	25609		M0	N0	Stage II	T2b	7th	not reported	0	88	1c09a7b9-0a93-5a3f-84e9-8010c0e86378	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage ii	2010	TCGA-GC-A3BM_treatment_1	TCGA-GC-A3BM_treatment	released	05341ce8-ce75-5417-88cc-5297edc9cef5	no	Pharmaceutical Therapy, NOS	released	865035fd-cbe8-5af7-853c-07b9112cbdf5	yes	Radiation Therapy, NOS	6a2e6ba5-2d47-4386-b3b7-a7b889dd0db6
8c803e5a-4042-4af0-9eae-4ae313e617d8.htseq.counts.gz	7e1491ab-7468-493a-b70a-7f3f9c7b8eb8	TCGA-K4-A4AB-01B-12R-A28M-07	TCGA-K4-A4AB-01B-12R	TCGA-K4-A4AB-01B-01-TSA		TCGA-K4-A4AB-01B-12	TCGA-K4-A4AB-01B	TCGA-K4-A4AB	8b7556ed-2dab-4180-af5b-0e113e26b36e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	189	130.0	False	true	A23011FA-CE59-4D74-8EBC-7B02AA30E1D1	1.93	d27207d8-a3cf-475b-963a-e393eef98538			0.18	23	released	1624a6f7-87f1-47fa-bd6b-97b941321331	RNA	R	0.18	UV Spec	released	False	f05723dd-3a33-409e-bd6b-8838e9bf3430	12	3.0	2.0	0.0	3.0	0.0	30.0	70.0	70.0	TOP	1e670158-fb23-42fe-aac1-d085c676039b	released												released	10.0	01ce305a-0181-4485-8860-f5b13851a22e	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A4AB_demographic	76	-27922		70fed5f0-2795-5fa7-916a-fac6c4adf6f9	not hispanic or latino	male	white	released	Not Reported	1936		TCGA-K4-A4AB_exposure	Not Reported			458de616-c91c-5138-be3e-dc28905d6f28			released		TCGA-K4-A4AB_diagnosis	27922		MX	N0	Stage III	T4a	7th	not reported	0	84	dbbe1450-2804-5ed5-888a-4a4cee09b2e4	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-K4-A4AB_treatment_1	TCGA-K4-A4AB_treatment	released	dece9062-45c0-5243-a964-104df97854e2	no	Pharmaceutical Therapy, NOS	released	78abc62d-cff9-5fb6-969c-e6b09428c01c	no	Radiation Therapy, NOS	7e1491ab-7468-493a-b70a-7f3f9c7b8eb8
745bfb19-5735-490b-a1a8-952f3afdea42.htseq.counts.gz	a6c66a5a-4fa0-44bc-bc29-1b24d353f482	TCGA-FD-A5C0-01A-11R-A28M-07	TCGA-FD-A5C0-01A-11R	TCGA-FD-A5C0-01A-01-TSA		TCGA-FD-A5C0-01A-11	TCGA-FD-A5C0-01A	TCGA-FD-A5C0	0628e443-3d7f-4a38-9d2a-ebc7f4f7e11d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	70	1030.0	False	true	55259128-2D24-433B-A556-632B9D1D0E6F	1.83	7773fd96-8ab7-417b-befd-ea63dc596a7a			0.17	23	released	f66eaa5f-7a2e-4285-a8c1-5a08bdf51f67	RNA	R	0.17	UV Spec	released	False	a643e345-2213-4040-9517-745ebeec5c01	11	5.0	2.0	0.0	3.0	0.0	20.0	80.0	80.0	TOP	0546b805-0ff2-4f72-a8a3-deaf8d9dce3e	released												released	30.0	e3429307-4ff7-450a-a9dd-5ca2f863a87a	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5C0_demographic	61	-22500	550	03e7a631-df67-51b6-a324-4ec00e38f781	not hispanic or latino	male	white	released	Dead	1951		TCGA-FD-A5C0_exposure	Not Reported	26.881720430107528	1.643835616438356	97214e7c-8eae-5322-a516-902207dcfb65	186.0	30.0	released	93.0	TCGA-FD-A5C0_diagnosis	22500		MX	N2	Stage IV	T3a	7th	not reported	0	407	4807ff2f-3a06-5633-9626-7faaf65f8028	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2012	TCGA-FD-A5C0_treatment	TCGA-FD-A5C0_treatment_1	released	3a999fb6-ed87-585d-a6bf-67e792aea1e5	no	Radiation Therapy, NOS	released	5bdc0927-b878-567c-9f32-40dcd0d02ec4	yes	Pharmaceutical Therapy, NOS	a6c66a5a-4fa0-44bc-bc29-1b24d353f482
5ce16a94-7795-4566-93d7-8de4b0386752.htseq.counts.gz	1a9b9098-f2d0-43c1-9424-25afe42960f7	TCGA-G2-A2EK-01A-22R-A18C-07	TCGA-G2-A2EK-01A-22R	TCGA-G2-A2EK-01A-02-TSB		TCGA-G2-A2EK-01A-22	TCGA-G2-A2EK-01A	TCGA-G2-A2EK	5da1cb68-c438-4ddc-999f-90aed0c4bd7a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	147	120	False	true	935F1F7B-F048-4B44-81F0-1E56842A73B1	1.86	bc993392-5f2f-4cb8-8d27-26f3df2b3583	2.34	13	0.18	23	released	49e87241-50b2-48d7-b735-d97c4cbec8fe	RNA	R	0.18	UV Spec	released	False	f3d4911d-b1c8-446f-9d44-5d49d3fcf9a5	22	2	0	0	0	0	30	70	70	TOP	21188f6a-8ce6-46c0-9f59-4242c433c8ed	released												released	30	ff1691f2-df11-4068-8d8d-a778f384ec60	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EK_demographic	57	-20995		96180fe4-d520-5b95-b84a-496b6846b8b0	not hispanic or latino	male	white	released	Alive	1953		TCGA-G2-A2EK_exposure	Not Reported	48.73252603962722		fa16a29d-a7ef-5c63-98ee-33b8fc73f6f4	180.8		released	159.3	TCGA-G2-A2EK_diagnosis	20995	T2	M0	N0	Stage II		7th	not reported	0	485	e5df742d-4934-5445-b03b-d9f2c3d08042	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2010	TCGA-G2-A2EK_treatment	TCGA-G2-A2EK_treatment_1	released	c81d8d6c-188a-5919-8317-7226ffa17462	no	Radiation Therapy, NOS	released	97474c8e-9b73-5e77-9f2a-5774db705ffb	yes	Pharmaceutical Therapy, NOS	1a9b9098-f2d0-43c1-9424-25afe42960f7
3893a3ce-8554-4de1-9070-4ad443e4fa03.htseq.counts.gz	76530c44-7357-4193-bada-a4eea20e79fe	TCGA-BL-A13J-01A-11R-A10U-07	TCGA-BL-A13J-01A-11R	TCGA-BL-A13J-01A-01-TS1	TCGA-BL-A13J-01A-01-BS1	TCGA-BL-A13J-01A-11	TCGA-BL-A13J-01A	TCGA-BL-A13J	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	246	280.0	False	false	3ABF8C6B-606C-41A9-B050-E115834A7616	1.82	3c499f07-67e2-4032-a0b5-b9edd90035f7			0.14	23	released	045a5461-0bdd-49c5-b6ee-dc007a10ef47	RNA	R	0.14	UV Spec	released	False	895dbae7-3a55-4707-a2bd-dc7b53d53ed1	11	3.0	0.0	0.0	0.0	0.0	35.0	65.0	84.0	TOP	e1ec785a-e7c8-4c27-a6a6-e4e8aaa88507	released	2.0	0.0	0.0	0.0	0.0	35.0	65.0	84.0	TOP	a2132bbb-39e8-4606-aad8-f0cbf010a138	released	released	30.0	cf23846d-a7d2-40a9-8b51-49a27967d101	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13J_demographic	65	-23927	81	3a19ccff-885d-524c-85e5-a2606dace97c	not hispanic or latino	male	white	released	Dead	1945	2010	TCGA-BL-A13J_exposure	Not Reported	22.98539751216874	1.3150684931506849	bbd00b5a-a20a-5205-b773-ac6250abbc20	172.0	24.0	released	68.0	TCGA-BL-A13J_diagnosis	23927		M0	N2	Stage IV	T4		not reported	0		48d48f46-0677-517c-b11e-8c7e100a85b2	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2010	TCGA-BL-A13J_treatment	TCGA-BL-A13J_treatment_1	released	691d6cde-1889-5398-be89-5d0b9c88851b	no	Radiation Therapy, NOS	released	04e5320c-e9af-52f4-af45-77a50901166e	no	Pharmaceutical Therapy, NOS	76530c44-7357-4193-bada-a4eea20e79fe
5a7c65fc-a8d4-4f1e-8c76-7bb937c327ca.htseq.counts.gz	69396123-be20-4cc2-b0a4-3b259252b3dd	TCGA-CF-A1HR-01A-11R-A13Y-07	TCGA-CF-A1HR-01A-11R	TCGA-CF-A1HR-01A-01-TS1		TCGA-CF-A1HR-01A-11	TCGA-CF-A1HR-01A	TCGA-CF-A1HR	39ea19e1-4959-4f1b-9934-54bdaf766842	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	64	300.0	False	true	A3E36F4A-596B-433A-8898-1BFA6E715816	1.87	c11e3246-c33d-47ef-b4b4-be287b92d91e			0.16	23	released	f8cbf8c8-bf89-4f3f-9b5e-d6c25bb1d045	RNA	R	0.16	UV Spec	released	False	c99e3fe2-c4a3-4858-bcef-98dc6b165e39	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	fb7810ac-8da1-4d51-b702-e3f8c53f8544	released												released	30.0	6e77ab45-9c53-4a74-9581-043005c3e685	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A1HR_demographic	62	-22777		2373bca5-3439-5264-9a04-49443a774c4b	not hispanic or latino	male	asian	released	Alive	1948		TCGA-CF-A1HR_exposure	Not Reported	20.619253650621957		ebb21802-77e3-51c7-9372-422a527adaf4	172.0		released	61.0	TCGA-CF-A1HR_diagnosis	22777		M0	N0	Stage III	T3	6th	not reported	0	389	1eae25f1-34e9-5dac-8e63-757b9d70f51a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-CF-A1HR_treatment	TCGA-CF-A1HR_treatment_1	released	4a9f5926-2696-5d46-860c-13fe78459efd	no	Radiation Therapy, NOS	released	16ce23d6-796d-5d84-9d0c-c2c049d8f0ed	no	Pharmaceutical Therapy, NOS	69396123-be20-4cc2-b0a4-3b259252b3dd
1ba61e5e-da39-4d95-a091-8a49a71b716b.htseq.counts.gz	0b0a3b61-7426-4b89-8a89-7f1cc49e37fb	TCGA-GC-A3RD-01A-12R-A22U-07	TCGA-GC-A3RD-01A-12R	TCGA-GC-A3RD-01A-01-TS1		TCGA-GC-A3RD-01A-12	TCGA-GC-A3RD-01A	TCGA-GC-A3RD	6a2155b3-915c-41b1-b730-32e55e0c1fbd	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	77	70	False	true	4C037ABC-7731-4DD8-A6CC-0F871C09D16F	1.82	66132b23-e10a-49d9-89c5-129d7d98c17b	2.08	13	0.16	23	released	5031e321-92b0-4a14-b5fa-7951ec54a88c	RNA	R	0.16	UV Spec	released	False	0ea591f5-2ba4-4aae-9fd8-0cc818dbb8a3	12	2	0	0	0	0	0	100	90	TOP	5ca46233-801c-44b8-a712-0cfc22f3b9ce	released												released	30	1c60f60e-a3c6-43a1-a56e-ba68801d2d90	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3RD_demographic	83	-30529		ba1f7b1a-988a-5f82-acf3-5e994b6163b4	not hispanic or latino	female	white	released	Alive	1928		TCGA-GC-A3RD_exposure	Not Reported	28.804413972169254		c40bb7c4-9bbc-56d4-b9c7-ebbd3a5815f6	157.0		released	71.0	TCGA-GC-A3RD_diagnosis	30529		M0	N0	Stage III	T3a	7th	not reported	0	428	ed523288-ac9e-552b-85bb-ee7a9aee7514	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2011	TCGA-GC-A3RD_treatment	TCGA-GC-A3RD_treatment_1	released	02c12f75-3025-5e49-8bf7-a3463c3db508	no	Radiation Therapy, NOS	released	a399a98b-217b-5d7f-810a-fccc5eae6dad	no	Pharmaceutical Therapy, NOS	0b0a3b61-7426-4b89-8a89-7f1cc49e37fb
99decb55-33ed-40cb-8068-8ab21bd2bc4f.htseq.counts.gz	93182519-4bed-47f5-a5f1-8eb1dcb26ae0	TCGA-E7-A5KE-01A-11R-A28M-07	TCGA-E7-A5KE-01A-11R	TCGA-E7-A5KE-01A-01-TSA		TCGA-E7-A5KE-01A-11	TCGA-E7-A5KE-01A	TCGA-E7-A5KE	514dcd02-0b33-40ef-8ef1-05272045fc39	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	310.0	False	true	6B72BC7B-5419-4B29-AAB1-AC15111183DC	1.82	4be53c32-b222-44dd-b0b9-6a935591380a			0.16	23	released	4b9a7722-fef7-4629-8149-237e0d4d0ede	RNA	R	0.16	UV Spec	released	False	054f5f96-c999-46ec-8d78-6a25d4a93088	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	07867ab1-6c94-4977-b432-8d42c106ad21	released												released	30.0	a281ea63-5db3-4db4-9294-89392a6c65a6	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A5KE_demographic	78	-28714		b9877eff-afa3-5fd5-98d0-14f45f2a8aed	not hispanic or latino	female	asian	released	Alive	1934		TCGA-E7-A5KE_exposure	Not Reported	16.015625		892683a6-c6a9-5d97-9dc7-61f7573288f4	160.0		released	41.0	TCGA-E7-A5KE_diagnosis	28714		M0	N0	Stage II	T2a	7th	not reported	0	17	bcd4b8d7-9d24-5e32-af99-09e667ff7536	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A5KE_treatment	TCGA-E7-A5KE_treatment_1	released	8d0896e7-364c-54b2-9db8-f87256bc9153	no	Radiation Therapy, NOS	released	7c5b6947-cba9-5dae-ac34-d77ec5595c55	not reported	Pharmaceutical Therapy, NOS	93182519-4bed-47f5-a5f1-8eb1dcb26ae0
598daf4d-d024-45ef-b92b-c03182b59312.htseq.counts.gz	2757ecca-6be1-466f-aea1-9790acabce60	TCGA-ZF-A9R9-01A-11R-A38B-07	TCGA-ZF-A9R9-01A-11R	TCGA-ZF-A9R9-01A-01-TSA		TCGA-ZF-A9R9-01A-11	TCGA-ZF-A9R9-01A	TCGA-ZF-A9R9	ebad8bc9-f196-4f53-bfea-de38488eb4e1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1239	140.0	False	true	164EE426-8661-404C-9E0F-4216A76253C8	1.85	d328ae95-7792-4953-a88a-f288a96c4a65			0.17	23	released	998942c2-a71e-4371-b5ee-1b907ddab2ba	RNA	R	0.17	UV Spec	released	False	50f81137-3390-44b3-a206-db0d93501e4b	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	372d6274-0776-486e-ae9d-ac13aaca6608	released												released	30.0	d4a7e1ea-870b-4bdd-9935-3284af040138	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R9_demographic	58	-21491	864	8bb73a59-5ecd-55d5-8477-beb41a251c10	not hispanic or latino	male	white	released	Dead	1952	2012	TCGA-ZF-A9R9_exposure	Not Reported		0.1643835616438356	edf71766-89b6-5822-a83e-2531f3118e18		3.0	released		TCGA-ZF-A9R9_diagnosis	21491	T2	MX	N2	Stage IV	T3b	7th	not reported	0		58f49fae-ca77-5646-b4cf-7b213dfd3290	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-ZF-A9R9_treatment	TCGA-ZF-A9R9_treatment_1	released	4b9c4b12-8895-548d-8767-d7f4aef84ecf	yes	Radiation Therapy, NOS	released	9a0c80cc-6a09-59ad-9ff2-9580f17a24b6	yes	Pharmaceutical Therapy, NOS	2757ecca-6be1-466f-aea1-9790acabce60
4ba6105e-9e64-4ce3-87ca-31e0d009bbb4.htseq.counts.gz	2c6fba0a-1069-4154-95c7-59ac509d45fa	TCGA-DK-A3IU-01A-11R-A20F-07	TCGA-DK-A3IU-01A-11R	TCGA-DK-A3IU-01A-01-TSA		TCGA-DK-A3IU-01A-11	TCGA-DK-A3IU-01A	TCGA-DK-A3IU	f093f043-efd4-4cba-a87f-8cbb5c1acd9e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	261	370.0	False	true	7BDC2B9E-DB52-4D92-9712-CBE3B6A67706	1.83	c07c2f21-21d4-49cb-93bb-8d128966fcd6			0.17	23	released	9807f66f-c87f-4446-af6c-df3609eba84a	RNA	R	0.17	UV Spec	released	False	6303a68e-78cf-4152-9f0b-e6d827796d6b	11	5.0	0.0	0.0	0.0	25.0	0.0	75.0	90.0	TOP	3c59fd9b-234a-4122-907c-5fb7f9607d63	released												released	30.0	b9c39e8b-d689-499a-bc06-ce3bffc9996c	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IU_demographic	58	-21369	706	f4c1e6c6-9623-5185-8669-1dcd60932d69	not hispanic or latino	male	white	released	Dead	1953		TCGA-DK-A3IU_exposure	Not Reported	31.40244626683488	3.287671232876712	b4676e87-1f1c-5153-b565-1f112a7ca268	175.3	60.0	released	96.5	TCGA-DK-A3IU_diagnosis	21369		M0	N0	Stage II	T2b	6th	not reported	0	609	0b4e4637-85a0-5bc6-bf4a-727fb34091b8	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2011	TCGA-DK-A3IU_treatment	TCGA-DK-A3IU_treatment_1	released	53d05051-e936-5026-87e2-4127797343a0	no	Radiation Therapy, NOS	released	333db1d5-5965-5227-8299-d72a82e49f34	yes	Pharmaceutical Therapy, NOS	2c6fba0a-1069-4154-95c7-59ac509d45fa
546a8f3e-b73a-4b3d-aa2a-f995db0e5752.htseq.counts.gz	a4000af3-2c20-4b7b-a91b-9dfe24aca715	TCGA-BT-A0YX-01A-11R-A10U-07	TCGA-BT-A0YX-01A-11R	TCGA-BT-A0YX-01A-01-TSA	TCGA-BT-A0YX-01A-01-BSA	TCGA-BT-A0YX-01A-11	TCGA-BT-A0YX-01A	TCGA-BT-A0YX	22473ad4-df39-4716-b558-3c1409d5fa0e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	296	320.0	False	true	C628DA27-9908-48F3-B191-99C9248774C9	1.82	2f3c17f6-be91-4195-9aa7-e02298d118f3			0.15	23	released	733588bc-2897-4338-8183-1f6971b402f2	RNA	R	0.15	UV Spec	released	False	5dc466e9-1d70-47fc-96cb-fa4418d3a8df	11	10.0	0.0	10.0	5.0	0.0	30.0	60.0	70.0	TOP	d7779cf8-1752-4623-950d-58521ec87b7a	released	10.0	0.0	10.0	5.0	0.0	30.0	60.0	70.0	BOTTOM	7c9e8fd9-9be9-44aa-a1c2-2ffa34edabd0	released	released	30.0	da614214-f84c-43ab-983c-d9d76cf2d6ae	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A0YX_demographic	70	-25570	400	9591aa55-64e4-5641-99e8-81e87966883d	not hispanic or latino	female	white	released	Dead	1939		TCGA-BT-A0YX_exposure	Not Reported			59da2ba4-e0bf-57a9-8145-df13bbafdb08			released		TCGA-BT-A0YX_diagnosis	25570	T3b	M0	N0	Stage III	T3b	6th	not reported	0	363	05a6247a-55cf-5ccd-ad0d-b9c45630156a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2009	TCGA-BT-A0YX_treatment	TCGA-BT-A0YX_treatment_1	released	b53368fe-e5e8-5970-9f26-5188a58d756e	no	Radiation Therapy, NOS	released	b1ad9344-c292-5a91-acb0-7307cfce2bde	yes	Pharmaceutical Therapy, NOS	a4000af3-2c20-4b7b-a91b-9dfe24aca715
7cd3f052-f437-4079-b205-69e2f1e60d0a.htseq.counts.gz	e81120dc-0909-4dd2-8977-bd79b5c90563	TCGA-2F-A9KO-01A-11R-A38B-07	TCGA-2F-A9KO-01A-11R	TCGA-2F-A9KO-01A-01-TSA		TCGA-2F-A9KO-01A-11	TCGA-2F-A9KO-01A	TCGA-2F-A9KO	dd3a6357-9087-44b2-9956-f981e0de6f1c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2168	160.0	False	false	FA1D30C7-E486-48DD-989F-E774B42EA1B1	1.91	689c1593-3903-4c82-9cb1-1471d8bca178			0.15	23	released	43c3a69b-e0cd-4254-96d5-bba4a7150812	RNA	R	0.15	UV Spec	released	False	9e4f9a5c-bb70-4c58-b315-d25dbd563352	11	4.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	114373f3-efe1-4775-a7d9-ab1c858a7bdc	released												released	30.0	6e63e194-e41f-4f0d-979b-1e0439da1bfc	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KO_demographic	63	-23323	734	e00cfb0f-f548-5de8-b4c7-2cbf5b47f3ba	not hispanic or latino	male	white	released	Dead	1945		TCGA-2F-A9KO_exposure	Not Reported	21.71806608974573	3.780821917808219	09ec79f4-5ace-5b11-b0f8-0260ec75a490	173.0	69.0	released	65.0	TCGA-2F-A9KO_diagnosis	23323		M0	N1	Stage IV	T3	6th	not reported	0	678	37252159-6507-5e1c-ad0f-1fff74fc3c5d	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2008	TCGA-2F-A9KO_treatment	TCGA-2F-A9KO_treatment_1	released	231a62ba-6315-57fd-8db0-e4b33a724514	yes	Radiation Therapy, NOS	released	ab6d5281-7afe-51d0-9088-22fd4d24d880	no	Pharmaceutical Therapy, NOS	e81120dc-0909-4dd2-8977-bd79b5c90563
417c2f85-aaed-4cce-87fa-b312f0861094.htseq.counts.gz	ba6e05a8-89b6-446f-95c4-5b34e22ea55e	TCGA-DK-AA6L-01A-11R-A39I-07	TCGA-DK-AA6L-01A-11R	TCGA-DK-AA6L-01A-01-TSA		TCGA-DK-AA6L-01A-11	TCGA-DK-AA6L-01A	TCGA-DK-AA6L	cbe6c328-f7e1-44b2-b4e5-b495f46a7fb7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1418		False	true	4F76D253-8752-4787-8B1C-CEE72FF7EE54	1.92	ccc6510d-4ef3-4471-8fd1-e240fe55d95c			0.16	23	released	ed1265b8-bbdb-45b4-906b-d36919d727f8	RNA	R	0.16	UV Spec	released	False	50e939d2-843b-47e5-9c91-6b5732b3f929	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	5794f0c6-9ed6-489a-9621-18ccc5935548	released												released	30.0	86cfbaf2-9db7-479e-964e-f3e69cd1dd7c	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6L_demographic	48	-17635	1163	bc64461e-b469-5273-88bb-6eba79cb23ab	not hispanic or latino	male	white	released	Dead	1962	2013	TCGA-DK-AA6L_exposure	Not Reported	37.98388162240719	40.0	def93622-1ab5-5f4d-8961-3dc83f55099a	174.0	730.0	released	115.0	TCGA-DK-AA6L_diagnosis	17635		MX	N1	Stage IV	T3	7th	not reported	0		7665b531-8a55-51c3-82a7-256f4bbefec2	C67.1	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Dome of bladder	released	Not Reported	Dome of bladder	not reported	stage iv	2010	TCGA-DK-AA6L_treatment_1	TCGA-DK-AA6L_treatment	released	86e078f4-5c31-504a-9a4f-f9e72fd433a5	yes	Pharmaceutical Therapy, NOS	released	b320a48a-7cae-5254-a8ff-01c03ffc285b	no	Radiation Therapy, NOS	ba6e05a8-89b6-446f-95c4-5b34e22ea55e
fc3e36fd-0421-4dbc-8414-be2b836e03e8.htseq.counts.gz	ce24e3c7-6d0b-4b20-9d94-26d2e3930277	TCGA-XF-A9SP-01A-11R-A39I-07	TCGA-XF-A9SP-01A-11R	TCGA-XF-A9SP-01A-01-TSA		TCGA-XF-A9SP-01A-11	TCGA-XF-A9SP-01A	TCGA-XF-A9SP	76388364-eb01-4b16-a2b9-0b6c05b4b386	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3382	430.0	False	true	E5DD1503-9CED-449F-8312-3BD96D9ED951	1.86	f279c9db-8b02-4df1-883c-28373ec10636			0.16	23	released	b383111a-f844-4b4e-b78e-88953688f258	RNA	R	0.16	UV Spec	released	False	0c1d5e58-785f-4d6e-990c-1916135bd28c	11	2.0	1.0	0.0	6.0	0.0	30.0	70.0	70.0	TOP	de73757b-9f6c-4326-a38a-cfefcebcfc59	released												released	30.0	51998fd1-4a8a-4014-853f-faaeb0bce6f0	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SP_demographic	59	-21776	454	5c9b4031-a37d-5230-870d-9cbf11d992b5	not hispanic or latino	male	white	released	Dead	1945	2005	TCGA-XF-A9SP_exposure	Not Reported	24.075473810923544	3.6164383561643834	b0ea0b9b-1694-538f-89fe-508b93ef123e	189.0	66.0	released	86.0	TCGA-XF-A9SP_diagnosis	21776		MX	N0	Stage III	T3b	6th	not reported	0		d5f2fe53-9f10-5540-8682-cab39679e447	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2004	TCGA-XF-A9SP_treatment_1	TCGA-XF-A9SP_treatment	released	5ed9b063-ea22-5508-bdd5-7028fc6580c1	no	Pharmaceutical Therapy, NOS	released	955032ec-165f-5463-93bd-af2a6c858408	no	Radiation Therapy, NOS	ce24e3c7-6d0b-4b20-9d94-26d2e3930277
982a23b0-6f0b-4bde-b722-978acf79f39b.htseq.counts.gz	99ef1be4-3b67-4878-8b4f-aecf897c4ece	TCGA-E7-A4XJ-01A-11R-A26T-07	TCGA-E7-A4XJ-01A-11R	TCGA-E7-A4XJ-01A-01-TSA		TCGA-E7-A4XJ-01A-11	TCGA-E7-A4XJ-01A	TCGA-E7-A4XJ	92495a89-9974-4f75-99e0-28bd11114460	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	82	860.0	False	true	BF8490C7-4535-4EFF-9785-887C7B58CC75	1.86	a40c2a50-5627-4fd2-a6a3-2661c4ee5839			0.16	23	released	1a62a7f4-fbdb-4c6b-921d-20bc5da87d8d	RNA	R	0.16	UV Spec	released	False	ee5bad12-0e72-4999-87bb-8a3721a2841b	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	80.0	TOP	fbca5802-0574-44dd-870e-8af7d26c8f8c	released												released	30.0	d3950f7b-a687-419e-9ad4-ea36c7de4c5d	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A4XJ_demographic	66	-24279	68	e4a13f1e-5934-5649-a1dd-7334559f006d	not hispanic or latino	male	asian	released	Dead	1946		TCGA-E7-A4XJ_exposure	Not Reported	22.136739730004354	1.095890410958904	ff532c03-5ed7-5de1-bc9a-4cd75d743397	166.0	20.0	released	61.0	TCGA-E7-A4XJ_diagnosis	24279	T2	M0	N0	Stage II	T2	7th	not reported	0	16	55e54395-4257-5490-b322-d6166907e38d	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A4XJ_treatment	TCGA-E7-A4XJ_treatment_1	released	057c04b8-56b1-5a5d-bcb4-3a2438eb7fc8	no	Radiation Therapy, NOS	released	209913c7-0149-55c9-840a-a5a28b0da0af	no	Pharmaceutical Therapy, NOS	99ef1be4-3b67-4878-8b4f-aecf897c4ece
e4d255ef-063c-4b98-9187-cfc8ac241717.htseq.counts.gz	df4e4e09-3e14-4165-b63c-aa983b55afe5	TCGA-K4-A5RJ-01A-11R-A28M-07	TCGA-K4-A5RJ-01A-11R	TCGA-K4-A5RJ-01A-01-TSA		TCGA-K4-A5RJ-01A-11	TCGA-K4-A5RJ-01A	TCGA-K4-A5RJ	5a25658c-2436-4a47-8902-8a2cf4a1c20d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	101	190.0	False	true	19AA5671-7AE1-49F3-8CF0-03D2871AFCCA	1.94	57baff29-25d2-46ce-937f-f25343dcebc3			0.16	23	released	a105a61c-b411-46f9-8d21-3429e77358d6	RNA	R	0.16	UV Spec	released	False	798571bf-619f-463e-be5b-8570de18c172	11	2.0	0.0	5.0	0.0	0.0	10.0	85.0	90.0	TOP	e0223893-09f7-46bf-9b9a-eefbe954991c	released												released	30.0	5cc33b47-d462-4417-aceb-3b5fd9f5189e	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A5RJ_demographic	75	-27518		05f11014-dcd4-5093-99cf-c7b5c059d230	not hispanic or latino	male	white	released	Alive	1937		TCGA-K4-A5RJ_exposure	Not Reported			f2e436c4-b07e-5818-b06f-4184fb4bd56a			released		TCGA-K4-A5RJ_diagnosis	27518		MX	N0	Stage II	T2b	7th	not reported	0	539	6b466329-6e11-5e1b-a90d-516fb18f5648	C67.4	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2012	TCGA-K4-A5RJ_treatment	TCGA-K4-A5RJ_treatment_1	released	0a5f3408-9902-5009-b3e0-bf4c16f8a7bb	not reported	Radiation Therapy, NOS	released	e0cc5305-80a1-57ec-bc2a-e1a8780a8b8b	not reported	Pharmaceutical Therapy, NOS	df4e4e09-3e14-4165-b63c-aa983b55afe5
fb7b4bc8-eb7c-4ddf-8109-e699c4b620bd.htseq.counts.gz	798b2b30-3bed-4184-9366-ace98429d860	TCGA-C4-A0F0-01A-12R-A10U-07	TCGA-C4-A0F0-01A-12R	TCGA-C4-A0F0-01A-01-BS1	TCGA-C4-A0F0-01A-01-MS1	TCGA-C4-A0F0-01A-12	TCGA-C4-A0F0-01A	TCGA-C4-A0F0	40398c03-a9cc-476b-9ee9-aecf161be43f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1207	380.0	False	false	0A00B798-B309-4D11-8E16-3D7EE4AC1122	1.89	958520af-f270-49ab-8fb6-57e1ae8ae68f			0.08	23	released	ca70f8cc-b018-4f80-9897-61be283fcc89	RNA	R	0.08	UV Spec	released	False	1baa8a51-464f-4e85-a969-f59d973505f8	12	10.0	0.0	20.0	1.0	8.0	0.0	72.0	85.0	BOTTOM	76fc3ba5-7e92-40bc-b634-d3abf9f77616	released	5.0	1.0	20.0	15.0	20.0	0.0	60.0	65.0	TOP	100087a3-8eaa-4932-8ab2-aeb90074f86f	released	released	10.0	54234a11-8674-4b01-b2ef-a4c6d772aa43	Primary Tumor	01	released	Not Reported	released	TCGA-C4-A0F0_demographic	60	-22068		62ae2b5d-c26c-50df-b597-654062760f00	not reported	male	not reported	released	Alive	1947		TCGA-C4-A0F0_exposure	Not Reported	23.8884409806205	3.3424657534246576	bcc88d59-ee38-5908-a153-22b33240f4b8	183.0	61.0	released	80.0	TCGA-C4-A0F0_diagnosis	22068		M0	N0	Stage II	T2b	5th	not reported	0	59	ee345c92-373e-56f0-a9b8-f9b88fbb9e2e	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2007	TCGA-C4-A0F0_treatment_1	TCGA-C4-A0F0_treatment	released	6b76b173-f3e8-507d-9f9e-e153c0c7ecab	not reported	Pharmaceutical Therapy, NOS	released	e1f5a26c-1d8c-599e-a0f4-c0f6034c5c1e	not reported	Radiation Therapy, NOS	798b2b30-3bed-4184-9366-ace98429d860
08a33147-7fc0-4d51-882f-2562db269b2c.htseq.counts.gz	e7f2ba8c-92b7-4363-9a85-e46908b8e935	TCGA-YF-AA3M-01A-11R-A42T-07	TCGA-YF-AA3M-01A-11R	TCGA-YF-AA3M-01A-01-TS1		TCGA-YF-AA3M-01A-11	TCGA-YF-AA3M-01A	TCGA-YF-AA3M	30ad8081-daa7-4e2b-96f8-07f5ad12e774	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	360.0	False	false	D0F09A8C-8431-4A41-B7A6-BE6E9621CC58	1.87	6f9d42b2-dcbf-440a-9d11-1a434f202227			0.17	23	released	8813b2c7-aeda-40b5-842d-6a1e7a6225a3	RNA	R	0.17	UV Spec	released	False	6591c35a-9a91-448c-b885-54a4e249c5df	11	3.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	df8733c4-97e3-441d-b6ff-86e018c54d85	released												released	30.0	88980406-0ed9-4154-8e0e-57abe8da254c	Primary Tumor	01	released	Not Reported	released	TCGA-YF-AA3M_demographic	57	-21097		3979664a-7665-530f-b72f-5762e6006c70	hispanic or latino	male	not reported	released	Alive	1956		TCGA-YF-AA3M_exposure	Not Reported	27.28174603174603	3.1780821917808217	b9826fd9-418b-5517-9fd3-5fb2aeb8d13f	168.0	58.0	released	77.0	TCGA-YF-AA3M_diagnosis	21097		MX	NX	Stage II	T2a	7th	not reported	0	415	c9768732-264c-5254-8cfb-10c046106570	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2013	TCGA-YF-AA3M_treatment	TCGA-YF-AA3M_treatment_1	released	b0e6ed56-9a35-5873-ba41-77841be79bd4	no	Radiation Therapy, NOS	released	349af15b-bbcb-576e-822f-d10e6b5dbf87	yes	Pharmaceutical Therapy, NOS	e7f2ba8c-92b7-4363-9a85-e46908b8e935
fce06ccd-9703-402e-90ed-05a73b2a2511.htseq.counts.gz	2ab52c4f-661c-4039-bc1d-2498dbdd533a	TCGA-FD-A43N-01A-11R-A23W-07	TCGA-FD-A43N-01A-11R	TCGA-FD-A43N-01A-01-TSA		TCGA-FD-A43N-01A-11	TCGA-FD-A43N-01A	TCGA-FD-A43N	3cccffea-bd7d-4548-bb38-fe5eda630de6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	322	1040.0	False	true	1F3E42FB-862D-4B8C-BAC0-9B69011D28F9	2.02	043d2756-1abf-411f-aaac-b448ed088be1			0.18	23	released	9d5f8a3c-75a9-4f8e-a63b-65e94e0defcc	RNA	R	0.18	UV Spec	released	False	652ce19c-f458-4953-bc42-3fae2750fe13	11	5.0	1.0	0.0	2.0	0.0	25.0	75.0	75.0	TOP	101dda75-3c2d-4a5d-9dbe-3acf5ab1bffb	released												released	30.0	a191db88-2aad-4571-9b93-ff16cc2ccbe9	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43N_demographic	76	-27833		f438ef6e-f2e8-5007-a189-78adf54cb41d	not hispanic or latino	male	white	released	Alive	1935		TCGA-FD-A43N_exposure	Not Reported	35.751278024658355	6.136986301369863	c4408a56-92b7-538d-bf07-73507a6bb7a6	173.0	112.0	released	107.0	TCGA-FD-A43N_diagnosis	27833	T2	MX	N0	Stage III	T3a	7th	not reported	0	699	92157042-1f08-5a90-b01c-b7a9345ed7f9	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2011	TCGA-FD-A43N_treatment_1	TCGA-FD-A43N_treatment	released	267d79d7-a87a-544a-9f94-50b9e15c6da3	no	Pharmaceutical Therapy, NOS	released	1f676321-6b77-5c5f-90e4-5945dcd566e0	no	Radiation Therapy, NOS	2ab52c4f-661c-4039-bc1d-2498dbdd533a
ff691f33-5e85-4295-88f5-c86b762da62b.htseq.counts.gz	05553f2e-2564-4e7a-8136-ab9f80eab4f5	TCGA-C4-A0F7-01A-11R-A084-07	TCGA-C4-A0F7-01A-11R	TCGA-C4-A0F7-01A-01-BS1	TCGA-C4-A0F7-01A-01-TS1	TCGA-C4-A0F7-01A-11	TCGA-C4-A0F7-01A	TCGA-C4-A0F7	ca554128-da9d-4f37-9560-ca083509e01d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	660	120	False	false	27D0A4B2-0CC8-46CB-8048-2AB02805A100	1.86	c0ccb685-0789-4559-9189-05b841173aff	4.27	26.7	0.16	23	released	d2e90442-2523-45f0-b900-67fc642807d7	RNA	R	0.16	UV Spec	released	False	c217f69c-08eb-457b-937d-6c8228e47f89	11	1	0	3	2	35	2	60	75	BOTTOM	3312b0e1-7991-42e9-8fda-48e00cf53adf	released	4	0	1	6	49	2	48	75	TOP	c66fc2c3-7ca2-4e96-a919-96ebe2e6b617	released	released	30	f206c24b-a9c5-4476-a2a2-8dc1c45b5199	Primary Tumor	01	released	Not Reported	released	TCGA-C4-A0F7_demographic	77	-28428	62	64da6338-be6b-5767-81aa-91854a626a59	not reported	male	not reported	released	Dead	1931	2008	TCGA-C4-A0F7_exposure	Not Reported	23.66143861546782		d6cda8e6-0a1f-5cb6-9341-d66575e37137	172.0		released	70.0	TCGA-C4-A0F7_diagnosis	28428		M0	N2	Stage IV	T4b	6th	not reported	0		c70c1304-164e-521a-a118-83cf498c8d5c	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-C4-A0F7_treatment	TCGA-C4-A0F7_treatment_1	released	47cb8bb0-8a23-51fd-bfb8-42045ebdc55d	not reported	Radiation Therapy, NOS	released	6ac285a1-c77a-5035-bcda-78d0dd95f68f	not reported	Pharmaceutical Therapy, NOS	05553f2e-2564-4e7a-8136-ab9f80eab4f5
8bfe9916-987b-445b-8ca0-1cac3e5df2a9.htseq.counts.gz	daa1e5ab-afa5-4486-bd8e-ebb8f8dd55a6	TCGA-XF-AAMR-01A-31R-A42T-07	TCGA-XF-AAMR-01A-31R	TCGA-XF-AAMR-01A-03-TSC		TCGA-XF-AAMR-01A-31	TCGA-XF-AAMR-01A	TCGA-XF-AAMR	818f5a45-4deb-49e4-9a73-55ef4269de4c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2686	750.0	False	true	907112FF-1E09-4BD1-97BE-01E9BAC0E4D9	1.87	19823203-33ed-4c89-a8af-611ad1e95f8a			0.15	23	released	4b53b099-54e0-476d-b15c-e92b0b05dca4	RNA	R	0.15	UV Spec	released	False	2178e6df-c25b-408e-b9aa-5dc9ff026499	31	3.0	0.0	2.0	0.0	0.0	70.0	28.0	95.0	TOP	56f2a1c7-63f6-417e-b04a-f8cd76abfd73	released												released	30.0	91b24777-efd1-42ed-8fa3-c873d8b79ab0	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMR_demographic	48	-17670		342a5231-7b97-5366-a7fd-67fce2ddd2f6	not hispanic or latino	male	white	released	Alive	1958		TCGA-XF-AAMR_exposure	Not Reported	25.79591836734694		25ba5c11-2825-5ca0-bbcc-de112d32f4fc	175.0		released	79.0	TCGA-XF-AAMR_diagnosis	17670		MX	N0	Stage III	T3b	6th	not reported	0	2790	2dadb391-0509-5667-b76f-f1baf76dc64b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-AAMR_treatment_1	TCGA-XF-AAMR_treatment	released	dd3cda01-4a6e-5b47-90c9-248b2cbe6c38	yes	Pharmaceutical Therapy, NOS	released	67021d3f-f533-512a-a069-7305d3d54245	no	Radiation Therapy, NOS	daa1e5ab-afa5-4486-bd8e-ebb8f8dd55a6
817a5168-1b30-4d30-ab20-609769815d4c.htseq.counts.gz	b8fd8f9c-e7e6-4ca6-8c6c-6b1d63d4f420	TCGA-XF-AAN7-01A-11R-A42T-07	TCGA-XF-AAN7-01A-11R	TCGA-XF-AAN7-01A-01-TSA		TCGA-XF-AAN7-01A-11	TCGA-XF-AAN7-01A	TCGA-XF-AAN7	9d7fbdeb-ea3d-4e07-8527-23c5997d77cf	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2087	1300.0	False	true	B680364D-6FEC-45A5-95FC-1055E37DFCE2	1.86	9e523e29-ea79-4124-97b4-d9c8686b3ddc			0.17	23	released	7f8dea93-d8db-4b7e-8f5d-079f6920f3c0	RNA	R	0.17	UV Spec	released	False	ffb719ef-1a70-4ac0-b595-69b9a78e928a	11	2.0	0.0	3.0	0.0	0.0	7.0	90.0	96.0	TOP	53f6a6c5-5d44-4a2d-a109-402de5518609	released												released	30.0	c1f6f709-4c79-465a-90d4-17e08dfa96cd	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN7_demographic	60	-21951	565	2e92b864-fe17-58d6-acd3-1a1d65dce07c	not hispanic or latino	male	white	released	Dead	1948	2009	TCGA-XF-AAN7_exposure	Not Reported	26.575890590940308	2.191780821917808	483a2a74-5e92-5dc3-ad45-a174c5a2fd9e	183.0	40.0	released	89.0	TCGA-XF-AAN7_diagnosis	21951		MX	N1	Stage IV	T3a	5th	not reported	0		4e6548e6-67c8-5699-84b1-668f007839fd	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-XF-AAN7_treatment_1	TCGA-XF-AAN7_treatment	released	05e13db9-7c4f-5594-97d2-0ca55d56a739	yes	Pharmaceutical Therapy, NOS	released	6909f581-7eb7-5bca-8b66-40795f1c8c1c	no	Radiation Therapy, NOS	b8fd8f9c-e7e6-4ca6-8c6c-6b1d63d4f420
e0b19af8-a2e5-495f-81d0-80347e8fb51f.htseq.counts.gz	6fbc6e08-18d8-48fe-8708-ae7b99f87c04	TCGA-UY-A8OD-01A-11R-A36F-07	TCGA-UY-A8OD-01A-11R	TCGA-UY-A8OD-01A-01-TS1		TCGA-UY-A8OD-01A-11	TCGA-UY-A8OD-01A	TCGA-UY-A8OD	fa2410b1-4f69-446d-99ee-a10a00034c42	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		40.0	False	true	B74B0DFB-0A6B-4E4C-A843-50130DE79C1A	1.92	1330c062-9641-4d39-a09f-18aebaa90550			0.17	23	released	bd038b0d-4d71-4aac-9a05-9f1a0eb1584d	RNA	R	0.17	UV Spec	released	False	7f8157bc-79ed-4d9e-9d6b-2294b6f026f9	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	4b01255a-91e2-4732-852b-bbd67a90fabe	released												released	25.0	c53ef182-b87d-4332-8fce-150e8cb904da	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A8OD_demographic	68	-24588		d756c3a5-181d-57ca-bb17-c83a2e0f85c3	not hispanic or latino	female	black or african american	released	Alive			TCGA-UY-A8OD_exposure	Not Reported			30fb9dda-2f13-5515-a639-dd32f446e1eb			released		TCGA-UY-A8OD_diagnosis	24588		MX	N0	Stage II	T2b	6th	not reported	0	3432	c8ee59df-dc15-52b5-8c51-2426d73c1152	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii		TCGA-UY-A8OD_treatment	TCGA-UY-A8OD_treatment_1	released	cc95dca7-5258-5f8e-80f3-ac0cbb74b243	no	Radiation Therapy, NOS	released	a73fb758-3345-50df-8716-ba575b46448c	no	Pharmaceutical Therapy, NOS	6fbc6e08-18d8-48fe-8708-ae7b99f87c04
75ce85f0-a6cc-4d85-9f4a-27e7e328dc3e.htseq.counts.gz	b6c58f76-5dc2-44d7-8e90-9e6e32da21df	TCGA-FD-A3SP-01A-31R-A22U-07	TCGA-FD-A3SP-01A-31R	TCGA-FD-A3SP-01A-03-TSC		TCGA-FD-A3SP-01A-31	TCGA-FD-A3SP-01A	TCGA-FD-A3SP	5f99dcff-d809-4c87-8024-c9b30bd565e9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	57	390	False	true	F20CA7B6-3109-4A49-9355-5DCED1AD7136	1.82	9ad7733f-a2a6-4985-8ed3-d2c539eeab96	2.08	13	0.16	23	released	83daf451-2b90-4c1f-a6ff-c3b81f8cae7f	RNA	R	0.16	UV Spec	released	False	f6b894e6-ef21-483d-8846-617f93b80fb8	31	0	0	0	0	20	0	80	70	TOP	b95e77ef-faed-49e3-9c5d-138cd7c05d66	released												released	30	3592a9c5-124e-428f-b1f9-40429c591429	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SP_demographic	60	-22005		da6da43b-5d7d-5093-8ba2-f411846bb104	not hispanic or latino	male	white	released	Alive	1952		TCGA-FD-A3SP_exposure	Not Reported	28.666129176744604	0.6575342465753424	f2938484-51b9-5108-9142-b958e670476d	183.0	12.0	released	96.0	TCGA-FD-A3SP_diagnosis	22005		MX	N0	Stage III	T3b	7th	not reported	0	783	8974c44b-d5c8-5a46-bf59-f650a94b05f1	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-FD-A3SP_treatment	TCGA-FD-A3SP_treatment_1	released	5f0efbbe-440e-5737-9e4a-1a3650e1a27d	no	Radiation Therapy, NOS	released	87cb7719-f492-572b-97cb-8ac462a0faaf	yes	Pharmaceutical Therapy, NOS	b6c58f76-5dc2-44d7-8e90-9e6e32da21df
64d36f74-2917-47fd-b645-fcdefc024c09.htseq.counts.gz	02ed47b1-2b8a-4c1c-aaa7-2afec025a67a	TCGA-DK-A2HX-01A-12R-A18C-07	TCGA-DK-A2HX-01A-12R	TCGA-DK-A2HX-01A-01-TSA		TCGA-DK-A2HX-01A-12	TCGA-DK-A2HX-01A	TCGA-DK-A2HX	c728fac9-5452-4759-a4ed-a366e0f757cb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	182	690.0	False	true	D531397C-85E3-4C46-BB9C-0780CBFE25D6	1.78	518085b3-f993-4346-bb4d-b7244e9435d6			0.17	23	released	4edf202c-9f6c-4baf-9613-6fa4d5320af8	RNA	R	0.17	UV Spec	released	False	9731c490-5f07-4d9c-89fd-b618e89dc4da	12	3.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	42631926-f1a6-4fee-bc0c-4d85a1315984	released												released	30.0	537f3fe6-4e8e-4570-827a-0f5cab193be0	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A2HX_demographic	80	-29332	1420	dc36a820-1bf4-5364-844f-b57bf6169cd8	not hispanic or latino	female	white	released	Dead	1930		TCGA-DK-A2HX_exposure	Not Reported	24.29543245869776	1.095890410958904	b533e852-e680-5d4d-8166-e1da8c575528	147.0	20.0	released	52.5	TCGA-DK-A2HX_diagnosis	29332		M0	N2	Stage IV	T3	6th	not reported	0	55	932992c1-5ff8-5c37-9f93-019b4bae0d08	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A2HX_treatment	TCGA-DK-A2HX_treatment_1	released	a8180ba2-9263-51b4-82b0-921563dc6135	not reported	Radiation Therapy, NOS	released	a2e49d1d-caaa-51aa-9094-3b75e52bf5c5	not reported	Pharmaceutical Therapy, NOS	02ed47b1-2b8a-4c1c-aaa7-2afec025a67a
43d48f39-2a2c-4b0c-a333-8fb61e3857ae.htseq.counts.gz	f08afa7a-03ec-4602-92b9-30da3ac4b4b8	TCGA-CF-A8HX-01A-11R-A36F-07	TCGA-CF-A8HX-01A-11R	TCGA-CF-A8HX-01A-01-TS1		TCGA-CF-A8HX-01A-11	TCGA-CF-A8HX-01A	TCGA-CF-A8HX	43f9b602-683a-4fa1-b044-8fc5794b1453	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	170.0	False	true	347944A8-FA38-477F-B68C-5851B2097790	2.0	eb31b7b3-ef3c-4ad9-a9e8-47b85753e2d6			0.16	23	released	714ac135-64e5-47ad-9809-7bffff07d577	RNA	R	0.16	UV Spec	released	False	cf0dad8b-36f6-45a6-84d4-3a2b45382870	11	3.0	0.0	2.0	1.0	0.0	23.0	75.0	92.0	TOP	e7b00b91-4488-4ec3-a03d-64dccd5665fd	released												released	30.0	8ddad133-cd3d-49d9-b144-f11e6e93431e	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A8HX_demographic	55	-20259		89a4f024-cad1-5e69-aa80-12af2b559b99	not hispanic or latino	female	asian	released	Alive	1958		TCGA-CF-A8HX_exposure	Not Reported	23.92242299970097		552bb5dc-5cd1-57fd-bf5a-39423ae1c55e	153.0		released	56.0	TCGA-CF-A8HX_diagnosis	20259		M0	N0	Stage II	T2	6th	not reported	0	345	54cb5f25-641f-5fa9-bdc0-ea2cefce550b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-CF-A8HX_treatment_1	TCGA-CF-A8HX_treatment	released	8753c594-7925-5247-ad0a-dce48d8cc880	no	Pharmaceutical Therapy, NOS	released	b8eb5124-ed1e-565a-bc8b-a67e838654fa	no	Radiation Therapy, NOS	f08afa7a-03ec-4602-92b9-30da3ac4b4b8
b64dd96f-0dd9-41b4-9e6c-8808c30697a7.htseq.counts.gz	be5fa197-77ba-4e97-a37c-f58f4ed1490e	TCGA-E7-A85H-01A-11R-A352-07	TCGA-E7-A85H-01A-11R	TCGA-E7-A85H-01A-01-TSA		TCGA-E7-A85H-01A-11	TCGA-E7-A85H-01A	TCGA-E7-A85H	c8adce3d-4914-4851-9952-846b0c9c32de	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	106	1670.0	False	true	4AAC565F-AE74-46E9-87D1-055DD38EFEBD	1.78	1e9aa67a-52fe-4af3-8bbf-3597a57a4b72			0.17	23	released	be935352-bf33-42c5-acd9-8f381a5bdb21	RNA	R	0.17	UV Spec	released	False	614b84a0-9393-4657-b7c5-ed4eaa71c4dc	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	f392eeba-36a9-4532-a648-cc8e0f1cda8e	released												released	30.0	3e301929-fcfd-4bf1-8314-595b4d8d382d	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A85H_demographic	64	-23497		f7364f60-4e1d-569b-9e26-1cc0713a7ce0	not hispanic or latino	male	asian	released	Alive	1949		TCGA-E7-A85H_exposure	Not Reported	17.006802721088434	0.273972602739726	a2023927-ce0d-5e29-b415-2260398fac49	168.0	5.0	released	48.0	TCGA-E7-A85H_diagnosis	23497		M0	N0	Stage III	T3	7th	not reported	0	394	2c897d8f-acc7-5369-8f90-3b65455c3906	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-E7-A85H_treatment	TCGA-E7-A85H_treatment_1	released	61359cc4-3989-55a9-87c2-dab1ebc6b526	no	Radiation Therapy, NOS	released	2e101ca9-ca18-5316-8fcf-727a0b62a7b5	not reported	Pharmaceutical Therapy, NOS	be5fa197-77ba-4e97-a37c-f58f4ed1490e
fca79db5-94e6-4a10-b6ae-0af615bf79b1.htseq.counts.gz	cd97e610-ce54-4742-a340-feff18a5e8d0	TCGA-ZF-A9RL-01A-11R-A38B-07	TCGA-ZF-A9RL-01A-11R	TCGA-ZF-A9RL-01A-01-TS1		TCGA-ZF-A9RL-01A-11	TCGA-ZF-A9RL-01A	TCGA-ZF-A9RL	386f51e4-d03a-4606-bf2e-6168f2122c5f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2221	10.0	False	true	EC382266-E28D-4F67-B363-84425688F82F	1.86	e15e8747-ff36-464a-bfc1-2909a23bd0a3			0.16	23	released	cbd25664-093c-49a7-a16e-155266a96997	RNA	R	0.16	UV Spec	released	False	ba09bd3f-94a4-43ab-8902-3b9127803cea	11	3.0	0.0	15.0	1.0	0.0	15.0	70.0	95.0	TOP	9fc22b8f-2a0a-49b0-bce8-f14e79dd9077	released												released	10.0	743c1949-46c8-4a6e-83d8-5e05f09d9337	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RL_demographic	61	-22480		bd5c554f-0d08-5d5a-be32-09204cdac9f7	not hispanic or latino	male	white	released	Alive	1946		TCGA-ZF-A9RL_exposure	Not Reported		2.0821917808219177	4e9f29bc-e6fc-58a0-9693-71b67d5c293d	164.0	38.0	released		TCGA-ZF-A9RL_diagnosis	22480	T2	MX		Stage II		6th	not reported	0	2703	6f5fd9c4-eb6e-5950-b84c-ec9a85c5c659	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2007	TCGA-ZF-A9RL_treatment_1	TCGA-ZF-A9RL_treatment	released	6301d2c4-d8fa-5ede-b927-6a144dcf065e	yes	Pharmaceutical Therapy, NOS	released	4d638fd1-07ef-50b7-bf32-ad8dd951d2d2	no	Radiation Therapy, NOS	cd97e610-ce54-4742-a340-feff18a5e8d0
f1ebdbe1-5c6c-4538-b1c5-03d4538908a0.htseq.counts.gz	010184c0-c104-4967-b83b-0fc613bd556a	TCGA-UY-A9PB-01A-11R-A38B-07	TCGA-UY-A9PB-01A-11R	TCGA-UY-A9PB-01A-01-TS1		TCGA-UY-A9PB-01A-11	TCGA-UY-A9PB-01A	TCGA-UY-A9PB	f90cff19-1c16-4514-8bc1-169539d01fca	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		90.0	False	true	1CCAA482-BC52-4F00-89E4-31D0D9BBEAF9	1.87	d9954580-b237-40a2-b4a3-3ce2482f8da2			0.17	23	released	7f9abeb0-d86a-45ed-bf43-5c79eb9430b3	RNA	R	0.17	UV Spec	released	False	418a6fe8-f098-4a46-a7c9-547f2528d838	11	2.0	2.0	1.0	5.0	0.0	24.0	75.0	75.0	TOP	c8a0dcee-9f3d-4cb1-bc63-15e69b742f8f	released												released	30.0	7ef5e57d-c08f-4749-9656-6d0ceabe824a	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PB_demographic	49	-17885		30c00f00-543e-5c39-a8e4-bd6b4232ae2f	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PB_exposure	Not Reported	41.50931618863331	1.36986301369863	e7a1c266-887c-5895-a7ee-22d9b423ef94	179.0	25.0	released	133.0	TCGA-UY-A9PB_diagnosis	17885		MX	N0	Stage III	T3a	6th	not reported	0	899	637fb9bb-33af-5127-975e-1304bdd5a133	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii		TCGA-UY-A9PB_treatment_1	TCGA-UY-A9PB_treatment	released	2b731323-235e-5023-b5dd-567a5723215a	no	Pharmaceutical Therapy, NOS	released	f0f1221c-6919-554b-888c-c2b9949eee00	no	Radiation Therapy, NOS	010184c0-c104-4967-b83b-0fc613bd556a
9830efa0-01e2-495a-9437-1d2506469fd8.htseq.counts.gz	5927bea1-f067-48b2-945e-ebcbb557c1bc	TCGA-GV-A3JV-01A-11R-A220-07	TCGA-GV-A3JV-01A-11R	TCGA-GV-A3JV-01A-01-TSA		TCGA-GV-A3JV-01A-11	TCGA-GV-A3JV-01A	TCGA-GV-A3JV	01ee41ef-1894-4408-9e96-a22a1f068190	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	281	390.0	False	true	098BAA98-ACDF-4E3B-9383-03ECFB214CB3	1.81	5ddb876d-dd32-4f33-89d1-d95e460e1e60			0.15	23	released	6b6d4bb2-166e-4ae3-9ee7-ff815cb0578d	RNA	R	0.15	UV Spec	released	False	a7a81283-221a-4fed-a919-5914c8efc421	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	32e4b559-07a8-478f-922d-5d6768d07719	released												released	30.0	55072935-cd20-4355-897b-f60f77a18847	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3JV_demographic	66	-24243	434	50ce3c79-e43b-55e2-a214-97c4a877ecdb	not hispanic or latino	male	white	released	Dead	1945		TCGA-GV-A3JV_exposure	Not Reported	25.716430586257502	4.931506849315069	d07527ff-104e-55f0-a105-e05f8c638882	172.7	90.0	released	76.7	TCGA-GV-A3JV_diagnosis	24243	T3	MX	N1	Stage IV	T3b	7th	not reported	0	134	581e66c1-0add-5ab5-ba2b-eb573ec73460	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GV-A3JV_treatment_1	TCGA-GV-A3JV_treatment	released	a1db269e-da25-579b-b0c5-5381c62fe0db	no	Pharmaceutical Therapy, NOS	released	9fc3fe45-bf79-551c-9ee3-f14b6c8d51b7	no	Radiation Therapy, NOS	5927bea1-f067-48b2-945e-ebcbb557c1bc
749d2d3e-a2bd-4f3e-a3fa-22a7e0a3ee9c.htseq.counts.gz	31b8bd04-4cb6-4777-acac-c04e409bbf67	TCGA-GD-A6C6-01A-21R-A31N-07	TCGA-GD-A6C6-01A-21R	TCGA-GD-A6C6-01A-02-TS2		TCGA-GD-A6C6-01A-21	TCGA-GD-A6C6-01A	TCGA-GD-A6C6	aadcf26b-c398-489f-a86a-e8db1b5db456	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	328	200.0	False	false	C8289619-F986-45C1-A5B3-D88DB3CFC138	1.9	433eed62-f9d3-440a-bc04-f0156c70ee65			0.17	23	released	3d66821a-2a91-49ff-a9a7-e161893dc643	RNA	R	0.17	UV Spec	released	False	65a00caa-4b6f-406c-a7cd-fe5e3a0e144c	21	4.0	0.0	13.0	0.0	0.0	0.0	87.0	75.0	TOP	2e9d8ef7-d64e-4dce-bc4b-ca3398e8f6f5	released												released	30.0	cc838dca-08f1-43e4-b483-35af5899bda3	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A6C6_demographic	64	-23631		fec7d402-1947-5ff2-a5ac-539661af20b3	not hispanic or latino	male	white	released	Alive	1948		TCGA-GD-A6C6_exposure	Not Reported	19.267171444023795	2.4657534246575343	6dcfbd89-8294-5f4a-b06b-e02a02105a82	172.0	45.0	released	57.0	TCGA-GD-A6C6_diagnosis	23631	T2	MX	N0	Stage III	T3a	7th	not reported	0	67	74767c77-1c23-5151-9559-5f94b20893e7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-GD-A6C6_treatment	TCGA-GD-A6C6_treatment_1	released	28972543-967b-5d07-8fd3-7bf4f7ad48ce	no	Radiation Therapy, NOS	released	e0d14254-2247-5f1f-8311-9bd91ac7f67d	no	Pharmaceutical Therapy, NOS	31b8bd04-4cb6-4777-acac-c04e409bbf67
7e3cdf24-75a8-4b20-87db-0dbab2fae971.htseq.counts.gz	5dc76199-e8a5-42c9-9153-32bc354dd73e	TCGA-XF-A9SW-01A-11R-A42T-07	TCGA-XF-A9SW-01A-11R	TCGA-XF-A9SW-01A-01-TSA		TCGA-XF-A9SW-01A-11	TCGA-XF-A9SW-01A	TCGA-XF-A9SW	f5e03536-26e1-480d-a7bb-010eb8210cd6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2721	480.0	False	true	FC0E8C4B-EC30-47FA-8582-5AE007A9F697	1.83	519498f2-999e-4b9c-980c-b83ec3828186			0.15	23	released	9e55a461-15b4-4d03-8bdb-88a62bf8ad57	RNA	R	0.15	UV Spec	released	False	af4fcf7c-f3e9-4574-aec2-733ed983b1c4	11	3.0	2.0	0.0	5.0	0.0	30.0	70.0	70.0	TOP	2f53c99a-77eb-4758-ab7d-5ddf21fb7a44	released												released	30.0	bb24b09a-7230-4e2c-92fd-f820981c65e9	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SW_demographic	85	-31049	362	fad5bbc3-4717-5302-95e7-ffd3c277b923	not hispanic or latino	male	white	released	Dead	1921	2006	TCGA-XF-A9SW_exposure	Not Reported	20.286507911738084		b693fc95-293c-5869-9515-fe21c02d8833	179.0		released	65.0	TCGA-XF-A9SW_diagnosis	31049		MX	N2	Stage IV	T3b	6th	not reported	0		8357327f-a5e5-561b-8825-d271470eb6ee	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-A9SW_treatment_1	TCGA-XF-A9SW_treatment	released	1b8de496-caab-5996-804f-b2b141d11334	no	Pharmaceutical Therapy, NOS	released	b48d456d-a8b8-5537-b5ad-d804ec85ab40	no	Radiation Therapy, NOS	5dc76199-e8a5-42c9-9153-32bc354dd73e
5a06ce70-77c7-4604-96a4-37de6df4306d.htseq.counts.gz	9e2e527b-c1c0-42ce-8a87-d54423687e40	TCGA-ZF-AA4V-01A-11R-A38B-07	TCGA-ZF-AA4V-01A-11R	TCGA-ZF-AA4V-01A-01-TSA		TCGA-ZF-AA4V-01A-11	TCGA-ZF-AA4V-01A	TCGA-ZF-AA4V	ccd65bc8-82ef-453e-b4bc-a005cc2262d5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1850	290.0	False	true	52B54951-E580-49D6-BBB5-4F2329A271B0	1.87	1ff7160a-3918-4942-8a87-9b78d2306c2e			0.17	23	released	9a8ec3a8-e756-4222-beab-a71eb4818d94	RNA	R	0.17	UV Spec	released	False	e6d59324-a30e-4be7-9e3b-c0b55fc98f64	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	259e042e-18a9-4b6a-83ab-5c9a4726762b	released												released	30.0	20a5ad24-3caf-478d-8bd0-b45a785f0624	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4V_demographic	66	-24448		313e835c-c8b0-5bf6-99fe-a515f9979725	not hispanic or latino	male	white	released	Alive	1942		TCGA-ZF-AA4V_exposure	Not Reported	27.13141179099237	1.5342465753424657	06290584-35f9-5d96-895d-8e992e0f6d49	177.0	28.0	released	85.0	TCGA-ZF-AA4V_diagnosis	24448	T2	M0	N0	Stage III	T3b	6th	not reported	0	1806	1c061296-e810-5b2e-9647-406a5703b3ea	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2008	TCGA-ZF-AA4V_treatment_1	TCGA-ZF-AA4V_treatment	released	251428c3-bbc1-562c-8b8c-436de5212b46	yes	Pharmaceutical Therapy, NOS	released	f35566ef-884e-58cb-97a8-e6f025bb0a73	no	Radiation Therapy, NOS	9e2e527b-c1c0-42ce-8a87-d54423687e40
9375f65d-23d3-4db0-b3e5-8cdd525cb3a9.htseq.counts.gz	38d0a10f-5296-45fe-b999-1ce72ca96745	TCGA-DK-A1AC-01A-11R-A13Y-07	TCGA-DK-A1AC-01A-11R	TCGA-DK-A1AC-01A-01-TSA		TCGA-DK-A1AC-01A-11	TCGA-DK-A1AC-01A	TCGA-DK-A1AC	36c14e9d-1863-4c55-bbbb-f8c9dd418932	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3689	330.0	False	true	6A32EB34-E83A-4665-8DEA-F4CEB7CBF52D	1.83	037904cf-92c3-443c-8800-0156db1e3a89			0.16	23	released	3a5e930c-38d6-4cc6-b4fd-914f8df7d6e7	RNA	R	0.16	UV Spec	released	False	acb1b490-a713-4fdf-bac2-53623e158b57	11	2.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	TOP	61c5ef15-d2d0-4091-b71a-edf8e6a38b03	released												released	30.0	cd2fb6b8-5db9-42b4-a407-a5b6f7b8665f	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AC_demographic	72	-26307		28b11d22-b550-5d57-8a25-a4e5c2b3badf	not reported	male	white	released	Alive	1928		TCGA-DK-A1AC_exposure	Not Reported	27.430169600917925	1.095890410958904	c12e00ac-b56e-5c0b-9588-cee6b08165f6	167.0	20.0	released	76.5	TCGA-DK-A1AC_diagnosis	26307		M0	N0	Stage III	T3b	6th	not reported	0	3981	35b5b1b7-8760-55e3-8a60-56e5cc88a91c	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2000	TCGA-DK-A1AC_treatment_1	TCGA-DK-A1AC_treatment	released	b82eba52-38fb-5166-b920-cfcb3c54808b	yes	Pharmaceutical Therapy, NOS	released	e1e69690-a2c5-5fa4-b982-bb3ab6d09779	no	Radiation Therapy, NOS	38d0a10f-5296-45fe-b999-1ce72ca96745
e8881b73-9739-4bf3-b1f7-b6724fadbdd7.htseq.counts.gz	762ab133-3ed7-4860-be83-7a8acb9e38c1	TCGA-FD-A5C1-01A-11R-A28M-07	TCGA-FD-A5C1-01A-11R	TCGA-FD-A5C1-01A-01-TSA		TCGA-FD-A5C1-01A-11	TCGA-FD-A5C1-01A	TCGA-FD-A5C1	070c66fa-ef48-46cb-af4f-357d2c641118	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1387	850.0	False	true	C65141F1-754F-4BE1-B19B-4D4C0B0E2BED	1.86	20da407e-268c-4a10-9d1f-751974e09067			0.16	23	released	82a4ee20-2d87-4f29-9912-0ffa44a6e0e9	RNA	R	0.16	UV Spec	released	False	cb32e07c-d473-451a-9156-97b3627a52a6	11	6.0	2.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	0a0548e9-e335-496b-82df-4ac4fbf5295b	released												released	30.0	d84e38e2-cd76-46ed-9ab7-454c16ebaa1b	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5C1_demographic	61	-22505		dfc8c2bb-f325-56a8-bb87-a8e66f49b648	not hispanic or latino	female	white	released	Alive	1948		TCGA-FD-A5C1_exposure	Not Reported	35.98615916955017		7e62b30e-b30d-59c0-a853-3445c80308ce	170.0		released	104.0	TCGA-FD-A5C1_diagnosis	22505		MX	N0	Stage III	T3b	7th	not reported	0	1792	f2c6c5d3-6331-5211-91b8-286bb8987ab9	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2009	TCGA-FD-A5C1_treatment	TCGA-FD-A5C1_treatment_1	released	0b12319b-fbe6-50d9-af92-dcf8ab0b6825	no	Radiation Therapy, NOS	released	3eb35945-2a07-503a-854f-c6b1fbd5cc4c	yes	Pharmaceutical Therapy, NOS	762ab133-3ed7-4860-be83-7a8acb9e38c1
6a04b8ef-00ac-45d7-ac72-2e311e383f35.htseq.counts.gz	e3f63f0b-72ae-4291-8fb6-e34a003899ca	TCGA-H4-A2HO-01A-11R-A180-07	TCGA-H4-A2HO-01A-11R	TCGA-H4-A2HO-01A-01-TSA		TCGA-H4-A2HO-01A-11	TCGA-H4-A2HO-01A	TCGA-H4-A2HO	86d1e388-b30f-48fd-9647-3848eb6134f1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	421	470.0	False	false	24DECC4E-928C-40D2-9269-FE2ABD53E289	1.94	eb5b988d-308e-4afb-b21b-8bdd45010c72			0.17	23	released	ab0ed433-4428-4090-8842-d1bde07baba6	RNA	R	0.17	UV Spec	released	False	49c8e2b2-fc57-4ba9-ba11-ce94448a5008	11	4.0	1.0	1.0	1.0	0.0	24.0	75.0	75.0	TOP	9c10a002-e4ac-46ce-9240-35eadaf30a2d	released												released	30.0	708501d2-b376-49ea-94ed-3e0ab73af619	Primary Tumor	01	released	Not Reported	released	TCGA-H4-A2HO_demographic	53	-19630		da9ac88a-aa70-5e4a-a9da-31458750a037	not hispanic or latino	male	white	released	Alive	1957		TCGA-H4-A2HO_exposure	Not Reported	22.024322512687924	1.643835616438356	afafe261-e374-55d2-af31-537814b998db	177.0	30.0	released	69.0	TCGA-H4-A2HO_diagnosis	19630		MX	N0	Stage III	T4a	7th	not reported	0	46	0965a1a9-ee61-5a5a-9609-babdbe174da5	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-H4-A2HO_treatment	TCGA-H4-A2HO_treatment_1	released	9d4a85c5-04b5-5044-9478-f84455ce086b	no	Radiation Therapy, NOS	released	00af1a6a-f783-5757-9b8d-2f04ae2f0a14	no	Pharmaceutical Therapy, NOS	e3f63f0b-72ae-4291-8fb6-e34a003899ca
e66c127e-5865-47c4-aaca-e0dc1ca393a3.htseq.counts.gz	03739c3c-af21-4e83-b672-728a43578c69	TCGA-GV-A3JX-01A-11R-A20F-07	TCGA-GV-A3JX-01A-11R	TCGA-GV-A3JX-01A-01-TS1		TCGA-GV-A3JX-01A-11	TCGA-GV-A3JX-01A	TCGA-GV-A3JX	d9dcbb57-f6c2-4465-8a60-afe876e113ca	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	161	80.0	False	true	754BC231-6859-478C-8874-66CB06F2596C	1.82	388f02e0-68bb-4be2-9271-60a42d3a3e9d			0.16	23	released	c7403c78-a6d3-4581-90a3-43e0b07377c3	RNA	R	0.16	UV Spec	released	False	2f8e74e3-1bc4-4c46-99ca-c7d44556c746	11	2.0	0.0	5.0	0.0	0.0	0.0	95.0	90.0	TOP	e0eadf44-739e-4c0a-af98-409d29afc797	released												released	30.0	ce32612d-f504-4164-ae50-04c4ac2999fb	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3JX_demographic	59	-21888		2419efc3-fd66-5689-8250-1a99995e7514	not hispanic or latino	male	white	released	Alive	1952		TCGA-GV-A3JX_exposure	Not Reported	21.851668252322213	4.383561643835616	6ed089ff-2d75-55a9-969e-63fb83ad6b3f	170.2	80.0	released	63.3	TCGA-GV-A3JX_diagnosis	21888		MX	N0	Stage III	T3b	7th	not reported	0	581	b81c34da-c4af-5cb6-b797-91655c9d7c86	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-GV-A3JX_treatment	TCGA-GV-A3JX_treatment_1	released	cdad3f3b-d1d5-55ee-bbaa-2c24b1f27e47	no	Radiation Therapy, NOS	released	715e5282-d91a-5a0b-bb90-f39c59eb1a54	no	Pharmaceutical Therapy, NOS	03739c3c-af21-4e83-b672-728a43578c69
bfafae27-ff43-4377-b308-323fe2fe5f1b.htseq.counts.gz	7bdf2ad9-e354-40f6-a56e-15e0d0b94866	TCGA-G2-AA3F-01A-12R-A42T-07	TCGA-G2-AA3F-01A-12R	TCGA-G2-AA3F-01A-01-TS1		TCGA-G2-AA3F-01A-12	TCGA-G2-AA3F-01A	TCGA-G2-AA3F	9883c38f-87bf-4421-bfc0-1b1001f8159c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	459	90.0	False	true	3421B447-B005-4F3D-9FAD-50C980F90F06	1.88	4b3c1687-622c-4c9f-9fe7-25b197629133			0.17	23	released	67403a47-12ad-48fe-93dd-26e41772cbed	RNA	R	0.17	UV Spec	released	False	50d588f4-023e-4e6e-9941-d931f8e698ec	12	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	be49d0f8-7012-41e6-8f61-a3ff8ad60f7f	released												released	30.0	260cf40d-2f85-45c8-8dcc-689b1385fadb	Primary Tumor	01	released	Not Reported	released	TCGA-G2-AA3F_demographic	77	-28457		3e0642d7-90e4-59be-9226-302a17eebf36	not hispanic or latino	male	white	released	Alive	1935		TCGA-G2-AA3F_exposure	Not Reported	30.405292525644022	5.917808219178082	c0f700f9-54e1-58a5-8cef-5239212858b8	173.0	108.0	released	91.0	TCGA-G2-AA3F_diagnosis	28457	T2	M0	N1	Stage IV	T3	7th	not reported	0	893	a730f3f4-0822-59c1-a0c4-4020b1342b86	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-G2-AA3F_treatment_1	TCGA-G2-AA3F_treatment	released	d7533c19-f873-5996-a1ad-fc795540189f	yes	Pharmaceutical Therapy, NOS	released	78a035fb-5425-58b4-89f7-394263ff7b39	no	Radiation Therapy, NOS	7bdf2ad9-e354-40f6-a56e-15e0d0b94866
39b9fc65-4293-473e-9f1a-2ae258bc89e4.htseq.counts.gz	8e116bc3-7df9-47de-a255-8b7554f7808f	TCGA-DK-A3X2-01A-11R-A22U-07	TCGA-DK-A3X2-01A-11R	TCGA-DK-A3X2-01A-01-TSA		TCGA-DK-A3X2-01A-11	TCGA-DK-A3X2-01A	TCGA-DK-A3X2	40551d53-388b-4067-9341-76e94d023703	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	548	830	False	true	8360D3E9-526D-4E99-86E0-C33F785DCF15	1.86	c4fbd136-4227-4792-ac53-8c887aa6ab1a	2.08	13	0.16	23	released	9af6b73a-bf31-4b37-975b-80943cad7cfc	RNA	R	0.16	UV Spec	released	False	b47003c6-4cb3-412f-b8a3-d56b62a0299c	11	2	1	5	0	0	17	78	90	TOP	393368bd-b486-4cb6-9c41-c799414e29e9	released												released	30	3b816277-91cb-413e-bc7c-ba33cd72b67d	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3X2_demographic	85	-31160	547	f9268bc5-4d07-59f8-a804-2a9141176884	not hispanic or latino	male	white	released	Dead	1925	2011	TCGA-DK-A3X2_exposure	Not Reported		2.191780821917808	aa09b16f-e0fa-51e8-a1d9-b732fe9180b5		40.0	released		TCGA-DK-A3X2_diagnosis	31160		M0	N2	Stage IV	T3	6th	not reported	0		ec71dbd6-cae9-59a7-934f-0979d5be9cc0	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2010	TCGA-DK-A3X2_treatment_1	TCGA-DK-A3X2_treatment	released	96af75a4-ff70-5ed3-95b5-2cbda0f190c3	no	Pharmaceutical Therapy, NOS	released	45564e9d-8c43-5fa7-9366-de189ce215c2	no	Radiation Therapy, NOS	8e116bc3-7df9-47de-a255-8b7554f7808f
bd78f432-6c71-4307-b2a2-ad2c8cb80c6e.htseq.counts.gz	62981652-048b-4a40-8687-736024c7c0a1	TCGA-BL-A13I-01A-11R-A277-07	TCGA-BL-A13I-01A-11R	TCGA-BL-A13I-01A-01-BSA	TCGA-BL-A13I-01A-01-TSA	TCGA-BL-A13I-01A-11	TCGA-BL-A13I-01A	TCGA-BL-A13I	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	127	410.0	False	false	976FBDBF-55C5-4957-986B-D2DE85FF7540	1.89	f36d565e-7fea-4fae-87b2-70d7e75b36ef			0.16	23	released	4977da8a-7478-4f86-a0c1-3a0edb30c907	RNA	R	0.16	UV Spec	released	False	821a50fb-ef50-4f3f-8bf4-651cf45733e3	11	3.0	0.0	12.0	0.0	0.0	3.0	85.0	90.0	BOTTOM	99c2ff81-c48c-431b-811a-4073e3f8c4e0	released	2.0	0.0	5.0	0.0	0.0	5.0	90.0	96.0	TOP	f6fba03e-6237-44ef-9a9f-56474654a91a	released	released	30.0	62c2ba8f-02e3-4100-86bc-5958038b4983	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13I_demographic	57	-20885	223	ba9fff81-0ad3-56b5-a9a5-a7f1ad7cd96d	not hispanic or latino	female	white	released	Dead	1953	2010	TCGA-BL-A13I_exposure	Not Reported	20.690494543389182	0.821917808219178	ec9dc6f1-7f95-5ead-a277-4f172b7f118c	157.0	15.0	released	51.0	TCGA-BL-A13I_diagnosis	20885		M0	N0	Stage III	T3	7th	not reported	0		d9b084dc-a65f-5913-923c-5e7ec4067300	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-BL-A13I_treatment_1	TCGA-BL-A13I_treatment	released	91bd2aa1-fe84-59d5-9733-6d6fb91a2e81	no	Pharmaceutical Therapy, NOS	released	dbe66ff2-4969-5523-8044-ad4730dc163f	no	Radiation Therapy, NOS	62981652-048b-4a40-8687-736024c7c0a1
5cf8ae27-a229-4309-9ba2-89bbab7f5da2.htseq.counts.gz	5880f997-ddbd-4f92-92c7-0fbcd8d444d8	TCGA-CU-A72E-01A-12R-A33J-07	TCGA-CU-A72E-01A-12R	TCGA-CU-A72E-01A-01-TSA		TCGA-CU-A72E-01A-12	TCGA-CU-A72E-01A	TCGA-CU-A72E	ae080e88-82da-480c-bd13-ae214da0463c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	197	240.0	False	false	8D56AE41-2A0C-4D82-971E-989CB5762FFF	1.83	69b30673-9ec0-4c05-b75c-12bcb1f7268f			0.17	23	released	db06539a-4bfc-4432-8b6d-a813c4a493d1	RNA	R	0.17	UV Spec	released	False	644f331d-b4a9-44a7-8e4f-2cfafb329abf	12	5.0	1.0	1.0	1.0	0.0	54.0	45.0	85.0	TOP	252fe5d2-5dcb-4db0-ad42-ca70685b9962	released												released	20.0	26543a29-59ab-4eba-b00f-e45c4c6e9a3e	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A72E_demographic	76	-27963	413	afc77667-cf8d-5043-ad54-aafa779e6bfe	not hispanic or latino	male	white	released	Dead	1937		TCGA-CU-A72E_exposure	Not Reported	42.28395061728395	3.7260273972602738	b5594f51-a892-5440-a59f-7578db797abe	180.0	68.0	released	137.0	TCGA-CU-A72E_diagnosis	27963		M0	N2	Stage IV	T3b	7th	not reported	0	284	f200122b-423b-5c79-ba2c-911c600302ed	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2013	TCGA-CU-A72E_treatment_1	TCGA-CU-A72E_treatment	released	96a6b501-d481-5aad-a2e9-7e165f0d50ed	no	Pharmaceutical Therapy, NOS	released	accdbd75-e8fa-51b4-babb-620bb96b843e	no	Radiation Therapy, NOS	5880f997-ddbd-4f92-92c7-0fbcd8d444d8
7c1cff27-9d25-4f4e-9c65-6cfb66749315.htseq.counts.gz	28bb4c9b-30f9-4087-9e8b-91f94e13d5c0	TCGA-GC-A4ZW-01A-11R-A26T-07	TCGA-GC-A4ZW-01A-11R	TCGA-GC-A4ZW-01A-01-TS1		TCGA-GC-A4ZW-01A-11	TCGA-GC-A4ZW-01A	TCGA-GC-A4ZW	a9e17a7d-7ff4-44e3-b8c9-b0d2f46b6cd5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	77	80.0	False	false	577035B3-655D-401B-8316-308DE1970F66	1.91	e7756fc3-3cc9-4417-a5c2-a69e67e8df10			0.18	23	released	b3470e81-af59-402e-8059-2ee1e38554c9	RNA	R	0.18	UV Spec	released	False	5c8f0337-faf3-4128-9c26-e1d70441413f	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	90.0	TOP	240d5e95-6934-435b-b612-1c907d42e553	released												released	30.0	1daa494f-8321-4d6c-a587-df92d07b54a5	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A4ZW_demographic	71	-25964		02187b46-c624-58d5-95a6-544d9b6037bc	not hispanic or latino	male	white	released	Alive	1941		TCGA-GC-A4ZW_exposure	Not Reported	26.575890590940308		791d3084-7d42-552e-8029-933ed71054c0	183.0		released	89.0	TCGA-GC-A4ZW_diagnosis	25964	T3	M0	N0	Stage III	T3a	7th	not reported	0	15	15fd4483-b9fa-5efb-9050-a33cfd9dd2da	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-GC-A4ZW_treatment_1	TCGA-GC-A4ZW_treatment	released	ba7ea710-5084-599a-b25e-cd7e77c2e89f	not reported	Pharmaceutical Therapy, NOS	released	facc7f27-2272-53d9-a781-9fc01e160760	not reported	Radiation Therapy, NOS	28bb4c9b-30f9-4087-9e8b-91f94e13d5c0
66f3c0b6-1b74-484b-8540-32400cef01a7.htseq.counts.gz	7c38d9e9-bb46-48fb-8a00-e8787267520f	TCGA-DK-A3IS-01A-21R-A21D-07	TCGA-DK-A3IS-01A-21R	TCGA-DK-A3IS-01A-02-TSB		TCGA-DK-A3IS-01A-21	TCGA-DK-A3IS-01A	TCGA-DK-A3IS	9f75cc89-cc3f-4ae9-973d-da37c6417bfc	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1279	100.0	False	true	2387C5D6-37CA-40C0-A122-228070BEE480	1.77	fd93cd6f-ab1c-460c-bfca-268c485a4f5b			0.18	23	released	6a7fa9e1-65fb-4580-9be9-c1795183c881	RNA	R	0.18	UV Spec	released	False	e1d61b2f-aa85-436a-8c99-ad7986698361	21	10.0	0.0	0.0	0.0	10.0	0.0	90.0	90.0	TOP	b47eac66-c51b-460d-b68d-af36e72f6bbc	released												released	30.0	956dedad-c152-4d04-b191-9a627f291efe	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IS_demographic	68	-25098		0bb61614-34b3-5b7b-9f41-5106658260a0	not hispanic or latino	male	white	released	Alive	1940		TCGA-DK-A3IS_exposure	Not Reported	23.87829220166433		a4269250-5b9c-5869-908f-1bfc30d79b48	187.0		released	83.5	TCGA-DK-A3IS_diagnosis	25098		M0	N0	Stage II	T2a	6th	not reported	0	1529	5ef63219-f090-52e1-84db-a5c84711dfb2	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2008	TCGA-DK-A3IS_treatment_1	TCGA-DK-A3IS_treatment	released	4fe222e9-732e-511e-adec-075b53684a96	no	Pharmaceutical Therapy, NOS	released	e803053e-7d38-5075-853e-b0b8103c83c0	no	Radiation Therapy, NOS	7c38d9e9-bb46-48fb-8a00-e8787267520f
15a2b972-3034-4456-b88f-960c9de9a7aa.htseq.counts.gz	21f88b65-d536-411e-b322-2e984596226d	TCGA-DK-A3WY-01A-11R-A22U-07	TCGA-DK-A3WY-01A-11R	TCGA-DK-A3WY-01A-01-TSA		TCGA-DK-A3WY-01A-11	TCGA-DK-A3WY-01A	TCGA-DK-A3WY	9bb5d187-033e-4e86-a76e-e1a6d20488f7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	4107	430	False	true	62654E3C-3796-43B4-A347-FF4C22EEE143	1.83	169e537f-9ffc-4d56-9e77-1f38951ee3d3	2.21	13	0.17	23	released	910b0f03-2f69-46a8-948d-2bff07495651	RNA	R	0.17	UV Spec	released	False	5632e39b-a9a4-4126-8800-8bf5cf737e7f	11	3	0	0	0	0	35	65	80	TOP	71340d36-753e-41ef-9897-4e1ab370d084	released												released	30	33d579b3-198d-46ca-b2cf-574a0673e26f	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3WY_demographic	67	-24536		092697aa-9a3d-52f9-9aba-79d8e01b29f6	not hispanic or latino	female	white	released	Alive	1934		TCGA-DK-A3WY_exposure	Not Reported	27.887617065556707		b8883609-6ff2-57d4-aaa8-27c21bd2e09a	155.0		released	67.0	TCGA-DK-A3WY_diagnosis	24536		M0	N0	Stage III	T3	5th	not reported	0	4967	b2ce7612-152f-5ece-9119-7a2e1caa956d	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii	2001	TCGA-DK-A3WY_treatment_1	TCGA-DK-A3WY_treatment	released	421def04-37de-571e-868d-c2d697c15505	yes	Pharmaceutical Therapy, NOS	released	5968ef5a-c726-5595-b3d4-777da5616b97	no	Radiation Therapy, NOS	21f88b65-d536-411e-b322-2e984596226d
8513e464-f8f9-42bf-ae6f-fe897fffa508.htseq.counts.gz	2646b2d1-1959-4116-ab8e-1c494eef3700	TCGA-DK-A6AV-01A-12R-A30C-07	TCGA-DK-A6AV-01A-12R	TCGA-DK-A6AV-01A-01-TS1		TCGA-DK-A6AV-01A-12	TCGA-DK-A6AV-01A	TCGA-DK-A6AV	b41df0b0-572e-4ddb-9f1d-1b69dd1ad290	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1836	80.0	False	true	B327B015-3D3E-400C-A172-8144085F6359	1.89	01a7643f-d7be-40e8-bdc1-562d825e8ba8			0.18	23	released	3e0bb906-c296-4de4-8af4-39ea1029b201	RNA	R	0.18	UV Spec	released	False	7b9da030-644b-47db-92ba-8d2e82cc79b7	12	10.0	0.0	4.0	1.0	0.0	30.0	66.0	85.0	TOP	eb81eece-d5d7-4fe0-a40c-3123a5a7e5d6	released												released	30.0	efef376f-7619-4319-888b-7fedbda73597	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6AV_demographic	82	-30089		75eee4b0-7b22-5bbd-b5c9-2a0072637a8c	not hispanic or latino	female	asian	released	Alive	1926		TCGA-DK-A6AV_exposure	Not Reported	23.80540166204986	0.6575342465753424	9ee6638e-ec3e-5c91-a8e5-4327ceadb30e	152.0	12.0	released	55.0	TCGA-DK-A6AV_diagnosis	30089	T2	M0	N0	Stage II	T2a	6th	not reported	0	1952	1fa1619c-bf5c-5802-a48b-5f31da33d9fe	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage ii	2008	TCGA-DK-A6AV_treatment_1	TCGA-DK-A6AV_treatment	released	8e62b9d9-1769-5df7-8eaf-716ba40c255f	no	Pharmaceutical Therapy, NOS	released	530a0da0-5547-5a7a-8f45-2fff22bdde30	no	Radiation Therapy, NOS	2646b2d1-1959-4116-ab8e-1c494eef3700
0708fd6a-8ed0-4a69-ac8c-3b0b0383ca45.htseq.counts.gz	8c9754a5-f588-4d09-8399-4a4750921420	TCGA-XF-A9SK-01A-11R-A42T-07	TCGA-XF-A9SK-01A-11R	TCGA-XF-A9SK-01A-01-TS1		TCGA-XF-A9SK-01A-11	TCGA-XF-A9SK-01A	TCGA-XF-A9SK	03f588d6-832e-47d8-a9c4-af6640a1a635	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3598	470.0	False	true	473BCE6C-7925-4E58-9257-B94046C707AC	1.89	1e48f03f-3939-4dfd-8d32-c85ec473678a			0.17	23	released	432da6ae-95f4-46f7-a72c-d9699961a5d5	RNA	R	0.17	UV Spec	released	False	5e44a6ab-75b1-4665-a73b-e3408cba2e92	11	4.0	1.0	0.0	5.0	0.0	30.0	70.0	70.0	TOP	308a87cb-1044-487f-b608-37a087dc172d	released												released	30.0	03e0aba8-e26c-4a61-a090-262ffeaf6523	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SK_demographic	65	-24019	486	3ed4bbd2-17aa-58a4-b712-155bad2d0a33	not hispanic or latino	male	white	released	Dead	1939	2005	TCGA-XF-A9SK_exposure	Not Reported	26.296566837107374	1.643835616438356	57964409-76f4-556f-970d-c004877d4ad7	185.0	30.0	released	90.0	TCGA-XF-A9SK_diagnosis	24019		MX	N1	Stage IV	T3b	6th	not reported	0		2fa5583d-30d2-5316-ba96-5c78e506b6a1	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2004	TCGA-XF-A9SK_treatment	TCGA-XF-A9SK_treatment_1	released	1deb8253-ea72-5f69-8864-d4fe90aeacf1	no	Radiation Therapy, NOS	released	03d24508-4ff6-5ef2-9fd8-6d54bdab5ade	yes	Pharmaceutical Therapy, NOS	8c9754a5-f588-4d09-8399-4a4750921420
56d2961d-f2c2-4f08-b299-7cd4e0e57da8.htseq.counts.gz	408a5c60-d5cf-4392-bfbf-32151d27e5de	TCGA-FD-A43Y-01A-21R-A26T-07	TCGA-FD-A43Y-01A-21R	TCGA-FD-A43Y-01A-02-TSB		TCGA-FD-A43Y-01A-21	TCGA-FD-A43Y-01A	TCGA-FD-A43Y	d349fae0-dd40-4292-908c-ac86a9938240	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	201	1040.0	False	true	DD36E5EA-D22A-47F7-AF4D-743FBDEBA629	1.79	5ee80128-f80f-4892-9668-43c03c41bd65			0.17	23	released	5ecf0a35-23f0-4e47-bd4e-4c404d58c20f	RNA	R	0.17	UV Spec	released	False	d1bc8ad5-d143-4024-a591-be7bdb067a67	21	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	1798af21-70e0-498b-b42c-e969e8bfa257	released												released	30.0	792e76bf-6fa5-4861-a311-8d848374ff21	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43Y_demographic	65	-23889	474	42f6fa0c-e43c-5191-a0c5-9d037f2445ac	not hispanic or latino	male	white	released	Dead	1947		TCGA-FD-A43Y_exposure	Not Reported	31.950789811579924	2.73972602739726	ba57b244-bb3f-59fd-843b-4e66591c3333	183.0	50.0	released	107.0	TCGA-FD-A43Y_diagnosis	23889	T2	MX	N0	Stage III	T4	7th	not reported	0	369	00137f74-b3b0-54a4-bca0-9a1477f4a082	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2012	TCGA-FD-A43Y_treatment	TCGA-FD-A43Y_treatment_1	released	8f2fe168-7f3d-5103-9ba9-5aa8536eda9b	no	Radiation Therapy, NOS	released	6b7d1f3e-9e1c-5b0b-a8f5-05860ba7a978	no	Pharmaceutical Therapy, NOS	408a5c60-d5cf-4392-bfbf-32151d27e5de
da9ac33a-cbad-4864-b545-0cdd2ebf24c2.htseq.counts.gz	3ade5684-5a00-418e-8105-9af0416f0b82	TCGA-FD-A5BY-01A-31R-A28M-07	TCGA-FD-A5BY-01A-31R	TCGA-FD-A5BY-01A-03-TSC		TCGA-FD-A5BY-01A-31	TCGA-FD-A5BY-01A	TCGA-FD-A5BY	8da76432-3004-47e5-a474-bd94bd4c0b33	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	90	540.0	False	true	DE874063-9AE8-4855-8CD2-D30F71E3C167	1.87	94309b2e-c58c-4e2b-981d-0badb3872db7			0.15	23	released	aaa93143-fb04-4419-b064-dea190454a96	RNA	R	0.15	UV Spec	released	False	90bc496d-a1c9-4ad9-b454-c8efcce53616	31	6.0	2.0	6.0	3.0	0.0	34.0	60.0	80.0	TOP	de95d27f-89f6-43cc-a50c-f3b198fdbd3e	released												released	30.0	e01fb843-d86d-42a6-81a5-30d678a17588	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BY_demographic	63	-23080		306c9c09-00bf-54f7-ac53-43ad3cb416ba	not hispanic or latino	female	white	released	Alive	1949		TCGA-FD-A5BY_exposure	Not Reported	23.836734693877553		705ecd31-b93e-585e-be4b-cfa1b61b906b	175.0		released	73.0	TCGA-FD-A5BY_diagnosis	23080		MX	N0	Stage III	T3a	7th	not reported	0	251	adbf91cd-b46c-5d7d-974d-e4701cb50dba	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2012	TCGA-FD-A5BY_treatment	TCGA-FD-A5BY_treatment_1	released	157e5c2b-41d8-5f55-b056-c25b3a683a84	no	Radiation Therapy, NOS	released	30cf21eb-0d6a-5ed0-b4a6-8b9c40d6db91	no	Pharmaceutical Therapy, NOS	3ade5684-5a00-418e-8105-9af0416f0b82
8111546f-1eec-4ae9-a1f2-0a1548b2f61d.htseq.counts.gz	444d1d25-dbc5-4deb-a4bb-9a698bc5a7ac	TCGA-CU-A3YL-01A-11R-A22U-07	TCGA-CU-A3YL-01A-11R	TCGA-CU-A3YL-01A-01-TS1		TCGA-CU-A3YL-01A-11	TCGA-CU-A3YL-01A	TCGA-CU-A3YL	087a7f70-2fa8-4a16-b130-4df10a70c662	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	191	510.0	False	false	A1AF7975-132E-469A-B4C8-A0A3F19EA0D0	1.82	68b08ead-5e38-490f-8654-b3db19c80fca			0.16	23	released	7ebd276e-3054-4dec-a6a2-8fd23a408073	RNA	R	0.16	UV Spec	released	False	0ee2895d-bad1-44fb-8ee5-7e27dcc4f779	11	2.0	0.0	2.0	0.0	0.0	18.0	80.0	95.0	TOP	f7ddc75f-0dd0-44e0-aaaa-582a847b038f	released												released	30.0	f66ad788-e2d8-4688-820f-49a609701533	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A3YL_demographic	67	-24524		f215b3a9-9576-5faa-ac23-1ffbccffe86d	not hispanic or latino	male	white	released	Alive	1944		TCGA-CU-A3YL_exposure	Not Reported	29.025311319871417	1.36986301369863	d1b42aa5-29f1-5a76-9fc6-899c00c7a37f	179.0	25.0	released	93.0	TCGA-CU-A3YL_diagnosis	24524		M0	N0	Stage III	T4a	7th	not reported	0	906	803b86e4-b9cb-5dbe-8261-3047e4e77cdc	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-CU-A3YL_treatment_1	TCGA-CU-A3YL_treatment	released	ac13a4a2-0f52-5e56-8b91-5ea30aa65a4b	yes	Pharmaceutical Therapy, NOS	released	6ae3b974-f11b-5249-afa6-c348cfd8285e	yes	Radiation Therapy, NOS	444d1d25-dbc5-4deb-a4bb-9a698bc5a7ac
be0eff0f-8ab2-4130-962c-3360e19ba8b4.htseq.counts.gz	c6a80935-dd2a-4d3e-a183-452a33b1309f	TCGA-2F-A9KT-01A-11R-A38B-07	TCGA-2F-A9KT-01A-11R	TCGA-2F-A9KT-01A-01-TSA		TCGA-2F-A9KT-01A-11	TCGA-2F-A9KT-01A	TCGA-2F-A9KT	bc6c516b-591e-4950-b6b0-decafa666f4e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2898	130.0	False	false	EC566A42-E711-458F-8082-1C113AECDF60	1.9	406a8f7c-1530-4ecf-95b0-b051d9a3184d			0.17	23	released	dcdb2260-1282-4ef0-ac1f-512e5007dcc3	RNA	R	0.17	UV Spec	released	False	ef7d5d89-fd63-4f94-a276-1f8b5c7012be	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	f194bfee-7002-4605-84f9-36a676234467	released												released	30.0	1be43154-67ab-4019-8987-5135ee4af419	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KT_demographic	83	-30520		a920ad4c-16b0-5122-baff-126aad103fc4	not hispanic or latino	male	white	released	Alive	1923		TCGA-2F-A9KT_exposure	Not Reported	24.691358024691358		3d96658a-b3e4-5028-aacc-fa1d23bc197b	180.0		released	80.0	TCGA-2F-A9KT_diagnosis	30520	T2	M0	N0	Stage II	T2b	6th	not reported	0	2352	221fcfab-23ac-5525-a3df-45d1900cd9dd	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2006	TCGA-2F-A9KT_treatment_1	TCGA-2F-A9KT_treatment	released	b6e0600a-af7c-5958-8d42-9f0d9110ad18	no	Pharmaceutical Therapy, NOS	released	e5ab1aab-bac1-56a9-a28d-f0e4fd3affa5	no	Radiation Therapy, NOS	c6a80935-dd2a-4d3e-a183-452a33b1309f
e5bdbaee-23f8-4024-aa6d-51efeee22e7c.htseq.counts.gz	e7722bfc-9d3a-4702-a805-8af65348907e	TCGA-BT-A2LB-01A-11R-A18C-07	TCGA-BT-A2LB-01A-11R	TCGA-BT-A2LB-01A-01-TSA		TCGA-BT-A2LB-01A-11	TCGA-BT-A2LB-01A	TCGA-BT-A2LB	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	317	160.0	False	true	CD9D52D3-87E7-4AC0-BBEA-E22C57F2E10A	1.88	b6a8b608-8bf6-4d57-a720-bd4aaced4591			0.16	23	released	7aae0555-c288-4bb2-9931-45186a32b74a	RNA	R	0.16	UV Spec	released	False	2a11da98-96ff-45bb-976d-c447c0598532	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	80.0	TOP	61863945-c6d8-4b53-b987-90d494fa2e81	released												released	30.0	7c6178a6-6d4c-4def-b4ac-a064ab4a6c8a	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A2LB_demographic	73	-26846	492	87b48a51-48e5-5c30-9524-1371850b1ba6	not hispanic or latino	female	white	released	Dead	1937		TCGA-BT-A2LB_exposure	Not Reported			dd62d7aa-4946-51b7-ae21-81cf24379360			released	82.0	TCGA-BT-A2LB_diagnosis	26846	T3a	M0	N0	Stage III	T3a	7th	not reported	0	170	6c1050bd-ad7a-563e-a92a-b55b5da5d2cf	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii	2010	TCGA-BT-A2LB_treatment	TCGA-BT-A2LB_treatment_1	released	06444461-e5e3-5733-828c-f6247b5a413b	no	Radiation Therapy, NOS	released	33fbfb5d-f3cc-5984-8ed7-8e62e02f90cb	no	Pharmaceutical Therapy, NOS	e7722bfc-9d3a-4702-a805-8af65348907e
4610a246-13d4-4c17-a359-afbd9265f548.htseq.counts.gz	36b513fa-bba0-42e8-b61c-50f41368a927	TCGA-5N-A9KM-01A-11R-A42T-07	TCGA-5N-A9KM-01A-11R	TCGA-5N-A9KM-01A-01-TS1		TCGA-5N-A9KM-01A-11	TCGA-5N-A9KM-01A	TCGA-5N-A9KM	9743e684-25dd-4dd9-9b84-6ae9518d1818	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	524	52.0	False	false	3DA2EAED-CD7A-4102-9871-74AA445DD4F3	1.92	d3011182-eb79-48a8-8698-f9cf8f091924			0.17	23	released	ed232289-0fea-4b94-ab8c-bbe2304debbc	RNA	R	0.17	UV Spec	released	False	14700c7a-8b0a-49d0-b2a9-7ca2a1651991	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	60.0	TOP	6e36c19a-89bc-4484-8e26-31179b87de5b	released												released	30.0	4ef0d483-b954-47dd-ab58-eb0f4db31b1d	Primary Tumor	01	released	Not Reported	released	TCGA-5N-A9KM_demographic	73	-26906	530	1e4e0cf3-7ae9-56d1-bf1f-1cf6373e265a	not hispanic or latino	female	white	released	Dead	1939	2013	TCGA-5N-A9KM_exposure	Not Reported	24.97704315886134	1.643835616438356	d8b6a469-22e8-5fe9-a258-00e043ca657a	165.0	30.0	released	68.0	TCGA-5N-A9KM_diagnosis	26906	T4a	MX	N0	Stage III	T4a	7th	not reported	0		0ff2535e-1330-5bd5-bee9-66586a9ea82d	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-5N-A9KM_treatment_1	TCGA-5N-A9KM_treatment	released	d36f73b9-1ae6-5fd7-a0e4-c181f1b10890	no	Pharmaceutical Therapy, NOS	released	4cd94faf-430c-5ac7-b616-264b7b675930	no	Radiation Therapy, NOS	36b513fa-bba0-42e8-b61c-50f41368a927
b5d0f60a-163e-43ea-b478-2d85bf0c379a.htseq.counts.gz	3e8ed5b7-1f0a-45be-b874-b5ca4891b374	TCGA-DK-A3IT-01A-31R-A20F-07	TCGA-DK-A3IT-01A-31R	TCGA-DK-A3IT-01A-03-TSC		TCGA-DK-A3IT-01A-31	TCGA-DK-A3IT-01A	TCGA-DK-A3IT	58520c66-7688-435a-b09f-653b18768c41	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	145	240.0	False	true	B42C9A76-53B5-46A6-833F-5A63871F92A0	1.83	e33ab42a-bfb3-4923-a305-a6babcee61f4			0.17	23	released	b7990784-2703-417d-9d38-3bc0aa75caca	RNA	R	0.17	UV Spec	released	False	a6af4d2c-4555-42b9-81e7-11dac0d6fbd4	31	2.0	0.0	0.0	0.0	40.0	0.0	60.0	70.0	TOP	c900466d-03ad-4b61-b7b7-99e16c005add	released												released	30.0	6b48dae5-b757-450a-8248-65c2434a7afc	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IT_demographic	62	-22786		627df89b-ef4b-563a-be90-f3d641efc78e	not hispanic or latino	male	white	released	Alive	1949		TCGA-DK-A3IT_exposure	Not Reported	33.576508653582		08e4a440-c38d-5477-aa00-7b8f4a2ea9d7	181.0		released	110.0	TCGA-DK-A3IT_diagnosis	22786		M0	N0	Stage III	T3	6th	not reported	0	648	b646ba9d-4b1e-534f-8f5a-c98672e1d178	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2011	TCGA-DK-A3IT_treatment_1	TCGA-DK-A3IT_treatment	released	643854c4-af87-5038-ba9f-ddf5a24340fc	no	Pharmaceutical Therapy, NOS	released	c9030191-8c01-50fa-ba00-97d91035c20b	no	Radiation Therapy, NOS	3e8ed5b7-1f0a-45be-b874-b5ca4891b374
bf08aa0a-127e-4fd9-a209-049645880245.htseq.counts.gz	87d5bf24-754a-4fa6-b7ae-86455ccc5698	TCGA-E7-A5KF-01A-11R-A28M-07	TCGA-E7-A5KF-01A-11R	TCGA-E7-A5KF-01A-01-TSA		TCGA-E7-A5KF-01A-11	TCGA-E7-A5KF-01A	TCGA-E7-A5KF	5d06cc19-8b10-4ed1-b6d4-8e044f1f8a8c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	107	670.0	False	true	4EE096A0-381D-468C-AA30-F914F4F6589E	1.8	a5118740-bf71-47e8-a2e3-506792865c90			0.16	23	released	f10d7655-8659-4b93-b48f-37ded9225e0f	RNA	R	0.16	UV Spec	released	False	88a6dbf4-86db-4a36-a707-bcca4267c0f8	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	15cba756-445a-43c8-90c9-a23fc4186290	released												released	30.0	ba110c03-750f-4b30-89b3-e1b1b41e8144	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A5KF_demographic	67	-24528		c1cc8622-bc9c-55cf-9281-e1d80d8bcf19	not hispanic or latino	male	asian	released	Alive	1945		TCGA-E7-A5KF_exposure	Not Reported	22.265625	1.36986301369863	8fc47614-d31d-5ed4-aa77-8c4cc8bef74a	160.0	25.0	released	57.0	TCGA-E7-A5KF_diagnosis	24528		M0	N0	Stage II	T2a	7th	not reported	0	20	5cc196ff-ea8f-5a84-8ed5-37d9068875a3	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A5KF_treatment	TCGA-E7-A5KF_treatment_1	released	2fd053c5-dbb8-5d69-8ba8-d954191b21b2	not reported	Radiation Therapy, NOS	released	0e6d18a6-c4ef-5f64-988f-75a8908f8148	not reported	Pharmaceutical Therapy, NOS	87d5bf24-754a-4fa6-b7ae-86455ccc5698
482f8985-06ea-4eb1-b38c-8793cacb5e03.htseq.counts.gz	b924dab9-cdc3-4db7-bc25-aaa2b972f0cb	TCGA-GD-A3OP-01A-21R-A220-07	TCGA-GD-A3OP-01A-21R	TCGA-GD-A3OP-01A-02-TS2		TCGA-GD-A3OP-01A-21	TCGA-GD-A3OP-01A	TCGA-GD-A3OP	31da07bb-6752-49a3-a7ea-5427c04a9458	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	340	False	false	6C700249-6A70-45C6-834B-DF271740FC33	1.84	c7f36dba-a507-46d3-8e68-7f98b8b645e9	2.34	13	0.18	23	released	e1450115-e61e-467c-956e-a3b641392bbf	RNA	R	0.18	UV Spec	released	False	bfdb9e48-ebc6-47da-9566-6c0abe2050bd	21	0	0	0	0	10	10	80	70	TOP	4c8251ad-63a1-4486-8fce-f3e81ca4da6b	released												released	30	c0773229-5a20-4451-9db5-f757e34921ae	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A3OP_demographic	84	-30956		5f4725ee-f7e9-5c1f-92a7-cadf8407ab33	not hispanic or latino	female	white	released	Alive	1927		TCGA-GD-A3OP_exposure	Not Reported			897e56dc-1f09-5203-a594-c79340889c62			released		TCGA-GD-A3OP_diagnosis	30956		MX	N2	Stage IV	T4a	7th	not reported	0	64	eb33f4c4-5a01-5da3-a735-b6fa9b706657	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A3OP_treatment_1	TCGA-GD-A3OP_treatment	released	79638d7c-f35b-5da5-87b8-4a4edd409862	not reported	Pharmaceutical Therapy, NOS	released	a51e720f-9ca8-59cb-bccd-c68fe848f424	not reported	Radiation Therapy, NOS	b924dab9-cdc3-4db7-bc25-aaa2b972f0cb
83a8e225-80e3-4d0f-8aa5-cef4828933ae.htseq.counts.gz	f2181c15-e595-47e0-a746-101c0d64da58	TCGA-DK-A6B5-01A-11R-A31N-07	TCGA-DK-A6B5-01A-11R	TCGA-DK-A6B5-01A-01-TSA		TCGA-DK-A6B5-01A-11	TCGA-DK-A6B5-01A	TCGA-DK-A6B5	d5e8d936-40ae-4fd3-b40e-cac54763d71f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	984	320.0	False	true	8265F65D-C5A6-4290-AE46-7A9A114C82C9	1.86	92e94724-a03e-4b58-91b2-f309ab8dc943			0.16	23	released	b08da63a-df30-4b23-80f9-9d1c6837d524	RNA	R	0.16	UV Spec	released	False	f3313974-3a88-4427-b554-4f51859b103b	11	3.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	a896e672-8e16-4ba3-b27c-ccfbfc0b97fb	released												released	30.0	b3694163-a186-4cf0-90b6-545cef6248bf	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6B5_demographic	45	-16453		6caf2c0b-5d00-5571-bb0f-129004b1f103	not hispanic or latino	male	white	released	Alive	1965		TCGA-DK-A6B5_exposure	Not Reported	29.320987654320987		ab039eae-6b92-5c8a-a2da-673724fa5369	180.0		released	95.0	TCGA-DK-A6B5_diagnosis	16453		M0	N2	Stage IV	T4a	6th	not reported	0	1542	4ebf2bf8-0223-5523-b08e-2fff7476bcd7	C67.3	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Anterior wall of bladder	released	Not Reported	Anterior wall of bladder	not reported	stage iv	2010	TCGA-DK-A6B5_treatment_1	TCGA-DK-A6B5_treatment	released	d564f5fc-a580-595b-8205-9e2e687e5bed	yes	Pharmaceutical Therapy, NOS	released	3254b3b2-25c3-5619-a5e5-42d52b8a2551	no	Radiation Therapy, NOS	f2181c15-e595-47e0-a746-101c0d64da58
782d0409-2385-468a-8395-beabf815ccc6.htseq.counts.gz	8eca0568-edf1-479b-8c00-90c5819cca30	TCGA-DK-AA6Q-01A-11R-A39I-07	TCGA-DK-AA6Q-01A-11R	TCGA-DK-AA6Q-01A-01-TS1		TCGA-DK-AA6Q-01A-11	TCGA-DK-AA6Q-01A	TCGA-DK-AA6Q	60419f8c-92c2-4e8f-b2fa-a767d30c9d59	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	516	110.0	False	true	1D50AD73-3AE6-427F-92D8-518FE4BD4B51	1.9	52e425cf-1fad-400e-bc39-6df2a3310a68			0.16	23	released	6d75cdb8-dec7-421a-a2af-5a433182be83	RNA	R	0.16	UV Spec	released	False	187db9d0-d8d0-42d7-874d-a4167f9a5263	11	3.0	0.0	0.0	0.0	15.0	0.0	85.0	70.0	TOP	ad1a1f6f-78f2-4b75-985e-3fc3af4ecdd1	released												released	30.0	daba59a9-8839-4b02-bbf8-4de9c6595a7c	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6Q_demographic	61	-22314	413	4959fe7e-986a-51ed-acb4-2346591bf8ca	not hispanic or latino	female	white	released	Dead	1951	2013	TCGA-DK-AA6Q_exposure	Not Reported	25.636917160711423		40ee6cbf-9e07-5bb5-a45c-ba32c48740aa	158.0		released	64.0	TCGA-DK-AA6Q_diagnosis	22314	T2	M0	N1	Stage IV	T3	7th	not reported	0		b0e13787-7f6c-5167-bef7-4fd89aa805ff	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2012	TCGA-DK-AA6Q_treatment	TCGA-DK-AA6Q_treatment_1	released	a1173265-645b-50ff-893a-c24798d6c32f	no	Radiation Therapy, NOS	released	f77847b5-ff51-53f4-9689-60a8730d7966	yes	Pharmaceutical Therapy, NOS	8eca0568-edf1-479b-8c00-90c5819cca30
694e84fe-2af3-4b41-a3d1-09fb324fa6eb.htseq.counts.gz	f24e8b9b-cbc9-44e8-b217-aad4e45092c6	TCGA-ZF-AA4U-01A-11R-A38B-07	TCGA-ZF-AA4U-01A-11R	TCGA-ZF-AA4U-01A-01-TS1		TCGA-ZF-AA4U-01A-11	TCGA-ZF-AA4U-01A	TCGA-ZF-AA4U	585dfb25-5013-4ae1-a26b-5fed08e6cdb3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1842	90.0	False	true	72EA5495-3D5D-4547-B2BE-54C138294216	1.87	842be247-70f7-4ac6-9e16-c07a1f62ff78			0.18	23	released	1b038918-8fe9-44f7-923e-b03c7677bcad	RNA	R	0.18	UV Spec	released	False	1d704ca1-1376-4d4e-b5f2-3615a5619719	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	98.0	TOP	831db569-494e-45a9-a8d1-4748bf3ed5f6	released												released	30.0	a30bceda-99e4-4b73-9cb6-0a080865f214	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4U_demographic	70	-25682	262	5c291010-359d-5194-8540-0bce7814f5e5	not hispanic or latino	male	white	released	Dead	1938	2008	TCGA-ZF-AA4U_exposure	Not Reported	29.320987654320987	1.36986301369863	899538f1-5337-50c4-84e6-85cfe968c9bd	180.0	25.0	released	95.0	TCGA-ZF-AA4U_diagnosis	25682	T2	MX	NX	Stage III	T4a	6th	not reported	0		7adcc316-0607-58e5-9e0f-898483d63ef4	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2008	TCGA-ZF-AA4U_treatment_1	TCGA-ZF-AA4U_treatment	released	75642f43-f512-52f3-a781-813060b143bb	no	Pharmaceutical Therapy, NOS	released	e8390f30-213b-5545-a387-fc4c2c73fd5d	no	Radiation Therapy, NOS	f24e8b9b-cbc9-44e8-b217-aad4e45092c6
c5a6f1e5-7ab7-4a73-9e01-3cb16332a602.htseq.counts.gz	449f7d83-aeaf-4279-b7ba-eddfec04d3e1	TCGA-K4-A6MB-01A-11R-A31N-07	TCGA-K4-A6MB-01A-11R	TCGA-K4-A6MB-01A-01-TS1		TCGA-K4-A6MB-01A-11	TCGA-K4-A6MB-01A	TCGA-K4-A6MB	661d7b4a-a2b2-4251-b464-292421665948	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	84	130.0	False	true	1CAB3206-121C-44C6-AD32-6DBCCAA94C94	1.94	7e8935da-773b-4337-8fa2-f52ebbaceaee			0.18	23	released	8ed02832-297f-4856-8319-c3de3b4c652f	RNA	R	0.18	UV Spec	released	False	0830b231-af58-4388-b739-ba4d985157e9	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	70.0	TOP	fd5857c4-beda-41c6-a85c-d645a1ead737	released												released	30.0	27fc991d-95c7-4ab1-bd42-cbaf91b199d0	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A6MB_demographic	64	-23664		1050f12f-82c4-57b9-9ba1-d128f0a1f67d	not hispanic or latino	male	white	released	Alive	1949		TCGA-K4-A6MB_exposure	Not Reported	27.77427092538821		ea222510-3854-5fb9-b5cd-289c179417ef	178.0		released	88.0	TCGA-K4-A6MB_diagnosis	23664	T3	MX	N1	Stage IV	T3b	7th	not reported	0	469	1ae7ee4d-d736-51a6-b4bc-186ed8f1f578	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2013	TCGA-K4-A6MB_treatment	TCGA-K4-A6MB_treatment_1	released	86d53b6f-571e-5c43-acf8-2e837295ae54	no	Radiation Therapy, NOS	released	5fd144ae-473d-5314-a9a8-fe0eaf2be144	yes	Pharmaceutical Therapy, NOS	449f7d83-aeaf-4279-b7ba-eddfec04d3e1
ef940b6c-10ef-42df-a5a9-c8f21044f096.htseq.counts.gz	87fd057b-4dfc-4f64-94b1-a35de7f18d28	TCGA-4Z-AA82-01A-11R-A39I-07	TCGA-4Z-AA82-01A-11R	TCGA-4Z-AA82-01A-01-TS1		TCGA-4Z-AA82-01A-11	TCGA-4Z-AA82-01A	TCGA-4Z-AA82	32e79b35-a33a-4ca0-bfb7-7ea7e4e26568	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1384	120.0	False	true	E5DA265D-FBA6-4EA0-9383-96C365A9679A	1.88	349245b6-2265-476a-845a-a7f44896cf52			0.17	23	released	726ca227-a54e-490b-b1bb-a8f9d5c672d7	RNA	R	0.17	UV Spec	released	False	63d9ab28-883b-4912-991c-e1f704c1d123	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	c29b520d-67d0-40d7-8222-6fd3f8531a40	released												released	30.0	2dc2d753-15c7-4f3b-918a-8155bc03b91e	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA82_demographic	59	-21893	1556	96c5ffa9-cf3e-54c3-9b4c-5f2c29cc16dd	not reported	male	black or african american	released	Dead	1951		TCGA-4Z-AA82_exposure	Not Reported	19.692665289256198		41b724f0-1548-51a6-a054-d5edcc657e83	176.0		released	61.0	TCGA-4Z-AA82_diagnosis	21893	T2	M0	N1	Stage IV	T2a	7th	not reported	0	1538	948029c4-616d-5e10-b947-f3fdbfdd3838	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2010	TCGA-4Z-AA82_treatment_1	TCGA-4Z-AA82_treatment	released	0e4c6b3f-2448-5e2b-af82-d6e33263a0c0	no	Pharmaceutical Therapy, NOS	released	23d24aa8-6133-5806-ad89-956b34c6b42e	yes	Radiation Therapy, NOS	87fd057b-4dfc-4f64-94b1-a35de7f18d28
879e4d3a-aa47-4a95-8c21-ba69ec44d9e2.htseq.counts.gz	1e2fabe6-2d65-4798-a4c4-8e9ce010a905	TCGA-FD-A3B5-01A-11R-A20F-07	TCGA-FD-A3B5-01A-11R	TCGA-FD-A3B5-01A-01-TSA		TCGA-FD-A3B5-01A-11	TCGA-FD-A3B5-01A	TCGA-FD-A3B5	462d5a6b-9f39-4aae-a35b-d06a7811d053	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	218	320.0	False	false	683132FE-FCA5-4D03-A018-45D36B12FFD4	1.79	1afbe0f3-e320-4d74-8648-0c26ddbeab7f			0.17	23	released	05363ffb-5954-4b85-b320-975e3703c3d4	RNA	R	0.17	UV Spec	released	False	0d9baf95-4ba8-4f13-8a79-c14cac3ee59d	11	2.0	0.0	4.0	1.0	0.0	26.0	70.0	85.0	TOP	8cb2df51-fd10-4df4-82e7-622fa39c6327	released												released	30.0	f9dedc8c-327d-456a-9c0b-e1ec58ae3169	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B5_demographic	86	-31442	272	412d2a83-ea8e-541e-b3ec-380bf6ed4bce	not hispanic or latino	male	black or african american	released	Dead	1925	2011	TCGA-FD-A3B5_exposure	Not Reported	22.955862238255083	1.36986301369863	d52a17af-a04d-5ca2-a27d-07276392c8ba	177.8	25.0	released	72.57	TCGA-FD-A3B5_diagnosis	31442	T2	MX	N1	Stage IV	T2b	7th	not reported	0		5fe0cabc-5730-56bf-9597-b34a05036011	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2011	TCGA-FD-A3B5_treatment_1	TCGA-FD-A3B5_treatment	released	a298c1c4-46d0-5651-908c-e6bfa7600eee	no	Pharmaceutical Therapy, NOS	released	aac7ff25-ac86-5933-ae71-d4a918e0770e	no	Radiation Therapy, NOS	1e2fabe6-2d65-4798-a4c4-8e9ce010a905
f817f863-8d9f-4b22-b371-4e342bfe07d1.htseq.counts.gz	ec4dcd27-4506-4bf8-9295-107a7a4885e6	TCGA-CU-A3QU-01A-11R-A22U-07	TCGA-CU-A3QU-01A-11R	TCGA-CU-A3QU-01A-01-TSA		TCGA-CU-A3QU-01A-11	TCGA-CU-A3QU-01A	TCGA-CU-A3QU	ae6d853b-a7f0-4465-b7bf-5a45006ab3b3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	182	940.0	False	false	3197D149-9CF0-4644-B192-F7BB6028AF45	1.83	c40ff5cd-bffa-40c4-a192-9830b0da3daa			0.17	23	released	c87c98db-8681-4940-a5df-d7e17e8336c0	RNA	R	0.17	UV Spec	released	False	e221790e-e489-4022-a32c-7d86c0b48ca9	11	0.0	0.0	3.0	0.0	0.0	1.0	96.0	99.0	TOP	f19736eb-e66c-41ac-84fa-6c548c1112d3	released												released	30.0	75448068-ded8-42f0-bb99-6d1c4b3ffa4e	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A3QU_demographic	58	-21233		933b7600-7978-569b-ad4b-a57fffebaba9	not hispanic or latino	male	white	released	Alive	1953		TCGA-CU-A3QU_exposure	Not Reported	29.06879615089044	0.821917808219178	7e8b27d9-d521-56d3-9394-088fe9bb8351	173.0	15.0	released	87.0	TCGA-CU-A3QU_diagnosis	21233		M0	N1	Stage IV	T2b	7th	not reported	0	158	c8cc206a-17b2-50bd-b149-cace8de6d893	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-CU-A3QU_treatment	TCGA-CU-A3QU_treatment_1	released	5f53fa88-de51-579d-8383-765512c24e16	no	Radiation Therapy, NOS	released	831f6d4a-d80d-5eb4-b5d4-bc0826fd7b93	no	Pharmaceutical Therapy, NOS	ec4dcd27-4506-4bf8-9295-107a7a4885e6
81e938b3-4387-4b94-a440-ce4206a66809.htseq.counts.gz	be532179-6441-429a-923d-230611afbb5d	TCGA-GV-A3QK-01B-11R-A23N-07	TCGA-GV-A3QK-01B-11R	TCGA-GV-A3QK-01B-01-TS1		TCGA-GV-A3QK-01B-11	TCGA-GV-A3QK-01B	TCGA-GV-A3QK	9ee8e704-c61d-413d-b69d-257ef829fdae	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	146	260.0	False	true	C6248F9C-58D2-4F68-9D45-B38F38DCCA53	1.82	bd5b7c93-fabe-4bb8-a78f-981aeed75d79			0.18	23	released	c82daed9-ea5e-4a42-8fbb-995a3a293aaa	RNA	R	0.18	UV Spec	released	False	641e7934-e448-4ba1-b88b-15a16d3c5f17	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	750adf53-b260-4c23-9a9d-ee8adf6fb4c2	released												released	30.0	9bf2d470-cbc4-454a-95ab-3109f045684c	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3QK_demographic	56	-20802		5b16aa06-3694-54b5-ba9d-b006e2b0fa86	not hispanic or latino	female	white	released	Alive	1956		TCGA-GV-A3QK_exposure	Not Reported	32.02036958450677	2.4657534246575343	449e6b8e-0e5b-51f4-99dd-97478d630b77	161.0	45.0	released	83.0	TCGA-GV-A3QK_diagnosis	20802		M0	N2	Stage IV	T4a	7th	not reported	0	832	12e2402b-379b-516f-8ac9-dbb33959d547	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2012	TCGA-GV-A3QK_treatment_1	TCGA-GV-A3QK_treatment	released	b84dda83-4c68-57cf-9a4b-87cc179411fd	yes	Pharmaceutical Therapy, NOS	released	900437da-e8e5-5b83-9d94-d1d3b631a214	yes	Radiation Therapy, NOS	be532179-6441-429a-923d-230611afbb5d
5b27b38e-d7c3-4af7-9fe8-4af4d7d49f1a.htseq.counts.gz	fb49b14b-dcd4-4b74-9672-b66164c5ef79	TCGA-DK-A6AW-01A-11R-A30C-07	TCGA-DK-A6AW-01A-11R	TCGA-DK-A6AW-01A-01-TSA		TCGA-DK-A6AW-01A-11	TCGA-DK-A6AW-01A	TCGA-DK-A6AW	01c815ba-7bda-4f7e-865c-0c5776febf2c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1183	110.0	False	true	FFC32668-B801-48EB-BBAC-0E624AEED12D	1.96	d1b0c4db-59b7-47ac-b26f-fb14c5aac200			0.16	23	released	da99e294-a133-4428-8c2d-c1289b4673c0	RNA	R	0.16	UV Spec	released	False	88bd4548-0369-46c8-8520-c7c931199e18	11	0.0	0.0	10.0	0.0	0.0	10.0	80.0	80.0	TOP	63275a3f-c502-4bd9-9391-e1905f690902	released												released	30.0	71ae41dc-20da-440f-a04a-c2516b79db19	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6AW_demographic	70	-25644		e2a8a947-8e87-5a6d-ad47-a263319f7987	not hispanic or latino	male	white	released	Alive	1940		TCGA-DK-A6AW_exposure	Not Reported	31.741788900397605	1.36986301369863	c3587a26-914d-5775-b70b-4ccb086f05c3	173.0	25.0	released	95.0	TCGA-DK-A6AW_diagnosis	25644		M0	N0	Stage II	T2a	6th	not reported	0	1621	dc86318c-5077-50b5-a869-e7ba4bdc71ee	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage ii	2010	TCGA-DK-A6AW_treatment	TCGA-DK-A6AW_treatment_1	released	9f0abcaa-19fd-58c0-8d7a-71a2a7ea04d7	no	Radiation Therapy, NOS	released	d54f3c55-56ae-5546-a6c7-dfdad0bb3f84	no	Pharmaceutical Therapy, NOS	fb49b14b-dcd4-4b74-9672-b66164c5ef79
ca2d4e75-ff39-41bd-9357-c096f697c7ec.htseq.counts.gz	52db50de-5761-44e5-a758-adf340bfa72e	TCGA-FD-A3N6-01A-11R-A21D-07	TCGA-FD-A3N6-01A-11R	TCGA-FD-A3N6-01A-01-TSA		TCGA-FD-A3N6-01A-11	TCGA-FD-A3N6-01A	TCGA-FD-A3N6	8c1dd7f7-b74a-4fa2-b6a7-86f0348d2567	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	181	280.0	False	true	66C80EC0-37D4-4F88-9988-2CA3D652C8C3	1.83	575f9b1e-4952-488a-bbdd-ac98c1f68382			0.17	23	released	648bb105-0db1-4314-be6b-ad32ec462cd5	RNA	R	0.17	UV Spec	released	False	6d9ff6cf-2577-47a2-9058-01126a422eab	11	2.0	1.0	5.0	1.0	0.0	20.0	75.0	75.0	TOP	7112fcef-9ded-4489-8437-76b58c7c5eeb	released												released	30.0	6cd6d1f4-d8e4-47f9-812f-eb7fec925f8d	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3N6_demographic	43	-15758		cd3480b2-5c85-57e8-9c82-edb593a3a847	not hispanic or latino	female	black or african american	released	Alive	1968		TCGA-FD-A3N6_exposure	Not Reported	49.33491711492222	0.4520547945205479	17723958-272e-5fd1-a982-64233e2be7bd	170.18	8.25	released	142.88	TCGA-FD-A3N6_diagnosis	15758		MX	N0	Stage II	T2b	7th	not reported	0	851	f30d0bc2-66c9-5ca0-951a-634e38f01ed6	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage ii	2011	TCGA-FD-A3N6_treatment	TCGA-FD-A3N6_treatment_1	released	d86dcd3a-21f6-5be9-86eb-556afcf779f9	no	Radiation Therapy, NOS	released	73ce33a6-0230-5ebf-b684-ab77ed722095	no	Pharmaceutical Therapy, NOS	52db50de-5761-44e5-a758-adf340bfa72e
1b3a1cd6-4115-4e32-8ae9-c24a05f0190e.htseq.counts.gz	38ea0f86-1593-4082-8a50-f6fbb955ba6d	TCGA-G2-A3IB-01A-11R-A20F-07	TCGA-G2-A3IB-01A-11R	TCGA-G2-A3IB-01A-01-TSA		TCGA-G2-A3IB-01A-11	TCGA-G2-A3IB-01A	TCGA-G2-A3IB	af53d51e-0b5c-437f-a1c0-ec5f55c49364	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1248	160.0	False	true	AD5273EB-8A12-4000-A0EB-99CED937D6D8	1.85	df755d45-141e-40d1-96c8-6bfe29c17edc			0.17	23	released	1ab89c69-ffa5-4c44-b8f2-a25738c2f187	RNA	R	0.17	UV Spec	released	False	76aae6a7-78fb-4bef-ad56-bc58b8ec518f	11	2.0	1.0	0.0	1.0	0.0	20.0	80.0	80.0	TOP	70aa56b1-1580-4fe2-a836-e6a4cb578a9a	released												released	30.0	791e4058-e872-4af8-a431-f5782811f02a	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A3IB_demographic	66	-24149	220	dc019b6b-2785-5918-b589-84f73ed11ef4	not hispanic or latino	male	black or african american	released	Dead	1942		TCGA-G2-A3IB_exposure	Not Reported	30.707070707070702		7cf513af-a80e-5cc3-b8f2-0f249fbcfeaf	165.0		released	83.6	TCGA-G2-A3IB_diagnosis	24149	T2a	MX	NX	Stage II		6th	not reported	0	214	c4e50bc8-2321-5989-a4ed-b5ff9cf5d14e	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2008	TCGA-G2-A3IB_treatment	TCGA-G2-A3IB_treatment_1	released	023c93e7-ad45-5c6a-a08e-86969faa7ac3	no	Radiation Therapy, NOS	released	66e03045-f66b-5380-beb5-6456bd5699e7	yes	Pharmaceutical Therapy, NOS	38ea0f86-1593-4082-8a50-f6fbb955ba6d
93293529-ae13-4ad2-94dc-a566275c606f.htseq.counts.gz	eb5a4059-c381-4579-8e89-4db7555c8935	TCGA-BL-A5ZZ-01A-31R-A30C-07	TCGA-BL-A5ZZ-01A-31R	TCGA-BL-A5ZZ-01A-03-TS3		TCGA-BL-A5ZZ-01A-31	TCGA-BL-A5ZZ-01A	TCGA-BL-A5ZZ	c1afc5eb-8c1d-4b6c-8453-48728fc023ba	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	750.0	False	false	DDA3DBFA-0ECA-4D47-8E8D-5C33F6E4D448	1.8	ac9729e9-6565-4e11-8828-ff43b752a5b6			0.15	23	released	483e66b4-8a04-4807-9461-8d7b4e90f099	RNA	R	0.15	UV Spec	released	False	d2463dda-ff70-41fc-b562-7aa99288dcf3	31	8.0	1.0	15.0	1.0	0.0	0.0	85.0	65.0	TOP	04c338ed-ba5c-41d9-8a03-37c916eae05c	released												released	30.0	336aca2f-d2ce-458b-be44-a40878d06973	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A5ZZ_demographic	80	-29247		c4c95f28-a1a4-57c7-8a58-c4f2d81f2346	not hispanic or latino	female	white	released	Alive	1932		TCGA-BL-A5ZZ_exposure	Not Reported	26.72287252060672	1.643835616438356	8c367d48-144a-58fa-b574-f0414d217d2d	163.0	30.0	released	71.0	TCGA-BL-A5ZZ_diagnosis	29247		MX	N0	Stage III	T4a	7th	not reported	0	377	4ad80ea6-06f8-5d38-842e-8a4361a0fc25	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2012	TCGA-BL-A5ZZ_treatment	TCGA-BL-A5ZZ_treatment_1	released	659da376-78d7-53a5-9b74-eff839f52bb2	no	Radiation Therapy, NOS	released	aef7e07b-d9a9-579e-949c-8d6399a2e018	yes	Pharmaceutical Therapy, NOS	eb5a4059-c381-4579-8e89-4db7555c8935
944e47ef-da39-4159-8298-3971c72c97cd.htseq.counts.gz	5a651c86-af6f-4e14-a7da-bda2d6891ec7	TCGA-XF-A8HF-01A-11R-A36F-07	TCGA-XF-A8HF-01A-11R	TCGA-XF-A8HF-01A-01-TSA		TCGA-XF-A8HF-01A-11	TCGA-XF-A8HF-01A	TCGA-XF-A8HF	8573e114-ac20-4113-a942-01f2d1562a7b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3418	150.0	False	true	1276CC52-8D49-40E9-A365-3E065E1B77EA	1.81	74bf5bf4-7a66-4316-9b43-a85db455dfd3			0.15	23	released	b9c09cf6-248e-4e23-b32b-332f46959740	RNA	R	0.15	UV Spec	released	False	c9294ef3-bd02-4410-a48c-b33947a2d3c9	11	0.0	0.0	0.0	0.0	0.0	50.0	50.0	60.0	TOP	0bd2a379-306d-427d-9f73-45452cd0c1e6	released												released	30.0	c9772460-2d06-4e6b-8804-b9a227311d58	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HF_demographic	80	-29288	2954	793a7138-3932-5290-a615-1551ebe45dde	not hispanic or latino	male	white	released	Dead	1924		TCGA-XF-A8HF_exposure	Not Reported	24.784257517393772	0.0547945205479452	1293da20-ac34-5816-8a8f-61b2752e888d	183.0	1.0	released	83.0	TCGA-XF-A8HF_diagnosis	29288		M0	N0	Stage III	T3a	6th	not reported	0	1709	a9a006b5-9e16-5f76-945d-d7775aa3d3fc	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2004	TCGA-XF-A8HF_treatment_1	TCGA-XF-A8HF_treatment	released	f4b58e89-8402-5f9c-a7ff-86a34247f9b2	no	Pharmaceutical Therapy, NOS	released	ce70576b-591c-5840-96b9-d1077c7d3555	no	Radiation Therapy, NOS	5a651c86-af6f-4e14-a7da-bda2d6891ec7
16979c41-375b-4b3a-adb9-b0a84f748c43.htseq.counts.gz	1d6c47f7-3f20-4171-b307-d638f9c62733	TCGA-XF-AAN1-01A-31R-A42T-07	TCGA-XF-AAN1-01A-31R	TCGA-XF-AAN1-01A-03-TSC		TCGA-XF-AAN1-01A-31	TCGA-XF-AAN1-01A	TCGA-XF-AAN1	5378f375-aa04-4eca-bc35-190b3efb52bc	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2644	710.0	False	true	7BD47644-AADB-40AE-A5BA-997B74F6AD80	1.82	4f40609b-40ad-44f2-9185-a4c99056c48e			0.16	23	released	e393ab3e-1ab7-49ae-ae0f-b4eac7efee97	RNA	R	0.16	UV Spec	released	False	ece0cced-7066-4809-8ff9-33953be3ed7a	31	7.0	0.0	4.0	0.0	0.0	18.0	78.0	90.0	TOP	198b46d5-33ab-4c1e-a42a-c843c2de4b59	released												released	30.0	724b5713-b867-4cff-9f1b-7ce3f667dfd1	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN1_demographic	75	-27687	941	49d0b7cd-c9e9-521b-a2d9-181f52757e96	not hispanic or latino	female	not reported	released	Dead	1931	2008	TCGA-XF-AAN1_exposure	Not Reported	32.59637188208617	2.5753424657534247	b7945cd5-26a6-58c3-ac37-6425fa6fbb4a	168.0	47.0	released	92.0	TCGA-XF-AAN1_diagnosis	27687		M0	N0	Stage III	T4a	6th	not reported	0		1a108cfa-d5ea-57d1-88da-eae8fd94a20e	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-AAN1_treatment	TCGA-XF-AAN1_treatment_1	released	086191a3-a803-559f-9602-b28ae5ef086a	no	Radiation Therapy, NOS	released	19dc0452-e2d5-5ea3-8b95-e045c816d674	no	Pharmaceutical Therapy, NOS	1d6c47f7-3f20-4171-b307-d638f9c62733
b2eeaa64-92f6-46cf-a721-6b7e2c96739b.htseq.counts.gz	f0670583-55a3-419c-baa5-b8cf095d3b10	TCGA-DK-A2I6-01A-12R-A18C-07	TCGA-DK-A2I6-01A-12R	TCGA-DK-A2I6-01A-01-TS1		TCGA-DK-A2I6-01A-12	TCGA-DK-A2I6-01A	TCGA-DK-A2I6	de810af0-4c18-4e8f-9836-f8abc425e3eb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2326	80.0	False	true	4CDD4632-B977-4B97-BAE5-8442F1D9319A	1.81	ad775597-406f-4470-894a-e37d0666761b			0.17	23	released	91ea9a9e-74bf-421e-b490-0522c6a73c22	RNA	R	0.17	UV Spec	released	False	2a93fd06-8907-4e0b-aaf6-6ad1a92c996d	12	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	56be33f9-f83c-4b83-a1ae-633120ce6de2	released												released	30.0	a536f8f9-3a68-4792-880d-387d78fd0c66	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A2I6_demographic	81	-29789		a259e0d7-cf88-52ef-b505-df84952ad8d4	not hispanic or latino	male	white	released	Alive	1924		TCGA-DK-A2I6_exposure	Not Reported	27.93207928291882	0.8767123287671232	9355895f-8fa2-57b1-aa07-5db9ec3d354e	178.0	16.0	released	88.5	TCGA-DK-A2I6_diagnosis	29789		M0	N1	Stage IV	T2b	6th	not reported	0	2656	ade4f685-7676-5f1b-be10-be5ea76f79e4	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iv	2005	TCGA-DK-A2I6_treatment	TCGA-DK-A2I6_treatment_1	released	bafce29c-e8ca-5d95-b9f8-a88592f820f1	no	Radiation Therapy, NOS	released	db09242d-5328-5b98-adab-52c195dae5c0	no	Pharmaceutical Therapy, NOS	f0670583-55a3-419c-baa5-b8cf095d3b10
74fa890a-d4e6-4718-959a-2b2c125c892e.htseq.counts.gz	56630b4d-5a25-4394-b540-de3b6646cc1d	TCGA-XF-A9SY-01A-21R-A42T-07	TCGA-XF-A9SY-01A-21R	TCGA-XF-A9SY-01A-02-TSB		TCGA-XF-A9SY-01A-21	TCGA-XF-A9SY-01A	TCGA-XF-A9SY	8a83f744-8469-41ef-a4cd-e983f849383f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2734	360.0	False	true	FACDA2AA-EE41-4EF5-8599-E72249E4B715	1.89	1e4801e3-d021-46c7-a157-0b2a2fc59cf7			0.17	23	released	93ab4912-22a6-464a-a59c-1fe0fbb8c28f	RNA	R	0.17	UV Spec	released	False	a1581e11-d7bc-4014-a377-c637337761cb	21	2.0	1.0	15.0	4.0	0.0	15.0	70.0	70.0	TOP	e92600ae-5f22-4103-bd83-c4e7d928d0dd	released												released	30.0	dc0fdf8b-079e-423d-b27e-471582e1c0cf	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SY_demographic	60	-22212		3702ca08-2380-5775-bc46-62dd9fc9f943	not hispanic or latino	female	white	released	Alive	1946		TCGA-XF-A9SY_exposure	Not Reported	22.675736961451246	2.191780821917808	f5c2b0fc-9099-5f07-a9a2-7e35d50c4ef0	168.0	40.0	released	64.0	TCGA-XF-A9SY_diagnosis	22212		MX	N2	Stage IV	T3b	6th	not reported	0	640	dbdd0b41-b3ab-56cc-9853-de7f94c4cff9	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-A9SY_treatment_1	TCGA-XF-A9SY_treatment	released	5d4d9508-8d5f-5a67-8d76-50b3602c494f	yes	Pharmaceutical Therapy, NOS	released	c21979e0-34c6-5b74-8085-dce625bfe110	no	Radiation Therapy, NOS	56630b4d-5a25-4394-b540-de3b6646cc1d
942024fb-1b24-4c73-8b99-ceeff8f7e065.htseq.counts.gz	246f0e61-786b-4c41-8d9a-dfd60670eb7a	TCGA-K4-A3WV-01A-11R-A22U-07	TCGA-K4-A3WV-01A-11R	TCGA-K4-A3WV-01A-01-TSA		TCGA-K4-A3WV-01A-11	TCGA-K4-A3WV-01A	TCGA-K4-A3WV	d53eade8-a845-4252-aece-92f3573486a7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	143	100.0	False	true	A3D8B88A-51FB-44D2-8E24-096107D60058	1.84	80ddbbc6-11ff-469a-96ec-a72e0e2ec9c4			0.16	23	released	1d662a31-dda0-4ca9-9fbc-7fa42713cf0f	RNA	R	0.16	UV Spec	released	False	57a48678-ddec-46e3-8f89-9eccf67ed79d	11	2.0	0.0	5.0	0.0	0.0	55.0	40.0	70.0	TOP	804fb265-7003-4dad-87c1-d44979584c05	released												released	30.0	3adfa409-a9f8-4edb-aaf7-c5285ae5f895	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A3WV_demographic	77	-28444		5b539b2b-7050-50ba-b7eb-78e4e68160de	hispanic or latino	female	white	released	Alive	1934		TCGA-K4-A3WV_exposure	Not Reported		4.383561643835616	bfb52f09-4dfc-5c63-b488-df833624bd5f		80.0	released		TCGA-K4-A3WV_diagnosis	28444		MX	N0	Stage II	T2b	7th	not reported	0	646	17b6a319-ca82-5b6a-bfc6-ce2fc1b50c34	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-K4-A3WV_treatment_1	TCGA-K4-A3WV_treatment	released	3c101dd3-2135-5524-ab42-a052f123b04a	no	Pharmaceutical Therapy, NOS	released	b7b2322f-f7b8-5f87-945b-339e27c622e2	no	Radiation Therapy, NOS	246f0e61-786b-4c41-8d9a-dfd60670eb7a
968dcd47-d996-44ed-8174-f63cfcde9446.htseq.counts.gz	df8226e8-aa09-4514-b029-8594324d0ec7	TCGA-FD-A6TE-01A-12R-A33J-07	TCGA-FD-A6TE-01A-12R	TCGA-FD-A6TE-01A-01-TSA		TCGA-FD-A6TE-01A-12	TCGA-FD-A6TE-01A	TCGA-FD-A6TE	5c771ee8-2aea-498d-ba8c-cdbaebfd57ac	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	147	720.0	False	true	648DDD7D-6C27-4CA1-BBB2-891A9F7839FE	1.9	535736bf-6e19-4fc6-bf3d-a2fb4739c763			0.17	23	released	a2f10197-8d20-4e0b-a966-884a6a7dbce7	RNA	R	0.17	UV Spec	released	False	02abe393-b7b5-40e9-b512-0fc8eef9c28c	12	10.0	0.0	7.0	1.0	0.0	23.0	70.0	85.0	TOP	b0ab2504-a625-44df-9c6f-4c77b9b3c7d7	released												released	30.0	d16650c9-487c-4668-9927-f982227c4b2b	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TE_demographic	54	-19874		76e0bcb2-e947-54b7-a297-804a49226eb9	not hispanic or latino	male	white	released	Alive	1959		TCGA-FD-A6TE_exposure	Not Reported	20.061728395061728	1.095890410958904	7a381b26-952b-5073-8144-93c7d24052cc	180.0	20.0	released	65.0	TCGA-FD-A6TE_diagnosis	19874		MX	N2	Stage IV	T3a	7th	not reported	0	376	a97f59bf-e567-54fa-ac35-11e11f14a069	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2013	TCGA-FD-A6TE_treatment	TCGA-FD-A6TE_treatment_1	released	70047b3f-6520-5e60-b6a7-56d3564dd9c7	no	Radiation Therapy, NOS	released	8ee93528-c323-53af-83e9-c2192595b085	no	Pharmaceutical Therapy, NOS	df8226e8-aa09-4514-b029-8594324d0ec7
a2ef11f9-f323-4b73-b6ad-8876100166d9.htseq.counts.gz	c7cdc759-c3b5-4af2-b002-a6ddeb762297	TCGA-GU-AATQ-01A-11R-A39I-07	TCGA-GU-AATQ-01A-11R	TCGA-GU-AATQ-01A-01-TSA		TCGA-GU-AATQ-01A-11	TCGA-GU-AATQ-01A	TCGA-GU-AATQ	aff1533b-486e-40b5-a35a-cfaac5823706	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	95	240.0	False	true	FF69B05C-B041-4CBA-A481-66AB2510A4AC	1.81	263c3285-8412-426e-a042-1e4266190a03			0.17	23	released	c3e104ff-b746-4c48-935d-03d043583daf	RNA	R	0.17	UV Spec	released	False	c82b515c-5086-49d4-8ddc-894233c25c4d	11	2.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	043a4bf0-5985-4af1-bdfb-8e0c105d6bb8	released												released	30.0	ad2067c7-9fba-4db9-ad14-877bc0c4e20b	Primary Tumor	01	released	Not Reported	released	TCGA-GU-AATQ_demographic	68	-25185	213	4b210b10-030f-5960-b9e0-82def1b47abd	not hispanic or latino	male	white	released	Dead	1945	2013	TCGA-GU-AATQ_exposure	Not Reported	25.259515570934255	1.643835616438356	7624c7a3-b0ce-5b26-ab2a-43ab633e966c	170.0	30.0	released	73.0	TCGA-GU-AATQ_diagnosis	25185	T2	MX	N0	Stage III	T3b	7th	not reported	0		72441939-dce5-52ac-a5b2-2adf6dd85ce8	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-GU-AATQ_treatment_1	TCGA-GU-AATQ_treatment	released	cb9fcf61-d43c-511f-9fe7-7758f1e4daae	no	Pharmaceutical Therapy, NOS	released	e8d3351d-0e80-5e86-9b80-ef25071ecead	no	Radiation Therapy, NOS	c7cdc759-c3b5-4af2-b002-a6ddeb762297
c3b51c97-dcea-4934-8cb3-9728439355c3.htseq.counts.gz	4f8a9e87-39dc-4cbf-a0dd-78323a66b269	TCGA-PQ-A6FN-01A-11R-A31N-07	TCGA-PQ-A6FN-01A-11R	TCGA-PQ-A6FN-01A-01-TS1		TCGA-PQ-A6FN-01A-11	TCGA-PQ-A6FN-01A	TCGA-PQ-A6FN	a3c849f2-c006-4368-950d-998a26cd368b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	562	30.0	False	true	33979746-6DCE-434E-86D4-16005FD5502F	1.87	3167baad-cb92-49e6-8a7d-c59f81709a52			0.18	23	released	4a0a00be-6945-490a-ad56-69df13f060ff	RNA	R	0.18	UV Spec	released	False	84de64a3-1b3f-41ac-a96b-4d223cbbac87	11	5.0	0.0	0.0	0.0	10.0	0.0	90.0	70.0	TOP	8dd0a460-bf41-48a6-9ed2-37c51605dbb4	released												released	20.0	7503e8e8-68c0-4243-93f2-399e0f4d9d10	Primary Tumor	01	released	Not Reported	released	TCGA-PQ-A6FN_demographic	78	-28546		90479718-cf93-5ebf-a341-fa998fccf1f2	not hispanic or latino	female	white	released	Alive	1933		TCGA-PQ-A6FN_exposure	Not Reported	24.22145328719723	1.5342465753424657	3f7f8fe1-f459-534b-825e-ca3376268a4e	170.0	28.0	released	70.0	TCGA-PQ-A6FN_diagnosis	28546		MX	N0	Stage III	T3a	7th	not reported	0	507	375bb443-d37e-5d26-a988-1974f883a713	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2011	TCGA-PQ-A6FN_treatment	TCGA-PQ-A6FN_treatment_1	released	25b1b3b5-ba71-5a9a-b81a-f3a5387ca1f8	no	Radiation Therapy, NOS	released	b9ec1324-e7be-50fb-9544-3c50b0783b10	no	Pharmaceutical Therapy, NOS	4f8a9e87-39dc-4cbf-a0dd-78323a66b269
077696fe-72e3-441b-87b1-981ed40c5b79.htseq.counts.gz	c7381b23-5508-42bf-be5c-a67c2c42b0ec	TCGA-CF-A47X-01A-31R-A23W-07	TCGA-CF-A47X-01A-31R	TCGA-CF-A47X-01A-03-TSC		TCGA-CF-A47X-01A-31	TCGA-CF-A47X-01A	TCGA-CF-A47X	82d5f37f-5a1b-49d8-b990-ac222b4e1c1d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	151	460.0	False	true	F3D1CD04-8E47-455D-9DA3-30CA82805AFB	1.78	c27a2180-0dec-43ec-bf0f-2cb0acaea022			0.16	23	released	28f44771-b9ac-4604-a432-1c90b2f468bd	RNA	R	0.16	UV Spec	released	False	dd5a14dc-2c27-4fd2-9338-699abe6106b5	31	3.0	1.0	5.0	0.0	0.0	0.0	95.0	80.0	TOP	a7484f9b-2ecd-41ef-ace4-66dfb432d58c	released												released	30.0	3571832f-968e-48cb-adbf-67f1f8e95b52	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47X_demographic	60	-22200		76cf667e-8963-5470-8eff-31270b102cda	not hispanic or latino	male	asian	released	Alive	1952		TCGA-CF-A47X_exposure	Not Reported	20.244897959183675	1.095890410958904	6b405d18-bc88-560a-9e1b-01415cd2c332	175.0	20.0	released	62.0	TCGA-CF-A47X_diagnosis	22200	T2	M0	N0	Stage II	T2	7th	not reported	0	384	82d9dc61-fdf4-5e7d-b8b1-5f8bebddb4cd	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A47X_treatment	TCGA-CF-A47X_treatment_1	released	a86b9241-b6d0-595e-86ca-0582536586bd	yes	Radiation Therapy, NOS	released	c0965845-3404-5d44-b027-1e6d3d1326fb	no	Pharmaceutical Therapy, NOS	c7381b23-5508-42bf-be5c-a67c2c42b0ec
e659b3e8-7f6b-4ba7-9bf8-689cadc1a615.htseq.counts.gz	833e9000-6d4a-4884-8e4d-4643fc3620e3	TCGA-GC-A6I3-11A-11R-A31N-07	TCGA-GC-A6I3-11A-11R	TCGA-GC-A6I3-11A-01-TS1		TCGA-GC-A6I3-11A-11	TCGA-GC-A6I3-11A	TCGA-GC-A6I3	acf6bdf3-6349-49dc-b99a-4eda648eeac5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	87	50.0	False	false		1.88	0c8724f7-8a7e-4fc3-8100-b06b22d36a67			0.16	23	released	6b7a6aa8-3707-4928-9675-2abf1cb4ad9b	RNA	R	0.16	UV Spec	released	False	d9c2ac9a-11b6-4667-8383-b7fc94e37263	11	65.0	1.0	0.0	1.0	12.0	88.0	0.0	0.0	TOP	de4517d2-0613-4578-8ced-7003bd816d44	released												released	30.0	a6bd07c0-2568-42a3-8433-5f2ebfec34b2	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GC-A6I3_demographic	90	-32872		e20a5b08-8b7e-50a7-8773-274a85b7a2c8	not hispanic or latino	female	black or african american	released	Alive	1923		TCGA-GC-A6I3_exposure	Not Reported	68.31944516329382		28b02413-7097-5366-802a-877aafce69f5	139.0		released	132.0	TCGA-GC-A6I3_diagnosis	32872	T3a	MX	N1	Stage IV	T3a	7th	not reported	0	0	100ac192-0981-58ec-8734-b54512416b2e	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-GC-A6I3_treatment_1	TCGA-GC-A6I3_treatment	released	17889429-c84b-5834-8475-ef0a82631ad2	no	Pharmaceutical Therapy, NOS	released	93e78e5e-d69d-5b7b-87d2-f525007abfe1	no	Radiation Therapy, NOS	833e9000-6d4a-4884-8e4d-4643fc3620e3
3bb8373b-9e5f-4ad8-96ab-196bee799d40.htseq.counts.gz	01ae4bef-8659-4790-ad86-6d6a8dffbfc8	TCGA-ZF-A9RC-01A-11R-A38B-07	TCGA-ZF-A9RC-01A-11R	TCGA-ZF-A9RC-01A-01-TS1		TCGA-ZF-A9RC-01A-11	TCGA-ZF-A9RC-01A	TCGA-ZF-A9RC	4ed34db5-ddb5-4efd-a49b-84bf26789aee	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2386	70.0	False	true	B7DD19FB-FF13-44CB-88FF-B42A6E20962B	1.86	73e05f0f-01df-484e-94f5-b0586480f000			0.16	23	released	3a9aac49-54aa-493b-a087-2de8d86e044d	RNA	R	0.16	UV Spec	released	False	b656a9bf-a583-43ff-adad-38d143defd75	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	388fbc54-e300-4bf6-9825-6f7e99839cc6	released												released	30.0	d9c9d1c0-9e14-4fdc-9463-fa8b223fa441	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RC_demographic	77	-28275		ce607cbd-d112-5648-b29e-5f2c5a68baee	not hispanic or latino	male	white	released	Alive	1930		TCGA-ZF-A9RC_exposure	Not Reported	32.326530612244895		d67eea3f-a630-5aa8-a8a8-6f44dfaf4d38	175.0		released	99.0	TCGA-ZF-A9RC_diagnosis	28275	T2	MX	N0	Stage III	T3a	6th	not reported	0	2868	4da6422f-8bc0-5ab2-93f3-1faa469890e4	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2007	TCGA-ZF-A9RC_treatment	TCGA-ZF-A9RC_treatment_1	released	b3a98a1c-9c49-55f5-b630-bddfc88e2338	no	Radiation Therapy, NOS	released	abdbee54-779e-522d-8c16-8b64e349d49e	no	Pharmaceutical Therapy, NOS	01ae4bef-8659-4790-ad86-6d6a8dffbfc8
575f11ed-961d-483d-9a2b-9568d355f412.htseq.counts.gz	559b32d8-9da9-43d6-b184-bc48340c71f8	TCGA-E7-A4IJ-01A-31R-A26T-07	TCGA-E7-A4IJ-01A-31R	TCGA-E7-A4IJ-01A-03-TSC		TCGA-E7-A4IJ-01A-31	TCGA-E7-A4IJ-01A	TCGA-E7-A4IJ	faf4c71c-c4f3-4513-8c44-9114a5d3729a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	114	1200.0	False	true	E926015A-3299-4F9B-AA80-3D46F3CF96C0	1.86	21c8f741-963f-463e-ac5b-1c2c1aa9d8cb			0.16	23	released	40e4dd7c-da20-4833-9ef9-dab56c869e95	RNA	R	0.16	UV Spec	released	False	23df5ae0-b818-4c69-b30b-81e8707fa8b2	31	3.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	48198ac7-a66f-4eab-acdd-696960a6954e	released												released	30.0	ad01a372-16a9-4c09-81bb-cd0383d0c24b	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A4IJ_demographic	56	-20723	674	76eb4501-8f4a-5de1-a726-8d1536c5d479	not hispanic or latino	male	asian	released	Dead	1956		TCGA-E7-A4IJ_exposure	Not Reported	18.902038132807363		afb193aa-4722-51ab-a87e-e008e4749306	156.0		released	46.0	TCGA-E7-A4IJ_diagnosis	20723		M0	NX	Stage II	T2b	7th	not reported	0	408	d8cf8323-64a5-5678-b784-a860c57f4499	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A4IJ_treatment_1	TCGA-E7-A4IJ_treatment	released	92c04c5a-a207-5829-8da6-b9a5f23c142d	no	Pharmaceutical Therapy, NOS	released	dbf6b3e5-a979-5e87-b322-785e184fe8f5	no	Radiation Therapy, NOS	559b32d8-9da9-43d6-b184-bc48340c71f8
91563d01-b6bf-49b3-a74c-e47f902defcb.htseq.counts.gz	2f330e0e-9384-4dcb-b1d4-89b19363f591	TCGA-DK-A1AG-01A-11R-A13Y-07	TCGA-DK-A1AG-01A-11R	TCGA-DK-A1AG-01A-01-TSA		TCGA-DK-A1AG-01A-11	TCGA-DK-A1AG-01A	TCGA-DK-A1AG	f8c0a69c-df53-4a0a-a30e-4424c0ce3dd5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	169	430.0	False	true	CDF2E5C1-FD42-4703-9803-6C08E2FD48BA	1.83	b5036d12-d9cc-46a4-b60a-49740310380c			0.16	23	released	adbd1851-35af-4716-a237-e39207a71291	RNA	R	0.16	UV Spec	released	False	a55f3672-8e3e-4e9c-88d3-47ca0998bb2c	11	1.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	TOP	d930a2e8-6f67-4320-b108-1b58e63e8704	released												released	30.0	64668aa0-dde5-4534-8cd0-378881e4a4e4	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AG_demographic	65	-24095		94c14010-621e-5c89-89a2-0a6c47ac3da1	not hispanic or latino	male	white	released	Alive	1945		TCGA-DK-A1AG_exposure	Not Reported	26.0387811634349		45012eeb-9400-5f0e-83f1-b4b9647192d2	190.0		released	94.0	TCGA-DK-A1AG_diagnosis	24095		M0	N0	Stage III	T3	6th	not reported	0	475	a22935fb-176f-5a66-8746-430a72743a7b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-DK-A1AG_treatment_1	TCGA-DK-A1AG_treatment	released	dd2cfcd0-5d35-547d-9f42-558e8903481d	no	Pharmaceutical Therapy, NOS	released	6a28a052-a3f7-5137-80a7-159b8b984b19	no	Radiation Therapy, NOS	2f330e0e-9384-4dcb-b1d4-89b19363f591
8c35357a-dc7c-4e70-bb53-ce8f520bdb86.htseq.counts.gz	32136c7e-6e8a-42f0-83f5-6b0df9852609	TCGA-CU-A0YR-11A-13R-A10U-07	TCGA-CU-A0YR-11A-13R	TCGA-CU-A0YR-11A-01-TS1		TCGA-CU-A0YR-11A-13	TCGA-CU-A0YR-11A	TCGA-CU-A0YR	811b3950-36e7-485f-bc48-aca1eee2ddef	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	184	160.0	False	false		1.84	6d1b727a-12fb-4756-a076-6be61253f480			0.13	23	released	ecbf14e8-4167-4755-b290-1ae552ae87f6	RNA	R	0.13	UV Spec	released	False	890f5720-bb8d-410a-960c-c28166f49ee6	13	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	35ccad4f-e144-4781-b26c-90eb0f395e7e	released												released	30.0	c60912e4-2f70-4c1e-91bd-f2f5548e532b	Solid Tissue Normal	11	released	Not Reported	released	TCGA-CU-A0YR_demographic	83	-30674	460	60bf1272-b67c-5d3c-94d0-45bd5bdf2728	not hispanic or latino	male	white	released	Dead	1927		TCGA-CU-A0YR_exposure	Not Reported	23.851068110299483	0.6575342465753424	c5793f49-6fee-5323-9c48-52cb46d7f727	177.8	12.0	released	75.4	TCGA-CU-A0YR_diagnosis	30674		M0	N2	Stage IV	T2		not reported	0	219	7ec9e042-33f7-57ce-a478-26f37e2ad028	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-CU-A0YR_treatment_1	TCGA-CU-A0YR_treatment	released	d80b9a75-8eb0-5129-959f-0f0189e982d4	no	Pharmaceutical Therapy, NOS	released	8168daf0-8cf6-509c-96e1-f910a657abb1	no	Radiation Therapy, NOS	32136c7e-6e8a-42f0-83f5-6b0df9852609
d4b81c99-3e09-41b5-b4df-2d7c611fcc73.htseq.counts.gz	2ec8c000-0991-4995-8dde-e499a1101d5d	TCGA-BT-A20W-11A-11R-A14Y-07	TCGA-BT-A20W-11A-11R	TCGA-BT-A20W-11A-01-TSA		TCGA-BT-A20W-11A-11	TCGA-BT-A20W-11A	TCGA-BT-A20W	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	751		False	true		1.91	d4a3d2d7-35c6-40b5-9e67-093f4f5834a4			0.16	23	released	6dd2f2a2-edd2-4cab-a1c5-42c7ba8a56fc	RNA	R	0.16	UV Spec	released	False	4b44cd89-be5e-48ea-92e3-d40b510b405a	11	3.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	TOP	3a5d5d16-a8e5-4be8-ac64-f50ac598983f	released												released	30.0	5ff660d2-10de-4d72-bde0-93840309b5e5	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A20W_demographic	71	-26078	254	eedd9a3c-ba25-5e6b-b3be-8691d0bd3762	not hispanic or latino	male	white	released	Dead	1938	2009	TCGA-BT-A20W_exposure	Not Reported			814ee2a1-7e3c-5e37-bd4e-fc6e656e377b			released		TCGA-BT-A20W_diagnosis	26078	T2b	M0	N0	Stage II	T2b	6th	not reported	0		1a57505d-1a54-5aad-a8ff-dbd1955dd062	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2009	TCGA-BT-A20W_treatment	TCGA-BT-A20W_treatment_1	released	3cfce4ba-f89f-5113-a346-7a7b24c7664f	no	Radiation Therapy, NOS	released	f6b37f89-cd70-5b08-8954-f98a347dae28	no	Pharmaceutical Therapy, NOS	2ec8c000-0991-4995-8dde-e499a1101d5d
fa7e05f3-8f14-4491-98f7-6262781a1013.htseq.counts.gz	61226070-67bc-4c6e-8b05-e6b46b53bbe6	TCGA-4Z-AA7S-01A-11R-A39I-07	TCGA-4Z-AA7S-01A-11R	TCGA-4Z-AA7S-01A-01-TS1		TCGA-4Z-AA7S-01A-11	TCGA-4Z-AA7S-01A	TCGA-4Z-AA7S	f001cc02-8119-4726-b41c-14ac1e6a4216	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1190	420.0	False	true	A406A3F6-80CB-48D6-A129-2837504B5DE2	1.9	7046aa00-ff84-4ff4-9157-63b3b1d898df			0.17	23	released	707d0cdf-66a3-4d8b-ae56-73195ad6452f	RNA	R	0.17	UV Spec	released	False	1a858fff-b393-4b9e-bee3-cea2aca482bc	11	4.0	0.0	0.0	0.0	20.0	0.0	80.0	70.0	TOP	28cfb2ad-0027-4b86-b67c-c34661b12ee2	released												released	30.0	6d7d103d-08a9-4acd-aefa-ea7580bdf6b0	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7S_demographic	66	-24111	1064	50feed00-38b5-5417-9fc0-52db4132c6f7	not reported	male	black or african american	released	Dead	1944	2012	TCGA-4Z-AA7S_exposure	Not Reported			5cbd48b9-9055-5b5b-94e3-62f4f8b6ce00			released		TCGA-4Z-AA7S_diagnosis	24111	T2a	M0	N0	Stage III	T4a	7th	not reported	0		48865ead-80f6-5e89-b1e5-1a8933daa49d	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-4Z-AA7S_treatment	TCGA-4Z-AA7S_treatment_1	released	9df9cc69-4edf-5dc0-b336-5b435e8decbb	no	Radiation Therapy, NOS	released	43f82f45-1a05-57ff-a923-2886d93a0a26	no	Pharmaceutical Therapy, NOS	61226070-67bc-4c6e-8b05-e6b46b53bbe6
1b71f4c9-51ff-402c-b321-c6927d60cd0c.htseq.counts.gz	b544ee3b-dad8-4f2d-8dbd-61082abdd94c	TCGA-DK-A1A6-01A-11R-A13Y-07	TCGA-DK-A1A6-01A-11R	TCGA-DK-A1A6-01A-01-TSA		TCGA-DK-A1A6-01A-11	TCGA-DK-A1A6-01A	TCGA-DK-A1A6	9c274536-3ca1-4f0e-93a8-1688074d862f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	874	160	False	true	EFF72FEC-98DC-42F0-B209-17625E653246	1.82	381b51af-d1f7-41db-a69e-49d681b3ef39	4.27	26.7	0.16	23	released	5e564bb7-17eb-40ee-b8e5-09814e92f1d1	RNA	R	0.16	UV Spec	released	False	d8e559ff-090e-463c-ae1b-be9a9cee3f98	11	2	0	0	0	0	10	90	90	TOP	eb7be81d-7fca-48a7-b9ae-c8971f39ddf4	released												released	30	7ad1cd01-0ea2-4fa4-9b05-c280bd256546	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1A6_demographic	53	-19554		e4e2b277-72f5-59d5-92be-1cd2aa2ef187	not reported	male	white	released	Alive	1955		TCGA-DK-A1A6_exposure	Not Reported	32.714090013030834	3.287671232876712	08c677d0-87f5-500e-8280-fbdc3e062b56	173.0	60.0	released	97.91	TCGA-DK-A1A6_diagnosis	19554		M0	N1	Stage IV	T2a	6th	not reported	0	2020	e6152499-4c74-57ad-96f8-6f5675b3f06f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2008	TCGA-DK-A1A6_treatment	TCGA-DK-A1A6_treatment_1	released	51b3472f-52aa-50f3-b879-628927d48dd8	no	Radiation Therapy, NOS	released	f57320c7-d630-5945-9191-2c153a18cf9e	no	Pharmaceutical Therapy, NOS	b544ee3b-dad8-4f2d-8dbd-61082abdd94c
8efeb042-6349-482c-ab64-c1d096c8493c.htseq.counts.gz	f6b76ff6-1de1-4e04-b810-4580923571c4	TCGA-XF-AAMZ-01A-11R-A42T-07	TCGA-XF-AAMZ-01A-11R	TCGA-XF-AAMZ-01A-01-TSA		TCGA-XF-AAMZ-01A-11	TCGA-XF-AAMZ-01A	TCGA-XF-AAMZ	ed36d054-53c4-465c-bd84-6ec5227097bf	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2557	370.0	False	true	45680E92-721E-4332-9E45-7F134D7AFCAE	1.89	ccc9fcec-f07a-498b-9389-9c2b3aa0d2bf			0.17	23	released	fb985671-22b6-478d-883a-4e7b615b8308	RNA	R	0.17	UV Spec	released	False	2578fb8b-1e26-4dd5-92dd-acc1f2e605bc	11	2.0	1.0	0.0	4.0	0.0	15.0	85.0	85.0	TOP	dcd90b6c-cc46-4404-b575-df7a2dc02789	released												released	30.0	0c9c512c-0d91-4f83-b706-cac1127cdab0	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMZ_demographic	81	-29667	1348	f8dab56c-fbb7-5e9d-a507-f06195c188cf	not hispanic or latino	female	white	released	Dead	1926	2010	TCGA-XF-AAMZ_exposure	Not Reported	20.3125		454df293-77a5-5772-8f54-fac4b77775bf	160.0		released	52.0	TCGA-XF-AAMZ_diagnosis	29667		MX	N2	Stage IV	T3a	6th	not reported	0		dd213a6d-0366-5584-969c-b19b1390f240	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2007	TCGA-XF-AAMZ_treatment_1	TCGA-XF-AAMZ_treatment	released	e27c464c-73df-52fc-a54f-e718dd06e932	no	Pharmaceutical Therapy, NOS	released	c365f6e8-fd27-5e6d-8a8a-791d084b7e15	no	Radiation Therapy, NOS	f6b76ff6-1de1-4e04-b810-4580923571c4
69296a5e-7973-4812-bfa1-06fc937db65b.htseq.counts.gz	a55eca95-df20-456a-9e6d-24dde4424238	TCGA-CF-A3MG-01A-11R-A20F-07	TCGA-CF-A3MG-01A-11R	TCGA-CF-A3MG-01A-01-TS1		TCGA-CF-A3MG-01A-11	TCGA-CF-A3MG-01A	TCGA-CF-A3MG	39efa06a-ffe5-40b3-8f8a-a2d7071bc9e3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	158	500.0	False	true	DB1F9F51-DFAE-4A1E-9976-E63EE782149C	1.78	772b8a77-bb90-40a8-ad48-f7a1fc1769de			0.16	23	released	04762120-cf4b-49c5-9661-7baf51a5ec81	RNA	R	0.16	UV Spec	released	False	3cbc7f98-4c2b-4938-8958-f32930af29b8	11	2.0	1.0	1.0	1.0	0.0	9.0	90.0	90.0	TOP	42b7a804-04db-4e02-9a72-55a6d9b21d13	released												released	30.0	1acf91c8-4971-4893-ac27-64ea4a4c3023	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A3MG_demographic	48	-17600		a1738b79-9b11-5f33-8dcc-c4bf02aa06d1	not hispanic or latino	male	asian	released	Alive	1963		TCGA-CF-A3MG_exposure	Not Reported	20.244897959183675		28137aad-8507-513d-936a-18aeb4d1eaf6	175.0		released	62.0	TCGA-CF-A3MG_diagnosis	17600		M0	N0	Stage II	T2	7th	not reported	0	369	e7d97b8b-c916-5181-8ca4-a0ded94c9d7f	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-CF-A3MG_treatment_1	TCGA-CF-A3MG_treatment	released	7692bf06-4abb-50ed-a951-bda7805a8540	no	Pharmaceutical Therapy, NOS	released	766ac92f-d696-50c2-8f66-6275556d8a1c	no	Radiation Therapy, NOS	a55eca95-df20-456a-9e6d-24dde4424238
71976893-498b-481d-9f66-d9f6186d785b.htseq.counts.gz	ffe073db-6383-4b73-9c97-fce39f631e58	TCGA-K4-AAQO-01A-11R-A38B-07	TCGA-K4-AAQO-01A-11R	TCGA-K4-AAQO-01A-01-TSA		TCGA-K4-AAQO-01A-11	TCGA-K4-AAQO-01A	TCGA-K4-AAQO	383bf27a-9216-492e-b4bd-2b4eef8278de	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	332	660.0	False	true	30D1A38A-F0C3-46F6-BDB9-6C629E6E517E	1.81	9da50002-f2ba-4a66-8668-79386cf5ea4d			0.17	23	released	a31cc223-94e3-405d-8952-eb503cc828c2	RNA	R	0.17	UV Spec	released	False	b86518eb-8b39-47b6-b147-23f7e6f6c9ee	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	073818a8-3062-44a8-baf0-04b7207c9a97	released												released	30.0	46e17793-8469-406c-9d05-d18ded850721	Primary Tumor	01	released	Not Reported	released	TCGA-K4-AAQO_demographic	56	-20683		8d44da37-fa59-5686-ad73-19baa205a510	not hispanic or latino	male	white	released	Alive	1957		TCGA-K4-AAQO_exposure	Not Reported	30.864197530864196	2.356164383561644	4206a389-9658-51ee-a2ca-5f5de7ed6669	180.0	43.0	released	100.0	TCGA-K4-AAQO_diagnosis	20683	T3	MX	N0	Stage III	T3a	7th	not reported	0	359	25c83ece-f258-58f4-8ab6-ecd163f48f53	C67.3	not reported	8120/3	Transitional cell carcinoma	no	Yes	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2013	TCGA-K4-AAQO_treatment	TCGA-K4-AAQO_treatment_1	released	4b141137-99f5-58d0-922c-164665370d8e	not reported	Radiation Therapy, NOS	released	2ad99363-c28a-5e5d-bcd5-f250fe7c8aef	not reported	Pharmaceutical Therapy, NOS	ffe073db-6383-4b73-9c97-fce39f631e58
4aaf1fb2-b7e6-4857-b3ff-002d269b7f34.htseq.counts.gz	162b67c2-3c11-48d7-9829-5912ff04647e	TCGA-FD-A3SM-01A-11R-A22U-07	TCGA-FD-A3SM-01A-11R	TCGA-FD-A3SM-01A-01-TSA		TCGA-FD-A3SM-01A-11	TCGA-FD-A3SM-01A	TCGA-FD-A3SM	474582f2-8dec-4fbc-803f-4fd9ba2e0957	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	195	1830.0	False	true	CAA50B17-CBA3-4AE7-BBF7-BED1DD7A3040	2.06	ae3c4446-cb58-4b5b-9eb8-6c81e1bf4535			0.18	23	released	f9619e15-9cfa-409b-845b-ba596828d1c3	RNA	R	0.18	UV Spec	released	False	d9e2c695-3194-4db9-96d3-e787ce4d62e3	11	5.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	a975e694-8c4e-4cc7-88b3-60c7f722ed72	released												released	20.0	5f7de481-c011-43a8-844b-f47569499f0d	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SM_demographic	70	-25852	547	0fa14f82-5688-5460-8e10-3f63ed7a3b0e	not hispanic or latino	male	white	released	Dead	1941		TCGA-FD-A3SM_exposure	Not Reported	27.72747849705749	4.383561643835616	6e6f2c5f-582d-52ea-9761-caecf2acc146	188.0	80.0	released	98.0	TCGA-FD-A3SM_diagnosis	25852		M1	N2	Stage IV	T3a	7th	not reported	0	186	fbc6b16f-ff52-5ed2-aeae-c1848ec825d4	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2011	TCGA-FD-A3SM_treatment	TCGA-FD-A3SM_treatment_1	released	0423b6c2-3d5c-5f73-b625-885359301730	no	Radiation Therapy, NOS	released	49e58227-3bdd-5d08-b79b-6b93cf1c0123	yes	Pharmaceutical Therapy, NOS	162b67c2-3c11-48d7-9829-5912ff04647e
a804f24a-0285-403a-9783-293f16da1382.htseq.counts.gz	d9d4a30e-3c92-4c56-b337-c55a409e7536	TCGA-YC-A89H-01A-11R-A36F-07	TCGA-YC-A89H-01A-11R	TCGA-YC-A89H-01A-01-TS1		TCGA-YC-A89H-01A-11	TCGA-YC-A89H-01A	TCGA-YC-A89H	95520295-90d3-4b4e-86b6-4bd856723315	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	205	380.0	False	false	0E633B83-3C48-4D53-B7BF-EFE0BDF73DED	1.87	347ce226-e621-4492-a821-c990b5ef4ff3			0.15	23	released	1867a324-1b3e-46f8-9678-0a7587839037	RNA	R	0.15	UV Spec	released	False	65fa1c6f-8262-4b01-bd3c-34ab499fdccc	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	8a29e7bf-bcf8-4c00-84e2-7e728cc88d6b	released												released	30.0	e02f0582-9183-4e63-bfd5-48f7c1565daf	Primary Tumor	01	released	Not Reported	released	TCGA-YC-A89H_demographic	78	-28741		215a0087-cddd-58ef-945d-d450eda3a502	not hispanic or latino	female	white	released	Alive	1935		TCGA-YC-A89H_exposure	Not Reported	20.92746730083234	1.726027397260274	7ddfa051-7c4c-584d-9028-3715230083b3	145.0	31.5	released	44.0	TCGA-YC-A89H_diagnosis	28741	T2	MX		Stage II		7th	not reported	0	573	d7be7b0a-df4c-5f16-9f5f-083987ea6018	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-YC-A89H_treatment_1	TCGA-YC-A89H_treatment	released	85594e79-ca9e-5e7f-a51e-82085e1d6997	yes	Pharmaceutical Therapy, NOS	released	71e2b230-3f88-5165-98b7-2d50a40e302d	no	Radiation Therapy, NOS	d9d4a30e-3c92-4c56-b337-c55a409e7536
649c3bb0-8f5c-4371-b0ba-e1894aca8244.htseq.counts.gz	cf74ab23-dfd7-4a2e-8029-89aed6dba7a9	TCGA-GU-AATO-01A-11R-A39I-07	TCGA-GU-AATO-01A-11R	TCGA-GU-AATO-01A-01-TSA		TCGA-GU-AATO-01A-11	TCGA-GU-AATO-01A	TCGA-GU-AATO	cd20b968-b348-44eb-9cdb-f557af8fb468	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	193	130.0	False	true	3C79B07E-8985-4F42-BEE6-56D308603409	1.84	f680256f-f3be-4742-8211-6635de93f0b6			0.16	23	released	1b65cb23-8023-434f-8051-e7d9cd4359fb	RNA	R	0.16	UV Spec	released	False	e1b53080-a011-427e-978e-ac0bf27d6bf4	11	3.0	2.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	9bca5325-4bbd-47e0-a3ae-eca33847884b	released												released	30.0	98fe54ec-98a0-4257-a805-fe1840eab39d	Primary Tumor	01	released	Not Reported	released	TCGA-GU-AATO_demographic	75	-27684	324	7e0a90ce-9847-5bfc-8851-feaf3ea5bb0b	not hispanic or latino	male	white	released	Dead	1938	2013	TCGA-GU-AATO_exposure	Not Reported	20.98765432098765	1.095890410958904	e0c9a2e4-0bc9-5b0d-b95d-9a6c004d1438	180.0	20.0	released	68.0	TCGA-GU-AATO_diagnosis	27684	T2	MX	N2	Stage IV	T4a	7th	not reported	0		f33e0c25-495e-505d-bd05-b66b1cd28a93	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-GU-AATO_treatment	TCGA-GU-AATO_treatment_1	released	365d77da-2bb9-542d-aa65-281f465a5632	no	Radiation Therapy, NOS	released	d41523bd-ca32-5ad3-9862-7b9dedbf4b3c	no	Pharmaceutical Therapy, NOS	cf74ab23-dfd7-4a2e-8029-89aed6dba7a9
1e2b0984-d841-4916-8cc1-7fce179109f1.htseq.counts.gz	21d61fa9-7aa6-405c-868b-62ec332f8018	TCGA-DK-A6B6-01A-11R-A30C-07	TCGA-DK-A6B6-01A-11R	TCGA-DK-A6B6-01A-01-TSA		TCGA-DK-A6B6-01A-11	TCGA-DK-A6B6-01A	TCGA-DK-A6B6	ab6580e4-5de9-4361-b06a-1d20e5571890	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	549	100.0	False	true	D7E1CBFA-6E00-48AF-804D-6AD61CA65506	1.86	fa1f8758-485c-4148-87b7-af891f652f48			0.16	23	released	4c76cc7c-0041-4339-bf0c-998a7533634b	RNA	R	0.16	UV Spec	released	False	def5a78b-5a29-4d12-9489-1b07102c24e7	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	TOP	4c81815d-f990-4ae2-853b-230d4f3b0298	released												released	30.0	897b2691-b681-4a6f-9163-528c1ae5b228	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6B6_demographic	57	-21007		0bf7550e-4a42-5d2f-8a8c-7aa58db423b9	not hispanic or latino	male	white	released	Alive	1954		TCGA-DK-A6B6_exposure	Not Reported	34.020346148764695	0.3835616438356164	6ba2cda7-6ade-5aeb-abf4-5440404aff86	174.0	7.0	released	103.0	TCGA-DK-A6B6_diagnosis	21007	T2	MX	NX	Stage II		6th	not reported	0	1115	eb71c449-9958-5bed-9dcf-8dc1bc8274c2	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2011	TCGA-DK-A6B6_treatment	TCGA-DK-A6B6_treatment_1	released	27d65428-458e-5e26-bf1b-132c20195ba5	no	Radiation Therapy, NOS	released	d915c195-59eb-5f68-bf0b-a4186d1ff0e2	no	Pharmaceutical Therapy, NOS	21d61fa9-7aa6-405c-868b-62ec332f8018
70477533-7219-4548-8c32-0688b929de95.htseq.counts.gz	24551460-a4eb-45a6-aa3d-b94bd26f78d3	TCGA-ZF-AA5H-01A-11R-A39I-07	TCGA-ZF-AA5H-01A-11R	TCGA-ZF-AA5H-01A-01-TS1		TCGA-ZF-AA5H-01A-11	TCGA-ZF-AA5H-01A	TCGA-ZF-AA5H	04477379-6c51-45d9-b9b9-d05d53b53945	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	437	40.0	False	true	34430EB2-DC78-41EC-A4BD-9452B1B01C92	1.89	183e007a-dd95-4907-a19f-410a2da7f39b			0.18	23	released	a62f054a-2f5b-4db8-a455-b8f641eb6fa5	RNA	R	0.18	UV Spec	released	False	94f1bb57-a1b9-47fe-8829-73699936acef	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	9ee5ef24-45ba-4b51-b502-dd17611ded2d	released												released	30.0	e693d75f-e58e-4f53-a402-6936226fbc32	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA5H_demographic	60	-22122		02b833a4-ef76-5db1-9fd0-eda2ec32cb7f	not hispanic or latino	female	white	released	Alive	1952		TCGA-ZF-AA5H_exposure	Not Reported	30.863035868869733	0.4383561643835616	e114c0a5-9a89-534b-94de-a3a05668d00d	163.0	8.0	released	82.0	TCGA-ZF-AA5H_diagnosis	22122	T2	M0	N2	Stage IV	T3b	7th	not reported	0	897	d3f69411-0b93-518a-971c-660d876e2cb2	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-ZF-AA5H_treatment	TCGA-ZF-AA5H_treatment_1	released	65aee747-4f5f-582b-b9ac-c2b340da0721	no	Radiation Therapy, NOS	released	95026320-6ddf-58e5-b521-b26f015b055e	yes	Pharmaceutical Therapy, NOS	24551460-a4eb-45a6-aa3d-b94bd26f78d3
83db4be1-0adb-49ff-826d-190b6968a82e.htseq.counts.gz	b0277d63-ee4b-4463-9b21-34543584fc34	TCGA-BT-A2LA-01A-11R-A18C-07	TCGA-BT-A2LA-01A-11R	TCGA-BT-A2LA-01A-01-TSA		TCGA-BT-A2LA-01A-11	TCGA-BT-A2LA-01A	TCGA-BT-A2LA	797a71ee-372d-41e5-aeee-5ab3c4661110	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	257	160.0	False	true	872A05BE-966A-4757-9FED-9FD4FFA460CC	1.81	312ea080-3831-453d-aa8c-e466192c8309			0.17	23	released	b7b77c14-032f-4591-b6ba-a931eae7aba3	RNA	R	0.17	UV Spec	released	False	b3c34982-57bd-4030-9562-e3b362bfe811	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	90.0	TOP	28cc6a2e-8721-4deb-b8b5-035912e5ce11	released												released	30.0	6ed52558-8039-4658-a245-78a29968ce2f	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A2LA_demographic	54	-20032		70a21fca-4b6e-59a2-ae33-1dd8700fbd3e	not hispanic or latino	male	white	released	Alive	1956		TCGA-BT-A2LA_exposure	Not Reported		2.191780821917808	be514149-65ff-50b2-a5b2-41aee84e1361		40.0	released	95.0	TCGA-BT-A2LA_diagnosis	20032	T3a	M0	N0	Stage III	T3a	7th	not reported	0	522	44193ccb-a51c-5366-928c-c43c5a8284d3	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii	2010	TCGA-BT-A2LA_treatment	TCGA-BT-A2LA_treatment_1	released	c653406a-ba51-5d81-8677-3bce7f5fbf0e	no	Radiation Therapy, NOS	released	4c23359d-908e-5cd5-a1c6-79dcc1b87e59	yes	Pharmaceutical Therapy, NOS	b0277d63-ee4b-4463-9b21-34543584fc34
76ef0645-c851-47d9-912b-2b7d778ffca1.htseq.counts.gz	e4750d76-2220-41bb-837a-c1e154d53a00	TCGA-HQ-A5NE-01A-12R-A28M-07	TCGA-HQ-A5NE-01A-12R	TCGA-HQ-A5NE-01A-01-TS1		TCGA-HQ-A5NE-01A-12	TCGA-HQ-A5NE-01A	TCGA-HQ-A5NE	e053a911-2202-4c1f-bc93-904e26564e79	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		330.0	False	false	464FAAEC-5FEB-4544-8B28-46559A81A09A	1.77	6621636c-4a29-4ad3-99bc-406b1820d063			0.16	23	released	e1049a17-223e-43db-8de3-51894317175c	RNA	R	0.16	UV Spec	released	False	439c7eb2-a76a-4ba7-a437-01f0eddc3b88	12	25.0	0.0	5.0	5.0	4.0	46.0	45.0	65.0	TOP	da5606e5-1a12-431a-82f3-9038be2dcde6	released												released	30.0	73a76b8a-ba29-459a-8395-3068a3a9b5ce	Primary Tumor	01	released	Not Reported	released	TCGA-HQ-A5NE_demographic	57	-20647	370	7a7653e8-8c66-586f-b87c-139052ee36c0	not reported	male	not reported	released	Dead			TCGA-HQ-A5NE_exposure	Not Reported	20.244897959183675	4.383561643835616	f8938314-9406-5416-9f63-5dea8be9aa02	175.0	80.0	released	62.0	TCGA-HQ-A5NE_diagnosis	20647	T3	M0	N0	Stage III	T3	6th	not reported	0	250	054768cc-3570-544f-9acb-2da4fe48978a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii		TCGA-HQ-A5NE_treatment_1	TCGA-HQ-A5NE_treatment	released	b9bfc6f1-fcdc-5cac-8116-58c6fb83b2c8	no	Pharmaceutical Therapy, NOS	released	4e880206-393f-5bb7-80de-396342445e91	yes	Radiation Therapy, NOS	e4750d76-2220-41bb-837a-c1e154d53a00
c9520c73-df8d-44a0-a1e5-e5d70695b002.htseq.counts.gz	08d8d94d-ec0e-473f-90c6-122f1d033210	TCGA-FD-A5BT-01A-11R-A26T-07	TCGA-FD-A5BT-01A-11R	TCGA-FD-A5BT-01A-01-TSA		TCGA-FD-A5BT-01A-11	TCGA-FD-A5BT-01A	TCGA-FD-A5BT	cc2350ca-9220-400d-8b76-cc36d26f68d6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	447	910.0	False	true	B5902DC7-953C-4944-B555-534BEDE6A248	1.84	31fbf484-2cee-49a8-bf99-6c1b9d721b57			0.16	23	released	ef37d9aa-3fcf-4884-af68-9fbd9427048e	RNA	R	0.16	UV Spec	released	False	144ab216-5076-4d99-9c5b-d02fe33fb9d8	11	5.0	2.0	0.0	4.0	0.0	30.0	70.0	70.0	TOP	0ad587b7-992d-4914-b58e-9a01eac31e7e	released												released	30.0	3fb8f48e-ccfd-4feb-b247-d6710dfaeca1	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BT_demographic	84	-30686	328	c02415ca-104f-5e73-8ca2-48dc3fe7473d	not hispanic or latino	male	white	released	Dead	1927	2011	TCGA-FD-A5BT_exposure	Not Reported	22.634676324128563	2.191780821917808	fc2dd6f0-581e-5427-a445-fadb6a89ecc5	188.0	40.0	released	80.0	TCGA-FD-A5BT_diagnosis	30686		MX	N0	Stage III	T3b	7th	not reported	0		e0aff0ac-7a60-5c7a-a946-e944f88fd735	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2011	TCGA-FD-A5BT_treatment	TCGA-FD-A5BT_treatment_1	released	5af1762d-fcb4-5f76-a902-352adbcb89da	no	Radiation Therapy, NOS	released	42121bb5-71d1-5782-945e-6b4daf5ade89	no	Pharmaceutical Therapy, NOS	08d8d94d-ec0e-473f-90c6-122f1d033210
5b341f38-0882-4a42-814b-bb8d614d82e7.htseq.counts.gz	86f9eea0-7b1f-49aa-9385-9d32a8027ab1	TCGA-DK-A3IQ-01A-31R-A32Y-07	TCGA-DK-A3IQ-01A-31R	TCGA-DK-A3IQ-01A-03-TSC		TCGA-DK-A3IQ-01A-31	TCGA-DK-A3IQ-01A	TCGA-DK-A3IQ	e44f60ec-66c4-45a2-a003-0a1faf1d6e03	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	230	280.0	False	true	11C9802C-072A-4B09-96FB-0CAC21BF43D8	1.79	b68f9935-3265-4930-a221-61bc9f8e2eda			0.16	23	released	f433b28b-9290-41c1-b531-7ad0809c9954	RNA	R	0.16	UV Spec	released	False	2244ae59-2c0d-45fa-a47e-240077804145	31	2.0	0.0	0.0	0.0	20.0	5.0	75.0	75.0	TOP	54e0c00c-2d39-4256-adc3-5c2f1088495c	released												released	30.0	1e375786-db8f-4a8c-ba1c-c6dd7de1a9be	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IQ_demographic	74	-27194	539	a2870f04-5c86-55c7-b80c-15898c291642	not hispanic or latino	male	white	released	Dead	1937		TCGA-DK-A3IQ_exposure	Not Reported	25.19295666410505	2.191780821917808	0c746719-8d70-554f-b01c-3405c1c19463	173.0	40.0	released	75.4	TCGA-DK-A3IQ_diagnosis	27194		M0	N0	Stage III	T3	6th	not reported	0	319	b61ff74e-8858-5979-a67a-37346b38e5c4	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2011	TCGA-DK-A3IQ_treatment	TCGA-DK-A3IQ_treatment_1	released	a0949da4-f565-583c-a7cc-f90c9be0b88b	no	Radiation Therapy, NOS	released	17521ad8-0f46-5abd-b6fd-c064c251b69a	yes	Pharmaceutical Therapy, NOS	86f9eea0-7b1f-49aa-9385-9d32a8027ab1
9da3bf7e-e8b8-4a33-9746-9febc35b2b93.htseq.counts.gz	02029bc6-5208-4238-9390-082a9fdbf82b	TCGA-ZF-AA4X-01A-11R-A38B-07	TCGA-ZF-AA4X-01A-11R	TCGA-ZF-AA4X-01A-01-TS1		TCGA-ZF-AA4X-01A-11	TCGA-ZF-AA4X-01A	TCGA-ZF-AA4X	e6f7bf6c-92b1-4795-94fc-b189d0c7877f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1603	60.0	False	true	56AEE38E-1301-436B-91CE-BCDB523A56E5	1.83	1dac1d16-2bc6-44db-b05a-30e8f2fb703f			0.17	23	released	1068fe68-a315-41e0-b49f-28b21815a80f	RNA	R	0.17	UV Spec	released	False	69328b14-dc2b-4e08-a3d2-45c449590270	11	0.0	0.0	20.0	0.0	0.0	10.0	70.0	90.0	TOP	3768e040-460d-48b4-a774-e52d1f9777bf	released												released	30.0	e332926d-4997-4beb-8f39-97aee0408809	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4X_demographic	56	-20579		d671992e-935b-5950-8a74-6803cf7fbcbd	not hispanic or latino	male	white	released	Alive	1953		TCGA-ZF-AA4X_exposure	Not Reported	23.836734693877553		a1070f9d-0a0b-5cbb-a2e8-4564ad06917e	175.0		released	73.0	TCGA-ZF-AA4X_diagnosis	20579	T2	M0	NX	Stage II	T2	6th	not reported	0	2044	0d414c16-d00d-53b9-b93a-1ebf79817719	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-ZF-AA4X_treatment	TCGA-ZF-AA4X_treatment_1	released	547c8655-0ffc-590f-9ad4-efb2399bec27	yes	Radiation Therapy, NOS	released	b19d03ba-a299-5d4e-85b0-37ab264ef9e4	yes	Pharmaceutical Therapy, NOS	02029bc6-5208-4238-9390-082a9fdbf82b
dcbd5bcd-4a10-4e8b-bbe3-91682845c7db.htseq.counts.gz	a0b085c8-9c4a-434d-86e8-118cb5db7a9f	TCGA-GD-A3OQ-01A-32R-A220-07	TCGA-GD-A3OQ-01A-32R	TCGA-GD-A3OQ-01A-03-TS3		TCGA-GD-A3OQ-01A-32	TCGA-GD-A3OQ-01A	TCGA-GD-A3OQ	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	297	280	False	false	E507237E-8A43-45E8-88CC-0AA7C62029E6	1.82	61b0add8-ad93-4f2a-a95b-fa257934962f	2.08	13	0.16	23	released	4aeb7870-dd44-49bd-8aa0-d281286e5fd1	RNA	R	0.16	UV Spec	released	False	60d6090f-f171-4074-98dc-c45b68356ca9	32	1	0	0	0	0	0	100	95	TOP	91737bff-dc42-4bfa-89c6-baa3c7bd3c70	released												released	20	e3d22638-c0ae-48aa-a523-8c9a6cfbf063	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A3OQ_demographic	48	-17682		def9d36b-00cd-5135-bae9-2f44cba27d54	not hispanic or latino	male	white	released	Alive	1963		TCGA-GD-A3OQ_exposure	Not Reported		1.6986301369863013	eb45ba1b-25d4-5588-af1f-aeef4768c855		31.0	released		TCGA-GD-A3OQ_diagnosis	17682	T2	MX	N1	Stage IV	T4a	7th	not reported	0	95	06be2b44-a613-51e1-8888-5bba9ffea8a0	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A3OQ_treatment	TCGA-GD-A3OQ_treatment_1	released	bfe3ffeb-5263-50dd-8fa1-2dff3b591255	not reported	Radiation Therapy, NOS	released	2b12a9f0-d64c-56b8-b8a9-4904e3c55e09	not reported	Pharmaceutical Therapy, NOS	a0b085c8-9c4a-434d-86e8-118cb5db7a9f
82447a0a-1a26-4042-b376-f96b3e1fe3c1.htseq.counts.gz	f686b453-072b-4183-af7a-d80c53b7c632	TCGA-ZF-AA51-01A-21R-A39I-07	TCGA-ZF-AA51-01A-21R	TCGA-ZF-AA51-01A-02-TS2		TCGA-ZF-AA51-01A-21	TCGA-ZF-AA51-01A	TCGA-ZF-AA51	1029514b-a32c-4c43-a440-a5ba2709f717	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1479	130.0	False	true	F2059BDD-0218-47A9-BBA8-BFE95D1CD55E	1.9	1be3a1d1-1300-4d9f-86d1-4b5faf7241fb			0.17	23	released	a8679413-b728-44b8-9890-a43a94cfd1ef	RNA	R	0.17	UV Spec	released	False	bb88f51c-8156-4242-b0c1-a4408f3c6c03	21	90.0	10.0	10.0	0.0	0.0	30.0	60.0	70.0	TOP	6ed8e11f-847e-49c8-8e39-2c5c73245874	released												released	30.0	71eb8fff-9d34-4727-9dbe-448297379ee8	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA51_demographic	69	-25484		e2828c27-a13f-575d-9b6f-5ea248af133b	not hispanic or latino	female	white	released	Alive	1940		TCGA-ZF-AA51_exposure	Not Reported	24.32322868339264	2.0821917808219177	213724c6-3523-5e23-b705-e7cd823211d2	149.0	38.0	released	54.0	TCGA-ZF-AA51_diagnosis	25484	T2	M0	NX	Stage II	T2	6th	not reported	0	1714	90d91715-3969-50e7-9473-7b91822f0dd9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-ZF-AA51_treatment_1	TCGA-ZF-AA51_treatment	released	0390b070-3dc5-5de6-9c91-f7f3de45ba3c	yes	Pharmaceutical Therapy, NOS	released	bb6f7410-aed5-5ac0-88c0-a6dd60713811	no	Radiation Therapy, NOS	f686b453-072b-4183-af7a-d80c53b7c632
fc2f3a9d-d7b4-4bef-9474-a892d77d4124.htseq.counts.gz	85a73e79-85f3-4ef5-9a7e-20f07bf72218	TCGA-FD-A3SL-01A-21R-A22U-07	TCGA-FD-A3SL-01A-21R	TCGA-FD-A3SL-01A-02-TSB		TCGA-FD-A3SL-01A-21	TCGA-FD-A3SL-01A	TCGA-FD-A3SL	4570b6e2-d430-41ca-aab1-ce4d14c36463	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	322	920	False	true	60008E3E-7CD4-4DB5-83C0-3273B7F962F6	1.79	d692892d-d63b-4ac2-9627-ae255ab17cab	1.95	13	0.15	23	released	c8b70d02-05dd-4dbf-b26e-b201b61949dd	RNA	R	0.15	UV Spec	released	False	0c93f88b-d658-4c03-bbd0-255678d114fc	21	3	0	0	0	0	25	75	75	TOP	56798312-194a-41f5-b415-7063f3ab1dcb	released												released	30	0a1e88e0-3593-40ba-86e5-751074885578	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SL_demographic	60	-22020	712	c7d1426a-3604-5823-b3f3-d47efb1fca30	not hispanic or latino	male	white	released	Dead	1951		TCGA-FD-A3SL_exposure	Not Reported	34.638239421899726		4d0ea27a-3dff-5f35-a75f-a7815ad3abfd	183.0		released	116.0	TCGA-FD-A3SL_diagnosis	22020		M1	N2	Stage IV	T4a	7th	not reported	0	683	436d78eb-f26a-5f10-94ce-3dd51f75944a	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2011	TCGA-FD-A3SL_treatment	TCGA-FD-A3SL_treatment_1	released	8733e633-8da6-58e2-b652-59d941aa2102	no	Radiation Therapy, NOS	released	9d0d86f0-5405-598f-b0c3-58c9bf450682	yes	Pharmaceutical Therapy, NOS	85a73e79-85f3-4ef5-9a7e-20f07bf72218
ad1d63e4-abf1-43db-95ce-09ee88d6ef2e.htseq.counts.gz	0e3cacde-8f6d-48a5-a77c-1489b29f236f	TCGA-BT-A42E-01A-11R-A23W-07	TCGA-BT-A42E-01A-11R	TCGA-BT-A42E-01A-01-TSA		TCGA-BT-A42E-01A-11	TCGA-BT-A42E-01A	TCGA-BT-A42E	8d434cfb-2414-4d93-bf79-7b957bf040db	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	143	240.0	False	true	5613DDA8-5440-428C-B12B-C4A8814139F2	1.45	f89742f4-3575-4dd4-860f-ea9ab0321a48			0.18	23	released	46dd1704-36c3-4b78-b376-60500e899bb8	RNA	R	0.18	UV Spec	released	False	ae6dc1f6-afef-4bff-864d-f21be23b889d	11	7.0	2.0	3.0	3.0	0.0	27.0	70.0	70.0	TOP	ac69de89-cf3d-47c0-ba10-d6ecc3fce8bf	released												released	30.0	b19a7c0e-bcf9-46f4-899d-1e68407a206b	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A42E_demographic	74	-27045		fc36115c-f9b1-5b60-b4d9-19fd9a83f79c	not hispanic or latino	male	white	released	Alive	1938		TCGA-BT-A42E_exposure	Not Reported	28.719723183391004	2.73972602739726	fdae60ff-0476-5c3b-8816-25bf781326c2	170.0	50.0	released	83.0	TCGA-BT-A42E_diagnosis	27045	T3a	M0	N0	Stage III	T3a	7th	not reported	0	1108	81868eb4-2f71-5e17-985b-63370f7cc799	C67.4	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-BT-A42E_treatment_1	TCGA-BT-A42E_treatment	released	56ed2159-601d-5c96-9d77-e7d86bc3d4a5	yes	Pharmaceutical Therapy, NOS	released	a61220d0-456c-546e-be0d-d9eba36d5925	no	Radiation Therapy, NOS	0e3cacde-8f6d-48a5-a77c-1489b29f236f
1feeca15-6ac2-4db2-b667-1a4a65f9a5de.htseq.counts.gz	e391906e-fe0f-4daa-873a-b595f927b42f	TCGA-ZF-A9R0-01A-11R-A38B-07	TCGA-ZF-A9R0-01A-11R	TCGA-ZF-A9R0-01A-01-TSA		TCGA-ZF-A9R0-01A-11	TCGA-ZF-A9R0-01A	TCGA-ZF-A9R0	5b39a0dc-8ab2-46c6-95c7-65df919ebc76	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	309	270.0	False	true	A69288AE-85B5-4041-A601-A7ACDBCBBEB2	1.88	d3eb9aa5-5e03-4c8d-88be-461184059d53			0.16	23	released	75d1867c-4a44-40ff-bc9b-52e16340bdcf	RNA	R	0.16	UV Spec	released	False	a310e1e3-24e0-4df5-9686-a0325e654f0c	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	71ded9de-da77-43c0-aca8-efd833545143	released												released	30.0	770c9b75-a491-4223-8038-6e0c9def9761	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R0_demographic	82	-30222	680	5aa691f8-e6e8-52c3-a2ca-16c423a6e234	not hispanic or latino	male	white	released	Dead	1931		TCGA-ZF-A9R0_exposure	Not Reported	27.04164413196322	0.273972602739726	28cf68ad-36ff-5a11-a27f-9fd9f0081e45	172.0	5.0	released	80.0	TCGA-ZF-A9R0_diagnosis	30222	T2	M0	NX	Stage III	T3b	7th	not reported	0	567	c4e91821-3aea-50ed-8ca4-2e9bc76f24f7	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2013	TCGA-ZF-A9R0_treatment	TCGA-ZF-A9R0_treatment_1	released	504e6426-02c9-5864-a2b9-787de4c82da5	no	Radiation Therapy, NOS	released	ef5d8296-e33a-524a-8221-edf286cf1c99	no	Pharmaceutical Therapy, NOS	e391906e-fe0f-4daa-873a-b595f927b42f
f84433d3-7588-4b84-b8ef-aade7becf0a6.htseq.counts.gz	1abe4db7-276a-48eb-97e8-484d3eca28e2	TCGA-DK-AA6R-01A-11R-A42T-07	TCGA-DK-AA6R-01A-11R	TCGA-DK-AA6R-01A-01-TSA		TCGA-DK-AA6R-01A-11	TCGA-DK-AA6R-01A	TCGA-DK-AA6R	5db4b168-a6ba-482c-b067-2274eba96aad	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	4591	340.0	False	true	4A588484-5C6C-4ACF-8AA6-8BE9F1AE804C	1.88	0ccf81b2-c760-4a37-acf1-c692868167b1			0.16	23	released	01045928-43e2-4b14-96dc-7eea95c175ec	RNA	R	0.16	UV Spec	released	False	b6a1bebd-2995-4780-b8d3-5e13907d520d	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	260432ab-829e-4040-8109-18471bb0202c	released												released	30.0	82bc393c-5391-497a-a0dc-41c077ae9c40	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6R_demographic	68	-25196		01998005-a43c-5ce1-95c9-83ecfec34f6c	not hispanic or latino	male	white	released	Alive	1933		TCGA-DK-AA6R_exposure	Not Reported	24.441802087462015	3.0136986301369864	bb6a48ac-fa26-57e6-953e-cdc709b03717	174.0	55.0	released	74.0	TCGA-DK-AA6R_diagnosis	25196		M0	N1	Stage IV	T4	5th	not reported	0	5041	1b1a6ccd-e251-5407-a882-685a6250fdc6	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2001	TCGA-DK-AA6R_treatment_1	TCGA-DK-AA6R_treatment	released	610d5fa1-daea-5433-a350-c24327669b3c	yes	Pharmaceutical Therapy, NOS	released	66288269-9500-5ec9-885a-5ecd83efd1eb	no	Radiation Therapy, NOS	1abe4db7-276a-48eb-97e8-484d3eca28e2
16ac1a9e-3ae4-4fa6-9fff-e0efaaabe9c9.htseq.counts.gz	f7d60758-9c20-4c3f-ba7e-97143e832201	TCGA-CF-A9FH-01A-11R-A38B-07	TCGA-CF-A9FH-01A-11R	TCGA-CF-A9FH-01A-01-TSA		TCGA-CF-A9FH-01A-11	TCGA-CF-A9FH-01A	TCGA-CF-A9FH	83a369ae-003b-432b-a7b2-c630805b43c1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	97	270.0	False	true	3F6B75DD-B8BE-42A1-AF6A-73B030EDD6FD	1.91	1e7def5c-75f1-471d-9fab-b7e350c794a8			0.18	23	released	49fc03d0-b2fb-4446-a614-dd84804eafc3	RNA	R	0.18	UV Spec	released	False	574228a4-951f-4b18-838c-2a0131e6e5af	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	a5639809-440e-4b8a-a06e-416f418123c4	released												released	30.0	8688b33d-76b7-4223-b647-d9b893d94041	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A9FH_demographic	85	-31236		4eae84b6-4952-5ba9-9ab4-49aab283b882	not hispanic or latino	male	asian	released	Alive	1928		TCGA-CF-A9FH_exposure	Not Reported	21.303948576675847	4.383561643835616	b6af7eea-f9c3-5e48-b7a3-772436d9337b	165.0	80.0	released	58.0	TCGA-CF-A9FH_diagnosis	31236		M0	N0	Stage II	T2	6th	not reported	0	-64	e111f9bb-4935-5d7c-8fe5-af3adbbe0f6c	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-CF-A9FH_treatment_1	TCGA-CF-A9FH_treatment	released	1dfbf1c2-173e-5790-9acb-28127248e419	no	Pharmaceutical Therapy, NOS	released	84fe61c4-54b3-57e0-822a-5fbe7397425c	no	Radiation Therapy, NOS	f7d60758-9c20-4c3f-ba7e-97143e832201
0f667075-ffca-4598-bfd1-51cfa2c3d426.htseq.counts.gz	fbbff7d9-5dda-4bed-a87d-6882c893a492	TCGA-KQ-A41N-01A-11R-A33J-07	TCGA-KQ-A41N-01A-11R	TCGA-KQ-A41N-01A-01-TSA		TCGA-KQ-A41N-01A-11	TCGA-KQ-A41N-01A	TCGA-KQ-A41N	67cadffc-460b-4a2a-b182-3794421992b4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	555	760.0	False	true	3C2A6E9E-9C14-40F5-BD61-7BF5FF26ECC3	1.83	2d83d812-8f9b-443b-8643-dd3104b5068e			0.17	23	released	8a74f643-6c4d-4fc3-ab28-456f7ea5e0a2	RNA	R	0.17	UV Spec	released	False	8f18f29a-2349-4e47-b7a9-396f16dd1706	11	2.0	0.0	0.0	0.0	0.0	15.0	85.0	85.0	TOP	0325399a-0ac8-4fe3-b09f-3352a8b0fb0e	released												released	30.0	85d9b3ae-d14a-445f-83bf-e4a9f9b076b8	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41N_demographic	73	-26837		d79ddde0-9404-5197-a7b0-7ce7a72e76a7	not hispanic or latino	male	black or african american	released	Alive	1938		TCGA-KQ-A41N_exposure	Not Reported	24.543462381300216	2.73972602739726	81aaedad-38c5-578b-83b1-c15de25e87fb	185.0	50.0	released	84.0	TCGA-KQ-A41N_diagnosis	26837	T2b	M0	N0	Stage III	T3b	7th	not reported	0	1604	99b0aebe-42bd-56fa-82e6-0aeac049daf1	C67.6	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Ureteric orifice	released	No	Ureteric orifice	not reported	stage iii	2011	TCGA-KQ-A41N_treatment_1	TCGA-KQ-A41N_treatment	released	f1cd5049-d3d0-519a-9665-16828b9a7d9b	no	Pharmaceutical Therapy, NOS	released	10c29ce4-46c0-54ef-ace5-3eca67b49512	no	Radiation Therapy, NOS	fbbff7d9-5dda-4bed-a87d-6882c893a492
84367da1-27f9-4b44-95e5-0b0f3a4610a9.htseq.counts.gz	87cb5651-7b70-49a2-88cc-f4896390441e	TCGA-E7-A3Y1-01A-11R-A22U-07	TCGA-E7-A3Y1-01A-11R	TCGA-E7-A3Y1-01A-01-TSA		TCGA-E7-A3Y1-01A-11	TCGA-E7-A3Y1-01A	TCGA-E7-A3Y1	f7c891eb-3b09-4e01-bb8a-53d570518cbe	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	101	850	False	true	015FB5A9-F21F-48CC-9EDA-43952CE358B7	1.78	791a46e8-4d45-4878-b09d-a4f64ce88746	2.08	13	0.16	23	released	d2fc5264-a3ec-4d3b-9817-06703ae6431a	RNA	R	0.16	UV Spec	released	False	46aef758-1656-4417-a994-dbd25d7b7765	11	2	0	2	0	0	13	85	95	TOP	2b66ed26-b1f7-42bd-84e9-b2615c4177bd	released												released	30	fabe5b98-4586-445d-9513-598bb7fd1909	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A3Y1_demographic	57	-20917		a081f8c5-3ca2-5387-ba22-db4bbc029d45	not hispanic or latino	male	white	released	Alive	1955		TCGA-E7-A3Y1_exposure	Not Reported	27.7176852352623		030f924f-1dab-551c-b00c-b1be44943d71	172.0		released	82.0	TCGA-E7-A3Y1_diagnosis	20917	T2a	M0	N0	Stage II		7th	not reported	0	163	82b8f2a8-2738-50ef-8bea-329fbc672e24	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A3Y1_treatment	TCGA-E7-A3Y1_treatment_1	released	b7777dcd-b953-56e4-bd17-8eb0a4308c98	yes	Radiation Therapy, NOS	released	5b8d832b-9cd5-57f7-a541-3b9c54b2340b	no	Pharmaceutical Therapy, NOS	87cb5651-7b70-49a2-88cc-f4896390441e
baccbbdd-01b9-4b53-b951-81a65e64ebcf.htseq.counts.gz	420a835f-286d-442d-bb60-60a2b2127611	TCGA-XF-A9T2-01A-11R-A42T-07	TCGA-XF-A9T2-01A-11R	TCGA-XF-A9T2-01A-01-TSA		TCGA-XF-A9T2-01A-11	TCGA-XF-A9T2-01A	TCGA-XF-A9T2	aa6b44ab-14b1-4b5d-8679-ba958b546afa	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2288	460.0	False	true	71F04D3B-0CA3-4CB3-9E94-E082F37C4097	1.88	5ca8593d-7217-476e-ae05-aa22fd11c332			0.17	23	released	a6f80e97-6fe3-4978-a73e-22919d1350f2	RNA	R	0.17	UV Spec	released	False	0d259306-a4ef-4ed4-ac87-ab9f6627261d	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	1039fe50-8e71-4437-838c-211fdb022fec	released												released	30.0	3cae49a3-6deb-40f9-84cc-68b9b53543ff	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T2_demographic	54	-19945	575	1aac108e-447c-53e5-9b96-4de33b29b909	not hispanic or latino	male	white	released	Dead	1953	2008	TCGA-XF-A9T2_exposure	Not Reported	33.16795043995504		33880b71-8005-51f4-95cd-14dffb0b1e60	191.0		released	121.0	TCGA-XF-A9T2_diagnosis	19945		MX	N0	Stage III	T3b	5th	not reported	0		dae66a76-14b8-5b94-99c2-b1363e255d95	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2007	TCGA-XF-A9T2_treatment_1	TCGA-XF-A9T2_treatment	released	bb23e7dd-a968-59d8-8e41-6e84a9e9e1fe	no	Pharmaceutical Therapy, NOS	released	3f132ff1-276c-58a8-8af1-5c95a1551b38	no	Radiation Therapy, NOS	420a835f-286d-442d-bb60-60a2b2127611
82abc0b9-e214-467e-8412-3b5cb7187e10.htseq.counts.gz	5361732a-6ed4-4339-801b-2101e9853fbc	TCGA-GU-AATP-01A-11R-A39I-07	TCGA-GU-AATP-01A-11R	TCGA-GU-AATP-01A-01-TS1		TCGA-GU-AATP-01A-11	TCGA-GU-AATP-01A	TCGA-GU-AATP	3b16881a-88c2-4048-b78f-e3e183503f70	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	594	140.0	False	true	6E966861-6052-4F99-8BD5-0835BAE0179D	1.87	6f3b244b-47b9-4af4-85c5-0051f6688aa8			0.17	23	released	94821537-d5a6-4d30-b018-da007fff32a8	RNA	R	0.17	UV Spec	released	False	ac3926c1-b35c-4a80-980f-74418d516076	11	3.0	2.0	0.0	5.0	0.0	20.0	80.0	80.0	TOP	b107bfb5-1821-4a07-a6d6-14db872304c1	released												released	30.0	c9320b64-3928-4a33-a20d-c491a9fb8872	Primary Tumor	01	released	Not Reported	released	TCGA-GU-AATP_demographic	74	-27049		35c3e0a7-8086-5e9c-a0ec-98622b7c9ec6	not hispanic or latino	male	white	released	Alive	1938		TCGA-GU-AATP_exposure	Not Reported	34.47772096420745	0.7671232876712328	d736c4cb-52f2-558d-896c-d2db7f5d0ced	185.0	14.0	released	118.0	TCGA-GU-AATP_diagnosis	27049	T1	MX	N2	Stage IV	T2	7th	not reported	0	1003	e4a9cde6-7172-5e93-a3b0-bb1eb50875bd	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2012	TCGA-GU-AATP_treatment_1	TCGA-GU-AATP_treatment	released	a8b3706f-04af-504e-a82e-e9246cbdacd6	yes	Pharmaceutical Therapy, NOS	released	aba5ed09-d1e4-5f35-b819-0e7d37c7785d	no	Radiation Therapy, NOS	5361732a-6ed4-4339-801b-2101e9853fbc
b6cc1a11-1805-4e41-8d7e-190c25609c17.htseq.counts.gz	85d1d5b6-b447-4606-ba9a-55445d72111c	TCGA-UY-A78O-01A-12R-A33J-07	TCGA-UY-A78O-01A-12R	TCGA-UY-A78O-01A-01-TSA		TCGA-UY-A78O-01A-12	TCGA-UY-A78O-01A	TCGA-UY-A78O	4319aa02-6d8b-4cb8-b4e4-c4eed1cb2ac7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		240.0	False	true	139E5F15-194A-451A-83D7-919C657C08A3	1.92	2480ce78-21a7-4717-8b08-8176d9fe6834			0.17	23	released	33a3e1d8-2268-43f7-9053-53b24c9870a6	RNA	R	0.17	UV Spec	released	False	90885a1f-de62-42e9-8b2f-d1777d69d098	12	3.0	1.0	7.0	5.0	0.0	23.0	70.0	70.0	TOP	92164516-9028-4b88-90b8-b985b75f461a	released												released	30.0	9b7bb0f3-020c-422e-959d-ce87e94e5f82	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78O_demographic	75	-27234		8f4fc737-af3a-5cec-9454-73ec65af1565	not hispanic or latino	female	white	released	Alive			TCGA-UY-A78O_exposure	Not Reported	46.29451024266039		83c65e84-b1d5-542f-9a2b-c7f52d93c962	161.0		released	120.0	TCGA-UY-A78O_diagnosis	27234		MX	N0	Stage II	T2	6th	not reported	0	2312	7e7ced3f-01ef-51a4-9cd7-21561d0d66b3	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii		TCGA-UY-A78O_treatment_1	TCGA-UY-A78O_treatment	released	3de1df9d-92bc-5273-9821-af0feba3ea48	no	Pharmaceutical Therapy, NOS	released	d481ce22-4896-571d-b63a-c8b783c27ddf	no	Radiation Therapy, NOS	85d1d5b6-b447-4606-ba9a-55445d72111c
c7458649-6ea8-48bb-936e-628aebeba07c.htseq.counts.gz	ee6436e0-fe19-4abc-8e5b-04158c9ef460	TCGA-ZF-A9R3-01A-11R-A38B-07	TCGA-ZF-A9R3-01A-11R	TCGA-ZF-A9R3-01A-01-TS1		TCGA-ZF-A9R3-01A-11	TCGA-ZF-A9R3-01A	TCGA-ZF-A9R3	ab77b411-4df2-4e3a-bfad-946e8bb1fa70	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	499	90.0	False	true	1B5918AB-3C48-405C-BE7F-348E3907060C	1.65	a5a9f82f-f3f4-47dc-9dcd-6b65c1c73a37			0.18	23	released	4be51905-1f0a-4326-93c2-8a77139c33c5	RNA	R	0.18	UV Spec	released	False	00b9a7be-3316-4995-be1e-66f7939c2d29	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	5e2a92bb-75b7-4882-b69b-db9b9a06c4af	released												released	30.0	67f0eda5-8a34-4a44-9b22-474875607617	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R3_demographic	53	-19384	949	9a632a3d-4318-54c6-a6d5-d359bb369c32	not hispanic or latino	female	white	released	Dead	1959		TCGA-ZF-A9R3_exposure	Not Reported	46.3821892393321	1.5890410958904109	4fbba723-2fc2-57bf-8711-0f434cf4da26	154.0	29.0	released	110.0	TCGA-ZF-A9R3_diagnosis	19384	T2	M0	NX	Stage II	T2	7th	not reported	0	734	691c99e8-bc7a-5891-8b8b-8ca143efae08	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-ZF-A9R3_treatment_1	TCGA-ZF-A9R3_treatment	released	cd7669b4-4f82-5562-b63a-d035c724630c	no	Pharmaceutical Therapy, NOS	released	3b352f6d-577f-5702-8e0f-20f0899a7ad9	no	Radiation Therapy, NOS	ee6436e0-fe19-4abc-8e5b-04158c9ef460
c5178a93-2f1b-4e20-b86c-97929a9dec68.htseq.counts.gz	f00682e2-05d3-4525-9856-e68d874c55ed	TCGA-CF-A1HS-01A-11R-A13Y-07	TCGA-CF-A1HS-01A-11R	TCGA-CF-A1HS-01A-01-TSA		TCGA-CF-A1HS-01A-11	TCGA-CF-A1HS-01A	TCGA-CF-A1HS	a73c0842-39c5-4c2c-aa6a-f31341a4f36e	Squamous Cell Neoplasms	Bladder	TCGA-BLCA	56	570.0	False	true	48DB8720-833D-467C-8BF2-95EF539B4D5E	1.88	7206d218-0e58-4722-8566-cbcbd8b8b4e0			0.15	23	released	14cf8337-520e-4dbc-a1e5-9be8440f038c	RNA	R	0.15	UV Spec	released	False	61c9c41c-3bb1-4481-8f26-e282c4903177	11	15.0	0.0	0.0	0.0	0.0	35.0	65.0	65.0	TOP	70beafdb-4d00-45a5-a6ff-cb7d2cbc83af	released												released	30.0	0a01e5ba-5549-4027-9e84-1bbb163a8f07	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A1HS_demographic	75	-27565		ac5a044f-a37e-5c78-8178-3393a3667f2b	not hispanic or latino	female	asian	released	Alive	1935		TCGA-CF-A1HS_exposure	Not Reported	21.926125822229718		6b566909-a891-594c-bda3-b9724f0933e8	154.0		released	52.0	TCGA-CF-A1HS_diagnosis	27565		M0	N0	Stage III	T3	6th	not reported	0	382	c4f68877-97f7-59a8-9516-a24899bc7110	C67.9	not reported	8070/3	Squamous cell carcinoma, NOS	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-CF-A1HS_treatment_1	TCGA-CF-A1HS_treatment	released	6d83faf7-520d-54b6-b050-32a76c2f5b1b	no	Pharmaceutical Therapy, NOS	released	388ea1dc-3aef-59da-87f5-66806d4a6a8f	yes	Radiation Therapy, NOS	f00682e2-05d3-4525-9856-e68d874c55ed
02f0ecc1-a546-4c1a-a743-d4c3c0ea42e1.htseq.counts.gz	56940754-8961-45f6-9674-85ea765c292f	TCGA-GU-A42P-01A-11R-A23W-07	TCGA-GU-A42P-01A-11R	TCGA-GU-A42P-01A-01-TS1		TCGA-GU-A42P-01A-11	TCGA-GU-A42P-01A	TCGA-GU-A42P	ff5b9238-38a7-42b4-9d44-3b8ec9913f6d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	176	70.0	False	true	EBD243F6-1508-4BDD-A2D4-58E23D812DF0	2.07	81018f98-fee6-4cde-b6f6-3b6254e3e8d7			0.16	23	released	c3b063da-ae9d-4ed7-b9f7-83d9681e145c	RNA	R	0.16	UV Spec	released	False	dc51dc1b-3a4e-4a8b-a770-7531d4198253	11	6.0	2.0	0.0	2.0	0.0	25.0	75.0	75.0	TOP	a265a399-f503-42f8-a670-b8587bee9478	released												released	30.0	59c6f5bb-2da7-427c-a319-ae0d4f42eaed	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A42P_demographic	72	-26546	332	883e9711-cb3d-5ed0-a5d1-5e3cf2305694	not hispanic or latino	male	white	released	Dead	1940		TCGA-GU-A42P_exposure	Not Reported	23.8884409806205	2.0821917808219177	895721e0-4902-5ebb-b0ce-165866de33fd	183.0	38.0	released	80.0	TCGA-GU-A42P_diagnosis	26546		M0	N1	Stage IV	T3a	7th	not reported	0	195	214dd7fe-05b5-5d8a-9eef-ae869d75aae7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-GU-A42P_treatment	TCGA-GU-A42P_treatment_1	released	608b8d9a-4e51-5dd2-8e00-e861b640a4d5	no	Radiation Therapy, NOS	released	9ea44359-60b0-5983-a310-bc5c7c7b1328	no	Pharmaceutical Therapy, NOS	56940754-8961-45f6-9674-85ea765c292f
0b6a6da5-cbd8-49e6-967a-95652031439d.htseq.counts.gz	570668ec-7286-4e86-8eba-2645fc3257db	TCGA-YC-A9TC-01A-22R-A39I-07	TCGA-YC-A9TC-01A-22R	TCGA-YC-A9TC-01A-02-TS2		TCGA-YC-A9TC-01A-22	TCGA-YC-A9TC-01A	TCGA-YC-A9TC	6ee03f14-14ac-4cb9-bd23-b69704176301	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	39	490.0	False	false	DA4F1C21-0B25-452C-BBC4-B27ECE0216F5	1.88	86fcf82f-c97c-4f01-998d-8e6f389438d5			0.16	23	released	ea640eee-83b7-4792-9d76-e5dab71c401c	RNA	R	0.16	UV Spec	released	False	4c25a362-c1cb-43b1-8a17-7e6ce094525d	22	3.0	2.0	5.0	5.0	0.0	20.0	75.0	75.0	TOP	83ad47f0-1899-41f8-98b4-e187fbf9e652	released												released	30.0	639fcf4e-d039-4913-b992-ce73aedf87c3	Primary Tumor	01	released	Not Reported	released	TCGA-YC-A9TC_demographic	71	-26283	20	6713aa96-fe72-5949-97ae-a3c85e903125	not hispanic or latino	male	white	released	Dead	1942	2013	TCGA-YC-A9TC_exposure	Not Reported	25.925925925925924		8acef042-9086-503d-9a9c-2ad2c7ad73bc	180.0		released	84.0	TCGA-YC-A9TC_diagnosis	26283	T2	M1		Stage IV		7th	not reported	0		10753857-5737-5671-ac6a-b8d3221aa2f2	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-YC-A9TC_treatment	TCGA-YC-A9TC_treatment_1	released	e4435263-4cec-577d-9626-05ea66a2f7b1	yes	Radiation Therapy, NOS	released	95a83a20-ef3f-5801-830f-86845070cec9	no	Pharmaceutical Therapy, NOS	570668ec-7286-4e86-8eba-2645fc3257db
5d17ba3e-51e8-442f-9b3f-26111bd986fe.htseq.counts.gz	4b459251-011a-48fe-a53f-7c3e1d79b83d	TCGA-XF-A9SX-01A-21R-A39I-07	TCGA-XF-A9SX-01A-21R	TCGA-XF-A9SX-01A-02-TSB		TCGA-XF-A9SX-01A-21	TCGA-XF-A9SX-01A	TCGA-XF-A9SX	a648d9bf-cf37-41fc-9515-e8f5ac85fcd4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2702	770.0	False	true	FFF56041-E252-4438-BD4A-C7FD5295A061	1.88	2c28e7b4-23b3-46b0-927b-c684d73d1543			0.16	23	released	b6fdb692-0401-4ac3-90fc-feb7d4f22073	RNA	R	0.16	UV Spec	released	False	cb888cc2-7e95-435a-81a5-d4a5fbc88836	21	90.0	0.0	0.0	0.0	10.0	40.0	50.0	60.0	TOP	107afe7d-46e7-49b3-ae82-7ec06a90b60a	released												released	30.0	c48c874a-a34e-49ed-8ec3-6a994ab2e4ff	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SX_demographic	63	-23349	719	c747de87-d8bb-5354-8eb3-093e25feeb6e	not hispanic or latino	female	white	released	Dead	1943	2007	TCGA-XF-A9SX_exposure	Not Reported	23.309053069719038	2.191780821917808	8de0bd63-883e-562a-946c-e94e711487e7	155.0	40.0	released	56.0	TCGA-XF-A9SX_diagnosis	23349		MX	N2	Stage IV	T3b	6th	not reported	0		ceb27a2c-9437-5b78-8758-0cdf015a9de7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-A9SX_treatment	TCGA-XF-A9SX_treatment_1	released	181a4ad7-4edd-5ab9-bb5e-ed77680ac6d7	no	Radiation Therapy, NOS	released	d2e977e7-18c9-5427-a4fe-118b98ac83e0	yes	Pharmaceutical Therapy, NOS	4b459251-011a-48fe-a53f-7c3e1d79b83d
9ac9047f-7c57-4173-a9cc-d45430e2ece0.htseq.counts.gz	8c6ffe1d-a2c4-4c94-a8b9-b8c5936223e7	TCGA-BL-A13I-01A-11R-A13Y-07	TCGA-BL-A13I-01A-11R	TCGA-BL-A13I-01A-01-BSA	TCGA-BL-A13I-01A-01-TSA	TCGA-BL-A13I-01A-11	TCGA-BL-A13I-01A	TCGA-BL-A13I	ebc094a6-cdc9-4c02-b8ec-a181b25a364d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	127	410.0	False	false	976FBDBF-55C5-4957-986B-D2DE85FF7540	1.89	c270c34c-0cfd-410e-ab3c-231033196d25			0.16	23	released	4977da8a-7478-4f86-a0c1-3a0edb30c907	RNA	R	0.16	UV Spec	released	False	821a50fb-ef50-4f3f-8bf4-651cf45733e3	11	3.0	0.0	12.0	0.0	0.0	3.0	85.0	90.0	BOTTOM	99c2ff81-c48c-431b-811a-4073e3f8c4e0	released	2.0	0.0	5.0	0.0	0.0	5.0	90.0	96.0	TOP	f6fba03e-6237-44ef-9a9f-56474654a91a	released	released	30.0	62c2ba8f-02e3-4100-86bc-5958038b4983	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13I_demographic	57	-20885	223	ba9fff81-0ad3-56b5-a9a5-a7f1ad7cd96d	not hispanic or latino	female	white	released	Dead	1953	2010	TCGA-BL-A13I_exposure	Not Reported	20.690494543389182	0.821917808219178	ec9dc6f1-7f95-5ead-a277-4f172b7f118c	157.0	15.0	released	51.0	TCGA-BL-A13I_diagnosis	20885		M0	N0	Stage III	T3	7th	not reported	0		d9b084dc-a65f-5913-923c-5e7ec4067300	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-BL-A13I_treatment_1	TCGA-BL-A13I_treatment	released	91bd2aa1-fe84-59d5-9733-6d6fb91a2e81	no	Pharmaceutical Therapy, NOS	released	dbe66ff2-4969-5523-8044-ad4730dc163f	no	Radiation Therapy, NOS	8c6ffe1d-a2c4-4c94-a8b9-b8c5936223e7
d5ec7cc7-0d7a-4276-bf21-cb13565dd436.htseq.counts.gz	427655dd-0e92-4520-b472-53267ebcd0d1	TCGA-G2-A3VY-01A-11R-A22U-07	TCGA-G2-A3VY-01A-11R	TCGA-G2-A3VY-01A-01-TS1		TCGA-G2-A3VY-01A-11	TCGA-G2-A3VY-01A	TCGA-G2-A3VY	cd50c69f-0f45-4c57-b61a-8c6b41ab4f7e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	42	450	False	true	329F5DB7-9FC7-4856-8B15-1DBC9D6C42F6	1.96	7d6ea81b-b8a5-4d3b-aa54-9bf51d8b698b	2.08	13	0.16	23	released	31d8882f-dfa3-4895-973f-f7ff40dbc963	RNA	R	0.16	UV Spec	released	False	3a633710-6de9-45e2-8913-5c6606b6dd37	11	0	0	0	0	0	0	100	90	TOP	f7b73fd2-dee4-4727-9181-ce5f5031fc41	released												released	30	5a66149f-8fb0-41bc-880c-56d5541e3d94	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A3VY_demographic	66	-24112		15c1e0ea-1077-55e6-beb9-f59501b371b2	not hispanic or latino	male	asian	released	Alive	1946		TCGA-G2-A3VY_exposure	Not Reported	20.716105372190025		a30f8851-4b2a-5565-88af-4ec9eae709db	189.0		released	74.0	TCGA-G2-A3VY_diagnosis	24112	T2			Stage II		7th	not reported	0	536	ad9e8a82-d2d5-5bb8-a25e-903601e29283	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2012	TCGA-G2-A3VY_treatment	TCGA-G2-A3VY_treatment_1	released	4d213c76-2ca9-5629-a6bc-8233634c3c5b	no	Radiation Therapy, NOS	released	9b8c1a3b-093b-5c35-b32b-5e183c1c4609	yes	Pharmaceutical Therapy, NOS	427655dd-0e92-4520-b472-53267ebcd0d1
42dac8a8-97f4-40f8-b2b9-170ffe3debc3.htseq.counts.gz	1adbd069-d82c-4da2-8fef-8d3df08d94ef	TCGA-BT-A20N-01A-11R-A14Y-07	TCGA-BT-A20N-01A-11R	TCGA-BT-A20N-01A-01-TSA		TCGA-BT-A20N-01A-11	TCGA-BT-A20N-01A	TCGA-BT-A20N	ebedab7c-dd7c-448e-8324-78c86f13be8b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2955	530.0	False	true	20F84480-449D-45CD-AEDC-509BE72C6B46	1.84	dfc4aacd-32b1-4cf8-91f9-3c865cf56ec9			0.17	23	released	d6e4f262-968b-4e27-ab64-43d5782628a6	RNA	R	0.17	UV Spec	released	False	3128ae0b-3684-41dd-af58-e43fa51e080e	11	5.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	6b663c7d-40e6-467a-bdc9-d80a471b1ced	released												released	30.0	89ec2dfd-7a0c-4631-958d-d5492bc89f8d	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20N_demographic	72	-26456	795	19cba497-5f32-5c6a-8ef2-50b0de719c44	not reported	male	not reported	released	Dead	1931	2005	TCGA-BT-A20N_exposure	Not Reported		2.73972602739726	b0e05c8d-317a-5480-9e48-5646995635bd		50.0	released		TCGA-BT-A20N_diagnosis	26456	T3a	MX	N0	Stage III	T3a	6th	not reported	0		db4cb9dd-289a-52ba-8ab0-aa66f8f94b0e	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iii	2003	TCGA-BT-A20N_treatment	TCGA-BT-A20N_treatment_1	released	65668751-80ea-58a2-821a-7ca63a54d40b	no	Radiation Therapy, NOS	released	e74f1e5d-9aa3-59a0-a798-ba90ced221f8	yes	Pharmaceutical Therapy, NOS	1adbd069-d82c-4da2-8fef-8d3df08d94ef
781a5fb7-d62a-439d-a062-2f6fcaad9168.htseq.counts.gz	30c6f0eb-0041-46a1-ad02-2004a5b707e1	TCGA-XF-A8HI-01A-11R-A38B-07	TCGA-XF-A8HI-01A-11R	TCGA-XF-A8HI-01A-01-TSA		TCGA-XF-A8HI-01A-11	TCGA-XF-A8HI-01A	TCGA-XF-A8HI	eed3908f-f1bd-4254-bca8-bc1a7427e95c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3153	270.0	False	true	737E5709-0C1B-488C-B915-84F26A4B86D8	1.85	9bd649f6-9b08-4d26-87b9-a6901a00f2ba			0.15	23	released	10de90e7-3ff1-437a-a243-a7245c369c31	RNA	R	0.15	UV Spec	released	False	ab6dfc94-020c-4a2d-a1f3-e930c3771fc9	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	7e8937cd-5962-4b0c-834a-ca88329a97db	released												released	30.0	227a8e56-3e04-4244-96ee-f9d2da882079	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HI_demographic	57	-21059	544	83ec023b-fe3d-508b-ab91-2109ff74910e	not hispanic or latino	female	white	released	Dead	1948	2006	TCGA-XF-A8HI_exposure	Not Reported	32.59637188208617		9c8b77a5-7e7f-54dc-a1b1-130263a09bde	168.0		released	92.0	TCGA-XF-A8HI_diagnosis	21059		MX	N2	Stage IV	T2b	6th	not reported	0		7e731e8c-247d-51f2-aab7-b29760cbb170	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2005	TCGA-XF-A8HI_treatment	TCGA-XF-A8HI_treatment_1	released	5c67e1c5-c325-5979-b84a-79791057cb6d	no	Radiation Therapy, NOS	released	18953517-fa85-56ac-b709-3969f33cc090	yes	Pharmaceutical Therapy, NOS	30c6f0eb-0041-46a1-ad02-2004a5b707e1
7e253c84-a94d-4918-822b-e68ae2ef71d4.htseq.counts.gz	aa51dbdf-d33d-4cf9-bac1-71b98546ff74	TCGA-E5-A2PC-01A-11R-A206-07	TCGA-E5-A2PC-01A-11R	TCGA-E5-A2PC-01A-01-TSA		TCGA-E5-A2PC-01A-11	TCGA-E5-A2PC-01A	TCGA-E5-A2PC	4107ae6f-502c-4bdc-bf14-e4b3711cba38	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1052	120.0	False	true	7E6EAFBD-51DD-4E4A-86F7-20CAA317F849	1.79	c32574a0-5f85-4053-bb98-8472b496975e			0.17	23	released	d221466d-8ffd-44d6-bef7-66850fe89328	RNA	R	0.17	UV Spec	released	False	f9dc4007-13e4-4979-8e19-f0035453cacd	11	1.0	0.0	2.0	0.0	0.0	23.0	75.0	90.0	TOP	d58c828a-5036-402a-a137-30d0732666a9	released												released	30.0	2195b75e-157f-4547-9705-1e7e75666ca8	Primary Tumor	01	released	Not Reported	released	TCGA-E5-A2PC_demographic	61	-22308		ed4488b6-58af-5735-a30c-fab803cff500	not hispanic or latino	female	white	released	Alive	1947		TCGA-E5-A2PC_exposure	Not Reported	27.055150884495315		19b4162b-b9f6-54f6-ab28-61d6916f51a3	155.0		released	65.0	TCGA-E5-A2PC_diagnosis	22308		MX	N1	Stage IV	T2b	6th	not reported	0	1326	0070620a-02b9-58dd-994c-56373b47f1b7	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2008	TCGA-E5-A2PC_treatment_1	TCGA-E5-A2PC_treatment	released	d113b9a7-6359-5b82-89e1-3c327f7a0656	yes	Pharmaceutical Therapy, NOS	released	9e0af80d-64b3-54f8-a328-95d34f95f159	no	Radiation Therapy, NOS	aa51dbdf-d33d-4cf9-bac1-71b98546ff74
77edcd96-eb35-415b-8e03-c61f225ae32d.htseq.counts.gz	d45663ad-ad18-4559-8662-974f6d26e1f1	TCGA-FD-A3B7-01A-31R-A20F-07	TCGA-FD-A3B7-01A-31R	TCGA-FD-A3B7-01A-03-TSC		TCGA-FD-A3B7-01A-31	TCGA-FD-A3B7-01A	TCGA-FD-A3B7	ef5dd4b3-b77a-444a-b5b0-c999a5a3d129	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	152	440.0	False	false	DC81B464-642D-444E-A110-D11E687B36C1	1.82	32d604cb-3bf5-427c-b60d-3c9cfeb7f0a5			0.17	23	released	428eb8ef-579b-4fe9-b450-ee86568ee265	RNA	R	0.17	UV Spec	released	False	e14a63cb-628f-4b91-bb3c-a42316b189ff	31	0.0	0.0	0.0	0.0	0.0	5.0	95.0	80.0	TOP	e65bd01d-126e-48dd-b16b-43723a622514	released												released	30.0	a307ca46-3a09-4f0c-84ab-9a9e8954de38	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B7_demographic	66	-24245	122	e23093fc-4c72-5f8e-8e1a-073d544ce658	not hispanic or latino	male	black or african american	released	Dead	1945	2011	TCGA-FD-A3B7_exposure	Not Reported	18.960068945705256	1.36986301369863	69cd5909-2d88-5712-a843-be3217d22e2c	177.0	25.0	released	59.4	TCGA-FD-A3B7_diagnosis	24245	T2	MX	N0	Stage III	T3a	7th	not reported	0		08ecc8f8-a669-5df7-b3d9-4f19fb6c3365	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2011	TCGA-FD-A3B7_treatment_1	TCGA-FD-A3B7_treatment	released	2a99438e-ea03-50f6-8a40-d8b757f59b9d	no	Pharmaceutical Therapy, NOS	released	7eaf4fc4-2f02-5f8c-ae41-b7097f856c11	no	Radiation Therapy, NOS	d45663ad-ad18-4559-8662-974f6d26e1f1
56195f30-f4b9-441c-a007-ce2ee2cf1475.htseq.counts.gz	1cec62d4-812f-4718-af16-81d26a71f9c0	TCGA-DK-A1AA-01A-11R-A13Y-07	TCGA-DK-A1AA-01A-11R	TCGA-DK-A1AA-01A-01-TSA		TCGA-DK-A1AA-01A-11	TCGA-DK-A1AA-01A	TCGA-DK-A1AA	56d8a1b8-1268-4362-a7f1-77b76fbf1b59	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	161	330.0	False	true	33855148-B5B5-46AE-B92D-61B64D771184	1.81	5b0896f2-8fd9-42ee-b56d-b140f8d8657e			0.17	23	released	4ac6b3e1-ea6e-4703-89d2-d09981afbbea	RNA	R	0.17	UV Spec	released	False	cd4b7179-2746-44bf-ad4b-2c8f32c91af1	11	1.0	0.0	0.0	0.0	0.0	5.0	95.0	95.0	TOP	6fa88a79-42b9-4443-9a7d-f03711efa0d4	released												released	30.0	577700d1-c366-41ef-8a0d-e50deefb5e3c	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AA_demographic	57	-21093		9767b999-7431-5dc2-be57-c901ad86aa0a	not hispanic or latino	male	white	released	Alive	1953		TCGA-DK-A1AA_exposure	Not Reported	32.55204269529665	1.095890410958904	95622238-4c15-5c9e-b11c-96565b4522a9	179.0	20.0	released	104.3	TCGA-DK-A1AA_diagnosis	21093		M0	N0	Stage III	T3	6th	not reported	0	578	1b62943f-4239-5c50-8f07-d8dcdde4ad81	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2010	TCGA-DK-A1AA_treatment	TCGA-DK-A1AA_treatment_1	released	9be012c0-d818-5421-8b9d-36245ef762fb	no	Radiation Therapy, NOS	released	e9a59b6e-b78a-55b3-8c22-dbc1a3134844	yes	Pharmaceutical Therapy, NOS	1cec62d4-812f-4718-af16-81d26a71f9c0
2ea66599-cfa6-4a42-b88c-0889cc98cc5f.htseq.counts.gz	928dff14-1754-46b3-b11b-3ca33099308c	TCGA-XF-A9SZ-01A-11R-A39I-07	TCGA-XF-A9SZ-01A-11R	TCGA-XF-A9SZ-01A-01-TSA		TCGA-XF-A9SZ-01A-11	TCGA-XF-A9SZ-01A	TCGA-XF-A9SZ	dc321b92-7275-48c9-adeb-7670db3195ef	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2352	1080.0	False	true	BBDDB909-1AE0-4F10-948A-DAA989CF87D2	1.88	73a57b9f-d780-4556-bf25-b75c2f75340e			0.16	23	released	db3e4cc7-4793-44c4-abe0-f0eaec68040e	RNA	R	0.16	UV Spec	released	False	5bd19ca9-24cc-4a01-88d2-9d5c7c26657a	11	0.0	0.0	0.0	0.0	10.0	20.0	70.0	80.0	TOP	78b01bfd-28b4-4f64-8810-64e667f01164	released												released	30.0	f3f9e379-d7e3-4657-825d-45f4d16a89f0	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SZ_demographic	79	-29100	859	0dea90f8-ae44-513d-96fa-8487e2e2444f	not hispanic or latino	male	white	released	Dead	1928	2009	TCGA-XF-A9SZ_exposure	Not Reported	26.643598615916954	1.643835616438356	342a624e-5afc-53b7-ba23-0742c1ee6398	170.0	30.0	released	77.0	TCGA-XF-A9SZ_diagnosis	29100		MX	N2	Stage IV	T3b	5th	not reported	0		6b1b12ca-60a9-5b1b-813a-708b985fa0a6	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2007	TCGA-XF-A9SZ_treatment	TCGA-XF-A9SZ_treatment_1	released	3257623d-1d59-59d3-bbf1-cc00538cc7e4	no	Radiation Therapy, NOS	released	cb417703-fd32-5031-8335-0ebf4ec1be42	yes	Pharmaceutical Therapy, NOS	928dff14-1754-46b3-b11b-3ca33099308c
edbc8f6d-d478-493a-a2b5-ee46edd67ab6.htseq.counts.gz	01eff87c-9e9b-4cc8-964d-9c0aa137424d	TCGA-G2-A2EC-01A-11R-A180-07	TCGA-G2-A2EC-01A-11R	TCGA-G2-A2EC-01A-01-TSA		TCGA-G2-A2EC-01A-11	TCGA-G2-A2EC-01A	TCGA-G2-A2EC	28e25ffb-8b0c-4839-a735-ed7b78e3213a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	481	60.0	False	true	77EEB2BE-B13B-41FD-B503-8C107D16FE38	1.73	61a9951d-6005-4d5a-a7ac-1146399de61c			0.16	23	released	234dda20-7e8e-4704-975b-f8c3b8c011dd	RNA	R	0.16	UV Spec	released	False	67f2e7e2-5867-4e7d-868a-ed63edb20e29	11	3.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	e6cd3f36-6ef9-4b87-85c9-25ef08650042	released												released	20.0	2da969e6-9a63-4c03-8347-01a51496c224	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EC_demographic	58	-21215	696	04d15437-d0f8-5191-890a-18a194ec72e1	not hispanic or latino	female	black or african american	released	Dead	1952		TCGA-G2-A2EC_exposure	Not Reported	27.34375		604fdcb3-e934-5d50-b83f-19f72f389bc2	160.0		released	70.0	TCGA-G2-A2EC_diagnosis	21215	T2a	M0	N0	Stage II		2nd	not reported	0	679	16beb884-26da-5068-a447-d0d8ba702abd	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2010	TCGA-G2-A2EC_treatment_1	TCGA-G2-A2EC_treatment	released	c5aedb26-1567-5635-9114-c3e71fa9b619	yes	Pharmaceutical Therapy, NOS	released	a4176a47-ece8-539b-aa06-f886a15c954f	no	Radiation Therapy, NOS	01eff87c-9e9b-4cc8-964d-9c0aa137424d
1387d266-cdf6-4076-9f74-97d6ebcf792a.htseq.counts.gz	ad7745ab-7ae3-49e6-97c3-8a75e9a37174	TCGA-FJ-A3ZF-01A-11R-A23N-07	TCGA-FJ-A3ZF-01A-11R	TCGA-FJ-A3ZF-01A-01-TSA		TCGA-FJ-A3ZF-01A-11	TCGA-FJ-A3ZF-01A	TCGA-FJ-A3ZF	fae38579-5fe2-4d81-9729-39fde866d18c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	27	370.0	False	true	5057B461-361A-4BF8-BF8E-59E49AF47A1F	1.82	e68b253d-6149-4c42-a5b3-1ddc2448759b			0.16	23	released	5b5f517d-2c05-4f97-afad-edebe89d72a0	RNA	R	0.16	UV Spec	released	False	2ffe41e1-58ae-4cfd-bfa6-3399f607a30b	11	3.0	2.0	1.0	2.0	0.0	14.0	85.0	85.0	TOP	a75e0696-5d40-425c-8f30-7d665cf2b26d	released												released	30.0	bf3850ef-e650-4727-bcd5-6608bfca2ae2	Primary Tumor	01	released	Not Reported	released	TCGA-FJ-A3ZF_demographic	73	-26825		b40d392a-5de6-5697-a593-fbbc9d0005fb	not hispanic or latino	male	white	released	Alive	1939		TCGA-FJ-A3ZF_exposure	Not Reported	30.23431594860166	2.7945205479452055	fda6192d-66eb-5cd6-bfe5-a56a2529801b	189.0	51.0	released	108.0	TCGA-FJ-A3ZF_diagnosis	26825	T3b	M0	N0	Stage III		7th	not reported	0	524	c94da13a-ff3f-579c-9756-4c8e82385264	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	Yes	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2012	TCGA-FJ-A3ZF_treatment_1	TCGA-FJ-A3ZF_treatment	released	417da1f3-8d68-5207-b2fa-c3f51015df3f	yes	Pharmaceutical Therapy, NOS	released	d1b1978a-6689-5d10-a49e-124a8c78a8bd	no	Radiation Therapy, NOS	ad7745ab-7ae3-49e6-97c3-8a75e9a37174
b6f0b71c-d213-4f4f-8950-03d18d63015a.htseq.counts.gz	f54c9a0e-19ce-4740-97bf-125e4f362fdd	TCGA-XF-A9SH-01A-11R-A39I-07	TCGA-XF-A9SH-01A-11R	TCGA-XF-A9SH-01A-01-TSA		TCGA-XF-A9SH-01A-11	TCGA-XF-A9SH-01A	TCGA-XF-A9SH	b838a4db-ef0a-4d88-a220-bf57e31e0b3c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3256	200.0	False	true	E84E385B-B56A-48AC-AD5B-EA7BE9E69CDE	1.88	1e640951-76e2-4691-bfda-301e6bd11c47			0.16	23	released	e5c53adf-7e86-4619-b650-610f27b0caea	RNA	R	0.16	UV Spec	released	False	9d750606-0718-4de4-a80c-3b2dce7b2d38	11	2.0	1.0	0.0	4.0	0.0	15.0	85.0	85.0	TOP	c6b5bca1-91bf-46ed-b96e-f2025bc44701	released												released	30.0	53a09ed7-04cb-4ccc-98e7-09b1f20597ec	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SH_demographic	65	-24060	1971	be206102-0488-5e7f-a924-fae1920c0998	not hispanic or latino	female	asian	released	Dead	1940	2010	TCGA-XF-A9SH_exposure	Not Reported	23.372576177285318		96e4c80c-168b-51b4-bbd3-1801f9f9fc6f	152.0		released	54.0	TCGA-XF-A9SH_diagnosis	24060		M0	N0	Stage II	T2b	6th	not reported	0		6c2556c1-284a-541c-ba7f-20e628b14537	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2005	TCGA-XF-A9SH_treatment	TCGA-XF-A9SH_treatment_1	released	7db3f93b-1a43-5f94-b2fa-d417f568dc08	yes	Radiation Therapy, NOS	released	b79e4b89-e26f-5c26-b7f4-3faf65959aa8	yes	Pharmaceutical Therapy, NOS	f54c9a0e-19ce-4740-97bf-125e4f362fdd
dd1d19b2-681b-447b-b16f-f9b0bf4f4c30.htseq.counts.gz	e5b4565c-9e79-4226-b106-29cf7f8f4a94	TCGA-BL-A13J-01A-11R-A277-07	TCGA-BL-A13J-01A-11R	TCGA-BL-A13J-01A-01-TS1	TCGA-BL-A13J-01A-01-BS1	TCGA-BL-A13J-01A-11	TCGA-BL-A13J-01A	TCGA-BL-A13J	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	246	280.0	False	false	3ABF8C6B-606C-41A9-B050-E115834A7616	1.82	06d706f6-4e05-4ffc-9b75-f9fccb639a33			0.14	23	released	045a5461-0bdd-49c5-b6ee-dc007a10ef47	RNA	R	0.14	UV Spec	released	False	895dbae7-3a55-4707-a2bd-dc7b53d53ed1	11	3.0	0.0	0.0	0.0	0.0	35.0	65.0	84.0	TOP	e1ec785a-e7c8-4c27-a6a6-e4e8aaa88507	released	2.0	0.0	0.0	0.0	0.0	35.0	65.0	84.0	TOP	a2132bbb-39e8-4606-aad8-f0cbf010a138	released	released	30.0	cf23846d-a7d2-40a9-8b51-49a27967d101	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13J_demographic	65	-23927	81	3a19ccff-885d-524c-85e5-a2606dace97c	not hispanic or latino	male	white	released	Dead	1945	2010	TCGA-BL-A13J_exposure	Not Reported	22.98539751216874	1.3150684931506849	bbd00b5a-a20a-5205-b773-ac6250abbc20	172.0	24.0	released	68.0	TCGA-BL-A13J_diagnosis	23927		M0	N2	Stage IV	T4		not reported	0		48d48f46-0677-517c-b11e-8c7e100a85b2	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2010	TCGA-BL-A13J_treatment	TCGA-BL-A13J_treatment_1	released	691d6cde-1889-5398-be89-5d0b9c88851b	no	Radiation Therapy, NOS	released	04e5320c-e9af-52f4-af45-77a50901166e	no	Pharmaceutical Therapy, NOS	e5b4565c-9e79-4226-b106-29cf7f8f4a94
676e6ddd-baba-4537-9af5-326f8e715998.htseq.counts.gz	81a46592-ba62-4136-ba24-cbd757f4fd7e	TCGA-XF-A9SU-01A-31R-A39I-07	TCGA-XF-A9SU-01A-31R	TCGA-XF-A9SU-01A-03-TSC		TCGA-XF-A9SU-01A-31	TCGA-XF-A9SU-01A	TCGA-XF-A9SU	42bcf1a7-2f3a-4ed8-a41d-cdd67e65b928	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2887	860.0	False	true	B2C3CDC0-DC42-4971-9203-30B712F89553	1.86	0cb1b6e8-1a05-472d-9651-126f92d17e73			0.17	23	released	1a144952-d6b3-4b5f-98b2-e9fea7c1a601	RNA	R	0.17	UV Spec	released	False	df2ccc33-c2b9-4c64-b134-f17edf905a37	31	2.0	1.0	0.0	5.0	0.0	30.0	70.0	70.0	TOP	80e5b11f-4eba-4eb3-a571-19697100277d	released												released	30.0	abe273cd-9f0d-45ca-b72b-a154685708c1	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SU_demographic	74	-27068	182	890d5fb4-66d2-5ff2-b9fc-f395db897fa3	not hispanic or latino	female	white	released	Dead	1932	2006	TCGA-XF-A9SU_exposure	Not Reported	24.560326301478007	1.643835616438356	6fa38cfa-ca9e-5359-8288-a52be1dea391	151.0	30.0	released	56.0	TCGA-XF-A9SU_diagnosis	27068		MX	N1	Stage IV	T3b	6th	not reported	0		d2a0e01e-86e0-5f8c-9631-937aadf13a11	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-A9SU_treatment_1	TCGA-XF-A9SU_treatment	released	2f3e775d-f533-5e67-8ad3-36297d1d7ee7	yes	Pharmaceutical Therapy, NOS	released	f3942d58-a91f-5436-9713-84ccc8d32db4	yes	Radiation Therapy, NOS	81a46592-ba62-4136-ba24-cbd757f4fd7e
4a4aab5b-ba1f-4bd1-ad05-eba7d186ca13.htseq.counts.gz	d3ba863f-990f-4d8a-b027-b47c61e8e79f	TCGA-DK-A6B0-01A-11R-A31N-07	TCGA-DK-A6B0-01A-11R	TCGA-DK-A6B0-01A-01-TSA		TCGA-DK-A6B0-01A-11	TCGA-DK-A6B0-01A	TCGA-DK-A6B0	73bc18a4-3600-409e-a2b5-e09e2b3f040d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2115	240.0	False	true	39DA362A-CFF2-4A9B-AAC9-963AA207AB37	1.89	b6ebbe90-feb4-4e8e-9408-031db2297c1c			0.18	23	released	b5372cc7-3d75-4059-a527-8804d215328e	RNA	R	0.18	UV Spec	released	False	fb075dd3-765f-4c20-91ed-055519a52b69	11	2.0	0.0	20.0	1.0	0.0	0.0	80.0	80.0	TOP	b5408888-6df6-4f6a-ae67-7ecfe0d12092	released												released	30.0	834bca7a-b13c-4618-b089-be975723a196	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6B0_demographic	61	-22439		00903da2-eb7e-5a9d-ba39-a884bf6039a3	not hispanic or latino	male	white	released	Alive	1946		TCGA-DK-A6B0_exposure	Not Reported	28.326580372189753	1.095890410958904	ecb905fd-351f-53c2-a86d-eaa9f15e3e4d	167.0	20.0	released	79.0	TCGA-DK-A6B0_diagnosis	22439		M0	N0	Stage II	T2b	6th	not reported	0	2330	1fc0499f-9f4b-5b63-aeb7-f893a147d6a4	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2007	TCGA-DK-A6B0_treatment	TCGA-DK-A6B0_treatment_1	released	878c658d-4418-55fd-a9da-acda29d0e3c8	no	Radiation Therapy, NOS	released	6d69e5ae-943f-5704-bec0-afa338cba815	no	Pharmaceutical Therapy, NOS	d3ba863f-990f-4d8a-b027-b47c61e8e79f
e9d9c32a-e05b-4b00-a4c9-93c9c54037c7.htseq.counts.gz	d37ccd9a-3430-482d-941a-06c654991634	TCGA-ZF-AA5N-01A-11R-A42T-07	TCGA-ZF-AA5N-01A-11R	TCGA-ZF-AA5N-01A-01-TS1		TCGA-ZF-AA5N-01A-11	TCGA-ZF-AA5N-01A	TCGA-ZF-AA5N	f78cb4fa-5548-40f8-b71b-663dde47f539	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	29	60.0	False	true	C115F113-1A42-4DB6-A6AA-7717C6DE227C	1.88	283dae7a-c249-4f56-b8ae-e9a13e451269			0.16	23	released	8f74064c-d8b6-41b0-9184-2ee8d4be212d	RNA	R	0.16	UV Spec	released	False	0228ebe4-3fbb-4c93-aafd-f6340490ab49	11	0.0	0.0	0.0	0.0	10.0	20.0	70.0	80.0	TOP	42f0737c-3389-47eb-adfe-45d1a4b5158e	released												released	30.0	8a928ba7-1211-4d9a-b060-b603206559f6	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA5N_demographic	62	-22741	168	2a6b6080-4771-5f69-9c98-9289c2a35b87	not hispanic or latino	female	white	released	Dead	1951	2013	TCGA-ZF-AA5N_exposure	Not Reported	28.698979591836736	0.547945205479452	bd8a41b1-338e-596b-9d98-946882035a8a	168.0	10.0	released	81.0	TCGA-ZF-AA5N_diagnosis	22741	T2	M1	NX	Stage IV	T2	7th	not reported	0		6e999e1f-9938-5160-a6ad-9dd9e165756b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-ZF-AA5N_treatment_1	TCGA-ZF-AA5N_treatment	released	1b91e0f6-b606-55d4-a373-d117a4a59432	yes	Pharmaceutical Therapy, NOS	released	5b3beb86-220d-5154-a510-a94490fb36b5	no	Radiation Therapy, NOS	d37ccd9a-3430-482d-941a-06c654991634
75bd84df-67ba-4bc4-8a88-c02e73e0be6d.htseq.counts.gz	33c1de97-a48e-4f65-898c-4a76b4d3f934	TCGA-FD-A43P-01A-31R-A23W-07	TCGA-FD-A43P-01A-31R	TCGA-FD-A43P-01A-03-TSC		TCGA-FD-A43P-01A-31	TCGA-FD-A43P-01A	TCGA-FD-A43P	41e8c196-ef93-47c6-ad06-0031f23d4347	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	168	610.0	False	true	8D2D5019-4C09-4B35-AEB9-4B162A47267A	1.83	0fa20811-219b-4d76-a8f6-d838e4de093e			0.15	23	released	df821b30-5fb7-4522-b1a3-e48aa9b04343	RNA	R	0.15	UV Spec	released	False	848bfc32-4ea9-4238-b55e-e0cad1e38a78	31	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	19dbea5f-7668-4647-8984-884ac4e27633	released												released	30.0	d1b619ca-f17d-4f77-a5c5-1d6b7bfb7574	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43P_demographic	74	-27201		57471cc5-f542-59bc-8f09-6b4ff40d7298	not hispanic or latino	male	black or african american	released	Alive	1938		TCGA-FD-A43P_exposure	Not Reported	47.342507259184444	2.410958904109589	3d943e6c-a299-5b80-b90b-325da6e78521	178.0	44.0	released	150.0	TCGA-FD-A43P_diagnosis	27201	T1	MX	N0	Stage II	T2a	7th	not reported	0	832	170299a1-5aaa-563c-8c8b-ee133afebf04	C67.1	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Dome of bladder	released	Not Reported	Dome of bladder	not reported	stage ii	2012	TCGA-FD-A43P_treatment	TCGA-FD-A43P_treatment_1	released	475c73fa-72a4-55d8-a7e9-ccddaf89539c	no	Radiation Therapy, NOS	released	080d2a28-81e4-5287-ad0b-1175273ef8ff	no	Pharmaceutical Therapy, NOS	33c1de97-a48e-4f65-898c-4a76b4d3f934
7abc25b7-742c-4511-b24d-3a9eeef37dbc.htseq.counts.gz	975813a2-3ddd-43ca-acc6-4dc08d8a38b9	TCGA-BT-A20U-01A-11R-A14Y-07	TCGA-BT-A20U-01A-11R	TCGA-BT-A20U-01A-01-TSA		TCGA-BT-A20U-01A-11	TCGA-BT-A20U-01A	TCGA-BT-A20U	83b41d35-69b1-4218-be1a-8821d8a6899c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1174	160	False	true	F1C2F8C6-C3F6-4E69-90FE-E55A44571779	1.68	36a95ee7-1822-4d07-8110-843792006625	4.54	26.7	0.17	23	released	0d341b26-341e-4d30-8130-035104a7f0b5	RNA	R	0.17	UV Spec	released	False	32d5d458-1a87-4c00-a065-696e8d4c52b6	11	0	0	5	0	0	15	80	65	TOP	0bc7e818-4a25-42a6-8ad7-276a91baf616	released												released	30	d29e555f-8467-45c8-9124-0e6a757b1adf	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20U_demographic	70	-25761	455	82d04e76-74d4-5009-8196-94ace7f93ebd	not hispanic or latino	female	white	released	Dead	1938	2009	TCGA-BT-A20U_exposure	Not Reported			7dd0e5d4-8a6b-5513-b30f-86df2efbc247			released		TCGA-BT-A20U_diagnosis	25761	T3a	M0	N0	Stage III	T3a	6th	not reported	0		5f53d094-88aa-5c69-abd6-bad079955707	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2008	TCGA-BT-A20U_treatment	TCGA-BT-A20U_treatment_1	released	fff71c42-024a-520e-98b6-0660f578163e	no	Radiation Therapy, NOS	released	e6d75ded-bbbe-5eb0-a903-366350d0ee5e	no	Pharmaceutical Therapy, NOS	975813a2-3ddd-43ca-acc6-4dc08d8a38b9
1d515f92-2b6f-41f3-abb3-fb312e5a468a.htseq.counts.gz	026112a8-334d-4c82-90b0-006d48499069	TCGA-FJ-A3Z9-01A-11R-A26T-07	TCGA-FJ-A3Z9-01A-11R	TCGA-FJ-A3Z9-01A-01-TSA		TCGA-FJ-A3Z9-01A-11	TCGA-FJ-A3Z9-01A	TCGA-FJ-A3Z9	72ff655f-bb08-40ed-b4c3-e9497d4da108	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	110	240.0	False	true	7AE1E138-C824-4547-AA87-F126748DA14D	1.94	83c4827f-742b-42bf-96d0-335b484ee724			0.16	23	released	2b119398-3c55-42d0-84fb-d5901bcd2b13	RNA	R	0.16	UV Spec	released	False	0e89d9d6-5433-441e-8d24-546121c02560	11	3.0	0.0	10.0	0.0	0.0	0.0	90.0	80.0	TOP	5e3bb767-1099-41d9-b58e-7db077a46f42	released												released	30.0	3ac90ddf-5007-4a45-a543-ea942949e030	Primary Tumor	01	released	Not Reported	released	TCGA-FJ-A3Z9_demographic	72	-26515	385	3b30fd3f-a97f-588d-b235-3d0f9273af8c	not hispanic or latino	male	white	released	Dead	1940		TCGA-FJ-A3Z9_exposure	Not Reported	31.35357878706441	0.7123287671232876	2777b322-946f-5be6-922b-e3c682005aa7	183.0	13.0	released	105.0	TCGA-FJ-A3Z9_diagnosis	26515	T3	M0	N0		TX	7th	not reported	0	217	e87917cd-61ac-5c27-b9e1-e076cedb1245	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	not reported	2012	TCGA-FJ-A3Z9_treatment_1	TCGA-FJ-A3Z9_treatment	released	3227e359-705a-5c1f-9d24-e3a851adba7c	yes	Pharmaceutical Therapy, NOS	released	b5a31169-b3c3-5c13-91ed-77d9b5b7a926	no	Radiation Therapy, NOS	026112a8-334d-4c82-90b0-006d48499069
ca3f7cb1-036f-4fec-8b52-c616a8fac489.htseq.counts.gz	d5ef7a12-d2b1-4c4f-af95-0b9dec716b3e	TCGA-E7-A519-01A-11R-A26T-07	TCGA-E7-A519-01A-11R	TCGA-E7-A519-01A-01-TSA		TCGA-E7-A519-01A-11	TCGA-E7-A519-01A	TCGA-E7-A519	74216d58-9e34-4a2b-b4af-886c4a3dc079	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	125	550.0	False	true	6CF5659C-C6A7-4019-B368-86A6525D4035	1.86	f11c2ee8-9bf1-4a41-b154-7fb31af15298			0.17	23	released	4c96b338-d14e-45f0-849c-575e1cb76098	RNA	R	0.17	UV Spec	released	False	a14c4274-d010-4ab3-bfed-5db0f1474321	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	7a29639b-613f-4ae7-b086-86ac3e89edf8	released												released	30.0	a7760929-71ca-4792-9828-2fddff3fca3c	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A519_demographic	72	-26427		18348495-acfe-566b-bc04-764dfb6f5d9c	not hispanic or latino	male	white	released	Alive	1940		TCGA-E7-A519_exposure	Not Reported	25.503615702479337	2.73972602739726	2f19f17a-a4f6-57f9-bb5b-8d5f2b68e312	176.0	50.0	released	79.0	TCGA-E7-A519_diagnosis	26427		M0	NX	Stage II	T2b	7th	not reported	0	508	629b4b05-8c7a-5ccf-8790-ef371b95c330	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A519_treatment	TCGA-E7-A519_treatment_1	released	17e1e28b-f48a-5950-9683-822fc25fafb2	no	Radiation Therapy, NOS	released	e1a789a7-6dce-509b-a099-c87287e6d7bb	no	Pharmaceutical Therapy, NOS	d5ef7a12-d2b1-4c4f-af95-0b9dec716b3e
6f0c496f-8069-49c1-a79e-da58976f44e9.htseq.counts.gz	59f7a890-c898-4db3-a9e8-021974ccd32a	TCGA-C4-A0F1-01A-11R-A034-07	TCGA-C4-A0F1-01A-11R	TCGA-C4-A0F1-01A-01-TS1	TCGA-C4-A0F1-01A-01-BS1	TCGA-C4-A0F1-01A-11	TCGA-C4-A0F1-01A	TCGA-C4-A0F1	ab20d2d5-ea10-4aba-b495-fbe7b18bb394	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1541	230	False	false	8410F811-09E4-40B9-B3CF-5A6F3DE628BD	1.83	791dd985-420e-46a0-a770-ebaf0d2beaf1	4.27	26.7	0.16	23	released	fa1fd379-a55f-46b8-a46e-e024611f4704	RNA	R	0.16	UV Spec	released	False	8ee1098e-8a96-4526-97ed-86254530558a	11	10	0	2	0	0	20	78	85	TOP	e418e55e-faa9-449f-aae5-003f515e31c4	released	12	0	15	3	10	20	55	75	BOTTOM	6e9b4d96-4894-44db-9740-05007e623e03	released	released	30	46b04710-466e-47f5-9c85-08bd686515d7	Primary Tumor	01	released	Not Reported	released	TCGA-C4-A0F1_demographic	71	-26178		adda7647-c015-5c6f-95ab-c99ab86ca260	not reported	male	not reported	released	Alive	1935		TCGA-C4-A0F1_exposure	Not Reported	26.472107438016526	4.109589041095891	50911d6a-29a9-5598-ab56-00eaec5819da	176.0	75.0	released	82.0	TCGA-C4-A0F1_diagnosis	26178		M0	N0	Stage III	T3b	5th	not reported	0	89	7763eec5-85bb-5994-9d34-acf2abbc113a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2006	TCGA-C4-A0F1_treatment	TCGA-C4-A0F1_treatment_1	released	300a54dd-7d5a-57ae-b32d-78503e05665f	not reported	Radiation Therapy, NOS	released	ffc60cac-3746-5db5-93bd-462ea1a04ab7	not reported	Pharmaceutical Therapy, NOS	59f7a890-c898-4db3-a9e8-021974ccd32a
1dc10cee-ec11-4083-bba9-0c6e79445b42.htseq.counts.gz	e7ec9fb0-92ca-4392-9771-8e0e3dfde0a1	TCGA-E5-A4U1-01A-11R-A31N-07	TCGA-E5-A4U1-01A-11R	TCGA-E5-A4U1-01A-01-TS1		TCGA-E5-A4U1-01A-11	TCGA-E5-A4U1-01A	TCGA-E5-A4U1	1c28f311-e0b0-4292-b29a-c6757665a4a4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	504	200.0	False	false	0010AA87-DA61-42F2-8A3D-49DCDDB7484C	1.86	fee1bb5e-af08-43f5-a313-ebe56ceb6a37			0.18	23	released	aaa03b68-f9dd-4627-80a3-7c8fa8e64d93	RNA	R	0.18	UV Spec	released	False	aa30f93f-7571-4951-b846-b0da8165f58a	11	0.0	0.0	0.0	0.0	5.0	5.0	90.0	90.0	TOP	706d0da9-fbc4-4810-b77f-6c42d408ee97	released												released	30.0	59e8792a-4a68-419d-b30c-3d16fc42a6ca	Primary Tumor	01	released	Not Reported	released	TCGA-E5-A4U1_demographic	72	-26305		2a63932f-c31c-51b5-8be0-0582fb0412be	not hispanic or latino	male	not reported	released	Alive	1939		TCGA-E5-A4U1_exposure	Not Reported	33.464034613304484		33ba5f87-8ceb-5ded-9200-25ceffaccb55	172.0		released	99.0	TCGA-E5-A4U1_diagnosis	26305	T2	M0	N0	Stage II	T2b	7th	not reported	0	1181	938e55b2-3028-51a3-b297-11df2266474a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-E5-A4U1_treatment_1	TCGA-E5-A4U1_treatment	released	a1843a1c-69af-534f-ba65-221467d5a723	yes	Pharmaceutical Therapy, NOS	released	c382cc96-283b-5d9a-b191-ad381d1d953c	no	Radiation Therapy, NOS	e7ec9fb0-92ca-4392-9771-8e0e3dfde0a1
64f1b5f5-28fc-40f6-a27f-547a05dbc6a8.htseq.counts.gz	a81f9743-adb5-4531-a8bc-665109e7c0c3	TCGA-FD-A3NA-01A-11R-A21D-07	TCGA-FD-A3NA-01A-11R	TCGA-FD-A3NA-01A-01-TSA		TCGA-FD-A3NA-01A-11	TCGA-FD-A3NA-01A	TCGA-FD-A3NA	14917461-dae4-44cb-909d-42ac45aef450	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	997	320.0	False	true	D738C31B-26D6-4B68-ABFE-01E6FE6A4F55	1.74	bb0c2732-5fb4-44e7-bc62-a645cf1c1a56			0.16	23	released	b3da05c4-6c39-41bd-a087-52576de6a8a0	RNA	R	0.16	UV Spec	released	False	4e1a741a-12ae-4ebb-8956-c0743f709409	11	5.0	2.0	0.0	2.0	0.0	25.0	75.0	75.0	TOP	d3a05ae7-36a3-4568-9ad1-af9b698e7e64	released												released	30.0	7bd000ab-6f48-4a9e-98a4-eaf47d6e3c05	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3NA_demographic	60	-21936		11e853f9-e12d-577a-a176-5f7fe73f0fbb	not hispanic or latino	male	white	released	Alive	1949		TCGA-FD-A3NA_exposure	Not Reported	25.54025516214297	2.4657534246575343	220ffb3f-4966-50db-8b23-6672e2d6c87c	177.8	45.0	released	80.74	TCGA-FD-A3NA_diagnosis	21936		MX	N0	Stage II	T2b	6th	not reported	0	1845	04b26302-055c-5613-906c-7a6feae29a93	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2009	TCGA-FD-A3NA_treatment_1	TCGA-FD-A3NA_treatment	released	6e51a6b4-bb47-588a-ad54-87a211412c5d	no	Pharmaceutical Therapy, NOS	released	88917c2e-6c75-5e52-80f7-c1d3fd603072	no	Radiation Therapy, NOS	a81f9743-adb5-4531-a8bc-665109e7c0c3
57fd6ef9-0c2f-48c5-9aeb-eff4726b1641.htseq.counts.gz	0fdd0aaf-7518-49b5-8b33-27f208bde725	TCGA-KQ-A41O-01A-12R-A352-07	TCGA-KQ-A41O-01A-12R	TCGA-KQ-A41O-01A-01-TSA		TCGA-KQ-A41O-01A-12	TCGA-KQ-A41O-01A	TCGA-KQ-A41O	9dd41965-7a62-464d-8a23-5c3f9565dd91	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	475	800.0	False	true	F8254DB1-B345-4799-9A39-56F06EB8DFF5	1.77	728aaa87-e83d-47ff-9559-5f2de0152949			0.16	23	released	77e226ec-d396-4a2e-8cbc-c9b0fb858f09	RNA	R	0.16	UV Spec	released	False	49504042-670a-4292-a0ca-bc3628a0637f	12	3.0	0.0	0.0	0.0	0.0	20.0	80.0	80.0	TOP	87725927-4bf3-4eab-bc4b-a16fe7680951	released												released	30.0	4d1b5d93-e1af-4c6b-b4f6-b327a6a82ae6	Primary Tumor	01	released	Not Reported	released	TCGA-KQ-A41O_demographic	84	-30774		0b7f6f57-1477-5390-9c88-7c4834dd30ba	not reported	male	not reported	released	Alive	1927		TCGA-KQ-A41O_exposure	Not Reported	18.818924310286423		de0b8443-7670-5591-8403-85e3df858625	163.0		released	50.0	TCGA-KQ-A41O_diagnosis	30774	TX	M0	N1	Stage IV	T3	7th	not reported	0	1538	a4e059f2-d702-51a5-8f0c-cba5a3877af8	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2011	TCGA-KQ-A41O_treatment	TCGA-KQ-A41O_treatment_1	released	b92ca137-77e7-5364-baa1-d1fe29ee4de4	no	Radiation Therapy, NOS	released	e8a3a966-f972-5146-90d6-224b7bed7fb9	no	Pharmaceutical Therapy, NOS	0fdd0aaf-7518-49b5-8b33-27f208bde725
a4d8965f-d69b-4074-a8ba-dc1780e2dc24.htseq.counts.gz	b8af7416-f421-4f7a-97ff-c350592e10fb	TCGA-CF-A47V-01A-11R-A23W-07	TCGA-CF-A47V-01A-11R	TCGA-CF-A47V-01A-01-TSA		TCGA-CF-A47V-01A-11	TCGA-CF-A47V-01A	TCGA-CF-A47V	e5086eab-c920-4e3e-a965-90f3f495363a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	206	420.0	False	true	D395DB4F-3DDF-48D2-97DE-0472E6B51A88	1.86	e43f2bcb-9ba5-4b65-9042-4d3b06224c0f			0.17	23	released	7cc2dcc4-bc77-4fff-9353-6e9f187c0f83	RNA	R	0.17	UV Spec	released	False	08c8b0b8-4e5b-4ef5-9520-da1aa8f870dd	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	99.0	TOP	8a9409be-f486-49f0-8152-6768ce2cb13e	released												released	30.0	50d76f90-60be-43ac-9de0-0242c1c2a13c	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47V_demographic	52	-19265		d26110e2-ef82-59ce-949b-d0cb44ecaefa	not hispanic or latino	male	asian	released	Alive	1960		TCGA-CF-A47V_exposure	Not Reported	20.17714852433227		082e8879-2c58-52b8-a657-aa4084489ee4	171.0		released	59.0	TCGA-CF-A47V_diagnosis	19265	T2	M0	N0	Stage II	T2	7th	not reported	0	379	ca79097f-1d2a-5622-8679-0e6c33a008d2	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A47V_treatment	TCGA-CF-A47V_treatment_1	released	fc5425d5-18d4-567b-82d2-787b5cc72895	yes	Radiation Therapy, NOS	released	f63fdc29-2662-55b5-a906-31d1720a2587	no	Pharmaceutical Therapy, NOS	b8af7416-f421-4f7a-97ff-c350592e10fb
a71e7122-02c6-4f90-b1ad-b651fa1f06a8.htseq.counts.gz	7cadc05b-1671-4a21-8b3e-d69007d1c854	TCGA-FT-A61P-01A-11R-A30C-07	TCGA-FT-A61P-01A-11R	TCGA-FT-A61P-01A-01-TSA		TCGA-FT-A61P-01A-11	TCGA-FT-A61P-01A	TCGA-FT-A61P	7c698a35-7694-47f0-b681-f08840b95c02	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	83	250.0	False	true	F2B10F1A-5A97-4FAE-8DF5-153FFBDE2C35	1.94	370c2202-46b7-4721-a1db-ee80f6ca7782			0.18	23	released	361a9d9c-4401-4b6f-8cca-bd97fa02db24	RNA	R	0.18	UV Spec	released	False	dffae8fb-3eef-4994-9fc2-91a411392b56	11	5.0	2.0	3.0	3.0	3.0	75.0	19.0	75.0	TOP	fe3064b6-bf4c-4824-9e26-3e5b3a7a8395	released												released	30.0	871de767-c6af-41a7-87cd-641cf2f59aa4	Primary Tumor	01	released	Not Reported	released	TCGA-FT-A61P_demographic	76	-28082		700c8415-94e9-5711-a122-84c87262bb2c	not hispanic or latino	male	white	released	Alive	1937		TCGA-FT-A61P_exposure	Not Reported	30.449826989619375	0.2191780821917808	6547a0a3-06bc-5158-9634-5e971b66ddf0	170.0	4.0	released	88.0	TCGA-FT-A61P_diagnosis	28082		MX	N2	Stage IV	T3b	7th	not reported	0	337	cfd3650c-fd00-50ee-853f-64f4f4e54240	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2013	TCGA-FT-A61P_treatment_1	TCGA-FT-A61P_treatment	released	b535ad56-1f6a-5e66-9769-5943b6f191ff	no	Pharmaceutical Therapy, NOS	released	a700bc82-0e14-5a9f-af4b-2bc01f0f0576	no	Radiation Therapy, NOS	7cadc05b-1671-4a21-8b3e-d69007d1c854
9a123f34-2427-4e44-944e-9cc29d15b921.htseq.counts.gz	ef11c5de-296b-49ec-94e2-21e3c56daa6c	TCGA-K4-A3WS-01A-11R-A22U-07	TCGA-K4-A3WS-01A-11R	TCGA-K4-A3WS-01A-01-TSA		TCGA-K4-A3WS-01A-11	TCGA-K4-A3WS-01A	TCGA-K4-A3WS	68adacd1-a16e-4489-9e68-792a6bd8811c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	175	130	False	true	57743D2E-0677-40AD-A1EE-430EFF8F3F2A	1.82	bf7a27d9-35a8-4c59-bf27-e3fa9b271e6e	2.21	13	0.17	23	released	ecb4c390-267e-4d98-a523-20e9287fff03	RNA	R	0.17	UV Spec	released	False	7d31161e-bd7c-464a-9312-75a409b063f6	11	1	0	1	0	0	54	45	70	TOP	fc4228f4-81b6-4771-8862-f04b15f18dde	released												released	30	54070ae0-0c10-4c10-b8bb-a7313b80a45f	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A3WS_demographic	66	-24124		b5e34d95-462a-5eac-bcb3-aec3599f5b1f	not hispanic or latino	male	white	released	Alive	1945		TCGA-K4-A3WS_exposure	Not Reported		1.36986301369863	7e48c16d-b88b-5853-9ec8-0158fc7ed729		25.0	released	292.0	TCGA-K4-A3WS_diagnosis	24124		MX	N0	Stage III	T3a	7th	not reported	0	761	df74f8db-09af-5791-8583-b19ce9d98114	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2011	TCGA-K4-A3WS_treatment_1	TCGA-K4-A3WS_treatment	released	880db3bf-0fb9-5b28-bb4f-5f56abbad3fd	no	Pharmaceutical Therapy, NOS	released	4c29bc84-4cbe-5d6d-8292-bd8e0f2c2abe	no	Radiation Therapy, NOS	ef11c5de-296b-49ec-94e2-21e3c56daa6c
2aa0ae87-9b93-4901-89aa-7cd45583cb3a.htseq.counts.gz	7e5e2925-ab20-499c-9652-f1f8a3d1b88a	TCGA-DK-AA75-01A-11R-A39I-07	TCGA-DK-AA75-01A-11R	TCGA-DK-AA75-01A-01-TSA		TCGA-DK-AA75-01A-11	TCGA-DK-AA75-01A	TCGA-DK-AA75	cea28eac-4442-4436-b737-536e45b89989	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	272	240.0	False	true	7BC5ECDC-33EB-42AA-AD88-71185A483309	1.92	8ac289ba-c81f-44ed-9fb4-8c2af9eccdb0			0.16	23	released	b0fa8c0a-c318-40b3-878c-0cc536887f9f	RNA	R	0.16	UV Spec	released	False	01c4e335-b5b7-4a46-8908-884497045dab	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	3077c4ef-6c0d-4290-849f-7dd900a4b422	released												released	30.0	5346c3ec-3060-40c5-8ad4-c6e4d37c8909	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA75_demographic	82	-30090	340	3310012c-d638-583a-9ce1-a78f2b8a3b85	not hispanic or latino	male	white	released	Dead	1931	2013	TCGA-DK-AA75_exposure	Not Reported	27.13141179099237	1.643835616438356	778e3ea9-4642-52b4-8838-a1b34ec8da3a	177.0	30.0	released	85.0	TCGA-DK-AA75_diagnosis	30090		M0	N0	Stage III	T3	7th	not reported	0		13cd6aea-e2d5-50af-a433-2a9763667566	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2013	TCGA-DK-AA75_treatment_1	TCGA-DK-AA75_treatment	released	ec91e249-584b-58e3-9847-4260697eb16c	no	Pharmaceutical Therapy, NOS	released	a92b9309-56c2-502b-b7e1-ee29d780cb62	no	Radiation Therapy, NOS	7e5e2925-ab20-499c-9652-f1f8a3d1b88a
da788779-75a5-496b-b056-d356cd77ca65.htseq.counts.gz	48f19949-5919-4eab-a39a-2ea5a1d62c0e	TCGA-HQ-A2OF-01A-11R-A26T-07	TCGA-HQ-A2OF-01A-11R	TCGA-HQ-A2OF-01A-01-TSA		TCGA-HQ-A2OF-01A-11	TCGA-HQ-A2OF-01A	TCGA-HQ-A2OF	691adaa9-196a-4b62-9437-640c4ae6e2b2	Adenomas and Adenocarcinomas	Bladder	TCGA-BLCA		140.0	False	false	255B8E38-1BBF-4B3B-B3C6-99F5A41779EA	1.8	99471b35-21e6-44cb-863e-d60521a71b31			0.15	23	released	ddcfa3d6-001e-46f6-843f-d521b76008f1	RNA	R	0.15	UV Spec	released	False	8d2a9597-fa2a-443b-9665-600451bfc194	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	eccae8ee-d845-4715-a97f-a1f573cbf53d	released												released	30.0	6a971539-f1c4-4404-b825-6b50bdbd9b11	Primary Tumor	01	released	Not Reported	released	TCGA-HQ-A2OF_demographic	52	-19016		8ff05f53-85aa-5782-a8aa-d781914eb625	not reported	female	not reported	released	Alive			TCGA-HQ-A2OF_exposure	Not Reported	25.970115548195263		ba660ac9-62cc-5bfd-bda7-8b7432717a09	163.0		released	69.0	TCGA-HQ-A2OF_diagnosis	19016		M0	N0	Stage III	T3b	6th	not reported	0	1947	53818876-dd70-5e73-9c70-221ed603e4ec	C67.1	not reported	8260/3	Papillary adenocarcinoma, NOS	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii		TCGA-HQ-A2OF_treatment	TCGA-HQ-A2OF_treatment_1	released	17b517ac-2ae5-53d5-871d-3196702fdeaf	yes	Radiation Therapy, NOS	released	351dd910-95f3-5c34-9f9f-09988eb0077d	yes	Pharmaceutical Therapy, NOS	48f19949-5919-4eab-a39a-2ea5a1d62c0e
23069015-19eb-403d-91df-8ae3198a8c9c.htseq.counts.gz	271fea6e-ef30-4d2f-bf3b-268f2715129d	TCGA-FD-A5BX-01A-11R-A26T-07	TCGA-FD-A5BX-01A-11R	TCGA-FD-A5BX-01A-01-TSA		TCGA-FD-A5BX-01A-11	TCGA-FD-A5BX-01A	TCGA-FD-A5BX	6bd85ae2-9d27-4285-a280-4469dd2a8b0a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	146	310.0	False	true	0D074A99-0D21-4430-B82F-28E56A0D4242	1.9	bd49f808-37de-43a4-8a5f-7a36b9661a16			0.17	23	released	62c243c3-1e7a-44d1-8a2f-28e656c00b51	RNA	R	0.17	UV Spec	released	False	f2c290f8-999b-44ee-ab64-c9e56e726c08	11	5.0	2.0	6.0	3.0	0.0	24.0	70.0	70.0	TOP	ff6f5ba9-e30a-438d-9bc0-f339210f8830	released												released	30.0	0ac8e522-3c64-42f2-a66f-bd40530a328a	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BX_demographic	82	-30276	173	02f07625-8676-5273-a2cd-62a26cc320b4	not hispanic or latino	male	white	released	Dead	1930	2012	TCGA-FD-A5BX_exposure	Not Reported	33.95918367346939	6.082191780821918	b4a036f4-1384-5964-a6ca-89ce7b211883	175.0	111.0	released	104.0	TCGA-FD-A5BX_diagnosis	30276		MX	N1	Stage IV	T3b	7th	not reported	0		39f361f5-ec1f-56c1-a8a7-fdf62a85e35d	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2012	TCGA-FD-A5BX_treatment	TCGA-FD-A5BX_treatment_1	released	31d9019c-c9d0-5f34-b926-1e67d203f368	no	Radiation Therapy, NOS	released	4da4e88b-363f-596a-808c-4673d246d380	no	Pharmaceutical Therapy, NOS	271fea6e-ef30-4d2f-bf3b-268f2715129d
a466927a-fe3d-4efe-9509-3a08338fe859.htseq.counts.gz	b314b5d3-800d-4d10-9cf8-03391503c08b	TCGA-CU-A3KJ-01A-11R-A21D-07	TCGA-CU-A3KJ-01A-11R	TCGA-CU-A3KJ-01A-01-TSA		TCGA-CU-A3KJ-01A-11	TCGA-CU-A3KJ-01A	TCGA-CU-A3KJ	a75584bc-bef7-48f6-b4b3-c1472a3af768	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	204	360.0	False	false	DC5E6643-868B-40C6-AC67-B594E2F7BFBA	1.79	511d6289-1558-4e90-a77a-05298e15b17c			0.15	23	released	a418fd44-ed1d-4be0-a608-50aaae931682	RNA	R	0.15	UV Spec	released	False	1a23f6db-78fa-4c66-99e4-d4104b33dde3	11	2.0	0.0	5.0	0.0	0.0	0.0	95.0	95.0	TOP	073c82b1-ae75-4a24-b0df-4ebc42c31ebc	released												released	30.0	3d92f5a6-949a-4176-9309-4294cca6fc25	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A3KJ_demographic	75	-27692		5d9f9ef8-8dd4-5fe8-a0cd-1b01fe396852	not hispanic or latino	male	white	released	Alive	1936		TCGA-CU-A3KJ_exposure	Not Reported	23.93948099205209	3.287671232876712	848877fc-573f-5d9c-b77c-01f5768b1738	177.0	60.0	released	75.0	TCGA-CU-A3KJ_diagnosis	27692		M0	N0	Stage III	T3b	7th	not reported	0	562	a2dfbef5-eb0f-5704-b686-4a87d1152c22	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2011	TCGA-CU-A3KJ_treatment	TCGA-CU-A3KJ_treatment_1	released	d55fe580-9722-5252-9f22-e79ea0c1d155	no	Radiation Therapy, NOS	released	ca8c223f-fc39-5514-a13a-25ed449995c1	yes	Pharmaceutical Therapy, NOS	b314b5d3-800d-4d10-9cf8-03391503c08b
094bf3c0-e72b-46a6-b940-9683a0039dfa.htseq.counts.gz	8ac1ec32-9a54-45d6-93d3-67c7c2dff672	TCGA-G2-A2ES-01A-11R-A180-07	TCGA-G2-A2ES-01A-11R	TCGA-G2-A2ES-01A-01-TSA		TCGA-G2-A2ES-01A-11	TCGA-G2-A2ES-01A	TCGA-G2-A2ES	72d8eae8-9efb-45b2-acbd-82c6b5732e38	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	694	670	False	true	A9EE4140-E3B4-4DF3-A898-65CCEAFE4072	1.97	fac8f7fd-3e80-410a-a281-2b564862b335	2.08	13	0.16	23	released	4e628441-b16a-48e1-9d7e-f3cb95fa36c3	RNA	R	0.16	UV Spec	released	False	7f6045e8-af9d-4846-9d70-a2cd6ffa9bb9	11	2	0	20	0	0	25	55	75	TOP	fe5d9ba0-e774-488b-a442-27cd0c77130b	released												released	30	c2288290-f17a-435c-90e7-5a4913f0c076	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2ES_demographic	85	-31293	1004	66f8487f-c6d2-5d92-b42f-d3409fdc0c37	not hispanic or latino	male	white	released	Dead	1924		TCGA-G2-A2ES_exposure	Not Reported	29.333844042261163	3.5616438356164384	1435a694-db16-5d1d-9f9e-0c062d0694a5	177.0	65.0	released	91.9	TCGA-G2-A2ES_diagnosis	31293		M0	N0	Stage II	T3b	6th	not reported	0	525	d701d225-efe4-568e-be12-f28996929a7c	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2009	TCGA-G2-A2ES_treatment	TCGA-G2-A2ES_treatment_1	released	a99173d5-9a73-546a-b172-4887e5c5c0e5	no	Radiation Therapy, NOS	released	16349c3e-175c-5d31-83b7-aa31f747aed2	no	Pharmaceutical Therapy, NOS	8ac1ec32-9a54-45d6-93d3-67c7c2dff672
27d5e9a3-b7b0-40b3-9f53-a074bef5628b.htseq.counts.gz	19b691c1-7649-4d3d-a2d0-1f1c3c4838bb	TCGA-FD-A6TI-01A-11R-A32O-07	TCGA-FD-A6TI-01A-11R	TCGA-FD-A6TI-01A-01-TSA		TCGA-FD-A6TI-01A-11	TCGA-FD-A6TI-01A	TCGA-FD-A6TI	0f956645-35aa-4a68-98d3-ea589459be00	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	68	1110.0	False	true	9262DABE-98EE-4544-8907-124CDE5197C0	1.9	c1ce17a6-3e8b-41b7-97bc-9213b352ce84			0.17	23	released	c06fc898-5ae9-4f95-81b9-843522ea7db6	RNA	R	0.17	UV Spec	released	False	1ef6fb15-5e86-4287-9c89-21e630422901	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	85.0	TOP	e46d1233-7e3c-4524-acb0-0decb0dd990c	released												released	30.0	8a145be8-1299-4837-b5da-83865d8ab461	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TI_demographic	73	-26874	294	335cc9ea-44cf-59ad-990c-8d424f2cba58	not hispanic or latino	male	white	released	Dead	1940		TCGA-FD-A6TI_exposure	Not Reported	45.36940686784599		744a624d-094b-583b-a283-edcc16c054d6	155.0		released	109.0	TCGA-FD-A6TI_diagnosis	26874	T2	MX	N1	Stage IV	T4b	7th	not reported	0	122	f31c3ee3-0f2a-518c-80f4-da61c7c637e4	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iv	2013	TCGA-FD-A6TI_treatment	TCGA-FD-A6TI_treatment_1	released	fb0b9f11-64c7-58ee-8b96-42911a345ee1	no	Radiation Therapy, NOS	released	ef62c97a-2e9e-5f35-89d8-839e02519749	no	Pharmaceutical Therapy, NOS	19b691c1-7649-4d3d-a2d0-1f1c3c4838bb
8e34285e-dbd0-4f4d-916e-0c74e722e640.htseq.counts.gz	f170cca2-65b5-4c6c-84ca-208a6b4bc03e	TCGA-XF-A9SL-01A-11R-A39I-07	TCGA-XF-A9SL-01A-11R	TCGA-XF-A9SL-01A-01-TSA		TCGA-XF-A9SL-01A-11	TCGA-XF-A9SL-01A	TCGA-XF-A9SL	51fdb034-5d05-427b-b6b8-b6eecd65d976	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3423	650.0	False	true	D8FA25D2-8119-47BA-8ECD-A2EA6E56E7B3	1.84	c5f00487-d24a-46fc-9f15-f7fc22e28e0b			0.18	23	released	f6687dff-7051-4242-90ca-ddfb9f324083	RNA	R	0.18	UV Spec	released	False	473cfee6-5bce-4c04-8a35-78a965c907dc	11	10.0	2.0	0.0	5.0	0.0	40.0	60.0	60.0	TOP	f3475b46-5cd9-46b1-8fcf-f055d1e2ebd1	released												released	30.0	f298b46c-ce8b-4ce6-870e-ea6f3e139f46	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SL_demographic	69	-25460	2020	74f7a311-8b2f-56e4-83ca-dcab272a6761	not hispanic or latino	male	white	released	Dead	1935	2009	TCGA-XF-A9SL_exposure	Not Reported	29.06122448979592	3.0136986301369864	d5d02980-54ff-58ed-b93e-e437f819df38	175.0	55.0	released	89.0	TCGA-XF-A9SL_diagnosis	25460		MX	N2	Stage IV	T3a	6th	not reported	0		a482f699-6d40-5b24-b032-72a51bb0ec6f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2004	TCGA-XF-A9SL_treatment	TCGA-XF-A9SL_treatment_1	released	c606500a-6977-59f8-9f3d-b2ac95d6e355	no	Radiation Therapy, NOS	released	c236acc1-21c7-543a-be75-5ffbe4dc1e8d	no	Pharmaceutical Therapy, NOS	f170cca2-65b5-4c6c-84ca-208a6b4bc03e
f018a202-567b-4ab7-9970-bf4ec8c1dff8.htseq.counts.gz	2cba507b-7b5b-42a3-9847-a2882860aa8a	TCGA-G2-A2EO-01A-11R-A180-07	TCGA-G2-A2EO-01A-11R	TCGA-G2-A2EO-01A-01-TSA		TCGA-G2-A2EO-01A-11	TCGA-G2-A2EO-01A	TCGA-G2-A2EO	98b9ad62-76ed-43e3-91bc-b8f065d79673	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	597	350.0	False	true	AB5DCF8B-A35D-4B20-A108-AB443795D3F3	1.88	91c8d1c3-1afe-4c4c-ae81-7d1f989e0139			0.18	23	released	f63b2542-ab81-48f0-9777-24651920b4fe	RNA	R	0.18	UV Spec	released	False	b59cb121-d227-4864-9a0e-1bb863a98fff	11	2.0	0.0	5.0	0.0	0.0	35.0	60.0	85.0	TOP	96ade22a-ff0e-4d79-9fd9-e6860be4d576	released												released	30.0	3a663626-0765-4dcb-8489-53f585e663ec	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EO_demographic	69	-25440	1804	e81271ac-532d-5adc-9e59-2d028a548bd9	not hispanic or latino	male	white	released	Dead	1940		TCGA-G2-A2EO_exposure	Not Reported	26.929114841202754		8be90731-573f-5b15-b88d-0350581f1a5e	182.0		released	89.2	TCGA-G2-A2EO_diagnosis	25440		M0	N0	Stage III	T3a	6th	not reported	0	1072	2a2474b8-914e-5623-9d0e-0882a91c4e81	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2009	TCGA-G2-A2EO_treatment	TCGA-G2-A2EO_treatment_1	released	305fe109-e1c6-55a9-be07-939d169dbb53	no	Radiation Therapy, NOS	released	cb658e58-dc86-5969-a1ca-44c730941c71	no	Pharmaceutical Therapy, NOS	2cba507b-7b5b-42a3-9847-a2882860aa8a
6c490675-8eb5-4f77-82be-008585cd8192.htseq.counts.gz	0dbc73a0-781f-4323-9d56-0ca7a5094423	TCGA-XF-A9T6-01A-11R-A42T-07	TCGA-XF-A9T6-01A-11R	TCGA-XF-A9T6-01A-01-TSA		TCGA-XF-A9T6-01A-11	TCGA-XF-A9T6-01A	TCGA-XF-A9T6	6ee18b9a-3f45-491f-9535-502820cfcf46	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2044	620.0	False	true	84E24E42-02F8-471F-B8A4-B50D89056CA2	1.86	cbc184c2-4bda-4a56-9b49-453f503e16ab			0.17	23	released	ed06a2c5-be1c-4f16-842e-c83d25fe9c09	RNA	R	0.17	UV Spec	released	False	3cebbf97-04f9-49ab-a8cd-4030fdc39e57	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	88d9f37c-d96d-40bd-962c-400570d2bb56	released												released	30.0	3ef041c5-ffd2-497e-89b6-0e5c552d279c	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T6_demographic	88	-32207		4a047724-7ef2-598d-9e25-9d23d606a4d3	not hispanic or latino	female	white	released	Alive	1920		TCGA-XF-A9T6_exposure	Not Reported	29.21010994360826		bcfb7fdf-39e4-5c81-870a-24a1f516c0a0	157.0		released	72.0	TCGA-XF-A9T6_diagnosis	32207		MX	N0	Stage III	T3b	6th	not reported	0	64	5286fa32-d0ab-5107-93c5-8ae61f89488e	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2008	TCGA-XF-A9T6_treatment	TCGA-XF-A9T6_treatment_1	released	0828ce8d-0404-5a48-9f44-6b7dccb353ac	not reported	Radiation Therapy, NOS	released	1fc2565c-5993-5622-8f28-7e7b79da8a69	not reported	Pharmaceutical Therapy, NOS	0dbc73a0-781f-4323-9d56-0ca7a5094423
762bff64-4ded-493f-b1e6-0c257468ff72.htseq.counts.gz	26a7650a-8293-477f-af2a-920d9a344cbb	TCGA-GV-A40G-01A-11R-A23N-07	TCGA-GV-A40G-01A-11R	TCGA-GV-A40G-01A-01-TS1		TCGA-GV-A40G-01A-11	TCGA-GV-A40G-01A	TCGA-GV-A40G	10422fe9-8d70-40a9-9875-3fe9fab68823	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	99	500.0	False	true	28754343-DA2B-4608-A66C-B4E41B52F6FF	1.83	73220a3d-e4e3-4494-a832-86baa98333b4			0.18	23	released	86dfcd87-fb9f-4b59-8e1f-f304146f7f73	RNA	R	0.18	UV Spec	released	False	eab7df5d-2c4c-4c40-ac0d-90ef5f913dc2	11	1.0	0.0	0.0	0.0	0.0	5.0	95.0	90.0	TOP	41997bab-e4cb-411a-9aa5-30350bf4968a	released												released	30.0	fe3f7c73-8e04-48ba-af35-e369f5c62e98	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A40G_demographic	77	-28204		4d27995f-e82e-515c-a4e4-b8bae7cdf96c	not hispanic or latino	male	white	released	Alive	1935		TCGA-GV-A40G_exposure	Not Reported	25.30864197530864	1.643835616438356	4a8751b2-57d9-585b-9c4a-6dcc682da85f	180.0	30.0	released	82.0	TCGA-GV-A40G_diagnosis	28204		MX	N0	Stage II	T2a	7th	not reported	0	580	9462cd0e-5e22-5e62-8178-6d9de4e39b38	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2012	TCGA-GV-A40G_treatment	TCGA-GV-A40G_treatment_1	released	c957db9d-1fd1-579d-b06c-694bc2b99a6c	no	Radiation Therapy, NOS	released	f4c75b70-c1e9-5c40-a7d5-aaad32f115dc	no	Pharmaceutical Therapy, NOS	26a7650a-8293-477f-af2a-920d9a344cbb
857ff1e4-0239-4f20-a6df-b4047660055d.htseq.counts.gz	57d457b8-22cf-43f3-9c5b-4d81f696da22	TCGA-XF-A9T0-01A-11R-A39I-07	TCGA-XF-A9T0-01A-11R	TCGA-XF-A9T0-01A-01-TSA		TCGA-XF-A9T0-01A-11	TCGA-XF-A9T0-01A	TCGA-XF-A9T0	5f5c1775-a908-483d-8a77-b902c5b7570e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2323	770.0	False	true	BD4F0E43-3FE5-4059-875E-70E998BEF60F	1.88	fe25dbd6-adbf-47a3-9929-f392d5347bde			0.16	23	released	6affedaf-0243-4750-8e75-481fd2e63acc	RNA	R	0.16	UV Spec	released	False	12a63e5d-9ffb-48ae-b6c1-d82a93cf020e	11	0.0	0.0	0.0	0.0	15.0	15.0	70.0	80.0	TOP	c9095cda-1907-443c-8762-a049ffabebf0	released												released	30.0	b97891bc-bf12-4c81-a2bb-b15e341b4bdf	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T0_demographic	68	-25190		cea5af48-b403-5ace-b203-9038249175d5	not hispanic or latino	male	white	released	Alive	1939		TCGA-XF-A9T0_exposure	Not Reported	25.88057063502083		3ce16fce-a038-5fd8-9a97-7eed4c156747	178.0		released	82.0	TCGA-XF-A9T0_diagnosis	25190		MX	N0	Stage III	T3b	6th	not reported	0	799	383d65d7-6797-5842-ac0c-eea1c7e7a10f	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2007	TCGA-XF-A9T0_treatment_1	TCGA-XF-A9T0_treatment	released	e224b767-7116-5fed-a043-b42ab514e800	no	Pharmaceutical Therapy, NOS	released	43d5070f-403c-535d-a2e8-9efce3a88922	no	Radiation Therapy, NOS	57d457b8-22cf-43f3-9c5b-4d81f696da22
55dccdbb-45a5-4bc1-963a-4f5a30aef326.htseq.counts.gz	2b0e3153-19d8-4c62-8bb3-dd4656b86724	TCGA-GV-A6ZA-01A-12R-A33J-07	TCGA-GV-A6ZA-01A-12R	TCGA-GV-A6ZA-01A-01-TS1		TCGA-GV-A6ZA-01A-12	TCGA-GV-A6ZA-01A	TCGA-GV-A6ZA	f5c187ef-dc08-4466-932a-43aa33285673	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	322	660.0	False	true	7FF8C90D-50A3-435B-B3C9-306DC4973DC9	1.89	5d19bc28-408e-4dc6-bc4b-95b28fa0dddc			0.18	23	released	910f3c48-ae9c-4ff5-8d79-a3646edb262e	RNA	R	0.18	UV Spec	released	False	99f019dc-c69e-4bd1-a3d6-ce9799e4de76	12	0.0	0.0	5.0	0.0	0.0	10.0	85.0	95.0	TOP	5b052a25-5295-4218-b14e-16ede6f218f5	released												released	30.0	927ac1a0-08c1-4d62-86c3-0df801fadbb9	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A6ZA_demographic	54	-19871		e18d4ad4-c658-5e0d-a499-acad2b7c0649	not hispanic or latino	male	white	released	Alive	1958		TCGA-GV-A6ZA_exposure	Not Reported	25.99243856332703		6195e8d9-cab8-59da-b104-d1c38cc614e7	184.0		released	88.0	TCGA-GV-A6ZA_diagnosis	19871		MX	N0	Stage II	T2b	7th	not reported	0	691	647cf9c1-c15e-5033-8763-a5f01227f2df	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-GV-A6ZA_treatment_1	TCGA-GV-A6ZA_treatment	released	0dd59467-24ed-509e-bc28-7a1978e7a4e1	no	Pharmaceutical Therapy, NOS	released	ff1aa7d0-ac44-50bb-8abe-9445689e557f	no	Radiation Therapy, NOS	2b0e3153-19d8-4c62-8bb3-dd4656b86724
9df07e2e-809d-4b3c-8af9-1091aa388c25.htseq.counts.gz	3358817d-3125-43ab-9466-96e0b36dc728	TCGA-DK-A3IN-01A-11R-A20F-07	TCGA-DK-A3IN-01A-11R	TCGA-DK-A3IN-01A-01-TSA		TCGA-DK-A3IN-01A-11	TCGA-DK-A3IN-01A	TCGA-DK-A3IN	fc0032db-b6d8-4da3-bd1b-beec4196abf0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	209	1020.0	False	true	750A04D5-2521-4E30-AEE6-E79BA25D6CC1	1.78	58382a39-eb95-4cd0-ad04-48c6da4b4a56			0.16	23	released	ea6dd021-2d74-483c-b225-e3ff5716d9a5	RNA	R	0.16	UV Spec	released	False	f6b7a5f5-cdae-4670-aae9-1cfcabffe944	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	3ca0db0a-fa04-4749-942b-f02f06fb6f2f	released												released	30.0	f8c14183-3982-44e5-967e-03967eaa8123	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IN_demographic	72	-26562	250	85aef21f-219f-5f67-89e7-3acf60d690bd	not hispanic or latino	male	white	released	Dead	1939	2011	TCGA-DK-A3IN_exposure	Not Reported	32.276224432351285	2.191780821917808	df3da276-d338-5995-a90d-f52d5677d6be	182.5	40.0	released	107.5	TCGA-DK-A3IN_diagnosis	26562		M0	N0	Stage III	T4a	7th	not reported	0		e28be400-26e7-52f0-8880-e455bd45253c	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2011	TCGA-DK-A3IN_treatment_1	TCGA-DK-A3IN_treatment	released	544ab690-17fb-5d34-9a0d-b1a81364b85d	no	Pharmaceutical Therapy, NOS	released	fc6b80b4-ae89-5ced-af38-d6d7df7c77f2	no	Radiation Therapy, NOS	3358817d-3125-43ab-9466-96e0b36dc728
c31622fb-6640-4050-8867-b695fe2d6a79.htseq.counts.gz	261b0aa8-21b6-4bdd-b0f1-ebad48d0b010	TCGA-GD-A3OQ-11A-21R-A220-07	TCGA-GD-A3OQ-11A-21R	TCGA-GD-A3OQ-11A-02-TS2		TCGA-GD-A3OQ-11A-21	TCGA-GD-A3OQ-11A	TCGA-GD-A3OQ	2e85c30c-c4c4-4096-9eef-4eb2c7d991a3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	297	490	False	false		1.82	bf1d6946-63b3-48ca-add1-1c5ec5cafd22	2.08	13	0.16	23	released	9994ff0c-9596-406e-aa14-060943c6fc3b	RNA	R	0.16	UV Spec	released	False	a0e2acfa-5477-493b-950c-2f3afffa5eab	21	0	0	0	0	10	90	0	0	TOP	b5f4bcd4-3153-4e86-832d-2d44457dab40	released												released	30	fa1b5772-8254-49ba-a385-af8c9ac7fa4f	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GD-A3OQ_demographic	48	-17682		def9d36b-00cd-5135-bae9-2f44cba27d54	not hispanic or latino	male	white	released	Alive	1963		TCGA-GD-A3OQ_exposure	Not Reported		1.6986301369863013	eb45ba1b-25d4-5588-af1f-aeef4768c855		31.0	released		TCGA-GD-A3OQ_diagnosis	17682	T2	MX	N1	Stage IV	T4a	7th	not reported	0	95	06be2b44-a613-51e1-8888-5bba9ffea8a0	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A3OQ_treatment	TCGA-GD-A3OQ_treatment_1	released	bfe3ffeb-5263-50dd-8fa1-2dff3b591255	not reported	Radiation Therapy, NOS	released	2b12a9f0-d64c-56b8-b8a9-4904e3c55e09	not reported	Pharmaceutical Therapy, NOS	261b0aa8-21b6-4bdd-b0f1-ebad48d0b010
07c84fed-72b8-49a4-a29c-050b6c299dc7.htseq.counts.gz	90a504a0-54ca-4188-a3c8-b65e1d91a695	TCGA-K4-A5RI-01A-11R-A28M-07	TCGA-K4-A5RI-01A-11R	TCGA-K4-A5RI-01A-01-TSA		TCGA-K4-A5RI-01A-11	TCGA-K4-A5RI-01A	TCGA-K4-A5RI	32efe5e2-e037-4547-8ead-619f61647639	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	100	320.0	False	true	F61654B9-A305-40B9-97FE-A22B9EE1375D	1.91	d3cf6983-3dfc-4533-8809-605c197fc24e			0.18	23	released	73dbcb00-a138-4024-b1db-0fe0cd164969	RNA	R	0.18	UV Spec	released	False	36c46c53-ef58-4178-9eb9-d6e2f76babfe	11	5.0	0.0	1.0	0.0	0.0	49.0	50.0	75.0	TOP	42903a95-8a7a-4f8e-aa63-cf017823698a	released												released	30.0	6e3f1eb8-b294-4058-b8dd-fc853d13b3f0	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A5RI_demographic	67	-24614	356	03b0ba6d-583e-5e7b-b611-c822b816ef26	not hispanic or latino	female	white	released	Dead	1945		TCGA-K4-A5RI_exposure	Not Reported		2.191780821917808	f1fd650a-d554-5859-9681-e6814a58566c		40.0	released		TCGA-K4-A5RI_diagnosis	24614	TX	MX	N0	Stage III	T3a	7th	not reported	0	239	44e07161-3e32-5449-b116-b12631536330	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-K4-A5RI_treatment_1	TCGA-K4-A5RI_treatment	released	569c1f76-4670-546f-9663-a029a5d04723	no	Pharmaceutical Therapy, NOS	released	3a1070e8-5108-59d7-86ab-bb62a29c1f78	no	Radiation Therapy, NOS	90a504a0-54ca-4188-a3c8-b65e1d91a695
e5e13a00-2365-497e-9145-1f6c5982416c.htseq.counts.gz	4f5e7d67-b8b8-47ff-8acd-199baa5270ba	TCGA-GC-A3I6-01A-11R-A20F-07	TCGA-GC-A3I6-01A-11R	TCGA-GC-A3I6-01A-01-TSA		TCGA-GC-A3I6-01A-11	TCGA-GC-A3I6-01A	TCGA-GC-A3I6	74cbb078-9aae-422a-a7af-dd29ebca949e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	132	320.0	False	false	FFC0F91A-AC95-4E02-BE22-EBDAE89AB5EA	1.84	652f8ab9-33b6-4e10-a84e-1e1b1ef0b707			0.16	23	released	915fc1ae-4880-4404-bc2b-1382f445830e	RNA	R	0.16	UV Spec	released	False	d44d60d0-41a7-490a-8556-1886f6d1cfbb	11	2.0	1.0	0.0	1.0	0.0	20.0	80.0	80.0	TOP	541c0db2-76de-4828-a4fe-ddd05e92e912	released												released	30.0	db9442f6-38f2-4092-9e85-f5ec0c924025	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3I6_demographic	45	-16504	630	838b36a7-3150-55ae-b848-8ebc11016b25	not hispanic or latino	male	white	released	Dead	1966		TCGA-GC-A3I6_exposure	Not Reported	27.379664683612763		c57d1f59-1375-551f-823a-e7de3a7bf51c	172.0		released	81.0	TCGA-GC-A3I6_diagnosis	16504		M0	N0	Stage III	T3a	7th	not reported	0	68	0a7550d5-165b-5e74-bcde-6d72098ab14c	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-GC-A3I6_treatment_1	TCGA-GC-A3I6_treatment	released	346e6ce9-6157-52ff-bc9c-07b76be25a36	yes	Pharmaceutical Therapy, NOS	released	7cc5140f-6384-50c6-a588-fc60dfb0616b	no	Radiation Therapy, NOS	4f5e7d67-b8b8-47ff-8acd-199baa5270ba
e9568b78-a371-42c0-88a0-813231c14aaf.htseq.counts.gz	a05a4575-c2cf-4aba-b7ca-c2c21797348d	TCGA-DK-A6B1-01A-12R-A30C-07	TCGA-DK-A6B1-01A-12R	TCGA-DK-A6B1-01A-01-TSA		TCGA-DK-A6B1-01A-12	TCGA-DK-A6B1-01A	TCGA-DK-A6B1	0d2cd56c-09c6-467d-b3aa-1f7fe0cc60e1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2059	230.0	False	true	D475F198-6FFF-4869-922E-5E0F5BC564C9	1.9	a66ddf41-6af9-47c0-952b-688aac83c8c8			0.17	23	released	8545e1ec-6f29-454e-b9ca-c6957fcb44e0	RNA	R	0.17	UV Spec	released	False	82f1f5da-d82e-402c-8841-04291580c23f	12	1.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	957872bb-a61c-44e4-ae19-63afd41b2b31	released												released	30.0	7da631ce-b5f9-480d-a420-ebbe76a0927c	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A6B1_demographic	67	-24607		eb0bb9bb-0691-5773-9232-5ba2f7ad7b3e	not hispanic or latino	male	white	released	Alive	1940		TCGA-DK-A6B1_exposure	Not Reported	29.6398891966759		8feaa700-a89d-5a9d-8e85-e02b06bb09c9	190.0		released	107.0	TCGA-DK-A6B1_diagnosis	24607		M0	N0	Stage II	T2a	6th	not reported	0	2049	01615479-fe27-50bd-8258-1d2cda0ae0d9	C67.3	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Anterior wall of bladder	released	Not Reported	Anterior wall of bladder	not reported	stage ii	2007	TCGA-DK-A6B1_treatment	TCGA-DK-A6B1_treatment_1	released	23562093-2cf8-5cd0-9c12-4c01b0f9d933	no	Radiation Therapy, NOS	released	61e3a4a0-d93d-519a-ba05-451b3c343af7	no	Pharmaceutical Therapy, NOS	a05a4575-c2cf-4aba-b7ca-c2c21797348d
66ed83db-99e7-4aa3-81a6-ebe05acf2054.htseq.counts.gz	439071ac-fa32-4871-9ede-c0aecb19f078	TCGA-XF-A9SV-01A-21R-A42T-07	TCGA-XF-A9SV-01A-21R	TCGA-XF-A9SV-01A-02-TSB		TCGA-XF-A9SV-01A-21	TCGA-XF-A9SV-01A	TCGA-XF-A9SV	cdfd86db-15e2-4d38-a717-2207e8de2d8f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2848	740.0	False	true	5C45E09E-9B8A-4CD4-92CC-873CF78D2524	1.83	d855e064-11e2-436f-8433-b114b4709247			0.17	23	released	af33ba7a-bb0d-4fd9-9eea-0f537268adc8	RNA	R	0.17	UV Spec	released	False	7b72b92b-0bd5-48a2-94a3-4aea5a644204	21	3.0	1.0	2.0	5.0	0.0	28.0	70.0	70.0	TOP	f16690da-b943-4d03-b4d8-720df2ab90a0	released												released	30.0	098e5b61-7125-4f72-b2a4-e0fdc4327ac9	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SV_demographic	82	-30265	388	d9b5b58a-4847-53c0-bb76-69ca41bcb55d	not hispanic or latino	male	white	released	Dead	1924	2007	TCGA-XF-A9SV_exposure	Not Reported	22.839506172839506	1.095890410958904	bc7a0dcf-ea2b-54de-a829-2af1112c4ebb	180.0	20.0	released	74.0	TCGA-XF-A9SV_diagnosis	30265		M1	N2	Stage IV	T4a	6th	not reported	0		8f75d112-8447-5fd5-a7d0-f3dda420fbf8	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-A9SV_treatment	TCGA-XF-A9SV_treatment_1	released	4aace4ac-49e3-5326-b71b-239947f4db0b	no	Radiation Therapy, NOS	released	d0a99e32-a99b-5c6c-910f-222398332205	yes	Pharmaceutical Therapy, NOS	439071ac-fa32-4871-9ede-c0aecb19f078
6ceed729-4ede-4103-8f42-c00eb2266292.htseq.counts.gz	10b6eef8-a5eb-4c0e-8734-987cef4898f8	TCGA-XF-AAN2-01A-11R-A42T-07	TCGA-XF-AAN2-01A-11R	TCGA-XF-AAN2-01A-01-TSA		TCGA-XF-AAN2-01A-11	TCGA-XF-AAN2-01A	TCGA-XF-AAN2	987e8157-fbea-40f3-aa01-0092d6cceb97	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2505	280.0	False	true	00D2C4D3-B209-4B54-992D-54E8048415BA	1.82	b1af0c13-8e8b-456f-9e4c-c8c22d8ac37f			0.17	23	released	2b6831c5-1b35-4c16-9df2-a8743521469e	RNA	R	0.17	UV Spec	released	False	dc4ca4e2-497e-4051-8a57-219e58a4f9b9	11	2.0	1.0	20.0	4.0	0.0	15.0	65.0	65.0	TOP	ed3b4a21-aa70-4d56-9b23-ef48081c818e	released												released	30.0	41f8f766-2304-4ed4-8777-5d8b027ff9f9	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN2_demographic	73	-26720	1869	071fec12-ef8f-5c04-86b3-539fc1ad2729	not hispanic or latino	male	white	released	Dead	1934	2012	TCGA-XF-AAN2_exposure	Not Reported	35.83326334649086	1.095890410958904	72a502db-43af-5bdd-8ed0-92e96d67fa28	189.0	20.0	released	128.0	TCGA-XF-AAN2_diagnosis	26720		MX	N0	Stage II	T2b	6th	not reported	0		11c91899-3704-500b-af68-e2c05482f804	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2007	TCGA-XF-AAN2_treatment	TCGA-XF-AAN2_treatment_1	released	481b3ba6-00d2-5ae2-83bf-29fb74f53cb2	no	Radiation Therapy, NOS	released	795695ff-0da7-5657-a560-45ff9dd15c3d	no	Pharmaceutical Therapy, NOS	10b6eef8-a5eb-4c0e-8734-987cef4898f8
9962ac22-d790-40ae-a9bb-94d117a188cb.htseq.counts.gz	89722041-e5e1-466c-a3b9-a6fd32f73478	TCGA-DK-A2I1-01A-11R-A180-07	TCGA-DK-A2I1-01A-11R	TCGA-DK-A2I1-01A-01-TSA		TCGA-DK-A2I1-01A-11	TCGA-DK-A2I1-01A	TCGA-DK-A2I1	036b9681-ab58-4734-a8fd-e0d5d078bf5a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	245	350.0	False	true	4E78ED88-FF1B-406C-98B8-A836D6AEA1E9	1.84	6c390573-7472-441d-956b-9f4747a18f2b			0.18	23	released	f4ca2ef6-afe0-4c2f-a883-80721bde6fce	RNA	R	0.18	UV Spec	released	False	61a007fc-f98d-4b2c-95ed-9f9841a0a860	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	66db90de-4972-42e7-91c9-cfc09e92a61d	released												released	30.0	f9bd70b2-6cde-48e5-9f0d-55d86ccfeba8	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A2I1_demographic	73	-26726		ec245032-d72e-5fe7-9bab-58afa9a47db3	not hispanic or latino	female	white	released	Alive	1937		TCGA-DK-A2I1_exposure	Not Reported	32.20575649745507		4db28e16-6b42-51d6-945d-f792576946ed	149.0		released	71.5	TCGA-DK-A2I1_diagnosis	26726		M0	N0	Stage II	T2b	6th	not reported	0	546	ce3551e2-c366-5b60-b150-1e95184954ee	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2010	TCGA-DK-A2I1_treatment	TCGA-DK-A2I1_treatment_1	released	8bd864ca-06cc-5d34-9a4d-118ddc24ac9b	no	Radiation Therapy, NOS	released	ba850f29-52e5-5186-bbd3-5344b0df4c08	no	Pharmaceutical Therapy, NOS	89722041-e5e1-466c-a3b9-a6fd32f73478
0df5ed77-67ee-436a-b4e2-63a4ec8b557c.htseq.counts.gz	fe5799a4-44d1-48a8-8c50-f9ddb309d30a	TCGA-4Z-AA87-01A-11R-A39I-07	TCGA-4Z-AA87-01A-11R	TCGA-4Z-AA87-01A-01-TS1		TCGA-4Z-AA87-01A-11	TCGA-4Z-AA87-01A	TCGA-4Z-AA87	45b4b153-e4aa-4080-b0dc-ee81a966978a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1159	230.0	False	true	0B1A1E8B-78FD-43B8-A6B1-2E7EB251FD52	1.87	3ae4a552-7df5-4a6b-a9c6-069cc96e7448			0.17	23	released	1a3d78bc-2a30-41ea-846b-092140b6c51b	RNA	R	0.17	UV Spec	released	False	60937196-6bdb-44cf-aef9-c7d66a308a13	11	7.0	0.0	7.0	0.0	0.0	43.0	50.0	90.0	TOP	b03264ba-dcc0-4a23-aa3a-f9d40802ab7f	released												released	30.0	7335875d-9a3c-47b3-80c0-9bd4576a4ea4	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA87_demographic	72	-26430		ac8bfbc9-c6a2-5f81-9fc6-0d23878d204e	not reported	male	black or african american	released	Alive	1938		TCGA-4Z-AA87_exposure	Not Reported	21.64412070759625		04c85ef2-8317-50df-9ee2-1753c5035ed9	155.0		released	52.0	TCGA-4Z-AA87_diagnosis	26430	T4a	M0	N0	Stage III	T4a	7th	not reported	0	1454	09058fdd-86c7-5eff-8e48-5144079fc292	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2010	TCGA-4Z-AA87_treatment_1	TCGA-4Z-AA87_treatment	released	84c62e75-5eb5-54f9-a51e-01c3987b95c4	yes	Pharmaceutical Therapy, NOS	released	fa9ad886-90b8-5442-b161-580d859b9d92	no	Radiation Therapy, NOS	fe5799a4-44d1-48a8-8c50-f9ddb309d30a
560d7be4-45d6-48e2-b0b4-243809b88724.htseq.counts.gz	92728f17-7999-4eb5-b4cd-0788279b6bd8	TCGA-BT-A2LA-11A-11R-A18C-07	TCGA-BT-A2LA-11A-11R	TCGA-BT-A2LA-11A-01-TSA		TCGA-BT-A2LA-11A-11	TCGA-BT-A2LA-11A	TCGA-BT-A2LA	797a71ee-372d-41e5-aeee-5ab3c4661110	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	257	200.0	False	true		1.79	e92d3c82-1aea-48da-97fd-bf6325d5c51b			0.16	23	released	09cf29fd-4035-45b6-a262-2ce38c69de3e	RNA	R	0.16	UV Spec	released	False	9de5ad3f-fb04-43b6-bd12-dc7aade1750d	11	0.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	TOP	b8d0ede2-6029-43bd-ba55-9c1f3c7f86aa	released												released	30.0	f12723ef-51a8-4071-b612-b47a14c2b459	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A2LA_demographic	54	-20032		70a21fca-4b6e-59a2-ae33-1dd8700fbd3e	not hispanic or latino	male	white	released	Alive	1956		TCGA-BT-A2LA_exposure	Not Reported		2.191780821917808	be514149-65ff-50b2-a5b2-41aee84e1361		40.0	released	95.0	TCGA-BT-A2LA_diagnosis	20032	T3a	M0	N0	Stage III	T3a	7th	not reported	0	522	44193ccb-a51c-5366-928c-c43c5a8284d3	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii	2010	TCGA-BT-A2LA_treatment	TCGA-BT-A2LA_treatment_1	released	c653406a-ba51-5d81-8677-3bce7f5fbf0e	no	Radiation Therapy, NOS	released	4c23359d-908e-5cd5-a1c6-79dcc1b87e59	yes	Pharmaceutical Therapy, NOS	92728f17-7999-4eb5-b4cd-0788279b6bd8
585ce2ea-045e-4aef-b005-e89709a042d7.htseq.counts.gz	d1780f82-6606-4bac-8a85-6afd1a9d9bdf	TCGA-GC-A3WC-01A-31R-A22U-07	TCGA-GC-A3WC-01A-31R	TCGA-GC-A3WC-01A-03-TSC		TCGA-GC-A3WC-01A-31	TCGA-GC-A3WC-01A	TCGA-GC-A3WC	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	230.0	False	false	91347009-C0A1-4BB1-8445-D00B769B59AF	1.81	3bea01e7-e5bc-484b-91f4-a143caed0aed			0.16	23	released	5ce1fcc3-2d5c-4cb0-b2e1-0d6c4ef2aadf	RNA	R	0.16	UV Spec	released	False	c34f8c84-bd12-481d-9490-e536c92fe030	31	0.0	0.0	10.0	0.0	0.0	30.0	60.0	70.0	TOP	51accd62-fdf0-4109-af52-d8d4dd0cef7b	released												released	30.0	24f9d01b-1210-4716-9466-8fe9f3612b8b	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3WC_demographic	80	-29295		7733ebc9-dd99-548b-af51-0b802858bec9	not hispanic or latino	female	white	released	Alive	1931		TCGA-GC-A3WC_exposure	Not Reported	26.83518005540166	0.7671232876712328	9b282bb5-c687-54e6-9fdf-f7866ac864ef	152.0	14.0	released	62.0	TCGA-GC-A3WC_diagnosis	29295		MX	N0	Stage III	T3	7th	not reported	0	540	21228792-dd85-5b8a-bf32-a2eae772f41a	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2011	TCGA-GC-A3WC_treatment	TCGA-GC-A3WC_treatment_1	released	f0b1a770-4d33-5616-ba5d-c42b48b305de	no	Radiation Therapy, NOS	released	9df77109-f5d4-568b-90a5-ba1abf530a29	no	Pharmaceutical Therapy, NOS	d1780f82-6606-4bac-8a85-6afd1a9d9bdf
bf483062-780d-4b23-9fad-3fd5790003dd.htseq.counts.gz	71e2cf9f-ace5-44ec-b5d6-658c04f86e81	TCGA-FJ-A3ZE-01A-11R-A23N-07	TCGA-FJ-A3ZE-01A-11R	TCGA-FJ-A3ZE-01A-01-TSA		TCGA-FJ-A3ZE-01A-11	TCGA-FJ-A3ZE-01A	TCGA-FJ-A3ZE	917961e2-78ad-4182-9cdb-5efb09808111	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	42	230.0	False	true	A6FF1E82-2C6B-40F5-9F5E-96562F8EE796	1.76	f7df4f7f-cd8e-44ba-b16f-203d6049c4fa			0.16	23	released	335985ce-8aea-48cb-ba88-d7866b50810b	RNA	R	0.16	UV Spec	released	False	3393db45-bea8-42b7-9b05-0a3081baaa3e	11	4.0	1.0	1.0	2.0	0.0	14.0	85.0	85.0	TOP	387c89b0-d72d-4f74-8f8a-e6135c3d318c	released												released	30.0	7f7de45f-a8cb-4273-82db-fb3dc7e080a7	Primary Tumor	01	released	Not Reported	released	TCGA-FJ-A3ZE_demographic	65	-23866	324	9b3edb44-b059-577e-be7c-5ab3da85c638	not hispanic or latino	male	white	released	Dead	1947		TCGA-FJ-A3ZE_exposure	Not Reported	32.54800083609543	1.36986301369863	18d91844-60a4-507c-8e6c-ce9239b4db0c	183.0	25.0	released	109.0	TCGA-FJ-A3ZE_diagnosis	23866	T2	M1	N3	Stage IV		7th	not reported	0	106	c230e863-b361-5b21-a958-1d155e69c1d7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-FJ-A3ZE_treatment	TCGA-FJ-A3ZE_treatment_1	released	7169ccba-4600-5803-882b-1bd5b47b76df	yes	Radiation Therapy, NOS	released	3080ee0f-5bd2-56ef-9bcb-e220ab3e9f9e	no	Pharmaceutical Therapy, NOS	71e2cf9f-ace5-44ec-b5d6-658c04f86e81
773cf932-d91e-4358-8c70-ea32c18fc7b2.htseq.counts.gz	1217dc36-517e-4d52-a10b-c26274c22826	TCGA-BT-A2LB-11A-11R-A18C-07	TCGA-BT-A2LB-11A-11R	TCGA-BT-A2LB-11A-01-TSA		TCGA-BT-A2LB-11A-11	TCGA-BT-A2LB-11A	TCGA-BT-A2LB	d17a5ab1-3789-4652-aff5-d8f4f2291f9c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	317	200.0	False	true		1.82	dc6e5a42-6613-41cb-af1e-7d7fa1904b62			0.16	23	released	a33e1b72-e0e2-414e-aed1-c442513861f4	RNA	R	0.16	UV Spec	released	False	9b4c9548-8400-4f80-9ed6-016d0e8f1f73	11	0.0	0.0	0.0	0.0	20.0	80.0	0.0	0.0	TOP	ccb9e339-e031-46f8-9e06-666868d29f05	released												released	30.0	085da7a1-e01d-4273-b5f2-7aab5d4d942a	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A2LB_demographic	73	-26846	492	87b48a51-48e5-5c30-9524-1371850b1ba6	not hispanic or latino	female	white	released	Dead	1937		TCGA-BT-A2LB_exposure	Not Reported			dd62d7aa-4946-51b7-ae21-81cf24379360			released	82.0	TCGA-BT-A2LB_diagnosis	26846	T3a	M0	N0	Stage III	T3a	7th	not reported	0	170	6c1050bd-ad7a-563e-a92a-b55b5da5d2cf	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iii	2010	TCGA-BT-A2LB_treatment	TCGA-BT-A2LB_treatment_1	released	06444461-e5e3-5733-828c-f6247b5a413b	no	Radiation Therapy, NOS	released	33fbfb5d-f3cc-5984-8ed7-8e62e02f90cb	no	Pharmaceutical Therapy, NOS	1217dc36-517e-4d52-a10b-c26274c22826
da28646f-8286-4c64-9b9e-033740888e41.htseq.counts.gz	e999f09b-ac49-40b8-9801-359d69a0982b	TCGA-CF-A7I0-01A-22R-A352-07	TCGA-CF-A7I0-01A-22R	TCGA-CF-A7I0-01A-02-TS2		TCGA-CF-A7I0-01A-22	TCGA-CF-A7I0-01A	TCGA-CF-A7I0	25ac9acd-328b-4fae-a448-4f3957b1b212	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	223	340.0	False	true	25D0EA9B-2E2B-40D3-A340-2CA9F0BBD48E	1.86	2ee1e299-76a9-4d45-a79b-02c1f31f9399			0.16	23	released	9e56aef9-b20e-4bca-bc2f-2d3bbdd0de6a	RNA	R	0.16	UV Spec	released	False	7cabd1a0-e5d7-4ab2-881d-a1b242157001	22	5.0	0.0	3.0	0.0	0.0	60.0	37.0	94.0	TOP	45507815-841d-45ed-bb49-16be4aa106cd	released												released	20.0	10fbdca9-5665-4441-a908-7c318100a5dc	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A7I0_demographic	54	-20059		02c59514-df7a-5af9-ac10-07aca6f16df6	not hispanic or latino	male	asian	released	Alive	1959		TCGA-CF-A7I0_exposure	Not Reported	20.32225286688924		e3639a39-05f3-5e20-8716-db466839566c	166.0		released	56.0	TCGA-CF-A7I0_diagnosis	20059		M0	N0	Stage II	T2	6th	not reported	0	368	9a17aeae-dc7d-55ec-acc9-bc6779a000ee	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-CF-A7I0_treatment_1	TCGA-CF-A7I0_treatment	released	0d591876-8e62-5c76-ac94-f05c6ccee0d3	no	Pharmaceutical Therapy, NOS	released	e01a3f24-21fc-5a64-994f-7ffcaf8e4383	no	Radiation Therapy, NOS	e999f09b-ac49-40b8-9801-359d69a0982b
1270306a-c43f-4960-88b8-fa45471c21ae.htseq.counts.gz	5dfb734a-2885-4302-bd64-0f09cfc0bfca	TCGA-GC-A3RB-01A-12R-A220-07	TCGA-GC-A3RB-01A-12R	TCGA-GC-A3RB-01A-01-TS1		TCGA-GC-A3RB-01A-12	TCGA-GC-A3RB-01A	TCGA-GC-A3RB	a0bcf1b1-4dd4-4d7f-b63e-b49296671451	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	174	80.0	False	true	2783B3D4-83FA-4E66-A424-715CAC7EFD53	1.85	5676c0ee-c460-492c-bf00-73d5ddb1d647			0.17	23	released	578d5d0c-00e8-4c2e-b928-00f6a6dd852d	RNA	R	0.17	UV Spec	released	False	d2db4e2a-a1b8-4c57-ab59-def67f0c0813	12	1.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	6995c6d1-9c67-4296-be8f-29d6fe5c89ee	released												released	30.0	b682e1f9-f9c8-41fb-9185-f734ff62917d	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3RB_demographic	54	-20021		5e946712-5e5d-590d-8ab4-eae1685ae7a5	not hispanic or latino	male	white	released	Alive	1957		TCGA-GC-A3RB_exposure	Not Reported		2.191780821917808	1ebc732e-1e8b-5d97-8fb4-f7ccecf4511d		40.0	released		TCGA-GC-A3RB_diagnosis	20021	T3b	M0	N0	Stage III	T3b	7th	not reported	0	582	dd9c14f3-3c34-59b9-a848-414348c9a543	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-GC-A3RB_treatment	TCGA-GC-A3RB_treatment_1	released	bc22c868-5614-58a8-a18f-00eb00558f9f	no	Radiation Therapy, NOS	released	3feab894-5b08-51a3-a697-d46b96e49007	no	Pharmaceutical Therapy, NOS	5dfb734a-2885-4302-bd64-0f09cfc0bfca
db852b9c-d9d3-476c-add6-9e7a99610b46.htseq.counts.gz	8a5e9676-2fc5-4e13-955b-2df2cffcce9a	TCGA-FD-A6TH-01A-11R-A32O-07	TCGA-FD-A6TH-01A-11R	TCGA-FD-A6TH-01A-01-TSA		TCGA-FD-A6TH-01A-11	TCGA-FD-A6TH-01A	TCGA-FD-A6TH	08d13748-0946-49a1-8eb3-5afd1deebc84	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	80	700.0	False	true	874A45C3-3707-4EDD-80C4-140655FAE95A	1.86	e71db8e9-8ee2-46dc-935a-3274f1fab863			0.17	23	released	1a3538c7-e292-48a5-912e-83c7f2c83c60	RNA	R	0.17	UV Spec	released	False	6a583643-8366-4309-9b9e-399caa657bf0	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	70.0	TOP	5d157181-33c7-461b-b30f-48e70ad7b4c1	released												released	30.0	73be4eab-ce32-4a3e-8252-6f0a0bdc13db	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TH_demographic	63	-23236	131	a0badd6f-99b3-5da2-839b-dbda91fce47a	not hispanic or latino	male	white	released	Dead	1950		TCGA-FD-A6TH_exposure	Not Reported	26.122448979591837	2.4657534246575343	fb0422d9-4d92-5c58-8b42-e439fe92d544	175.0	45.0	released	80.0	TCGA-FD-A6TH_diagnosis	23236	T2	MX	N2	Stage IV	T3	7th	not reported	0	67	bdb1ef95-0ed2-535b-be0b-13fc38f7fb28	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iv	2013	TCGA-FD-A6TH_treatment_1	TCGA-FD-A6TH_treatment	released	8fc853c6-5c30-5940-b113-d2903969b357	no	Pharmaceutical Therapy, NOS	released	63774fb1-b774-5501-932d-f4425fc744e2	no	Radiation Therapy, NOS	8a5e9676-2fc5-4e13-955b-2df2cffcce9a
b4055612-fbf6-475b-b74d-5a067dad4fff.htseq.counts.gz	75d7e08f-7be9-4c9b-b1b9-dd7f8fe5bd5c	TCGA-XF-AAN4-01A-11R-A42T-07	TCGA-XF-AAN4-01A-11R	TCGA-XF-AAN4-01A-01-TSA		TCGA-XF-AAN4-01A-11	TCGA-XF-AAN4-01A	TCGA-XF-AAN4	b6c36037-56b1-4957-8df8-fda72b0d3c39	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2457	900.0	False	true	4BE36D8A-9841-4CC7-9331-A2A14D5C2C30	1.83	60b688ac-61c5-4407-82e4-545cb869dca4			0.15	23	released	fc719c79-21f4-4f25-9edc-0905ef508d57	RNA	R	0.15	UV Spec	released	False	78a586b7-a6c4-469a-81a9-68ec6c518d70	11	22.0	2.0	5.0	2.0	0.0	50.0	45.0	70.0	TOP	2c51a2bc-11cf-4dd5-97ef-d79980235b1f	released												released	30.0	da8f7fc5-8b5e-449a-a9c4-04e029dd4cb6	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN4_demographic	77	-28302	823	0245b327-1b48-574b-9daa-91e3c58a98eb	not hispanic or latino	female	white	released	Dead	1930	2009	TCGA-XF-AAN4_exposure	Not Reported	21.671258034894397	1.36986301369863	6bfeb157-fefd-5d54-b542-0a1efe265046	165.0	25.0	released	59.0	TCGA-XF-AAN4_diagnosis	28302		MX	N0	Stage III	T3b	6th	not reported	0		2c7e5b80-2e4f-501d-a6e4-7a64c55331aa	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2007	TCGA-XF-AAN4_treatment_1	TCGA-XF-AAN4_treatment	released	baa14d31-5c12-5797-b141-336c88899418	no	Pharmaceutical Therapy, NOS	released	f635a6eb-152c-5e49-a067-0572efae52a4	no	Radiation Therapy, NOS	75d7e08f-7be9-4c9b-b1b9-dd7f8fe5bd5c
fafbee16-e4fc-4f30-a1c4-a4aa03f5ece0.htseq.counts.gz	8ef98d3b-2079-4c5e-8544-745455cdc5a8	TCGA-CF-A5U8-01A-11R-A28M-07	TCGA-CF-A5U8-01A-11R	TCGA-CF-A5U8-01A-01-TSA		TCGA-CF-A5U8-01A-11	TCGA-CF-A5U8-01A	TCGA-CF-A5U8	4cc25adb-6db4-46aa-9fc9-c2c6339fb6d3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	120	240.0	False	true	'-A9CA-D5039E0450B1.pdf	1.88	58e49daa-eced-4ca8-af92-98af61f8b6f1			0.17	23	released	1fa859ab-3e78-4756-8c7f-1d25dd7642fb	RNA	R	0.17	UV Spec	released	False	73c3ee95-93fd-49e8-8ee4-acbd0412368a	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	cb3b5182-b41c-4499-9769-1720760c914c	released												released	30.0	7b29b034-86e4-4266-8657-036e96e04430	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A5U8_demographic	59	-21734		ed5f7855-2dcc-5926-94a1-e69bc378bb66	not hispanic or latino	male	asian	released	Alive	1953		TCGA-CF-A5U8_exposure	Not Reported	19.628264701169684		25d25e66-a550-5845-9d25-1ad0480420f0	158.0		released	49.0	TCGA-CF-A5U8_diagnosis	21734		M0	N0	Stage II	T2	6th	not reported	0	399	55a50de8-e653-5d01-b1c7-939d441631d7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A5U8_treatment	TCGA-CF-A5U8_treatment_1	released	7d5d3fb3-f924-55ec-a98d-fcc69be5731e	no	Radiation Therapy, NOS	released	eabb93b6-46d2-53c4-b041-3250ea8e6c99	no	Pharmaceutical Therapy, NOS	8ef98d3b-2079-4c5e-8544-745455cdc5a8
be81ed72-5acd-400e-b500-52e5151b957d.htseq.counts.gz	a497ffb2-e022-4769-9049-88cc659e31b3	TCGA-E7-A8O8-01A-11R-A36F-07	TCGA-E7-A8O8-01A-11R	TCGA-E7-A8O8-01A-01-TSA		TCGA-E7-A8O8-01A-11	TCGA-E7-A8O8-01A	TCGA-E7-A8O8	854e5236-f2d6-4681-be62-0bead955c926	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	105	620.0	False	true	F6B4EF0F-8E4C-4B07-B946-3D55CB975799	1.86	a77cf51f-45de-4a5b-a6ca-6773f8e236d2			0.18	23	released	18af9c50-5c74-4512-8341-f276363f3496	RNA	R	0.18	UV Spec	released	False	a3018bde-b529-4c0d-8cb4-cc1301fd0da7	11	3.0	1.0	2.0	1.0	0.0	8.0	90.0	95.0	TOP	82254e95-cc00-4f0c-806c-a7a594a5bb01	released												released	30.0	c867c28d-635d-4074-a148-04c4b29fc410	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A8O8_demographic	59	-21629		25e9d221-865c-5483-bfbf-06fe684bbf59	not hispanic or latino	male	asian	released	Alive	1954		TCGA-E7-A8O8_exposure	Not Reported	19.473406629072173	0.7123287671232876	6802ee16-1e25-5705-b028-35677fbafa9b	157.0	13.0	released	48.0	TCGA-E7-A8O8_diagnosis	21629	T3	M0	N0	Stage II	T2	7th	not reported	0	13	cfdd73fd-34a2-5f3f-b714-d1649e05fe43	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-E7-A8O8_treatment_1	TCGA-E7-A8O8_treatment	released	bf42ebfd-d3bb-53cb-baa2-25af74a3af88	not reported	Pharmaceutical Therapy, NOS	released	25419b08-023c-5122-af4b-f70e46e536c9	no	Radiation Therapy, NOS	a497ffb2-e022-4769-9049-88cc659e31b3
26590bb6-10f5-4c18-8706-d2ed89727038.htseq.counts.gz	b060d6f7-d881-4369-a9ba-36f23e7b7051	TCGA-BT-A20Q-01A-11R-A14Y-07	TCGA-BT-A20Q-01A-11R	TCGA-BT-A20Q-01A-01-TSA		TCGA-BT-A20Q-01A-11	TCGA-BT-A20Q-01A	TCGA-BT-A20Q	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1898	320.0	False	true	E686B42F-3A8C-4181-836E-79D4443DC0CD	1.87	ca10d08d-3cc5-4171-9a70-66fdff3c0c3d			0.16	23	released	06c37dd0-1919-4f90-bf88-ec3d16e42beb	RNA	R	0.16	UV Spec	released	False	b51abe3b-44dc-466f-959d-fa71f8a2224b	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	a8c23e1d-ff24-4e7d-b680-a55d38c62ec0	released												released	30.0	f3906cd4-31c7-48a8-935b-5b7fafec1ae7	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20Q_demographic	73	-26778	593	92366abf-7135-5bce-8e71-ac4cf40a5256	not hispanic or latino	male	white	released	Dead	1933	2007	TCGA-BT-A20Q_exposure	Not Reported			45ecb356-dde6-5d74-b4fa-e0de4a5f3da9			released		TCGA-BT-A20Q_diagnosis	26778	T3b	M0	N2	Stage IV	T3b	6th	not reported	0		c8bf1857-b842-5c8f-99be-fddbb29a127c	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2006	TCGA-BT-A20Q_treatment	TCGA-BT-A20Q_treatment_1	released	7e44b7fd-c728-5b40-923a-59946e48eba9	no	Radiation Therapy, NOS	released	93c86cdf-cfd1-5f6d-b7f9-902f54db7c05	no	Pharmaceutical Therapy, NOS	b060d6f7-d881-4369-a9ba-36f23e7b7051
590580de-17b7-441c-9701-f17034fb3fda.htseq.counts.gz	15870f1c-c765-43df-9161-9c241da0e262	TCGA-4Z-AA7O-01A-31R-A39I-07	TCGA-4Z-AA7O-01A-31R	TCGA-4Z-AA7O-01A-03-TS3		TCGA-4Z-AA7O-01A-31	TCGA-4Z-AA7O-01A	TCGA-4Z-AA7O	835084d6-9f1e-408b-a58c-9d60493bbc6a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	189	380.0	False	true	1B91CBCE-11F7-4B83-BF5B-CBA6F9CEB799	1.87	fac0db5e-3c8c-4ca2-b119-da810af35fc7			0.17	23	released	578efbd4-4643-4a87-ac3f-633a405cce71	RNA	R	0.17	UV Spec	released	False	3731577a-d30a-4bf6-9e0c-480c0785da12	31	2.0	1.0	0.0	4.0	0.0	20.0	80.0	80.0	TOP	3a99e818-5c0f-4b21-8683-231b17a92096	released												released	30.0	ce2b1693-5b06-436a-8cde-7d7ee48a84e1	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7O_demographic	64	-23645		3f0413a2-e5b7-5622-8da0-2563ee3121dd	not reported	male	black or african american	released	Alive	1949		TCGA-4Z-AA7O_exposure	Not Reported	25.765713456234575		098713b6-64e7-561f-a8c4-7e13f0ce6376	166.0		released	71.0	TCGA-4Z-AA7O_diagnosis	23645		M0	N0	Stage II	T2a	7th	not reported	0	512	15c07421-6372-5976-b241-4d8d13c6b3d2	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-4Z-AA7O_treatment	TCGA-4Z-AA7O_treatment_1	released	ebcae0d5-8709-5b2f-bfc8-d1d2e64db234	no	Radiation Therapy, NOS	released	441b2968-a6fb-5942-ab36-9aa868a7bd5c	no	Pharmaceutical Therapy, NOS	15870f1c-c765-43df-9161-9c241da0e262
07fc096b-52e7-4d70-add0-07911843d0a5.htseq.counts.gz	232fab43-25b0-4feb-99f0-41d111f48839	TCGA-GV-A40E-01A-12R-A23N-07	TCGA-GV-A40E-01A-12R	TCGA-GV-A40E-01A-01-TS1		TCGA-GV-A40E-01A-12	TCGA-GV-A40E-01A	TCGA-GV-A40E	aa6142af-bad7-493c-98a0-fd070de39073	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	135	140.0	False	true	45815B18-3A6E-4A3D-8D48-0F4653026DFD	1.83	221bd562-e77d-4374-9491-efb5c3b026c3			0.15	23	released	0168f914-2cd6-41b1-a92d-8588cd3fe500	RNA	R	0.15	UV Spec	released	False	0888a3d9-8aa6-4a7b-96c4-e42663edb2d0	12	2.0	1.0	5.0	0.0	0.0	0.0	95.0	85.0	TOP	8547763d-4cd8-4f75-b875-5982512b6904	released												released	30.0	fe1b2be2-296a-4b78-a009-cfb676357323	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A40E_demographic	75	-27569	261	017d3170-f8ca-518c-aa28-15fdb7ce03b8	not hispanic or latino	male	white	released	Dead	1937		TCGA-GV-A40E_exposure	Not Reported	36.295922232041406	1.095890410958904	c2996394-ebaa-5ed8-a1eb-22d0cd6b2974	178.0	20.0	released	115.0	TCGA-GV-A40E_diagnosis	27569	T2	MX	NX	Stage II		7th	not reported	0	195	847bb550-9dba-5d45-a608-4f666ca630e8	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2012	TCGA-GV-A40E_treatment	TCGA-GV-A40E_treatment_1	released	bd1b9fe0-b441-5648-8890-16c433821aef	yes	Radiation Therapy, NOS	released	05714d7c-8e70-5962-9532-f02d09d6a7f9	yes	Pharmaceutical Therapy, NOS	232fab43-25b0-4feb-99f0-41d111f48839
54ae668e-07de-47fb-b72f-c364bbcf2f02.htseq.counts.gz	d19be996-0e3c-4301-93be-0f826367a4de	TCGA-C4-A0F6-01A-11R-A10U-07	TCGA-C4-A0F6-01A-11R	TCGA-C4-A0F6-01A-01-BS1	TCGA-C4-A0F6-01A-01-TS1	TCGA-C4-A0F6-01A-11	TCGA-C4-A0F6-01A	TCGA-C4-A0F6	4ff9b4f2-6d04-4fed-8796-155902a8bf28	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	568	140.0	False	false	6141ED7C-45EC-4157-9064-47EA7C945CE0	1.79	b1984010-7ef5-4df4-abfc-d18502cf124c			0.15	23	released	785a770e-2375-418b-bc41-a21203d35d77	RNA	R	0.15	UV Spec	released	False	4552a0eb-418d-4a21-bf7f-252736fcc612	11	3.0	0.0	3.0	0.0	9.0	18.0	70.0	70.0	BOTTOM	f6d7c990-0c7c-433c-b8c6-463f40a966ae	released	2.0	0.0	1.0	1.0	12.0	12.0	75.0	75.0	TOP	de349f74-f986-468d-a2c0-4bec403956f6	released	released	30.0	905d2bf1-08cb-4260-8188-00b60d881cf2	Primary Tumor	01	released	Not Reported	released	TCGA-C4-A0F6_demographic	82	-29951		e53dc3ca-b727-5a5e-af01-c03c61f80476	not reported	female	not reported	released	Alive	1926		TCGA-C4-A0F6_exposure	Not Reported	23.52941176470588	1.917808219178082	a6e71edf-dc58-5cde-b147-e99dd4ef2421	170.0	35.0	released	68.0	TCGA-C4-A0F6_diagnosis	29951		M0	N0	Stage III	T3b	6th	not reported	0	700	dc44cdad-53f8-5419-baca-4e7ec09feaa7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2008	TCGA-C4-A0F6_treatment_1	TCGA-C4-A0F6_treatment	released	d63d486d-aa41-5832-84aa-a6e1573793de	not reported	Pharmaceutical Therapy, NOS	released	2e5a7e79-c6ee-5de1-bda3-5fa946763677	not reported	Radiation Therapy, NOS	d19be996-0e3c-4301-93be-0f826367a4de
56dd8737-fd50-481b-864a-940760613b52.htseq.counts.gz	db364d29-62fd-462b-9dc9-9ea390c625aa	TCGA-G2-A2EJ-01A-11R-A180-07	TCGA-G2-A2EJ-01A-11R	TCGA-G2-A2EJ-01A-01-TSA		TCGA-G2-A2EJ-01A-11	TCGA-G2-A2EJ-01A	TCGA-G2-A2EJ	c6227d39-d9e8-4e28-9e70-d7f720ab25e4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	741	250.0	False	true	2C46A6D2-74EE-4389-9D8F-4737CE4832FB	2.11	968143b4-2bc1-4c77-88e7-a907a7cd018c			0.17	23	released	86fe7695-1346-49b7-bb5f-ac7dab1da806	RNA	R	0.17	UV Spec	released	False	082e282b-384e-44e5-aadc-cf92549c5a46	11	2.0	3.0	10.0	0.0	0.0	20.0	70.0	80.0	TOP	1fb06de0-098f-4463-abcc-4ba749b5eace	released												released	30.0	fbad20ba-ee08-4d46-825b-870126aad539	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A2EJ_demographic	56	-20649		110a4833-8df2-5579-b39c-e78caa7f624c	not hispanic or latino	female	white	released	Alive	1953		TCGA-G2-A2EJ_exposure	Not Reported	28.115334008445792	1.095890410958904	3988c12a-ce01-50bc-abfc-4b4cc6142b53	152.4	20.0	released	65.3	TCGA-G2-A2EJ_diagnosis	20649	T2a	M0	N0	Stage II		6th	not reported	0	1460	6f607910-41f6-5e25-a745-bd38f2ce5a75	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-G2-A2EJ_treatment_1	TCGA-G2-A2EJ_treatment	released	7819186e-8658-5f82-a40e-c6e48afe3929	yes	Pharmaceutical Therapy, NOS	released	5ed32d71-3b98-5f89-8ba1-3e5d1ebdb5f8	no	Radiation Therapy, NOS	db364d29-62fd-462b-9dc9-9ea390c625aa
b5e4d37a-3e0a-4058-885a-8ff47736db7d.htseq.counts.gz	ca3c0d3c-95f6-426d-8428-b4b661dd6e10	TCGA-GU-A762-01A-11R-A33J-07	TCGA-GU-A762-01A-11R	TCGA-GU-A762-01A-01-TSA		TCGA-GU-A762-01A-11	TCGA-GU-A762-01A	TCGA-GU-A762	6a1eee8d-cf62-47e9-9322-c18633cb3ee9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	386	120.0	False	true	3EDC13B8-36AF-4C66-B4A2-38EC382FF39A	1.92	fa74ebb2-007d-407a-ba07-12976b75056d			0.17	23	released	f48548c4-c781-4be5-9b45-8f402ef00807	RNA	R	0.17	UV Spec	released	False	04c8ac7d-d041-4485-8cd0-13a5d57e2514	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	748ef7df-5288-453e-a6e5-5e363a5fc161	released												released	30.0	e70bf0b1-0e0e-4484-93f2-e312aa575f98	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A762_demographic	87	-31812	232	014b2876-9fbd-526e-8a08-56dd64bc0352	not hispanic or latino	male	white	released	Dead	1925		TCGA-GU-A762_exposure	Not Reported	22.6421929718633		f092d1c6-4480-577f-be72-5b9887d79d76	182.0		released	75.0	TCGA-GU-A762_diagnosis	31812		MX	N2	Stage IV	T4a	7th	not reported	0	62	7ba60159-12de-5de5-af19-2f2ffe43cd4d	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-GU-A762_treatment_1	TCGA-GU-A762_treatment	released	745bdc22-2687-5afe-ae2e-40620a9ffeae	no	Pharmaceutical Therapy, NOS	released	182770d7-a2eb-58e7-b5ed-45150a42e27f	no	Radiation Therapy, NOS	ca3c0d3c-95f6-426d-8428-b4b661dd6e10
9eb73e5b-9275-4855-8395-38facb0aa18b.htseq.counts.gz	bf8dd5dc-91ec-4f73-a8ed-84d74698565e	TCGA-E7-A3X6-01A-12R-A22U-07	TCGA-E7-A3X6-01A-12R	TCGA-E7-A3X6-01A-01-TSA		TCGA-E7-A3X6-01A-12	TCGA-E7-A3X6-01A	TCGA-E7-A3X6	c871ea6b-fbd2-4e6f-ab29-f43f6e3ddcbb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	280	590	False	true	BC75580D-4F4D-408C-9E9C-116A260DDED3	1.85	b4bb6509-7d67-4d5e-8fd1-624fa373df4d	2.21	13	0.17	23	released	d496b3f0-01e8-4aea-98cb-498e18c9cbcd	RNA	R	0.17	UV Spec	released	False	db1cf2fc-07bb-4a22-a98f-f0ca90b3b506	12	0	0	0	0	0	20	80	90	TOP	20ffffac-3403-44d1-ad10-88786e15bcfe	released												released	30	554ae735-9991-4cb3-afe8-4951490bd709	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A3X6_demographic	70	-25584	904	1ab053a6-1101-576d-a41d-183d2881f8f9	not hispanic or latino	male	white	released	Dead	1941		TCGA-E7-A3X6_exposure	Not Reported	30.79584775086505		e15eb5ac-9d10-560e-b46c-20a9575351ff	170.0		released	89.0	TCGA-E7-A3X6_diagnosis	25584		M0	NX	Stage II	T2	7th	not reported	0	750	c9b75a26-7410-5c42-8d94-ca5785d6ca11	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2011	TCGA-E7-A3X6_treatment	TCGA-E7-A3X6_treatment_1	released	8fe526cd-444a-5e5b-8a66-88c6d6d83427	yes	Radiation Therapy, NOS	released	ec517dc0-2504-5763-b7f5-4afa3752f2a8	no	Pharmaceutical Therapy, NOS	bf8dd5dc-91ec-4f73-a8ed-84d74698565e
1e91b6e6-ecaf-491d-b2f6-2fb0710f79ef.htseq.counts.gz	cb34b833-285b-4644-8863-9c3093aec0e7	TCGA-BT-A42F-01A-11R-A23W-07	TCGA-BT-A42F-01A-11R	TCGA-BT-A42F-01A-01-TS1		TCGA-BT-A42F-01A-11	TCGA-BT-A42F-01A	TCGA-BT-A42F	da98be9d-7acf-43ce-aa24-38d1d2604506	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	282	50.0	False	true	2A58F62D-F2F7-454A-A9E3-F7AE46DF70C5	1.29	36f98bd7-f044-4497-9d19-e25c8e847def			0.18	23	released	e38bddc2-3adb-4308-9685-92cba54edccb	RNA	R	0.18	UV Spec	released	False	2ccb2761-51f7-47d1-a986-feb4906e4ec2	11	6.0	2.0	5.0	3.0	0.0	25.0	70.0	70.0	TOP	b138c224-d923-4710-b7f9-af3a4b8c58fb	released												released	30.0	d5f2a552-91c3-4750-a66f-30c3c854d6e1	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A42F_demographic	64	-23713		13fd3d14-2688-5f90-b731-ca491c3a82c7	not hispanic or latino	male	white	released	Alive	1947		TCGA-BT-A42F_exposure	Not Reported	31.48148148148148		a84d2eaf-7b1f-5ddb-a1ae-8afddea1de19	180.0		released	102.0	TCGA-BT-A42F_diagnosis	23713	T4a	MX	N1	Stage IV	T4a	7th	not reported	0	864	62fbfdb4-1e19-58a5-a404-ecbad204c5cb	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2011	TCGA-BT-A42F_treatment	TCGA-BT-A42F_treatment_1	released	ac1bdbad-ba6b-57bf-bf9b-4bdfb03e0251	no	Radiation Therapy, NOS	released	73430661-4790-5b74-80b2-72dc56a8e780	no	Pharmaceutical Therapy, NOS	cb34b833-285b-4644-8863-9c3093aec0e7
f35321db-9fca-4de9-a14a-1bcae60bb202.htseq.counts.gz	604418ee-8dfc-4238-9127-83bbdedd5443	TCGA-BT-A20J-01A-11R-A14Y-07	TCGA-BT-A20J-01A-11R	TCGA-BT-A20J-01A-01-TSA		TCGA-BT-A20J-01A-11	TCGA-BT-A20J-01A	TCGA-BT-A20J	74b1e72d-fdd0-4d84-8858-3bb32d58ff7e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	4466	300.0	False	true	74E5CF6B-F334-44D7-944E-8E59879AAE90	1.9	09898301-3dac-4b86-af1b-6cbad9f2d380			0.17	23	released	e94c17ef-5951-48cc-9100-cfe52d192b98	RNA	R	0.17	UV Spec	released	False	d6c7a58b-a363-4050-968a-20586aaf8e67	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	75.0	TOP	93c0ef1a-f83b-4dae-968b-6fc4e1084dd7	released												released	30.0	ad4e36cd-0036-4f63-bb06-d32b51acac7a	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20J_demographic	75	-27646	579	54f02728-6d25-5451-af46-9e3ec3b40a93	not hispanic or latino	male	white	released	Dead	1924	2000	TCGA-BT-A20J_exposure	Not Reported		1.095890410958904	be4d3e03-003a-5d74-8c22-6fd0cdea337a		20.0	released		TCGA-BT-A20J_diagnosis	27646	T2b	MX	N0	Stage II	T2b	5th	not reported	0		aa95a7da-70c8-52dc-b40e-f467b213b988	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	1999	TCGA-BT-A20J_treatment	TCGA-BT-A20J_treatment_1	released	1ce323bd-8e43-5143-92c1-00047ba71e2c	no	Radiation Therapy, NOS	released	e4fb368d-e9ce-51ef-940f-b61c0232a18b	no	Pharmaceutical Therapy, NOS	604418ee-8dfc-4238-9127-83bbdedd5443
719df11d-29e7-4e41-b276-d45e72b2de51.htseq.counts.gz	bd32c670-6515-44bc-8c6d-0023b50c5041	TCGA-FD-A5BR-01A-11R-A26T-07	TCGA-FD-A5BR-01A-11R	TCGA-FD-A5BR-01A-01-TSA		TCGA-FD-A5BR-01A-11	TCGA-FD-A5BR-01A	TCGA-FD-A5BR	dfdaebd6-e0ab-49d1-9ae9-3a57b3c318b5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	307	600.0	False	true	2C24A4C8-5866-4077-8497-5294CA674C36	1.83	8f1bfe41-e48c-4b5d-8b03-8def7666da02			0.17	23	released	9e7b3f74-5531-4979-adb6-ec0cc1603fb8	RNA	R	0.17	UV Spec	released	False	bb8eb681-493a-4cc2-bc48-50d98e3d5ef9	11	5.0	2.0	0.0	3.0	0.0	35.0	65.0	65.0	TOP	a6603a8a-fc64-4dd9-9211-81150526abd1	released												released	30.0	02351552-109a-48b6-a2e5-8d2a7e4b6c96	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BR_demographic	57	-20964		fea1efee-16b7-563d-a6fd-769cbbc3d765	not hispanic or latino	male	white	released	Alive	1955		TCGA-FD-A5BR_exposure	Not Reported	37.34567901234568		e4f3737d-a940-5031-a86f-dea62f789815	180.0		released	121.0	TCGA-FD-A5BR_diagnosis	20964		MX	N0	Stage II	T2b	7th	not reported	0	813	e7118b7d-8fb5-5beb-8ca6-cf51254a2b67	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2012	TCGA-FD-A5BR_treatment	TCGA-FD-A5BR_treatment_1	released	b91cea10-28b6-55a0-920f-dcec87b6640b	no	Radiation Therapy, NOS	released	5d5432f2-661c-5175-a816-b6b09290f158	no	Pharmaceutical Therapy, NOS	bd32c670-6515-44bc-8c6d-0023b50c5041
d4be1d22-3ece-42e9-9d92-0fdb3dc95c3a.htseq.counts.gz	f832dfd0-f52e-4835-8ae1-144a171e922f	TCGA-BL-A0C8-01A-11R-A277-07	TCGA-BL-A0C8-01A-11R	TCGA-BL-A0C8-01A-01-TS1	TCGA-BL-A0C8-01A-01-BS1	TCGA-BL-A0C8-01A-11	TCGA-BL-A0C8-01A	TCGA-BL-A0C8	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	213	790.0	False	false	5077D8C6-57D2-4C6A-9316-71BE40224195	1.72	45e06598-828f-4d6f-92ed-5f05fb72f8d7			0.15	23	released	8e5a28fd-7a37-47d8-ba70-c250cc67e543	RNA	R	0.15	UV Spec	released	False	bad15dae-37fe-45f7-9210-260f2a2d8018	11	0.0	0.0	5.0	22.0	0.0	45.0	50.0	80.0	TOP	f49fc0a4-705a-4421-83b8-8453591b173f	released	1.0	0.0	8.0	10.0	0.0	32.0	60.0	80.0	BOTTOM	81bdf088-09b9-4982-bd6d-51faedff76d2	released	released	30.0	5feed572-07c0-4da0-8649-ca8f8682657a	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A0C8_demographic	73	-26819		55a888fc-b0f7-5238-a6b7-c823d70676f4	not hispanic or latino	male	white	released	Alive	1936		TCGA-BL-A0C8_exposure	Not Reported	42.41888650422926	0.547945205479452	d9d9da95-b150-5f9e-a211-b3122e64f138	178.0	10.0	released	134.4	TCGA-BL-A0C8_diagnosis	26819		M0	NX	Stage I	T1		not reported	0	1219	325c1514-52f8-5ea4-8e87-78d1911d3cf9	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage i	2009	TCGA-BL-A0C8_treatment_1	TCGA-BL-A0C8_treatment	released	04001d39-fe03-51fc-bbd4-85e050d41997	yes	Pharmaceutical Therapy, NOS	released	d93cde56-03c3-5823-850d-bab213286b6a	no	Radiation Therapy, NOS	f832dfd0-f52e-4835-8ae1-144a171e922f
09c11f8a-844b-49e8-9a73-5bfe52c26979.htseq.counts.gz	358eb6cc-dc90-4228-952e-8a61f47e4d40	TCGA-ZF-AA56-01A-31R-A39I-07	TCGA-ZF-AA56-01A-31R	TCGA-ZF-AA56-01A-03-TS3		TCGA-ZF-AA56-01A-31	TCGA-ZF-AA56-01A	TCGA-ZF-AA56	eb30ae33-2076-475d-aac9-804a8f1119a0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1344	230.0	False	true	835DF5D1-5F61-4C7A-860B-265F1209DDC9	1.88	5cfa74de-919c-4c0a-9f17-d609268723d6			0.16	23	released	090dc75e-df6c-41a2-8f7a-8244eb94d744	RNA	R	0.16	UV Spec	released	False	6fccecfd-cc8c-49b1-9f4b-af6498adfa4f	31	7.0	0.0	3.0	0.0	0.0	0.0	97.0	65.0	TOP	8e33d817-e4ee-4cdd-bed9-1be0916acbaa	released												released	30.0	72f50bb3-c7a3-49b5-8262-185eb830e17e	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA56_demographic	79	-28937	259	1c44313a-b005-5551-ae04-d6cfedd6adcb	not hispanic or latino	female	white	released	Dead	1931	2010	TCGA-ZF-AA56_exposure	Not Reported			19d2d375-7d4b-5199-9c2f-82dec1ca93ff			released	63.0	TCGA-ZF-AA56_diagnosis	28937	T2a	MX	N0	Stage III	T4a	7th	not reported	0		a1fdae3d-5b1a-5ba7-bd9d-51bbf4d8761c	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2010	TCGA-ZF-AA56_treatment_1	TCGA-ZF-AA56_treatment	released	1f915c6a-80db-5a45-b83c-71105ea15a6d	no	Pharmaceutical Therapy, NOS	released	dd2ed8bb-0643-55cd-b21b-2c1708da2630	no	Radiation Therapy, NOS	358eb6cc-dc90-4228-952e-8a61f47e4d40
ebabf0ba-ab2c-4325-86ff-dbf231a27c05.htseq.counts.gz	eed00aac-ca6a-495e-94ea-485b36f9b3f9	TCGA-XF-AAML-01A-11R-A42T-07	TCGA-XF-AAML-01A-11R	TCGA-XF-AAML-01A-01-TSA		TCGA-XF-AAML-01A-11	TCGA-XF-AAML-01A	TCGA-XF-AAML	329d372c-c44e-4595-b8ac-474c5a1321a5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2288	300.0	False	true	919C33FD-44F5-440A-8A7B-B8EBACBCCC55	1.85	fbca79e2-8904-4bdf-aede-b2049cb81302			0.17	23	released	f5f6f2c0-9359-4d50-9cdc-95bd713a64a1	RNA	R	0.17	UV Spec	released	False	d170223a-1051-409e-ade5-14442153ca20	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	b2ea5ee3-f417-4d68-b167-7c91629c922d	released												released	30.0	90f7397e-7264-4a41-b5f0-e9725a84de3e	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAML_demographic	75	-27422	232	230944fb-3d63-53dc-8954-264572f90219	not hispanic or latino	male	white	released	Dead	1932	2007	TCGA-XF-AAML_exposure	Not Reported	38.944571911604875		7d19e671-bd7a-52c6-922f-47a3cd677330	182.0		released	129.0	TCGA-XF-AAML_diagnosis	27422		MX	N0	Stage II	T2b	6th	not reported	0		7b9df887-b0e4-5c98-8594-41e76f6bce4d	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2007	TCGA-XF-AAML_treatment_1	TCGA-XF-AAML_treatment	released	3d712dbd-fbf3-5d76-b9af-5ed0d6acfa12	no	Pharmaceutical Therapy, NOS	released	03adcfe9-caa7-5a37-abde-9d1805059a6f	no	Radiation Therapy, NOS	eed00aac-ca6a-495e-94ea-485b36f9b3f9
dca59b25-894b-4969-b7fc-5b8b6c5a2055.htseq.counts.gz	1e4c5abb-6806-41e9-b51e-a64a9d7e934d	TCGA-XF-A8HH-01A-11R-A38B-07	TCGA-XF-A8HH-01A-11R	TCGA-XF-A8HH-01A-01-TSA		TCGA-XF-A8HH-01A-11	TCGA-XF-A8HH-01A	TCGA-XF-A8HH	02964d82-cc94-4286-a66f-03567101950c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3312	420.0	False	true	33C8B2EA-980D-4CDC-B8A9-B8583E04BCCA	1.84	d9f01cb3-7b78-4330-9a2c-5923cdbfa142			0.18	23	released	db6e1325-ebf7-499b-93b5-4a1967182ff3	RNA	R	0.18	UV Spec	released	False	54f895ca-46b4-44ed-a5eb-0e040579cfd4	11	0.0	0.0	0.0	0.0	20.0	10.0	70.0	80.0	TOP	f429621e-12a5-4b70-b746-632bee6441c7	released												released	30.0	4c811177-e110-44a7-8c3f-729d5948fce3	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HH_demographic	61	-22393	57	37ee4692-669e-51d9-8d81-be106ccc119f	not hispanic or latino	female	white	released	Dead	1943	2004	TCGA-XF-A8HH_exposure	Not Reported	27.099251006812448		fc4a2b3e-d819-5564-8b3f-59deb0edae8d	163.0		released	72.0	TCGA-XF-A8HH_diagnosis	22393		M0	N2	Stage IV	T3b	6th	not reported	0		277e011e-a53f-56e2-82e6-c414a2698369	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2004	TCGA-XF-A8HH_treatment_1	TCGA-XF-A8HH_treatment	released	4652ba7f-4eac-5080-97a3-449479b41210	no	Pharmaceutical Therapy, NOS	released	0e1d5339-176d-5437-b636-20fae59ff6f2	no	Radiation Therapy, NOS	1e4c5abb-6806-41e9-b51e-a64a9d7e934d
79351170-4d3c-46ec-8852-b7e702573bb1.htseq.counts.gz	db5202f1-0512-44a2-90a8-7d3f8cb4d6d8	TCGA-UY-A9PD-01A-11R-A38B-07	TCGA-UY-A9PD-01A-11R	TCGA-UY-A9PD-01A-01-TS1		TCGA-UY-A9PD-01A-11	TCGA-UY-A9PD-01A	TCGA-UY-A9PD	9ef9e328-ac74-4c8a-9990-347b87cf7764	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		160.0	False	true	0698B674-4D6D-4FEF-8129-F66DF28A45F9	1.9	417805b3-9c10-4724-ab87-480c773f7d16			0.17	23	released	b67eb255-a3bb-45c0-8cdc-f0c097b6e3cf	RNA	R	0.17	UV Spec	released	False	e9fd80f7-8710-42b5-850a-1db0d51c7f4e	11	2.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	6557cf55-112e-4f58-a0d4-4621a9907a00	released												released	30.0	5a1b7ff4-0966-4fa1-a91e-03196eff112d	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PD_demographic	80	-29565		46b421a7-a441-53b9-91e3-fdf1fbdee391	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PD_exposure	Not Reported	22.720438370810918		864b4549-98a8-57e3-b0a1-0388649d3f42	173.0		released	68.0	TCGA-UY-A9PD_diagnosis	29565		MX	N0	Stage III	T3a	7th	not reported	0	542	fcc234ed-eb67-56a9-81c5-52237a779c56	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii		TCGA-UY-A9PD_treatment_1	TCGA-UY-A9PD_treatment	released	2f03c787-8aac-5468-a286-e0a23d7cf27a	no	Pharmaceutical Therapy, NOS	released	d94e359c-2286-5688-85fa-94079d48a86f	no	Radiation Therapy, NOS	db5202f1-0512-44a2-90a8-7d3f8cb4d6d8
aa1141f7-6c85-4676-bfa1-4782594b0b48.htseq.counts.gz	5189a50f-94a9-4324-a00f-c1db7c0f569b	TCGA-S5-AA26-01A-11R-A38B-07	TCGA-S5-AA26-01A-11R	TCGA-S5-AA26-01A-01-TSA		TCGA-S5-AA26-01A-11	TCGA-S5-AA26-01A	TCGA-S5-AA26	a540fcec-58a1-4e58-8e0a-8bf73b78e30d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	31	130.0	False	true	1EE92799-E860-4C6B-B525-0C238D8B2E2F	1.91	fd9b4ba5-8cb9-4867-81c9-33c608584488			0.18	23	released	2b398a38-7e2f-4473-8e79-2cb04e5bc668	RNA	R	0.18	UV Spec	released	False	9826a53f-21da-4605-bc9f-88c279f6ddf1	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	3f85cd34-f86c-4df4-8e9d-27689233c7d8	released												released	30.0	4fa5a2e9-e3b5-4179-a6b5-5f57d4415614	Primary Tumor	01	released	Not Reported	released	TCGA-S5-AA26_demographic	46	-16972		e4cfa050-8add-5f6c-8078-7ff501b80803	not hispanic or latino	male	black or african american	released	Alive	1967		TCGA-S5-AA26_exposure	Not Reported	27.250887446663558		48ff4e77-5cf6-510a-b041-0d86045369c5	167.0		released	76.0	TCGA-S5-AA26_diagnosis	16972		MX	N0	Stage III	T3a	7th	not reported	0	503	08b1e24f-785d-5a15-81fd-f168eb7dea31	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-S5-AA26_treatment	TCGA-S5-AA26_treatment_1	released	1659d8b0-c245-5191-aa07-daac8be2cee4	no	Radiation Therapy, NOS	released	683aaccc-e26b-5d23-bb83-e9a87b75aa0b	no	Pharmaceutical Therapy, NOS	5189a50f-94a9-4324-a00f-c1db7c0f569b
ac221a46-de94-4e57-9901-5d45e84cf4d0.htseq.counts.gz	78e09acb-0869-47e2-968e-76c2dce18b1f	TCGA-GC-A3RC-01A-11R-A22U-07	TCGA-GC-A3RC-01A-11R	TCGA-GC-A3RC-01A-01-TS1		TCGA-GC-A3RC-01A-11	TCGA-GC-A3RC-01A	TCGA-GC-A3RC	bd7f2c90-863e-4380-ad31-8755bcb2f975	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	80	6.0	False	true	77A23BED-7B17-4854-A6E3-D6E8ECD460F8	1.81	3208f694-4779-4548-8cb4-74df829b3345			0.15	23	released	1b8ec3f4-639f-4aad-a10c-6bfc722edaf4	RNA	R	0.15	UV Spec	released	False	e6c0f017-20ed-4109-891b-b74ec56d2e37	11	0.0	0.0	0.0	0.0	0.0	15.0	85.0	60.0	TOP	e5eace79-a73d-4cfa-915b-02c7fd55dd7f	released												released	6.0	af6db5e4-2286-4123-9e49-ee03359fd09f	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A3RC_demographic	59	-21668		39b06e40-da6b-55ce-97f5-22878f9bc8f6	not hispanic or latino	male	white	released	Alive	1952		TCGA-GC-A3RC_exposure	Not Reported	36.244897959183675		4c90bd69-987e-5ac9-a645-e03ee749206c	175.0		released	111.0	TCGA-GC-A3RC_diagnosis	21668	T2b	M0	N0	Stage II	T2b	7th	not reported	0	484	41dfe3db-ffb5-5f31-958a-9cf6373aaa19	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-GC-A3RC_treatment	TCGA-GC-A3RC_treatment_1	released	05b0fbb8-0c16-5ee8-9f87-bf8dada5a866	no	Radiation Therapy, NOS	released	6de25391-079b-5ead-8b64-da1dcaeed875	no	Pharmaceutical Therapy, NOS	78e09acb-0869-47e2-968e-76c2dce18b1f
323a8944-dd67-4010-aa40-506285dbe4bd.htseq.counts.gz	3144bf27-fd0b-4319-906f-679c0f6c7d2c	TCGA-GD-A3OS-01A-12R-A220-07	TCGA-GD-A3OS-01A-12R	TCGA-GD-A3OS-01A-01-TS1		TCGA-GD-A3OS-01A-12	TCGA-GD-A3OS-01A	TCGA-GD-A3OS	2a41b7d4-132f-4fb6-87b5-487c445379c7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	205	350.0	False	false	FB313E2A-4B08-44FA-A872-00EF40064FB7	1.89	80b2573f-d8e0-4d0d-84a6-301c5103267d			0.18	23	released	5edf14f4-a41f-4abd-9dc9-e949b0f06f6c	RNA	R	0.18	UV Spec	released	False	d1823d27-5fd3-409a-a6ac-d95debb6d606	12	0.0	0.0	3.0	0.0	0.0	17.0	80.0	85.0	TOP	bd64def1-221d-48f6-9b1b-83d778c5d102	released												released	20.0	c629cd55-54d7-4e31-ab90-955ebff0b20a	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A3OS_demographic	54	-19776		45d1fcfe-452d-5bec-a153-e2f4e726e123	not hispanic or latino	female	white	released	Alive	1957		TCGA-GD-A3OS_exposure	Not Reported	29.72107910379515	0.958904109589041	e314b068-60f7-545f-a538-fe99f4ad8d43	162.0	17.5	released	78.0	TCGA-GD-A3OS_diagnosis	19776	T2a	MX	NX	Stage II		7th	not reported	0	638	171dde1e-3ad5-52ed-a32c-fba1e007ed0f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-GD-A3OS_treatment	TCGA-GD-A3OS_treatment_1	released	ee4f5d77-8840-5ba2-8f36-e582ef73ef56	no	Radiation Therapy, NOS	released	28ae936c-c2a3-5b0c-9c89-42e4c36e2208	yes	Pharmaceutical Therapy, NOS	3144bf27-fd0b-4319-906f-679c0f6c7d2c
b4610520-9d1e-4bfe-ab3b-2864067bdc9c.htseq.counts.gz	d4916681-2ee6-4f38-8f6e-d60ac7d2db6a	TCGA-XF-AAN5-01A-11R-A42T-07	TCGA-XF-AAN5-01A-11R	TCGA-XF-AAN5-01A-01-TSA		TCGA-XF-AAN5-01A-11	TCGA-XF-AAN5-01A	TCGA-XF-AAN5	c1591625-e794-4155-8ae4-b74d6264659f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2172	350.0	False	true	43F485E6-346F-483A-826F-6960F00025C9	1.79	e1adc304-07de-493e-a800-50fc1ab65b30			0.16	23	released	80c29f46-d5db-4ed8-b2c0-12e980f80d94	RNA	R	0.16	UV Spec	released	False	e591f509-c4af-4bd9-b85e-907243386b93	11	10.0	2.0	15.0	2.0	0.0	18.0	67.0	80.0	TOP	899b8712-e690-408c-9856-521ab4f392be	released												released	30.0	120124c2-da96-44bc-869e-07c3489b4d39	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN5_demographic	61	-22411		9aacb22d-7958-5604-b02f-20318865bb4c	not hispanic or latino	female	white	released	Alive	1947		TCGA-XF-AAN5_exposure	Not Reported	19.60715661216344	1.643835616438356	41de3413-3fa5-5532-8208-f31102da4df1	169.0	30.0	released	56.0	TCGA-XF-AAN5_diagnosis	22411		MX	N0	Stage III	T3b	6th	not reported	0	2293	d10bed22-2e95-51cc-aa1f-c24e60d33157	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2008	TCGA-XF-AAN5_treatment	TCGA-XF-AAN5_treatment_1	released	9622e0c4-5b8b-5c77-85fd-657556cdad1e	no	Radiation Therapy, NOS	released	190ec659-aa39-53f4-97b9-fff607a27518	yes	Pharmaceutical Therapy, NOS	d4916681-2ee6-4f38-8f6e-d60ac7d2db6a
5532e9a2-66b8-4dd2-aa1a-ebbb08163280.htseq.counts.gz	fc7a01ba-7862-48d4-aa50-10b6bb041ac9	TCGA-FD-A3SR-01A-11R-A22U-07	TCGA-FD-A3SR-01A-11R	TCGA-FD-A3SR-01A-01-TS1		TCGA-FD-A3SR-01A-11	TCGA-FD-A3SR-01A	TCGA-FD-A3SR	72d6e9aa-4a99-4fc9-a67b-4631e95fb043	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	569	340.0	False	true	04E024F2-1D17-446A-868D-DCC2C2564103	2.06	dafc2af2-7b91-45a4-ae67-fe22ab060f06			0.17	23	released	13d624eb-b033-42f7-bec1-06dcdc49f6df	RNA	R	0.17	UV Spec	released	False	1845f566-7076-450a-8994-236919e5311b	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	a88bcfdb-7086-4aab-ad1c-20ea2657d418	released												released	20.0	8e9683f4-52b4-4646-921e-7bf89f56774a	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SR_demographic	68	-24979	602	d2856cc8-8a4e-572b-8e69-66888dccdd7c	not hispanic or latino	male	white	released	Dead	1942	2011	TCGA-FD-A3SR_exposure	Not Reported	30.756367762548898	2.191780821917808	f704cd1e-fe62-569c-bda2-49915f8424d4	183.0	40.0	released	103.0	TCGA-FD-A3SR_diagnosis	24979		MX	N2	Stage IV	T4a	7th	not reported	0		636f1c85-afcb-5dc2-a6ca-1469d789a7e8	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2010	TCGA-FD-A3SR_treatment	TCGA-FD-A3SR_treatment_1	released	add66cd2-36f8-508e-bba8-98a60dce574e	yes	Radiation Therapy, NOS	released	c172e428-ff07-57b9-96ad-09a76e9fdc3a	yes	Pharmaceutical Therapy, NOS	fc7a01ba-7862-48d4-aa50-10b6bb041ac9
9ae0ab75-bcb7-40e2-b987-2f14f8d254dc.htseq.counts.gz	0cf09e7d-c0ce-4532-a2be-9177894493fa	TCGA-4Z-AA7Q-01A-11R-A39I-07	TCGA-4Z-AA7Q-01A-11R	TCGA-4Z-AA7Q-01A-01-TS1		TCGA-4Z-AA7Q-01A-11	TCGA-4Z-AA7Q-01A	TCGA-4Z-AA7Q	ffafcbfd-0eb3-4e14-acd0-4407b641a4a5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	518	240.0	False	true	5715E28F-8C16-48DD-B92B-568EFCD0CA8D	1.9	7d08924f-7f7e-48f2-80d6-275b4d964697			0.17	23	released	70930181-8ba4-4fc4-8dfd-4f078b15b85c	RNA	R	0.17	UV Spec	released	False	09a49523-90d0-4b8e-b7eb-fdf187090002	11	3.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	bc06a4d8-f196-4c73-9262-6578eeb3fc6b	released												released	30.0	c9131c2e-4230-482a-8847-566b2f4f9254	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7Q_demographic	79	-28981	510	a50f6751-4643-5299-abb0-dea6bf2e5252	not reported	male	white	released	Dead	1933	2013	TCGA-4Z-AA7Q_exposure	Not Reported	24.16716240333135		d1675054-24e0-5ab9-b7f6-2be3b41af040	164.0		released	65.0	TCGA-4Z-AA7Q_diagnosis	28981	T3a	M0	NX	Stage III	T3a	7th	not reported	0		934adb6b-d0f4-5e16-855c-2cacb12a4aee	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-4Z-AA7Q_treatment_1	TCGA-4Z-AA7Q_treatment	released	225ae57a-f405-5434-877b-b65d9a7432cc	no	Pharmaceutical Therapy, NOS	released	b2555385-bb8d-5bd7-9d55-b9034299ba87	no	Radiation Therapy, NOS	0cf09e7d-c0ce-4532-a2be-9177894493fa
827ee9a3-e5fc-427f-855d-9cabac010795.htseq.counts.gz	1b513606-77b1-4edd-8cce-a411e2a3d8c2	TCGA-DK-AA6S-01A-21R-A39I-07	TCGA-DK-AA6S-01A-21R	TCGA-DK-AA6S-01A-02-TSB		TCGA-DK-AA6S-01A-21	TCGA-DK-AA6S-01A	TCGA-DK-AA6S	45eea556-e97b-4912-8aa9-7e5c709eb52b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	4782	390.0	False	true	64478CAB-EA92-4334-AC37-3A0906057203	1.9	f4159732-6dd2-4614-b3e2-3a528fdfa527			0.16	23	released	431076a9-e6f9-4364-ba5d-b792d7e858ed	RNA	R	0.16	UV Spec	released	False	ecf99810-ad0b-4661-8b8f-29c7614db1ef	21	2.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	2d759715-02d7-436a-8fc0-3446a13e071c	released												released	30.0	61cf45dc-21ec-40a3-a72b-3edd21895f6b	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6S_demographic	60	-22027		fdc132cf-069d-575f-8727-530275c5b9d8	not hispanic or latino	male	white	released	Alive	1940		TCGA-DK-AA6S_exposure	Not Reported	34.602076124567475		d1180a98-7112-507c-ad19-00a363380bdc	170.0		released	100.0	TCGA-DK-AA6S_diagnosis	22027		M0	N0	Stage III	T3b	5th	not reported	0	5050	43b0cbd3-1c5b-5a13-a563-4cf6cb99ed42	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iii	2000	TCGA-DK-AA6S_treatment	TCGA-DK-AA6S_treatment_1	released	97b60c5f-8ef5-5987-8c9a-7ee45fdcb047	yes	Radiation Therapy, NOS	released	131d3cca-3213-5886-962f-3d159e3206af	yes	Pharmaceutical Therapy, NOS	1b513606-77b1-4edd-8cce-a411e2a3d8c2
339381d9-5255-4b9c-a195-0fa6467e79a0.htseq.counts.gz	4c06145e-20e6-489e-a06a-8aca72a27e20	TCGA-LT-A8JT-01A-11R-A36F-07	TCGA-LT-A8JT-01A-11R	TCGA-LT-A8JT-01A-01-TSA		TCGA-LT-A8JT-01A-11	TCGA-LT-A8JT-01A	TCGA-LT-A8JT	6aa72ca1-b378-4db4-b4ef-b12386683d1f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	303	220.0	False	true	69E369C4-2BAA-4E33-9EB9-D9E0487C990B	1.9	85f596e4-9591-49f5-8408-25e4ce16c7f7			0.17	23	released	14d24ac2-ddc2-4978-b881-4059ecf8f32e	RNA	R	0.17	UV Spec	released	False	a09ea3b7-e527-4805-b0b7-2179062196c7	11	0.0	0.0	0.0	0.0	20.0	0.0	80.0	90.0	TOP	3708b897-c617-4885-9343-a149092e5356	released												released	30.0	a85b114d-2f7b-4678-8508-e3bc04552093	Primary Tumor	01	released	Not Reported	released	TCGA-LT-A8JT_demographic	69	-25498		c43d7ebb-2e9c-518e-96d2-fd8a73cfdc26	not hispanic or latino	female	white	released	Alive	1944		TCGA-LT-A8JT_exposure	Not Reported	21.296296296296294	4.109589041095891	48aa4af8-b5fd-5ceb-b4e0-79f4694a7691	180.0	75.0	released	69.0	TCGA-LT-A8JT_diagnosis	25498	T2	M0	N0	Stage II	T2a	7th	not reported	0	641	5d17cbdd-6988-5f19-af74-8b1fb8f6735c	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-LT-A8JT_treatment_1	TCGA-LT-A8JT_treatment	released	99a49678-a35a-52cd-9f51-3ddb65107a08	no	Pharmaceutical Therapy, NOS	released	ca375034-8bdf-56c3-a24c-2aa9efa47ea3	no	Radiation Therapy, NOS	4c06145e-20e6-489e-a06a-8aca72a27e20
c6b63416-9f37-4290-a362-b4ee3a0e2e46.htseq.counts.gz	e80773d9-46c8-4a9a-9eaa-12fe80fdb84f	TCGA-UY-A8OC-01A-11R-A36F-07	TCGA-UY-A8OC-01A-11R	TCGA-UY-A8OC-01A-01-TS1		TCGA-UY-A8OC-01A-11	TCGA-UY-A8OC-01A	TCGA-UY-A8OC	5a0e4dc3-4ec6-4d27-bb7e-1d2221d06d33	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		280.0	False	true	A3441B74-07BB-4A9F-9B66-0071AD46CB21	1.89	59551fc3-7885-44d9-bf8a-ffdd5bea8238			0.18	23	released	341a1cf3-7403-4f3a-b331-fddb4a432467	RNA	R	0.18	UV Spec	released	False	af3aa1e9-f9ce-46de-9f4b-2bc5a5f9dba7	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	fccb957e-66a0-4228-bce6-81ceabefcd73	released												released	30.0	2a83d2ac-f8b9-4c24-9af1-4149ad400a21	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A8OC_demographic	90	-32872	0	70aaf584-8b01-53b4-81dd-2d4ec2676b2d	not hispanic or latino	male	white	released	Dead			TCGA-UY-A8OC_exposure	Not Reported			56b08cd7-156a-5803-a69b-0f8a0e3b5150			released		TCGA-UY-A8OC_diagnosis	32872		MX	N1	Stage IV	T4	6th	not reported	0		8027757c-3049-5f69-a419-b4a743bc02d7	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A8OC_treatment_1	TCGA-UY-A8OC_treatment	released	dce33585-8868-5835-9493-8b3fedbe056f	no	Pharmaceutical Therapy, NOS	released	d11663d8-7cd0-54b8-9d63-852f2467ce23	no	Radiation Therapy, NOS	e80773d9-46c8-4a9a-9eaa-12fe80fdb84f
15ed73ff-f2e4-467a-aa1c-7a89a3b1171e.htseq.counts.gz	1dc53f60-25e9-4f98-b9c9-7d47d926248e	TCGA-K4-A83P-01A-11R-A352-07	TCGA-K4-A83P-01A-11R	TCGA-K4-A83P-01A-01-TSA		TCGA-K4-A83P-01A-11	TCGA-K4-A83P-01A	TCGA-K4-A83P	aa14ffb4-a715-4636-8251-73d019dddd8c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	104	220.0	False	true	B5339E3F-D046-4C1F-B3B1-8E5C20D15663	1.94	b19c4e9c-2caf-436b-b728-9849b668c663			0.18	23	released	72338f7e-4e3d-46db-8b7c-af697a5e93dc	RNA	R	0.18	UV Spec	released	False	ead258c0-b540-4c59-a33d-e44c79df9e26	11	0.0	0.0	0.0	0.0	10.0	40.0	50.0	60.0	TOP	9bdf4f1a-e34d-4675-8040-d8cf66aa056d	released												released	30.0	50d2886e-f232-433c-8062-c3c237fb5c09	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A83P_demographic	77	-28463		6a819969-8fe0-5700-abef-741ab9867321	not hispanic or latino	male	white	released	Alive	1936		TCGA-K4-A83P_exposure	Not Reported	33.41240936883958	7.671232876712328	99cc2ca3-1bf3-5e28-8a52-62f5ae96d789	173.0	140.0	released	100.0	TCGA-K4-A83P_diagnosis	28463		MX	N1	Stage IV	T4a	7th	not reported	0	495	d7c398ed-72a7-5d01-bb11-ccdf207da1dc	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-K4-A83P_treatment_1	TCGA-K4-A83P_treatment	released	721aa103-f081-54ca-98c4-e110c613dd36	yes	Pharmaceutical Therapy, NOS	released	8f750837-8eb2-5a4c-8224-2df8c26d5286	no	Radiation Therapy, NOS	1dc53f60-25e9-4f98-b9c9-7d47d926248e
7c7c4ee8-e9cc-48c9-a74a-82c3b741d967.htseq.counts.gz	2498ce1b-8077-4600-a5f4-0e55a3b52bbd	TCGA-XF-AAMJ-01A-11R-A42T-07	TCGA-XF-AAMJ-01A-11R	TCGA-XF-AAMJ-01A-01-TSA		TCGA-XF-AAMJ-01A-11	TCGA-XF-AAMJ-01A	TCGA-XF-AAMJ	8f10e006-531a-49ac-b51b-df3fdcb20929	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2914	480.0	False	true	40212BF3-FE4C-4B89-8583-76C73560DD2C	1.9	c3919da2-0345-4374-940a-89fc70b7f393			0.16	23	released	21809eba-4936-4a59-b94e-c78619b3d5b3	RNA	R	0.16	UV Spec	released	False	8d0ae62c-49db-418b-a1e4-324f73c434c8	11	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	5a477740-4717-4ef0-b6b0-8aa5783cb3d8	released												released	30.0	8bc818a8-8828-43db-b37e-d364f69ac6d6	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMJ_demographic	70	-25838	1670	18c65d3f-eb0a-5257-baf6-293c82325782	not hispanic or latino	male	asian	released	Dead	1936	2010	TCGA-XF-AAMJ_exposure	Not Reported	22.313278429145196		c75dec01-834c-5dbe-9ef9-9b8cff797334	157.0		released	55.0	TCGA-XF-AAMJ_diagnosis	25838		M0	N0	Stage III	T3b	6th	not reported	0		bd0785c8-e447-5849-972c-6a2ca16b7cce	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-AAMJ_treatment_1	TCGA-XF-AAMJ_treatment	released	5e540cb3-830e-5584-8e2a-d01e24de808e	yes	Pharmaceutical Therapy, NOS	released	11313e7b-1a7b-51cf-a04c-242d28988fe5	yes	Radiation Therapy, NOS	2498ce1b-8077-4600-a5f4-0e55a3b52bbd
2d6fc33e-c553-427e-9e1c-8008f694b0ce.htseq.counts.gz	000aa330-a5f6-4a2c-b4d5-8df4304b6fa8	TCGA-G2-AA3B-01A-11R-A39I-07	TCGA-G2-AA3B-01A-11R	TCGA-G2-AA3B-01A-01-TS1		TCGA-G2-AA3B-01A-11	TCGA-G2-AA3B-01A	TCGA-G2-AA3B	22424a05-0546-44c2-8ab7-abb8e49c3363	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1754	110.0	False	true	F2410C77-1B33-47AA-A820-8A0E637234FC	1.82	50731ae0-4466-47c1-9e65-42227a3fc252			0.16	23	released	9dd3c7f3-6e1c-47d5-9464-d334a96ba768	RNA	R	0.16	UV Spec	released	False	9b3b3114-1957-42e2-a7b3-63ed21ebd47f	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	e7731085-9405-4803-8b17-0d46cfe83db8	released												released	30.0	991fa342-863b-4708-9a95-f0c8590c7a63	Primary Tumor	01	released	Not Reported	released	TCGA-G2-AA3B_demographic	75	-27646		f49e8ecf-011e-5689-82ca-a2e48a52da13	not hispanic or latino	female	white	released	Alive	1934		TCGA-G2-AA3B_exposure	Not Reported	27.250887446663558	1.4246575342465753	e94b4643-3e52-50b0-9a52-7e048329a74c	167.0	26.0	released	76.0	TCGA-G2-AA3B_diagnosis	27646	T2	M0	N0	Stage II	T2	6th	not reported	0	2008	11c9b8b3-86a3-5c03-8661-ce840c360812	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-G2-AA3B_treatment_1	TCGA-G2-AA3B_treatment	released	8bcbc4b6-0d3a-5b0d-bcd6-886716a41ec4	no	Pharmaceutical Therapy, NOS	released	3c7991a5-328e-5cdb-83ce-7328a14f5a89	no	Radiation Therapy, NOS	000aa330-a5f6-4a2c-b4d5-8df4304b6fa8
87bed1c7-0f8e-4415-ad1a-12feecb2e56a.htseq.counts.gz	51fa427e-ba30-4d51-93bf-d7d6c4dd5386	TCGA-CU-A0YN-11A-11R-A10U-07	TCGA-CU-A0YN-11A-11R	TCGA-CU-A0YN-11A-01-TS1		TCGA-CU-A0YN-11A-11	TCGA-CU-A0YN-11A	TCGA-CU-A0YN	679a6869-2ce9-4472-8db1-8869e2c1a440	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1827	80.0	False	false		1.75	61c103bc-8fe0-43d7-aa15-a6fe7f503112			0.13	23	released	c840cd00-6e57-42a7-8085-e48bbc762ef4	RNA	R	0.13	UV Spec	released	False	b4ee5a58-b364-417f-9015-cae10bdafbd6	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	68404c9c-0e8b-4519-8286-d4925bf2029f	released												released	30.0	caac9355-9bac-41d8-b7a7-8eeb775179fa	Solid Tissue Normal	11	released	Not Reported	released	TCGA-CU-A0YN_demographic	60	-21927	393	52bcca0e-66d3-563b-9d5e-32f95fe87cfa	not hispanic or latino	male	white	released	Dead	1945	2006	TCGA-CU-A0YN_exposure	Not Reported	21.27256659512688	2.191780821917808	40d5a527-56f9-514b-b498-b9d592828e1a	178.0	40.0	released	67.4	TCGA-CU-A0YN_diagnosis	21927		M0	N0	Stage III	T3a	6th	not reported	0		9710f220-c2ba-54af-905e-26226f53c6c3	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2005	TCGA-CU-A0YN_treatment	TCGA-CU-A0YN_treatment_1	released	f5b72aca-780b-52b7-8cd9-32caafee920a	no	Radiation Therapy, NOS	released	2d1d5195-975d-5c26-80ba-cb48fdfe2d7f	no	Pharmaceutical Therapy, NOS	51fa427e-ba30-4d51-93bf-d7d6c4dd5386
d3a1a774-4083-4eb9-89ba-fdcc01eaa648.htseq.counts.gz	a3604977-2989-4088-a646-faefbfd5dcb5	TCGA-GV-A3QH-01A-11R-A220-07	TCGA-GV-A3QH-01A-11R	TCGA-GV-A3QH-01A-01-TSA		TCGA-GV-A3QH-01A-11	TCGA-GV-A3QH-01A	TCGA-GV-A3QH	33bc6a7c-9844-41e3-96b3-1e34bb3fedd5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	162	120	False	true	7492187D-9243-482E-B2A0-08CAD7EB7DBE	1.88	dc901511-9e0f-4fc6-b6f4-bee8e627ce25	2.21	13	0.17	23	released	eecabd63-4c2e-49c3-ad85-fdd208132430	RNA	R	0.17	UV Spec	released	False	fa0a1863-6496-46f3-a7b7-a0845331a756	11	8	1	15	1	0	0	85	80	TOP	e3d77609-052e-47a6-a43e-39d7caff2193	released												released	30	deb7311f-e747-44ec-92c3-1e56cd5cacf2	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3QH_demographic	67	-24681	258	cd5b6748-953d-529a-9f91-63b531b033db	not hispanic or latino	male	white	released	Dead	1944		TCGA-GV-A3QH_exposure	Not Reported	26.878544423440452	0.547945205479452	45897ded-c97f-5410-b9bb-b7d96a630325	184.0	10.0	released	91.0	TCGA-GV-A3QH_diagnosis	24681	T2	MX	NX	Stage II		7th	not reported	0	237	f5a51efc-7307-533f-8372-f73877dc03b4	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage ii	2011	TCGA-GV-A3QH_treatment_1	TCGA-GV-A3QH_treatment	released	a43bba83-08cf-5f01-91fb-76a5f82be6b8	yes	Pharmaceutical Therapy, NOS	released	163dd9e9-8d81-5a87-aefb-569d6030fd03	no	Radiation Therapy, NOS	a3604977-2989-4088-a646-faefbfd5dcb5
cf403d76-24f1-4712-8eea-d3dc36a5365f.htseq.counts.gz	dafcba77-da3e-46a4-b065-b882856bcc92	TCGA-ZF-A9RD-01A-11R-A42T-07	TCGA-ZF-A9RD-01A-11R	TCGA-ZF-A9RD-01A-01-TS1		TCGA-ZF-A9RD-01A-11	TCGA-ZF-A9RD-01A	TCGA-ZF-A9RD	f57122dd-a6f1-484d-b08a-cb1194de2f9d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2074	220.0	False	true	6B721B6B-AD81-422E-8390-D615EA75EF64	1.89	4333b9aa-34fb-429f-b622-6ab259f12367			0.18	23	released	631d9011-c236-48d4-951b-8230829cdf73	RNA	R	0.18	UV Spec	released	False	7e022348-5bb8-4343-8092-0ac83bc3d9d0	11	5.0	0.0	0.0	0.0	40.0	0.0	60.0	60.0	TOP	ce35ccdf-8f3c-41b4-85f4-12100f2ec1f5	released												released	30.0	3c7de6de-68e0-443b-946d-437b8aece057	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RD_demographic	75	-27496	408	fb8101eb-c359-5c61-83a1-f66ebec2aa13	not hispanic or latino	female	white	released	Dead	1933	2009	TCGA-ZF-A9RD_exposure	Not Reported	25.96454217209623	0.547945205479452	91092c6c-c03c-5ec8-b35c-3eb9f04b75bb	157.0	10.0	released	64.0	TCGA-ZF-A9RD_diagnosis	27496	T2	MX	N2	Stage IV	T3a	6th	not reported	0		1334366f-f1d8-570a-b4b5-281dd824265a	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2008	TCGA-ZF-A9RD_treatment	TCGA-ZF-A9RD_treatment_1	released	5ec2241e-a7c3-5c2a-9720-d8563e2fe51a	no	Radiation Therapy, NOS	released	736eae88-d40d-54c1-b04f-0882d3ac3a72	no	Pharmaceutical Therapy, NOS	dafcba77-da3e-46a4-b065-b882856bcc92
44888c35-36ef-4e87-a5a4-a8fb30457ca1.htseq.counts.gz	a03c13f8-d0f2-4ab9-8bd0-32dfdce5b37a	TCGA-2F-A9KR-01A-11R-A38B-07	TCGA-2F-A9KR-01A-11R	TCGA-2F-A9KR-01A-01-TSA		TCGA-2F-A9KR-01A-11	TCGA-2F-A9KR-01A	TCGA-2F-A9KR	f6d916b0-8e4c-49cb-a0d4-883908f3284f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	4919	650.0	False	false	EC17D988-194A-4C20-9BF8-D7CC75D9DF55	1.87	a9321523-588e-40f2-95d2-2501fd1b23ee			0.18	23	released	08c34ade-f53c-4294-ad36-2c5d1e7074c4	RNA	R	0.18	UV Spec	released	False	4f3591e8-ebce-4711-9348-71f3748111e2	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	7a358bbe-1fb6-4093-bb32-d1d9013a13d4	released												released	30.0	b83bab59-8667-4920-9593-575997621b34	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KR_demographic	59	-21848	3183	9b5ea0ba-a94a-5446-b9b8-52c8903ccbaa	not reported	female	not reported	released	Dead	1941		TCGA-2F-A9KR_exposure	Not Reported	25.826446280991732	1.2328767123287672	48d844a6-b855-5b76-8ad2-b713f4b7f8bf	176.0	22.5	released	80.0	TCGA-2F-A9KR_diagnosis	21848	T2	M0	N0	Stage III	T3a	5th	not reported	0	3148	2aae77f9-7847-5b4d-bf34-f375100e9132	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2000	TCGA-2F-A9KR_treatment_1	TCGA-2F-A9KR_treatment	released	d8d68053-df4f-5c6a-90fd-85445e999b49	no	Pharmaceutical Therapy, NOS	released	31308d34-1eed-5cd2-bd37-16d6b4c2ca7b	yes	Radiation Therapy, NOS	a03c13f8-d0f2-4ab9-8bd0-32dfdce5b37a
705a38c7-5af6-43df-8ac4-581d54212db6.htseq.counts.gz	b6f60f1e-9685-4481-997d-6c78f9108887	TCGA-SY-A9G0-01A-12R-A38B-07	TCGA-SY-A9G0-01A-12R	TCGA-SY-A9G0-01A-01-TS1		TCGA-SY-A9G0-01A-12	TCGA-SY-A9G0-01A	TCGA-SY-A9G0	423b7fc5-3970-4c96-990d-96ad0842f1eb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	752	50.0	False	true	D586B06E-08E2-4C46-89B3-121BF0FFF693	1.85	97226f81-8074-4b17-bcc7-c74e51216706			0.18	23	released	94211d48-3488-4593-b864-bcccb61865f2	RNA	R	0.18	UV Spec	released	False	032cf5a8-442a-4988-9944-5b17593f199d	12	5.0	0.0	0.0	0.0	10.0	25.0	65.0	65.0	TOP	e0f4aaad-162f-485e-a4f6-085db9b08391	released												released	10.0	14e1cb71-07e9-46af-84da-e35a360a2bbc	Primary Tumor	01	released	Not Reported	released	TCGA-SY-A9G0_demographic	82	-30205	1008	2825a3ba-114c-555d-84bc-ba070d919e79	not hispanic or latino	male	white	released	Dead	1929		TCGA-SY-A9G0_exposure	Not Reported	28.37370242214533	0.5342465753424658	dfd0b9ac-ac94-5963-b5dc-8a0b501e1c17	170.0	9.75	released	82.0	TCGA-SY-A9G0_diagnosis	30205	T4	M0	N1	Stage IV	T4	7th	not reported	0	378	e66e857c-8b5e-5e0e-8546-f0b83a975b3c	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2011	TCGA-SY-A9G0_treatment	TCGA-SY-A9G0_treatment_1	released	4e47cacd-5bac-56d2-b241-f45a2c388b28	no	Radiation Therapy, NOS	released	c5f9ad52-07b3-58e7-a38f-e3287cc024e7	no	Pharmaceutical Therapy, NOS	b6f60f1e-9685-4481-997d-6c78f9108887
16c74720-66a9-4c6b-9450-3d12a28ca214.htseq.counts.gz	0a3135cb-f854-4944-898e-1985754c754f	TCGA-FD-A3SO-01A-11R-A22U-07	TCGA-FD-A3SO-01A-11R	TCGA-FD-A3SO-01A-01-TSA		TCGA-FD-A3SO-01A-11	TCGA-FD-A3SO-01A	TCGA-FD-A3SO	94809fbf-4895-42c0-a7c6-f39ee1a41f1a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	66	700.0	False	true	9F88F244-C30A-409F-BA44-94BEA0177116	2.07	bd1ba628-0cb5-4103-baa4-3f430d24d359			0.15	23	released	1f616ecf-6214-4d15-ac6b-86c4902cd96b	RNA	R	0.15	UV Spec	released	False	65384662-c05c-42c9-91be-403fb1b6789e	11	5.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	82d023c9-88b5-425a-a826-c3907188c7f7	released												released	20.0	869e3d55-cad8-436e-b6a8-7ed90ad0a535	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SO_demographic	68	-25147	168	674c396c-f100-5740-94b7-70c1032d27cd	not hispanic or latino	male	white	released	Dead	1944	2012	TCGA-FD-A3SO_exposure	Not Reported	25.712198685171657	1.643835616438356	1099dce3-2343-5d21-9faa-bd87f96f7352	185.0	30.0	released	88.0	TCGA-FD-A3SO_diagnosis	25147		MX	N1	Stage IV	T3a	7th	not reported	0		4d1baea0-7f8d-58ff-9ad6-e86e89f978c8	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2012	TCGA-FD-A3SO_treatment_1	TCGA-FD-A3SO_treatment	released	e723b632-6455-52ac-a69a-0f43d49d951b	yes	Pharmaceutical Therapy, NOS	released	387c60ae-d1d2-5fff-98c4-330058453f7f	yes	Radiation Therapy, NOS	0a3135cb-f854-4944-898e-1985754c754f
8e536759-ed60-418c-8a0b-4de7a6cb1b5f.htseq.counts.gz	c3eaf22a-77c6-421e-a610-00e393709f61	TCGA-BT-A20R-11A-11R-A16R-07	TCGA-BT-A20R-11A-11R	TCGA-BT-A20R-11A-01-TSA		TCGA-BT-A20R-11A-11	TCGA-BT-A20R-11A	TCGA-BT-A20R	f8780a4b-7f55-41d1-bf92-8513955d150e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1794	270.0	False	true		1.71	9846d55d-971d-4e69-b6ea-ce8c48cafede			0.17	23	released	61cf92e8-ece2-4ea5-a394-a1b5157ba97a	RNA	R	0.17	UV Spec	released	False	fa622e84-7db8-44fe-8daa-37d8a66f3ad8	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	0f9b4c4b-5237-49f1-932d-9448154d16c4	released												released	20.0	4f6353e2-fb61-48b7-b784-3c0d391d708b	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A20R_demographic	79	-28987	154	22bf7106-accf-514f-a1e8-c9ca34ee2367	not hispanic or latino	female	white	released	Dead	1927	2006	TCGA-BT-A20R_exposure	Not Reported			f983c151-07e0-5519-99f9-9c8f04ad8465			released		TCGA-BT-A20R_diagnosis	28987	T3b	M0	N1	Stage IV	T3b	6th	not reported	0		fe910470-54ec-5a10-acba-f1aa4b14186c	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2006	TCGA-BT-A20R_treatment	TCGA-BT-A20R_treatment_1	released	e8ef11c4-39ad-589b-83db-caad8cc5e42f	no	Radiation Therapy, NOS	released	3f6bb63a-0c1e-5f26-9650-a69cc299f3b9	no	Pharmaceutical Therapy, NOS	c3eaf22a-77c6-421e-a610-00e393709f61
2a0bb88a-8f8d-4a9e-bed2-f1a3d43eda86.htseq.counts.gz	cb815de6-05cb-4aa3-b7aa-eef6390dee14	TCGA-4Z-AA86-01A-11R-A39I-07	TCGA-4Z-AA86-01A-11R	TCGA-4Z-AA86-01A-01-TS1		TCGA-4Z-AA86-01A-11	TCGA-4Z-AA86-01A	TCGA-4Z-AA86	939b73d8-39fd-410e-aeae-53080ea99618	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1466	120.0	False	true	B0958D4E-B2F8-4D76-96E7-714662E3B677	1.89	7bd745b4-8009-4841-b775-1d8c4942591c			0.17	23	released	09272e3d-270a-48c7-8d3d-7b78fc47c0c3	RNA	R	0.17	UV Spec	released	False	2936d0c9-5d34-439d-ae2f-1d4bc71928f9	11	5.0	0.0	20.0	0.0	0.0	50.0	30.0	90.0	TOP	864d4e6d-ed0f-426e-b3ac-613d813bd955	released												released	30.0	c14a0121-4f7b-4980-9194-94574dc6fecc	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA86_demographic	66	-24465	311	6afc43c3-4576-5918-ac6c-21e5deacfb43	not reported	male	black or african american	released	Dead	1943		TCGA-4Z-AA86_exposure	Not Reported			6c49f5e9-8aea-58b2-b8af-f3d36d17fb14			released		TCGA-4Z-AA86_diagnosis	24465	T2	M0	N1	Stage IV	T3a	7th	not reported	0	270	e01dd793-68b1-5424-b6d6-ab5c1fc1dce1	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iv	2009	TCGA-4Z-AA86_treatment	TCGA-4Z-AA86_treatment_1	released	4ebf66e3-c70e-525f-baf3-44c4293367d9	no	Radiation Therapy, NOS	released	df585b7d-ed2a-591d-b7aa-1035b0970489	no	Pharmaceutical Therapy, NOS	cb815de6-05cb-4aa3-b7aa-eef6390dee14
2ba27799-1d8a-44d2-8bca-af1779dc3990.htseq.counts.gz	aeed2630-aaa1-423c-b5e4-8919edca020d	TCGA-XF-AAN8-01A-11R-A42T-07	TCGA-XF-AAN8-01A-11R	TCGA-XF-AAN8-01A-01-TSA		TCGA-XF-AAN8-01A-11	TCGA-XF-AAN8-01A	TCGA-XF-AAN8	aa14e232-c6c6-4075-9d15-e1857373d233	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2275	1220.0	False	true	07718E82-778A-4797-BBAD-4494AAE3CAA2	1.8	6d466393-6b0c-4624-b385-5d689695de6b			0.17	23	released	37033253-b4bc-49da-bebc-fbcc28d9bdf9	RNA	R	0.17	UV Spec	released	False	a1cbbe0e-990a-4e39-b329-deb37ded4940	11	10.0	0.0	10.0	3.0	0.0	75.0	15.0	85.0	TOP	777bb6df-aa6b-4815-a62f-cc37f284e1f2	released												released	30.0	7569d782-f14e-47e5-93bc-b58b0bd6f697	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAN8_demographic	74	-27309	118	e26e48af-556b-54ff-b00f-582f2f02262c	not hispanic or latino	female	white	released	Dead	1933	2007	TCGA-XF-AAN8_exposure	Not Reported	22.837370242214533	3.287671232876712	d38f93ff-5140-5835-b61f-909f1048c3ef	170.0	60.0	released	66.0	TCGA-XF-AAN8_diagnosis	27309		MX	N0	Stage III	T3b	6th	not reported	0		0783e6b4-8ee7-5966-82ab-1a479111a16a	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2007	TCGA-XF-AAN8_treatment_1	TCGA-XF-AAN8_treatment	released	0857c1a8-cb9a-5ad3-bd51-c12c22443e94	no	Pharmaceutical Therapy, NOS	released	6a441a50-172b-574f-b1ce-83099e4611b5	no	Radiation Therapy, NOS	aeed2630-aaa1-423c-b5e4-8919edca020d
3278ba63-a2b0-414a-baf0-01d37f24d71d.htseq.counts.gz	5cf73d8e-40a2-475a-a983-9c2d3cf3cd7b	TCGA-FD-A6TG-01A-11R-A32O-07	TCGA-FD-A6TG-01A-11R	TCGA-FD-A6TG-01A-01-TSA		TCGA-FD-A6TG-01A-11	TCGA-FD-A6TG-01A	TCGA-FD-A6TG	0c890030-9bdb-4247-a3d5-a004f992f99c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	69	1100.0	False	true	0F4A353C-3292-4C6C-85AC-A621109D3F24	2.06	088b27e8-38f6-41ff-a861-d371415fd7f0			0.17	23	released	2507357c-3b44-41d8-809c-e81136ced9cc	RNA	R	0.17	UV Spec	released	False	744bb2c4-8fb8-4518-a30b-306d212907b7	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	75.0	TOP	1cbebd3d-bf4f-48ef-b748-2ec40e826794	released												released	30.0	fa9f9744-0123-4d33-be9a-000e8a24bd22	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TG_demographic	73	-26893	93	7206239f-bcd3-50f8-9f0d-d3c3e353ea73	not hispanic or latino	male	white	released	Dead	1940		TCGA-FD-A6TG_exposure	Not Reported	25.102391333069097	0.547945205479452	d61ce462-6b52-5339-96bc-4ed01c27d665	174.0	10.0	released	76.0	TCGA-FD-A6TG_diagnosis	26893	T2	MX	N2	Stage IV	T3a	7th	not reported	0	81	823101aa-82c2-5029-b013-8d883fe3669f	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2013	TCGA-FD-A6TG_treatment	TCGA-FD-A6TG_treatment_1	released	f35b5222-b612-5388-82ec-eecaaceec22f	no	Radiation Therapy, NOS	released	107982d5-65e9-5c03-b811-3fc68f75fcf0	yes	Pharmaceutical Therapy, NOS	5cf73d8e-40a2-475a-a983-9c2d3cf3cd7b
be992bf3-efe9-47ef-a37c-890bb0a76ae7.htseq.counts.gz	d74ec051-aa84-431a-8cd5-839d4296e682	TCGA-UY-A78P-01A-12R-A36F-07	TCGA-UY-A78P-01A-12R	TCGA-UY-A78P-01A-01-TS1		TCGA-UY-A78P-01A-12	TCGA-UY-A78P-01A	TCGA-UY-A78P	b8f3d552-2d4b-4dd8-b0e8-6a38e1baa2f3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		80.0	False	true	89019149-B6D2-4540-9BFE-BACCA9F5DA14	1.9	500beee6-a0cf-44aa-9102-de22b7210aba			0.17	23	released	eb1337be-a471-4b67-b065-f1066512eaa2	RNA	R	0.17	UV Spec	released	False	81c24fcf-4b88-4e81-9c11-a91de24d26c3	12	3.0	1.0	2.0	5.0	0.0	23.0	75.0	75.0	TOP	6c19d357-eb48-4462-a073-85232596ab3b	released												released	20.0	be09731d-cb80-4cdf-bc66-872334b00b8e	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78P_demographic	78	-28719		c7930caa-583f-5485-9416-23bb980e8ecf	not hispanic or latino	female	white	released	Alive			TCGA-UY-A78P_exposure	Not Reported		0.821917808219178	d78bd313-c25b-5da2-92c8-886d6458925d		15.0	released		TCGA-UY-A78P_diagnosis	28719		MX	N0	Stage II	T2	6th	not reported	0	2380	bbc672c5-ce0a-54bb-96e4-28645c9154c3	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii		TCGA-UY-A78P_treatment_1	TCGA-UY-A78P_treatment	released	ba7e440f-fff5-519a-bae8-c5e68c721236	no	Pharmaceutical Therapy, NOS	released	59030b29-e9b1-5c72-aad8-fb87cb3b297b	no	Radiation Therapy, NOS	d74ec051-aa84-431a-8cd5-839d4296e682
c947395a-e0f1-4539-8f56-9c569f01821b.htseq.counts.gz	4b1f6fe3-4971-41b8-8b29-57ad0cec4c79	TCGA-4Z-AA84-01A-11R-A39I-07	TCGA-4Z-AA84-01A-11R	TCGA-4Z-AA84-01A-01-TS1		TCGA-4Z-AA84-01A-11	TCGA-4Z-AA84-01A	TCGA-4Z-AA84	8b091ac3-d03a-4dd2-bdde-f7f5c6987155	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1880	470.0	False	true	528501A3-F7C9-4D93-AC98-7CFFF0C11D0A	1.87	210311b9-88d7-4e29-974a-0e807ea88d1b			0.17	23	released	42f5d131-0792-4181-a153-97ac31603a8f	RNA	R	0.17	UV Spec	released	False	07bf9364-4dca-4ea7-8af4-9a9d2ba4a655	11	4.0	0.0	6.0	0.0	0.0	8.0	86.0	93.0	TOP	ad3fc2c8-d332-4800-9256-378ce446f297	released												released	30.0	7ab33f7c-e09c-45b2-b951-928778af30d7	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA84_demographic	61	-22397		93feaf22-28bd-50e7-bdc3-4131fa717a21	not reported	male	white	released	Alive	1947		TCGA-4Z-AA84_exposure	Not Reported	22.862534475250396		cbff22b0-0d70-5919-9b4f-4ca65f84ee84	166.0		released	63.0	TCGA-4Z-AA84_diagnosis	22397	T1	M1	N2	Stage IV	T3a	7th	not reported	0	460	fbe33907-29de-5475-8050-7ac2a6487aa6	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-4Z-AA84_treatment	TCGA-4Z-AA84_treatment_1	released	2afb3925-53d1-59d7-96c2-c052658923ae	no	Radiation Therapy, NOS	released	8786c29d-3809-51b9-a635-8df09ca259e7	no	Pharmaceutical Therapy, NOS	4b1f6fe3-4971-41b8-8b29-57ad0cec4c79
5fe61ab5-d40f-4369-8166-d540a0e9b4df.htseq.counts.gz	5418e847-4f57-4b7d-ad6e-db21e464e46a	TCGA-E7-A677-01A-11R-A30C-07	TCGA-E7-A677-01A-11R	TCGA-E7-A677-01A-01-TSA		TCGA-E7-A677-01A-11	TCGA-E7-A677-01A	TCGA-E7-A677	d492383f-5449-4845-bfb3-b2cb4eb49c4e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	126	700.0	False	true	C721E01B-0C35-41AE-952C-5D2AB8373BC0	1.82	0aba0f10-05b2-4045-822b-045f61457427			0.17	23	released	fa1e1361-6538-48b7-948e-ce9fe60fbafc	RNA	R	0.17	UV Spec	released	False	243cfb59-0cd1-4f68-abad-cbe592945cd7	11	3.0	0.0	3.0	0.0	0.0	25.0	72.0	90.0	TOP	479f5737-523e-46aa-ac92-e08ad2af07b4	released												released	30.0	9620a30c-6760-4f22-bdd0-cfa1c9000d02	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A677_demographic	81	-29613		5c875dce-50fa-58c5-84ce-d30f2ebe58b7	not hispanic or latino	male	asian	released	Alive	1931		TCGA-E7-A677_exposure	Not Reported	17.065556711758582		b4c86c7f-90d3-5bb2-9e70-4fe5e406eeaa	155.0		released	41.0	TCGA-E7-A677_diagnosis	29613		M0	N0	Stage II	T2b	7th	not reported	0	820	e2cca96c-de92-580c-8666-dd36f4554481	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A677_treatment_1	TCGA-E7-A677_treatment	released	6955627a-8f54-59a5-b17f-25afd96475a4	no	Pharmaceutical Therapy, NOS	released	aaa55cca-c45a-5fc8-b3ed-04eb68b4b418	no	Radiation Therapy, NOS	5418e847-4f57-4b7d-ad6e-db21e464e46a
7e897441-3be3-472a-b15d-aa5bbe2aae8e.htseq.counts.gz	f4538e94-0413-431b-81db-abd405458ea2	TCGA-CF-A3MH-01A-11R-A20F-07	TCGA-CF-A3MH-01A-11R	TCGA-CF-A3MH-01A-01-TSA		TCGA-CF-A3MH-01A-11	TCGA-CF-A3MH-01A	TCGA-CF-A3MH	b8a8d2fc-421b-4393-8d5a-946cf72cb496	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	64	460.0	False	true	5C446B3A-D6FB-4301-97E9-D713F985FEBE	1.82	38e62ae5-729f-41fa-94e7-7e3caa0a246b			0.16	23	released	f7e7ff17-0578-4a7a-a5f4-810f64d8b981	RNA	R	0.16	UV Spec	released	False	9d09657e-eff9-4df8-9c89-79702359871c	11	2.0	1.0	0.0	1.0	0.0	15.0	85.0	85.0	TOP	776d5932-de30-43b1-888c-1cabf68f093a	released												released	30.0	8cf68bb1-5966-40cd-a038-e9e91e608766	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A3MH_demographic	75	-27458		1434f484-3e1b-549a-89e0-70cb74ffe6f2	not hispanic or latino	male	asian	released	Alive	1936		TCGA-CF-A3MH_exposure	Not Reported	21.671258034894397	1.36986301369863	0773a502-7b43-5791-8e89-076f8b74d410	165.0	25.0	released	59.0	TCGA-CF-A3MH_diagnosis	27458		M0	N0	Stage II	T2	7th	not reported	0	398	0777429c-1c4a-5ff3-9134-aea63b23166c	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-CF-A3MH_treatment	TCGA-CF-A3MH_treatment_1	released	4f93cbf5-1c89-5d39-8995-c1a621007389	yes	Radiation Therapy, NOS	released	086a41de-0092-5431-8631-0be5c557965c	no	Pharmaceutical Therapy, NOS	f4538e94-0413-431b-81db-abd405458ea2
62a84486-f035-481e-bcda-0bfa9a847358.htseq.counts.gz	6ab4e8bc-acf3-4f17-aa2a-1d9f2d6e8b6d	TCGA-ZF-AA53-01A-11R-A39I-07	TCGA-ZF-AA53-01A-11R	TCGA-ZF-AA53-01A-01-TS1		TCGA-ZF-AA53-01A-11	TCGA-ZF-AA53-01A	TCGA-ZF-AA53	92c6856a-b26f-4512-bbb1-8a8aff4636ab	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1434	270.0	False	true	07A1F163-55AF-4D64-AFD9-DE8DFF7CB2C6	1.83	97d051a1-0b25-45eb-a9ac-c2006d89752e			0.15	23	released	acd790f2-50b1-4924-a112-39fa7de1b3b4	RNA	R	0.15	UV Spec	released	False	b5de7000-e944-443f-95ae-bc24a0cb4131	11	30.0	2.0	20.0	3.0	0.0	45.0	35.0	60.0	TOP	6dab9f7b-fbfc-47a0-a16d-6d48a18b355a	released												released	30.0	aa672ec6-de2c-4020-857f-f99abd029aea	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA53_demographic	60	-22035		b4056a7f-0c58-5a32-8bb6-9e55e33890ca	not hispanic or latino	male	white	released	Alive	1950		TCGA-ZF-AA53_exposure	Not Reported	35.03345537179649		7e60130e-9276-5126-a6bd-f5e8fdee7590	178.0		released	111.0	TCGA-ZF-AA53_diagnosis	22035	T2a	M0	NX	Stage II	T2	7th	not reported	0	1761	8c0ccc82-d897-5061-88cc-e87ef37e0747	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2010	TCGA-ZF-AA53_treatment_1	TCGA-ZF-AA53_treatment	released	5ef05d81-d4eb-54ee-a78c-a472947e9945	yes	Pharmaceutical Therapy, NOS	released	d010f37a-e9a4-58bd-aa92-2c3a4ccbaa71	no	Radiation Therapy, NOS	6ab4e8bc-acf3-4f17-aa2a-1d9f2d6e8b6d
b6b39b8d-9072-4a01-b48b-0bbd77760bec.htseq.counts.gz	10be5c37-2c69-4e34-b324-76be3d1f0873	TCGA-CU-A0YR-01A-12R-A10U-07	TCGA-CU-A0YR-01A-12R	TCGA-CU-A0YR-01A-01-BS1	TCGA-CU-A0YR-01A-01-TS1	TCGA-CU-A0YR-01A-12	TCGA-CU-A0YR-01A	TCGA-CU-A0YR	811b3950-36e7-485f-bc48-aca1eee2ddef	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	184	80.0	False	false	F46FA517-9F64-46C0-AE22-36F1453D3266	1.84	cec64615-07c6-4e49-8e59-afb97d37464f			0.17	23	released	3888e124-3ea3-423a-bebb-7284106f6c15	RNA	R	0.17	UV Spec	released	False	9c3ddce8-9d41-4015-91d4-1e71050ff6f1	12	0.0	0.0	12.0	0.0	0.0	3.0	85.0	85.0	BOTTOM	cd5d7ac1-8851-4716-b46b-064de826e254	released	0.0	0.0	25.0	0.0	0.0	2.0	73.0	73.0	TOP	cb201822-eaeb-4c83-aa10-f1724a36ef32	released	released	30.0	b362fcfa-4e31-4321-9e17-11a8bae839c3	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A0YR_demographic	83	-30674	460	60bf1272-b67c-5d3c-94d0-45bd5bdf2728	not hispanic or latino	male	white	released	Dead	1927		TCGA-CU-A0YR_exposure	Not Reported	23.851068110299483	0.6575342465753424	c5793f49-6fee-5323-9c48-52cb46d7f727	177.8	12.0	released	75.4	TCGA-CU-A0YR_diagnosis	30674		M0	N2	Stage IV	T2		not reported	0	219	7ec9e042-33f7-57ce-a478-26f37e2ad028	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-CU-A0YR_treatment_1	TCGA-CU-A0YR_treatment	released	d80b9a75-8eb0-5129-959f-0f0189e982d4	no	Pharmaceutical Therapy, NOS	released	8168daf0-8cf6-509c-96e1-f910a657abb1	no	Radiation Therapy, NOS	10be5c37-2c69-4e34-b324-76be3d1f0873
7e81acaf-fbcd-4561-8749-536ad12ba5f3.htseq.counts.gz	21d4a738-b75a-467b-b525-84b8ae12bb8c	TCGA-4Z-AA7Y-01A-11R-A39I-07	TCGA-4Z-AA7Y-01A-11R	TCGA-4Z-AA7Y-01A-01-TS1		TCGA-4Z-AA7Y-01A-11	TCGA-4Z-AA7Y-01A	TCGA-4Z-AA7Y	49ea6676-ae27-4ca0-a7b3-48423d606d48	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1172	530.0	False	true	E0AF3F47-9EBB-4E83-B664-6C139C75D402	1.87	e189bbc1-0308-4f79-b296-01c4b38b8919			0.17	23	released	d30efff3-756e-4e59-a2e8-dfb241f6f1c6	RNA	R	0.17	UV Spec	released	False	7ddcec5f-0690-428f-b729-a4c24446783a	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	88f8f6ed-c12a-426d-8058-5fcbefa5e7f0	released												released	30.0	e6657dc9-da7f-4cc9-97f2-f26eaa31666c	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7Y_demographic	60	-22056		f723fc48-67d8-5be7-8f02-d9909378de64	not reported	male	white	released	Alive	1950		TCGA-4Z-AA7Y_exposure	Not Reported	28.30599506459573		bee7e142-0e65-515e-b9c4-b9a178ef1e3e	166.0		released	78.0	TCGA-4Z-AA7Y_diagnosis	22056	T2a	M0	N0	Stage II	T2a	7th	not reported	0	1522	d08c6f56-a03e-576e-86f6-54fc397cdafc	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2010	TCGA-4Z-AA7Y_treatment	TCGA-4Z-AA7Y_treatment_1	released	0e0cb23b-9316-5f97-baa4-ee63ecf1dd72	no	Radiation Therapy, NOS	released	d566b3b9-a92f-508a-b403-908d4e332906	no	Pharmaceutical Therapy, NOS	21d4a738-b75a-467b-b525-84b8ae12bb8c
83db35fc-70bb-440e-97d7-1fae8fdae1d4.htseq.counts.gz	adc4137f-47a5-4192-b89c-f71c59269817	TCGA-UY-A78L-01A-12R-A33J-07	TCGA-UY-A78L-01A-12R	TCGA-UY-A78L-01A-01-TSA		TCGA-UY-A78L-01A-12	TCGA-UY-A78L-01A	TCGA-UY-A78L	d46f7976-6061-4ca9-8294-6c215703662b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		150.0	False	true	34137AE9-26C3-4CCC-8172-C8DEDF9689A7	1.89	e356927b-b100-4adf-9935-e4fbf31d1fd3			0.18	23	released	1d5b3732-377f-4e13-bbaa-e287ea3c92ff	RNA	R	0.18	UV Spec	released	False	b37120cc-b9d9-47ef-84b6-99bde395a168	12	4.0	1.0	0.0	5.0	0.0	30.0	70.0	70.0	TOP	2fc984d1-974c-4081-b6ff-35cc670bb45c	released												released	30.0	e5198cce-ef9d-4f17-be93-36016270f6de	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78L_demographic	62	-22717		8a1ec177-1fa8-5c43-8b4a-b03f2b149121	not hispanic or latino	male	white	released	Alive			TCGA-UY-A78L_exposure	Not Reported	31.833910034602074		4abc516a-1360-53ae-8b86-37849b353ce3	170.0		released	92.0	TCGA-UY-A78L_diagnosis	22717	T2	MX	N1	Stage IV		6th	not reported	0	1127	d76fa660-66e1-5fcf-841c-4bdcad4ee44e	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A78L_treatment_1	TCGA-UY-A78L_treatment	released	1fc0ced1-f6ee-5ecd-a455-d4ccb385cce1	yes	Pharmaceutical Therapy, NOS	released	46ac8e3d-1a3d-586e-8d40-c7ba602a1c0f	no	Radiation Therapy, NOS	adc4137f-47a5-4192-b89c-f71c59269817
2cf39837-fb85-4581-9d72-de39d0c4566e.htseq.counts.gz	7bfdeb35-a1b2-41aa-b457-af692145d1e9	TCGA-DK-AA6P-01A-11R-A39I-07	TCGA-DK-AA6P-01A-11R	TCGA-DK-AA6P-01A-01-TSA		TCGA-DK-AA6P-01A-11	TCGA-DK-AA6P-01A	TCGA-DK-AA6P	4e702ca1-c0e0-4b9c-b9c7-7d7946818561	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	329	340.0	False	true	2D499EC2-59F5-462D-A60C-BD19B4BE8E46	1.9	c048b775-7679-424f-a008-8f7def9c0523			0.16	23	released	8d0b9328-4d99-4d19-9316-dfc609a1fc72	RNA	R	0.16	UV Spec	released	False	f0f38812-2556-4ee3-918c-780c4704930e	11	3.0	0.0	0.0	0.0	20.0	0.0	80.0	70.0	TOP	e2677252-a0ba-4fb9-8f17-f53b14cabba5	released												released	30.0	3c71158d-98ff-4ef5-923f-ba31a25036ec	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6P_demographic	72	-26560		3e689649-f368-5d9e-9c06-5009343ace58	not hispanic or latino	female	white	released	Alive	1941		TCGA-DK-AA6P_exposure	Not Reported	26.438070821983658	1.643835616438356	3b51ced3-ec90-553b-b45c-ef4ea28a89ca	158.0	30.0	released	66.0	TCGA-DK-AA6P_diagnosis	26560	T2	M0	N0	Stage II		7th	not reported	0	457	7d95200d-f19f-583e-979f-8a785ae4cbf7	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-DK-AA6P_treatment_1	TCGA-DK-AA6P_treatment	released	81b8c448-ab21-5200-8361-7ad78ed804d6	yes	Pharmaceutical Therapy, NOS	released	3d8a0ac8-02f6-5c18-b0fd-3acab8daf94f	no	Radiation Therapy, NOS	7bfdeb35-a1b2-41aa-b457-af692145d1e9
9c982f5a-7b9e-4627-9909-d9ef6db01cf6.htseq.counts.gz	2a08302d-01ce-4415-a223-2d3a1e767c8a	TCGA-4Z-AA7M-01A-11R-A39I-07	TCGA-4Z-AA7M-01A-11R	TCGA-4Z-AA7M-01A-01-TS1		TCGA-4Z-AA7M-01A-11	TCGA-4Z-AA7M-01A	TCGA-4Z-AA7M	1ecfdf16-f5e9-4a08-8834-37f4b474179d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	172	170.0	False	true	C14C42D1-6359-4625-90E1-B3E43646DB64	1.92	4cab604d-59f6-46d2-8c35-d3416977e313			0.17	23	released	084df420-19fa-4c46-b4b2-98a023b7430d	RNA	R	0.17	UV Spec	released	False	9427731c-b88b-4826-9428-136ccf419f6d	11	3.0	1.0	0.0	5.0	0.0	30.0	70.0	70.0	TOP	a10f52dc-3866-4eae-99b6-12731bd21577	released												released	30.0	837e7e71-56f8-4438-887c-406b5eeacc71	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7M_demographic	65	-23817		272c8430-d462-5bba-bab6-4c371cde7fca	not reported	male	white	released	Alive	1948		TCGA-4Z-AA7M_exposure	Not Reported	20.380434782608695	0.547945205479452	80b688c7-a3cb-5e74-a2ee-c6ec702ed558	184.0	10.0	released	69.0	TCGA-4Z-AA7M_diagnosis	23817	T2	M0	N0	Stage III	T3a	7th	not reported	0	495	915c1c6d-1c45-5300-9d0a-2c52c29ba1eb	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2013	TCGA-4Z-AA7M_treatment_1	TCGA-4Z-AA7M_treatment	released	93740dae-0265-5382-8670-458d022c0956	no	Pharmaceutical Therapy, NOS	released	9b33cb92-3cd8-5e84-8e02-09f423e03176	no	Radiation Therapy, NOS	2a08302d-01ce-4415-a223-2d3a1e767c8a
80aaa47c-5c2a-4886-87d3-644553bf82a1.htseq.counts.gz	437703be-577c-4dfa-b7f2-d2a15416fb8b	TCGA-E7-A541-01A-11R-A26T-07	TCGA-E7-A541-01A-11R	TCGA-E7-A541-01A-01-TSA		TCGA-E7-A541-01A-11	TCGA-E7-A541-01A	TCGA-E7-A541	d51abc3a-a652-4b13-9a41-ce52be87218b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	265	1670.0	False	true	2363E39A-F372-406C-B41B-E2260D50611D	1.83	dbffd0f0-d063-45a2-8cdb-e6ffa6c9e66d			0.18	23	released	1c093808-95b5-485a-a0d2-e18aa16f75db	RNA	R	0.18	UV Spec	released	False	1c59b56d-0389-4141-8cc4-7cb16cdb692e	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	b3144f2e-88aa-48f3-8269-f67c5c0a917d	released												released	30.0	ea8d5230-c27d-4cf4-9964-6bab8a68e933	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A541_demographic	66	-24206	778	9c0f13df-0a22-563e-b564-8f6b58a1b2ba	not hispanic or latino	male	white	released	Dead	1946		TCGA-E7-A541_exposure	Not Reported			b2e00f60-ec28-511f-a622-364f8f42b883			released		TCGA-E7-A541_diagnosis	24206		MX	N0	Stage II	T2b	7th	not reported	0	529	cbea817a-e677-5202-8ef4-22755ae55ba6	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-E7-A541_treatment	TCGA-E7-A541_treatment_1	released	3c5f1e0e-e8f6-5a7c-8dba-85d81258f7fe	no	Radiation Therapy, NOS	released	28fe615f-fbbd-58b6-978e-9f89b01e90f3	no	Pharmaceutical Therapy, NOS	437703be-577c-4dfa-b7f2-d2a15416fb8b
de063a8c-8dc0-4301-af55-c92450020bbb.htseq.counts.gz	7361e2bf-23e2-4451-acb2-523c4edf2358	TCGA-ZF-AA5P-01A-11R-A39I-07	TCGA-ZF-AA5P-01A-11R	TCGA-ZF-AA5P-01A-01-TS1		TCGA-ZF-AA5P-01A-11	TCGA-ZF-AA5P-01A	TCGA-ZF-AA5P	24d56331-4bca-4ab8-9fb7-a95a30b4c8fe	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	85	160.0	False	true	BB68912E-1368-47BF-BC76-0C1C8532E6BF	1.89	8612349c-596c-4938-92c8-79b8919f5bd6			0.18	23	released	591abb32-727d-4e51-9fc9-23f4785bca2a	RNA	R	0.18	UV Spec	released	False	be4843e6-544f-4129-80ca-9e9597b16097	11	0.0	0.0	0.0	0.0	0.0	25.0	75.0	90.0	TOP	59933ec2-e4fd-44de-a82a-53a1781356a9	released												released	30.0	f90c92b0-9251-4ef5-972c-3e6d6824b6ac	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA5P_demographic	65	-23971		038d6935-2252-5d00-86cf-c8bca05acba1	not hispanic or latino	male	white	released	Alive	1948		TCGA-ZF-AA5P_exposure	Not Reported	26.812218711098343	3.3972602739726026	91073be0-1a53-5512-8919-c357aaef2aea	177.0	62.0	released	84.0	TCGA-ZF-AA5P_diagnosis	23971	T2	M0	N2	Stage IV	T2b	7th	not reported	0	372	36d5ac1b-f770-5170-ad27-f6886f2c010c	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2013	TCGA-ZF-AA5P_treatment_1	TCGA-ZF-AA5P_treatment	released	f10cfffe-c23e-5412-9396-bcf790ed7de8	no	Pharmaceutical Therapy, NOS	released	748010b6-8b95-5da7-be6c-a343a566cd49	no	Radiation Therapy, NOS	7361e2bf-23e2-4451-acb2-523c4edf2358
9f7b3d20-3456-4ae5-ac03-11c61cfd16d4.htseq.counts.gz	c8bd37ae-ccb7-46c0-a8e3-96ae1c0315c6	TCGA-ZF-AA4W-01A-12R-A38B-07	TCGA-ZF-AA4W-01A-12R	TCGA-ZF-AA4W-01A-01-TS1		TCGA-ZF-AA4W-01A-12	TCGA-ZF-AA4W-01A	TCGA-ZF-AA4W	63443198-4fcf-40bd-befb-4a6920d29ca4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1742	200.0	False	true	CEDD5865-4B14-4F0C-9BBD-CBE89E68C2C3	1.86	c8d6dc3d-024b-4b68-9395-c3c2c38e8bb2			0.16	23	released	c9b00e2d-a525-41dc-9621-5e758615d3f8	RNA	R	0.16	UV Spec	released	False	106b9eb6-7b64-46a5-a1c1-cd4bf50fa725	12	0.0	0.0	0.0	0.0	0.0	50.0	50.0	60.0	TOP	138d55c6-a62b-4ddb-9647-64c74196d527	released												released	30.0	579dd91d-d4ac-40bc-b406-5a799dacce39	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4W_demographic	56	-20611		ec2cc880-1262-5d87-b2fc-b2b8a904a53f	not hispanic or latino	male	white	released	Alive	1953		TCGA-ZF-AA4W_exposure	Not Reported	27.452886842632044		0ec1b762-f6b6-530b-aacb-f4e8f282f316	187.0		released	96.0	TCGA-ZF-AA4W_diagnosis	20611	T3	MX	N0	Stage III	T3b	6th	not reported	0	1830	1ac2a6ef-d0a4-5af6-8f34-cfe098bbacee	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2009	TCGA-ZF-AA4W_treatment_1	TCGA-ZF-AA4W_treatment	released	3598bcb2-36d9-5f5d-8f30-43278d965173	yes	Pharmaceutical Therapy, NOS	released	222e948f-70b2-5e9c-b1aa-2c2c56f6d8c3	no	Radiation Therapy, NOS	c8bd37ae-ccb7-46c0-a8e3-96ae1c0315c6
765462be-c6c3-491c-b588-fe173f4e2a33.htseq.counts.gz	dacc9676-fb97-4b8e-88db-716198c84b8b	TCGA-ZF-A9RE-01A-11R-A38B-07	TCGA-ZF-A9RE-01A-11R	TCGA-ZF-A9RE-01A-01-TS1		TCGA-ZF-A9RE-01A-11	TCGA-ZF-A9RE-01A	TCGA-ZF-A9RE	284e175c-3229-4fee-a627-a49eac538e3a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1364	30.0	False	true	9AF70357-D696-4AEB-B338-7A711A39DAE5	1.86	2c9b61fa-9d26-41fe-9d79-a34bd08182f1			0.18	23	released	e8855462-625e-46de-973a-ba3bf5ba309b	RNA	R	0.18	UV Spec	released	False	1260a21f-83ac-45f1-84a6-454cc15cafb7	11	8.0	0.0	10.0	2.0	0.0	35.0	55.0	85.0	TOP	59e81caf-5c15-4e7b-9e58-f3e60c42800b	released												released	30.0	7a2362d1-3f48-472a-aad8-d822fdafff0d	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RE_demographic	78	-28622	106	e1997677-66c5-5a3e-a129-d5af89c070eb	not hispanic or latino	female	white	released	Dead	1932	2010	TCGA-ZF-A9RE_exposure	Not Reported	22.773186409550046		94caddaa-5116-569b-a522-e15753ffea47	165.0		released	62.0	TCGA-ZF-A9RE_diagnosis	28622	T2	MX		Stage II		7th	not reported	0		ec24a84e-bd6e-5518-a4b3-283aa86eb4ae	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2010	TCGA-ZF-A9RE_treatment	TCGA-ZF-A9RE_treatment_1	released	8dd5f7f0-f862-5766-b4a3-55d9167fa4e5	yes	Radiation Therapy, NOS	released	c0d02537-ff2d-5d37-bd51-74db6fa8320b	no	Pharmaceutical Therapy, NOS	dacc9676-fb97-4b8e-88db-716198c84b8b
04e84524-f75f-4cb5-9e9c-e78850d7b6f5.htseq.counts.gz	6773017e-694f-4da0-87ed-c1dce6c008cd	TCGA-DK-A1AD-01A-11R-A13Y-07	TCGA-DK-A1AD-01A-11R	TCGA-DK-A1AD-01A-01-TSA		TCGA-DK-A1AD-01A-11	TCGA-DK-A1AD-01A	TCGA-DK-A1AD	88a521ce-a5e9-4c6f-83d4-ec36a62fedb6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3101	210.0	False	true	E4D38398-CB3D-431A-8A1A-192565082A98	1.86	6491f391-9704-4249-bc81-d712e755ec74			0.15	23	released	9d04761e-b7db-46e2-ac3d-c7b1aeec8399	RNA	R	0.15	UV Spec	released	False	1f141304-dde0-47f3-97c5-7a9d7c08a605	11	2.0	1.0	0.0	1.0	0.0	20.0	80.0	80.0	TOP	4450ce53-4e52-480f-9053-a594b71bd4cb	released												released	30.0	c79f4327-675d-4651-994d-e683096df9c3	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1AD_demographic	69	-25317		56a7924d-e947-53b1-8ef1-a10dd6e6679d	not reported	male	white	released	Alive	1933		TCGA-DK-A1AD_exposure	Not Reported	26.052427685950413		9c9f5ce9-c26b-5ef1-8109-4a9d63bafbab	176.0		released	80.7	TCGA-DK-A1AD_diagnosis	25317		M0	N2	Stage IV	T3b	5th	not reported	0	3420	1e4de3a3-e8f1-50fc-80bb-c288fabdb826	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2002	TCGA-DK-A1AD_treatment	TCGA-DK-A1AD_treatment_1	released	9f078494-a8c6-5b4f-91e3-868c353aa864	no	Radiation Therapy, NOS	released	b738bbc2-921d-5077-b872-0a092b469b8b	not reported	Pharmaceutical Therapy, NOS	6773017e-694f-4da0-87ed-c1dce6c008cd
561df8ae-013f-4622-89a2-a5b5b00509e1.htseq.counts.gz	2b0d09a5-cd92-4aea-a68f-779f206d8302	TCGA-GU-A42Q-01A-11R-A23W-07	TCGA-GU-A42Q-01A-11R	TCGA-GU-A42Q-01A-01-TS1		TCGA-GU-A42Q-01A-11	TCGA-GU-A42Q-01A	TCGA-GU-A42Q	9c46846e-7f66-4936-af97-50a7b8189d84	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	191	80	False	true	7A1C2B15-348F-484B-A15E-CD39996517E2	2.08	7668e1a3-cf31-411a-8bce-aff592a0f053	2.21	13	0.17	23	released	98524830-e926-46f7-a621-f5d6ad82d833	RNA	R	0.17	UV Spec	released	False	8dde77d9-207d-4361-982f-53964289a15d	11	7	1	3	3	0	27	70	70	TOP	35b5f42b-cc1b-446b-90c1-7541830f9670	released												released	30	40957a46-c3ef-4a77-8a43-755918ecd6c6	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A42Q_demographic	67	-24534	344	03de66b2-1a23-52f3-9fd5-a9bf762ea6cd	not hispanic or latino	male	white	released	Dead	1945		TCGA-GU-A42Q_exposure	Not Reported	26.004382761139514	3.1232876712328768	22160bde-76f4-5f6c-9909-17df08d722c2	185.0	57.0	released	89.0	TCGA-GU-A42Q_diagnosis	24534		M0	N0	Stage III	T3b	7th	not reported	0	231	d45d0d4b-ea73-5905-a254-18d78e4f2f0d	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-GU-A42Q_treatment	TCGA-GU-A42Q_treatment_1	released	a6841f8c-e4f0-56c9-80ba-805dbc4e07a0	no	Radiation Therapy, NOS	released	144d1e07-39c1-5a11-abdb-78c5177f2f23	no	Pharmaceutical Therapy, NOS	2b0d09a5-cd92-4aea-a68f-779f206d8302
95800161-3f66-4e18-9d77-23a421dac0e8.htseq.counts.gz	f645781b-6f59-4798-a0fa-ee121cc54fae	TCGA-CF-A5UA-01A-11R-A28M-07	TCGA-CF-A5UA-01A-11R	TCGA-CF-A5UA-01A-01-TS1		TCGA-CF-A5UA-01A-11	TCGA-CF-A5UA-01A	TCGA-CF-A5UA	b52c870c-bfb8-4e68-86c0-64d57e5c9ae3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	84	320.0	False	true	6D1029C3-2277-488A-A02D-0048DBDFABE0	1.85	6ab37abf-8cc9-4274-bf5c-f08ec3f4d136			0.17	23	released	0d7dfa9d-2388-4288-97c5-c1fb8f926d0e	RNA	R	0.17	UV Spec	released	False	7e3c0d7e-b510-4a1c-ae08-4d728c3980df	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	11408170-c852-482f-b200-2448bf65da3e	released												released	30.0	1245bfa9-f7c3-4d74-976a-26338aa55ef1	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A5UA_demographic	67	-24625		c5da45b6-6f36-5640-b08a-3bbe8aadb641	not hispanic or latino	male	asian	released	Alive	1945		TCGA-CF-A5UA_exposure	Not Reported	17.993079584775085	1.643835616438356	d66304e8-5250-5bad-9ffc-bf2f4fd88ab2	170.0	30.0	released	52.0	TCGA-CF-A5UA_diagnosis	24625		M0	N0	Stage II	T2	6th	not reported	0	365	0d52687a-7686-55fd-b933-65eb7f82ad89	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A5UA_treatment	TCGA-CF-A5UA_treatment_1	released	55c793bb-3fe8-5e06-9f2c-2e17116f137f	no	Radiation Therapy, NOS	released	542b0162-8880-5934-9399-8d440f2eccda	no	Pharmaceutical Therapy, NOS	f645781b-6f59-4798-a0fa-ee121cc54fae
123812eb-b41f-444e-b547-50a8fa41b893.htseq.counts.gz	14f63bbb-9477-4872-b152-5239a1a1f244	TCGA-BT-A20W-01A-21R-A14Y-07	TCGA-BT-A20W-01A-21R	TCGA-BT-A20W-01A-02-TSB		TCGA-BT-A20W-01A-21	TCGA-BT-A20W-01A	TCGA-BT-A20W	4dc5cffe-ed8c-47ab-b5fc-f9615b5414f7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	751	270.0	False	true	4BCE7132-F235-4C57-9DAB-0C51C8737E87	1.7	3cefcb0b-796f-4ef0-b50d-a6ed17e9be4d			0.16	23	released	4116278c-7652-4fc4-946d-88255092348c	RNA	R	0.16	UV Spec	released	False	9068ac1f-ddb0-449d-9368-c4b7bcee15bc	21	8.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	d59b951c-6760-4732-a16e-c5def1d94970	released												released	30.0	ca14f475-1be4-450c-80c3-7094d23d0b3d	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20W_demographic	71	-26078	254	eedd9a3c-ba25-5e6b-b3be-8691d0bd3762	not hispanic or latino	male	white	released	Dead	1938	2009	TCGA-BT-A20W_exposure	Not Reported			814ee2a1-7e3c-5e37-bd4e-fc6e656e377b			released		TCGA-BT-A20W_diagnosis	26078	T2b	M0	N0	Stage II	T2b	6th	not reported	0		1a57505d-1a54-5aad-a8ff-dbd1955dd062	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2009	TCGA-BT-A20W_treatment	TCGA-BT-A20W_treatment_1	released	3cfce4ba-f89f-5113-a346-7a7b24c7664f	no	Radiation Therapy, NOS	released	f6b37f89-cd70-5b08-8954-f98a347dae28	no	Pharmaceutical Therapy, NOS	14f63bbb-9477-4872-b152-5239a1a1f244
f9795277-af1d-4b9f-96fc-61ea52bb6e4f.htseq.counts.gz	63a85b2d-99c3-436c-8f1d-ed0e45a79820	TCGA-DK-A1A7-01A-11R-A13Y-07	TCGA-DK-A1A7-01A-11R	TCGA-DK-A1A7-01A-01-TS1		TCGA-DK-A1A7-01A-11	TCGA-DK-A1A7-01A	TCGA-DK-A1A7	3ed614e7-f356-4d87-985b-d3bbbae3bb40	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	164	20.0	False	true	B64F829C-9624-4F01-BD7A-9E223D81BEE1	1.86	94447759-c20c-49f5-b51f-cbfdea41f2e8			0.17	23	released	d40e6623-f33c-4fbe-b7c6-53ba3fad8f6c	RNA	R	0.17	UV Spec	released	False	4a6d1251-ed9b-41a2-b4ca-920c6739256b	11	2.0	1.0	1.0	1.0	0.0	14.0	85.0	85.0	TOP	9919ce34-84bb-4e0a-ab3a-270528e5a20c	released												released	10.0	d68d16f7-6117-4d3d-8347-cf5cd3f23ae4	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1A7_demographic	67	-24499		38b31aff-578d-506a-98df-0dbd351a4c6c	not hispanic or latino	female	white	released	Alive	1943		TCGA-DK-A1A7_exposure	Not Reported	21.91380569758948		8bbd8ea8-d20b-5321-b3ee-ada410974d59	148.0		released	48.0	TCGA-DK-A1A7_diagnosis	24499		M0	N2	Stage IV	T3	6th	not reported	0	560	701bcb27-3916-56df-845b-aeb00d9c0d57	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A1A7_treatment	TCGA-DK-A1A7_treatment_1	released	e415a498-3762-54f2-867d-358a039c07fd	no	Radiation Therapy, NOS	released	5be9c5bc-2d01-54e8-a45f-1bb199476aa7	yes	Pharmaceutical Therapy, NOS	63a85b2d-99c3-436c-8f1d-ed0e45a79820
a5578f3e-ca22-4ea9-8f3a-ac626fc51557.htseq.counts.gz	cced1d78-3531-4da1-8f35-1be872aa9a44	TCGA-CF-A9FM-01A-11R-A38B-07	TCGA-CF-A9FM-01A-11R	TCGA-CF-A9FM-01A-01-TSA		TCGA-CF-A9FM-01A-11	TCGA-CF-A9FM-01A	TCGA-CF-A9FM	aad167ab-4772-4616-afb3-265e00d4a3f0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	122	430.0	False	true	D8D401F9-26CE-4A36-9A01-2EC6A02BC35B	1.9	5071fd5a-8c44-4dfb-bcca-31885b033372			0.17	23	released	4c9cbf56-35ed-4c61-9a6e-54335032acc2	RNA	R	0.17	UV Spec	released	False	ad71463b-f257-4c32-9ced-92356db2e21f	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	a8a47050-75b5-42be-abf0-70aaa85ea88c	released												released	30.0	282dcd5c-c35c-4b72-a3ab-571867e304d0	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A9FM_demographic	50	-18445		99917f44-e815-5bab-baec-7926fe9f9d14	not hispanic or latino	male	asian	released	Alive	1963		TCGA-CF-A9FM_exposure	Not Reported	19.467401285583104		844a6604-ff1a-57a9-859f-0a4286ecee9a	165.0		released	53.0	TCGA-CF-A9FM_diagnosis	18445		M0	N0	Stage I	T1	6th	not reported	0	398	781675dc-7b97-5118-ad9f-a8baa9301b57	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage i	2013	TCGA-CF-A9FM_treatment_1	TCGA-CF-A9FM_treatment	released	ab063e63-176b-5793-91fc-cff812f6548f	no	Pharmaceutical Therapy, NOS	released	648eba0e-4ce0-5dec-957e-ee8bd97fb226	no	Radiation Therapy, NOS	cced1d78-3531-4da1-8f35-1be872aa9a44
7cd2635c-b115-465c-917b-34815895409d.htseq.counts.gz	9ff984ce-1458-4f58-8539-dd6dc9fa923c	TCGA-BT-A20Q-11A-11R-A14Y-07	TCGA-BT-A20Q-11A-11R	TCGA-BT-A20Q-11A-01-TSA		TCGA-BT-A20Q-11A-11	TCGA-BT-A20Q-11A	TCGA-BT-A20Q	419deaac-ea45-4bdd-9fa0-b5cd8429b44f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1898	370.0	False	true		1.76	da9b7c51-c544-4ead-93c9-39b334b6bef2			0.16	23	released	fc6fe6e2-1444-4a1a-a4a6-d6c922692d58	RNA	R	0.16	UV Spec	released	False	4d892311-e574-4583-8335-7219c1f10c1f	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	76bfc6fb-cfa0-4292-bf66-2e6a5ab71f23	released												released	30.0	df346965-b972-445d-9aac-35605b908f4d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A20Q_demographic	73	-26778	593	92366abf-7135-5bce-8e71-ac4cf40a5256	not hispanic or latino	male	white	released	Dead	1933	2007	TCGA-BT-A20Q_exposure	Not Reported			45ecb356-dde6-5d74-b4fa-e0de4a5f3da9			released		TCGA-BT-A20Q_diagnosis	26778	T3b	M0	N2	Stage IV	T3b	6th	not reported	0		c8bf1857-b842-5c8f-99be-fddbb29a127c	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2006	TCGA-BT-A20Q_treatment	TCGA-BT-A20Q_treatment_1	released	7e44b7fd-c728-5b40-923a-59946e48eba9	no	Radiation Therapy, NOS	released	93c86cdf-cfd1-5f6d-b7f9-902f54db7c05	no	Pharmaceutical Therapy, NOS	9ff984ce-1458-4f58-8539-dd6dc9fa923c
ec17798a-03bc-4db8-87a6-0f17ab3849a9.htseq.counts.gz	d1c00d17-e7c3-4bfb-8dbc-e19028e9a6a9	TCGA-ZF-A9RF-01A-11R-A38B-07	TCGA-ZF-A9RF-01A-11R	TCGA-ZF-A9RF-01A-01-TS1		TCGA-ZF-A9RF-01A-11	TCGA-ZF-A9RF-01A	TCGA-ZF-A9RF	fa05f7f6-50e9-4878-a834-f655c0877394	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1536	80.0	False	true	CBA9E3B1-AD28-4E0B-B851-D70ACAED921A	1.86	56907638-5828-4ad8-9be9-a6cf5aa90f7b			0.16	23	released	c3459c60-7ead-41a4-bace-6c2becc78862	RNA	R	0.16	UV Spec	released	False	a70fa08a-1191-465e-9c23-a1bb5ff992cc	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	3ed09eea-fb13-445a-977b-91d607184759	released												released	30.0	29695237-1ba7-4e7e-a89f-158f53f2c4bc	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9RF_demographic	74	-27281		74205658-f87e-5676-a275-e823bf4229bd	not hispanic or latino	male	white	released	Alive	1935		TCGA-ZF-A9RF_exposure	Not Reported		2.8493150684931505	4f17db54-1766-5175-905d-4f456fcadb34		52.0	released		TCGA-ZF-A9RF_diagnosis	27281	T2	M0	NX	Stage II	T1	6th	not reported	0	1949	81d1ce08-c5fc-5ab5-bcd1-e51562240852	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-ZF-A9RF_treatment_1	TCGA-ZF-A9RF_treatment	released	004783c7-56c2-55f9-9002-5246161e9370	no	Pharmaceutical Therapy, NOS	released	9e00aa1c-174d-54c9-8a58-b8b9613b1c9e	no	Radiation Therapy, NOS	d1c00d17-e7c3-4bfb-8dbc-e19028e9a6a9
b142177f-f89e-4e5a-834b-a75e7ab0b618.htseq.counts.gz	20976445-b2a0-45ad-a89a-9273938727c6	TCGA-BL-A0C8-01A-11R-A10U-07	TCGA-BL-A0C8-01A-11R	TCGA-BL-A0C8-01A-01-TS1	TCGA-BL-A0C8-01A-01-BS1	TCGA-BL-A0C8-01A-11	TCGA-BL-A0C8-01A	TCGA-BL-A0C8	a6003b1c-56a9-430a-a5e2-b70af3f81bdb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	213	790.0	False	false	5077D8C6-57D2-4C6A-9316-71BE40224195	1.72	12c0b9eb-97fc-4fa1-8f64-49c0e3e171a2			0.15	23	released	8e5a28fd-7a37-47d8-ba70-c250cc67e543	RNA	R	0.15	UV Spec	released	False	bad15dae-37fe-45f7-9210-260f2a2d8018	11	0.0	0.0	5.0	22.0	0.0	45.0	50.0	80.0	TOP	f49fc0a4-705a-4421-83b8-8453591b173f	released	1.0	0.0	8.0	10.0	0.0	32.0	60.0	80.0	BOTTOM	81bdf088-09b9-4982-bd6d-51faedff76d2	released	released	30.0	5feed572-07c0-4da0-8649-ca8f8682657a	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A0C8_demographic	73	-26819		55a888fc-b0f7-5238-a6b7-c823d70676f4	not hispanic or latino	male	white	released	Alive	1936		TCGA-BL-A0C8_exposure	Not Reported	42.41888650422926	0.547945205479452	d9d9da95-b150-5f9e-a211-b3122e64f138	178.0	10.0	released	134.4	TCGA-BL-A0C8_diagnosis	26819		M0	NX	Stage I	T1		not reported	0	1219	325c1514-52f8-5ea4-8e87-78d1911d3cf9	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage i	2009	TCGA-BL-A0C8_treatment_1	TCGA-BL-A0C8_treatment	released	04001d39-fe03-51fc-bbd4-85e050d41997	yes	Pharmaceutical Therapy, NOS	released	d93cde56-03c3-5823-850d-bab213286b6a	no	Radiation Therapy, NOS	20976445-b2a0-45ad-a89a-9273938727c6
504f6808-68ef-4064-a3b4-ce462dea3849.htseq.counts.gz	87f1d5bd-72f4-4d2b-9aa2-6d41ee3df60d	TCGA-FD-A3SQ-01A-21R-A22U-07	TCGA-FD-A3SQ-01A-21R	TCGA-FD-A3SQ-01A-02-TSB		TCGA-FD-A3SQ-01A-21	TCGA-FD-A3SQ-01A	TCGA-FD-A3SQ	3071cb51-dcf5-41f7-b047-afc2dcbf0aaf	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1375	180	False	true	CEE5BD08-0FC9-4780-A5CB-A0962A3BE721	2.09	029cb0c8-9a67-4af0-9137-a5fbe08fce20	2.21	13	0.17	23	released	4cce2592-0b55-49c1-abea-b7aa13827689	RNA	R	0.17	UV Spec	released	False	76b292a7-70e8-4c16-b12c-9003c2e4edb0	21	3	0	5	0	0	20	75	80	TOP	e699bdfe-9760-4ab6-ac63-29330f9f9465	released												released	20	a78a8c62-06ed-4562-b529-d30a5d1508e7	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SQ_demographic	62	-22687	1423	57ce23b0-79bf-51fd-9b3f-312b7df4e34b	not hispanic or latino	male	white	released	Dead	1946	2011	TCGA-FD-A3SQ_exposure	Not Reported	23.16743023740108	3.287671232876712	56e6b584-cc60-52c2-91f2-56eae81f4645	196.0	60.0	released	89.0	TCGA-FD-A3SQ_diagnosis	22687		MX	N2	Stage IV	T3a	6th	not reported	0		3899b702-eafc-51a2-aa24-2e36e34fbfde	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2008	TCGA-FD-A3SQ_treatment_1	TCGA-FD-A3SQ_treatment	released	ea3e8cf5-1a17-5663-a2d1-c6e58bc8458d	yes	Pharmaceutical Therapy, NOS	released	33f74d95-48dc-5aac-af0b-791701bf1923	yes	Radiation Therapy, NOS	87f1d5bd-72f4-4d2b-9aa2-6d41ee3df60d
695edbe7-d46a-433f-9ae8-a8978a19a320.htseq.counts.gz	51982f7f-b7cc-41d7-8827-2b733926a454	TCGA-E7-A97Q-01A-11R-A38B-07	TCGA-E7-A97Q-01A-11R	TCGA-E7-A97Q-01A-01-TS1		TCGA-E7-A97Q-01A-11	TCGA-E7-A97Q-01A	TCGA-E7-A97Q	ada19f65-5256-4c79-b3b9-7b9da69be437	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	171	90.0	False	true	E7CE7632-FA80-4509-AC4D-C0EC646E6CB7	1.89	90e6e8a1-98b3-4f38-92ef-df460d78d657			0.17	23	released	fcbf7e1a-1b35-4362-8dde-c51ec463435a	RNA	R	0.17	UV Spec	released	False	5bda8205-5ee9-4034-b680-d56eb7dc91b5	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	85.0	TOP	867865b1-43aa-4676-b511-6675b0dbd668	released												released	30.0	6a126e5d-c433-4e51-bb11-7c6ca68e108b	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A97Q_demographic	60	-22249	246	f9017c5a-3112-5205-ae81-381f1ef0dbc3	not hispanic or latino	female	white	released	Dead	1953		TCGA-E7-A97Q_exposure	Not Reported	23.66524436157625	1.095890410958904	1e1175d2-fc30-5381-a34c-3f1d06a32ba4	167.0	20.0	released	66.0	TCGA-E7-A97Q_diagnosis	22249		MX	N3	Stage IV	T4a	7th	not reported	0	82	56d7672f-9c69-53c8-a66c-7e0f002c0a9f	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-E7-A97Q_treatment_1	TCGA-E7-A97Q_treatment	released	5e5a8fa4-2250-5031-93da-4c2bc49735bf	no	Pharmaceutical Therapy, NOS	released	9f1466b7-c15f-5d6f-846c-151de1440da1	no	Radiation Therapy, NOS	51982f7f-b7cc-41d7-8827-2b733926a454
2543837b-b725-437e-918a-8cf15169558e.htseq.counts.gz	ac8bca8f-8df5-47e9-a5a7-c61d88e086bc	TCGA-GD-A76B-01A-11R-A32O-07	TCGA-GD-A76B-01A-11R	TCGA-GD-A76B-01A-01-TS1		TCGA-GD-A76B-01A-11	TCGA-GD-A76B-01A	TCGA-GD-A76B	6c1ffaf7-fdae-4ab0-8dd1-6738937357ba	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	121	210.0	False	false	89C0C498-8414-4CF3-A1BE-3AF53C6DE610	1.92	227c6e50-7801-4fb6-91d3-eda4313024bb			0.17	23	released	e910be40-fbdb-4e84-a0ab-5b0c82c9e6bf	RNA	R	0.17	UV Spec	released	False	49ec558d-6f5d-4c05-85ec-268e5933e77b	11	0.0	0.0	0.0	0.0	0.0	30.0	70.0	80.0	TOP	217990b7-1812-4f85-9103-242e69b71098	released												released	30.0	575339db-e63d-4778-8386-6d08831d318b	Primary Tumor	01	released	Not Reported	released	TCGA-GD-A76B_demographic	86	-31571		844e1fd8-4a48-5a59-b962-e1570bb57b76	not hispanic or latino	female	white	released	Dead	1927		TCGA-GD-A76B_exposure	Not Reported	26.078971533516988		cb85f60c-8263-5266-9b9d-8eb7897322be	165.0		released	71.0	TCGA-GD-A76B_diagnosis	31571	T2a	MX	N0	Stage II	T2b	7th	not reported	0	224	c1ac30a6-8fef-56ad-959d-9b3a4da010f9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-GD-A76B_treatment_1	TCGA-GD-A76B_treatment	released	a7337e6f-8354-5062-98f7-8f69f255d05c	no	Pharmaceutical Therapy, NOS	released	2cfbd09d-d5ae-5590-b056-2d65e2498137	no	Radiation Therapy, NOS	ac8bca8f-8df5-47e9-a5a7-c61d88e086bc
a81c0179-62fa-4d06-975c-439d54a968bd.htseq.counts.gz	2fb1bb91-ab95-432b-9b7b-0f941468c7b0	TCGA-FJ-A3Z7-01A-12R-A23N-07	TCGA-FJ-A3Z7-01A-12R	TCGA-FJ-A3Z7-01A-01-TSA		TCGA-FJ-A3Z7-01A-12	TCGA-FJ-A3Z7-01A	TCGA-FJ-A3Z7	6b2d63f2-f390-4601-9640-f769f6e91bf4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	539	120.0	False	true	67B47EFA-A6C9-40B6-AF17-8A4E1FF6656B	1.82	8c79f5ec-ce4f-4c86-8d1c-71495c276d74			0.16	23	released	a7688164-47fb-4374-a7ba-20f284b0aad8	RNA	R	0.16	UV Spec	released	False	af7ebcb4-b095-4139-8386-bb11ab290621	12	3.0	2.0	4.0	2.0	0.0	21.0	75.0	75.0	TOP	bb66688f-087f-4986-acde-6571a3baa79a	released												released	20.0	59c94c10-41dc-4599-aa18-ae37f3715134	Primary Tumor	01	released	Not Reported	released	TCGA-FJ-A3Z7_demographic	76	-28052		c74ff264-0518-5120-8eb2-5890ff8a482c	not hispanic or latino	male	white	released	Alive	1934		TCGA-FJ-A3Z7_exposure	Not Reported	27.428571428571427		59ce5e72-38e1-5930-9c50-09af083741a7	175.0		released	84.0	TCGA-FJ-A3Z7_diagnosis	28052		MX	N2	Stage IV	T4a	7th	not reported	0	945	8d98d241-111a-5539-bfc1-982f57c84682	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	Yes	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2010	TCGA-FJ-A3Z7_treatment_1	TCGA-FJ-A3Z7_treatment	released	a6252e63-e9b9-5571-aeae-ef3249fb99d1	yes	Pharmaceutical Therapy, NOS	released	eaddd95a-5e1e-5565-951d-1fb8d4330e21	no	Radiation Therapy, NOS	2fb1bb91-ab95-432b-9b7b-0f941468c7b0
4e22d3aa-a223-4ea7-bf40-4e2a2f4dd5f1.htseq.counts.gz	11018a0d-6a94-4528-bf3f-27d08244d12c	TCGA-K4-A3WV-11A-21R-A22U-07	TCGA-K4-A3WV-11A-21R	TCGA-K4-A3WV-11A-02-TSB		TCGA-K4-A3WV-11A-21	TCGA-K4-A3WV-11A	TCGA-K4-A3WV	d53eade8-a845-4252-aece-92f3573486a7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	143	100.0	False	true		1.83	20d3ac92-e654-415e-8031-5a8bdd1662b3			0.15	23	released	c76bdbd4-e610-4382-9457-d2af6c858715	RNA	R	0.15	UV Spec	released	False	9916ce98-4bb4-4a07-86e6-f5022eb28d40	21	1.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	TOP	b65c72e3-ef21-4341-bfe9-cbcf78df47d7	released												released	30.0	c8b4ed6d-69c0-4052-bec2-9fe6a3cfc481	Solid Tissue Normal	11	released	Not Reported	released	TCGA-K4-A3WV_demographic	77	-28444		5b539b2b-7050-50ba-b7eb-78e4e68160de	hispanic or latino	female	white	released	Alive	1934		TCGA-K4-A3WV_exposure	Not Reported		4.383561643835616	bfb52f09-4dfc-5c63-b488-df833624bd5f		80.0	released		TCGA-K4-A3WV_diagnosis	28444		MX	N0	Stage II	T2b	7th	not reported	0	646	17b6a319-ca82-5b6a-bfc6-ce2fc1b50c34	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-K4-A3WV_treatment_1	TCGA-K4-A3WV_treatment	released	3c101dd3-2135-5524-ab42-a052f123b04a	no	Pharmaceutical Therapy, NOS	released	b7b2322f-f7b8-5f87-945b-339e27c622e2	no	Radiation Therapy, NOS	11018a0d-6a94-4528-bf3f-27d08244d12c
78cf84b3-5e39-408e-b85e-2ad998971dd4.htseq.counts.gz	59d90b98-d3bd-493c-86bf-b0e15cb7d7e1	TCGA-DK-AA6W-01A-12R-A39I-07	TCGA-DK-AA6W-01A-12R	TCGA-DK-AA6W-01A-01-TS1		TCGA-DK-AA6W-01A-12	TCGA-DK-AA6W-01A	TCGA-DK-AA6W	63fa8434-4a6f-4c32-9c5d-89dcc913900b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	68	80.0	False	true	6ED3ACF0-57B3-4E7C-92DF-EA92499CA9CD	1.86	4d4cc53b-06d2-4baa-bf1c-03f9509e422c			0.17	23	released	8d4ba43c-9712-40e6-9950-2aac5abff6d6	RNA	R	0.17	UV Spec	released	False	0ceb6f14-e73b-4fff-819f-d049833ba40c	12	2.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	6f47819d-7fd6-459a-a345-4414af431585	released												released	20.0	e6db8232-33b3-4449-a2fc-cde3b7d3d72b	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6W_demographic	78	-28853	415	aaa12ce0-5e40-54ff-9cc3-f9a795f0e56e	not hispanic or latino	male	white	released	Dead	1935		TCGA-DK-AA6W_exposure	Not Reported	31.79012345679012		910b925f-ac0b-5daf-979b-761b1261c640	180.0		released	103.0	TCGA-DK-AA6W_diagnosis	28853	T2	M0	N0	Stage II	T2	7th	not reported	0	263	0c900310-2cf2-58c0-ad9c-b1922f4d8efe	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2013	TCGA-DK-AA6W_treatment	TCGA-DK-AA6W_treatment_1	released	567aa2ee-fa41-5457-bdf8-1a41a2f67358	yes	Radiation Therapy, NOS	released	324fcb7c-95c1-574f-ad22-1da5c903fee0	yes	Pharmaceutical Therapy, NOS	59d90b98-d3bd-493c-86bf-b0e15cb7d7e1
3fb58934-0f65-4b55-9d04-3db875d60521.htseq.counts.gz	108d9357-b834-490f-a09d-e5b694923908	TCGA-4Z-AA7R-01A-11R-A39I-07	TCGA-4Z-AA7R-01A-11R	TCGA-4Z-AA7R-01A-01-TS1		TCGA-4Z-AA7R-01A-11	TCGA-4Z-AA7R-01A	TCGA-4Z-AA7R	72fe54b5-c1c8-468a-954a-09992429512a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1189	350.0	False	true	0E7DC845-C56F-4179-9972-B1F51F00937D	1.92	eac6c8bf-f85e-4eb7-a700-034cd91722d7			0.17	23	released	d99302bf-5794-4d8f-b8c4-02e95fd9e8f0	RNA	R	0.17	UV Spec	released	False	bbcfda43-6460-4088-b8a2-2f3d39b647ee	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	a565505c-99ed-4e24-83e0-96b8ac772ad6	released												released	30.0	b168a02c-205b-47bf-9a2a-7f951974bc66	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA7R_demographic	73	-26781	522	192ecb2a-e115-568f-9416-4818922ea52d	not reported	male	black or african american	released	Dead	1937		TCGA-4Z-AA7R_exposure	Not Reported	25.03991871098853		592a8e89-df2d-524d-a835-1c45f4e23b86	166.0		released	69.0	TCGA-4Z-AA7R_diagnosis	26781	T2a	M0	N0	Stage IV	T4b	7th	not reported	0	493	c84495ea-fa22-5a60-a0a4-221a1bd72ac2	C67.0	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iv	2010	TCGA-4Z-AA7R_treatment_1	TCGA-4Z-AA7R_treatment	released	55d666e0-5a46-5643-8077-da40c2fca2a0	no	Pharmaceutical Therapy, NOS	released	4e34466a-176a-5363-9859-75025b6cffe4	no	Radiation Therapy, NOS	108d9357-b834-490f-a09d-e5b694923908
733af299-34cf-4bd8-b3ff-eb988c345810.htseq.counts.gz	ea28860c-a193-40a7-a0f5-8e1f73f15d7a	TCGA-ZF-AA4R-01A-11R-A38B-07	TCGA-ZF-AA4R-01A-11R	TCGA-ZF-AA4R-01A-01-TS1		TCGA-ZF-AA4R-01A-11	TCGA-ZF-AA4R-01A	TCGA-ZF-AA4R	b36e3b5f-8904-4722-adae-b00812efec65	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1834	60.0	False	true	6E9D0F98-3697-46E7-96E6-1CDAAE63DFC5	1.82	d4ba2875-9bea-46eb-8279-72975c812701			0.18	23	released	b8be0c38-be02-4c5d-8005-d8769aefdf67	RNA	R	0.18	UV Spec	released	False	37ab3adc-2440-4765-b603-18e13fa3af9e	11	2.0	1.0	0.0	3.0	0.0	25.0	75.0	75.0	TOP	406f997f-556c-4a9d-9552-2eb31f76c68a	released												released	30.0	b06b5035-a792-4afa-baa0-307f665a7bdd	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4R_demographic	67	-24537	1036	5a5d4fc2-00ef-5e67-bac2-31c44592713d	not hispanic or latino	male	white	released	Dead	1941	2010	TCGA-ZF-AA4R_exposure	Not Reported	35.34907208685772		7bc2c5a7-37ad-5e16-83d1-beff86490095	178.0		released	112.0	TCGA-ZF-AA4R_diagnosis	24537	T2	MX	N1	Stage IV	T3a	6th	not reported	0		a3036239-8a38-5127-ab0e-b60b28a065cd	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-ZF-AA4R_treatment_1	TCGA-ZF-AA4R_treatment	released	788d8424-ef9d-518c-bdac-d45c337a8e88	yes	Pharmaceutical Therapy, NOS	released	0f4ab4e8-43be-5617-980f-4a7cdbf55af4	no	Radiation Therapy, NOS	ea28860c-a193-40a7-a0f5-8e1f73f15d7a
d4e48e9c-1706-4539-9f81-106ab0f0c5ee.htseq.counts.gz	a863099d-c934-46f4-9fda-4413f8306f65	TCGA-ZF-AA4N-01A-11R-A38B-07	TCGA-ZF-AA4N-01A-11R	TCGA-ZF-AA4N-01A-01-TS1		TCGA-ZF-AA4N-01A-11	TCGA-ZF-AA4N-01A	TCGA-ZF-AA4N	c692e696-37fe-4fc1-90eb-8e34a91a98fc	Epithelial Neoplasms, NOS	Bladder	TCGA-BLCA	919	220.0	False	true	2330755B-EBE4-46DA-ABAB-A240CD849F36	1.85	8baefcdb-0b95-4f4a-a7ba-3ee75c227bd1			0.18	23	released	143759ca-a1b3-4674-b78b-2794d73f5421	RNA	R	0.18	UV Spec	released	False	fc2e2cc8-8807-42f1-9150-45cf6d2bc247	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	70.0	TOP	596d27b2-1418-43b5-8c79-e5bac018cf7c	released												released	30.0	15b108cc-1b8d-4583-bdf0-43c7973b2cb2	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA4N_demographic	74	-27056	88	3a634a04-615d-5d22-ae8b-05c6d1722c45	not hispanic or latino	male	white	released	Dead	1937	2011	TCGA-ZF-AA4N_exposure	Not Reported	25.711662075298438		31385f44-6c85-5501-81b3-42e2ff9b0945	165.0		released	70.0	TCGA-ZF-AA4N_diagnosis	27056	T2			Stage II		7th	not reported	0		068efdbc-fbef-57cf-812c-01ee1bc37391	C67.9	not reported	8010/3	Carcinoma, NOS	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-ZF-AA4N_treatment	TCGA-ZF-AA4N_treatment_1	released	e9df5217-05eb-5f09-b9ff-695169fbfa89	no	Radiation Therapy, NOS	released	1d4dffc6-1a19-50ca-9ab8-18180933dcc7	no	Pharmaceutical Therapy, NOS	a863099d-c934-46f4-9fda-4413f8306f65
06b37211-10dc-42e6-baf9-677f337c1c31.htseq.counts.gz	eeb84575-9469-4f28-b71b-151b89581f3e	TCGA-CF-A27C-01A-11R-A16R-07	TCGA-CF-A27C-01A-11R	TCGA-CF-A27C-01A-01-TSA		TCGA-CF-A27C-01A-11	TCGA-CF-A27C-01A	TCGA-CF-A27C	7fee9d6f-c0ea-43c2-89c2-66d965a077a8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	79	430	False	true	F8FF65C1-F032-4CED-A0EA-FFDBA1E25DC2	1.89	d6d7412b-5ec2-413e-a85d-7f765c67afa3	2.08	13	0.16	23	released	2a5c0096-ffcc-45bf-9f7b-ea4d36a408a3	RNA	R	0.16	UV Spec	released	False	41aa8814-15ab-4f74-870d-6fafa1a5a7bc	11	1	0	4	1	0	12	84	95	TOP	3469908c-9cf3-44bd-806c-d57e2a94b0a1	released												released	30	ead6792b-4e52-4c28-891c-6d8696873a13	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A27C_demographic	52	-19270		6390f86e-7390-5521-9bf6-4d63657f7435	not hispanic or latino	male	asian	released	Alive	1959		TCGA-CF-A27C_exposure	Not Reported	20.415224913494807		b30f5056-f0bb-5844-b1ba-dcc6738aaa1d	170.0		released	59.0	TCGA-CF-A27C_diagnosis	19270		M0	N0	Stage III	T3	6th	not reported	0	425	1cf4b4f9-3778-5cd7-ae42-798168acceed	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-CF-A27C_treatment_1	TCGA-CF-A27C_treatment	released	6d153018-de4f-535d-a9da-ec95638a9887	no	Pharmaceutical Therapy, NOS	released	3dcb878e-7949-5e2f-b15b-a0c682f97402	yes	Radiation Therapy, NOS	eeb84575-9469-4f28-b71b-151b89581f3e
bf255f2e-514d-401c-939b-48812b85f307.htseq.counts.gz	900383d6-2581-4b51-a83b-d94685b7cbff	TCGA-E7-A6ME-01A-22R-A32O-07	TCGA-E7-A6ME-01A-22R	TCGA-E7-A6ME-01A-02-TSB		TCGA-E7-A6ME-01A-22	TCGA-E7-A6ME-01A	TCGA-E7-A6ME	9f00847c-bd1f-4cd0-99f9-d51d638c0795	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	93	1200.0	False	true	491F83D0-4A70-4076-9BDF-1A266925116C	1.92	dfffbe9c-c83a-4087-a3f7-2be3d63a2eaa			0.16	23	released	30395c11-129e-4f59-8c24-90775705fc1a	RNA	R	0.16	UV Spec	released	False	3d763a43-a540-4a6f-aca5-06b63597226a	22	6.0	2.0	0.0	2.0	20.0	20.0	60.0	60.0	TOP	ee77ae42-306b-4273-bd8d-92ce50d81bee	released												released	30.0	fe3e0288-c9bd-4d2a-a6a7-86404b22d005	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A6ME_demographic	75	-27670		8f05291f-e625-5f2d-b072-41f54ee83b44	not hispanic or latino	male	asian	released	Alive	1938		TCGA-E7-A6ME_exposure	Not Reported	21.15529420201513	0.821917808219178	78bade43-6963-5527-9fc2-f061761c6cc9	167.0	15.0	released	59.0	TCGA-E7-A6ME_diagnosis	27670	T2	M0	NX	Stage II	T2b	7th	not reported	0	731	136e3d62-528e-5b1c-a735-1c079aaae4eb	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage ii	2013	TCGA-E7-A6ME_treatment	TCGA-E7-A6ME_treatment_1	released	a51b2eac-209e-5b58-a644-4b83d8cf2ada	no	Radiation Therapy, NOS	released	cd833256-0a3c-5441-92ab-d3b07d393c85	no	Pharmaceutical Therapy, NOS	900383d6-2581-4b51-a83b-d94685b7cbff
fda0a4e8-9897-43d1-9914-f4d6022e6248.htseq.counts.gz	c6251f3c-fb00-44f9-a3a4-8a80d641b660	TCGA-DK-AA6M-01A-11R-A39I-07	TCGA-DK-AA6M-01A-11R	TCGA-DK-AA6M-01A-01-TSA		TCGA-DK-AA6M-01A-11	TCGA-DK-AA6M-01A	TCGA-DK-AA6M	d8b07fdd-5580-4bcc-9619-b5e0c9f0aa3d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1176	290.0	False	true	C1106CFA-9382-4748-927C-E46BA18D4991	1.88	230c9517-0296-4966-8dd7-14c062e82224			0.16	23	released	f7d14335-8b65-4e61-9dda-45470d37409d	RNA	R	0.16	UV Spec	released	False	2bad86d5-3fa0-4d2d-a837-0fa6f189c479	11	2.0	0.0	0.0	0.0	10.0	0.0	90.0	70.0	TOP	2ec30a99-1a56-4ad8-87be-50933d413b8a	released												released	30.0	10f2ed03-4e58-41aa-ae19-4d44f57cbdf5	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6M_demographic	64	-23574		7c346c89-7bd1-50f0-8675-32775c860242	not hispanic or latino	female	white	released	Alive	1946		TCGA-DK-AA6M_exposure	Not Reported	29.666548000474663		2b98ef0c-a879-5de9-b8f3-f233f6aa67a8	159.0		released	75.0	TCGA-DK-AA6M_diagnosis	23574	T2	M0	N0	Stage II	T2	7th	not reported	0	1582	cc35fed0-c312-5666-8664-4860be16084e	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2010	TCGA-DK-AA6M_treatment_1	TCGA-DK-AA6M_treatment	released	e96fb55e-5a84-52b5-aa6f-7f79641b6e82	yes	Pharmaceutical Therapy, NOS	released	3811fc2e-ddee-5372-a80c-21a6fcd32d04	no	Radiation Therapy, NOS	c6251f3c-fb00-44f9-a3a4-8a80d641b660
a1230c68-c8d1-4521-8bb3-dd27d2a5bfc4.htseq.counts.gz	a4197b3e-c09b-42d4-8ead-cc5b3335d6da	TCGA-CF-A47W-01A-11R-A23W-07	TCGA-CF-A47W-01A-11R	TCGA-CF-A47W-01A-01-TSA		TCGA-CF-A47W-01A-11	TCGA-CF-A47W-01A	TCGA-CF-A47W	122fc134-8915-47db-96c9-ab1853c3cd18	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	192	450.0	False	true	2246A9D0-E96B-4FC1-83D1-D04845B003F9	1.8	cbc4cdac-a504-47ed-96cf-5c459f7febd0			0.16	23	released	974bfe5b-7a95-49a9-bc61-907b221458ba	RNA	R	0.16	UV Spec	released	False	8889a24a-2052-480e-b18b-1e458b86fb90	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	85.0	TOP	e2da86a5-7b32-434f-8084-50daa208730c	released												released	30.0	3e3f2238-288d-42f4-95ff-1bb8c1a3373b	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47W_demographic	42	-15497		6df20ac0-2d71-5ce3-9c46-bbf83dfe3e19	not hispanic or latino	male	asian	released	Alive	1970		TCGA-CF-A47W_exposure	Not Reported	21.007667798746542	0.547945205479452	d8b6d45d-dc39-5974-927f-5a56c0e7ccc1	169.0	10.0	released	60.0	TCGA-CF-A47W_diagnosis	15497	T2	M0	N0	Stage II	T2	7th	not reported	0	368	d879cb66-9671-5ca5-a4a7-c35b33d8d5df	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A47W_treatment	TCGA-CF-A47W_treatment_1	released	2da49231-d07c-5335-a1b6-3a199e217c73	no	Radiation Therapy, NOS	released	8a779972-38a0-5ab5-828e-f8b96da7e161	no	Pharmaceutical Therapy, NOS	a4197b3e-c09b-42d4-8ead-cc5b3335d6da
6f0c806c-0ac3-471e-9f30-1c43ac548f0d.htseq.counts.gz	184888af-ff05-40e7-89f5-baa027ac1900	TCGA-XF-A9ST-01A-11R-A42T-07	TCGA-XF-A9ST-01A-11R	TCGA-XF-A9ST-01A-01-TSA		TCGA-XF-A9ST-01A-11	TCGA-XF-A9ST-01A	TCGA-XF-A9ST	33708951-0a0d-4ad0-b472-23151c9f76f6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2992	900.0	False	true	DD442B47-AE60-4492-AE4A-0BCD1AC15A0C	1.89	378c51fa-27d3-4e70-a471-9f1006513d24			0.18	23	released	013331bb-a071-441f-b835-811a791fcfeb	RNA	R	0.18	UV Spec	released	False	f99682dc-eca0-40db-b25f-201cae592810	11	2.0	1.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	3287e942-c596-4ceb-b27a-6982d35eb236	released												released	30.0	a995dd33-498e-45f6-b928-edbf0929186b	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9ST_demographic	68	-25080	128	8efea06e-06d9-5643-affc-63e0bb4d5836	not hispanic or latino	male	white	released	Dead	1937	2005	TCGA-XF-A9ST_exposure	Not Reported	31.877288221184195	3.287671232876712	fa49aae1-f9e8-5a11-9ad4-52065720cad5	178.0	60.0	released	101.0	TCGA-XF-A9ST_diagnosis	25080		MX	N0	Stage III	T3b	6th	not reported	0		346ae698-d036-5cad-a0a6-3c144376398d	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2005	TCGA-XF-A9ST_treatment_1	TCGA-XF-A9ST_treatment	released	7a831c6e-923d-5fb6-8bf7-afaa30db8fc7	no	Pharmaceutical Therapy, NOS	released	f8cbf549-55ea-5110-90a0-f4adc9372bc2	no	Radiation Therapy, NOS	184888af-ff05-40e7-89f5-baa027ac1900
b47eff6e-2f1a-41a1-8f59-0f77006ba38e.htseq.counts.gz	014d8038-9d2b-4eb4-b31e-a1e91b6102fe	TCGA-FD-A3SN-01A-12R-A22U-07	TCGA-FD-A3SN-01A-12R	TCGA-FD-A3SN-01A-01-TSA		TCGA-FD-A3SN-01A-12	TCGA-FD-A3SN-01A	TCGA-FD-A3SN	0fb043d3-d86b-4cd8-8c01-9e2b3e965bb0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	105	380	False	true	E204500A-A1F4-400C-A8C3-B830A832B719	1.84	41836f0e-f807-4afa-ae39-c0eb16fa6b54	2.08	13	0.16	23	released	181be5fa-45d9-4d5b-9a17-f37677afb3ba	RNA	R	0.16	UV Spec	released	False	041503e6-302d-4a61-8e38-517fd2e229a9	12	3	0	0	0	0	20	80	80	TOP	458e13a3-3b6f-4515-8569-f4a59ef1ba3c	released												released	30	127892ed-8a7a-41cb-8abe-353e09e6d327	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SN_demographic	79	-29169		8cedbd3d-125a-56bd-b310-b33e96cc1b3e	hispanic or latino	male	white	released	Alive	1932		TCGA-FD-A3SN_exposure	Not Reported	24.22145328719723	0.273972602739726	c0ae7d29-da9f-58a1-ab16-3e003aaaac50	170.0	5.0	released	70.0	TCGA-FD-A3SN_diagnosis	29169		MX	N0	Stage III	T3b	7th	not reported	0	887	72cc38b3-ff9d-51c7-859f-2568c745de62	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2011	TCGA-FD-A3SN_treatment	TCGA-FD-A3SN_treatment_1	released	08f3c3d9-686d-5034-8aae-59a2639696cc	no	Radiation Therapy, NOS	released	abcd8f50-a570-5353-a792-cbdcfe55df07	yes	Pharmaceutical Therapy, NOS	014d8038-9d2b-4eb4-b31e-a1e91b6102fe
22544620-df4b-4d2d-96f8-ed9a2684df39.htseq.counts.gz	c6ba7082-d1e6-43b4-84b4-408584405be0	TCGA-FD-A3B6-01A-21R-A20F-07	TCGA-FD-A3B6-01A-21R	TCGA-FD-A3B6-01A-02-TSB		TCGA-FD-A3B6-01A-21	TCGA-FD-A3B6-01A	TCGA-FD-A3B6	36054200-3fa4-4541-a25c-47282e4ef88d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	470.0	False	false	7FC255AC-F494-49EB-B90A-A43409E15CD5	1.79	1a1e861c-14bd-45ea-904a-b14d4059ac95			0.18	23	released	26cec658-eba4-44ca-8b23-80eaee14c275	RNA	R	0.18	UV Spec	released	False	182bc362-1d82-49b3-b16d-9deea93d8d2f	21	8.0	0.0	5.0	0.0	0.0	25.0	70.0	75.0	TOP	a58d9d6e-86e3-4c50-827c-37ed76118e88	released												released	30.0	d6818c85-5857-44b0-ad64-1eeb53b80606	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B6_demographic	75	-27541	1005	b6f278a3-d228-5361-a5ce-b633d6e432aa	not hispanic or latino	male	white	released	Dead	1936		TCGA-FD-A3B6_exposure	Not Reported	24.32606508811633	3.287671232876712	91072b32-08c4-5d46-b7af-855496b56b86	172.72	60.0	released	72.57	TCGA-FD-A3B6_diagnosis	27541	T2	MX	N0	Stage II	T2b	7th	not reported	0	209	30298f42-74b5-52d3-af7b-f1584c2d2277	C67.4	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2011	TCGA-FD-A3B6_treatment	TCGA-FD-A3B6_treatment_1	released	01749a96-4353-5bd7-9baf-f3d694c88fc2	no	Radiation Therapy, NOS	released	8ec437ba-4bb2-5d2d-9365-19cd5fdeb61b	no	Pharmaceutical Therapy, NOS	c6ba7082-d1e6-43b4-84b4-408584405be0
21606713-f4ad-4e3c-99ba-92b2d7079cb0.htseq.counts.gz	486207d3-5ed3-4235-bb7a-4cab27b6803d	TCGA-ZF-A9R7-01A-11R-A38B-07	TCGA-ZF-A9R7-01A-11R	TCGA-ZF-A9R7-01A-01-TS1		TCGA-ZF-A9R7-01A-11	TCGA-ZF-A9R7-01A	TCGA-ZF-A9R7	ce4e4549-befc-447f-9b79-ed46e302e6d7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	910	50.0	False	true	4AC6F4EE-B501-4C35-B35A-576C03866311	1.88	9e1c37bb-1c94-4a98-8e44-e03953aa8ad9			0.16	23	released	645a5974-ff00-4d66-9225-f1bc8cef7b17	RNA	R	0.16	UV Spec	released	False	4983e1aa-db98-48ac-b647-7f645ffbedd4	11	3.0	0.0	0.0	0.0	20.0	0.0	80.0	75.0	TOP	ef46e028-09af-4dcf-807e-81a6984204eb	released												released	30.0	616b3b82-df11-428b-8882-6b830125ae4b	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R7_demographic	76	-28063		ff04d8e7-4f18-53f0-a0a6-894ec8d51a72	not hispanic or latino	female	white	released	Alive	1935		TCGA-ZF-A9R7_exposure	Not Reported	26.106562240417702		b8a8ea12-daab-5e8d-8e42-626408b8ff8c	159.0		released	66.0	TCGA-ZF-A9R7_diagnosis	28063	T2	M0	NX	Stage II		7th	not reported	0	665	47cfbec1-f690-5aed-a10d-8823759123ec	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-ZF-A9R7_treatment_1	TCGA-ZF-A9R7_treatment	released	312b007d-c898-5301-9641-01458cbe508b	no	Pharmaceutical Therapy, NOS	released	eef3a6d6-635e-56cf-ae73-24d6a3b257a6	no	Radiation Therapy, NOS	486207d3-5ed3-4235-bb7a-4cab27b6803d
ffd68836-6dcf-4965-8799-970e6eaf885c.htseq.counts.gz	7fdda99d-54b7-48c8-84c8-b714ec4f54c7	TCGA-BT-A3PK-01A-21R-A220-07	TCGA-BT-A3PK-01A-21R	TCGA-BT-A3PK-01A-02-TSB		TCGA-BT-A3PK-01A-21	TCGA-BT-A3PK-01A	TCGA-BT-A3PK	73041fcf-f3b6-4851-b34d-1d62a1fcf6fe	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	58	300.0	False	true	AD597E1C-BC15-46A3-9B7C-324250540B05	1.83	20ca7c4d-7ef0-4fc5-907b-a90fec12a561			0.17	23	released	489503b1-2bdf-4182-9576-609aeaf93f42	RNA	R	0.17	UV Spec	released	False	98d64e26-420e-4c11-b33a-76577adaacc6	21	9.0	6.0	1.0	6.0	0.0	39.0	60.0	60.0	TOP	df6c0810-d5e2-4832-9578-2cf4a23d1e5d	released												released	30.0	f09e1eeb-bcd5-4dba-92f0-7d4b34b81ce7	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A3PK_demographic	80	-29314	303	c4b14a94-6d5f-52b0-86ee-755c29a767c9	not hispanic or latino	male	white	released	Dead	1931		TCGA-BT-A3PK_exposure	Not Reported	27.777777777777775		435255ff-87d0-561d-8e2e-37e5bf7cd608	180.0		released	90.0	TCGA-BT-A3PK_diagnosis	29314	T2b	MX	N0	Stage II	T2b	7th	not reported	0	63	c81fc78b-5fa6-5fbe-b955-6a49691d9a3e	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2011	TCGA-BT-A3PK_treatment_1	TCGA-BT-A3PK_treatment	released	b308997e-99f9-524f-bef7-ced2aeba31c8	no	Pharmaceutical Therapy, NOS	released	a460f205-853f-5d4e-8100-ba4b8932d76d	no	Radiation Therapy, NOS	7fdda99d-54b7-48c8-84c8-b714ec4f54c7
a963bd42-3f63-4ae3-a031-4d7ebb8ff18a.htseq.counts.gz	6c08afb7-5b66-44fc-8922-3754cecba0c5	TCGA-FD-A62P-01A-32R-A30C-07	TCGA-FD-A62P-01A-32R	TCGA-FD-A62P-01A-03-TSC		TCGA-FD-A62P-01A-32	TCGA-FD-A62P-01A	TCGA-FD-A62P	741311b6-cb15-498f-932d-ca282e1db10d	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	120	680.0	False	true	491E768C-1E7C-4461-BFF7-BA846758B39F	1.87	4a0b6e3c-a167-4ca6-876b-6fb82fa8fdb6			0.15	23	released	97a11130-d337-492b-b050-f3d5cb1c8a6c	RNA	R	0.15	UV Spec	released	False	a187ae37-31f2-4662-a749-20b7ceaa1dcc	32	5.0	1.0	0.0	1.0	0.0	30.0	70.0	70.0	TOP	38709153-23b6-4415-8736-24955dc88cdc	released												released	30.0	670f42fc-c213-4ba5-bde8-3855c4868168	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A62P_demographic	76	-27843	191	951cd549-89d5-5695-a45f-c94d57ad4915	not hispanic or latino	male	white	released	Dead	1936	2012	TCGA-FD-A62P_exposure	Not Reported	29.53099412064753		6410aed2-c732-5523-8d88-62a9f4575f5b	193.0		released	110.0	TCGA-FD-A62P_diagnosis	27843		MX	N0	Stage II	T2b	7th	not reported	0		c41a2f4c-6dfa-5c13-be4c-14d55967e025	C67.4	not reported	8120/3	Transitional cell carcinoma	no	Yes	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2012	TCGA-FD-A62P_treatment	TCGA-FD-A62P_treatment_1	released	3dac9e84-839e-50e7-9463-2518a9b5cf35	no	Radiation Therapy, NOS	released	21591f16-c583-5c32-bc7b-b8e29c0433cd	no	Pharmaceutical Therapy, NOS	6c08afb7-5b66-44fc-8922-3754cecba0c5
fd8c34b3-036f-4fe0-ac39-7303a9afdd27.htseq.counts.gz	85cfbe64-ccd5-4960-98ef-4fa46b061648	TCGA-LC-A66R-01A-41R-A30C-07	TCGA-LC-A66R-01A-41R	TCGA-LC-A66R-01A-04-TSD		TCGA-LC-A66R-01A-41	TCGA-LC-A66R-01A	TCGA-LC-A66R	39fdc742-8bdb-4e77-b20b-0f967a75e659	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	136	600.0	False	true	4E013D66-E9BD-49D1-8CA5-CABFE070D7BE	1.88	538ad820-310d-4463-83a2-44ce1cac920c			0.16	23	released	ea48bfe1-20ce-4d7e-ac5d-22a3aee86acf	RNA	R	0.16	UV Spec	released	False	0c4cdf9e-fa14-4f5a-9baa-6b384ff1e737	41	13.0	0.0	3.0	1.0	0.0	0.0	97.0	70.0	TOP	d535521f-8e1e-48a5-a05c-41d09a33b267	released												released	30.0	94379846-7eaf-4fe6-81c5-1520f2fb4ee4	Primary Tumor	01	released	Not Reported	released	TCGA-LC-A66R_demographic	78	-28793		1dab1b3c-4931-501d-a88a-5c4c31f2f186	not hispanic or latino	male	white	released	Alive	1934		TCGA-LC-A66R_exposure	Not Reported	20.98765432098765		9db08f9e-7aea-5157-8e7d-21ccf3b69e15	180.0		released	68.0	TCGA-LC-A66R_diagnosis	28793	T4a	MX	N2	Stage IV	T4a	7th	not reported	0	466	a01c300b-a9ed-58b0-85c4-7ce6e333ef11	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2012	TCGA-LC-A66R_treatment	TCGA-LC-A66R_treatment_1	released	ef7a6d08-8457-5a98-80aa-aa5420bb35fd	no	Radiation Therapy, NOS	released	cc0d1b2c-9c6b-506d-8b42-565ced5ffb1f	no	Pharmaceutical Therapy, NOS	85cfbe64-ccd5-4960-98ef-4fa46b061648
c183624c-10c6-40c7-9aba-46e2efb19930.htseq.counts.gz	4c45990d-5526-48c3-8987-4f4a80b97790	TCGA-DK-AA76-01A-11R-A39I-07	TCGA-DK-AA76-01A-11R	TCGA-DK-AA76-01A-01-TSA		TCGA-DK-AA76-01A-11	TCGA-DK-AA76-01A	TCGA-DK-AA76	d37b0460-efa4-4cf5-8082-f27ff2cf2f28	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	216	380.0	False	true	3271070D-5B10-4243-BEE5-AFDD60B7CDDA	1.88	4ecec21e-cbd5-42ec-af2e-bf58f2710458			0.16	23	released	824df8ad-dfcf-448c-b6ae-5e4bdcc1c5b4	RNA	R	0.16	UV Spec	released	False	f8acf225-dd07-4eb2-9c77-ecd3a0d3738a	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	6f343dde-2751-4a7d-a0c3-8187e0bf4c6d	released												released	30.0	e98b7d82-0274-4fbe-829b-552552799ad9	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA76_demographic	64	-23542		a695f583-b66e-5a5c-a1d4-de5aea3cd39f	not hispanic or latino	female	white	released	Alive	1949		TCGA-DK-AA76_exposure	Not Reported	32.79194475521777	2.191780821917808	e7254a2f-7b5b-598a-8e9e-3e9eae40d4e9	161.0	40.0	released	85.0	TCGA-DK-AA76_diagnosis	23542	T2	M0	N0	Stage II		7th	not reported	0	366	2fd1a497-437f-5180-820b-6c39f1ee009b	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage ii	2013	TCGA-DK-AA76_treatment_1	TCGA-DK-AA76_treatment	released	6b0edfa8-8b90-5878-b0df-1bb5d7587326	yes	Pharmaceutical Therapy, NOS	released	46092259-eb81-5c8d-9c6e-e2b4d4c3b345	no	Radiation Therapy, NOS	4c45990d-5526-48c3-8987-4f4a80b97790
333d5e75-56ba-4a36-86de-34569303e416.htseq.counts.gz	f3d7198f-6421-42d6-af17-0aa5754df440	TCGA-DK-AA6T-01A-11R-A39I-07	TCGA-DK-AA6T-01A-11R	TCGA-DK-AA6T-01A-01-TS1		TCGA-DK-AA6T-01A-11	TCGA-DK-AA6T-01A	TCGA-DK-AA6T	f9b55748-605a-4313-bb19-dcf5476590c2	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	186	80.0	False	true	7424FFA2-7BE6-4268-BAF4-4589C4F210AE	1.87	a9eb4088-1eb0-47ac-867b-df97fbeb318c			0.15	23	released	d448870a-c5d5-4f08-bff4-a0888277f391	RNA	R	0.15	UV Spec	released	False	2eab3492-995c-4f54-8a09-0cb2286dc782	11	2.0	0.0	0.0	0.0	25.0	0.0	75.0	65.0	TOP	789b1afb-6fa0-47a9-a8ef-797b0d29fdf0	released												released	30.0	a886d3cb-5733-4a50-8ddb-1fb7fb8c4f71	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6T_demographic	63	-23198		eb8439a6-94a1-56d1-b005-53f199e61f81	not hispanic or latino	male	white	released	Alive	1950		TCGA-DK-AA6T_exposure	Not Reported	21.54509079716836	1.643835616438356	59261d97-9f15-5664-abd1-b270cb802433	171.0	30.0	released	63.0	TCGA-DK-AA6T_diagnosis	23198	T2	M0	N0	Stage II		7th	not reported	0	572	fa16bfb1-bbfd-5f19-8700-67e1a4ebb8b2	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage ii	2013	TCGA-DK-AA6T_treatment	TCGA-DK-AA6T_treatment_1	released	34ad3ea8-2971-5ce3-9dc3-740f37920946	yes	Radiation Therapy, NOS	released	91b441b2-47cd-5782-8e09-cfbe246aea9e	yes	Pharmaceutical Therapy, NOS	f3d7198f-6421-42d6-af17-0aa5754df440
0a1b146d-7b9f-4382-9cfc-c187fafbb47c.htseq.counts.gz	7ae22982-a4a1-4352-ba42-6b7755d94cd3	TCGA-XF-AAMH-01A-11R-A42T-07	TCGA-XF-AAMH-01A-11R	TCGA-XF-AAMH-01A-01-TSA		TCGA-XF-AAMH-01A-11	TCGA-XF-AAMH-01A	TCGA-XF-AAMH	0ec37c2c-8d90-48c1-9cbc-69fe6473c980	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3271	150.0	False	true	5262C4FA-045C-4F50-8C82-D5CA53A406F1	1.81	4cdcbbae-5859-414b-bc81-001b25a3d4f1			0.18	23	released	b21b3252-4caa-4afd-b79d-93c79ff1b61d	RNA	R	0.18	UV Spec	released	False	d59c7eab-1d74-4ef2-bddf-81d9940f7b21	11	0.0	0.0	10.0	0.0	0.0	25.0	65.0	75.0	TOP	084a87d1-61aa-455e-8b6c-ce697fb63b56	released												released	30.0	917a011e-65bd-44fc-879d-6d710693db1f	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMH_demographic	80	-29547	344	61d0bdae-ddda-5e59-bbae-bd53c4048701	not hispanic or latino	male	white	released	Dead	1925	2005	TCGA-XF-AAMH_exposure	Not Reported	34.850184265342094	1.095890410958904	e95907e7-abed-576d-a2d8-cb8d8e25d3e8	158.0	20.0	released	87.0	TCGA-XF-AAMH_diagnosis	29547		MX	N1	Stage IV	T3b	6th	not reported	0		b61d6c1b-0013-5c6f-9709-d4a6cb164abb	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2005	TCGA-XF-AAMH_treatment_1	TCGA-XF-AAMH_treatment	released	69c8afcc-f925-5a70-8c0b-2930e1a881bd	no	Pharmaceutical Therapy, NOS	released	d9737cbf-6d90-5279-89cb-40c310ea9d82	no	Radiation Therapy, NOS	7ae22982-a4a1-4352-ba42-6b7755d94cd3
0e46571a-ea12-458c-bcde-63e30fe4c8f9.htseq.counts.gz	9a5c32d9-fff5-4ea4-ab1a-f0cf859ce594	TCGA-FD-A43U-01A-11R-A23W-07	TCGA-FD-A43U-01A-11R	TCGA-FD-A43U-01A-01-TSA		TCGA-FD-A43U-01A-11	TCGA-FD-A43U-01A	TCGA-FD-A43U	140b83db-badd-4b8d-b0f5-0f8c8060a228	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	910.0	False	true	FB7CF869-AA10-4C3E-9BDA-5686130DB4C6	1.84	1cd3bf53-27a7-4fda-8501-8270da2b8ceb			0.18	23	released	f5e6d6a7-f948-4130-b771-539fd08f61a3	RNA	R	0.18	UV Spec	released	False	fd795957-cc03-4d6b-ae20-26a9eaa4142a	11	0.0	0.0	10.0	0.0	0.0	10.0	80.0	80.0	TOP	092bb15a-8609-40b7-9542-49b7561d9e97	released												released	30.0	1336ab5a-0103-4fab-b057-1d387ddf0ded	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43U_demographic	70	-25841		ca36754f-2cd3-5b07-b745-5ae38fc484cb	not hispanic or latino	male	white	released	Alive	1942		TCGA-FD-A43U_exposure	Not Reported	27.17310161545582	1.095890410958904	b83563bf-d5f1-55ab-a367-80e7c7fd0780	183.0	20.0	released	91.0	TCGA-FD-A43U_diagnosis	25841	T4	MX	N2	Stage IV	T4a	7th	not reported	0	636	34e52e4f-66d1-52ed-b9dc-8ed28a8b52e8	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2012	TCGA-FD-A43U_treatment_1	TCGA-FD-A43U_treatment	released	b2d77437-e23b-5179-8930-e4a4f0a453c5	yes	Pharmaceutical Therapy, NOS	released	30481e81-5fb0-5546-9c08-74387a7d0c9b	yes	Radiation Therapy, NOS	9a5c32d9-fff5-4ea4-ab1a-f0cf859ce594
8ba209cf-5a74-4e51-8991-ed5b1e5c3ce4.htseq.counts.gz	e0a6d9fc-38fb-43f7-bf5e-b296a5538b0f	TCGA-GC-A6I3-01A-11R-A31N-07	TCGA-GC-A6I3-01A-11R	TCGA-GC-A6I3-01A-01-TS1		TCGA-GC-A6I3-01A-11	TCGA-GC-A6I3-01A	TCGA-GC-A6I3	acf6bdf3-6349-49dc-b99a-4eda648eeac5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	87	60.0	False	false	84221F34-EFA9-4ADD-A483-6B419D8A025B	1.92	b660dd38-f986-4143-9445-b66cb60f42dd			0.17	23	released	9c211e99-aeb6-4989-8da4-d579f7549ac8	RNA	R	0.17	UV Spec	released	False	29e18a7e-b739-4ea5-91dc-c02e8082fb64	11	20.0	2.0	3.0	0.0	0.0	30.0	67.0	75.0	TOP	bcb572ea-ca1a-4b2a-a8f1-2355d4f4409c	released												released	30.0	e1a1b0fa-4cae-4542-9dfb-0a7569bd60f3	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A6I3_demographic	90	-32872		e20a5b08-8b7e-50a7-8773-274a85b7a2c8	not hispanic or latino	female	black or african american	released	Alive	1923		TCGA-GC-A6I3_exposure	Not Reported	68.31944516329382		28b02413-7097-5366-802a-877aafce69f5	139.0		released	132.0	TCGA-GC-A6I3_diagnosis	32872	T3a	MX	N1	Stage IV	T3a	7th	not reported	0	0	100ac192-0981-58ec-8734-b54512416b2e	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2013	TCGA-GC-A6I3_treatment_1	TCGA-GC-A6I3_treatment	released	17889429-c84b-5834-8475-ef0a82631ad2	no	Pharmaceutical Therapy, NOS	released	93e78e5e-d69d-5b7b-87d2-f525007abfe1	no	Radiation Therapy, NOS	e0a6d9fc-38fb-43f7-bf5e-b296a5538b0f
6be696a3-6811-4686-9e7e-2590eef273ca.htseq.counts.gz	5d7f1c08-78dc-4e74-a412-5bf00f0a6338	TCGA-GC-A6I1-01A-12R-A31N-07	TCGA-GC-A6I1-01A-12R	TCGA-GC-A6I1-01A-01-TS1		TCGA-GC-A6I1-01A-12	TCGA-GC-A6I1-01A	TCGA-GC-A6I1	54c04bcc-ebd5-461e-bbd5-b4d791b00c95	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	168	50.0	False	false	30B23BF3-A3EC-444C-A43A-F080EEDFB6CC	1.87	159e6f18-943e-4e7b-af13-da273c52dc16			0.18	23	released	e659c968-d040-490e-8136-def86638c7cb	RNA	R	0.18	UV Spec	released	False	56384452-9a80-4667-b03d-da0cff7d665a	12	12.0	0.0	20.0	1.0	0.0	10.0	70.0	80.0	TOP	07e9b4a2-8cb5-42d7-a81d-f123cd6074d2	released												released	20.0	016eb791-6835-49a0-add9-612716fe431c	Primary Tumor	01	released	Not Reported	released	TCGA-GC-A6I1_demographic	90	-32872	0	ca1c82fc-fff4-57b3-b20c-0dfe9f13d56a	not hispanic or latino	female	white	released	Dead	1922		TCGA-GC-A6I1_exposure	Not Reported	23.243408017070568		0f917154-d0a0-5c73-8cf7-a8abf05fcf2c	162.0		released	61.0	TCGA-GC-A6I1_diagnosis	32872	T2b	MX	N0	Stage II	T2b	7th	not reported	0	0	ce6beb0f-1164-5e48-8ca6-d79f4c573b35	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-GC-A6I1_treatment_1	TCGA-GC-A6I1_treatment	released	aaaa708b-f405-55aa-9649-8d9b21b796b8	no	Pharmaceutical Therapy, NOS	released	b7238960-e431-5c70-b69d-5e7dec9222a1	no	Radiation Therapy, NOS	5d7f1c08-78dc-4e74-a412-5bf00f0a6338
3a72243a-6fab-453f-a1b0-e9cb00e84064.htseq.counts.gz	6e27578f-0d62-480d-abb1-57c320661142	TCGA-FD-A3B8-01A-31R-A20F-07	TCGA-FD-A3B8-01A-31R	TCGA-FD-A3B8-01A-03-TSC		TCGA-FD-A3B8-01A-31	TCGA-FD-A3B8-01A	TCGA-FD-A3B8	537ca5d1-5b26-496f-b7b4-05fea7b46353	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	232	400.0	False	false	1F9298B4-73AC-4B72-946B-443278540E6A	1.82	a45e5587-488f-4348-a724-fe64e0c5be7d			0.18	23	released	b44005ea-2792-4ee9-b458-dc060a017375	RNA	R	0.18	UV Spec	released	False	ff496715-d0db-4122-b2c0-8bbc3c5b8a74	31	0.0	0.0	0.0	0.0	30.0	0.0	70.0	85.0	TOP	19a3e760-e887-404a-9004-836631c04533	released												released	30.0	9a27aa84-d541-4fa3-a798-d7559a5ae70c	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B8_demographic	56	-20555		f076d957-0d6d-5603-9c51-a3a9279b7404	hispanic or latino	male	white	released	Alive	1955		TCGA-FD-A3B8_exposure	Not Reported	29.26026260215785	2.191780821917808	54af3829-6e77-599c-9361-586db725e5d9	177.8	40.0	released	92.5	TCGA-FD-A3B8_diagnosis	20555	T2	MX	N0	Stage II	T2b	7th	not reported	0	384	f347e363-0e99-5a7b-ac16-0a8a9e47fef3	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2011	TCGA-FD-A3B8_treatment	TCGA-FD-A3B8_treatment_1	released	e487596c-d011-5ff6-9ae9-833d15405d44	no	Radiation Therapy, NOS	released	9c5bd2de-4e6e-518b-8e81-63856f7dcfb1	no	Pharmaceutical Therapy, NOS	6e27578f-0d62-480d-abb1-57c320661142
fd3f0e6c-9c4a-4849-ba9d-d86c96effe36.htseq.counts.gz	bf0f3bcf-b0a9-4c60-a89a-ecc0f20131d4	TCGA-XF-A8HD-01A-11R-A36F-07	TCGA-XF-A8HD-01A-11R	TCGA-XF-A8HD-01A-01-TSA		TCGA-XF-A8HD-01A-11	TCGA-XF-A8HD-01A	TCGA-XF-A8HD	dfc67e7b-3986-4129-ae02-4d8f57e776e3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2820	760.0	False	true	CB491DC7-F20F-496F-A416-AA32105D32D7	1.84	f40981b0-a1e6-43d2-ae38-c2a7d6166fbf			0.16	23	released	e6a64ee5-8076-48e0-bbe2-05ebfcd05b28	RNA	R	0.16	UV Spec	released	False	83900a03-7daf-4086-9119-b115e514d793	11	2.0	0.0	19.0	0.0	0.0	0.0	81.0	80.0	TOP	8c41896a-89b6-4f20-8880-8249550a46d4	released												released	30.0	652e7049-0114-4dba-ab6d-2bfb8df5bed3	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HD_demographic	77	-28305		289fe831-5ea2-526a-90b7-d4a21814f450	not hispanic or latino	male	white	released	Alive	1929		TCGA-XF-A8HD_exposure	Not Reported	23.76543209876543	0.6575342465753424	55d31466-47fa-581a-8e96-b6e1b2dcac13	180.0	12.0	released	77.0	TCGA-XF-A8HD_diagnosis	28305	T2	MX	N0	Stage III	T3a	6th	not reported	0	2964	c3bb52c1-9bd6-5e07-bcd5-543e438b0cf1	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-A8HD_treatment	TCGA-XF-A8HD_treatment_1	released	ce1ef467-ba4a-5b57-aaac-4b17de4b10b9	no	Radiation Therapy, NOS	released	5eb64578-293d-564a-9e68-5a5d37fd3ea7	no	Pharmaceutical Therapy, NOS	bf0f3bcf-b0a9-4c60-a89a-ecc0f20131d4
ed6534e0-f180-42f3-81cd-ff41e4485f92.htseq.counts.gz	8b2aaa1b-5284-46c1-a131-3c0a0c1e1f6f	TCGA-ZF-A9R2-01A-11R-A39I-07	TCGA-ZF-A9R2-01A-11R	TCGA-ZF-A9R2-01A-01-TSA		TCGA-ZF-A9R2-01A-11	TCGA-ZF-A9R2-01A	TCGA-ZF-A9R2	aeb08986-a802-43dd-a5b4-17f4ec018790	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	307	240.0	False	true	B5679648-237C-4F65-87BB-CD92D0C53393	1.86	f29aacd1-503d-4f56-8faa-2ba309ce4f23			0.17	23	released	b79f775e-a327-4c23-ba50-4eedded6930e	RNA	R	0.17	UV Spec	released	False	6c672524-c962-4426-a4b0-a9c1faeb720f	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	6a466006-3dd2-484b-878c-c3f8e83025d2	released												released	30.0	d0027b26-44ea-4276-9ad4-e0c47a4564e9	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R2_demographic	75	-27537		9ca59367-50bb-58e8-80e0-f17efe04d79f	not hispanic or latino	male	white	released	Alive	1938		TCGA-ZF-A9R2_exposure	Not Reported	20.109164033323754	3.1780821917808217	90d8c9c6-7e84-5449-bd99-70909cf3525c	177.0	58.0	released	63.0	TCGA-ZF-A9R2_diagnosis	27537	T1	M0	N0	Stage II	T2b	7th	not reported	0	642	c27f6068-7756-57c1-a92a-b60313f6f7b5	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2013	TCGA-ZF-A9R2_treatment	TCGA-ZF-A9R2_treatment_1	released	bb4e973d-353d-5325-bb9f-c10893a7bfff	no	Radiation Therapy, NOS	released	f1b31a6d-a16f-5ba1-8f54-f79210cbeeeb	no	Pharmaceutical Therapy, NOS	8b2aaa1b-5284-46c1-a131-3c0a0c1e1f6f
e9e955be-706d-464a-afba-37a52b19e092.htseq.counts.gz	0b56c9da-6e5c-47a5-8ffd-cbbbd4d7da04	TCGA-GD-A2C5-11A-11R-A180-07	TCGA-GD-A2C5-11A-11R	TCGA-GD-A2C5-11A-01-TS1		TCGA-GD-A2C5-11A-11	TCGA-GD-A2C5-11A	TCGA-GD-A2C5	5d54c742-5a8e-4c40-8d62-95e75e210ab8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	76	120.0	False	false		1.87	381f4721-580b-4b93-9988-862780e177bb			0.16	23	released	72ee46de-ec80-4b0c-87ed-0bc743e7dc7c	RNA	R	0.16	UV Spec	released	False	b2e41454-2575-4878-aef8-85d9daf0ea46	11	20.0	0.0	0.0	1.0	20.0	80.0	0.0	0.0	TOP	58935bad-933a-44d8-aa45-6cbd6362c5ab	released												released	30.0	892eb338-9c49-4378-a934-623f4edacf7d	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GD-A2C5_demographic	53	-19498		208a3f03-443c-58b9-b020-5d02d8865a7e	not hispanic or latino	female	white	released	Alive	1958		TCGA-GD-A2C5_exposure	Not Reported	24.32322868339264	1.6986301369863013	38f332cf-2700-5a71-8167-dd809d32398b	149.0	31.0	released	54.0	TCGA-GD-A2C5_diagnosis	19498		MX	N2	Stage IV	T3a	7th	not reported	0	812	870f150b-96ab-535d-943c-923968f71a41	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2011	TCGA-GD-A2C5_treatment_1	TCGA-GD-A2C5_treatment	released	a07c757d-75fc-5f75-b4b7-6d259dafcc33	yes	Pharmaceutical Therapy, NOS	released	51cdd7a1-2def-5ae5-a12c-dfce613d8d60	yes	Radiation Therapy, NOS	0b56c9da-6e5c-47a5-8ffd-cbbbd4d7da04
8e9479ba-8a57-4c3b-9b0a-f318747268ca.htseq.counts.gz	1e503b70-bc6a-4274-a584-90aa3b5a39c9	TCGA-FD-A62S-01A-11R-A30C-07	TCGA-FD-A62S-01A-11R	TCGA-FD-A62S-01A-01-TSA		TCGA-FD-A62S-01A-11	TCGA-FD-A62S-01A	TCGA-FD-A62S	05a1402e-5a79-4d54-9430-065844ed1505	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	49	1150.0	False	true	690C8ADC-7F33-4E3A-A616-990B588F0029	1.9	341d1383-93bd-42d7-80ad-5dba732c1925			0.17	23	released	e639cd39-b1a4-4f54-8359-fb6017f49ac0	RNA	R	0.17	UV Spec	released	False	da75a6d8-ca62-4c39-84fe-83371d57f8a2	11	4.0	2.0	0.0	4.0	0.0	25.0	75.0	75.0	TOP	e7eb731a-6c41-4537-9290-3c2a62aad415	released												released	30.0	3d473acb-5c41-4d9f-a4a9-41846f445b48	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A62S_demographic	60	-22000	406	7ba08de8-fb13-5c82-8a98-98db45714094	not hispanic or latino	female	black or african american	released	Dead	1953		TCGA-FD-A62S_exposure	Not Reported	28.90625		296e3395-4d7a-52ca-8ba9-192698416ce4	160.0		released	74.0	TCGA-FD-A62S_diagnosis	22000		MX	N0	Stage III	T3b	7th	not reported	0	368	2cf6942d-9444-505a-a4fc-2cd5ba4eb87b	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2013	TCGA-FD-A62S_treatment_1	TCGA-FD-A62S_treatment	released	19c974d8-126b-55ef-adc8-61f8c58701a5	yes	Pharmaceutical Therapy, NOS	released	83e9e3ba-d2ce-509f-9feb-bad3f16900cd	yes	Radiation Therapy, NOS	1e503b70-bc6a-4274-a584-90aa3b5a39c9
059ef699-2da2-4f3e-8f7c-996ae394a87b.htseq.counts.gz	e52b775a-d191-484d-9a5e-abc79a75bf27	TCGA-BT-A0S7-01A-11R-A10U-07	TCGA-BT-A0S7-01A-11R	TCGA-BT-A0S7-01A-01-TSA	TCGA-BT-A0S7-01A-01-BSA	TCGA-BT-A0S7-01A-11	TCGA-BT-A0S7-01A	TCGA-BT-A0S7	68bc786e-07c7-4964-bc88-5e2a8633626a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1210	910	False	true	FF162E4D-8399-4DD8-BCD6-7D4D701CD7E2	1.82	2bdc311e-59cc-449f-b8dc-6662052678fd	3.47	26.7	0.13	23	released	902e5733-4e33-4bfd-bee0-7f1b6797155c	RNA	R	0.13	UV Spec	released	False	c2f21bbc-8c86-494a-8458-0186fc7f7148	11	3	0	0	0	0	30	70	70	TOP	a48d10f1-b338-4985-bb2e-068d4b5b9214	released	3	0	0	0	0	20	80	80	BOTTOM	2598f6b9-c077-43da-b6e0-b3662b134365	released	released	30	a9b73851-4609-4df7-8eb8-45a56f4b2dd6	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A0S7_demographic	75	-27533	200	012ac9d8-7571-5c46-a371-c97ac39dfec3	not hispanic or latino	male	white	released	Dead	1932	2007	TCGA-BT-A0S7_exposure	Not Reported			ee7c04f2-0c8f-5ce3-b73b-a0334d42d7a7			released	104.0	TCGA-BT-A0S7_diagnosis	27533		MX	N0	Stage III	T4a	6th	not reported	0		94660927-e346-5b40-8d70-0599b2fc0038	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2007	TCGA-BT-A0S7_treatment	TCGA-BT-A0S7_treatment_1	released	d5c8ae36-fb2f-5639-ab71-8de5f3c702c3	no	Radiation Therapy, NOS	released	70ffe2f4-febf-5f98-8c0d-447195ca474e	no	Pharmaceutical Therapy, NOS	e52b775a-d191-484d-9a5e-abc79a75bf27
e48eec75-ddbc-4824-8be6-e7fe0627239b.htseq.counts.gz	5c2d569f-b8df-4330-b258-38c01c42856f	TCGA-CF-A8HY-01A-11R-A36F-07	TCGA-CF-A8HY-01A-11R	TCGA-CF-A8HY-01A-01-TSA		TCGA-CF-A8HY-01A-11	TCGA-CF-A8HY-01A	TCGA-CF-A8HY	6a3e87d7-e360-44c5-9764-4b630df383e6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	360.0	False	true	A2BA1C88-630C-42B0-97E2-B58E22AC8EB3	1.85	0f1dc780-622d-4f97-80e2-25d8074ff8b1			0.17	23	released	aa83633a-f885-4de7-843e-d106a37e9a99	RNA	R	0.17	UV Spec	released	False	3b386295-1fbe-43f7-94f9-bf0b1831cf50	11	2.0	0.0	1.0	1.0	0.0	30.0	69.0	94.0	TOP	3899aa69-ccd2-4710-b964-af71d602ab1c	released												released	30.0	e8a0dd0b-abd7-4e8e-a9e8-46876d2f99de	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A8HY_demographic	59	-21636		731eeff3-e33d-517e-97ee-9fbb4c3b33ae	not hispanic or latino	male	asian	released	Alive	1954		TCGA-CF-A8HY_exposure	Not Reported	21.79944510503369		45bc4232-ff57-52ca-a865-4b3a2dee8c12	174.0		released	66.0	TCGA-CF-A8HY_diagnosis	21636		M0	N0	Stage II	T2	6th	not reported	0	345	2bb7e236-84ec-56fd-91fd-512635162960	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2013	TCGA-CF-A8HY_treatment_1	TCGA-CF-A8HY_treatment	released	6c1af1ac-e226-57bc-9dff-5a75be01161d	no	Pharmaceutical Therapy, NOS	released	5737cca9-002d-55f6-b7af-d0f79654051f	no	Radiation Therapy, NOS	5c2d569f-b8df-4330-b258-38c01c42856f
c2cc4c19-ace6-4e6f-a1d2-18ddf29de194.htseq.counts.gz	94c4e859-308a-477b-96c0-cb7369ad82ef	TCGA-FD-A3B4-01A-12R-A206-07	TCGA-FD-A3B4-01A-12R	TCGA-FD-A3B4-01A-01-TS1		TCGA-FD-A3B4-01A-12	TCGA-FD-A3B4-01A	TCGA-FD-A3B4	899f8d52-4c3a-4371-90eb-1f106001eddc	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	141	310.0	False	false	164CD26F-CF77-4490-BFD5-BDA5B81AC30E	1.8	80e9793f-4e30-45ad-8660-3686685f2db9			0.16	23	released	228291d9-3714-498e-a684-81cdb9c84769	RNA	R	0.16	UV Spec	released	False	cbc62b58-dca1-40bb-af82-9622c81fffe6	12	2.0	0.0	10.0	0.0	0.0	35.0	55.0	80.0	TOP	e10f3e6c-a573-4bb2-b3df-e3b90c352db2	released												released	30.0	6895a68f-0efd-4b0e-8cf2-9195833dbba1	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B4_demographic	55	-20379	510	26e5ed2d-a3a2-57b7-a047-fc0275780652	not hispanic or latino	female	black or african american	released	Dead	1956		TCGA-FD-A3B4_exposure	Not Reported	26.5625	1.643835616438356	ae2265ff-fa17-5b1c-86b1-1d03544ffc47	160.0	30.0	released	68.0	TCGA-FD-A3B4_diagnosis	20379	T2	MX	N0	Stage III	T4a	7th	not reported	0	477	7a672159-7d3c-5f0a-ba71-e21429300c4e	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2011	TCGA-FD-A3B4_treatment_1	TCGA-FD-A3B4_treatment	released	9a0379a9-9932-5e69-a447-c4a33db66e12	yes	Pharmaceutical Therapy, NOS	released	f3e2800a-2bda-5eab-ba7e-ff282e9dff13	yes	Radiation Therapy, NOS	94c4e859-308a-477b-96c0-cb7369ad82ef
37507a2a-32f7-418f-8d50-02bb4ff44767.htseq.counts.gz	478b05a6-90c8-404f-a514-7d1060097256	TCGA-XF-A8HB-01A-11R-A36F-07	TCGA-XF-A8HB-01A-11R	TCGA-XF-A8HB-01A-01-TSA		TCGA-XF-A8HB-01A-11	TCGA-XF-A8HB-01A	TCGA-XF-A8HB	90bf49b7-6710-4665-82df-30ecc22c59a3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2731	740.0	False	true	AEEB69FF-8CC6-4E22-AD71-A55B11595314	1.88	7bee34e3-b559-48e9-bbc3-2d162b8f128a			0.16	23	released	37c12241-f23a-460e-8391-57025058ad15	RNA	R	0.16	UV Spec	released	False	e10b71f6-2dfe-4a5c-86c3-e7d2e18c7d59	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	e2ce7af9-064d-409a-996a-a4057f702115	released												released	30.0	23790892-a2b5-4e06-af1d-248e0f0def4f	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HB_demographic	50	-18544		5430ee19-3c7d-5a7c-b6a8-25c6d7aa9dac	hispanic or latino	female	not reported	released	Alive	1956		TCGA-XF-A8HB_exposure	Not Reported	23.836734693877553	1.095890410958904	3fdf631d-2304-5090-bbb3-85a136741342	175.0	20.0	released	73.0	TCGA-XF-A8HB_diagnosis	18544		MX	N0	Stage II	T2b	6th	not reported	0	1370	6770a9aa-47af-55fa-b91b-ee7f2b4a4e3d	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2006	TCGA-XF-A8HB_treatment_1	TCGA-XF-A8HB_treatment	released	a773c3cc-f24d-5f37-9303-e6be02b78164	no	Pharmaceutical Therapy, NOS	released	0be26d76-c476-56a1-beeb-2c717045f5ba	no	Radiation Therapy, NOS	478b05a6-90c8-404f-a514-7d1060097256
b688a335-231c-42a5-9c00-c10584ba1d2b.htseq.counts.gz	3d70dbc0-c0eb-4191-944f-75b49c917f86	TCGA-SY-A9G5-01A-11R-A38B-07	TCGA-SY-A9G5-01A-11R	TCGA-SY-A9G5-01A-01-TS1		TCGA-SY-A9G5-01A-11	TCGA-SY-A9G5-01A	TCGA-SY-A9G5	7d198ee2-d80a-4759-804f-a7ef85971843	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	805	90.0	False	true	9D1D2500-3E1D-4FDB-B2BC-3B215FB7F9C6	1.89	183b63ef-c966-4348-a989-9c7e2b4a8082			0.17	23	released	8de16f52-e443-466b-b132-41f05e8ef69c	RNA	R	0.17	UV Spec	released	False	0c01b62d-eb7e-4ea2-a1ef-3c6bebeb2453	11	0.0	0.0	0.0	0.0	2.0	38.0	60.0	70.0	TOP	6f88653d-88ad-4c16-8854-6725f90a0e3c	released												released	30.0	d3afd0db-926a-4df8-9499-af5523e243e3	Primary Tumor	01	released	Not Reported	released	TCGA-SY-A9G5_demographic	66	-24260		76f4402c-1c34-52cb-aa61-34971e833533	not hispanic or latino	male	white	released	Alive	1945		TCGA-SY-A9G5_exposure	Not Reported	32.14631253706189		b67c2483-7b85-55cf-a581-219c7fab06db	179.0		released	103.0	TCGA-SY-A9G5_diagnosis	24260	T4a	M0	N0	Stage III	T4a	7th	not reported	0	1186	b456f4b3-8509-5786-9f6c-afaf494e7b7c	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-SY-A9G5_treatment_1	TCGA-SY-A9G5_treatment	released	ce492c4e-b9ca-51e7-8752-d6b68b2995ff	yes	Pharmaceutical Therapy, NOS	released	e80ade62-e2c6-5d16-a489-a4e04e5d198a	no	Radiation Therapy, NOS	3d70dbc0-c0eb-4191-944f-75b49c917f86
df7aeb83-6be5-46d4-b218-7335608c2596.htseq.counts.gz	b62d9623-3b0d-4b97-bcfe-2aa925b0b37d	TCGA-XF-AAMX-01A-11R-A42T-07	TCGA-XF-AAMX-01A-11R	TCGA-XF-AAMX-01A-01-TSA		TCGA-XF-AAMX-01A-11	TCGA-XF-AAMX-01A	TCGA-XF-AAMX	edc290bf-9731-4f03-bc37-64542e78e8bb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2730	1410.0	False	true	22526530-46B1-4DB8-A1EB-2D97AB18FD63	1.89	f40bfbec-9e14-4f28-a4d5-5aa06e90a4bb			0.18	23	released	1d777715-b101-4a59-89f7-79092e3af218	RNA	R	0.18	UV Spec	released	False	d5f867f7-fa7d-4c2b-96fe-861714feb405	11	0.0	0.0	0.0	0.0	0.0	25.0	75.0	80.0	TOP	f107b5c9-8e54-47a9-9d33-18e9fb43831c	released												released	30.0	c4f39a7a-fc9c-4ed1-b5ba-a6ca641dee58	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMX_demographic	87	-31884	206	98d107b3-3711-56a7-961c-a7d0f685b3ae	not hispanic or latino	female	black or african american	released	Dead	1919	2006	TCGA-XF-AAMX_exposure	Not Reported	27.28174603174603		4e5bc1eb-57b5-51ee-b6b3-0c4daf9273b7	168.0		released	77.0	TCGA-XF-AAMX_diagnosis	31884		MX	N0	Stage III	T3b	6th	not reported	0		e097b31c-a8db-543c-873d-1b14fe4f4104	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2006	TCGA-XF-AAMX_treatment	TCGA-XF-AAMX_treatment_1	released	aef0808f-0afb-5972-980b-5e032189e27b	no	Radiation Therapy, NOS	released	f01609f0-7bcc-5a0f-a57d-1f2ce8662654	no	Pharmaceutical Therapy, NOS	b62d9623-3b0d-4b97-bcfe-2aa925b0b37d
b9e40f63-6533-4259-8b54-05639aea4a2d.htseq.counts.gz	c734a79c-3976-4153-a2b0-6b9cfd96e328	TCGA-ZF-AA58-01A-12R-A42T-07	TCGA-ZF-AA58-01A-12R	TCGA-ZF-AA58-01A-01-TSA		TCGA-ZF-AA58-01A-12	TCGA-ZF-AA58-01A	TCGA-ZF-AA58	0da6502c-058d-47f5-9996-8aa1d511d7e4	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1252	220.0	False	true	31EED29A-65A9-4DB1-8E78-799A927D59F3	1.77	563f3a26-7e97-41ff-a52c-48ba484e3a39			0.16	23	released	3fbd9b94-2b9c-4ef7-81f0-a64dc091ee82	RNA	R	0.16	UV Spec	released	False	fe008982-1fee-4c77-8d58-e555c55c0ef7	12	0.0	0.0	10.0	0.0	0.0	20.0	70.0	90.0	TOP	4b7fc848-db6a-4d5c-8a59-1cc97a0d615e	released												released	30.0	56f1ae65-b100-4340-8afe-854e4de7b584	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA58_demographic	61	-22549		55a382da-a546-58b0-9aa6-fc7d0dc61a1d	not hispanic or latino	female	white	released	Alive	1949		TCGA-ZF-AA58_exposure	Not Reported	25.458065904119906	2.136986301369863	3e326041-7a8f-59b7-ad91-444081e3dbed	167.0	39.0	released	71.0	TCGA-ZF-AA58_diagnosis	22549	T2	MX	N2	Stage IV	T3a	7th	not reported	0	1649	ba273eba-8112-5961-aa85-282ccd4bc8c1	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-ZF-AA58_treatment_1	TCGA-ZF-AA58_treatment	released	a5dc2c22-7f1c-55d4-a28c-8f840b6c1df3	yes	Pharmaceutical Therapy, NOS	released	e094f720-5267-5509-8e1e-2d5916d58c54	no	Radiation Therapy, NOS	c734a79c-3976-4153-a2b0-6b9cfd96e328
94e7674d-7c7b-406e-a8d3-135e3659cb2d.htseq.counts.gz	21a13e51-c1c2-4d91-8e77-3ba1bf86eb97	TCGA-XF-AAMG-01A-11R-A42T-07	TCGA-XF-AAMG-01A-11R	TCGA-XF-AAMG-01A-01-TSA		TCGA-XF-AAMG-01A-11	TCGA-XF-AAMG-01A	TCGA-XF-AAMG	390a29fe-2cfd-43c4-a247-69e692763e17	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3366	540.0	False	true	3B9E30D8-1671-465F-9425-951912C1ECF5	1.78	e204f212-b8ad-47d1-ab9c-179b7389e47e			0.16	23	released	034f0d40-b537-468c-97c3-eaf318fdb037	RNA	R	0.16	UV Spec	released	False	dbd978ee-c953-4c29-9982-88adfca97fdc	11	5.0	0.0	5.0	0.0	0.0	30.0	65.0	70.0	TOP	128c13d6-87ed-4e9c-b9e0-13e7ddfa1bc3	released												released	30.0	d8ab144a-616b-45ca-b54b-d7106f707155	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMG_demographic	49	-18021		fc3708eb-9f1c-5fe5-9bd2-48f6a13281d7	hispanic or latino	male	white	released	Alive	1955		TCGA-XF-AAMG_exposure	Not Reported	23.510204081632654		b7afd16d-029f-5edb-933b-975046e98ca2	175.0		released	72.0	TCGA-XF-AAMG_diagnosis	18021		MX	N0	Stage III	T4a	6th	not reported	0	3364	5e3a7dcb-bfd6-5e0b-9441-30451db4325c	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2004	TCGA-XF-AAMG_treatment_1	TCGA-XF-AAMG_treatment	released	354f02b4-f551-5ea0-ab4a-0b8996d9a3fa	yes	Pharmaceutical Therapy, NOS	released	f0f7e6ad-3f76-51a5-961f-a7f83734877e	no	Radiation Therapy, NOS	21a13e51-c1c2-4d91-8e77-3ba1bf86eb97
11571d6e-b840-4492-9bd4-700a925d83ea.htseq.counts.gz	7e41565e-ccf3-43ca-bc1a-73c6a789c67f	TCGA-BT-A20U-11A-11R-A14Y-07	TCGA-BT-A20U-11A-11R	TCGA-BT-A20U-11A-01-TSA		TCGA-BT-A20U-11A-11	TCGA-BT-A20U-11A	TCGA-BT-A20U	83b41d35-69b1-4218-be1a-8821d8a6899c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1174	260	False	true		1.79	20f18a89-bca9-4f97-98c5-7b58a4444823	4.27	26.7	0.16	23	released	a35a03df-9ae5-4279-912c-2f3ee4bd8bd0	RNA	R	0.16	UV Spec	released	False	1d991dd5-060d-4f2a-8b06-8cb4cb5f1dc5	11	0	0	0	0	100	0	0	0	TOP	e07d1efe-0bf7-446d-afdb-3bfe90d2acf0	released												released	30	996ee634-a7f1-4273-80d2-adbd68d5a1ce	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A20U_demographic	70	-25761	455	82d04e76-74d4-5009-8196-94ace7f93ebd	not hispanic or latino	female	white	released	Dead	1938	2009	TCGA-BT-A20U_exposure	Not Reported			7dd0e5d4-8a6b-5513-b30f-86df2efbc247			released		TCGA-BT-A20U_diagnosis	25761	T3a	M0	N0	Stage III	T3a	6th	not reported	0		5f53d094-88aa-5c69-abd6-bad079955707	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2008	TCGA-BT-A20U_treatment	TCGA-BT-A20U_treatment_1	released	fff71c42-024a-520e-98b6-0660f578163e	no	Radiation Therapy, NOS	released	e6d75ded-bbbe-5eb0-a903-366350d0ee5e	no	Pharmaceutical Therapy, NOS	7e41565e-ccf3-43ca-bc1a-73c6a789c67f
3a031010-7222-497e-8400-01d633c450d7.htseq.counts.gz	159dba8e-180c-4c0e-9639-6e4a479823bd	TCGA-YC-A8S6-01A-31R-A38B-07	TCGA-YC-A8S6-01A-31R	TCGA-YC-A8S6-01A-03-TS3		TCGA-YC-A8S6-01A-31	TCGA-YC-A8S6-01A	TCGA-YC-A8S6	97d6568c-0a89-4327-8988-71e81ee8dae6	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	21	220.0	False	false	9945C51F-169C-48D5-81FC-9BFEA1C276C6	1.85	a2b8a4b8-202d-4705-89ab-5ac06028d7b0			0.17	23	released	cd04cab8-1bf9-4659-afa6-374060eb4fbc	RNA	R	0.17	UV Spec	released	False	f115ac0b-e0bd-47e3-b930-8100124bd8ae	31	4.0	2.0	0.0	4.0	3.0	32.0	65.0	65.0	TOP	cc77935f-798d-428c-861e-47ba5f350521	released												released	30.0	38a7d76d-1ec7-4469-a204-02f3ca423488	Primary Tumor	01	released	Not Reported	released	TCGA-YC-A8S6_demographic	71	-26130		9b435868-eccb-5e25-878b-71c4c4bc9dd7	not hispanic or latino	male	white	released	Alive	1942		TCGA-YC-A8S6_exposure	Not Reported	38.204081632653065		36e3707c-660b-5b07-9e5a-d755f1aeaa3f	175.0		released	117.0	TCGA-YC-A8S6_diagnosis	26130		MX	N0	Stage II	T2a	7th	not reported	0	293	03fb3391-a100-513c-8f1a-0905e9f347c3	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2013	TCGA-YC-A8S6_treatment	TCGA-YC-A8S6_treatment_1	released	0f50cad3-29b4-545d-8500-ff912af4fb99	no	Radiation Therapy, NOS	released	303abbe4-60bb-5c17-95d9-3b87b7aaf10d	no	Pharmaceutical Therapy, NOS	159dba8e-180c-4c0e-9639-6e4a479823bd
c1d9c2de-c351-4f44-90c2-7ee6f0eaf6a4.htseq.counts.gz	e2389bc9-b722-406f-81d6-91c4534e496b	TCGA-UY-A78N-01A-12R-A33J-07	TCGA-UY-A78N-01A-12R	TCGA-UY-A78N-01A-01-TSA		TCGA-UY-A78N-01A-12	TCGA-UY-A78N-01A	TCGA-UY-A78N	573e124f-98cb-4014-b9d2-0499f7fbdb7a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		340.0	False	true	9DE74A4B-6785-40FE-8117-496F4A32DFE5	1.94	fd7fac82-d8e3-4133-be0e-ec5b2badc5d1			0.17	23	released	3758ae63-549a-4a63-980b-c00fcdf346d4	RNA	R	0.17	UV Spec	released	False	6b463d08-ed39-4b56-bbbc-84b7f2c3403a	12	3.0	2.0	3.0	5.0	0.0	27.0	70.0	70.0	TOP	fb549296-7109-4d9d-9a81-671e13f09a04	released												released	20.0	fa16f098-4c30-4d95-9534-605399027088	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78N_demographic	80	-29132	2641	db43bbe4-50c1-551d-a52a-fa8620c0f2fd	not hispanic or latino	male	white	released	Dead			TCGA-UY-A78N_exposure	Not Reported	25.05930702662969	1.36986301369863	5a8f1395-bf15-52fa-a195-46f7ce038c56	173.0	25.0	released	75.0	TCGA-UY-A78N_diagnosis	29132		MX	N1	Stage IV	T2	6th	not reported	0		87275041-4619-59a8-8499-03b2032acaab	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv		TCGA-UY-A78N_treatment_1	TCGA-UY-A78N_treatment	released	e56f59f8-34ff-528f-ab2a-8a4b8982169d	no	Pharmaceutical Therapy, NOS	released	b20c2af2-f65c-5ac4-bca1-26c8fb843452	no	Radiation Therapy, NOS	e2389bc9-b722-406f-81d6-91c4534e496b
33bea9c9-f6ba-4768-9349-a085202a0b9d.htseq.counts.gz	f86e1f8c-9067-41f2-a58a-f98eeb22e1ea	TCGA-2F-A9KP-01A-11R-A38B-07	TCGA-2F-A9KP-01A-11R	TCGA-2F-A9KP-01A-01-TS1		TCGA-2F-A9KP-01A-11	TCGA-2F-A9KP-01A	TCGA-2F-A9KP	65d1eaec-28db-4a41-a4db-1a710fcb24ad	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	916	90.0	False	false	19580F74-7FD9-4366-9FFB-D66D2BC33336	1.93	c4cd3829-e7e0-4f1e-8796-856fddcf50ae			0.18	23	released	a35c822b-122f-4152-a245-c2a1f724a1d8	RNA	R	0.18	UV Spec	released	False	b71475b3-8285-4e5a-96c7-6ea96fe49b12	11	3.0	0.0	0.0	0.0	10.0	0.0	90.0	75.0	TOP	1bd6ff57-7f82-4444-9918-d8ceba1d8987	released												released	30.0	96e66b43-ffbf-4ad8-95ef-1b9165ad751e	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KP_demographic	66	-24428	364	3c7eeefc-7e8e-5ad2-b57d-ca5eefcdbd81	not hispanic or latino	male	white	released	Dead	1945	2011	TCGA-2F-A9KP_exposure	Not Reported	37.57659845068794	3.3972602739726026	16547dae-12ee-5643-9f8c-76c73af27d15	186.0	62.0	released	130.0	TCGA-2F-A9KP_diagnosis	24428	T2	MX	N2	Stage IV	T3a	7th	not reported	0		19099413-ca2c-53af-9e86-cfb23d26842d	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iv	2011	TCGA-2F-A9KP_treatment	TCGA-2F-A9KP_treatment_1	released	b8001728-0010-51bd-8d62-e0629c7c7e00	no	Radiation Therapy, NOS	released	38775ab0-8b7e-5591-b3e6-8a0e5873adb0	no	Pharmaceutical Therapy, NOS	f86e1f8c-9067-41f2-a58a-f98eeb22e1ea
ac69d62a-af65-43d2-aac7-216908fc1116.htseq.counts.gz	9c191b5f-419c-4cfd-b508-e2aad2c07db2	TCGA-XF-A9T3-01A-11R-A42T-07	TCGA-XF-A9T3-01A-11R	TCGA-XF-A9T3-01A-01-TSA		TCGA-XF-A9T3-01A-11	TCGA-XF-A9T3-01A	TCGA-XF-A9T3	5f7c3b2d-9a5b-470f-bd12-9c7787a543f0	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2140	130.0	False	true	F782DE7F-4DE3-476D-BDF6-549CD871EE9C	1.72	2dd4a5e0-3008-4615-bcc5-9cc8d9a708b2			0.18	23	released	1857dc51-e7f9-4b02-8256-549add5cd69b	RNA	R	0.18	UV Spec	released	False	6c4ba2f3-2487-4dcb-9395-efcbdf2f5e66	11	4.0	0.0	0.0	0.0	35.0	0.0	65.0	65.0	TOP	b9f9b005-0db5-4f29-9fff-55e8dfd79ab5	released												released	30.0	41bcf107-12ad-4732-8e88-35347137a05f	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9T3_demographic	69	-25532		c55bc7d9-da81-5052-bffa-55aa7ae29a72	not hispanic or latino	female	white	released	Alive	1939		TCGA-XF-A9T3_exposure	Not Reported	19.53125	2.8493150684931505	5cc4cc17-40e3-50a7-a9dd-80a86b60bdfd	160.0	52.0	released	50.0	TCGA-XF-A9T3_diagnosis	25532		MX	N2	Stage IV	T3b	4th	not reported	0	68	b262fd90-f42d-5516-aab8-2335100052cb	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2008	TCGA-XF-A9T3_treatment	TCGA-XF-A9T3_treatment_1	released	ad70d20c-8a7b-58b8-83b4-543bc46e4c48	not reported	Radiation Therapy, NOS	released	96697f00-ad48-521a-b39f-efd7725fdd30	not reported	Pharmaceutical Therapy, NOS	9c191b5f-419c-4cfd-b508-e2aad2c07db2
96be17e0-8ee2-4956-9527-2b966d7e8ce6.htseq.counts.gz	a369f5cd-48f6-4f73-81aa-ef1634ba145c	TCGA-UY-A8OB-01A-12R-A42T-07	TCGA-UY-A8OB-01A-12R	TCGA-UY-A8OB-01A-01-TSA		TCGA-UY-A8OB-01A-12	TCGA-UY-A8OB-01A	TCGA-UY-A8OB	fe33e5e0-a54d-481a-897c-e32b4708da69	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		250.0	False	true	1D6D35DC-D4B8-4186-9EA4-97F53314D01B	1.84	fb37dcdd-00a6-49b7-b0ca-1fe0d9c4782a			0.18	23	released	c06fea48-b63f-4d94-99a9-5a6ff1330fb4	RNA	R	0.18	UV Spec	released	False	2dc19732-fdea-48ee-9b79-65858efff2fc	12	3.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	b13d1a90-1957-48f1-8feb-918f84f8ec99	released												released	30.0	db9be25a-e321-4fbd-a6eb-1d7521c16ece	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A8OB_demographic	63	-23360		c4067e34-b3b3-54a8-8c9c-1c7921875444	hispanic or latino	male	white	released	Alive			TCGA-UY-A8OB_exposure	Not Reported	22.03172568498638	1.36986301369863	5ec04180-2f44-5216-a3f7-7fbc87710388	158.0	25.0	released	55.0	TCGA-UY-A8OB_diagnosis	23360		MX	N1	Stage IV	T3a	6th	not reported	0	2109	c431ed8f-9ac4-5968-9c1a-d13e5efc39bf	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A8OB_treatment	TCGA-UY-A8OB_treatment_1	released	51531baa-611f-5690-a120-5834b36c86e0	no	Radiation Therapy, NOS	released	c508fbb6-623f-5749-a8b0-7e7c6f05a40f	yes	Pharmaceutical Therapy, NOS	a369f5cd-48f6-4f73-81aa-ef1634ba145c
069bb049-794f-474e-8238-9132c2b57a8f.htseq.counts.gz	03a0c35b-f94e-4681-81f9-9afcc976ad2d	TCGA-DK-A1A3-01A-11R-A13Y-07	TCGA-DK-A1A3-01A-11R	TCGA-DK-A1A3-01A-01-TSA		TCGA-DK-A1A3-01A-11	TCGA-DK-A1A3-01A	TCGA-DK-A1A3	c5b20ccc-523d-491c-8536-008e05c57212	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	240	120.0	False	true	2FDD45DD-21FB-492B-8458-6D96FBF46509	1.82	d22b6ef3-9b08-44d9-b37f-e7f61ce89404			0.17	23	released	a12eaa1e-3a4c-47f9-88dd-c3f782fca6b2	RNA	R	0.17	UV Spec	released	False	e7e84567-04e8-431b-a555-7f4452c2c171	11	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	337b1183-3641-4278-99da-423cdd1e0b1a	released												released	30.0	954e46ba-514f-4708-ad3c-ecbf8cef005a	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1A3_demographic	60	-22235	665	e6e94096-f9c6-5a97-a3b6-0a0e4fa1b6bf	not hispanic or latino	male	white	released	Dead	1950		TCGA-DK-A1A3_exposure	Not Reported	22.694018931589476	1.3150684931506849	6ab354e1-ad80-5b9b-9fd5-573f12959d2b	183.0	24.0	released	76.0	TCGA-DK-A1A3_diagnosis	22235		M0	N2	Stage IV	T3	6th	not reported	0	77	42769ef9-2dd5-574f-96b8-b2608bef53c0	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-DK-A1A3_treatment_1	TCGA-DK-A1A3_treatment	released	43ae6505-e163-5ce2-ad3a-77326c1909ba	not reported	Pharmaceutical Therapy, NOS	released	d0381096-2931-546a-9879-1f074f490888	not reported	Radiation Therapy, NOS	03a0c35b-f94e-4681-81f9-9afcc976ad2d
bd45cb33-8e1c-4b37-8bd2-29f804269838.htseq.counts.gz	1492b289-12f5-4c54-83ff-1ce3aebd84b2	TCGA-DK-AA6X-01A-12R-A42T-07	TCGA-DK-AA6X-01A-12R	TCGA-DK-AA6X-01A-01-TS1		TCGA-DK-AA6X-01A-12	TCGA-DK-AA6X-01A	TCGA-DK-AA6X	071b350d-8745-4795-8194-a8c6491f0931	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	60	90.0	False	true	669554D5-C608-4028-B24E-1F2129FA0925	1.82	254061df-9073-4d41-a519-e79cc2d5c562			0.16	23	released	a27b374a-76fd-46bd-b02c-e1d58a39e887	RNA	R	0.16	UV Spec	released	False	d271c8ed-710a-4560-bce5-16ca082e7f7c	12	4.0	0.0	0.0	0.0	0.0	0.0	100.0	60.0	TOP	8d2d10d9-c2d5-4049-83ea-dabb1c34c045	released												released	30.0	03523592-740d-4a06-ac8c-f921bf3f7952	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA6X_demographic	63	-23208		82e9a22d-d799-595b-987e-4281f4996b3c	not hispanic or latino	male	white	released	Alive	1950		TCGA-DK-AA6X_exposure	Not Reported	30.02324380165289		e71652df-75b5-587f-8e9c-7c06befdd49a	176.0		released	93.0	TCGA-DK-AA6X_diagnosis	23208	T2	M0	N0	Stage II		7th	not reported	0	467	c458b944-437e-5eeb-8b24-27936dd4d431	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2013	TCGA-DK-AA6X_treatment	TCGA-DK-AA6X_treatment_1	released	8c2ebd84-96e8-5c0d-855c-d7b61d2d1752	no	Radiation Therapy, NOS	released	473174d1-ff7e-5515-9bcd-05413f9dcf9e	no	Pharmaceutical Therapy, NOS	1492b289-12f5-4c54-83ff-1ce3aebd84b2
11233a5a-7e02-47b8-a50d-2b306d67a93b.htseq.counts.gz	c1a0f021-c825-4db9-a083-b514b10f2bae	TCGA-G2-A3IE-01A-11R-A20F-07	TCGA-G2-A3IE-01A-11R	TCGA-G2-A3IE-01A-01-TSA		TCGA-G2-A3IE-01A-11	TCGA-G2-A3IE-01A	TCGA-G2-A3IE	c65ba2b8-e867-42e8-bbd0-c2cdf5130cfb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1539	130.0	False	true	7412115B-6EA2-43B6-970B-F0ACDB77EAFC	1.83	eb59f0f9-3b20-4dce-833e-6a67076ddc01			0.17	23	released	f2c833a0-dfd5-4a1a-8637-49af3163af07	RNA	R	0.17	UV Spec	released	False	f0e49b80-179a-4984-9b62-1838ac784f54	11	2.0	1.0	0.0	1.0	0.0	15.0	85.0	85.0	TOP	1234b8c8-e3a6-4ffd-85ea-1625a236c735	released												released	30.0	fc529667-d055-4fc3-806d-c0431d9a6cff	Primary Tumor	01	released	Not Reported	released	TCGA-G2-A3IE_demographic	51	-18983	612	06f35601-b6f3-54ea-beff-fcb853120977	not hispanic or latino	male	white	released	Dead	1956	2008	TCGA-G2-A3IE_exposure	Not Reported	29.615988407197193	0.0821917808219178	08ff2371-cd94-5386-b357-8ad6676b1dc7	182.0	1.5	released	98.1	TCGA-G2-A3IE_diagnosis	18983	T2a	MX	NX	Stage II		6th	not reported	0		e7a338d1-363e-5d2b-b1de-a50da1a056b9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2007	TCGA-G2-A3IE_treatment_1	TCGA-G2-A3IE_treatment	released	79c6a754-0838-5933-895d-4adfbf567139	yes	Pharmaceutical Therapy, NOS	released	a147b39a-19e0-5917-9c7d-d6ab34b2d1ab	no	Radiation Therapy, NOS	c1a0f021-c825-4db9-a083-b514b10f2bae
fc412747-9050-4c51-8e1e-9b6e1bc3b5f5.htseq.counts.gz	43269136-7770-4216-8a0e-c63ae43b9b24	TCGA-FD-A5BU-01A-31R-A26T-07	TCGA-FD-A5BU-01A-31R	TCGA-FD-A5BU-01A-03-TSC		TCGA-FD-A5BU-01A-31	TCGA-FD-A5BU-01A	TCGA-FD-A5BU	980c7214-f708-4499-818d-f3de87dc6de7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	153	780.0	False	true	A724558E-615F-4565-86B0-389FE9083D88	1.87	06d4cd28-11fb-4f25-8ae0-3fa8e3f3e325			0.17	23	released	3da161b4-520f-4872-b51d-e3e40b12abea	RNA	R	0.17	UV Spec	released	False	086d7de7-bb17-4e44-b6d0-2155c8e924af	31	22.0	2.0	3.0	4.0	0.0	67.0	30.0	60.0	TOP	141cafdc-00e9-401a-a8d8-633c20f43d98	released												released	30.0	5f0353bd-0f8b-44d5-8e0f-7f99c6b9e4ba	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BU_demographic	76	-27882		b51578ef-1357-53e3-934d-14474c8f661b	not hispanic or latino	female	black or african american	released	Alive	1936		TCGA-FD-A5BU_exposure	Not Reported	23.306680053067517	3.671232876712329	004ab147-911b-5510-98c1-49fcf403bf5b	167.0	67.0	released	65.0	TCGA-FD-A5BU_diagnosis	27882		MX	N0	Stage II	T2b	7th	not reported	0	588	0ba3134f-3742-5c6b-a10b-435ac878943a	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2012	TCGA-FD-A5BU_treatment_1	TCGA-FD-A5BU_treatment	released	4dacf0db-adc7-5924-8047-21140fe9daf8	no	Pharmaceutical Therapy, NOS	released	5079b217-c553-59d2-82d5-5bd254096209	no	Radiation Therapy, NOS	43269136-7770-4216-8a0e-c63ae43b9b24
ffd65a1e-2709-4905-b013-55c4b3f6a237.htseq.counts.gz	b90fa420-7bd0-474f-89b4-0487a2c2031d	TCGA-C4-A0EZ-01A-21R-A24X-07	TCGA-C4-A0EZ-01A-21R	TCGA-C4-A0EZ-01A-01-BS1	TCGA-C4-A0EZ-01A-02-BS2	TCGA-C4-A0EZ-01A-21	TCGA-C4-A0EZ-01A	TCGA-C4-A0EZ	05935f1d-77c2-46ca-b87a-7a84bce38afd	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1299	210.0	False	false	DB053F32-6DBF-45A8-AF18-4DF817CB6444	1.73	8f482c29-37fe-400f-b178-224765a0c037			0.16	23	released	5558611f-b8f6-4cfe-ad00-35c9f0706368	RNA	R	0.16	UV Spec	released	False	86376599-bce2-4d80-9bae-43e43c35f84b	21	8.0	0.0	2.0	0.0	44.0	5.0	55.0	80.0	TOP	f1b25afc-18f9-4494-af43-3430f5e3dda5	released	0.0	0.0	5.0	0.0	5.0	1.0	89.0	97.0	BOTTOM	6f3290c1-6a2b-46e2-958d-be4f2cd77900	released	released	30.0	75f55447-5584-4a98-a3a3-8e90d50efdbc	Primary Tumor	01	released	Not Reported	released	TCGA-C4-A0EZ_demographic	69	-25202	273	2339378a-6e1d-5a72-9b28-980b65dd82c2	not reported	female	not reported	released	Dead	1937	2006	TCGA-C4-A0EZ_exposure	Not Reported	26.609712545078953	1.8630136986301369	125787dc-fbe5-559d-891a-b505372f1a99	169.0	34.0	released	76.0	TCGA-C4-A0EZ_diagnosis	25202		M1	N1	Stage IV	T3a	5th	not reported	0		1f9cd203-5c80-5ed7-a4be-f3c73a84f45b	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iv	2006	TCGA-C4-A0EZ_treatment	TCGA-C4-A0EZ_treatment_1	released	46c2e0b0-ec30-5828-8315-84839cf28c51	no	Radiation Therapy, NOS	released	9b168bcf-eb43-5f86-ae7b-bc452c6ba8ba	yes	Pharmaceutical Therapy, NOS	b90fa420-7bd0-474f-89b4-0487a2c2031d
72fde82f-1da6-4e4c-963f-13450fa6faf1.htseq.counts.gz	0edeb7a0-42d5-4f1f-b0f2-9b0338339ce2	TCGA-FD-A3B3-01A-12R-A206-07	TCGA-FD-A3B3-01A-12R	TCGA-FD-A3B3-01A-01-TSA		TCGA-FD-A3B3-01A-12	TCGA-FD-A3B3-01A	TCGA-FD-A3B3	4b5d873b-bfda-482e-92a0-bf84c0f9032a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	182	270.0	False	false	F0E3A01E-2B43-4BE1-BAE5-85340943A422	1.81	1cc49a56-ee39-4fd1-bf80-a6b71695c1f1			0.16	23	released	4fb71faf-9327-4531-ae12-7b6639f73852	RNA	R	0.16	UV Spec	released	False	2d833628-fa8d-4556-be6d-b85f3b41ed2f	12	15.0	0.0	0.0	0.0	0.0	15.0	85.0	75.0	TOP	c4431f39-e467-4177-8b1b-8e4844d410a0	released												released	30.0	769ee027-5ed7-4ec2-86b5-fe40f9d6fb5a	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3B3_demographic	74	-27068	974	cad0c697-e8e5-5a6a-801b-491787941ae7	not hispanic or latino	female	white	released	Dead	1937		TCGA-FD-A3B3_exposure	Not Reported	36.02401947508283	1.7534246575342465	b1eea58f-ef15-59a3-9868-df787dd683aa	170.18	32.0	released	104.33	TCGA-FD-A3B3_diagnosis	27068	T2	MX	N0	Stage III	T3	7th	not reported	0	392	12f839e8-ea9e-53c6-b764-6b74f431db21	C67.0	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2011	TCGA-FD-A3B3_treatment_1	TCGA-FD-A3B3_treatment	released	12f9f599-534f-57d2-a7f6-bf710c438f6e	no	Pharmaceutical Therapy, NOS	released	0b8b0e4c-f2c2-53d1-b324-021a7e0b49ce	no	Radiation Therapy, NOS	0edeb7a0-42d5-4f1f-b0f2-9b0338339ce2
55735ee9-5194-4208-9813-b9f24db0a0bf.htseq.counts.gz	4d349396-5903-4967-b2cb-cd57ce8503b0	TCGA-FD-A5BZ-01A-11R-A28M-07	TCGA-FD-A5BZ-01A-11R	TCGA-FD-A5BZ-01A-01-TS1		TCGA-FD-A5BZ-01A-11	TCGA-FD-A5BZ-01A	TCGA-FD-A5BZ	ac187cd1-a5ef-47da-88b2-1d4df27e0e76	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1304	290.0	False	true	1FC2AC75-824B-4284-82C6-D664FA8DEB0A	1.87	ee7d92c6-8a20-41ec-8e43-7a7c462b13d5			0.17	23	released	0a87e09b-2602-4c1f-9619-c05dc82c58fd	RNA	R	0.17	UV Spec	released	False	04b6ead7-a685-48d0-ac8b-e059f901cc96	11	6.0	2.0	4.0	4.0	0.0	21.0	75.0	75.0	TOP	125189ab-775b-4ecf-b40e-ae6e8afe8704	released												released	30.0	a9f1edf4-9f35-4c85-95cf-cf32b0b0e073	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A5BZ_demographic	77	-28451	835	3053ce37-b702-54bf-a659-84829020c26a	not hispanic or latino	female	white	released	Dead	1932	2011	TCGA-FD-A5BZ_exposure	Not Reported	26.40235457063712		7a410912-d315-5f89-8d90-0215650a9276	152.0		released	61.0	TCGA-FD-A5BZ_diagnosis	28451		MX	N1	Stage IV	T3a	6th	not reported	0		cbfde92d-6569-5ee7-ace7-032fef635189	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iv	2009	TCGA-FD-A5BZ_treatment_1	TCGA-FD-A5BZ_treatment	released	85f2708c-a092-50a8-b020-ad4775a8883a	yes	Pharmaceutical Therapy, NOS	released	6e8fb47d-2e1c-5ef0-acf7-f43b90b94f63	yes	Radiation Therapy, NOS	4d349396-5903-4967-b2cb-cd57ce8503b0
54b3225b-c8ae-4fef-a346-735e6ee576f9.htseq.counts.gz	2f281c50-91e3-409c-b03f-aa6abddc612b	TCGA-FD-A6TC-01A-21R-A33J-07	TCGA-FD-A6TC-01A-21R	TCGA-FD-A6TC-01A-02-TSB		TCGA-FD-A6TC-01A-21	TCGA-FD-A6TC-01A	TCGA-FD-A6TC	00d8e96f-f231-4475-9e9f-c1f8aec28e4e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	139	380.0	False	true	035F00F9-9B4B-4628-829B-D4C1E3219C90	1.9	30f1a64e-5df3-4e26-b820-a4254e7e3a7e			0.17	23	released	53665f82-431c-414b-89c7-af57fd594747	RNA	R	0.17	UV Spec	released	False	45c1849f-ec96-409e-8138-249dc827a8b7	21	4.0	1.0	10.0	2.0	0.0	55.0	35.0	80.0	TOP	ab15913f-56fe-4173-9cd9-c77f5dee4b99	released												released	30.0	cbb32aa6-5088-43dc-8e7f-bcdac17e33ff	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TC_demographic	79	-28963		79dd5297-cbc0-57dc-92ed-2a63c3947116	not hispanic or latino	female	white	released	Alive	1934		TCGA-FD-A6TC_exposure	Not Reported	22.265625	0.547945205479452	ee6837e4-99f6-5576-be9f-8c26f889cb3f	160.0	10.0	released	57.0	TCGA-FD-A6TC_diagnosis	28963	T2	MX	N0	Stage III	T4a	7th	not reported	0	187	1504b84b-3daa-5b16-b701-9853580c2915	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iii	2013	TCGA-FD-A6TC_treatment	TCGA-FD-A6TC_treatment_1	released	135d6557-eea8-5bc4-96b4-48558ce0283d	no	Radiation Therapy, NOS	released	2c130eaa-7f4e-5bb2-ad5a-8fe32227f8f9	yes	Pharmaceutical Therapy, NOS	2f281c50-91e3-409c-b03f-aa6abddc612b
47371d44-7d65-43af-a207-4e25ae47204f.htseq.counts.gz	ceb6ab17-b6ce-4da9-9077-6e4cfe72db3a	TCGA-4Z-AA80-01A-11R-A39I-07	TCGA-4Z-AA80-01A-11R	TCGA-4Z-AA80-01A-01-TS1		TCGA-4Z-AA80-01A-11	TCGA-4Z-AA80-01A	TCGA-4Z-AA80	5df620fa-44d9-4361-91d0-f242e3e5e595	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	612	160.0	False	true	B2F4C3E3-1740-4C76-86A3-51103954FA72	1.88	b76b37cf-c9af-419d-a7c4-f97747de2946			0.17	23	released	8697c48c-0f66-44f9-a77c-5912072ac7f6	RNA	R	0.17	UV Spec	released	False	5951c0ea-12c1-4f17-a644-7dbb08aa4741	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	847570e4-f988-4177-aaf3-21d0e7399ce1	released												released	30.0	c4b78493-09e1-4509-bea2-a86ebc601eb1	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA80_demographic	73	-26873	19	15fd97bf-6d44-5541-8435-84944b30086b	not reported	male	white	released	Dead	1939	2012	TCGA-4Z-AA80_exposure	Not Reported	29.036737785633125		d780ddc7-c256-59ee-ba1b-cba8434ccea5	178.0		released	92.0	TCGA-4Z-AA80_diagnosis	26873	T1	M0	N0	Stage II	T2a	7th	not reported	0		611171be-a1c7-517b-9e9f-0bf5e12d5341	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-4Z-AA80_treatment_1	TCGA-4Z-AA80_treatment	released	62249ea5-5c38-5c2f-b4f6-f9da56a87c32	no	Pharmaceutical Therapy, NOS	released	006e16c7-3b9f-5092-aef7-4b29010c5777	no	Radiation Therapy, NOS	ceb6ab17-b6ce-4da9-9077-6e4cfe72db3a
fd74b13e-34e7-4736-a41d-cc5844441520.htseq.counts.gz	1274623c-3d90-4a0e-8f62-967c08a8c736	TCGA-DK-A3WW-01A-22R-A23N-07	TCGA-DK-A3WW-01A-22R	TCGA-DK-A3WW-01A-02-TSB		TCGA-DK-A3WW-01A-22	TCGA-DK-A3WW-01A	TCGA-DK-A3WW	2ab0fb7b-ad2a-403d-9411-712974ccd878	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	210	880.0	False	true	5EA5657B-39DE-49F8-BFFF-AC48B4491370	1.83	edde0611-3cdb-4f1c-a259-68cb4a905bea			0.17	23	released	5e0533ad-d119-4f4e-b267-1ef8c43fc1db	RNA	R	0.17	UV Spec	released	False	0cf57264-ba4c-4cb5-b416-686cf97d9040	22	15.0	2.0	5.0	8.0	0.0	15.0	80.0	60.0	TOP	17c26aec-2a73-4b1c-8f33-ed634b587407	released												released	30.0	5f78ba36-59d4-475e-9582-df5e361876b5	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3WW_demographic	57	-20909		850d1bbd-c4a1-5b90-96c4-5ab8d877d805	not hispanic or latino	male	white	released	Alive	1954		TCGA-DK-A3WW_exposure	Not Reported	24.569314371603653		498fef97-7870-52f1-985a-0e4679c23a48	186.0		released	85.0	TCGA-DK-A3WW_diagnosis	20909		M0	N0	Stage III	T3	7th	not reported	0	633	eda5667e-cebb-5db4-9c87-a527f84c22d4	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2011	TCGA-DK-A3WW_treatment_1	TCGA-DK-A3WW_treatment	released	ffda01f3-ec68-5b65-a0d2-6eca5bda379a	yes	Pharmaceutical Therapy, NOS	released	ae27b72a-bd6b-5c0f-a90e-2c38da4fb54d	no	Radiation Therapy, NOS	1274623c-3d90-4a0e-8f62-967c08a8c736
23e449b8-2d88-4820-8e5a-e010d0538d0a.htseq.counts.gz	c933655d-9ee5-4753-9eb5-5028958bff33	TCGA-GC-A3WC-11A-11R-A22U-07	TCGA-GC-A3WC-11A-11R	TCGA-GC-A3WC-11A-01-TS1		TCGA-GC-A3WC-11A-11	TCGA-GC-A3WC-11A	TCGA-GC-A3WC	db52c68a-ed44-4ec4-9381-d75f9bcbc29a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	119	80.0	False	false		1.81	2dbb5e17-f331-49be-8bfa-314627ffb8a5			0.17	23	released	2bf965d0-d19c-47a5-8447-9cf7d4286761	RNA	R	0.17	UV Spec	released	False	bc7d512c-2fe0-4182-b37f-8ef9a5b0708d	11	0.0	0.0	0.0	0.0	100.0	0.0	0.0	0.0	TOP	30e967b2-d170-492b-86a6-2b5404a48376	released												released	30.0	67ecde91-9420-41f4-ae8a-5da68d3eeabc	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GC-A3WC_demographic	80	-29295		7733ebc9-dd99-548b-af51-0b802858bec9	not hispanic or latino	female	white	released	Alive	1931		TCGA-GC-A3WC_exposure	Not Reported	26.83518005540166	0.7671232876712328	9b282bb5-c687-54e6-9fdf-f7866ac864ef	152.0	14.0	released	62.0	TCGA-GC-A3WC_diagnosis	29295		MX	N0	Stage III	T3	7th	not reported	0	540	21228792-dd85-5b8a-bf32-a2eae772f41a	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage iii	2011	TCGA-GC-A3WC_treatment	TCGA-GC-A3WC_treatment_1	released	f0b1a770-4d33-5616-ba5d-c42b48b305de	no	Radiation Therapy, NOS	released	9df77109-f5d4-568b-90a5-ba1abf530a29	no	Pharmaceutical Therapy, NOS	c933655d-9ee5-4753-9eb5-5028958bff33
6b49ebfc-983e-415d-bdf9-d55b27e2f0e6.htseq.counts.gz	23233bfa-186c-4fb8-84ef-60498c5ab23a	TCGA-XF-A9SI-01A-11R-A39I-07	TCGA-XF-A9SI-01A-11R	TCGA-XF-A9SI-01A-01-TSA		TCGA-XF-A9SI-01A-11	TCGA-XF-A9SI-01A	TCGA-XF-A9SI	6b0c8e8d-8aba-413d-85ed-631653f00ca9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2855	950.0	False	true	BB424BA5-5E43-410B-B27C-EFBBDE18DA00	1.87	dee47fe6-4c8e-4801-abae-d3a03be1ea8e			0.17	23	released	d51c347a-1803-40b1-9de6-b35648a30c92	RNA	R	0.17	UV Spec	released	False	60f27b8e-c897-42b7-83d8-2cd80649b54d	11	2.0	1.0	0.0	4.0	0.0	20.0	80.0	80.0	TOP	a0ab54ec-fb6c-4b5e-b228-8f55dffc77ca	released												released	30.0	864eca46-7b3f-4ca5-9606-df53bd704130	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A9SI_demographic	73	-26719		1e47c956-c4a8-5c06-bf5b-fd74011c4fcf	not hispanic or latino	female	asian	released	Alive	1933		TCGA-XF-A9SI_exposure	Not Reported	24.919900320398717		802943b3-ca4c-5e3a-8469-d64be80a09e3	159.0		released	63.0	TCGA-XF-A9SI_diagnosis	26719		MX	N0	Stage II	T2b	6th	not reported	0	2423	60f248c8-9142-59ad-bfbf-6484878f0de9	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2006	TCGA-XF-A9SI_treatment_1	TCGA-XF-A9SI_treatment	released	faf230b4-c00e-5467-aad5-648e5571aa78	no	Pharmaceutical Therapy, NOS	released	f0657b09-4a6c-5be3-844b-029de56a30e9	no	Radiation Therapy, NOS	23233bfa-186c-4fb8-84ef-60498c5ab23a
acdae03f-b186-4d3e-8463-f586dac1c2f5.htseq.counts.gz	5dcedd72-0c67-4083-8f9b-233b91e71fea	TCGA-XF-AAMQ-01A-11R-A42T-07	TCGA-XF-AAMQ-01A-11R	TCGA-XF-AAMQ-01A-01-TSA		TCGA-XF-AAMQ-01A-11	TCGA-XF-AAMQ-01A	TCGA-XF-AAMQ	82f4c181-e022-4799-9f7f-01abcdc3803e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2785	570.0	False	true	6A895DCD-0417-4FC1-AE0C-CB72BE55E889	1.9	ab8a3b08-8687-42c2-9c03-ae6691e8a183			0.16	23	released	57208d5a-9ac8-4919-a13d-0902659120f5	RNA	R	0.16	UV Spec	released	False	0d4d7d0e-7822-4aa1-8774-813793dace55	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	69f805f6-877a-4244-9240-ce8c9826bbf6	released												released	30.0	6b4530dd-edd5-4bf5-b6b2-d58177ae6082	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMQ_demographic	59	-21660		b5223c38-aa5d-5f54-8d75-d0db1910f3c9	not hispanic or latino	female	white	released	Alive	1947		TCGA-XF-AAMQ_exposure	Not Reported	30.116213151927436	0.6575342465753424	d95509c9-9d6c-5ff8-a4db-d8ab60a2b300	168.0	12.0	released	85.0	TCGA-XF-AAMQ_diagnosis	21660		MX	N0	Stage II	T2a	6th	not reported	0	2177	e4333026-59ed-5130-b518-b815a012b0e6	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage ii	2006	TCGA-XF-AAMQ_treatment	TCGA-XF-AAMQ_treatment_1	released	45157245-c2a3-556d-8cf1-9b98b95b3c4a	no	Radiation Therapy, NOS	released	7feaa00d-51cc-5496-8783-1c336c1fb8c6	no	Pharmaceutical Therapy, NOS	5dcedd72-0c67-4083-8f9b-233b91e71fea
96edd51f-4101-44d1-b522-8cfbe69f3963.htseq.counts.gz	7ab759b4-b9d7-47e1-b704-1e3a1bec6366	TCGA-K4-A54R-01A-11R-A26T-07	TCGA-K4-A54R-01A-11R	TCGA-K4-A54R-01A-01-TS1		TCGA-K4-A54R-01A-11	TCGA-K4-A54R-01A	TCGA-K4-A54R	52fddd92-fa5e-4fac-8e44-e64c98c84f86	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	224	90.0	False	true	176B5C21-B423-41BE-AFAB-565E58E5404C	1.85	e9acf520-2eb5-4b29-84c8-10ae6c5919e7			0.18	23	released	d0a547b0-aa32-43a7-ad17-764558c57131	RNA	R	0.18	UV Spec	released	False	fae02896-fa59-4021-b729-aef511a12b6c	11	3.0	1.0	0.0	2.0	0.0	20.0	80.0	80.0	TOP	cb16b863-47ac-4bd9-b629-d68ae2e27a1b	released												released	30.0	89b2a25d-6626-4ca8-9dfb-4b8ac8dda1de	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A54R_demographic	59	-21601		7b9988aa-478f-5845-aaca-049569893e03	not hispanic or latino	male	white	released	Alive	1953		TCGA-K4-A54R_exposure	Not Reported			1c0a981b-5db4-57fd-b2d3-78ab3bcfb7d1			released		TCGA-K4-A54R_diagnosis	21601		MX	N0	Stage II	T2b	7th	not reported	0	842	f5941d8f-afdb-53ac-9f94-f6e29471d54d	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage ii	2012	TCGA-K4-A54R_treatment_1	TCGA-K4-A54R_treatment	released	0d158d59-d3ac-52df-b618-2f23884e8b55	no	Pharmaceutical Therapy, NOS	released	40167fe7-9131-5a02-b2ea-30eecbbd5a50	no	Radiation Therapy, NOS	7ab759b4-b9d7-47e1-b704-1e3a1bec6366
2f3d6852-161a-4f58-a4bd-26dc7589c92d.htseq.counts.gz	c099ebf8-3ecc-4ac5-b895-a015ca895d42	TCGA-GV-A3QG-01A-11R-A220-07	TCGA-GV-A3QG-01A-11R	TCGA-GV-A3QG-01A-01-TSA		TCGA-GV-A3QG-01A-11	TCGA-GV-A3QG-01A	TCGA-GV-A3QG	79f23a0e-5aae-4618-8191-7dd7c0552408	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	64	180.0	False	true	60B86A97-E046-40B9-B86E-6498CC6F864B	1.88	d7c8fab5-a3c9-4650-9935-56c0fe27cbe6			0.16	23	released	48090320-86c9-40b5-ae53-38dd0cf99e91	RNA	R	0.16	UV Spec	released	False	418e249a-9707-4a4c-a754-1dc1a78ef6c6	11	10.0	1.0	5.0	1.0	40.0	0.0	55.0	65.0	TOP	8b6e9a66-14dd-4c92-8719-ddf94f4d8895	released												released	30.0	fb9b1639-242f-4019-937f-dd13c40d9c2b	Primary Tumor	01	released	Not Reported	released	TCGA-GV-A3QG_demographic	65	-23847		4bb44c58-e698-5724-b813-cce20ea33af4	not hispanic or latino	male	white	released	Dead	1946		TCGA-GV-A3QG_exposure	Not Reported	23.836734693877553	2.5205479452054793	521991b7-5064-51d7-a3d9-a2c2206e2614	175.0	46.0	released	73.0	TCGA-GV-A3QG_diagnosis	23847		MX	N3	Stage IV	T3a	7th	not reported	0		0419ac74-7b85-57c0-84da-866338f4aa26	C67.4	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage iv	2011	TCGA-GV-A3QG_treatment	TCGA-GV-A3QG_treatment_1	released	571db996-6eb7-5755-943f-1aa53e48e398	no	Radiation Therapy, NOS	released	85e9f634-405c-5619-a625-dfb561828d27	no	Pharmaceutical Therapy, NOS	c099ebf8-3ecc-4ac5-b895-a015ca895d42
334edce0-62d3-40b0-843b-7078c4818151.htseq.counts.gz	c8a41770-cc0e-4ae7-a95f-eb0dfaca1dee	TCGA-DK-A2I4-01A-11R-A21D-07	TCGA-DK-A2I4-01A-11R	TCGA-DK-A2I4-01A-01-TSA		TCGA-DK-A2I4-01A-11	TCGA-DK-A2I4-01A	TCGA-DK-A2I4	5c4aebeb-fb6f-4d66-b24a-89ef20de971e	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3656	320.0	False	true	C521242F-494B-4399-AF73-302A96F3BC48	1.87	4c4fbc19-727b-48b0-82e0-42ca8309f315			0.16	23	released	faf4f89a-9a1f-4780-8a19-e7ba9c7fe79b	RNA	R	0.16	UV Spec	released	False	1d1bffc4-2a60-4770-a9d5-5e80c76f7751	11	4.0	1.0	1.0	2.0	0.0	19.0	80.0	80.0	TOP	175dac33-2b23-41a7-9ec9-1a42319998bb	released												released	30.0	aa0cccc2-14b3-4b88-b42c-25adf1764fe3	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A2I4_demographic	79	-29037		5f85c264-bf20-5480-9ae2-a617a0f1be2b	not hispanic or latino	male	white	released	Alive	1922		TCGA-DK-A2I4_exposure	Not Reported	31.745062727022983		46021ffc-d42b-5e9a-97da-e59de9b5f964	181.0		released	104.0	TCGA-DK-A2I4_diagnosis	29037		M0	N0	Stage III	T3b	6th	not reported	0	3835	a8c90a87-6940-5767-bb23-fe84b30728f1	C67.3	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2001	TCGA-DK-A2I4_treatment_1	TCGA-DK-A2I4_treatment	released	99589c36-6fe8-5e0e-a542-73831d658701	no	Pharmaceutical Therapy, NOS	released	d09d4d7e-e1db-5648-b4ff-041cf649e05f	no	Radiation Therapy, NOS	c8a41770-cc0e-4ae7-a95f-eb0dfaca1dee
063df1ef-c033-465b-b0ec-1ed202005968.htseq.counts.gz	adaa63b6-0e33-4231-907c-a8806434bde6	TCGA-FD-A6TK-01A-42R-A33J-07	TCGA-FD-A6TK-01A-42R	TCGA-FD-A6TK-01A-04-TSD		TCGA-FD-A6TK-01A-42	TCGA-FD-A6TK-01A	TCGA-FD-A6TK	65295450-36cd-45a7-a4a6-2d52ee11378f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	59	390.0	False	true	74DA50BD-1762-42A2-84A3-637C8C1D435B	1.9	842484b0-6661-4dc2-bf70-b1216ab05475			0.17	23	released	1bb698b4-9cc4-4a1f-9e77-bd394b0e3fb6	RNA	R	0.17	UV Spec	released	False	64dd5467-9f6a-4c1b-bd96-50de3f120d2a	42	4.0	0.0	0.0	0.0	25.0	0.0	75.0	75.0	TOP	d05aacd0-14ab-455c-9769-362a9326f72d	released												released	30.0	290dcc7f-5957-4fe7-9e6a-32daeb18fe69	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A6TK_demographic	60	-21942		16269f6c-28e4-5842-a157-66289ff89a02	not hispanic or latino	male	white	released	Alive	1953		TCGA-FD-A6TK_exposure	Not Reported	22.189349112426033	0.821917808219178	10550f9f-16da-51a2-9df4-d626ea45dd56	156.0	15.0	released	54.0	TCGA-FD-A6TK_diagnosis	21942	T2	MX	N0	Stage III	T3a	7th	not reported	0	330	ff8d8bce-6d2f-5be5-a555-adba024968d6	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iii	2013	TCGA-FD-A6TK_treatment_1	TCGA-FD-A6TK_treatment	released	e08124ba-349c-5fb3-992a-f988ba2aa0dd	no	Pharmaceutical Therapy, NOS	released	dd9f8d6f-398d-57d6-aa2b-b30d797eef6d	no	Radiation Therapy, NOS	adaa63b6-0e33-4231-907c-a8806434bde6
e730b796-61b4-4dc2-8319-f9c08f42d189.htseq.counts.gz	40f94a7b-3088-4511-bc18-084b4b2e4491	TCGA-E7-A678-01A-11R-A30C-07	TCGA-E7-A678-01A-11R	TCGA-E7-A678-01A-01-TSA		TCGA-E7-A678-01A-11	TCGA-E7-A678-01A	TCGA-E7-A678	29c52372-d3a7-4188-b468-67c3451c4f20	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	104	950.0	False	true	21E3AC3F-5CD6-4E9F-8583-B21642258D07	1.89	4e0401b2-6ad4-4709-aa43-f2af0afef259			0.16	23	released	9ceff607-d3ec-47a0-93b5-7001d2c46ae8	RNA	R	0.16	UV Spec	released	False	e178dd4a-ab64-451c-b582-6536c330e569	11	1.0	0.0	1.0	0.0	0.0	14.0	85.0	95.0	TOP	8236a2e4-966e-4927-908a-b1846401ef30	released												released	30.0	64ed8359-fb2a-4403-b863-7d5988df5ffe	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A678_demographic	55	-20169		62593d25-9ab1-5777-9673-058018ce4b5e	not hispanic or latino	male	asian	released	Alive	1957		TCGA-E7-A678_exposure	Not Reported	21.484375	1.36986301369863	41cd2c39-21dc-5d85-b4fe-a1dbb90aadf1	160.0	25.0	released	55.0	TCGA-E7-A678_diagnosis	20169		M0	N0	Stage III	T3	7th	not reported	0	798	da7de5b6-726b-5429-a97f-25f3e712d4c0	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-E7-A678_treatment	TCGA-E7-A678_treatment_1	released	e6b3c6c7-10d0-5d6d-80b7-a10624d15beb	no	Radiation Therapy, NOS	released	53d3384f-38fc-55fe-9ac7-1763c162955b	no	Pharmaceutical Therapy, NOS	40f94a7b-3088-4511-bc18-084b4b2e4491
3b54924c-24e6-4cad-a930-f5450ec8de23.htseq.counts.gz	46685719-3558-40dc-a1c6-ef21b94b5537	TCGA-K4-A5RH-01A-11R-A30C-07	TCGA-K4-A5RH-01A-11R	TCGA-K4-A5RH-01A-01-TSA		TCGA-K4-A5RH-01A-11	TCGA-K4-A5RH-01A	TCGA-K4-A5RH	eeca58fe-b5cb-4d13-a93f-a5a2ca00b6e2	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	221	720.0	False	true	60531FDD-78B7-4DAF-8B6F-ED9C4D6AA2BB	1.94	a83e6d94-8bef-4ffe-889a-2eecc4b97cae			0.17	23	released	e7be7030-ec96-46c8-8ef2-adb3020090a7	RNA	R	0.17	UV Spec	released	False	621e081d-ada9-4310-9c4a-a595695818b7	11	25.0	3.0	2.0	3.0	0.0	63.0	35.0	65.0	TOP	9ab414a4-65f5-4338-b555-27a5c6683bb8	released												released	30.0	a4acab2e-d8f9-41ab-8e03-d3580221d2af	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A5RH_demographic	69	-25305		cd343414-c714-5de6-acde-61a23298d906	not hispanic or latino	male	white	released	Alive	1943		TCGA-K4-A5RH_exposure	Not Reported		2.191780821917808	162d0a26-f1c5-5ce2-9872-7a96a2b4205a		40.0	released		TCGA-K4-A5RH_diagnosis	25305	TX	MX	N0	Stage III	T3a	7th	not reported	0	276	9d47c8ce-f23c-5f8a-a8f1-efc3e2ddb2aa	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2012	TCGA-K4-A5RH_treatment	TCGA-K4-A5RH_treatment_1	released	2fe945af-e2c9-5c95-b94b-5ab41bc1010f	yes	Radiation Therapy, NOS	released	e7194958-481e-5e40-bb68-34cc3cc7e0bc	no	Pharmaceutical Therapy, NOS	46685719-3558-40dc-a1c6-ef21b94b5537
706aa79b-34a0-4577-95bf-3fdfae5b54cb.htseq.counts.gz	2de27ff7-4722-42ea-9934-ae9b57372984	TCGA-XF-A8HC-01A-11R-A36F-07	TCGA-XF-A8HC-01A-11R	TCGA-XF-A8HC-01A-01-TSA		TCGA-XF-A8HC-01A-11	TCGA-XF-A8HC-01A	TCGA-XF-A8HC	17ee3278-dc2a-4021-a903-e4ed11e3218b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	3146	640.0	False	true	A2FF709D-B1C0-4287-BB27-0F96F81BA2CD	1.81	bd8b95cf-34c9-4bc1-98fd-6c7e1c20680b			0.18	23	released	2a3723a5-dce9-4e81-8ca9-c2bd0592a47c	RNA	R	0.18	UV Spec	released	False	80a274f6-b8a4-4039-8cdb-d0d7d011ee91	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	bc00069b-6260-4123-9fa3-57d5cf21155c	released												released	30.0	19aa5ad0-f253-4837-8f04-a21dacb7cf15	Primary Tumor	01	released	Not Reported	released	TCGA-XF-A8HC_demographic	79	-28996	200	07994a93-1031-510f-8e64-165ea28acfbc	not hispanic or latino	male	asian	released	Dead	1926	2005	TCGA-XF-A8HC_exposure	Not Reported	24.835763499439192		73e2bb18-2911-59e1-88df-f2413b4c05c2	158.0		released	62.0	TCGA-XF-A8HC_diagnosis	28996		MX	N2	Stage IV	T3a	6th	not reported	0		b500cdf9-89f4-59bd-856d-2c1f011e34e2	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2005	TCGA-XF-A8HC_treatment	TCGA-XF-A8HC_treatment_1	released	7bece475-32b6-5b67-ba52-0eeee9656beb	no	Radiation Therapy, NOS	released	705733ee-9dc1-5fe4-9afb-a1263f6e7311	no	Pharmaceutical Therapy, NOS	2de27ff7-4722-42ea-9934-ae9b57372984
18c4e21e-2f12-4d7f-a0d7-85d812eccce6.htseq.counts.gz	dd33589c-d157-4249-b8d5-b780f255e344	TCGA-BT-A20T-01A-11R-A14Y-07	TCGA-BT-A20T-01A-11R	TCGA-BT-A20T-01A-01-TSA		TCGA-BT-A20T-01A-11	TCGA-BT-A20T-01A	TCGA-BT-A20T	096b4f32-10c1-4737-a0dd-cae04c54ee33	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1464	190.0	False	true	6DCDDE73-580E-46FF-9A06-39A85EB4830A	1.78	22e154de-0e3b-443b-8420-48d68d6c1ce4			0.15	23	released	f18b480a-aa34-4e27-a32e-8d98507d99e9	RNA	R	0.15	UV Spec	released	False	282d2321-3d7e-4857-9b4e-80048d58960c	11	3.0	0.0	0.0	0.0	0.0	25.0	75.0	75.0	TOP	aa2eb218-f0b5-49fc-b812-83c09ce3a2fc	released												released	30.0	52f538ef-b05d-4c76-9976-ce6d49158016	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20T_demographic	63	-23220	453	26e381eb-438b-5c6e-b6e2-81a02b8f11ce	not hispanic or latino	male	white	released	Dead	1944	2008	TCGA-BT-A20T_exposure	Not Reported			b8354084-2137-5f35-ac5e-74ab38266bc4			released		TCGA-BT-A20T_diagnosis	23220	T3	M0	N1	Stage IV	T3b	6th	not reported	0		69f0c76e-6297-5ea9-b271-f999d1e37aa9	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage iv	2007	TCGA-BT-A20T_treatment	TCGA-BT-A20T_treatment_1	released	9f163616-5816-51a2-ae67-f5cc971bef4a	no	Radiation Therapy, NOS	released	8c8ac181-b82e-5221-82e9-3812d0987529	yes	Pharmaceutical Therapy, NOS	dd33589c-d157-4249-b8d5-b780f255e344
4f2319b7-fdfb-4682-bb16-f86ba1a8fac9.htseq.counts.gz	4cde544f-6cb6-4d53-b01f-633b85d9ba62	TCGA-CU-A5W6-01A-11R-A28M-07	TCGA-CU-A5W6-01A-11R	TCGA-CU-A5W6-01A-01-TS1		TCGA-CU-A5W6-01A-11	TCGA-CU-A5W6-01A	TCGA-CU-A5W6	7a7fcdd3-cce9-47cf-a26f-cc6ff34ecd9a	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	133	300.0	False	false	16450945-2661-4167-84D2-9469077B4CDD	1.82	168e440a-b356-45c7-849c-43823703417e			0.18	23	released	3085b587-1d90-4a5c-a908-40b33b2ad462	RNA	R	0.18	UV Spec	released	False	59411bbe-ce41-48a8-8311-6ce980cb9825	11	0.0	0.0	5.0	0.0	0.0	15.0	80.0	85.0	TOP	bbd5c09e-d74a-4018-84ff-8595be6680aa	released												released	30.0	ca04ec9f-df17-4a7c-ac61-3f9ac4d8e546	Primary Tumor	01	released	Not Reported	released	TCGA-CU-A5W6_demographic	70	-25706	56	6cc76257-654d-5505-bd39-65c43f53f900	not hispanic or latino	male	white	released	Dead	1942	2012	TCGA-CU-A5W6_exposure	Not Reported	26.448979591836736	2.0273972602739727	511f6f37-099b-55af-b9da-1b34d375b4b0	175.0	37.0	released	81.0	TCGA-CU-A5W6_diagnosis	25706		M0	N0	Stage III	T4a	7th	not reported	0		e3d3288c-fd62-5f04-aee1-0e23f4bd5ce9	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2012	TCGA-CU-A5W6_treatment_1	TCGA-CU-A5W6_treatment	released	aba40ce7-6e6f-5bb6-a43f-2102128b0303	no	Pharmaceutical Therapy, NOS	released	267e8e72-081d-5980-a9b5-fcbd7e31ee44	no	Radiation Therapy, NOS	4cde544f-6cb6-4d53-b01f-633b85d9ba62
a29ce333-9dd6-4026-9ee4-98674fcea032.htseq.counts.gz	a522398d-a7b7-439b-81ca-da06551d57c7	TCGA-CF-A47Y-01A-11R-A23W-07	TCGA-CF-A47Y-01A-11R	TCGA-CF-A47Y-01A-01-TSA		TCGA-CF-A47Y-01A-11	TCGA-CF-A47Y-01A	TCGA-CF-A47Y	9bcff619-f75a-4aa4-9e09-2e9aa7b59225	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	130	500.0	False	true	67559C16-8825-456D-8C4B-927C1004F6E2	1.89	0c1e7ecc-d20d-4047-8419-6347537cb8a3			0.17	23	released	fc326e04-4ba3-472a-b2ed-3cf7cb2f0be9	RNA	R	0.17	UV Spec	released	False	73368f94-574f-408a-8662-9f023306d0ac	11	0.0	0.0	0.0	0.0	0.0	5.0	95.0	99.0	TOP	6051e23d-dd52-4053-8e21-ea9de229df77	released												released	30.0	9e5dc3cf-b6f8-4eca-9637-55c100a78168	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A47Y_demographic	55	-20432		d07cfccf-8ca6-5524-9ca6-00835a9c48fe	not hispanic or latino	male	asian	released	Alive	1957		TCGA-CF-A47Y_exposure	Not Reported	23.52941176470588		abc10572-2d6a-56f1-ab8e-5e22828e0573	170.0		released	68.0	TCGA-CF-A47Y_diagnosis	20432	T2	M0	N0	Stage II	T2	7th	not reported	0	373	2204daae-3aed-5866-b5d1-e74d4ab193a4	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2012	TCGA-CF-A47Y_treatment	TCGA-CF-A47Y_treatment_1	released	f0fb3033-3b8e-5f38-baab-215794dcee8e	no	Radiation Therapy, NOS	released	1eaa1918-1d04-5c4e-b264-5005d83384d1	no	Pharmaceutical Therapy, NOS	a522398d-a7b7-439b-81ca-da06551d57c7
31365cc1-6425-4966-98b4-0eb1af4578ec.htseq.counts.gz	e1ce8aa6-9ed2-4858-aa3d-7b05d9900145	TCGA-UY-A78K-01A-11R-A33J-07	TCGA-UY-A78K-01A-11R	TCGA-UY-A78K-01A-01-TSA		TCGA-UY-A78K-01A-11	TCGA-UY-A78K-01A	TCGA-UY-A78K	5f587f1b-f835-4869-9e6d-8cb3b9e0610b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		160.0	False	true	5A6AB084-6B3E-4C9F-9DD6-E055376EF290	1.84	d31897c3-5d0a-4104-bdc6-4b12eb061c2a			0.16	23	released	681de444-6e29-4394-a767-375a20b481d7	RNA	R	0.16	UV Spec	released	False	eae1d53d-12ab-42e2-8eae-ef0fb3a73e17	11	5.0	1.0	1.0	4.0	0.0	29.0	70.0	70.0	TOP	64cfe29c-7661-41b2-bdc3-e6a7f576cb73	released												released	30.0	5a08f98a-0f35-49b2-991b-ef2764246e18	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A78K_demographic	60	-22020	536	298ae07c-aac4-55db-8b9d-130a47fc7b44	not hispanic or latino	male	white	released	Dead			TCGA-UY-A78K_exposure	Not Reported			4da7cbb9-3f76-5b8a-9943-5dac74eb9053			released	65.0	TCGA-UY-A78K_diagnosis	22020	T2	MX	N2	Stage IV		6th	not reported	0		c9cd61f9-d42f-5421-b426-7691935a5890	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-UY-A78K_treatment_1	TCGA-UY-A78K_treatment	released	012b49d6-93f0-5030-8b20-8bde74f63608	not reported	Pharmaceutical Therapy, NOS	released	f762be0e-43e6-5475-b94f-d799281c4ac1	not reported	Radiation Therapy, NOS	e1ce8aa6-9ed2-4858-aa3d-7b05d9900145
f86397e1-1ae1-4868-8999-3b9f9b74b80d.htseq.counts.gz	34a63e13-20be-4270-b85b-74106538e431	TCGA-BT-A20N-11A-11R-A14Y-07	TCGA-BT-A20N-11A-11R	TCGA-BT-A20N-11A-01-TSA		TCGA-BT-A20N-11A-11	TCGA-BT-A20N-11A	TCGA-BT-A20N	ebedab7c-dd7c-448e-8324-78c86f13be8b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2955	160.0	False	true		1.83	5231c5c8-f25b-4d0d-b7e3-14df112ccd7c			0.16	23	released	9d796185-66fe-435c-8704-a0ee9acc0f80	RNA	R	0.16	UV Spec	released	False	59b604e2-ba76-4e43-9d70-3e8faacf6332	11	5.0	0.0	0.0	0.0	0.0	100.0	0.0	0.0	TOP	e8d64445-7e5e-44b7-8500-bf3c69fa001e	released												released	30.0	753c9421-02be-4ecd-9f8e-5dbb4fe72c38	Solid Tissue Normal	11	released	Not Reported	released	TCGA-BT-A20N_demographic	72	-26456	795	19cba497-5f32-5c6a-8ef2-50b0de719c44	not reported	male	not reported	released	Dead	1931	2005	TCGA-BT-A20N_exposure	Not Reported		2.73972602739726	b0e05c8d-317a-5480-9e48-5646995635bd		50.0	released		TCGA-BT-A20N_diagnosis	26456	T3a	MX	N0	Stage III	T3a	6th	not reported	0		db4cb9dd-289a-52ba-8ab0-aa66f8f94b0e	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iii	2003	TCGA-BT-A20N_treatment	TCGA-BT-A20N_treatment_1	released	65668751-80ea-58a2-821a-7ca63a54d40b	no	Radiation Therapy, NOS	released	e74f1e5d-9aa3-59a0-a798-ba90ced221f8	yes	Pharmaceutical Therapy, NOS	34a63e13-20be-4270-b85b-74106538e431
9eea9c04-9172-42cc-b38b-78c9740601ab.htseq.counts.gz	ffe2d991-3481-4f3b-aa88-11c5457074cd	TCGA-E7-A7DU-01A-11R-A32O-07	TCGA-E7-A7DU-01A-11R	TCGA-E7-A7DU-01A-01-TSA		TCGA-E7-A7DU-01A-11	TCGA-E7-A7DU-01A	TCGA-E7-A7DU	6f30b069-c8f5-424c-9fb5-f7dba508cb8b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	149	1470.0	False	true	BEB0E95C-EDF2-40A5-BB95-588D07369CEE	1.93	c87fa518-41c5-417a-88ac-0b300f1a8732			0.18	23	released	365e541d-81f0-4903-8b60-41cd81d5ce86	RNA	R	0.18	UV Spec	released	False	d74b22d6-b796-413d-b327-76c5e6a7a669	11	3.0	0.0	12.0	0.0	0.0	20.0	68.0	95.0	TOP	6c57a327-fd34-446c-b528-17ab52827881	released												released	30.0	784e85bb-9c4c-44b4-8bfc-3b2dbc1406c8	Primary Tumor	01	released	Not Reported	released	TCGA-E7-A7DU_demographic	73	-27000		a7e56a23-b7a5-59dd-a049-730b9924ee75	not hispanic or latino	male	white	released	Alive	1940		TCGA-E7-A7DU_exposure	Not Reported	36.753650305723546		04b1cdd9-2490-5ac7-9491-73c8a9d173ae	173.0		released	110.0	TCGA-E7-A7DU_diagnosis	27000		M0	N0	Stage III	T3	7th	not reported	0	28	1db2c719-b22c-54bb-809a-1a64f7fd1b17	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iii	2013	TCGA-E7-A7DU_treatment_1	TCGA-E7-A7DU_treatment	released	dd1331a3-a7ff-5437-ae02-56f1cdb23934	not reported	Pharmaceutical Therapy, NOS	released	a1b69d08-b4f5-5df8-a98c-5a7bce3023fb	no	Radiation Therapy, NOS	ffe2d991-3481-4f3b-aa88-11c5457074cd
524c7b57-49a6-4bd4-b095-d52172d10c1e.htseq.counts.gz	cfe9392a-dcac-4ead-a431-424fcad599bd	TCGA-XF-AAMT-01A-11R-A42T-07	TCGA-XF-AAMT-01A-11R	TCGA-XF-AAMT-01A-01-TSA		TCGA-XF-AAMT-01A-11	TCGA-XF-AAMT-01A	TCGA-XF-AAMT	ada95115-275f-4229-aa00-f298a5ff931c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2680	800.0	False	true	DDAC8877-7594-4939-B98F-0BAB7D3CDBB9	1.92	72dcc6a3-c2ce-4e24-897d-880a0f01c1aa			0.17	23	released	cedaa6cb-0ed9-4e1e-8c66-327fc9c1759f	RNA	R	0.17	UV Spec	released	False	dfe7382b-09d2-4d5b-916c-3529bbf4f972	11	3.0	0.0	0.0	0.0	0.0	0.0	100.0	65.0	TOP	6297ae31-a25d-4323-93d5-b0acaa1f101f	released												released	30.0	ea2028dc-8a2f-4eca-84a5-cd403ce100d4	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMT_demographic	75	-27397	90	86cacaa3-e7e7-5ce2-92eb-2b5679e45c1d	not hispanic or latino	female	white	released	Dead	1931	2006	TCGA-XF-AAMT_exposure	Not Reported	23.4375	0.547945205479452	30a5b9cd-a78a-5311-ae40-768a6dee488e	160.0	10.0	released	60.0	TCGA-XF-AAMT_diagnosis	27397		MX	N2	Stage IV	T3b	5th	not reported	0		19210462-2a67-589c-943d-a96ff667f2a5	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-AAMT_treatment	TCGA-XF-AAMT_treatment_1	released	c1bb5cab-b4bb-55d2-bad4-d0f5781ff7fe	no	Radiation Therapy, NOS	released	fa8088f2-f389-5e2b-8e4b-1fd0275127e2	no	Pharmaceutical Therapy, NOS	cfe9392a-dcac-4ead-a431-424fcad599bd
6c0d24b4-b01c-4262-bf0d-60a4c4c11087.htseq.counts.gz	f96c0a94-5c7c-4196-ac32-817b4b659857	TCGA-FD-A3SJ-01A-12R-A22U-07	TCGA-FD-A3SJ-01A-12R	TCGA-FD-A3SJ-01A-01-TSA		TCGA-FD-A3SJ-01A-12	TCGA-FD-A3SJ-01A	TCGA-FD-A3SJ	6d8d8169-0c1a-4cdb-be6f-9761c981a369	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	785	670	False	true	58C20FBF-E737-4DA9-9602-AAF4D483371A	1.84	b8afe780-f680-40db-a941-e984660ff90c	2.08	13	0.16	23	released	76bdaa1a-1373-45cc-abab-d08d12fc9dec	RNA	R	0.16	UV Spec	released	False	92eca0cc-76ef-4fcb-84ba-8147c46bc121	12	5	0	5	0	0	25	70	75	TOP	803ac669-8128-45d9-b770-82d3d0680d56	released												released	30	491a8898-7cc5-45d9-9502-fd24399c239d	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SJ_demographic	59	-21615	739	8a3fd71d-526b-57cc-9212-58fa6696b013	not hispanic or latino	male	white	released	Dead	1951	2012	TCGA-FD-A3SJ_exposure	Not Reported	24.933720489837143	2.191780821917808	431d80e3-0cca-5b2c-945f-d8209e67d5bc	178.0	40.0	released	79.0	TCGA-FD-A3SJ_diagnosis	21615		MX	N2	Stage IV	T2b	7th	not reported	0		4c40bb6d-f81c-5117-aeaf-58e1a98bf402	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage iv	2010	TCGA-FD-A3SJ_treatment	TCGA-FD-A3SJ_treatment_1	released	4e1f536f-1694-5e44-bbc3-ae07b3eb528a	no	Radiation Therapy, NOS	released	92817873-291e-534d-83b4-cd002a7e0e0b	yes	Pharmaceutical Therapy, NOS	f96c0a94-5c7c-4196-ac32-817b4b659857
08f9bace-d0fa-4dc3-b181-d805799af58d.htseq.counts.gz	2e20dad0-4322-4fff-a2a8-dba1f22cb430	TCGA-GU-A764-01A-11R-A352-07	TCGA-GU-A764-01A-11R	TCGA-GU-A764-01A-01-TSA		TCGA-GU-A764-01A-11	TCGA-GU-A764-01A	TCGA-GU-A764	20ebeff1-e5a7-423a-be93-e7ebb82438ac	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	232	140.0	False	true	55AD4C75-61D8-4377-A4F0-1311CFD6ACA8	1.88	7fe70e80-a35e-4a3d-bfb5-e044aec3e6a2			0.17	23	released	e4bf8881-c227-4fa7-99de-62797d835c82	RNA	R	0.17	UV Spec	released	False	34de8ce4-9ed8-4fc8-97d1-4e35c5237aec	11	0.0	0.0	0.0	0.0	0.0	40.0	60.0	70.0	TOP	8dfc4c9b-24d1-4e25-98f6-55693b763062	released												released	30.0	3d503261-c0d3-473a-b9cc-498e78f00da1	Primary Tumor	01	released	Not Reported	released	TCGA-GU-A764_demographic	66	-24343		2a07a7a0-456e-5cee-9039-5523d1d8db86	not hispanic or latino	male	white	released	Alive	1946		TCGA-GU-A764_exposure	Not Reported	22.03840115928028	1.0410958904109588	29dda733-921d-5056-b9fa-1db9b8cbc251	182.0	19.0	released	73.0	TCGA-GU-A764_diagnosis	24343		MX	N0	Stage II	T2b	7th	not reported	0	610	a62df349-1b22-5c11-a6a3-e95f5d601e7b	C67.3	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Anterior wall of bladder	released	No	Anterior wall of bladder	not reported	stage ii	2012	TCGA-GU-A764_treatment_1	TCGA-GU-A764_treatment	released	55010079-d445-5890-bd5f-a6dca7e94404	no	Pharmaceutical Therapy, NOS	released	732acc2c-2fd4-5d76-a2c8-d53793224261	no	Radiation Therapy, NOS	2e20dad0-4322-4fff-a2a8-dba1f22cb430
679c8a49-57eb-4462-9940-0ad964135a3b.htseq.counts.gz	18a7a182-63af-4f73-bba6-1b81660c2195	TCGA-K4-A5RI-11A-11R-A28M-07	TCGA-K4-A5RI-11A-11R	TCGA-K4-A5RI-11A-01-TS1		TCGA-K4-A5RI-11A-11	TCGA-K4-A5RI-11A	TCGA-K4-A5RI	32efe5e2-e037-4547-8ead-619f61647639	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	100	230.0	False	true		1.87	74ba151c-f3c8-4f11-8940-1cefb87570a7			0.18	23	released	a03d20b6-a88f-4c3e-9ddc-00e17422eea6	RNA	R	0.18	UV Spec	released	False	8e05f488-cf38-4d95-b9da-207ca6dfd324	11	20.0	2.0	0.0	3.0	8.0	92.0	0.0	0.0	TOP	a8937da1-6b55-45e8-8cbe-450d01c0bced	released												released	30.0	c7d68b77-e250-42e7-8bad-987843191eea	Solid Tissue Normal	11	released	Not Reported	released	TCGA-K4-A5RI_demographic	67	-24614	356	03b0ba6d-583e-5e7b-b611-c822b816ef26	not hispanic or latino	female	white	released	Dead	1945		TCGA-K4-A5RI_exposure	Not Reported		2.191780821917808	f1fd650a-d554-5859-9681-e6814a58566c		40.0	released		TCGA-K4-A5RI_diagnosis	24614	TX	MX	N0	Stage III	T3a	7th	not reported	0	239	44e07161-3e32-5449-b116-b12631536330	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-K4-A5RI_treatment_1	TCGA-K4-A5RI_treatment	released	569c1f76-4670-546f-9663-a029a5d04723	no	Pharmaceutical Therapy, NOS	released	3a1070e8-5108-59d7-86ab-bb62a29c1f78	no	Radiation Therapy, NOS	18a7a182-63af-4f73-bba6-1b81660c2195
69ddc270-f711-46e0-ae55-a3eb0a50fc9f.htseq.counts.gz	f6579850-7988-48f1-b3bb-d9fa4908bb3d	TCGA-2F-A9KW-01A-11R-A38B-07	TCGA-2F-A9KW-01A-11R	TCGA-2F-A9KW-01A-01-TS1		TCGA-2F-A9KW-01A-11	TCGA-2F-A9KW-01A	TCGA-2F-A9KW	3b464065-b2e9-4fb2-a7da-09e963fd43b3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	56	40.0	False	false	C4DACE91-4ED5-4259-9C31-F1C118E40AAE	1.83	88275e49-b282-414c-a941-9a77b991ff16			0.15	23	released	f6404e36-d0d8-4401-83fc-2de38c84f08b	RNA	R	0.15	UV Spec	released	False	21006a7a-6721-46c2-860b-2e9d0265d444	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	ee9c61ed-da21-4574-841b-cf5075e3aa85	released												released	30.0	0ed8d2ee-d9bb-488c-ab40-1e9b43d5b9c9	Primary Tumor	01	released	Not Reported	released	TCGA-2F-A9KW_demographic	67	-24703	254	5c474310-9761-509f-9524-5164e2adf1be	not hispanic or latino	female	white	released	Dead	1946		TCGA-2F-A9KW_exposure	Not Reported	25.099501595611173		09b4cfc0-2829-515d-be09-60728bde579b	167.0		released	70.0	TCGA-2F-A9KW_diagnosis	24703	T2	MX	N0	Stage III	T3b	7th	not reported	0	147	c395b656-525c-5361-9ed0-36c1b54b701b	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2013	TCGA-2F-A9KW_treatment_1	TCGA-2F-A9KW_treatment	released	374440d2-021a-5889-bb21-1d63d0cddc7f	no	Pharmaceutical Therapy, NOS	released	965808fe-3077-51b5-9efb-6e2c75a4d9c1	yes	Radiation Therapy, NOS	f6579850-7988-48f1-b3bb-d9fa4908bb3d
4b68dd95-805d-42cc-a1e8-9bb64e29f9f5.htseq.counts.gz	75335a2a-0938-4119-83cd-08d68af9135d	TCGA-4Z-AA81-01A-11R-A39I-07	TCGA-4Z-AA81-01A-11R	TCGA-4Z-AA81-01A-01-TS1		TCGA-4Z-AA81-01A-11	TCGA-4Z-AA81-01A	TCGA-4Z-AA81	35c7bb8a-7b5c-488d-9d3a-725b24d14478	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1400	300.0	False	true	715A2080-BE4D-4A75-B7A7-C68FD032997E	1.89	db105bbd-3501-4916-b032-dd3480038d55			0.18	23	released	1cecdf5f-af52-4d07-9dd3-97fb589fc3a4	RNA	R	0.18	UV Spec	released	False	a1dd2010-88c2-4e2a-af2c-0e15127e8f0d	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	75.0	TOP	162bea3f-faff-40c0-aa1f-0b32ae9d88b1	released												released	30.0	75b242d6-392c-478f-b787-9e1da640ac33	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA81_demographic	80	-29457	1270	77ade13c-d244-5ca5-ad94-89495832f3e5	not reported	male	white	released	Dead	1930		TCGA-4Z-AA81_exposure	Not Reported	26.98961937716263		4edf9bb9-6e03-5621-9f71-34df79015492	170.0		released	78.0	TCGA-4Z-AA81_diagnosis	29457	T2	M0	N0	Stage II	T2b	7th	not reported	0	710	daa94ab6-eeb8-58d0-b01b-0d95d3819477	C67.4	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage ii	2010	TCGA-4Z-AA81_treatment_1	TCGA-4Z-AA81_treatment	released	4f6a0652-bb09-5968-a30e-9639e5e24a68	no	Pharmaceutical Therapy, NOS	released	c30eb50a-4f6b-583e-bdde-87f3cb8ae00c	no	Radiation Therapy, NOS	75335a2a-0938-4119-83cd-08d68af9135d
5c875572-a75a-411a-89e3-6eac50a72648.htseq.counts.gz	13d4d305-37a8-46ef-9c58-a57aafa6e49d	TCGA-ZF-AA54-01A-11R-A39I-07	TCGA-ZF-AA54-01A-11R	TCGA-ZF-AA54-01A-01-TS1		TCGA-ZF-AA54-01A-11	TCGA-ZF-AA54-01A	TCGA-ZF-AA54	bca645ae-a0c9-4005-b672-85d8920b6afb	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1472	180.0	False	true	6B1A202D-C715-4495-9F28-0235F69BF983	1.9	b7db14a4-5268-44e5-aed1-7200c6c82a2d			0.17	23	released	16ea6a7e-0c8b-4098-be58-b95476aece9e	RNA	R	0.17	UV Spec	released	False	e892a6cf-b92f-4ef2-a7a7-9f75c8598b8b	11	0.0	0.0	0.0	0.0	0.0	10.0	90.0	95.0	TOP	6687b3cc-1f78-4ea6-bf93-d723b169f294	released												released	30.0	52097937-cbcb-43f8-a505-9b4da32d5c6a	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-AA54_demographic	71	-26128	590	4d063a70-c565-5e1b-a419-a42974051666	not hispanic or latino	male	white	released	Dead	1938	2010	TCGA-ZF-AA54_exposure	Not Reported	28.36035152830783		f66634b5-3a9e-5a30-9fad-6c711e46aed1	169.0		released	81.0	TCGA-ZF-AA54_diagnosis	26128	T2	MX	NX	Stage III	T3	6th	not reported	0		141868ea-a625-559a-948b-4ef6d621f2b2	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2009	TCGA-ZF-AA54_treatment_1	TCGA-ZF-AA54_treatment	released	a72e7618-ba23-5a6f-997e-531f821884f3	not reported	Pharmaceutical Therapy, NOS	released	3848321b-937f-5ca9-8df7-06ed746bd70a	not reported	Radiation Therapy, NOS	13d4d305-37a8-46ef-9c58-a57aafa6e49d
c5047f59-c194-4cb9-9538-9d06d0946d64.htseq.counts.gz	18a7a30e-208f-4860-847a-2ce3ad7dcaf4	TCGA-CF-A3MF-01A-12R-A21D-07	TCGA-CF-A3MF-01A-12R	TCGA-CF-A3MF-01A-01-TSA		TCGA-CF-A3MF-01A-12	TCGA-CF-A3MF-01A	TCGA-CF-A3MF	1e308b12-0590-4dae-94d0-a539fcf25df7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	165	430.0	False	true	D7C5EE9B-98F3-46C1-A568-F989E97ABFCC	1.78	429f0e9d-c160-4b36-a31b-dab1097c6129			0.17	23	released	3ba2c2c4-9c7f-407c-9779-397d307efa59	RNA	R	0.17	UV Spec	released	False	635f1c12-6dcd-44d7-b6be-d1c978453c48	12	2.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	TOP	47d11180-87d1-468a-8d89-bb57ed67931b	released												released	20.0	e9889071-4c6e-4761-9d65-06c6b5989fb7	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A3MF_demographic	34	-12557		4d6c4911-68b9-5d6f-b845-31b091647b9f	not hispanic or latino	male	asian	released	Alive	1977		TCGA-CF-A3MF_exposure	Not Reported			24689bf1-f120-5825-8a54-4e3aef464474			released		TCGA-CF-A3MF_diagnosis	12557		M0	N0	Stage III	T3	7th	not reported	0	383	ff8e0376-b6bf-5574-860f-a50585cfba83	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iii	2011	TCGA-CF-A3MF_treatment	TCGA-CF-A3MF_treatment_1	released	1b7be257-495e-54a6-bd15-d4c17c2ae063	yes	Radiation Therapy, NOS	released	6c59181d-b6ed-5ed2-abcd-63b0108caa6b	no	Pharmaceutical Therapy, NOS	18a7a30e-208f-4860-847a-2ce3ad7dcaf4
b719e8c8-3c22-4822-b551-c1b337704d99.htseq.counts.gz	bfaf12cb-849a-499f-a4d8-5fa987b5b66d	TCGA-FD-A3SS-01A-12R-A22U-07	TCGA-FD-A3SS-01A-12R	TCGA-FD-A3SS-01A-01-TSA		TCGA-FD-A3SS-01A-12	TCGA-FD-A3SS-01A	TCGA-FD-A3SS	7b98b829-fdc7-4719-bee9-c83f6154019c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	55	840.0	False	true	66492A0C-48DA-4C18-A4A8-905282DCE5DB	1.81	6aec2686-fcea-4d3e-8311-0b6ccad4c000			0.16	23	released	10a4a964-b045-4db4-bfd3-be0b22090f3a	RNA	R	0.16	UV Spec	released	False	637dc12b-4df7-4519-804a-2b9597b4e73f	12	5.0	0.0	0.0	0.0	0.0	30.0	70.0	70.0	TOP	564c9e0a-9519-4f80-894e-03c1a75a0e94	released												released	20.0	015e6b08-ab3c-4d1d-99e4-77b5e10bd7fc	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A3SS_demographic	66	-24408	391	268a0445-a726-5caa-b067-352867d5dacd	not hispanic or latino	male	white	released	Dead	1946		TCGA-FD-A3SS_exposure	Not Reported	29.06879615089044	1.643835616438356	91407386-91e7-5fa5-96fd-ba9639218995	173.0	30.0	released	87.0	TCGA-FD-A3SS_diagnosis	24408		MX	N3	Stage IV	T4	7th	not reported	0	60	08898645-96f7-58cc-9337-3775c592604e	C67.0	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Trigone of bladder	released	Not Reported	Trigone of bladder	not reported	stage iv	2012	TCGA-FD-A3SS_treatment_1	TCGA-FD-A3SS_treatment	released	f2e8b21c-debb-52b9-bfc9-73d2f1403e9a	yes	Pharmaceutical Therapy, NOS	released	ff771331-427e-5942-aaec-3a832b0845d4	no	Radiation Therapy, NOS	bfaf12cb-849a-499f-a4d8-5fa987b5b66d
86865850-1b95-41cc-a0ce-22b2bcaa1d22.htseq.counts.gz	8c17f57e-6790-4122-a75c-c510c0508db4	TCGA-DK-AA71-01A-31R-A39I-07	TCGA-DK-AA71-01A-31R	TCGA-DK-AA71-01A-03-TSC		TCGA-DK-AA71-01A-31	TCGA-DK-AA71-01A	TCGA-DK-AA71	22dbea93-3e1b-4e1b-ba40-55f08b99e73b	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	337	820.0	False	true	5C8A75F5-A08D-4CA9-A3D3-67F77C4A65EB	1.85	eb3cfcc9-657c-4527-ac58-948307cae54c			0.16	23	released	bf5bda9b-248b-4211-b8bd-0fc9f1f95407	RNA	R	0.16	UV Spec	released	False	aebc9f9e-bf1a-4a3d-80d0-6b0a014d0b06	31	3.0	1.0	0.0	5.0	0.0	25.0	75.0	75.0	TOP	61fba3e7-5dbe-4cbf-aa23-30ff1e036085	released												released	30.0	ac4bbd07-dd86-460a-870a-648b5dabda57	Primary Tumor	01	released	Not Reported	released	TCGA-DK-AA71_demographic	71	-25950		bf84eedf-b7cb-51de-b84a-a133d15e7913	not hispanic or latino	male	white	released	Alive	1942		TCGA-DK-AA71_exposure	Not Reported	22.98539751216874		a9a9a63c-dbba-5240-be8b-14cecbf3e984	172.0		released	68.0	TCGA-DK-AA71_diagnosis	25950		M0	N0	Stage II	T2b	7th	not reported	0	415	cf271197-c3ff-5439-9632-4e885a810973	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2013	TCGA-DK-AA71_treatment	TCGA-DK-AA71_treatment_1	released	2f5dba16-9f3e-5c14-8862-f1e17b58c857	no	Radiation Therapy, NOS	released	d996a550-c1a1-5288-9203-489d7e487db4	no	Pharmaceutical Therapy, NOS	8c17f57e-6790-4122-a75c-c510c0508db4
7d74dfd7-8884-42ae-8bf8-b39dfbc2bbae.htseq.counts.gz	a6ffc7ec-8dbc-489d-90d7-4b76ce7f06d4	TCGA-4Z-AA83-01A-11R-A39I-07	TCGA-4Z-AA83-01A-11R	TCGA-4Z-AA83-01A-01-TS1		TCGA-4Z-AA83-01A-11	TCGA-4Z-AA83-01A	TCGA-4Z-AA83	7976dbb0-57b0-463e-a766-126e23825743	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	1701	340.0	False	true	C177DD54-DBBB-44F1-9476-D5D1E543DE04	1.86	ede7cca5-c3f8-43e0-9354-b99821de60c0			0.16	23	released	4ff6306c-3525-4642-9c4d-14717cd4722d	RNA	R	0.16	UV Spec	released	False	df837366-1768-43d7-82b9-c416403b26a6	11	2.0	0.0	2.0	0.0	0.0	24.0	74.0	95.0	TOP	1c1ffc94-77e6-488c-893c-518282391d69	released												released	30.0	ffa67234-ec2a-4e86-a4d8-d35c5266d985	Primary Tumor	01	released	Not Reported	released	TCGA-4Z-AA83_demographic	52	-19280		4f6c5e6e-d85a-5341-94c7-b11da4ec37c0	not reported	male	white	released	Alive	1957		TCGA-4Z-AA83_exposure	Not Reported	30.159156738033385		66244231-0ea4-52a4-94d7-795360f20d16	183.0		released	101.0	TCGA-4Z-AA83_diagnosis	19280	T2	M0	N0	Stage II	T2a	7th	not reported	0	2024	f1f86db2-a2dd-5979-b91c-dcbf23159838	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2009	TCGA-4Z-AA83_treatment	TCGA-4Z-AA83_treatment_1	released	f1a00dcb-4646-5547-b5f9-fa19d2fb2146	no	Radiation Therapy, NOS	released	21e511ea-6776-5538-b8e8-5860789e4dc9	no	Pharmaceutical Therapy, NOS	a6ffc7ec-8dbc-489d-90d7-4b76ce7f06d4
9b383e44-11a8-463f-b3dc-a38e1d87e341.htseq.counts.gz	8a37a985-f6f6-45d6-99db-1ddc3c195cbc	TCGA-ZF-A9R4-01A-11R-A38B-07	TCGA-ZF-A9R4-01A-11R	TCGA-ZF-A9R4-01A-01-TS1		TCGA-ZF-A9R4-01A-11	TCGA-ZF-A9R4-01A	TCGA-ZF-A9R4	371b5d70-9797-4dae-b523-247f5eaeb4ab	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	588	40.0	False	true	8E623BA9-F937-4DFC-97F5-7B8E5FE8498B	1.84	530bf880-039e-490c-8a9d-a27bc9b3d918			0.16	23	released	b9a98228-637d-4d5e-abe7-95a58058746d	RNA	R	0.16	UV Spec	released	False	4b425354-b63c-4064-9c80-7dbcf2ea59b9	11	2.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	e0f7e03b-2c91-48ee-91b6-b088ec7b1f13	released												released	30.0	733b0ca7-7350-459c-b7c6-9d3c7745417c	Primary Tumor	01	released	Not Reported	released	TCGA-ZF-A9R4_demographic	83	-30398		1c94d7d0-6583-56e4-92fc-9ad9dfbe2488	not hispanic or latino	male	white	released	Alive	1929		TCGA-ZF-A9R4_exposure	Not Reported			fe6f506a-7ae5-52c6-92f9-fb66eb642da4			released		TCGA-ZF-A9R4_diagnosis	30398	T2	M0	NX	Stage II	T2	7th	not reported	0	921	668f21fa-d257-547f-ad24-de9bfa24febb	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2012	TCGA-ZF-A9R4_treatment_1	TCGA-ZF-A9R4_treatment	released	b94f6f71-9610-5653-bbac-36117100159c	no	Pharmaceutical Therapy, NOS	released	a3faae85-fa7e-575e-b50b-f3672ace8a58	no	Radiation Therapy, NOS	8a37a985-f6f6-45d6-99db-1ddc3c195cbc
dfcc3adf-acac-470d-a49d-3285de250c86.htseq.counts.gz	fe213ff9-8bc7-48e1-adbd-1288319d5ba2	TCGA-BT-A20P-01A-11R-A14Y-07	TCGA-BT-A20P-01A-11R	TCGA-BT-A20P-01A-01-TSA		TCGA-BT-A20P-01A-11	TCGA-BT-A20P-01A	TCGA-BT-A20P	f48937ed-e294-41f0-8872-7010391167a9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2270	220.0	False	true	C35A6F61-D5C4-4F8C-B82B-1349E6CDCA43	1.83	febead73-3b12-44e6-8bab-a7cfa7bf1129			0.16	23	released	068f2f9e-7e3a-4476-bf1b-dbb281ee126e	RNA	R	0.16	UV Spec	released	False	4efa9f2a-d025-4010-bb2b-354f760c4ad4	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	90.0	TOP	88edb313-0918-4fd7-9048-b38815e5e87a	released												released	30.0	6b43eeec-4feb-4062-827a-e63ed8ce3820	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20P_demographic	81	-29634	544	a5d0469a-5945-59f1-9605-a35bd6581480	not hispanic or latino	female	white	released	Dead	1924	2006	TCGA-BT-A20P_exposure	Not Reported			be7e20e6-4070-5a31-b524-3a7c7efdd2fd			released		TCGA-BT-A20P_diagnosis	29634	T3a	M0	N0	Stage III	T3a	6th	not reported	0		fd5abf15-15b7-5e02-98b2-b7341ea21b47	C67.0	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Trigone of bladder	released	No	Trigone of bladder	not reported	stage iii	2005	TCGA-BT-A20P_treatment_1	TCGA-BT-A20P_treatment	released	46d8f3ae-c793-5c7e-842e-e94d411e92d8	no	Pharmaceutical Therapy, NOS	released	07c70b2a-e4cd-56f1-bcc2-fbdf9d35a247	no	Radiation Therapy, NOS	fe213ff9-8bc7-48e1-adbd-1288319d5ba2
3af7d540-1401-43db-917f-277ff4da96d4.htseq.counts.gz	55cf9804-e8e1-4ad3-ba34-326eff5c21b4	TCGA-HQ-A2OE-01A-11R-A206-07	TCGA-HQ-A2OE-01A-11R	TCGA-HQ-A2OE-01A-01-TSA		TCGA-HQ-A2OE-01A-11	TCGA-HQ-A2OE-01A	TCGA-HQ-A2OE	353c5fcc-9c6a-4ac6-99dc-fb4573b2ae6c	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		170.0	False	false	FFCA27E4-3A1F-4626-AB67-2DE62CAD713F	1.77	eb210789-9eb4-4def-a83d-3f0254b3c6dd			0.16	23	released	8b9f9540-dfe1-4ed2-aa03-113b40232709	RNA	R	0.16	UV Spec	released	False	d1c9e991-26b1-480a-b60d-e2ea85e320a3	11	0.0	0.0	0.0	0.0	0.0	0.0	100.0	95.0	TOP	d6728c69-15f4-4510-b23f-5a34de59279e	released												released	30.0	65dbbe08-4645-4552-9a1a-e6f79a621013	Primary Tumor	01	released	Not Reported	released	TCGA-HQ-A2OE_demographic	69			d9a2c755-c9d3-5e0e-ab1a-ffdca9a99fce	not reported	male	not reported	released	Alive	1938		TCGA-HQ-A2OE_exposure	Not Reported	20.756387167668876		59daf23a-0ecc-50f0-9d23-cc05ecaf98a7	181.0		released	68.0	TCGA-HQ-A2OE_diagnosis			MX	N2		T2a	6th	not reported	0	1174	a14c89c7-3fa6-58f4-ab28-4d4348be777a	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	not reported	2007	TCGA-HQ-A2OE_treatment	TCGA-HQ-A2OE_treatment_1	released	1b48c1a9-9ffc-59ec-b109-8201313e0cb8	no	Radiation Therapy, NOS	released	cffc28ce-8bfa-5d50-83e9-d7d263204fa4	yes	Pharmaceutical Therapy, NOS	55cf9804-e8e1-4ad3-ba34-326eff5c21b4
48c1aaad-a891-46d7-ba38-1a042b66336f.htseq.counts.gz	938042ac-0f45-4bf6-adbd-ae9fa804402d	TCGA-GC-A3BM-11A-11R-A22U-07	TCGA-GC-A3BM-11A-11R	TCGA-GC-A3BM-11A-01-TSA		TCGA-GC-A3BM-11A-11	TCGA-GC-A3BM-11A	TCGA-GC-A3BM	7840aea9-40c4-473e-be33-8fa0b9f332c9	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	276	130	False	false		1.78	55f7869a-9583-4696-a281-b3c4ef4bd426	2.34	13	0.18	23	released	66b8d7dc-ee9f-4d3a-a4df-40cfcba65b84	RNA	R	0.18	UV Spec	released	False	70166f82-dbf5-47b0-ab3b-0801a4d45aea	11	0	0	0	0	100	0	0	0	TOP	c70af788-4fe5-497b-8ca7-4c210a093d31	released												released	30	bfba8167-6acc-47f8-b7aa-e9ab2b2f1005	Solid Tissue Normal	11	released	Not Reported	released	TCGA-GC-A3BM_demographic	70	-25609	651	d856cf7f-3e38-5370-b2d3-716dc3652816	not hispanic or latino	male	white	released	Dead	1940		TCGA-GC-A3BM_exposure	Not Reported	28.081632653061224	1.643835616438356	778627ac-4b18-5ae3-8a94-6eb04c691278	175.0	30.0	released	86.0	TCGA-GC-A3BM_diagnosis	25609		M0	N0	Stage II	T2b	7th	not reported	0	88	1c09a7b9-0a93-5a3f-84e9-8010c0e86378	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage ii	2010	TCGA-GC-A3BM_treatment_1	TCGA-GC-A3BM_treatment	released	05341ce8-ce75-5417-88cc-5297edc9cef5	no	Pharmaceutical Therapy, NOS	released	865035fd-cbe8-5af7-853c-07b9112cbdf5	yes	Radiation Therapy, NOS	938042ac-0f45-4bf6-adbd-ae9fa804402d
054759b1-f014-4a1c-a0c8-8f10298d56b6.htseq.counts.gz	11f6ee44-4a7e-4b54-a5a7-a29c5b0536eb	TCGA-R3-A69X-01A-22R-A30C-07	TCGA-R3-A69X-01A-22R	TCGA-R3-A69X-01A-02-TS2		TCGA-R3-A69X-01A-22	TCGA-R3-A69X-01A	TCGA-R3-A69X	692a6ced-0246-4e5e-ad2f-20450073f335	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	448	420.0	False	false	65FF34F8-65D4-4DC8-80D8-FED4DB244F4B	1.92	c394bf58-ce01-4ad3-a0f7-f2c5a251356d			0.16	23	released	69da212d-63ee-40ab-928c-51b00a1ac52d	RNA	R	0.16	UV Spec	released	False	2a7835ec-ceea-47f5-8b15-a301ce19a7d9	22	4.0	1.0	2.0	1.0	4.0	56.0	38.0	75.0	TOP	e8d6c71c-c3b1-4364-b65a-7e4c9cb1ebba	released												released	10.0	311ccb15-c5d3-4e70-850a-bdf75779238c	Primary Tumor	01	released	Not Reported	released	TCGA-R3-A69X_demographic	70	-25576		49339f4a-21f8-5195-80b0-242b2af1aa6e	not hispanic or latino	male	white	released	Alive	1942		TCGA-R3-A69X_exposure	Not Reported	14.958448753462603	2.6301369863013697	c0cd6665-b66c-532e-8926-8edbd1afc55c	190.0	48.0	released	54.0	TCGA-R3-A69X_diagnosis	25576	T3a	M0	N0	Stage III	T3a	7th	not reported	0	433	d83ca5c2-aa3d-5914-985e-e409c53ab8ce	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii	2012	TCGA-R3-A69X_treatment_1	TCGA-R3-A69X_treatment	released	42bb4fda-6798-5dde-8d17-016064b73030	no	Pharmaceutical Therapy, NOS	released	8c4313d8-6748-5304-8e58-9373bb8f20c1	no	Radiation Therapy, NOS	11f6ee44-4a7e-4b54-a5a7-a29c5b0536eb
748316bc-c1df-4dbf-b365-defbc050e9f9.htseq.counts.gz	911551da-540a-4ba6-a6bd-4015d2b961e6	TCGA-BT-A3PH-01A-11R-A220-07	TCGA-BT-A3PH-01A-11R	TCGA-BT-A3PH-01A-01-TSA		TCGA-BT-A3PH-01A-11	TCGA-BT-A3PH-01A	TCGA-BT-A3PH	932bcdd4-5145-49e8-9a95-8a546396f572	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	427	200.0	False	true	25DF244E-6548-4304-A720-4CC31BDCB305	1.94	b290727b-23ed-4e73-9071-cf2c06671430			0.16	23	released	21829783-5a96-49d8-ad3f-87268bdff8c3	RNA	R	0.16	UV Spec	released	False	275bc002-7f33-4136-b599-650118d9d127	11	1.0	1.0	1.0	1.0	0.0	9.0	90.0	90.0	TOP	173d1292-cc20-4ae2-844d-f9975c1a7b0b	released												released	30.0	33a83e54-3be5-4a68-8ab0-d31d0bcd3b67	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A3PH_demographic	76	-28030	142	ec7ca683-0725-5b21-ac1e-4543209b85d6	not hispanic or latino	male	white	released	Dead	1934	2010	TCGA-BT-A3PH_exposure	Not Reported			66830fe2-2c71-5d26-8011-d5b23f7f596c			released		TCGA-BT-A3PH_diagnosis	28030	T3b	MX	N2	Stage IV	T3b	7th	not reported	0		450bc236-a1d5-59b2-a632-0119ed9102bc	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-BT-A3PH_treatment_1	TCGA-BT-A3PH_treatment	released	e8d76e63-144b-5026-9f8e-9b880d3312d8	no	Pharmaceutical Therapy, NOS	released	b5f0b9b7-15a9-5f09-8505-a066e5000b8f	no	Radiation Therapy, NOS	911551da-540a-4ba6-a6bd-4015d2b961e6
c50f35ad-c7d6-4667-a5ea-a56b964ca77a.htseq.counts.gz	4bdb7067-aa57-40d1-b522-6596ad564bf6	TCGA-UY-A9PA-01A-11R-A38B-07	TCGA-UY-A9PA-01A-11R	TCGA-UY-A9PA-01A-01-TS1		TCGA-UY-A9PA-01A-11	TCGA-UY-A9PA-01A	TCGA-UY-A9PA	45f5af14-060a-49a3-b51d-25ab8a88feb7	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		50.0	False	true	73CA1D6C-0158-4324-9D82-4442254EF8A4	1.86	c2a2d7ab-c8d6-4481-9e91-1f16969e8105			0.16	23	released	9e649a38-e3ba-4f0c-972a-a33bc9a7fd1a	RNA	R	0.16	UV Spec	released	False	9b03a254-afd1-4e9b-866e-4c9abe114040	11	2.0	1.0	0.0	3.0	3.0	17.0	80.0	80.0	TOP	ce3d2d3b-040d-4885-96a4-5a9c59f79d95	released												released	20.0	64a966f2-6bab-4b17-a377-2eb3b1a1124d	Primary Tumor	01	released	Not Reported	released	TCGA-UY-A9PA_demographic	48	-17520		5fa5fc08-ac18-5334-abc2-854d1978972d	not hispanic or latino	male	white	released	Alive			TCGA-UY-A9PA_exposure	Not Reported	24.489795918367346		48ab9147-ddd2-5fe2-9a1c-f6d354e6be2f	175.0		released	75.0	TCGA-UY-A9PA_diagnosis	17520		MX	N0	Stage III	T3a	6th	not reported	0	1072	541e7785-2051-5073-8b7c-650e2231f678	C67.2	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Lateral wall of bladder	released	No	Lateral wall of bladder	not reported	stage iii		TCGA-UY-A9PA_treatment_1	TCGA-UY-A9PA_treatment	released	c83c5584-d69e-5900-8e29-c9aff82ee092	no	Pharmaceutical Therapy, NOS	released	b5aa6710-bddf-506f-af03-e54ae56aca53	no	Radiation Therapy, NOS	4bdb7067-aa57-40d1-b522-6596ad564bf6
eff731a9-5955-42ed-8d2d-3981feabe59d.htseq.counts.gz	96ee0893-21d0-439f-af4a-9f40102483d6	TCGA-BL-A13J-01B-04R-A277-07	TCGA-BL-A13J-01B-04R	TCGA-BL-A13J-01B-04-BS4	TCGA-BL-A13J-01B-03-BS3	TCGA-BL-A13J-01B-04	TCGA-BL-A13J-01B	TCGA-BL-A13J	556fcbc8-172a-4af1-8822-ae036e8d68e8	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	622		True	false	3ABF8C6B-606C-41A9-B050-E115834A7616	1.88	cd889d58-7d2f-4c0a-8252-de3c6f056333			0.17	23	released	ec3dc318-0c0a-4ff4-9a45-fbe47bac546a	RNA	R	0.17	UV Spec	released	True	c5a66d5e-2a67-43a7-8218-b97b2a7ad5ff	04	0.0	0.0	0.0	0.0	15.0	5.0	80.0	80.0	BOTTOM	1061ba91-692b-4183-b473-99236fa21899	released	0.0	0.0	0.0	0.0	15.0	5.0	80.0	80.0	TOP	e5df36d1-f2de-426c-886d-5ad847929eb3	released	released	400.0	a696305c-e8c6-40d3-aa4c-1738d0987885	Primary Tumor	01	released	Not Reported	released	TCGA-BL-A13J_demographic	65	-23927	81	3a19ccff-885d-524c-85e5-a2606dace97c	not hispanic or latino	male	white	released	Dead	1945	2010	TCGA-BL-A13J_exposure	Not Reported	22.98539751216874	1.3150684931506849	bbd00b5a-a20a-5205-b773-ac6250abbc20	172.0	24.0	released	68.0	TCGA-BL-A13J_diagnosis	23927		M0	N2	Stage IV	T4		not reported	0		48d48f46-0677-517c-b11e-8c7e100a85b2	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iv	2010	TCGA-BL-A13J_treatment	TCGA-BL-A13J_treatment_1	released	691d6cde-1889-5398-be89-5d0b9c88851b	no	Radiation Therapy, NOS	released	04e5320c-e9af-52f4-af45-77a50901166e	no	Pharmaceutical Therapy, NOS	96ee0893-21d0-439f-af4a-9f40102483d6
c68e4fc6-a690-4667-9335-af2eb563a8b5.htseq.counts.gz	32aca9fc-3fe8-47a4-aac4-07f3166c83c5	TCGA-CF-A3MI-01A-11R-A20F-07	TCGA-CF-A3MI-01A-11R	TCGA-CF-A3MI-01A-01-TSA		TCGA-CF-A3MI-01A-11	TCGA-CF-A3MI-01A	TCGA-CF-A3MI	f1ebf96b-8df9-4e59-acef-7ad433e40214	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	57	500.0	False	true	F492F839-CD0D-43EC-9037-247EAE5B796C	1.83	63fcdb32-0c58-4541-afbc-96b34020c5c8			0.17	23	released	f3f7a3fc-4aad-488c-8093-e253ba9882f5	RNA	R	0.17	UV Spec	released	False	761ea8c0-5b78-40cf-b32f-e9e0af8583c8	11	2.0	1.0	0.0	1.0	0.0	10.0	90.0	90.0	TOP	03a02f78-ad8b-48cc-be2f-4f7bd85e7f8e	released												released	30.0	a373568a-bbd3-4d67-92d6-96e8378065cf	Primary Tumor	01	released	Not Reported	released	TCGA-CF-A3MI_demographic	62	-22716		dc33bb46-a036-5fcb-a094-f1d43467b683	not hispanic or latino	male	asian	released	Alive	1949		TCGA-CF-A3MI_exposure	Not Reported	24.21875	2.191780821917808	32a7789f-2b49-5934-ae11-c4d384b30ed9	160.0	40.0	released	62.0	TCGA-CF-A3MI_diagnosis	22716		M0	N0	Stage II	T2	7th	not reported	0	370	207b91c1-cfc8-5964-b159-f5e7dda65af2	C67.9	not reported	8130/3	Papillary transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage ii	2011	TCGA-CF-A3MI_treatment	TCGA-CF-A3MI_treatment_1	released	60eb015a-e66f-504a-b56b-67c7006aea18	no	Radiation Therapy, NOS	released	995ffbc2-3049-5436-87be-0abbf5803b10	no	Pharmaceutical Therapy, NOS	32aca9fc-3fe8-47a4-aac4-07f3166c83c5
5b39b3d7-2aa0-4dc8-b814-53e42fcc86fb.htseq.counts.gz	1876f5fa-3e0e-4780-9f01-93e40083cb18	TCGA-XF-AAMW-01A-11R-A42T-07	TCGA-XF-AAMW-01A-11R	TCGA-XF-AAMW-01A-01-TSA		TCGA-XF-AAMW-01A-11	TCGA-XF-AAMW-01A	TCGA-XF-AAMW	19da59a8-b67a-438d-900a-92a71e03bef3	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	2682	640.0	False	true	F763F16E-C76C-4A58-9096-8B19B9825C9B	1.9	74bb1ce2-532c-4667-9650-765e25c26724			0.17	23	released	df40ca29-1756-4e65-b504-af19fcaf35aa	RNA	R	0.17	UV Spec	released	False	f834b9b3-3d97-4d4d-bfdf-c0e21ca162c7	11	30.0	70.0	0.0	0.0	10.0	30.0	60.0	70.0	TOP	f8c4cd68-92fb-4873-8e31-ed6a7c1990a8	released												released	30.0	10fe7dbb-4bf4-486e-ada4-bd311aa967c2	Primary Tumor	01	released	Not Reported	released	TCGA-XF-AAMW_demographic	79	-28903	253	d15c61fe-f016-5634-b194-1a246527e09a	not hispanic or latino	female	white	released	Dead	1927	2006	TCGA-XF-AAMW_exposure	Not Reported	25.236340330075308		3063cf36-bced-5976-8fbe-2f0de6d88c1e	158.0		released	63.0	TCGA-XF-AAMW_diagnosis	28903			N0	Stage IV	T2b	5th	not reported	0		f65f876b-8569-52be-8b8c-832c8142f064	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2006	TCGA-XF-AAMW_treatment_1	TCGA-XF-AAMW_treatment	released	838bb2bd-d6cb-58ca-870f-2b8d2b5ffde2	no	Pharmaceutical Therapy, NOS	released	4d06447b-5de3-5691-b640-af255ccf338c	no	Radiation Therapy, NOS	1876f5fa-3e0e-4780-9f01-93e40083cb18
93880534-eea3-4dde-831c-ebb30be61b32.htseq.counts.gz	afd1fdfd-75ee-4b5d-9782-ef24b46ddf47	TCGA-H4-A2HQ-01A-11R-A180-07	TCGA-H4-A2HQ-01A-11R	TCGA-H4-A2HQ-01A-01-TSA		TCGA-H4-A2HQ-01A-11	TCGA-H4-A2HQ-01A	TCGA-H4-A2HQ	cede5274-279d-4021-8aca-5ecc4bf94d66	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	200	120.0	False	false	87991E38-AE15-4163-BC44-6AEA8105A203	1.98	2c681223-21a5-4c58-acbb-2d51516bff12			0.16	23	released	1b5f00ef-6e94-4c70-af9d-9cf77a3a6049	RNA	R	0.16	UV Spec	released	False	f5b53c2d-2de7-491c-a555-b04db636a0f3	11	3.0	1.0	7.0	1.0	0.0	18.0	75.0	75.0	TOP	987a6962-4d0a-441b-8372-b139a6b50b37	released												released	30.0	cbedc0db-39fd-4661-9531-cc24d422fac4	Primary Tumor	01	released	Not Reported	released	TCGA-H4-A2HQ_demographic	64	-23538		3569a0d2-bdd0-5937-b5c7-f5f7762d87ff	not hispanic or latino	female	black or african american	released	Alive	1946		TCGA-H4-A2HQ_exposure	Not Reported	22.862534475250396	0.3835616438356164	29cf8fed-de68-5d1c-9f9b-3c67cf31dcba	166.0	7.0	released	63.0	TCGA-H4-A2HQ_diagnosis	23538	T2b	M1	NX	Stage IV		7th	not reported	0	590	d2141291-3a61-5ce6-bff5-0f503c784b75	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv	2010	TCGA-H4-A2HQ_treatment_1	TCGA-H4-A2HQ_treatment	released	abc3aa11-2dc1-516d-a1c9-b8b1e1fae380	yes	Pharmaceutical Therapy, NOS	released	1b1eeed1-d89c-5f3b-8453-acebfed130b1	no	Radiation Therapy, NOS	afd1fdfd-75ee-4b5d-9782-ef24b46ddf47
3025ad45-1d29-4c05-b90f-3d4a348c82c6.htseq.counts.gz	e322b0e5-458a-4cbf-a64f-9b348e413939	TCGA-HQ-A5ND-01A-11R-A26T-07	TCGA-HQ-A5ND-01A-11R	TCGA-HQ-A5ND-01A-01-TS1		TCGA-HQ-A5ND-01A-11	TCGA-HQ-A5ND-01A	TCGA-HQ-A5ND	001944e5-af34-4061-9c09-bb9ea346f6fd	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA		560.0	False	false	90EBB6AD-C8DC-44FE-AE88-674F15041327	1.89	a56ef438-c2ac-4c6f-9283-59e38ba14f28			0.16	23	released	59a95970-c1ed-4c18-96aa-b31efb429a7f	RNA	R	0.16	UV Spec	released	False	42b4e9da-2f11-49ed-b170-f767f69df187	11	7.0	2.0	4.0	2.0	0.0	45.0	51.0	80.0	TOP	1e40416d-66d0-41e9-8c24-26234d5d8325	released												released	30.0	8fef5013-4e57-4043-8770-a56135aeac9b	Primary Tumor	01	released	Not Reported	released	TCGA-HQ-A5ND_demographic	78	-28555	274	fc3f5550-48dc-5854-9106-53eac54bb5f7	not reported	male	not reported	released	Dead			TCGA-HQ-A5ND_exposure	Not Reported	23.52941176470588	2.191780821917808	64499e21-c583-5247-8603-0163048d0492	170.0	40.0	released	68.0	TCGA-HQ-A5ND_diagnosis	28555		M0	N1	Stage IV	T3b	6th	not reported	0		e12e0826-637e-5f14-9e42-2e3bcd06ffb1	C67.9	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Bladder, NOS	released	No	Bladder, NOS	not reported	stage iv		TCGA-HQ-A5ND_treatment_1	TCGA-HQ-A5ND_treatment	released	83136421-54d5-5b88-bfe7-73f3f08e6719	no	Pharmaceutical Therapy, NOS	released	f516cc0b-6cc3-5b34-8347-631fbbd5a265	yes	Radiation Therapy, NOS	e322b0e5-458a-4cbf-a64f-9b348e413939
3a2e1ad4-3e9f-4cf5-99ef-007c33a53b48.htseq.counts.gz	90cd9fe4-6d68-4a2e-9b8e-7c041809ce98	TCGA-K4-A6FZ-01A-11R-A31N-07	TCGA-K4-A6FZ-01A-11R	TCGA-K4-A6FZ-01A-01-TS1		TCGA-K4-A6FZ-01A-11	TCGA-K4-A6FZ-01A	TCGA-K4-A6FZ	610811d5-e45e-4a4f-bdc1-8d700efd6e43	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	154	150.0	False	true	16FB3E38-2BB2-4DE2-8DCF-AF6C9225DFC4	1.89	f873fe6d-9733-48a9-b7e0-23dc50874fbc			0.18	23	released	45e83ad4-97d9-4c9c-b61b-dfff5350788d	RNA	R	0.18	UV Spec	released	False	9cd48ea7-6dac-44c7-8cc4-40b5147cae02	11	0.0	0.0	0.0	0.0	15.0	5.0	80.0	70.0	TOP	fe0c96a8-caff-4e01-b4d1-a7cecbe53348	released												released	30.0	81dcb3af-128a-4934-8781-cc60310b258f	Primary Tumor	01	released	Not Reported	released	TCGA-K4-A6FZ_demographic	75	-27686		09c58faa-5bba-5678-b58f-e6ef5680a441	not hispanic or latino	female	white	released	Alive	1937		TCGA-K4-A6FZ_exposure	Not Reported	25.61728395061728		fa91b306-d22e-5a5d-94c2-20814c5b8fa1	180.0		released	83.0	TCGA-K4-A6FZ_diagnosis	27686		MX	N0	Stage III	T3a	7th	not reported	0	55	46550dff-48aa-572d-bbbc-bd800cd84b20	C67.4	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Posterior wall of bladder	released	No	Posterior wall of bladder	not reported	stage iii	2012	TCGA-K4-A6FZ_treatment_1	TCGA-K4-A6FZ_treatment	released	0173d730-75fb-5602-a30d-6f67cedf3b9f	no	Pharmaceutical Therapy, NOS	released	35ba9fb4-977e-53b0-9808-2240b14820c0	no	Radiation Therapy, NOS	90cd9fe4-6d68-4a2e-9b8e-7c041809ce98
8bdf08d2-3506-4e2d-bcec-629f6dd0b82c.htseq.counts.gz	747a8fb9-7c1c-47a0-871e-3065c1d986e6	TCGA-DK-A3IV-01A-22R-A21D-07	TCGA-DK-A3IV-01A-22R	TCGA-DK-A3IV-01A-02-TSB		TCGA-DK-A3IV-01A-22	TCGA-DK-A3IV-01A	TCGA-DK-A3IV	f953dc5d-58bf-4936-b9fe-74b45e8c00e5	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	226	120.0	False	true	258903DE-CB30-4577-9571-C470256E21C6	1.76	70c7f658-5208-4b3f-9767-27a3b06b8ddc			0.15	23	released	62c7ca75-d7dc-404b-8426-c3928aa4de8a	RNA	R	0.15	UV Spec	released	False	3a5fc750-1f6c-4352-addc-d4cc556f910c	22	0.0	0.0	0.0	0.0	0.0	20.0	80.0	90.0	TOP	98178db6-2038-4adf-9227-e76aa71b1361	released												released	20.0	bc065247-1179-4fc2-b45c-8efb13aade65	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A3IV_demographic	60	-22237	294	58230c45-9269-507a-96e4-eaccf3253dce	not hispanic or latino	male	white	released	Dead	1951	2011	TCGA-DK-A3IV_exposure	Not Reported	28.86695511087074	4.383561643835616	9ad3cade-2f97-55cc-8d32-a444251cf7a0	172.0	80.0	released	85.4	TCGA-DK-A3IV_diagnosis	22237	T2	M0	NX	Stage II		6th	not reported	0		a5f19dfa-c7ad-5749-8579-98bf087e3af1	C67.2	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2011	TCGA-DK-A3IV_treatment	TCGA-DK-A3IV_treatment_1	released	f3b189d6-e291-59a2-8c08-4ad6188578bf	no	Radiation Therapy, NOS	released	2dc2ead0-ef91-54da-8015-d105ef17f47d	no	Pharmaceutical Therapy, NOS	747a8fb9-7c1c-47a0-871e-3065c1d986e6
19f094bc-108c-46d0-bc32-0c9e10681272.htseq.counts.gz	6d03f7c8-d6f1-4b78-86ca-d7946a89a867	TCGA-BT-A20X-01A-11R-A16R-07	TCGA-BT-A20X-01A-11R	TCGA-BT-A20X-01A-01-TSA		TCGA-BT-A20X-01A-11	TCGA-BT-A20X-01A	TCGA-BT-A20X	be8b3f36-aaa1-4302-b28e-de1996faceaf	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	555	390.0	False	true	60D4B255-2F73-4F45-83D5-68B8CC422D1C	1.82	b3797921-4b9a-43c4-8904-6fb80fc80c08			0.16	23	released	cf79d0ba-2355-43bc-a9e0-8d0373004c50	RNA	R	0.16	UV Spec	released	False	3e15e4a0-3e91-4d17-95fa-3f8967ca35d3	11	0.0	0.0	20.0	0.0	0.0	10.0	70.0	80.0	TOP	d5591b6a-d55a-4c60-a153-4210ebb2f362	released												released	30.0	4d7d3354-6588-4e02-9354-ab5044ba1ab3	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A20X_demographic	56	-20519	251	0115f05c-00e2-5e7a-8b88-b6e3d6742d25	not hispanic or latino	male	white	released	Dead	1953	2009	TCGA-BT-A20X_exposure	Not Reported			4af326e4-1834-560a-9071-a03bde65e302			released		TCGA-BT-A20X_diagnosis	20519	T4a	M0	N2	Stage IV	T4a	6th	not reported	0		521ebb65-4b20-537a-b063-ab709e82ca6a	C67.1	not reported	8120/3	Transitional cell carcinoma	no	No	not reported	Dome of bladder	released	No	Dome of bladder	not reported	stage iv	2009	TCGA-BT-A20X_treatment	TCGA-BT-A20X_treatment_1	released	457f1562-11b5-561b-9d54-a582a16ae670	no	Radiation Therapy, NOS	released	8cd42817-c98f-57dc-8fa3-ff22c455159e	no	Pharmaceutical Therapy, NOS	6d03f7c8-d6f1-4b78-86ca-d7946a89a867
8d798acc-b2fe-4e02-85e1-7b8ba1ba9ed2.htseq.counts.gz	d584402e-37ec-40ac-8038-0dec44a5da70	TCGA-DK-A1A5-01A-11R-A13Y-07	TCGA-DK-A1A5-01A-11R	TCGA-DK-A1A5-01A-01-TSA		TCGA-DK-A1A5-01A-11	TCGA-DK-A1A5-01A	TCGA-DK-A1A5	904a8757-e0c5-41ef-b583-c8f170caaac1	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	120	210	False	true	07970DA4-6136-48BA-BCA4-3ACC8C3DC1E9	1.83	5e7e3e20-cbfa-476d-bb92-fa3a58207a9b	4.54	26.7	0.17	23	released	51e24e2b-b3e3-4e4a-a55d-2a04958a409d	RNA	R	0.17	UV Spec	released	False	98175d97-c00b-42d3-a049-3e92de0e89da	11	5	0	0	0	0	30	70	70	TOP	566f48a1-36f9-4932-ad84-7b576a0442ab	released												released	30	a9ef3ec5-b1c1-481f-89cf-1729fab50173	Primary Tumor	01	released	Not Reported	released	TCGA-DK-A1A5_demographic	79	-29111	65	a3ccf12f-593c-551c-aa3c-dda56ae9aa62	not hispanic or latino	male	white	released	Dead	1931	2010	TCGA-DK-A1A5_exposure	Not Reported	22.038567493112946	1.095890410958904	2bde2dee-ddc4-505b-8eb0-07155f6eab04	165.0	20.0	released	60.0	TCGA-DK-A1A5_diagnosis	29111		M0	N0	Stage II	T2b	6th	not reported	0		88a9081e-d803-500f-962d-77c0e440907c	C67.9	not reported	8120/3	Transitional cell carcinoma	yes	No	not reported	Bladder, NOS	released	Not Reported	Bladder, NOS	not reported	stage ii	2010	TCGA-DK-A1A5_treatment	TCGA-DK-A1A5_treatment_1	released	4ab4db07-3016-5383-bd59-a2059cde6d57	no	Radiation Therapy, NOS	released	804f5f1a-6311-5a7a-a457-7ab48d1db796	no	Pharmaceutical Therapy, NOS	d584402e-37ec-40ac-8038-0dec44a5da70
28d7daba-c3bb-4bfa-ab8d-cda43cb1c22c.htseq.counts.gz	2ea8cbe7-506a-4d82-b945-2059d48b6f44	TCGA-FD-A43X-01A-11R-A23W-07	TCGA-FD-A43X-01A-11R	TCGA-FD-A43X-01A-01-TSA		TCGA-FD-A43X-01A-11	TCGA-FD-A43X-01A	TCGA-FD-A43X	4ff4d9fe-eab8-4ab3-9ae4-9f15b2581a8f	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	26	1000.0	False	true	1DE6AC6C-BA81-4CB1-8595-21D6E9033C7F	1.86	f68894de-6db1-472b-bbda-f1c6e60a818b			0.16	23	released	7ffe49af-a55a-46ee-9f3d-ae0e695ed1f3	RNA	R	0.16	UV Spec	released	False	3f959db6-b155-4706-9283-bd1ee6bfb31a	11	1.0	0.0	0.0	0.0	0.0	0.0	100.0	80.0	TOP	31ffb974-c223-4fcb-ab5d-423f0ceaff0f	released												released	30.0	88c99351-f64d-4310-bc80-44c4399da91e	Primary Tumor	01	released	Not Reported	released	TCGA-FD-A43X_demographic	84	-30764		778d714b-52cd-5533-8190-8c8bedb03856	not hispanic or latino	male	white	released	Alive	1928		TCGA-FD-A43X_exposure	Not Reported	24.242424242424242	3.287671232876712	580dff05-837c-5dac-bf93-c65461474c8e	165.0	60.0	released	66.0	TCGA-FD-A43X_diagnosis	30764	T1	MX	N0	Stage II	T2a	7th	not reported	0	110	8f9cf785-c249-5fda-b3c7-d02646910ce0	C67.4	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Posterior wall of bladder	released	Not Reported	Posterior wall of bladder	not reported	stage ii	2012	TCGA-FD-A43X_treatment_1	TCGA-FD-A43X_treatment	released	41c87f14-c558-5240-8230-272c5abc86d5	no	Pharmaceutical Therapy, NOS	released	ca7a2220-3f05-5c90-8943-560ad4565df7	no	Radiation Therapy, NOS	2ea8cbe7-506a-4d82-b945-2059d48b6f44
63eee5ed-417c-41cb-bdcf-7635b42e2246.htseq.counts.gz	388c9cba-f20d-4233-8a96-bb4b95924786	TCGA-BT-A42C-01A-11R-A23N-07	TCGA-BT-A42C-01A-11R	TCGA-BT-A42C-01A-01-TSA		TCGA-BT-A42C-01A-11	TCGA-BT-A42C-01A	TCGA-BT-A42C	b9808ef9-e917-45f9-9e0f-b86f7834b5ff	Transitional Cell Papillomas and Carcinomas	Bladder	TCGA-BLCA	274	190.0	False	true	8716FEB2-A4DD-4EFF-B1A6-D679A5C75C76	1.81	f6b30464-1e34-4b52-baff-544f5fc8f52f			0.15	23	released	1bf016c7-0c52-4159-bb48-d7b8742021a5	RNA	R	0.15	UV Spec	released	False	2996e855-c4b4-459d-b066-d136409a7531	11	1.0	0.0	2.0	0.0	0.0	28.0	70.0	92.0	TOP	2fee5057-2b0f-4be6-a8fe-ab03819088d0	released												released	30.0	384aea4d-d779-49d2-aa44-9945ab702fa2	Primary Tumor	01	released	Not Reported	released	TCGA-BT-A42C_demographic	64	-23584		f554fae6-d482-5d4e-a6fe-78557afe08fc	not hispanic or latino	male	white	released	Alive	1947		TCGA-BT-A42C_exposure	Not Reported	25.536703601108034	7.232876712328767	04e82333-c934-5a77-a60b-536c6608823b	152.0	132.0	released	59.0	TCGA-BT-A42C_diagnosis	23584	T2a	M0	N0	Stage II		7th	not reported	0	873	43176966-46f4-5f0d-b2c1-3237ddf22b90	C67.2	not reported	8130/3	Papillary transitional cell carcinoma	yes	No	not reported	Lateral wall of bladder	released	Not Reported	Lateral wall of bladder	not reported	stage ii	2011	TCGA-BT-A42C_treatment	TCGA-BT-A42C_treatment_1	released	89f05166-e8a1-5126-8828-6adc03f1320c	no	Radiation Therapy, NOS	released	3b787f49-053b-5b40-b8cf-3c379e6d755a	no	Pharmaceutical Therapy, NOS	388c9cba-f20d-4233-8a96-bb4b95924786